<SEC-DOCUMENT>0001104659-24-126297.txt : 20241206
<SEC-HEADER>0001104659-24-126297.hdr.sgml : 20241206
<ACCEPTANCE-DATETIME>20241206160736
ACCESSION NUMBER:		0001104659-24-126297
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20241206
DATE AS OF CHANGE:		20241206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eagle Point Credit Co Inc.
		CENTRAL INDEX KEY:			0001604174
		ORGANIZATION NAME:           	
		IRS NUMBER:				465215217
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269139
		FILM NUMBER:		241532330

	BUSINESS ADDRESS:	
		STREET 1:		600 STEAMBOAT RD, SUITE 202
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		203.862.3150

	MAIL ADDRESS:	
		STREET 1:		600 STEAMBOAT RD, SUITE 202
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eagle Point Credit Co LLC
		DATE OF NAME CHANGE:	20140331
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>tm2429841d6_424b2.htm
<DESCRIPTION>424B2
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--INTEGIX by Ez-XBRL-->
<!-- Assembled by CompSci Transform  (tm) - http://www.compsciresources.com - version 1.2 -->
<!-- Created: Fri Dec 06 16:10:01 UTC 2024 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:ck0001604174="http://www.eaglepointcreditcompany.com/20241204" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Eagle Point Credit Co Inc - 1604174 - 2024</title></head><body><!-- BannerFile="tm2429841d6_inlinepackage.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2429841-6/tm2429841-6_424b2seq1" -->        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" contextRef="C_20241204to20241204" id="Fxbrl_20241203040648920">424B2</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20241204to20241204" id="F20241202224021923_0">0001604174</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20241204to20241204" id="F20241202224021923_1">false</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="ck0001604174-20241204.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20241204to20241204"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes66875Due2028Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes66875Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-09-30</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes5375Due2029Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes5375Due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-09-30</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes675Due2031Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes675Due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-09-30</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes775Due2030Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes775Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-09-30</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174NoActiveMarketMayDevelopFor2030NotesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:NoActiveMarketMayDevelopFor2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174CreditRatingDowngradeMayImpactLiquidityAndValueMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:CreditRatingDowngradeMayImpactLiquidityAndValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174IndentureOffersLimitedProtectionForHoldersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:IndentureOffersLimitedProtectionForHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174OptionalRedemptionMayNegativelyAffectReturnsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:OptionalRedemptionMayNegativelyAffectReturnsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_cefRiskAxis_ck0001604174DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20241204to20241204_usgaapDebtInstrumentAxis_ck0001604174Notes2030Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001604174</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:Notes2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2024-12-04</xbrli:startDate>
        <xbrli:endDate>2024-12-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
</ix:resources></ix:header></div><div>
  <div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><span style="font-family:Times New Roman,Times,serif"><strong>Filed pursuant to Rule&#160;<span style="-sec-ix-hidden:Fxbrl_20241203040648920">424(b)(2)</span><br/>1933 Act File No.&#160;333-269139</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman,Times,serif"><strong>PROSPECTUS SUPPLEMENT<br/>(to Prospectus dated June&#160;9, 2023)</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>$100,000,000</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonNumeric id="Fxbrl_20241203040714240" name="dei:EntityRegistrantName" contextRef="C_20241204to20241204">EAGLE POINT CREDIT COMPANY INC.</ix:nonNumeric></strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>7.75% Notes due 2030</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">We are an externally managed, non-diversified closed-end management investment company that has registered as an investment company under the Investment Company Act of 1940, as amended, or the &#8220;1940 Act.&#8221; Our primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. We seek to achieve our investment objectives by investing primarily in equity and junior debt tranches of collateralized loan obligations, or &#8220;CLOs,&#8221; that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. We may also invest in other related securities and instruments or other securities and instruments that our investment adviser believes are consistent with our investment objectives, including senior debt tranches of CLOs, loan accumulation facilities, or &#8220;LAFs,&#8221; and securities issued by other securitization vehicles, such as credit-linked notes and collateralized bond obligations, or &#8220;CBOs,&#8221; and synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions. LAFs are short- to medium-term facilities often provided by the bank that will serve as the placement agent or arranger on a CLO transaction. LAFs typically incur leverage between four and six times prior to a CLO&#8217;s pricing. The CLO securities in which we primarily seek to invest are unrated or rated below investment grade and are considered speculative with respect to timely payment of interest and repayment of principal. Unrated and below investment grade securities are also sometimes referred to as &#8220;junk&#8221; securities. In addition, the CLO equity and junior debt securities in which we invest are highly leveraged (with CLO equity securities typically being leveraged approximately ten times), which magnifies our risk of loss on such investments. See &#8220;<strong><i>Risk Factors &#8211; Risks Related to Our Investments &#8211; We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us</i></strong>&#8221; in the accompanying prospectus.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">Eagle Point Credit Management LLC, or the &#8220;Adviser,&#8221; our investment adviser, manages our investments subject to the supervision of our board of directors (the &#8220;Board of Directors&#8221;). As of September&#160;30, 2024, the Adviser, collectively with certain affiliates, had over $10&#160;billion in total assets under management, including capital commitments that were undrawn as of such date. Eagle Point Administration LLC, an affiliate of the Adviser, or the &#8220;Administrator,&#8221; serves as our administrator.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">We are offering $100,000,000 aggregate principal amount of 7.75% notes due 2030, or the &#8220;2030 Notes.&#8221;</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">The 2030 Notes will mature on June 30, 2030 and 100% of the aggregate principal amount will be paid at maturity. The 2030 Notes will be issued in minimum denominations of $25 and integral multiples of $25 in excess thereof. We will pay interest on the 2030 Notes offered by this prospectus supplement on March&#160;31, June&#160;30, September&#160;30 and December&#160;31 of each year, or the next business day thereafter, beginning on March 31, 2025. We may redeem the 2030 Notes in whole or in part at any time or from time to time on or after June 30, 2027, at our sole option, at the redemption price set forth under the caption&#160;<strong><i>&#8220;Description of the Notes&#8201;&#8212;&#8201;Optional Redemption&#8221;</i></strong>&#160;in this prospectus supplement. Holders of the 2030 Notes will not have the option to have the 2030 Notes repaid prior to June 30, 2030.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">The 2030 Notes are our direct unsecured obligations and will rank equal in right of payment with our existing unsecured indebtedness, including our 6.6875% notes due 2028 (the &#8220;2028 Notes&#8221;), our 5.375% Notes due 2029 (the &#8220;2029 Notes&#8221;) and our 6.75% notes due 2031 (the &#8220;2031 Notes&#8221; and, together with the 2028 Notes and 2029 Notes, the &#8220;Existing Notes&#8221;), and any other unsecured indebtedness that we may incur in the future. The 2030 Notes are effectively subordinated, or junior in right of payment, to any future secured indebtedness that we may incur and structurally subordinated to all future indebtedness and other obligations of our subsidiaries. We intend to list the 2030 Notes on the New York Stock Exchange, or the &#8220;NYSE,&#8221; under the symbol &#8220;ECCU,&#8221; and we expect trading in the 2030 Notes on the NYSE to begin within 30&#160;days of the original issue date. The 2030 Notes are expected to trade &#8220;flat.&#8221; This means that purchasers will not pay, and sellers will not receive, any accrued and unpaid interest on the 2030 Notes that is not reflected in the trading price. Currently, there is no public market for the 2030 Notes.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif"><strong>Investing in the 2030 Notes involves a high degree of risk, including the risk of a substantial loss of investment. Before purchasing any 2030 Notes, you should read the discussion of the principal risks of investing in the 2030 Notes, which are summarized in&#160;<i>&#8220;Risk Factors&#8221;</i>&#160;beginning on page&#160;S-10 of this prospectus supplement and page&#160;13 of the accompanying prospectus.</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">This prospectus supplement, the accompanying prospectus, any free writing prospectus, and the documents incorporated by reference in this prospectus supplement and the accompanying prospectus contain important information you should know before investing in the 2030 Notes. Please read these documents before you invest and retain them for future reference. We file annual and semi-annual stockholder reports, proxy statements and other information with the U.S. Securities and Exchange Commission, or the &#8220;SEC.&#8221; To obtain this information free of charge or make other inquiries pertaining to us, please visit our website (<i>www.eaglepointcreditcompany.com</i>) or call (844) 810-6501 (toll-free). You may also obtain a copy of any information regarding us filed with the SEC from the SEC&#8217;s website (<i>www.sec.gov</i>). Information on our website is not incorporated by reference into or part of this prospectus supplement or the accompanying prospectus. See &#8220;Additional Information&#8221; on page&#160;S-35 of this prospectus supplement.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif"><strong>Neither the SEC nor any state securities commission, nor any other regulatory body, has approved or disapproved of these securities or determined that this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

        <tr style="vertical-align:bottom">
          <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
          <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
          <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman,Times,serif">Per 2030<br/>Note</span></td>
          <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
          <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
          <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Total<sup>(1)</sup></strong></span></span></td>
          <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="width:72%;font:10pt Times New Roman, Times, Serif"><span style="font-family:Times New Roman,Times,serif">Public offering price</span></td>
          <td style="width:2%;font-size:10pt">&#160;</td>
          <td style="width:1%;font-size:10pt;text-align:left"><span style="font-family:Times New Roman,Times,serif">$</span></td>
          <td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman,Times,serif">25.00</span></td>
          <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
          <td style="width:2%;font-size:10pt">&#160;</td>
          <td style="width:1%;font-size:10pt;text-align:left"><span style="font-family:Times New Roman,Times,serif">$</span></td>
          <td style="width:10%;font-size:10pt;text-align:right"><span style="font-family:Times New Roman,Times,serif">100,000,000</span></td>
          <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-family:Times New Roman,Times,serif">Sales load (underwriting discounts and commissions)</span></td>
          <td style="font-size:10pt">&#160;</td>
          <td style="font-size:10pt;text-align:left"><span style="font-family:Times New Roman,Times,serif">$</span></td>
          <td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman,Times,serif">0.78125</span></td>
          <td style="font-size:10pt;text-align:left">&#160;</td>
          <td style="font-size:10pt">&#160;</td>
          <td style="font-size:10pt;text-align:left"><span style="font-family:Times New Roman,Times,serif">$</span></td>
          <td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman,Times,serif">3,125,000</span></td>
          <td style="font-size:10pt;text-align:left">&#160;</td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-align:left"><span style="font-family:Times New Roman,Times,serif">Proceeds to us (before expenses)<sup>(2)</sup></span></td>
          <td style="font-size:10pt">&#160;</td>
          <td style="font-size:10pt;text-align:left"><span style="font-family:Times New Roman,Times,serif">$</span></td>
          <td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman,Times,serif">24.21875</span></td>
          <td style="font-size:10pt;text-align:left">&#160;</td>
          <td style="font-size:10pt">&#160;</td>
          <td style="font-size:10pt;text-align:left"><span style="font-family:Times New Roman,Times,serif">$</span></td>
          <td style="font-size:10pt;text-align:right"><span style="font-family:Times New Roman,Times,serif">96,875,000</span></td>
          <td style="font-size:10pt;text-align:left">&#160;</td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman,Times,serif">(1)&#160;We have granted the underwriters an option to purchase up to an additional $15,000,000 aggregate principal amount of the 2030 Notes from us at the public offering price, less the sales load payable by us, for 30&#160;days after the date of this prospectus supplement solely to cover overallotments, if any. If the underwriters exercise this option in full, the total sales load paid by us will be $3,593,750, and total proceeds to us, before expenses, will be $111,406,250. The 2030 Notes will accrue interest from December 10, 2024. The underwriters have agreed to pay us any interest accrued on 2030 Notes issued after such date pursuant to the overallotment option.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-family:Times New Roman,Times,serif">(2)&#160;Total offering expenses payable by us, excluding sales load, are estimated to be $400,000.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif"><strong>THE 2030 NOTES ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF A BANK AND ARE NOT INSURED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION OR ANY OTHER GOVERNMENT AGENCY.</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman,Times,serif">The underwriters expect to deliver the 2030 Notes in book-entry form through The Depository Trust Company on or about December 10, 2024.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><i>Joint Book-Running Managers</i></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table border="0" cellpadding="0" cellspacing="0" style="width:100%;margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif">

        <tr style="vertical-align:top">
          <td style="text-align:center;width:15pc"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Lucid Capital Markets</strong></span></span></td>
          <td style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>B. Riley Securities</strong></span></td>
          <td style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>Piper Sandler</strong></span></td>
          <td style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>Janney Montgomery Scott</strong></span></td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><i>Lead Managers</i></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table border="0" cellpadding="0" cellspacing="0" style="width:70%;margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif;margin:auto">

        <tr style="vertical-align:top">
          <td style="text-align:center;width:50%"><span style="font-family:Times New Roman,Times,serif"><strong>InspereX</strong></span></td>
          <td style="text-align:center;width:50%"><span style="font-family:Times New Roman,Times,serif"><strong>William Blair</strong></span></td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><i>Co-Managers</i></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table border="0" cellpadding="0" cellspacing="0" style="width:70%;margin-top:0pt;margin-bottom:0pt;font:10pt Times New Roman, Times, Serif;margin:auto">

        <tr style="vertical-align:top">
          <td style="text-align:center;width:50%"><span style="font-family:Times New Roman,Times,serif"><strong>Clear Street</strong></span></td>
          <td style="text-align:center;width:50%"><span style="font-family:Times New Roman,Times,serif"><strong>Wedbush Securities</strong></span></td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif">The date of this prospectus supplement is December 4, 2024</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="margin:0pt">&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>ABOUT THIS PROSPECTUS SUPPLEMENT</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif">This document is in two parts. The first part is this prospectus supplement, which describes the specific details regarding this offering of the 2030 Notes and also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part is the accompanying prospectus, which provides general information about us and the securities we may offer from time to time, some of which may not apply to this offering. To the extent the information contained in this prospectus supplement differs from the information contained in the accompanying prospectus or the information included in any document filed prior to the date of this prospectus supplement and incorporated by reference in this prospectus supplement and the accompanying prospectus, the information in this prospectus supplement shall control. Generally, when we refer to this &#8220;prospectus,&#8221; we are referring to both this prospectus supplement and the accompanying prospectus combined, together with any free writing prospectus that we have authorized for use in connection with this offering.</span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman,Times,serif"><strong>YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROSPECTUS SUPPLEMENT AND THE ACCOMPANYING PROSPECTUS,&#160;INCLUDING THE DOCUMENTS INCORPORATED BY REFERENCE HEREIN AND THEREIN, AND ANY FREE WRITING PROSPECTUS PREPARED BY, OR ON BEHALF OF, US THAT RELATES TO THIS OFFERING OF THE 2030 NOTES. WE HAVE NOT, AND THE UNDERWRITERS HAVE NOT, AUTHORIZED ANY OTHER PERSON TO PROVIDE YOU WITH DIFFERENT OR ADDITIONAL INFORMATION. IF ANYONE PROVIDES YOU WITH DIFFERENT OR ADDITIONAL INFORMATION, YOU SHOULD NOT RELY ON IT. WE ARE NOT, AND THE UNDERWRITERS ARE NOT, MAKING AN OFFER TO SELL THE 2030 NOTES IN ANY JURISDICTION WHERE THE OFFER OR SALE IS NOT PERMITTED. YOU SHOULD ASSUME THAT THE INFORMATION APPEARING IN THIS PROSPECTUS SUPPLEMENT AND THE ACCOMPANYING PROSPECTUS,&#160;INCLUDING THE DOCUMENTS INCORPORATED BY REFERENCE HEREIN AND THEREIN, AND ANY FREE WRITING PROSPECTUS PREPARED BY OR ON BEHALF OF US THAT RELATES TO THIS OFFERING IS ACCURATE ONLY AS OF ITS RESPECTIVE DATE, REGARDLESS OF THE TIME OF DELIVERY OF THIS PROSPECTUS SUPPLEMENT, THE ACCOMPANYING PROSPECTUS, ANY FREE WRITING PROSPECTUS OR ANY SALES OF THE 2030 NOTES. OUR BUSINESS, FINANCIAL CONDITION, RESULTS OF OPERATIONS AND PROSPECTS MAY&#160;HAVE CHANGED SINCE THOSE DATES.</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="margin:0pt">&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
    </div>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>TABLE OF CONTENTS</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>PROSPECTUS SUPPLEMENT</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;border-collapse:collapse;width:100%">

        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt;width:93%">&#160;</td>
          <td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:7%;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Page</strong></span></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_01">PROSPECTUS SUPPLEMENT SUMMARY</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_01"><span style="font-size:10pt;text-decoration:underline">S-1</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_02">THE OFFERING</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_02"><span style="font-size:10pt;text-decoration:underline">S-6</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_03">RISK FACTORS</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_03"><span style="font-size:10pt;text-decoration:underline">S-10</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline"><span style="font-family:Times New Roman,Times,serif"><a href="#h_04">USE OF PROCEEDS</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_04"><span style="font-size:10pt;text-decoration:underline">S-14</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline"><span style="font-family:Times New Roman,Times,serif"><a href="#h_05">CAPITALIZATION</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_05"><span style="font-size:10pt;text-decoration:underline">S-15</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_06">DESCRIPTION OF THE NOTES</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_06"><span style="font-size:10pt;text-decoration:underline">S-17</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline"><span style="font-family:Times New Roman,Times,serif"><a href="#h_07">UNDERWRITING</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_07"><span style="font-size:10pt;text-decoration:underline">S-28</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_08">U.S. FEDERAL INCOME TAX MATTERS</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_08"><span style="font-size:10pt;text-decoration:underline">S-31</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_09">LEGAL MATTERS</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_09"><span style="font-size:10pt;text-decoration:underline">S-35</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_10">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_10"><span style="font-size:10pt;text-decoration:underline">S-35</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_11">ADDITIONAL INFORMATION</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_11"><span style="font-size:10pt;text-decoration:underline">S-35</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:White">
          <td style="font:10pt Times New Roman, Times, Serif;text-decoration:underline;text-align:left"><span style="font-family:Times New Roman,Times,serif"><a href="#h_12">INCORPORATION BY REFERENCE</a></span></td>
          <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#h_12"><span style="font-size:10pt;text-decoration:underline">S-35</span></a></span></td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-family:Times New Roman,Times,serif"><strong>PROSPECTUS</strong></span></p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">

        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td style="width:93%"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_001"><span style="font-size:10pt">PROSPECTUS SUMMARY </span></a></span></td>
          <td style="white-space:nowrap;text-align:right;width:7%"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_001"><span style="font-size:10pt">1</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_002"><span style="font-size:10pt">FEES AND EXPENSES </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_002"><span style="font-size:10pt">13</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_003"><span style="font-size:10pt">RISK FACTORS</span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_003"><span style="font-size:10pt">14</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_004"><span style="font-size:10pt">USE OF PROCEEDS</span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_004"><span style="font-size:10pt">54</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_005"><span style="font-size:10pt">SENIOR SECURITIES </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_005"><span style="font-size:10pt">54</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_006"><span style="font-size:10pt">PRICE RANGE OF COMMON STOCK </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_006"><span style="font-size:10pt">54</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_007"><span style="font-size:10pt">ADDITIONAL BUSINESS INFORMATION </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_007"><span style="font-size:10pt">55</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_008"><span style="font-size:10pt">THE ADVISER AND THE ADMINISTRATOR </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_008"><span style="font-size:10pt">57</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_009"><span style="font-size:10pt">MANAGEMENT </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_009"><span style="font-size:10pt">67</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_010"><span style="font-size:10pt">DETERMINATION OF NET ASSET VALUE </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_010"><span style="font-size:10pt">71</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_011"><span style="font-size:10pt">DIVIDEND REINVESTMENT PLAN </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_011"><span style="font-size:10pt">71</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_012"><span style="font-size:10pt">CONFLICTS OF INTEREST </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_012"><span style="font-size:10pt">72</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_013"><span style="font-size:10pt">U.S. FEDERAL INCOME TAX MATTERS </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_013"><span style="font-size:10pt">76</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_014"><span style="font-size:10pt">DESCRIPTION OF OUR SECURITIES </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_014"><span style="font-size:10pt">89</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_015"><span style="font-size:10pt">DESCRIPTION OF OUR CAPITAL STOCK </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_015"><span style="font-size:10pt">90</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_016"><span style="font-size:10pt">DESCRIPTION OF OUR PREFERRED STOCK </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_016"><span style="font-size:10pt">97</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_017"><span style="font-size:10pt">DESCRIPTION OF OUR SUBSCRIPTION RIGHTS </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_017"><span style="font-size:10pt">98</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_018"><span style="font-size:10pt">DESCRIPTION OF OUR DEBT SECURITIES </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_018"><span style="font-size:10pt">100</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_019"><span style="font-size:10pt">BOOK-ENTRY ISSUANCE </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_019"><span style="font-size:10pt">112</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_020"><span style="font-size:10pt">PLAN OF DISTRIBUTION </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_020"><span style="font-size:10pt">114</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_021"><span style="font-size:10pt">REGULATION AS A CLOSED-END MANAGEMENT INVESTMENT COMPANY </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_021"><span style="font-size:10pt">116</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_022"><span style="font-size:10pt">ADDITIONAL INVESTMENTS AND TECHNIQUES </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_022"><span style="font-size:10pt">119</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_023"><span style="font-size:10pt">CONTROL PERSONS, PRINCIPAL STOCKHOLDERS AND SELLING STOCKHOLDERS </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_023"><span style="font-size:10pt">122</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_024"><span style="font-size:10pt">BROKERAGE ALLOCATION </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_024"><span style="font-size:10pt">123</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_025"><span style="font-size:10pt">LEGAL MATTERS </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_025"><span style="font-size:10pt">123</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_026"><span style="font-size:10pt">CUSTODIAN AND TRANSFER AGENT </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_026"><span style="font-size:10pt">123</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_027"><span style="font-size:10pt">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_027"><span style="font-size:10pt">124</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_028"><span style="font-size:10pt">ADDITIONAL INFORMATION </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_028"><span style="font-size:10pt">124</span></a></span></td>
        </tr>
        <tr style="vertical-align:bottom;background-color:#CCEEFF">
          <td><span style="font-family:Times New Roman,Times,serif"><a href="#sa_029"><span style="font-size:10pt">INCORPORATION BY REFERENCE </span></a></span></td>
          <td style="white-space:nowrap;text-align:right"><span style="font-family:Times New Roman,Times,serif"><a href="#sa_029"><span style="font-size:10pt">124</span></a></span></td>
        </tr>

    </table>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
      <p style="margin:0pt">&#160;</p>
    </div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
      <p style="margin:0pt">&#160;</p>
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>


  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_01"><strong>PROSPECTUS SUPPLEMENT SUMMARY</strong></span></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>The following summary highlights some of the information included elsewhere, or incorporated by reference, in this prospectus supplement or the accompanying prospectus. It is not complete and may not contain all the information that you may want to consider before making any investment decision regarding the 2030 Notes offered hereby. To understand the terms of the 2030 Notes offered hereby before making any investment decision, you should carefully read this entire prospectus supplement and the accompanying prospectus, including the documents incorporated by reference herein or therein, and any free writing prospectus related to the offering of the 2030 Notes, including &#8220;Risk Factors,&#8221; &#8220;Additional Information,&#8221; &#8220;Incorporation by Reference,&#8221; and &#8220;Use of Proceeds&#8221; and the financial statements contained elsewhere or incorporated by reference in this prospectus supplement and the accompanying prospectus. Together, these documents describe the specific terms of the 2030 Notes we are offering</i></span>.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><i>Except where the context suggests otherwise, the terms:</i></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

      <tr style="vertical-align:top">
        <td style="width:0.25in">&#160;</td>
        <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
        <td style="text-align:justify"><i>&#8220;Eagle Point Credit Company,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Eagle Point Credit Company Inc., a Delaware corporation, and its consolidated subsidiaries or, for periods prior to our conversion to a corporation, Eagle Point Credit Company LLC, a Delaware limited liability company;</i></td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

      <tr style="vertical-align:top">
        <td style="width:0.25in">&#160;</td>
        <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
        <td style="text-align:justify"><i>&#8220;Eagle Point Credit Management&#8221; and &#8220;Adviser&#8221; refer to Eagle Point Credit Management LLC, a Delaware limited liability company;</i></td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

      <tr style="vertical-align:top">
        <td style="width:0.25in">&#160;</td>
        <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
        <td style="text-align:justify"><i>&#8220;Eagle Point Administration&#8221; and &#8220;Administrator&#8221; refer to Eagle Point Administration LLC, a Delaware limited liability company; and</i></td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

      <tr style="vertical-align:top">
        <td style="width:0.25in">&#160;</td>
        <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
        <td style="text-align:justify"><i>Risk-adjusted returns&#8221; refers to the profile of expected asset returns across a range of potential macroeconomic scenarios, and does not imply that a particular strategy or investment should be considered low-risk.</i></td>
      </tr>

  </table>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><i>Unless otherwise noted, the information contained in this prospectus supplement assumes the underwriters&#8217; overallotment option is not exercised.</i></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Eagle Point Credit Company</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We are an externally managed, non-diversified closed-end management investment company that has registered as an investment company under the 1940 Act. We have elected to be treated, and intend to qualify annually, as a regulated investment company, or &#8220;RIC,&#8221; under Subchapter M of the Internal Revenue Code of 1986, as amended, or the &#8220;Code,&#8221; commencing with our tax year ended November&#160;30, 2014.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <ix:nonNumeric id="Fxbrl_20241203042042875" name="cef:InvestmentObjectivesAndPracticesTextBlock" contextRef="C_20241204to20241204" escape="true">
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. We seek to achieve our investment objectives by investing primarily in equity and junior debt tranches of CLOs that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. We may also invest in other related securities and instruments or other securities and instruments that the Adviser believes are consistent with our investment objectives, including senior debt tranches of CLOs, LAFs, securities issued by other securitization vehicles, such as credit-linked notes and CBOs, and synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions. We may also acquire securities issued by other investments companies, including closed-end funds, business development companies, mutual funds, and exchange-traded funds, and may otherwise invest indirectly in securities consistent with our investment objectives. The amount that we will invest in other securities and instruments, which may include investments in debt and other securities issued by CLOs collateralized by non-U.S. loans or securities of other collective investment vehicles, will vary from time to time and, as such, may constitute a material part of our portfolio on any given date, all as based on the Adviser&#8217;s assessment of prevailing market conditions.</p>
  </ix:nonNumeric>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-1</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div>
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The CLO securities in which we primarily seek to invest are rated below investment grade or, in the case of CLO equity securities, are unrated, and are considered speculative with respect to timely payment of interest and repayment of principal. Unrated and below investment grade securities are also sometimes referred to as &#8220;junk&#8221; securities. In addition, the CLO equity and junior debt securities in which we invest are highly leveraged (with CLO equity securities typically being leveraged approximately ten times), which magnifies our risk of loss on such investments. LAFs are short- to medium-term facilities often provided by the bank that will serve as the placement agent or arranger on a CLO transaction. LAFs typically incur leverage between four and six times prior to a CLO&#8217;s pricing.</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">These investment objectives and strategies are not fundamental policies of ours and may be changed by our Board of Directors without prior approval of our stockholders. See &#8220;<strong><i>Regulation as a Closed-End Management Investment Company &#8211; Investment Restrictions</i></strong>&#8221; in the accompanying prospectus.</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In the primary CLO market (i.e., acquiring securities at the inception of a CLO), we seek to invest in CLO securities that the Adviser believes have the potential to generate attractive risk-adjusted returns and to outperform other similar CLO securities issued within the respective vintage period. In the secondary CLO market (i.e., acquiring existing CLO securities), we seek to invest in CLO securities that the Adviser believes have the potential to generate attractive risk-adjusted returns.</p>
    </div>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>&#8220;Names Rule&#8221; Policy</i></strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In accordance with the requirements of the 1940 Act, we have adopted a policy to invest at least 80% of our assets in the particular type of investments suggested by our name. Accordingly, under normal circumstances, we invest at least 80% of the aggregate of our net assets and borrowings for investment purposes in credit and credit-related instruments. For purposes of this policy, we consider credit and credit-related instruments to include, without limitation: (i)&#160;equity and debt tranches of CLOs, LAFs, securities issued by other securitization vehicles, such as credit-linked notes and CBOs, and synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions; (ii)&#160;secured and unsecured floating rate and fixed rate loans; (iii)&#160;investments in corporate debt obligations, including bonds, notes, debentures, commercial paper and other obligations of corporations to pay interest and repay principal; (iv)&#160;debt issued by governments, their agencies, instrumentalities, and central banks; (v)&#160;commercial paper and short-term notes; (vi)&#160;preferred stock; (vii)&#160;convertible debt securities; (viii)&#160;certificates of deposit, bankers&#8217; acceptances and time deposits; and (ix)&#160;other credit-related instruments. Our investments in derivatives, other investment companies, and other instruments designed to obtain indirect exposure to credit and credit-related instruments are counted towards our 80% investment policy to the extent such instruments have similar economic characteristics to the investments included within that policy.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our 80% policy with respect to investments in credit and credit-related instruments is not fundamental and may be changed by our Board of Directors without stockholder approval. Stockholders will be provided with sixty (60) days&#8217; notice in the manner prescribed by the SEC before making any change to this policy. Our investments in derivatives, other investment companies, and other instruments designed to obtain indirect exposure to credit and credit-related instruments are counted towards our 80% investment policy to the extent such instruments have similar economic characteristics to the investments included within that policy. See &#8220;<strong><i>Regulation as a Closed-End Management Investment Company &#8211; Investment Restrictions</i></strong>&#8221; in the accompany prospectus.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Eagle Point Credit Management</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Eagle Point Credit Management, our investment adviser, manages our investments subject to the supervision of our Board of Directors pursuant to an amended and restated investment advisory agreement, or the &#8220;Investment Advisory Agreement.&#8221; An affiliate of the Adviser, Eagle Point Administration, performs, or arranges for the performance of, our required administrative services. For a description of the fees and expenses that we pay to the Adviser and the Administrator, see &#8220;<strong><i>The Adviser and the Administrator&#8201;&#8212;&#8201;Investment Advisory Agreement&#8201;&#8212;&#8201;Management Fee and Incentive Fee</i></strong>&#8221; and &#8220;<strong><i>The Adviser and the Administrator&#8201;&#8212;&#8201;The Administrator and the Administration Agreement</i></strong>&#8221; in the accompanying prospectus.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-2</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Adviser is registered as an investment adviser with the SEC. As of September&#160;30, 2024, the Adviser, collectively with certain affiliates, had over $10 billion of total assets under management, including capital commitments that were undrawn as of such date. See &#8220;<strong><i>The Adviser and the Administrator</i></strong>&#8221; in the accompanying prospectus.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Financing and Hedging Strategy</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong><i>Leverage by the Company.</i></strong></span>&#160;&#160;&#160;We may use leverage as and to the extent permitted by the 1940 Act. We are permitted to obtain leverage using any form of financial leverage instruments, including funds borrowed from banks or other financial institutions, margin facilities, notes or preferred stock and leverage attributable to reverse repurchase agreements or similar transactions. Over the long term, management expects us to operate under normal market conditions generally with leverage within a range of 25% to 35% of total assets, although the actual amount of our leverage will vary over time. Certain instruments that create leverage are considered to be senior securities under the 1940 Act.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">With respect to senior securities representing indebtedness (i.e., borrowing or deemed borrowing, including our Existing Notes), other than temporary borrowings as defined under the 1940 Act, we are required under current law to have an asset coverage of at least 300%, as measured at the time of borrowing and calculated as the ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount of our outstanding senior securities representing indebtedness. With respect to senior securities that are stocks (i.e., shares of our Preferred Stock), we are required under current law to have an asset coverage of at least 200%, as measured at the time of the issuance of any such shares of Preferred Stock and calculated as the ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount of our outstanding senior securities representing indebtedness plus the aggregate liquidation preference of any outstanding shares of Preferred Stock.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">As of November&#160;30, 2024, we had five series of Preferred Stock outstanding: the Series&#160;AA Convertible Perpetual Preferred Stock and Series&#160;AB Convertible Perpetual Preferred Stock (together, the &#8220;Convertible Perpetual Preferred Stock&#8221;), the Series&#160;C Term Preferred Stock, the Series&#160;D Preferred Stock and the Series&#160;F Term Preferred Stock, (together with any additional shares of preferred stock the Company may issue from time to time, including the Offered Preferred Stock, the &#8220;Preferred Stock&#8221;).</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">As of September 30, 2024, our leverage, including the outstanding Notes and Preferred Stock, represented approximately 30.7% of our total assets (less current liabilities). On a pro forma basis, after giving effect to (i) the $43.2 million in net proceeds received from sales of our common stock from October 1, 2024 through November 25, 2024 in connection with our ATM Program (as defined below), (ii) $13.9 million in net proceeds received from the issuance of 0.7 million shares of our Series D Preferred Stock through the ATM Program, (iii) $3.0 million in net proceeds received from the issuance of 0.1 million shares of our Series F Term Preferred Stock through the ATM Program, and (iv) $11.5 million in net proceeds received from the issuance of 0.5 million shares of our Convertible Perpetual Preferred Stock, our leverage represented approximately 31.2% of our total assets (less current liabilities) as of October 31, 2024 (based on an estimated common stock NAV per share of $8.60, representing management&#8217;s unaudited estimate of the NAV per share of our common stock as of such date). As of September 30, 2024, our asset coverage ratios in respect of (i) senior securities representing indebtedness and (ii) our outstanding Preferred Stock, each as calculated pursuant to Section 18 of the 1940 Act, were 735% and 326%, respectively. In the event we fail to meet our applicable asset coverage ratio requirements, we may not be able to incur additional debt and/or issue Preferred Stock, and could be required by law or otherwise to sell a portion of our investments to repay some debt or redeem or convert shares of Preferred Stock (if any) when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make certain distributions or pay dividends of an amount necessary to continue to qualify as a RIC for U.S. federal income tax purposes.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-3</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We expect that we will, or that we may need to, raise additional capital in the future to fund our continued growth, and we may do so by entering into a credit facility, issuing additional shares of Preferred Stock or debt securities or through other leveraging instruments. Subject to the limitations under the 1940 Act, we may incur additional leverage opportunistically or not at all and may choose to increase or decrease our leverage. In addition, we may borrow for temporary, emergency or other purposes as permitted under the 1940 Act, which indebtedness would be in addition to the asset coverage requirements described above. By leveraging our investment portfolio, we may create an opportunity for increased net income and capital appreciation. However, the use of leverage also involves significant risks and expenses, which will be borne entirely by our common stockholders, and our leverage strategy may not be successful. For example, the more leverage is employed, the more likely a substantial change will occur in the NAV per share of our common stock. Accordingly, any event that adversely affects the value of an investment would be magnified to the extent leverage is utilized. See &#8220;<strong><i>Risk Factors &#8211; Risks Related to Our Investments &#8211; We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us</i></strong>&#8221; in the accompanying prospectus.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong><i>Derivative Transactions</i></strong></span>. We may engage in &#8220;Derivative Transactions,&#8221; as described below, from time to time. To the extent we engage in Derivative Transactions, we expect to do so to hedge against interest rate, credit, currency, and/or other risks, or for other investment or risk management purposes. We may use Derivative Transactions for investment purposes to the extent consistent with our investment objectives if the Adviser deems it appropriate to do so. We may purchase and sell a variety of derivative instruments, including exchange-listed and over-the-counter, or &#8220;OTC,&#8221; options, futures, options on futures, swaps and similar instruments, various interest rate transactions, such as swaps, caps, floors or collars, and credit transactions and credit default swaps. We also may purchase and sell derivative instruments that combine features of these instruments. Collectively, we refer to these financial management techniques as &#8220;Derivative Transactions.&#8221; Our use of Derivative Transactions, if any, will generally be deemed to create leverage for us and involves significant risks. No assurance can be given that our strategy and use of derivatives will be successful, and our investment performance could diminish compared with what it would have been if Derivative Transactions were not used. See &#8220;<strong><i>Risk Factors &#8211; Risks Related to Our Investments &#8211; We are subject to risks associated with any hedging or Derivative Transactions in which we participate</i></strong>&#8221; in the accompanying prospectus.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Operating and Regulatory Structure</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We are an externally managed, non-diversified closed-end management investment company that has registered as an investment company under the 1940 Act. As a registered closed-end management investment company, we are required to meet certain regulatory tests. See &#8220;<strong><i>Regulation as a Closed-End Management Investment Company</i></strong>&#8221; in the accompanying prospectus. In addition, we have elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code, commencing with our tax year ended on November&#160;30, 2014.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Our investment activities are managed by the Adviser and supervised by our Board of Directors. Under the Investment Advisory Agreement, we have agreed to pay the Adviser an annual base management fee based on our &#8220;Total Equity Base&#8221; as well as an incentive fee based on our &#8220;Pre-Incentive Fee Net Investment Income.&#8221; See &#8220;<strong><i>The Adviser and The Administrator&#8201;&#8212;&#8201;Investment Advisory Agreement&#8201;&#8212;&#8201;Management Fee and Incentive Fee</i></strong>&#8221; in the accompanying prospectus. </span>&#8220;Total Equity Base&#8221; means the NAV attributable to the common stock and the paid-in, or stated, capital of the Preferred Stock.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We have also entered into an administration agreement, which we refer to as the &#8220;Administration Agreement,&#8221; under which we have agreed to reimburse the Administrator for our allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement. See &#8220;<strong><i>The Adviser and the Administrator &#8211; The Administrator and the Administration Agreement</i></strong>&#8221; in the accompanying prospectus.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-4</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Recent Developments</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>ATM Offering</i></strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">On February&#160;24, 2024, we entered into a Fourth Amended and Restated At Market Issuance Sales Agreement with B. Riley Securities,&#160;Inc. (the &#8220;ATM Agent&#8221;), pursuant to which we may offer and sell, from time to time at our sole discretion, shares of our common stock, Series&#160;C Term Preferred Stock, Series&#160;D Preferred Stock and Series&#160;F Term Preferred Stock through the ATM Agent (our &#8220;ATM Program&#8221;).</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">From October&#160;1, 2024 through November&#160;25, 2024, we sold 4.5 million shares of our common stock through our ATM Program, for total net proceeds to us of approximately $43.2 million. In connection with such sales, we paid a total of $0.9 million in fees and commissions.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">From October&#160;1, 2024 through November&#160;25, 2024, we sold 0.7 million shares of our Series&#160;D Preferred Stock and 0.1 million shares of our Series&#160;F Term Preferred Stock through our ATM Program, for total net proceeds to us of approximately $16.9 million. In connection with such sales, we paid a total of $0.3 million in fees and commissions.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Continuous Offering of Convertible Perpetual Preferred Stock</i></strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">From October&#160;1, 2024 through November&#160;25, 2024, we sold 0.5 million shares of our Convertible Perpetual Preferred Stock through our continuous offering, for total net proceeds to us of approximately $11.5 million. In connection with such sales, we paid a total of $0.9 million in fees and commissions.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Our Corporate Information</strong></p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our offices are located at 600 Steamboat Road, Suite&#160;202, Greenwich, CT 06830, and our telephone number is (203) 340-8500.</p>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-5</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span></span></p>
<div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_02"><span style="font-family:Times New Roman,Times,serif"><strong>THE OFFERING</strong></span></span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:30%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Issuer</strong></span></span></td><td style="width:70%;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Eagle Point Credit Company Inc.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Title of the securities</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif">7.75% Notes due 2030</span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Aggregate principal amount offered</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$100,000,000</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Overallotment Option</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The underwriters may also purchase up to an additional $15,000,000 aggregate principal amount of the 2030 Notes to cover overallotments, if any, within 30&#160;days from the date of this prospectus supplement.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Public offering price</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">100% of the aggregate principal amount ($25 per 2030 Note).</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Denominations</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">We will issue these 2030 Notes in denominations of $25 and integral multiples of $25 in excess thereof.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Principal payable maturity</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">100% of the aggregate principal amount; the principal amount of each 2030 Note is payable on its stated maturity date (or, if such date is not a business day, the immediately succeeding business day) at the office of the trustee for the 2030 Notes or at such other office in New York City as we may designate.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Interest</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif">7.75% per year, payable every March&#160;31, June&#160;30, September&#160;30 and December&#160;31. If an interest payment date is a non-business day, the applicable interest payment will be made on the next business day, and no additional interest will accrue as a result of such delayed payment. Interest payments on the 2030 Notes offered by this prospectus supplement will commence on March&#160;31, 2025.</span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Regular record dates for interest</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Every March&#160;15, June&#160;15, September&#160;15 and December&#160;15. The first record date for the 2030 Notes offered by this prospectus supplement will be March&#160;15, 2025. If the record date for an interest payment is a non-business day, the record date will be the next business day.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Day count basis</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">360-day year of twelve 30-day&#160;months</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Original issue date</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif">December 10, 2024</span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Stated maturity date</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif">June 30, 2030</span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Specified currency</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">U.S. Dollars</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Interest periods</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The initial interest period for the 2030 Notes offered by this prospectus supplement will be the period from and including December 10, 2024, to, but excluding the initial interest payment date. The subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.</span></span></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">S-6</span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;font:10pt Times New Roman, Times, Serif;width:100%"><tr style="vertical-align:top;text-align:left"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Ranking of notes</strong></span></span></td><td colspan="2"><span style="font-family:Times New Roman,Times,serif">The 2030 Notes are our direct unsecured obligations and rank:</span></td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td colspan="2">&#160;</td></tr><tr style="vertical-align:top;text-align:left"><td style="width:30%">&#160;</td><td style="text-align:center;width:3%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Symbol">&#183;</span></p></td><td style="text-align:justify;width:67%"><span style="font-family:Times New Roman,Times,serif">Senior to the outstanding shares of our common stock and our preferred stock;</span></td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td style="text-align:center"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Symbol">&#183;</span></p></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><i>pari&#160;passu</i>&#160;with existing unsecured indebtedness, including the Existing Notes, and any future unsecured indebtedness;</span></td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td style="text-align:center"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Symbol">&#183;</span></p></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif">effectively subordinated to all of our existing and future secured indebtedness (including indebtedness that is initially unsecured, but to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness; and</span></td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top;text-align:left"><td>&#160;</td><td style="text-align:center;width:3%"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Symbol">&#183;</span></p></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif">structurally subordinated to all existing and future indebtedness and other obligations of any of our subsidiaries, financing vehicles or similar facilities.</span></td></tr></table><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:30%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Business days</strong></span></span></td><td style="text-align:justify;width:70%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York City are authorized or required by law or executive order to close.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Optional redemption</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The 2030 Notes may be redeemed in whole or in part at any time or from time to time at our option on or after June 30, 2027&#160;upon not less than 30-days&#8217; nor more than 60-days&#8217; written notice by mail prior to the date fixed for redemption thereof, at the redemption price set forth under the caption &#8220;<strong><i>Description of the Notes&#8201;&#8212;&#8201;Optional Redemption</i></strong>&#8221; in this prospectus supplement.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Sinking fund</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The 2030 Notes are not subject to any sinking fund (i.e., no amounts will be set aside by us to ensure repayment of the 2030 Notes at maturity).</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Repurchase at the option of the holder</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Holders of the 2030 Notes do not have the option to have the 2030 Notes repaid prior to June 30, 2030.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Defeasance</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The 2030 Notes are subject to legal and covenant defeasance by us. See &#8220;<strong><i>Description of the Notes&#8201;&#8212;&#8201;Defeasance</i></strong>&#8221; in this prospectus supplement.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Form&#160;of 2030 Notes</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The 2030 Notes are represented by global securities that will be deposited and registered in the name of The Depository Trust Company, or &#8220;DTC,&#8221; or its nominee. This means that, except in limited circumstances, you will not receive certificates for the 2030 Notes. Beneficial interests in the 2030 Notes are represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may elect to hold interests in the 2030 Notes through either DTC, if they are a participant, or indirectly through organizations that are participants in DTC. See &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus.</span></span></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">S-7</span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:30%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Trustee, Paying Agent, Registrar and Transfer Agent</strong></span></span></td><td style="text-align:justify;width:70%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Equiniti Trust Company, LLC</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Events of default</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">If an event of default on the 2030 Notes occurs, the principal amount of the 2030 Notes, plus accrued and unpaid interest, may be declared immediately due and payable, subject to the conditions set forth in the indenture. See &#8220;<strong><i>Description of the Notes&#8201;&#8212;&#8201;Events of Default</i></strong>&#8221; in this prospectus supplement.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Other covenants</strong></span></span></td><td><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman,Times,serif">The covenants described under &#8220;<strong><i>Description of the Notes&#8201;&#8212;&#8201;Covenants,</i></strong>&#8221; including the following, will apply to the 2030 Notes:</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify;text-indent:-0.25in"><span style="font-family:Symbol">&#183;</span><span style="font-family:Times New Roman,Times,serif"><span></span>&#160;&#160;&#160;&#160;&#160;We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with respect to such borrowings equals at least 300% after such borrowings.</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify;text-indent:-0.25in">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify;text-indent:-0.25in"><span style="font-family:Symbol">&#183;</span><span style="font-family:Times New Roman,Times,serif"><span></span>&#160;&#160;&#160;&#160;&#160;We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#8217;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our preferred stock as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify;text-indent:-0.25in">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in;text-align:justify;text-indent:-0.25in"><span style="font-family:Symbol">&#183;</span><span style="font-family:Times New Roman,Times,serif"><span></span>&#160;&#160;&#160;&#160;&#160;If, at any time, we are not subject to the requirements of Sections&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934, as amended, or the &#8220;Exchange Act,&#8221; to file any periodic reports with the SEC, we agree to furnish to holders of the 2030 Notes and the trustee, for the period of time during which the 2030 Notes are outstanding, our audited annual consolidated financial statements, within 60&#160;days of our fiscal year end, and unaudited interim consolidated financial statements, within 60&#160;days of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles, or &#8220;GAAP.&#8221;</span></p></td></tr></table><p style="margin:0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">S-8</span></p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="margin:0">&#160;</p><table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse"><tr style="vertical-align:top"><td style="width:30%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Listing</strong></span></span></td><td style="text-align:justify;width:70%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">We intend to list the 2030 Notes on the NYSE under the symbol &#8220;ECCU.&#8221; We expect trading in the 2030 Notes on the NYSE to begin within 30&#160;days of the original issue date.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Use of Proceeds</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">We intend to use the net proceeds from the sale of the 2030 Notes to acquire investments in accordance with our investment objectives and strategies described in this prospectus supplement and in the accompanying prospectus and for general working capital purposes, including, as applicable, paying expenses, making distributions to our stockholders and/or repaying any outstanding indebtedness or Preferred Stock. See &#8220;<strong><i>Use of Proceeds</i></strong>&#8221; in this prospectus supplement.</span></span></td></tr><tr style="vertical-align:top"><td>&#160;</td><td style="text-align:justify">&#160;</td></tr><tr style="vertical-align:top"><td><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><strong>Additional Information</strong></span></span></td><td style="text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">We have filed with the SEC a registration statement on Form&#160;N-2 under the Securities Act, which contains additional information about us and the 2030 Notes being offered by this prospectus supplement and the accompanying prospectus. We file annual and semi-annual reports, proxy statements and other information with the SEC. Our SEC filings are also available to the public at the SEC&#8217;s website at&#160;<i>www.sec.go</i>v. This information is also available free of charge by contacting us at Eagle Point Credit Company Inc., Attention: Investor Relations, by telephone at (844) 810-6501, or via email at ir@eaglepointcredit.com.</span></span></td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">S-9</span></p></div></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>
  <ix:nonNumeric id="Fxbrl_20241203045833870" name="cef:RiskFactorsTableTextBlock" contextRef="C_20241204to20241204" continuedAt="F20241203045906236" escape="true">
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_03"><strong>RISK FACTORS</strong></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><i>Investing in the 2030 Notes involves a number of significant risks. You should carefully consider the risks described below and all other information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus and the documents incorporated by reference in this prospectus supplement and the accompanying prospectus before making a decision to purchase the 2030 Notes. The risks and uncertainties described below are not the only ones facing us. Additional risks and uncertainties not presently known to us, or not presently deemed material by us, may also impair our operations and performance.</i></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><i>If any of the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, our net asset value and the trading price of the 2030 Notes could decline and you may lose all or part of your investment.</i></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Risks Related to the Offering</strong></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203045943756" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The 2030 Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur in the future and will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by and us and our general liabilities (total liabilities, less debt).</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the 2030 Notes are effectively subordinated to any secured indebtedness we may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the 2030 Notes. In addition, the 2030 Notes will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by us and our general liabilities (total liabilities, less debt).</p>
        </div>
      </ix:nonNumeric>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203050000022" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The 2030 Notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will be obligations exclusively of Eagle Point Credit Company Inc. and not of any of our subsidiaries. None of our subsidiaries will be or will act as a guarantor of the 2030 Notes and the 2030 Notes will not be required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of any such subsidiary are not directly available to satisfy the claims of our creditors, including holders of the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the 2030 Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the 2030 Notes will be structurally subordinated to all indebtedness and other liabilities of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish.</p>
        </div>
      </ix:nonNumeric>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203050004350" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174NoActiveMarketMayDevelopFor2030NotesMember" continuedAt="F20241203055935796" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>There is no existing trading market for the 2030 Notes and, even if the NYSE approves the listing of the 2030 Notes, an active trading market for the 2030 Notes may not develop, which could limit your ability to sell the 2030 Notes and/or the market price of the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will be a new issue of debt securities for which there is no trading market. We intend to list the 2030 Notes on the NYSE within 30 days of the original issue date under the symbol &#8220;ECCU.&#8221; However, there is no assurance that the 2030 Notes will be approved for listing on the NYSE. Moreover, even if the listing of the 2030 Notes is approved, we cannot provide any assurances that an active trading market will develop or be maintained for the 2030 Notes or that you will be able to sell your 2030 Notes. If the 2030 Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the 2030 Notes, but they are not obligated to do so. The underwriters may discontinue any market-making activities in the 2030 Notes at any time at their sole discretion.</p>
        </div>
      </ix:nonNumeric>
      <div style="display:none">
        <ix:continuation id="F20241203055935796" continuedAt="F20241203052329344">
          <div>&#160;</div>
        </ix:continuation>
      </div>
    </div>
  </ix:nonNumeric>
  <div style="display:none">
    <ix:continuation id="F20241203045906236" continuedAt="F20241203045845855">
      <div>&#160;</div>
    </ix:continuation>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-10</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <ix:continuation id="F20241203045845855" continuedAt="F20241203045909898">
    <div>
      <ix:continuation id="F20241203052329344">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Accordingly, we cannot assure you that the 2030 Notes will be approved for listing on the NYSE, that a liquid trading market will develop or be maintained for the 2030 Notes, that you will be able to sell your 2030 Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the 2030 Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the 2030 Notes for an indefinite period of time.</p>
      </ix:continuation>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203050011679" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174CreditRatingDowngradeMayImpactLiquidityAndValueMember" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>A downgrade, suspension or withdrawal of the credit rating assigned by a rating agency to us or the 2030 Notes, if any, or change in the debt markets could cause the liquidity or market value of the 2030 Notes to decline significantly.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in any credit ratings will generally affect the market value of the 2030 Notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the 2030 Notes. Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization in its sole discretion. Neither we nor any underwriter undertakes any obligation to obtain or maintain any credit ratings or to advise holders of 2030 Notes of any changes in any credit ratings. There can be no assurance that any credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the rating agencies if in their judgment future circumstances relating to the basis of the credit ratings, such as adverse changes in our Company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future, which could have an adverse effect on the market prices of the 2030 Notes.</p>
        </div>
      </ix:nonNumeric>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203050019822" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174IndentureOffersLimitedProtectionForHoldersMember" continuedAt="F20241203124740263" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The indenture under which the 2030 Notes will be issued contains limited protection for holders of the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The indenture under which the 2030 Notes will be issued offers limited protection to holders of the 2030 Notes. The terms of the indenture and the 2030 Notes do not restrict our or any of our subsidiaries&#8217; ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have an adverse impact on your investment in the 2030 Notes. In particular, the terms of the indenture and the 2030 Notes do not place any restrictions on our or our subsidiaries&#8217; ability to:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">issue securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations that would be equal in right of payment to the 2030 Notes, (2)&#160;any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the 2030 Notes to the extent of the values of the assets securing such debt, (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank structurally senior to the 2030 Notes and (4)&#160;securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the 2030 Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the 2030 Notes, other than a distribution, dividend or purchase that would cause a violation of Section&#160;18(a)(1)(B)&#160;of the 1940 Act or any successor provisions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">enter into transactions with affiliates;</td>
              </tr>

          </table>
        </div>
      </ix:nonNumeric>
      <div style="display:none">
        <ix:continuation id="F20241203124740263" continuedAt="F20241203052316525">
          <div>&#160;</div>
        </ix:continuation>
      </div>
    </div>
  </ix:continuation>
  <div style="display:none">
    <ix:continuation id="F20241203045909898" continuedAt="F20241203045854342">
      <div>&#160;</div>
    </ix:continuation>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-11</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <ix:continuation id="F20241203045854342">
    <div>
      <ix:continuation id="F20241203052316525">
        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">make investments; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">create restrictions on the payment of dividends or other amounts to us from our subsidiaries.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Furthermore, the terms of the indenture and the 2030 Notes do not protect holders of the 2030 Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity, except as required under the 1940 Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the 2030 Notes may have important consequences for you as a holder of the 2030 Notes, including making it more difficult for us to satisfy our obligations with respect to the 2030 Notes or negatively affecting the trading value of the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the 2030 Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the 2030 Notes.</p>
        </div>
      </ix:continuation>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203050027639" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174OptionalRedemptionMayNegativelyAffectReturnsMember" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The optional redemption provision may materially adversely affect your return on the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are redeemable in whole or in part at any time or from time to time on or after June 30, 2027 at our sole option at the redemption price set forth under the caption &#8220;<strong><em>Description of the Notes &#8212; Optional Redemption</em></strong>&#8221; in this prospectus supplement. We may choose to redeem the 2030 Notes at times when prevailing interest rates are lower than the interest rate paid on the 2030 Notes. In this circumstance, you may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the 2030 Notes being redeemed.</p>
        </div>
      </ix:nonNumeric>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20241203050033213" name="cef:RiskTextBlock" contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any default under the agreements governing our indebtedness or under other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the 2030 Notes and substantially decrease the market value of the 2030 Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the 2030 Notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders of the debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating performance declines, we may in the future need to refinance or restructure our debt, including the 2030 Notes, sell assets, reduce or delay capital investments, seek to raise additional capital or seek to obtain waivers from the required lenders or holders of any debt that we may incur in the future to avoid being in default. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the 2030 Notes or our other debt. If we breach our covenants under our debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or holders. If this occurs, we would be in default and our lenders or debt holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because any future debt will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due.</p>
        </div>
      </ix:nonNumeric>
    </div>
  </ix:continuation>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
  <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
    <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-12</p>
  </div>
  <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
    <p style="margin:0pt">&#160;</p>
  </div>
  <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">All statements contained
in or incorporated by reference into this prospectus supplement or the accompanying prospectus, other than historical facts, may constitute
&#8220;forward-looking statements.&#8221; These statements may relate to, among other things, future events or our future operating results,
actual and potential conflicts of interest with the Adviser, the Administrator and their affiliates, and the adequacy of our financing
sources and working capital, among other factors. In some cases, you can identify forward-looking statements by terminology such as &#8220;estimate,&#8221;
&#8220;may,&#8221; &#8220;might,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;provided,&#8221; &#8220;anticipate,&#8221; &#8220;future,&#8221;
&#8220;could,&#8221; &#8220;growth,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221;
&#8220;would,&#8221; &#8220;if,&#8221; &#8220;seek,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;likely&#8221; or the
negative or other variations of such terms or comparable terminology. These forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different
from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Such
factors include:</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">changes in the economy and the capital markets;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">risks associated with negotiation and consummation of pending and future transactions;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">changes in our investment objectives and strategy;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">availability, terms (including the possibility of interest rate volatility) and deployment of capital;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">changes in interest rates, exchange rates, regulation or the general economy;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">changes in governmental regulations, tax rates and similar matters;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our ability to exit investments in a timely manner;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our ability to maintain our qualification as a RIC;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">the use of the proceeds of this offering;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our ability to sell the 2030 Notes in this offering in the amounts and on the terms contemplated, or at
all; and</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">those factors described in the &#8220;<i>Risk Factors</i>&#8221; section of this prospectus supplement
and the accompanying prospectus and in similar sections in the documents incorporated by reference into this prospectus supplement and
the accompanying prospectus.</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We caution readers not to
place undue reliance on any such forward-looking statements, which speak only as of the date made. Actual results could differ materially
from those anticipated in our forward-looking statements and future results could differ materially from historical performance. We have
based forward-looking statements on information available to us on the date of this prospectus supplement. We undertake no obligation
to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after
the date of this prospectus supplement or the accompanying prospectus, except as otherwise required by applicable law. The forward-looking
statements contained in or incorporated by reference into this prospectus supplement and the accompanying prospectus are excluded from
the safe harbor protection provided by the Private Securities Litigation Reform Act of 1995 and Section&#160;27A of the Securities Act.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-13</p></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><span id="h_04"></span>USE OF PROCEEDS</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The net proceeds to us of this offering are expected to be approximately $96.5 million (or approximately $111.0 million if the underwriters exercise the overallotment option in full), based on a public offering price of $25 per 2030 Note, after deducting the payment of underwriting discounts and commissions payable by us of approximately $3.1 million (or approximately $3.6 million if the underwriters exercise the overallotment option in full) and estimated offering expenses payable by us of approximately $400,000.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">We intend to use the proceeds from the sale of the 2030 Notes pursuant to this prospectus supplement to acquire investments in accordance with our investment objectives and strategies described in this prospectus supplement and the accompanying prospectus supplement and </span>for general working capital purposes, including, as applicable, making distributions to our stockholders, repaying any outstanding indebtedness or Preferred Stock, and/or paying expenses related to the Company and offerings of the Company&#8217;s securities. We cannot estimate the approximate amount intended to be used for each of these purposes. Such amounts will depend on our cash flow needs after closing of the offering, market conditions and other factors.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We currently anticipate that it will generally take approximately three to six months after the receipt of proceeds from the offering of the 2030 Notes to invest substantially all of such proceeds of the offering in our targeted investments or otherwise utilize such proceeds, although such period may vary and depends on the availability of appropriate investment opportunities consistent with our investment objectives and market conditions. We cannot assure you we will achieve our targeted investment pace, which may negatively impact our returns. Until appropriate investments or other uses can be found, we may invest in temporary investments, such as cash, cash equivalents, U.S. government securities, other high-quality debt investments that mature in one year or less, or other short-term investments selected by our Adviser, which we expect will have returns substantially lower than the returns that we anticipate earning from investments in CLO securities and related investments. Investors should expect, therefore, that before we have fully invested the proceeds of the offering in accordance with our investment objectives and strategies, our income may not exceed our expenses. To the extent that the net proceeds from the offering have not been fully invested in accordance with our investment objectives and strategies, a portion of the proceeds may be used to pay distribution and may represent a return of capital.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-14</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><span id="h_05"></span>CAPITALIZATION</strong></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table sets forth our capitalization as of September&#160;30, 2024:</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

          <tr style="vertical-align:top">
            <td style="width:0.25in">&#160;</td>
            <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
            <td style="text-align:justify">on an actual basis;</td>
          </tr>

      </table>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

          <tr style="vertical-align:top">
            <td style="width:0.25in">&#160;</td>
            <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
            <td style="text-align:justify">on a pro&#160;forma basis to give effect to (1)&#160;the payment of distributions of $0.16 per share of common stock (consisting of a $0.14 per share regular monthly distribution and $0.02 per share supplemental distribution) on each of October&#160;31, 2024 and November&#160;29, 2024 to holders of record as of October&#160;11, 2024 and November&#160;12, 2024, respectively; (2)&#160;the issuance and sale of 4.5 million shares of common stock through our ATM Program from October&#160;1, 2024 through November&#160;25, 2024, yielding net proceeds to us of approximately $43.2 million; (3)&#160;the issuance and sale from October&#160;1, 2024 through November&#160;25, 2024 of 0.7 million shares of Series&#160;D Preferred Stock and 0.1 million shares of Series&#160;F Term Preferred Stock through our ATM Program, yielding net proceeds to us of approximately $16.9 million and (4)&#160;the issuance and sale of 0.5 million shares of our Convertible Perpetual Preferred Stock through our continuous offering from October&#160;1, 2024 through November&#160;25, 2024, yielding net proceeds to us of approximately $11.5 million; and</td>
          </tr>

      </table>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

          <tr style="vertical-align:top">
            <td style="width:0.25in">&#160;</td>
            <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
            <td style="text-align:justify">on a pro forma (as adjusted) basis to give effect to (1) the distributions and issuances described above; and (2) the issuance and sale of $100,000,000 aggregate principal amount of the 2030 Notes in this offering based on a public offering price of $25 per 2030 Note, after deducting the assumed underwriting discounts and commissions payable by us and estimated offering expenses of approximately $400,000 payable by us.</td>
          </tr>

      </table>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-15</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">

          <tr style="vertical-align:bottom">
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Actual</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center">Pro Forma</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="padding-bottom:1pt">&#160;</td>
            <td colspan="2" style="border-bottom:Black 1pt solid;text-align:center"><strong>Pro Forma<br/>(as adjusted)</strong></td>
            <td style="padding-bottom:1pt">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom">
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
            <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:1pt">&#160;</span></td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
            <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-size:1pt">&#160;</span></td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
            <td style="padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
            <td colspan="2" style="text-align:center"><span style="font-size:1pt">&#160;</span></td>
            <td style="padding-bottom:1pt"><span style="font-size:1pt">&#160;</span></td>
          </tr>
          <tr style="vertical-align:bottom">
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td colspan="10" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">(Dollars in Thousands)</td>
            <td>&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:bold 10pt Times New Roman, Times, Serif">Assets:</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:right">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:right">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td>&#160;</td>
            <td colspan="2">&#160;</td>
            <td>&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;width:61%;text-align:left">Cash and cash equivalents</td>
            <td style="width:1%;font-size:10pt">&#160;</td>
            <td style="width:1%;font-size:10pt;text-align:left">$</td>
            <td style="width:10%;font-size:10pt;text-align:right">23,819</td>
            <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
            <td style="width:1%;font-size:10pt">&#160;</td>
            <td style="width:1%;font-size:10pt;text-align:left">$</td>
            <td style="width:10%;font-size:10pt;text-align:right">60,392</td>
            <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">156,867</p>
            </td>
            <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Investments at fair value</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,214,383</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1,214,383</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,214,383</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt">Other assets</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">44,328</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">44,328</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">44,328</p>
            </td>
            <td style="padding-bottom:1pt;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:2.5pt">Total assets</td>
            <td style="font-size:10pt;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:right">1,282,530</td>
            <td style="padding-bottom:2.5pt;font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">1,319,103</td>
            <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,415,578</p>
            </td>
            <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:bold 10pt Times New Roman, Times, Serif">Liabilities:</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;text-align:right">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;text-align:right">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">&#160;</td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20241203103148645" name="cef:LongTermDebtTitleTextBlock" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes66875Due2028Member" escape="true"><span style="font-size:10pt;font-family:Times New Roman">6.6875% Unsecured Notes due 2028</span></ix:nonNumeric> ($<ix:nonFraction id="Fxbrl_20241203043041984" name="cef:LongTermDebtPrincipal" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes66875Due2028Member" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">32,423,800</ix:nonFraction> aggregate principal amount, actual, pro&#160;forma and pro&#160;forma (as adjusted))</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">$</td>
            <td style="font-size:10pt;text-align:right">31,976</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">$</td>
            <td style="font-size:10pt;text-align:right">31,976</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">31,976</p>
            </td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20241203103331149" name="cef:LongTermDebtTitleTextBlock" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes5375Due2029Member" escape="true"><span style="font-size:10pt;font-family:Times New Roman">5.375% Unsecured Notes due 2029</span></ix:nonNumeric> ($<ix:nonFraction id="Fxbrl_20241203043126393" name="cef:LongTermDebtPrincipal" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes5375Due2029Member" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">93,250,000</ix:nonFraction> aggregate principal amount, actual, pro&#160;forma and pro&#160;forma (as adjusted))</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">85,899</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">85,899</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">85,899</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="text-indent:-0.125in;padding-left:0.125in;font:10pt Times New Roman, Times, Serif;text-align:left"><ix:nonNumeric id="Fxbrl_20241203103437094" name="cef:LongTermDebtTitleTextBlock" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes675Due2031Member" escape="true"><span style="font-size:10pt;font-family:Times New Roman">6.75% Unsecured Notes due 2031</span></ix:nonNumeric> ($<ix:nonFraction id="Fxbrl_20241203043315048" name="cef:LongTermDebtPrincipal" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes675Due2031Member" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">44,850,000</ix:nonFraction> aggregate principal amount, actual, pro&#160;forma and pro&#160;forma (as adjusted))</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">44,617</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">44,617</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">44,617</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, serif;text-align:left">
              <p style="margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="Fxbrl_20241206110824109" name="cef:LongTermDebtTitleTextBlock" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes775Due2030Member" escape="true"><span style="font-size:10pt;font-family:Times New Roman">7.75% Unsecured Notes due 2030</span></ix:nonNumeric><span style="font-size:10pt"> offered hereby ($</span><ix:nonFraction id="Fxbrl_20241206110857069" name="cef:LongTermDebtPrincipal" contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes775Due2030Member" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction><span style="font-size:10pt"> aggregate principal amount, actual and pro forma; $100,000,000 aggregate principal amount pro forma (as adjusted))</span></p>
            </td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#8212;</p>
            </td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">100,000</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, serif;text-align:left">6.50% Series&#160;C Term Preferred Stock due 2031, par value $0.001 per share; 20,000,000 shares aggregate authorized, 2,172,553 shares issued and outstanding, actual, pro&#160;forma and pro&#160;forma (as adjusted)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">51,055</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">51,055</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">51,055</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, serif;text-align:left">8.00% Series&#160;F Term Preferred Stock due 2029, par value $0.001 per share; 20,000,000 shares aggregate authorized, 2,345,670 shares issued and outstanding, actual; 2,469,603&#160;&#160;shares, pro&#160;forma and pro&#160;forma (as adjusted)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">58,454</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">61,552</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">61,552</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:10pt Times New Roman, Times, Serif;text-align:left">Unamortized share issuance (discount)/premium associated with 8.00% Series&#160;F Term Preferred Stock due 2029</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">(9</p>
            </td>
            <td style="text-align:left">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">)</p>
            </td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt">Other liabilities</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">30,006</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">30,006</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">30,006</p>
            </td>
            <td style="padding-bottom:1pt;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:2.5pt">Total liabilities</td>
            <td style="font-size:10pt;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:right">301,998</td>
            <td style="padding-bottom:2.5pt;font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">305,096</td>
            <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">405,096</p>
            </td>
            <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left">Temporary Equity:</td>
            <td style="font-size:10pt;font-weight:bold">&#160;</td>
            <td style="font-size:10pt;font-weight:bold;text-align:left">&#160;</td>
            <td style="font-size:10pt;font-weight:bold;text-align:right">&#160;</td>
            <td style="font-size:10pt;font-weight:bold;text-align:left">&#160;</td>
            <td style="font-size:10pt;font-weight:bold">&#160;</td>
            <td style="font-size:10pt;font-weight:bold;text-align:left">&#160;</td>
            <td style="font-size:10pt;font-weight:bold;text-align:right">&#160;</td>
            <td style="font-size:10pt;font-weight:bold;text-align:left">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;text-align:right">&#160;</td>
            <td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:10pt Times New Roman, Times, Serif;text-align:left">6.75% Series&#160;D Perpetual Preferred Stock, par value $0.001 per share; 20,000,000 shares aggregate authorized, 3,212,502 shares issued and outstanding, actual; 3,930,363 shares, pro&#160;forma and pro&#160;forma (as adjusted)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p>
            </td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">68,346</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p>
            </td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">82,260</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">$</p>
            </td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">82,260</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:10pt Times New Roman, Times, Serif;text-align:left">7.00% Series&#160;AA Convertible Perpetual Preferred Stock, par value $0.001 per share; 20,000,000 shares aggregate authorized, 803,830 shares issued and outstanding, actual; 1,248,177&#160;&#160;shares, pro&#160;forma and pro&#160;forma (as adjusted)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">18,416</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">28,636</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">28,636</p>
            </td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt">7.00% Series&#160;AB Convertible Perpetual Preferred Stock, par value $0.001 per share; 20,000,000 shares aggregate authorized, 8,850 shares issued and outstanding, actual; 59,839&#160;&#160;shares, pro&#160;forma and pro&#160;forma (as adjusted)</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">215</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">1,464</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,464</p>
            </td>
            <td style="padding-bottom:1pt;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:2.5pt">Total Temporary Equity</td>
            <td style="font-size:10pt;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:right">86,977</td>
            <td style="padding-bottom:2.5pt;font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:right">112,360</td>
            <td style="padding-bottom:2.5pt;font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">112,360</p>
            </td>
            <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;text-indent:-0.125in;font:bold 10pt Times New Roman, Times, Serif;text-align:left">Net Assets applicable to 105,932,755 shares of common stock, actual; 110,456,488 shares outstanding pro&#160;forma, pro&#160;forma as adjusted</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">$</td>
            <td style="font-size:10pt;text-align:right">893,555</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">$</td>
            <td style="font-size:10pt;text-align:right">901,647</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">898,122</p>
            </td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">Net Assets consist of:</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;text-align:right">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;text-align:right">&#160;</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">&#160;</td>
            <td style="text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;font:10pt Times New Roman, Times, Serif;text-align:left">Paid-in capital</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">$</td>
            <td style="font-size:10pt;text-align:right">1,215,833</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt">&#160;</td>
            <td style="font-size:10pt;text-align:left">$</td>
            <td style="font-size:10pt;text-align:right">1,258,992</td>
            <td style="font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,258,992</p>
            </td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="padding-left:0.125in;font:10pt Times New Roman, Times, Serif;text-align:left">Aggregate distributable earnings (losses)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(317,933</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)</td>
            <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(353,000</td>
            <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)</td>
            <td>&#160;</td>
            <td style="text-align:left">&#160;</td>
            <td style="text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">(356,525</p>
            </td>
            <td style="text-align:left">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">)</p>
            </td>
          </tr>
          <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
            <td style="padding-left:0.125in;font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt">Accumulated other comprehensive income (loss)</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">(4,345</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">)</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">(4,345</td>
            <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">)</td>
            <td style="padding-bottom:1pt">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:left">&#160;</td>
            <td style="border-bottom:Black 1pt solid;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">(4,345</p>
            </td>
            <td style="padding-bottom:1pt;text-align:left">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">)</p>
            </td>
          </tr>
          <tr style="vertical-align:bottom;background-color:White">
            <td style="padding-left:0.125in;font:10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:2.5pt">Total Net Assets</td>
            <td style="font-size:10pt;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:right">893,555</td>
            <td style="padding-bottom:2.5pt;font-size:10pt;text-align:left">&#160;</td>
            <td style="font-size:10pt;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font-size:10pt;text-align:right">901,647</td>
            <td style="padding-bottom:2.5pt;font-size:10pt;text-align:left">&#160;</td>
            <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
            <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">898,122</p>
            </td>
            <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
          </tr>

      </table>
      <p style="margin:0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-16</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="margin:0">&#160;</p>

      <ix:nonNumeric id="Fxbrl_20241203044735112" name="cef:LongTermDebtTableTextBlock" contextRef="C_20241204to20241204" continuedAt="F20241203095554431" escape="true">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_06"><strong><ix:nonNumeric id="Fxbrl_20241203044425896" name="cef:LongTermDebtTitleTextBlock" contextRef="C_20241204to20241204" escape="true"><span style="font-size:10pt;font-family:Times New Roman">DESCRIPTION OF THE NOTES</span></ix:nonNumeric></strong></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The following description of the particular terms of the 2030 Notes supplements and, to the extent inconsistent with, replaces the description of the general terms and provisions of our debt securities set forth in the accompanying prospectus.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes to be sold pursuant to this prospectus supplement will be issued under an indenture, dated as of December&#160;4, 2015, between us and Equiniti Trust Company, LLC (formerly known as American Stock Transfer&#160;&amp; Trust Company, LLC), and a sixth supplemental indenture thereto, to be entered into between us and Equiniti Trust Company, LLC, as trustee. We refer to the indenture and the sixth supplemental indenture thereto collectively as the &#8220;Indenture&#8221; and to Equiniti Trust Company, LLC as the &#8220;Trustee.&#8221; The 2030 Notes are governed by the Indenture, as required by federal law for all bonds and notes of companies that are publicly offered. An indenture is a contract between us and the financial institution acting as trustee on your behalf, and is subject to, and governed by the Trust Indenture Act of 1939, as amended. The Trustee has two main roles. First, the Trustee can enforce your rights against us if we default. There are some limitations on the extent to which the Trustee acts on your behalf, described in the second paragraph under &#8220;<strong><i>&#8212; Events of Default&#8201;&#8212;&#8201;Remedies if an Event of Default Occurs</i></strong>.&#8221; Second, the Trustee performs certain administrative duties for us with respect to the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This section includes a description of the material terms of the 2030 Notes and the Indenture. Because this section is a summary, however, it does not describe every aspect of the 2030 Notes and the Indenture. We urge you to read the Indenture because it, and not this description, defines your rights as a holder of the 2030 Notes. The Indenture has been attached as an exhibit to the registration statement of which this prospectus supplement forms a part and has been filed with the SEC. See &#8220;<strong><i>Additional Information</i></strong>&#8221; in this prospectus supplement for information on how to obtain a copy of the Indenture.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>General</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <ix:nonNumeric id="Fxbrl_20241203113713500" name="cef:LongTermDebtStructuringTextBlock" contextRef="C_20241204to20241204" escape="true">
            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes initially are being offered in the aggregate principal amount of $<ix:nonFraction id="Fxbrl_20241206151452562" name="cef:LongTermDebtPrincipal" contextRef="C_20241204to20241204_usgaapDebtInstrumentAxis_ck0001604174Notes2030Member" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">100,000,000</ix:nonFraction>.</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will mature on June 30, 2030 and 100% of the aggregate principal amount will be paid at maturity (unless the 2030 Notes are earlier redeemed as described below). The interest rate of the 2030 Notes is 7.75% per year and will be paid every March 31, June 30, September 30 and December 31. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment. Interest payments on the 2030 Notes offered by this prospectus supplement will commence on March 31, 2025. The regular record dates for interest payments will be every March 15, June 15, September 15 and December 15. The first record date for the 2030 Notes offered by this prospectus supplement will be March 15, 2024. If a record date for an interest payment falls on a non-business day, the record date will be the next business day. The initial interest period for the 2030 Notes offered by this prospectus supplement will be the period from and including &#160;December 10, 2024, to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.</p>
            </div>
          </ix:nonNumeric>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will issue the 2030 Notes offered pursuant to this prospectus supplement in denominations of $25 and integral multiples of $25 in excess thereof. The 2030 Notes will not be subject to any sinking fund and holders of the 2030 Notes will not have the option to have the 2030 Notes repaid prior to June 30, 2030.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Indenture does not contain any provisions that give you protection in the event we issue a large amount of debt. Other than the restrictions described under &#8220;<strong><i>&#8212; Merger or Consolidation</i></strong>,&#8221; the Indenture does not contain any covenants or other provisions designed to afford holders of the 2030 Notes protection in the event we are acquired by another entity.</p>
        </div>
      </ix:nonNumeric>
      <div style="display:none">
        <ix:continuation id="F20241203095554431" continuedAt="F20241203044810659">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-17</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203044810659" continuedAt="F20241203100920572">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Pursuant to the Indenture, we have the ability, without the consent of the holders thereof, to reopen the 2030 Notes and issue additional 2030 Notes having identical terms and conditions as the 2030 Notes, except for the offering price and the issue date, in one or more series. We may also issue additional series of debt securities under the Indenture and other debt securities in accordance with the limitations of the 1940 Act. Under the 1940 Act, so long as any 2030 Notes are outstanding, additional debt securities, including the Existing Notes, must rank in parity with the 2030 Notes with respect to the payment of interest and as to the distribution of assets upon dissolution, liquidation or the winding-up of our affairs. In addition, we may also enter certain other evidences of indebtedness (including bank borrowings and commercial paper) representing senior securities. We may also borrow in amounts up to 5% of our total assets if the borrowing is for temporary purposes only (i.e., if it is to be repaid within 60&#160;days and not extended or renewed).</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Under the current requirements of the 1940 Act, immediately after issuing any senior securities representing indebtedness (i.e., indebtedness other than borrowings for temporary purposes), including the 2030 Notes and the Existing Notes, we must have an asset coverage of at least 300%. Asset coverage means the ratio which the value of our total assets (including the proceeds of indebtedness), less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness. Other types of borrowings also may result in our being subject to similar covenants in credit agreements.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">While any indebtedness and senior securities remain outstanding, we cannot make distributions to our stockholders or repurchase our capital stock unless we meet the applicable asset coverage requirements under the 1940 Act at the time of, and after giving effect to, the distribution or repurchase.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Ranking</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are unsecured obligations of us and, upon our liquidation, dissolution or winding up, will rank (1)&#160;senior to the outstanding shares of our common stock and our preferred stock, (2)&#160;<i>pari&#160;passu</i>&#160;(or equally) with our existing and future unsecured indebtedness, including the Existing Notes, (3)&#160;effectively subordinated to any existing or future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness and (4)&#160;structurally subordinated to all existing and future indebtedness of our subsidiaries, financing vehicles or similar facilities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Optional Redemption</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes may be redeemed in whole or in part at any time or from time to time on or after June 30, 2027 at our option, upon not less than 30-days&#8217; nor more than 60-days&#8217; written notice by mail prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the aggregate principal amount thereof plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">You may be prevented from exchanging or transferring the 2030 Notes when they are subject to redemption. If the 2030 Notes become represented by certificates and, in case any 2030 Notes are to be redeemed in part only, the redemption notice will provide that, upon surrender of such 2030 Note, you will receive, without a charge, a new 2030 Note or 2030 Notes of authorized denominations representing the principal amount of your remaining unredeemed 2030 Notes. Any exercise of our option to redeem the 2030 Notes will be done in compliance with the 1940 Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we redeem only some of the 2030 Notes, the Trustee will determine the method for selection of the particular 2030 Notes to be redeemed, in accordance with the Indenture and the rules&#160;of the NYSE. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the 2030 Notes called for redemption.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100920572" continuedAt="F20241203044827119">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-18</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203044827119" continuedAt="F20241203100925034">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Global Securities</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">DTC will act as securities depository for the 2030 Notes. The 2030 Notes will initially be issued in the form of one or more fully registered 2030 Notes in global form, or &#8220;Global Notes,&#8221; registered in the name of Cede&#160;&amp; Co. (DTC&#8217;s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One Global Note will be issued for each issuance of the 2030 Notes, in the aggregate principal amount thereof, and will be deposited with DTC. As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all the 2030 Notes represented by a Global Note and investors will be permitted to own only beneficial interests in a Global Note. For more information about these arrangements, see &#8220;<strong><i>&#8212; Global Notes; Book-Entry</i></strong>&#8221; below and &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Termination of a Global Security</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If a global security is terminated for any reason, interests in it will be exchanged for certificates in non-book-entry form (certificated securities). After that exchange, the choice of whether to hold the certificated 2030 Notes directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in a global security transferred on termination to their own names, so that they will be holders. See &#8220;<strong><i>&#8212; Form, Exchange and Transfer of Certificated Registered Securities</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Conversion and Exchange</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are not convertible into or exchangeable for other securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Payment and Paying Agents</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will pay interest to the person listed in the Trustee&#8217;s records as the owner of the 2030 Notes at the close of business on a particular day in advance of each due date for interest, even if that person no longer owns any of the 2030 Notes on the interest due date. That day, usually about two weeks in advance of the interest due date, is called the &#8220;record date.&#8221; Because we will pay all the interest for an interest period to the holders on the record date, holders buying and selling the 2030 Notes must work out between themselves the appropriate purchase price. The most common manner is to adjust the sales price of the 2030 Notes to prorate interest fairly between buyer and seller based on their respective ownership periods within the particular interest period. This prorated interest amount is called &#8220;accrued interest.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Payments on Global Securities</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will make payments on the 2030 Notes so long as they are represented by Global Notes in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the Global Notes. An indirect holder&#8217;s right to those payments will be governed by the rules&#160;and practices of the depositary and its participants, as described under &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Payments on Certificated Securities</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In the event the 2030 Notes become represented by certificates, we will make payments on the 2030 Notes as follows. We will pay interest that is due on an interest payment date by a check mailed on the interest payment date to the holder of the 2030 Notes at his or her address shown on the Trustee&#8217;s records as of the close of business on the record date. We will make all payments of principal and premium, if any, by check at the office of the Trustee in Brooklyn, New York and/or at other offices that may be specified in the Indenture or a notice to holders against surrender of the 2030 Note.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Alternatively, if the holder asks us to do so, we will pay any amount that becomes due on the 2030 Notes by wire transfer of immediately available funds to an account at a bank in the United States, on the due date. To request payment by wire, the holder must give the Trustee appropriate transfer instructions at least 15 business days before the requested wire payment is due. In the case of any interest payment due on an interest payment date, the instructions must be given by the person who is the holder on the relevant regular record date. Any wire instructions, once properly given, will remain in effect unless and until new instructions are given in the manner described above.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100925034" continuedAt="F20241203044850272">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-19</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203044850272" continuedAt="F20241203100931138">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Payment When Offices Are Closed</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If any payment is due on the 2030 Notes on a day that is not a business day, we will make the payment on the next day that is a business day. Payments made on the next business day in this situation will be treated under the Indenture as if they were made on the original due date. Such payment will not result in a default under the 2030 Notes or the Indenture, and no interest will accrue on the payment amount from the original due date to the next day that is a business day.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Events of Default</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">You will have rights if an Event of Default occurs in respect of the 2030 Notes and is not cured, as described later in this subsection. The term &#8220;Event of Default&#8221; in respect of the 2030 Notes means any of the following:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We do not pay the principal of, or any premium on, any 2030 Note when due and payable, and such default is not cured within five days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We do not pay interest on any 2030 Note when due, and such default is not cured within 30&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We remain in breach of any other covenant with respect to the 2030 Notes for 60&#160;days after we receive a written notice of default stating we are in breach. The notice must be sent by either the Trustee or holders of at least 25% of the principal amount of the 2030 Notes.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We file for bankruptcy, or certain other events of bankruptcy, insolvency or reorganization occur, and in the case of certain orders or decrees entered against us under any bankruptcy law, such order or decree remains undischarged or unstayed for a period of 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">On the last business day of each of twenty-four consecutive calendar&#160;months, all series of our debt securities issued under the Indenture together have an asset coverage, as defined in the 1940 Act, of less than 100% after giving effect to exemptive relief, if any, granted to us by the SEC.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">An Event of Default for the 2030 Notes does not necessarily constitute an Event of Default for any other series of debt securities issued under the same or any other indenture. The Trustee may withhold notice to the holders of the 2030 Notes of any default, except in the payment of principal or interest, if it in good faith considers the withholding of notice to be in the best interests of the holders.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Remedies if an Event of Default Occurs</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If an Event of Default has occurred and is continuing, the following remedies are available. The Trustee or the holders of not less than 25% in principal amount of the 2030 Notes may declare the entire principal amount of all of the 2030 Notes to be due and immediately payable. This is called a declaration of acceleration of maturity. In certain circumstances, a declaration of acceleration of maturity may be canceled by the holders of a majority in principal amount of the 2030 Notes if (1)&#160;we have deposited with the Trustee all amounts due and owing with respect to the 2030 Notes (other than principal that has become due solely by reason of such acceleration) and certain other amounts, and (2)&#160;any other Events of Default have been cured or waived.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Trustee is not required to take any action under the Indenture at the request of any holders unless the holders offer the Trustee protection from expenses and liability reasonably satisfactory to it (called an &#8220;indemnity&#8221;). If indemnity reasonably satisfactory to the Trustee is provided, the holders of a majority in principal amount of the 2030 Notes may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the Trustee. The Trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100931138" continuedAt="F20241203050306143">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-20</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050306143" continuedAt="F20241203100937011">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Before you are allowed to bypass the Trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the 2030 Notes, the following must occur:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">you must give the Trustee written notice that an Event of Default has occurred and remains uncured;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">the holders of at least 25% in principal amount of the 2030 Notes must make a written request that the Trustee take action because of the default and must offer the Trustee reasonable indemnity, security or both against the cost and other liabilities of taking that action;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">the Trustee must not have taken action for 60&#160;days after receipt of the above notice and offer of indemnity and/or security; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">the holders of a majority in principal amount of the 2030 Notes must not have given the Trustee a direction inconsistent with the above notice during that 60-day period.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">However, you are entitled at any time to bring a lawsuit for the payment of money due on your 2030 Notes on or after the due date thereof.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Book-entry and other indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the Trustee and how to declare or cancel an acceleration of maturity.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Each year, we will furnish to the Trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the Indenture and the 2030 Notes, or else specifying any default.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Waiver of Default</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The holders of a majority in principal amount of the 2030 Notes may waive any past defaults other than a default:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">in the payment of principal or interest; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">in respect of a covenant that cannot be modified or amended without the consent of each holder.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Merger or Consolidation</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Under the terms of the Indenture, we are generally permitted to consolidate or merge with another entity. We are also permitted to sell all or substantially all of our assets to another entity. However, we may not take any of these actions unless all the following conditions are met:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">where we merge out of existence or convey or transfer all of our assets, the resulting entity must agree to be legally responsible for our obligations under the 2030 Notes;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">immediately after the transaction, no Default or Event of Default will have happened and be continuing; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver certain certificates and documents to the Trustee.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Modification or Waiver</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">There are three types of changes we can make to the Indenture and the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Changes Requiring Your Approval</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">First, there are changes that we cannot make to your 2030 Notes without your specific approval. The following is a list of those types of changes:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">change the stated maturity of the principal of or interest on the 2030 Notes;</td>
              </tr>

          </table>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100937011" continuedAt="F20241203050534511">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-21</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050534511" continuedAt="F20241203100943194">
        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce any amounts due on the 2030 Notes;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce the amount of principal payable upon acceleration of the maturity of a 2030 Note following a default;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">change the place or currency of payment on a 2030 Note;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">impair your right to sue for payment on the 2030 Notes following the date on which such amount is due and payable;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce the&#160;percentage in principal amount of holders of 2030 Notes whose consent is needed to modify or amend the Indenture;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce the&#160;percentage in principal amount of holders of 2030 Notes whose consent is needed to waive compliance with certain provisions of the Indenture or to waive certain defaults; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">modify any other aspect of the provisions of the Indenture dealing with supplemental indentures, waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Changes Not Requiring Approval</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The second type of change does not require any vote by the holders of the 2030 Notes. This type is limited to clarifications and certain other changes that would not materially adversely affect holders of the 2030 Notes in any material respect. We also do not need any approval to make any change that affects only 2030 Notes to be issued under the Indenture after the change takes effect.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Changes Requiring Majority Approval</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Any other change to the Indenture and the 2030 Notes would require the following approval:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">if the change affects only the 2030 Notes, it must be approved by the holders of a majority in principal amount of the 2030 Notes; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">if the change affects more than one series of debt securities issued under the Indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">In each case, the required approval must be given by either written consent or written ballot.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The holders of a majority in principal amount of all of the series of debt securities issued under the Indenture, voting together as one class for this purpose, may waive our compliance with some of our covenants in the Indenture. However, we cannot obtain a waiver of a payment default or of any of the matters covered by the bullet points included above under &#8220;<strong><i>&#8212; Changes Requiring Your Approval</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Further Details Concerning Voting</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">When taking a vote, we will use the following rules&#160;to decide how much principal to attribute to the 2030 Notes:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption. The 2030 Notes will also not be eligible to vote if they have been fully defeased as described later under &#8220;<strong><i>&#8212; Defeasance&#8201;&#8212;&#8201;Full Defeasance</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will generally be entitled to set any day as a record date for the purpose of determining the holders of the 2030 Notes that are entitled to vote or take other action under the Indenture. However, the record date may not be more than 30&#160;days before the date of the first solicitation of holders to vote on or take such action and not later than the date on which solicitation is completed. If we set a record date for a vote or other action to be taken by holders of the 2030 Notes, that vote or action may be taken only by persons who are holders of the 2030 Notes on the record date and must be taken within eleven&#160;months following the record date.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100943194" continuedAt="F20241203050544620">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-22</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050544620" continuedAt="F20241203100949100">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Book-entry and other indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change the Indenture or the 2030 Notes or request a waiver.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Satisfaction and Discharge; Defeasance</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We may satisfy and discharge our obligations under the Indenture by delivering to the Trustee for cancellation all outstanding 2030 Notes or by depositing with the Trustee after the 2030 Notes have become due and payable, or otherwise, moneys sufficient to pay all of the outstanding 2030 Notes and paying all other sums payable under the Indenture by us. Such discharge is subject to terms contained in the Indenture.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Defeasance</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The following defeasance provisions will be applicable to the 2030 Notes. &#8220;Defeasance&#8221; means that, by depositing with the Trustee an amount of cash and/or government securities sufficient to pay all principal and interest, if any, on the 2030 Notes when due and satisfying any additional conditions noted below, we will be deemed to have been discharged from our obligations under the 2030 Notes. In the event of a &#8220;covenant defeasance,&#8221; upon depositing such funds and satisfying similar conditions discussed below we would be released from certain covenants under the Indenture relating to the 2030 Notes. The consequences to the holders of the 2030 Notes would be that, while they would no longer benefit from certain covenants under the Indenture, and while the 2030 Notes could not be accelerated for any reason, the holders of 2030 Notes nonetheless would be guaranteed to receive the principal and interest owed to them.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Covenant Defeasance</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Under current U.S. federal income tax law and the Indenture, we can make the deposit described below and be released from some of the restrictive covenants in the Indenture under which the 2030 Notes were issued. This is called &#8220;covenant defeasance.&#8221; In that event, you would lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside in trust to repay your 2030 Notes. In order to achieve covenant defeasance, the following must occur:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">since the 2030 Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the 2030 Notes a combination of cash and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the 2030 Notes on their various due dates;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the 2030 Notes any differently than if we did not make the deposit and just repaid the debt securities ourselves at maturity;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion and officers&#8217; certificate stating that all conditions precedent to covenant defeasance have been complied with;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">defeasance must not result in a breach or violation of, or result in a default under, the Indenture or any of our other material agreements or instruments; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">no default or Event of Default with respect to the 2030 Notes shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization shall occur during the next 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we accomplish covenant defeasance, you can still look to us for repayment of the 2030 Notes if there were a shortfall in the trust deposit or the Trustee is prevented from making payment. In fact, if one of the remaining Events of Default occurred (such as our bankruptcy) and the 2030 Notes became immediately due and payable, there might be a shortfall. Depending on the event causing the default, you may not be able to obtain payment of the shortfall.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100949100" continuedAt="F20241203050610695">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-23</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050610695" continuedAt="F20241203100954891">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Full Defeasance</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If there is a change in U.S. federal income tax law, as described below, we can legally release ourselves from all payment and other obligations on the 2030 Notes (called &#8220;full defeasance&#8221;) if we put in place the following other arrangements for you to be repaid:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">since the 2030 Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the 2030 Notes a combination of money and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the 2030 Notes on their various due dates;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion confirming that there has been a change in current U.S. federal income tax law or an IRS ruling that allows us to make the above deposit without causing you to be taxed on the 2030 Notes any differently than if we did not make the deposit. Under current U.S. federal income tax law the deposit and our legal release from the 2030 Notes would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your 2030 Notes and you would recognize gain or loss on the 2030 Notes at the time of the deposit;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion and officers&#8217; certificate stating that all conditions precedent to defeasance have been complied with;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">defeasance must not result in a breach or violation of, or constitute a default under, the Indenture or any of our other material agreements or instruments; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">no default or Event of Default with respect to the 2030 Notes shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization shall occur during the next 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we ever did accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the 2030 Notes. You could not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever became bankrupt or insolvent. If your 2030 Notes were effectively subordinated as described under &#8220;<strong><i>&#8212; Ranking</i></strong>,&#8221; such subordination would not prevent the Trustee under the Indenture from applying the funds available to it from the deposit referred to in the first bullet of the preceding paragraph to the payment of amounts due in respect of such 2030 Notes for the benefit of the subordinated debtholders.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <ix:nonNumeric id="Fxbrl_20241203114027683" name="cef:LongTermDebtDividendsAndCovenantsTextBlock" contextRef="C_20241204to20241204" continuedAt="F20241203114036203" escape="true">
            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Covenants</strong></p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In addition to any other covenants described in the accompanying prospectus, as well as standard covenants relating to payment of principal and interest, maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following covenants will apply to the 2030 Notes:</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes remain outstanding, our payment obligations under the Indenture and the 2030 Notes will at all times rank&#160;<i>pari&#160;passu</i>, without preference or priority, with all of our existing and future unsecured indebtedness and senior to any preferred stock we may issue.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with respect to such borrowings equals at least 300% after such borrowings. See &#8220;<strong><i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us</i></strong>&#8221; in the accompanying prospectus.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#8217;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our preferred stock as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).</td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
          <div style="display:none">
            <ix:continuation id="F20241203114036203" continuedAt="F20241203114050549">
              <div>&#160;</div>
            </ix:continuation>
          </div>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203100954891" continuedAt="F20241203050627479">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-24</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050627479" continuedAt="F20241203101000546">
        <div>
          <ix:continuation id="F20241203114050549">
            <div>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">If, at any time, we are not subject to the reporting requirements of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we agree to furnish to holders of the 2030 Notes and the Trustee, for the period of time during which the 2030 Notes are outstanding, our audited annual consolidated financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements, within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance with applicable GAAP.</td>
                  </tr>

              </table>
            </div>
          </ix:continuation>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Form, Exchange and Transfer of Certificated Registered Securities</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">2030 Notes in physical, certificated form will be issued and delivered to each person that DTC identifies as a beneficial owner of the related 2030 Notes only if:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">DTC notifies us at any time that it is unwilling or unable to continue as depositary for the Global Notes and a successor depositary is not appointed within 90&#160;days; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">DTC ceases to be registered as a clearing agency under the Exchange Act and a successor depositary is not appointed within 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Holders may exchange their certificated securities for 2030 Notes of smaller denominations or combined into fewer 2030 Notes of larger denominations, as long as the total principal amount is not changed and as long as the denomination is equal to or greater than $25.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Holders may exchange or transfer their certificated securities at the office of the Trustee. We have appointed the Trustee to act as our agent for registering 2030 Notes in the names of holders transferring 2030 Notes. We may appoint another entity to perform these functions or perform them ourselves.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Holders will not be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange will be made only if our transfer agent is satisfied with the holder&#8217;s proof of legal ownership.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We may appoint additional transfer agents or cancel the appointment of any particular transfer agent. We may also approve a change in the office through which any transfer agent acts.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we redeem any of the 2030 Notes, we may block the transfer or exchange of those 2030 Notes selected for redemption during the period beginning 15&#160;days before the day we mail the notice of redemption and ending on the day of that mailing, in order to determine and fix the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of any certificated 2030 Notes selected for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any 2030 Note that will be partially redeemed.</p>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203101000546" continuedAt="F20241203050638119">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-25</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050638119" continuedAt="F20241203101005747">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Resignation of Trustee</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Trustee may resign or be removed with respect to the 2030 Notes, provided that a successor trustee is appointed to act with respect to the 2030 Notes. In the event that two or more persons are acting as trustee with respect to different series of indenture securities under the Indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any other trustee.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Concerning the Trustee</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Trustee serves as trustee for the Existing Notes, transfer agent for our common stock and Preferred Stock and agent for our dividend reinvestment plan. We will appoint the Trustee as registrar and paying agent under the Indenture.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Governing Law</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Indenture and the 2030 Notes will be governed by, and construed in accordance with, the laws of the State of New York.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Global Notes; Book-Entry</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Global Notes</i></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Ownership of beneficial interests in a Global Note will be limited to persons who have accounts with DTC, or the DTC participants, or persons who hold interests through DTC participants. We expect that under procedures established by DTC:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">upon deposit of a Global Note with DTC&#8217;s custodian, DTC will credit portions of the principal amount of the Global Note to the accounts of the DTC participants designated by the underwriters, if applicable; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">ownership of beneficial interests in a Global Note will be shown on, and transfer of ownership of those interests will be effected only through, records maintained by DTC (with respect to interests of DTC participants) and the records of DTC participants (with respect to other owners of beneficial interests in the Global Note).</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Beneficial interests in Global Notes may not be exchanged for 2030 Notes in physical, certificated form except in the limited circumstances described under &#8220;<strong><i>&#8212; Form, Exchange and Transfer of Certificated Registered Securities</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Book-Entry Procedures for Global Notes</i></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">All interests in the Global Notes will be subject to the operations and procedures of DTC. The operations and procedures of DTC are controlled by that settlement system and may be changed at any time. Neither we nor the underwriters are responsible for those operations or procedures. See &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus for a description of DTC&#8217;s operations and procedures.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">So long as DTC&#8217;s nominee is the registered owner of a Global Note, that nominee will be considered the sole owner or holder of the 2030 Notes represented by that Global Note for all purposes under the Indenture. Except as provided under &#8220;<strong><i>&#8212; Form, Exchange and Transfer of Certificated Registered Securities</i></strong>,&#8221; owners of beneficial interests in a Global Note:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">will not be entitled to have 2030 Notes represented by the Global Note registered in their names;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">will not receive or be entitled to receive physical, certificated 2030 Notes; and</td>
              </tr>

          </table>
        </div>
      </ix:continuation>
      <div style="display:none">
        <ix:continuation id="F20241203101005747" continuedAt="F20241203050654438">
          <div>&#160;</div>
        </ix:continuation>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-26</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <ix:continuation id="F20241203050654438">
        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">will not be considered the owners or holders of the 2030 Notes under the Indenture for any purpose, including with respect to the giving of any direction, instruction or approval to the Trustee under the Indenture.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">As a result, each investor who owns a beneficial interest in a Global Note must rely on the procedures of DTC to exercise any rights of a holder of 2030 Notes under the Indenture (and, if the investor is not a participant or an indirect participant in DTC, on the procedures of the DTC participant through which the investor owns its interest). Payments of principal and interest with respect to the 2030 Notes represented by a Global Note will be made by the Trustee to DTC&#8217;s nominee as the registered holder of the Global Note. Neither we nor the Trustee will have any responsibility or liability for the payment of amounts to owners of beneficial interests in a Global Note, for any aspect of the records relating to or payments made on account of those interests by DTC, or for maintaining, supervising or reviewing any records of DTC relating to those interests.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Payments by participants and indirect participants in DTC to the owners of beneficial interests in a Global Note will be governed by standing instructions and customary industry practice and will be the responsibility of those participants or indirect participants and DTC.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Transfers between participants in DTC will be effected under DTC&#8217;s procedures and will be settled in same-day funds.</p>
        </div>
      </ix:continuation>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">
        <p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-27</p>
      </div>
      <div style="break-before:page;margin-top:6pt;margin-bottom:12pt">
        <p style="margin:0pt">&#160;</p>
      </div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong><span id="h_07"></span>UNDERWRITING</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Lucid Capital Markets, LLC is acting as representative of the several underwriters named below. Subject to the terms and conditions stated in the underwriting agreement dated December 4, 2024, each underwriter named below has agreed to purchase, and we have agreed to sell to that underwriter, the aggregate principal amount of the 2030 Notes set forth opposite the underwriter&#8217;s name.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"><tr style="vertical-align:bottom;background-color:White"><td style="border-bottom:Black 1pt solid;width:85%;font:bold 10pt Times New Roman, Times, Serif">Underwriter</td><td style="font:bold 10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt;width:1%;text-align:left">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:12%;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Aggregate<br/>Principal<br/>Amount</strong></span></td><td style="font:bold 10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Lucid Capital Markets, LLC</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">62,040,000</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">B. Riley Securities,&#160;Inc.</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">6,522,500</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Piper Sandler&#160;&amp; Co.</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">6,740,000</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Janney Montgomery Scott LLC</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2,175,000</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">InspereX LLC</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">6,522,500</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">William Blair&#160;&amp; Company, L.L.C.</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">8,587,500</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Clear Street LLC</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">5,760,000</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">Wedbush Securities Inc.</td><td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="border-bottom:Black 1pt solid;padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">1,652,500</p></td><td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">Total</td><td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right"><p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">100,000,000</p></td><td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed, severally and not jointly, to purchase all of the 2030 Notes sold under the underwriting agreement if any of the 2030 Notes are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the underwriting agreement may be terminated.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We, the Adviser and the Administrator have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The underwriting agreement provides that the obligations of the underwriters to purchase the 2030 Notes are subject to approval of legal matters by counsel to the underwriters and certain other conditions, including the receipt by the underwriters of officers&#8217; certificates and legal opinions. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. Investors must pay for the 2030 Notes purchased in this offering on or about December 10, 2024.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Commission and Discount</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">An underwriting discount of 3.125% per 2030 Note will be paid by us. This underwriting discount will also apply to any 2030 Notes purchased pursuant to the overallotment option. The underwriters have advised us that they propose initially to offer the 2030 Notes to the public at the public offering price on the cover of this prospectus supplement and to certain other Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) members at that price less a concession not in excess of $0.50 per 2030 Note.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The following table shows the total underwriting discounts and commissions that we are to pay to the underwriters in connection with this offering. The information assumes either no exercise or full exercise by the underwriters of their overallotment option.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"><tr style="vertical-align:bottom;background-color:White"><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td colspan="5" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Total</strong></span></td><td style="padding-bottom:1pt;text-align:center">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Per 2030<br/>Note</strong></span></td><td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Without<br/>Overallotment</strong></span></td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:center">&#160;</td><td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt">&#160;</td><td style="border-bottom:Black 1pt solid;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif;text-align:center">&#160;</td><td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>With<br/>Overallotment</strong></span></td><td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:center">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="width:61%;font:10pt Times New Roman, Times, Serif">Public offering price</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">100</p></td><td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">%</span></td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">100,000,000</p></td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">115,000,000</p></td><td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:White"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Sales load (underwriting discounts and commissions)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">3.125</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">%</span></td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">3,125,000</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">3,593,750</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr><tr style="vertical-align:bottom;background-color:rgb(204,238,255)"><td style="font:10pt Times New Roman, Times, Serif;text-align:left">Proceeds to us (before expenses)</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">96.875</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">%</span></td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">96,875,000</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td><td style="font:10pt Times New Roman, Times, Serif">&#160;</td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">$</td><td style="font:10pt Times New Roman, Times, Serif;text-align:right"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">111,406,250</p></td><td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr></table><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-28</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We estimate that the total expenses of this offering, excluding the sales load, will be approximately $400,000. As part of our payment of our offering expenses, we have agreed to pay expenses related to the fees and disbursements of counsel to the underwriters, in an amount not to exceed $35,000 in the aggregate, in connection with entering into the underwriting agreement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Overallotment Option</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We have granted an option to the underwriters to purchase up to an additional $15,000,000 aggregate principal amount of the 2030 Notes offered hereby at the public offering price, less the underwriting discounts and commissions, within 30 days from the date of this prospectus supplement solely to cover any overallotments. If the underwriters exercise this option, each will be obligated, subject to conditions contained in the underwriting agreement, to purchase a number of additional 2030 Notes proportionate to that underwriter&#8217;s initial principal amount reflected in the table above.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>No Sales of Debt Securities</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Subject to certain exceptions, we have agreed not to sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, any debt securities issued or guaranteed by us or any securities convertible into or exercisable or exchangeable for debt securities issued or guaranteed by us or file or cause to be declared effective a registration statement under the Securities Act with respect to any of the foregoing, without the consent of the underwriters, for a period of 30&#160;days from the date of this prospectus supplement. This consent may be given at any time without public notice.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Listing</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are a new issue of securities with no established trading market. We intend to list the 2030 Notes on the NYSE under the symbol &#8220;ECCU,&#8221; and we expect trading in the 2030 Notes on the NYSE to begin within 30&#160;days of the original issue date.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We have been advised by certain of the underwriters that they presently intend to make a market in the 2030 Notes after completion of the offering as permitted by applicable laws and regulations. The underwriters are not obligated, however, to make a market in the 2030 Notes and any such market-making may be discontinued at any time in the sole discretion of the underwriters without any notice. Accordingly, no assurance can be given as to the liquidity of, or development of a public trading market for, the 2030 Notes. If an active public trading market for the 2030 Notes does not develop, the market price and liquidity of the 2030 Notes may be adversely affected.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Price Stabilization and Short Positions</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In connection with the offering, the underwriters may purchase and sell 2030 Notes in the open market. These transactions may include overallotment, covering transactions and stabilizing transactions. Overallotment involves sales of securities in excess of the aggregate principal amount of securities to be purchased by the underwriters in the offering, which creates a short position for the underwriters. Covering transactions involve purchases of the securities in the open market after the distribution has been completed in order to cover short positions. Stabilizing transactions consist of certain bids or purchases of securities made for the purpose of preventing or retarding a decline in the market price of the securities while the offering is in progress.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-29</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representative has repurchased 2030 Notes sold by or for the account of such underwriter in stabilizing or short covering transactions.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any of these activities may cause the price of the 2030 Notes to be higher than the price that otherwise would exist in the open market in the absence of such transactions. These transactions may be affected in the over-the-counter market or otherwise and, if commenced, may be discontinued at any time without any notice relating thereto.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Alternative Settlement Cycle</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We expect that delivery of the 2030 Notes will be made against payment therefor on or about December 10, 2024, which will be the third business day following the date of the pricing of the 2030 Notes (such settlement being herein referred to as &#8220;T+3&#8221;). Under Rule 15c6-1 promulgated under the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the 2030 Notes prior to the date of delivery hereunder will be required, by virtue of the fact that the 2030 Notes initially will settle in T+3 business days, to specify an alternative settlement arrangement at the time of any such trade to prevent a failed settlement.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Other Relationships</strong></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We anticipate that, from time to time, certain of the underwriters may act as a broker or a dealer in connection with the execution of our portfolio transactions after it has ceased to be an underwriter and, subject to certain restrictions, may act as a broker while it is an underwriter.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Certain underwriters may have performed investment banking and financial advisory services for us, the Adviser and our affiliates from time to time, for which they have received customary fees and expenses. Certain underwriters may, from time to time, engage in transactions with or perform services for us, the Adviser and our affiliates in the ordinary course of business.</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The principal business addresses of the underwriters are: </span><span style="color:#212529;background-color:white">Lucid Capital Markets, LLC, 570 Lexington Ave, 40th Floor, New York, NY 10022; B. Riley Securities,&#160;Inc., 299 Park Avenue, 21st Floor, New York, NY 10171; Piper Sandler&#160;&amp; Co., 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402; Janney Montgomery Scott LLC, 1717 Arch Street, Philadelphia, PA 19103; InspereX LLC, 25 SE 4th Avenue, Suite&#160;400, Delray Beach, FL 33483; William Blair&#160;&amp; Company, L.L.C., 150 North Riverside Plaza, Chicago,&#160;IL 60606; Clear Street LLC, 4 World Trade Center, 45th Floor, New York, NY 10007; and Wedbush Securities Inc., 142 West 57th Street, 12th Floor, New York, NY 10019.</span></p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-30</p></div><div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p><p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"> <strong><span id="h_08"></span>U.S. FEDERAL INCOME TAX MATTERS</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The following is a summary
of certain U.S. federal income tax consequences generally applicable to the purchase, ownership and disposition of the 2030 Notes as of
the date of this prospectus supplement. Unless otherwise stated, this summary principally applies only to holders of the 2030 Notes who
acquire the 2030 Notes pursuant to this offering at their &#8220;issue price&#8221; within the meaning of the applicable provisions of
the Code and who hold the 2030 Notes as capital assets for U.S. federal tax purposes (generally, property held for investment).</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">As used herein, a &#8220;U.S.
holder&#8221; means a beneficial owner of the 2030 Notes that is for U.S. federal income tax purposes any of the following:</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">an individual citizen or resident of the United States;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created
or organized in or under the laws of the United States, any state or other political subdivision thereof (including the District of Columbia);</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a trust if it (a)&#160;is subject to the primary supervision of a court within the United States and one
or more United States persons have the authority to control all substantial decisions of the trust or (b)&#160;has a valid election in
effect under applicable United States Treasury regulations, or &#8220;Treasury Regulations,&#8221; to be treated as a United States person;
or</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">an estate, the income of which is subject to U.S. federal income taxation regardless of its source.</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The term &#8220;non-U.S.
holder&#8221; means a beneficial owner of the 2030 Notes (other than a partnership or any other entity or other arrangement treated as
a partnership for U.S. federal income tax purposes) that is not a U.S. holder.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">An individual may, subject
to exceptions, be deemed to be a resident of the United States for U.S. federal income tax purposes, as opposed to a non-resident alien,
by, among other ways, being present in the United States (i)&#160;on at least 31&#160;days in the calendar year, and (ii)&#160;for an
aggregate of at least 183&#160;days during a three-year period ending in the current calendar year, counting for such purposes all of
the days present in the current year, one-third of the days present in the immediately preceding calendar year, and one-sixth of the days
present in the second preceding calendar year. Individuals who are residents for such purposes are subject to U.S. federal income tax
as if they were United States citizens.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This summary does not represent
a detailed description of the U.S. federal income tax consequences applicable to you, as a holder of the 2030 Notes, if you are a person
subject to special tax treatment under the U.S. federal income tax laws, including, without limitation:</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a dealer in securities or currencies;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a financial institution;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a RIC;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a real estate investment trust;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a tax-exempt organization;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">an insurance company;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a person holding the 2030 Notes as part of a hedging, integrated, conversion or constructive sale transaction
or a straddle;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a trader in securities that has elected the mark-to-market method of accounting for their securities;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a person subject to alternative minimum tax;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a partnership or other pass-through entity for U.S. federal income tax purposes;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a U.S. holder whose &#8220;functional currency&#8221; is not the U.S. dollar;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a U.S. holder who is subject to the special tax accounting rules&#160;under Section&#160;451(b)&#160;of
the Code;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a &#8220;controlled foreign corporation,&#8221; or &#8220;CFC&#8221;;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a &#8220;passive foreign investment company,&#8221; or &#8220;PFIC&#8221;; or</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">a United States expatriate or foreign persons or entities (except to the extent set forth below).</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-31</p></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If a partnership (including
any entity classified or arrangement treated as a partnership for U.S. federal income tax purposes) holds 2030 Notes, the tax treatment
of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are a partnership or a
partner in a partnership holding 2030 Notes, you should consult your own tax advisors regarding the tax consequences of an investment
in the 2030 Notes.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This summary is based on
the Code, Treasury Regulations, rulings and judicial decisions as of the date hereof. Those authorities may be changed, possibly on a
retroactive basis, so as to result in U.S. federal income tax consequences different from those summarized below. This summary does not
represent a detailed description of the U.S. federal income tax consequences that may be applicable to you in light of your particular
circumstances and, except as noted below, does not address the effects of any aspects of U.S. estate or gift, or state, local or non-U.S.
income, estate or gift tax laws. It is not intended to be, and should not be construed to be, legal or tax advice to any particular purchaser
of 2030 Notes. We have not sought and will not seek any ruling from the Internal Revenue Service, or the &#8220;IRS.&#8221; No assurance
can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax aspects set forth
below. For a summary of the U.S. federal income tax considerations applicable to us regarding our election to be treated as a RIC, please
refer to &#8220;<strong><i>U.S. Federal Income Tax Matters&#8201;&#8212;&#8201;Important U.S. Federal Income Tax Considerations Affecting
Us</i></strong>&#8221; in the accompanying prospectus.&#160;<strong>You should consult your own tax advisors concerning the particular U.S. federal
income tax consequences to you of the ownership of the 2030 Notes, as well as the consequences to you arising under the laws or other
guidance of any other taxing jurisdiction.</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Taxation of Note Holders</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Taxation
of U.S. holders</i></span>.&#160;&#160;&#160;Payments or accruals of interest on a 2030 Note generally will be taxable to a U.S. holder
as ordinary interest income at the time they are received (actually or constructively) or accrued, in accordance with the U.S. holder&#8217;s
regular method of tax accounting.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Upon the sale, exchange,
redemption or retirement of a 2030 Note, a U.S. holder generally will recognize capital gain or loss equal to the difference between the
amount realized on the sale, exchange, redemption or retirement (excluding any amounts representing accrued and unpaid interest, which
are treated as ordinary income) and the U.S. holder&#8217;s adjusted tax basis in the 2030 Note. A U.S. holder&#8217;s tax basis in a
2030 Note generally will equal the amount of the U.S. holder&#8217;s initial investment in the 2030 Note. Capital gain or loss recognized
upon the sale or other disposition of a 2030 Note generally will be long-term capital gain or loss if the 2030 Note is held for more than
one year. Long-term capital gains recognized by individuals and certain other non-corporate U.S. holders generally are eligible for preferential
rates of U.S. federal income taxation, currently at a rate of generally either 15% or 20%, depending on whether the U.S. holder&#8217;s
income exceeds certain threshold amounts. The deductibility of capital losses is subject to certain limitations prescribed under the Code.
The distinction between capital gain or loss and ordinary income or loss is also important in other contexts, such as, for example, for
purposes of the limitations on a U.S. holder&#8217;s ability to offset capital losses against ordinary income.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Medicare
Tax on Net Investment Income</i></span>.&#160;&#160;&#160;A 3.8% tax is imposed under Section&#160;1411 of the Code on the &#8220;net
investment income&#8221; of certain U.S. citizens and residents and on the undistributed net investment income of certain estates and
trusts. Among other items, net investment income generally includes payments of interest on, and net gains recognized from the sale, exchange,
redemption, retirement or other taxable disposition of 2030 Notes (unless the 2030 Notes are held in connection with certain trades or
businesses), less certain deductions. Prospective investors in the 2030 Notes should consult their own tax advisors regarding the effect,
if any, of this tax on their ownership and disposition of the 2030 Notes.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Taxation
of Non-U.S. Holders</i></span>.&#160;&#160;&#160;A non-U.S. holder generally will not be subject to U.S. federal income or withholding
taxes on payments or accruals of principal or stated interest on a 2030 Note provided that in the case of interest on the 2030 Note (i)&#160;the
interest is not effectively connected with the conduct by the non-U.S. holder of a trade or business within the United States, (ii)&#160;the
non-U.S. holder is not a CFC directly or indirectly related to the Company through sufficient stock ownership, (iii)&#160;the recipient
is not a bank receiving interest described in Section&#160;881(c)(3)(A)&#160;of the Code, (iv)&#160;the non-U.S. holder does not own (actually
or constructively) 10% or more of the total combined voting power of all classes of stock of the Company and (v)&#160;(A)&#160;the non-U.S.
holder provides to the applicable withholding agent a statement on an IRS Form&#160;W-8BEN, W-8BEN-E or other applicable U.S. nonresident
withholding tax certification form signed under penalties of perjury that includes its name and address and certifies that it is not a
United States person in compliance with applicable requirements, or satisfies documentary evidence requirements for establishing that
it is a non-U.S. holder, or (B)&#160;a securities clearing organization, bank, or other financial institution that holds customer securities
in the ordinary course of its trade or business (<i>i.e</i>., a &#8220;financial institution&#8221;) and holds a 2030 Note certifies to
us under penalties of perjury that either it or another financial institution has received the required statement from the non-U.S. Holder
certifying that it is a non-U.S. person and furnishes us with a copy of the statement.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-32</p></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">A non-U.S. holder that is
not exempt from tax under these rules&#160;generally will be subject to withholding of U.S. federal income tax on payments of interest
on the 2030 Notes at a rate of 30% unless (i)&#160;the interest is effectively connected with the conduct of a United States trade or
business, in which case the interest will be subject to United States federal income tax on a net income basis as applicable to U.S. holders
generally (unless an applicable income tax treaty provides otherwise), or (ii)&#160;an applicable income tax treaty provides for a lower
rate of, or exemption from, this withholding. In the case of a non-U.S. holder that is a corporation for U.S. federal income tax purposes
and that receives income that is effectively connected with the conduct of a United States trade or business, such income may also be
subject to a branch profits tax (which is generally imposed on a non-U.S. corporation on the actual or deemed repatriation from the United
States of earnings and profits attributable to a United States trade or business) at a 30% rate. The branch profits tax may not apply
(or may apply at a reduced rate) if the non-U.S. holder is a qualified resident of a country with which the United States has an income
tax treaty.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">To claim the benefit of an
income tax treaty or to claim exemption from withholding because interest is effectively connected with a United States trade or business,
the non-U.S. holder must timely provide the appropriate, properly executed applicable U.S. nonresident withholding tax certification form
signed under penalties of perjury to the applicable withholding agent.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Generally, a non-U.S. holder
will not be subject to U.S. federal income or withholding taxes on any amount that constitutes capital gain realized upon the sale, exchange,
redemption or retirement of a 2030 Note, provided the gain is not effectively connected with the conduct of a trade or business in the
United States by the non-U.S. holder (and, if required by an applicable income tax treaty, is not attributable to a United States &#8220;permanent
establishment&#8221; maintained by the non-U.S. holder). Certain other exceptions may be applicable, and a non-U.S. holder should consult
its tax advisor in this regard.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">A 2030 Note that is held
by an individual who, at the time of death, is not a citizen or resident of the United States (as specially defined for U.S. federal estate
tax purposes) generally will not be subject to the U.S. federal estate tax, unless, at the time of death, (i)&#160;such individual directly
or indirectly, actually or constructively, owns ten&#160;percent or more of the total combined voting power of all classes of our stock
entitled to vote within the meaning of Section&#160;871(h)(3)&#160;of the Code and the Treasury Regulations thereunder or (ii)&#160;such
individual&#8217;s interest in the 2030 Notes is effectively connected with the individual&#8217;s conduct of a United States trade or
business.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Information
Reporting and Backup Withholding</i></span>.&#160;&#160;&#160;A U.S. holder (other than an &#8220;exempt recipient,&#8221; including a
corporation and certain other persons who, when required, demonstrate their exempt status) may be subject to backup withholding at a rate
of 24% on, and will be subject to information reporting requirements with respect to, payments of principal or interest on, and proceeds
from the sale, exchange, redemption or retirement of, the 2030 Notes. In general, if a non-corporate U.S. holder subject to information
reporting fails to furnish a correct taxpayer identification number or otherwise fails to comply with applicable backup withholding requirements,
backup withholding at the applicable rate may apply. Backup withholding is not an additional tax. Any amount withheld under backup withholding
is allowed as a credit against a U.S. holder&#8217;s U.S. federal income tax liability and may entitle such U.S. holder to a refund, provided
that proper information is timely furnished to the IRS.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-33</p></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If you are a non-U.S. holder,
generally, the applicable withholding agent generally reports to the IRS and to you payments of interest, if any, on the 2030 Notes and
the amount of tax, if any, withheld with respect to those payments. Copies of the information returns reporting such interest payments
and any withholding may also be made available to the tax authorities in the country in which you reside under the provisions of a treaty
or agreement. In general, backup withholding will not apply to payments of interest on your 2030 Notes if you have provided to the applicable
withholding agent the required certification that you are not a U.S. person and the applicable withholding agent does not have actual
knowledge or reason to know that you are a U.S. person. Information reporting and, depending on the circumstances, backup withholding
will apply to payment to you of the proceeds of a sale or other disposition (including a retirement or redemption) of your 2030 Notes
within the United States or conducted through certain U.S.-related financial intermediaries, unless you certify under penalties of perjury
that you are not a U.S. person or you otherwise establish an exemption, and the applicable withholding agent does not have actual knowledge
or reason to know that you are a U.S. person.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">You should consult your own
tax advisor regarding the application of information reporting and backup withholding in your particular circumstance and the availability
of, and procedure for, obtaining an exemption from backup withholding. Backup withholding is not an additional tax, and any amounts withheld
under the backup withholding rules&#160;may be allowed as a refund or a credit against your U.S. federal income tax liability, provided
the required information is timely furnished to the IRS.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>FATCA
Withholding on Payments to Certain Foreign Entities</i></span>.&#160;&#160;&#160;FATCA generally imposes a U.S. federal withholding tax
of 30% on (i)&#160;interest earned in respect of a debt instrument, and (ii)&#160;the gross proceeds from the disposition of a debt instrument
that pays U.S. source interest income paid after December&#160;31, 2018, which, in each case, would include the 2030 Notes, to certain
non-U.S. entities (including, in some circumstances, where such an entity is acting as an intermediary) that fail to comply, or is not
deemed compliant with, certain certification and information reporting requirements that are in addition to, and significantly more onerous
than, the requirement to provide an applicable U.S. nonresident withholding tax certification form, as discussed above. FATCA withholding
taxes generally apply to all withholdable payments without regard to whether the beneficial owner of the payment would otherwise be entitled
to an exemption from withholding taxes pursuant to an applicable tax treaty with the United States or under U.S. domestic law. Proposed
U.S. Treasury regulations which may be relied upon until final regulations are promulgated, suspended indefinitely the requirement for
withholding on payments of the gross proceeds from the sale of any property occurring after December&#160;31, 2018, that could produce
U.S. source interest. If FATCA withholding taxes are imposed with respect to any payments of interest or proceeds made under the 2030
Notes, under certain circumstances, a holder might be eligible for a refund or credit of such taxes. Prospective holders of the 2030 Notes
should consult their own tax advisors regarding the effect, if any, of the FATCA rules&#160;for them based on their particular circumstances.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><strong>The preceding discussion
of material U.S. federal income tax considerations is for general information only and is not tax advice. We urge you to consult your
own tax advisor with respect to the particular tax consequences to you of an investment in the 2030 Notes, including the possible effect
of any pending legislation or proposed regulations.</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-34</p></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





 <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_09"></span><strong>LEGAL MATTERS</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Certain
legal matters in connection with the 2030 Notes will be passed upon for us by Dechert LLP, One International Place, 40</span><span style="font-size:10pt">th</span>&#160;Floor,
100 Oliver Street, Boston, Massachusetts, and for the underwriters by Duane Morris LLP, 1540 Broadway, New York, New York 10036.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_10"></span><strong>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">KPMG LLP, an independent
registered public accounting firm located at 345 Park Avenue, New York, New York 10154, provides audit services, tax return preparation,
and assistance and consultation with respect to the preparation of filings with the SEC.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_11"></span><strong>ADDITIONAL INFORMATION</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This prospectus supplement
and the accompanying prospectus constitute part of a registration statement on Form&#160;N-2 that we have filed with the SEC, together
with any and all amendments and related exhibits under the Securities Act. This prospectus supplement and the accompanying prospectus
do not contain all of the information set forth in the registration statement, some of which is contained in exhibits filed as part of,
or incorporated by reference into, the registration statement as permitted by the rules&#160;and regulations of the SEC. For further information
with respect to us and the 2030 Notes we are offering under this prospectus supplement and the accompanying prospectus, we refer you to
the registration statement, including the exhibits filed as a part of, or incorporated by reference into, the registration statement.
Statements contained in this prospectus supplement and the accompanying prospectus concerning the contents of any contract or any other
document are not necessarily complete. If a contract or other document has been filed as an exhibit to the registration statement or otherwise
incorporated by reference as an exhibit thereto, please see the copy of the contract or document that has been filed or incorporated by
reference. Each statement in this prospectus supplement and the accompanying prospectus relating to a contract or document filed or incorporated
by reference as an exhibit is qualified in all respects by such exhibit.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We file with or submit to
the SEC annual and semi-annual reports, proxy statements and other information meeting the informational requirements of the Exchange
Act. The SEC maintains a website that contains reports, proxy and information statements and other information we file with the SEC at&#160;<i>www.sec.gov</i>.
Information contained on our website is not incorporated into this prospectus supplement or the accompanying prospectus and you should
not consider such information to be part of this prospectus supplement or the accompanying prospectus. This information is also available
free of charge by writing us at Eagle Point Credit Company Inc., 600 Steamboat Road, Suite&#160;202, Greenwich, CT 06830, Attention: Investor
Relations, by telephone at (844) 810-6501, or on our website at&#160;<i>www.eaglepointcreditcompany.com</i>. Information on our website
is not incorporated by reference into or a part of this prospectus supplement or the accompanying prospectus.</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_12"></span><strong>INCORPORATION BY REFERENCE</strong></p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We incorporate by reference
in this prospectus supplement the documents listed below and any future reports and other documents we file with the SEC pursuant to Sections&#160;13(a),
13(c), 14 or 15(d)&#160;of the Exchange Act or pursuant to Rule&#160;30b2-1 under the 1940, until all of the securities offered by this
prospectus supplement have been sold or we otherwise terminate the offering of these securities (such reports and other documents deemed
to be incorporated by reference into this prospectus supplement and to be part hereof from the date of filing of such reports and other
documents). To obtain copies of these filings, see &#8220;Additional Information.&#8221;</p>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924026226/tm246277d1_ncsr.htm" style="-sec-extract:exhibit">Annual Report on Form&#160;N-CSR for fiscal year ended December&#160;31, 2023, filed with the SEC on February&#160;22, 2024</a>.</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924086065/tm2420706d1_ncsrs.htm" style="-sec-extract:exhibit">Semi-Annual Report on Form&#160;N-CSR for the period ended June&#160;30, 2024, filed with the SEC on August&#160;6, 2024</a>;</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-35</p></div>
    <div style="break-before:page;margin-top:6pt;margin-bottom:12pt"><p style="margin:0pt">&#160;</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our interim reports filed pursuant to Rule&#160;30b2-1 under the 1940 Act for the quarters ended March&#160;31,
2024 and September&#160;30, 2024, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1604174/000110465924063622/tm2414830d1_n30b2.htm" style="-sec-extract:exhibit">May&#160;21, 2024</a> and <a href="https://www.sec.gov/Archives/edgar/data/1604174/000110465924118028/tm2427936d1_n30b2.htm" style="-sec-extract:exhibit">November&#160;14, 2024</a>, respectively; and</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>




<table cellpadding="0" cellspacing="0" width="100%" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt"><tr style="vertical-align:top">
<td style="width:0.25in"/><td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td><td style="text-align:justify">our Current Reports on Form&#160;8-K filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924004178/tm243431d1_8k.htm" style="-sec-extract:exhibit">January&#160;16, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924005927/tm243805d1_8k.htm" style="-sec-extract:exhibit">January&#160;23, 2024</a>
<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924024090/tm246314d1_8k.htm" style="-sec-extract:exhibit">February&#160;15, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924033567/tm248686d1_8k.htm" style="-sec-extract:exhibit">March&#160;13, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924046368/tm2411683d1_8k.htm" style="-sec-extract:exhibit">April&#160;11, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924058779/tm2413499d1_8k.htm" style="-sec-extract:exhibit">May&#160;8, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924060029/tm2414189d1_8k.htm" style="-sec-extract:exhibit">May&#160;13, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924062005/tm2414627d1_8k.htm" style="-sec-extract:exhibit">May&#160;15, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924070483/tm2417016d1_8k.htm" style="-sec-extract:exhibit">June&#160;11, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924078579/tm2419114d1_8k.htm" style="-sec-extract:exhibit">July&#160;9, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924083999/tm2420496d1_8k.htm" style="-sec-extract:exhibit">July&#160;30, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924087300/tm2421120d1_8k.htm" style="-sec-extract:exhibit">August&#160;8, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924098645/tm2423720d1_8k.htm" style="-sec-extract:exhibit">September&#160;10, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924107080/tm2425726d1_8k.htm" style="-sec-extract:exhibit">October&#160;8, 2024</a>, and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465924115358/tm2427813d1_8k.htm" style="-sec-extract:exhibit">November&#160;7, 2024</a>.</td></tr></table>




<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>












    <div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid"><p style="text-align:center;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt">S-36</p></div>





<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>






</div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2429841d6_pros.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2429841-6/tm2429841-6_424b2seq1" --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>$1,000,000,000</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Eagle Point Credit Company Inc.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Common Stock</b>&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Preferred Stock</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subscription Rights</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Debt Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are an externally managed,
non-diversified closed-end management investment company that has registered as an investment company under the Investment Company Act
of 1940, as amended, or the &#8220;1940 Act.&#8221; Our primary investment objective is to generate high current income, with a secondary
objective to generate capital appreciation. We seek to achieve our investment objectives by investing primarily in equity and junior
debt tranches of collateralized loan obligations, or &#8220;CLOs,&#8221; that are collateralized by a portfolio consisting primarily
of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
We may also invest in other related securities and instruments or other securities and instruments that the Adviser believes are consistent
with our investment objectives, including senior debt tranches of CLOs, loan accumulation facilities (&#8220;LAFs&#8221;), securities
issued by other securitization vehicles, such as credit-linked notes and collateralized bond obligations, or &#8220;CBOs&#8221;, and
synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial
institutions. LAFs are short- to medium-term facilities often provided by the bank that will serve as the placement agent or arranger
on a CLO transaction. LAFs typically incur leverage between four and six times prior to a CLO&#8217;s pricing. The CLO securities in
which we primarily seek to invest are unrated or rated below investment grade and are considered speculative with respect to timely payment
of interest and repayment of principal. Unrated and below investment grade securities are also sometimes referred to as &#8220;junk&#8221;
securities. In addition, the CLO equity and junior debt securities in which we invest are highly leveraged (with CLO equity securities
typically being leveraged ten times), which magnifies our risk of loss on such investments. See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks
Related to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on
amounts invested and will increase the risk of investing in us.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Eagle Point Credit Management
LLC, or the &#8220;Adviser,&#8221; our investment adviser, manages our investments subject to the supervision of our board of directors.
As of March&#160;31, 2023, the Adviser, collectively with an affiliate of the Adviser, Eagle Point Income Management LLC, or &#8220;Eagle
Point Income Management,&#8221; had approximately $7.8&#160;billion in total assets under management, including capital commitments that
were undrawn as of such date. Eagle Point Administration LLC, an affiliate of the Adviser, or the &#8220;Administrator,&#8221; serves
as our administrator.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may offer, from time
to time, in one or more offerings or series, together or separately, up to $1,000,000,000 of our common stock, Preferred Stock (as defined
herein), subscription rights or debt securities, which we refer to, collectively, as the &#8220;securities.&#8221; We may sell our securities
through underwriters or dealers, &#8220;at-the-market&#8221; to or through a market maker into an existing trading market or otherwise
directly to one or more purchasers or through agents or through a combination of methods of sale. The identities of such underwriters,
dealers, market makers or agents, as the case may be, will be described in one or more supplements to this prospectus. The securities
may be offered at prices and on terms to be described in one or more supplements to this prospectus. In the event we offer common stock,
the offering price per share of our common stock exclusive of any underwriting commissions or discounts will not be less than the net
asset value, or &#8220;NAV,&#8221; per share of our common stock at the time we make the offering except (1)&#160;in connection with
a rights offering to our existing stockholders, (2)&#160;with the consent of the majority of our common stockholders, (3)&#160;upon the
conversion of a convertible security in accordance with its terms or (4)&#160;under such circumstances as the Securities and Exchange
Commission, or the &#8220;SEC,&#8221; may permit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, this prospectus
relates to 5,822,728 shares of our common stock that may be sold by the selling stockholders identified under &#8220;<b><i>Control Persons,
Principal Stockholders and Selling Stockholders</i></b>.&#8221; Sales of our common stock by the selling stockholders, which may occur
at prices below the NAV per share of our common stock, may adversely affect the market price of our common stock and may make it more
difficult for us to raise capital. The selling stockholders acquired their shares of our common stock in connection with our conversion
to a corporation. Each offering by the selling stockholders of their shares of our common stock through agents, underwriters or dealers
will be accompanied by a prospectus supplement that will identify the selling stockholder that is participating in such offering. We
will not receive any proceeds from the sale of shares of our common stock by the selling stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our common stock, 6.50%
Series&#160;C Term Preferred Stock due 2031, 6.75% Series&#160;D Preferred Stock, 6.6875% notes due 2028, 5.375% notes due 2029 and 6.75%
notes due 2031 trade on the New York Stock Exchange under the symbols &#8220;ECC,&#8221; &#8220;ECCC,&#8221; &#8220;ECC PRD,&#8221; &#8220;ECCX,&#8221;
&#8220;ECCV,&#8221; and &#8220;ECCW,&#8221; respectively. Based on the closing price of our common stock on June&#160;5, 2023, the aggregate
market value of the 5,822,728 shares of our common stock held by the selling stockholders is approximately $59.2&#160;million. We determine
the NAV per share of our common stock on a quarterly basis. As of March&#160;31, 2023, the NAV per share of our common stock was $9.10
(the last date prior to the date of this prospectus as of which we determined our NAV). Management&#8217;s unaudited estimate of the
range of our NAV per share of our common stock as of April&#160;30, 2023 was between $8.83 and $8.93. The last reported closing sales
price for our common stock on June&#160;5, 2023 was $10.17 per share, representing a 11.8% premium to our NAV per share as of May&#160;25,
2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Shares of common stock
of closed-end management investment companies that are listed on an exchange frequently trade at a discount to their NAV. If our shares
of common stock trade at a discount to our NAV, it will likely increase the risk of loss for purchasers of our securities.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>Investing
in our securities involves a high degree of risk, including the risk of a substantial loss of investment. Before purchasing any securities,
you should read the discussion of the principal risks of investing in our securities, which are summarized in &#8220;<i>Risk Factors</i>&#8221;
beginning on page&#160;</b></span><b>14 of this prospectus.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>This prospectus contains
important information you should know before investing in our securities. Please read this prospectus and retain it for future reference.
We file annual and semi-annual stockholder reports, proxy statements and other information with the Securities and Exchange Commission,
or the &#8220;SEC.&#8221; To obtain this information free of charge or make other inquiries pertaining to us, please visit our website
(www.eaglepointcreditcompany.com) or call (844) 810-6501 (toll-free). You may also obtain a copy of any information regarding us filed
with the SEC from the SEC&#8217;s website (<i>www.sec.gov</i>).</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Neither the SEC nor any
state securities commission has approved or disapproved of these securities or determined that this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>This prospectus may not
be used to consummate sales of securities unless accompanied by a prospectus supplement.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is June&#160;9, 2023</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; color: #211d1e; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>TABLE OF CONTENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; color: #211d1e; margin: 0pt 0 0pt 1in; text-align: center">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: white 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page&#160;</b></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 95%"><a href="#sa_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY </span></a></td>
    <td style="white-space: nowrap; text-align: right; width: 5%"><a href="#sa_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FEES AND EXPENSES </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SENIOR SECURITIES</span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRICE RANGE OF COMMON STOCK </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL BUSINESS INFORMATION </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE ADVISER AND THE ADMINISTRATOR </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DETERMINATION OF NET ASSET VALUE </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND REINVESTMENT PLAN </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFLICTS OF INTEREST </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. FEDERAL INCOME TAX MATTERS </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF OUR SECURITIES </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF OUR CAPITAL STOCK </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF OUR PREFERRED STOCK </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF OUR SUBSCRIPTION RIGHTS </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF OUR DEBT SECURITIES </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOOK-ENTRY ISSUANCE </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGULATION AS A CLOSED-END MANAGEMENT INVESTMENT COMPANY
    </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL INVESTMENTS AND TECHNIQUES </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROL PERSONS, PRINCIPAL STOCKHOLDERS AND SELLING
    STOCKHOLDERS </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BROKERAGE ALLOCATION </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSTODIAN AND TRANSFER AGENT </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></a></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><a href="#sa_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL INFORMATION </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></a></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><a href="#sa_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION BY REFERENCE </span></a></td>
    <td style="white-space: nowrap; text-align: right"><a href="#sa_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124</span></a></td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">******</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>You should rely only
on the information contained or incorporated by reference in this prospectus. We have not, and the selling stockholders have not, authorized
any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should
not rely on it. We are not, and the selling stockholders identified under <i>&#8220;Control Persons, Principal Stockholders and Selling
Stockholders&#8221;</i> are not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.
You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus.
Our business, financial condition and results of operations may have changed since that date. We will notify securityholders promptly
of any material change to this prospectus during the period in which we are required to deliver the prospectus.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>ABOUT THIS PROSPECTUS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This prospectus is part
of a registration statement that we have filed with the SEC using the &#8220;shelf&#8221; registration process. Under the shelf registration
process, we may offer from time to time up to $1,000,000,000 of our securities on the terms to be determined at the time of the offering.
We may sell our securities through underwriters or dealers, &#8220;at-the-market&#8221; to or through a market maker, into an existing
trading market or otherwise directly to one or more purchasers or through agents or through a combination of methods of sale. The identities
of such underwriters, dealers, market makers or agents, as the case may be, will be described in one or more supplements to this prospectus.
The securities may be offered at prices and on terms described in one or more supplements to this prospectus. In addition, this prospectus
relates to 5,822,728 shares of our common stock that may be sold by the selling stockholders identified under <b><i>&#8220;Control&#160;Persons,
Principal Stockholders and Selling Stockholders.&#8221;</i></b> This prospectus provides you with a general description of the securities
that we and the selling stockholders may offer. Each time we or the selling stockholders use this prospectus to offer securities, we
will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus supplement
may also add, update or change information contained in this prospectus, and the prospectus and prospectus supplement will together serve
as the prospectus. Please carefully read this prospectus and any prospectus supplement, together with any exhibits, before you make an
investment decision.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><div style="padding: 10pt; border: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>


<a id="sa_001"></a><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS SUMMARY</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>The following summary
highlights some of the information contained in this prospectus. It is not complete and may not contain all the information that is important
to a decision to invest in our securities. You should read carefully the more detailed information set forth under &#8220;<b>Risk Factors</b>&#8221;
and the other information included in this prospectus and any applicable prospectus supplement. Except where the context suggests otherwise,
the terms:</i></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.2in; text-align: left"><span><i>&#9679;</i></span></td><td style="text-align: justify"><i>The
                                            &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to
                                            Eagle Point Credit Company Inc., a Delaware corporation, and its consolidated subsidiaries
                                            or, for periods prior to our conversion to a corporation on October&#160;6, 2014, Eagle Point
                                            Credit Company LLC, a Delaware limited liability company;</i></td>
</tr><tr style="vertical-align: top; text-align: justify">
<td><i>&#160;</i></td><td style="text-align: left"><i>&#160;</i></td><td style="text-align: justify"><i>&#160;</i></td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td><i>&#160;</i></td><td style="text-align: left"><span>&#9679;</span><i>&#160;</i></td><td style="text-align: justify"><i>The
                                            &#8220;Adviser&#8221; refers to Eagle Point Credit Management LLC, a Delaware limited liability
                                            company;</i></td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td><i>&#160;</i></td><td style="text-align: left"><i>&#160;</i></td><td style="text-align: justify"><i>&#160;</i></td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td><i>&#160;</i></td><td style="text-align: left"><span><i>&#9679;</i></span></td><td style="text-align: justify"><i>The
                                            &#8220;Administrator&#8221; refers to Eagle Point Administration LLC, a Delaware limited
                                            liability company; and</i></td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td><i>&#160;</i></td><td style="text-align: left"><i>&#160;</i></td><td style="text-align: justify"><i>&#160;</i></td></tr>
     <tr style="vertical-align: top; text-align: justify">
<td><i>&#160;</i></td><td style="text-align: left"><span><i>&#9679;</i></span></td><td style="text-align: justify"><i>&#8220;Risk-adjusted
                                            returns&#8221; refers to the profile of expected asset returns across a range of potential
                                            macroeconomic scenarios, and does not imply that a particular strategy or investment should
                                            be considered low-risk.</i></td></tr>
     </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Eagle Point Credit Company Inc.</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
are an externally managed, non-diversified closed-end management investment company that has registered as an investment company under
the 1940 Act. We have elected to be treated, and intend to qualify annually, as a regulated investment company, or &#8220;RIC,&#8221;
under Subchapter M of the Internal Revenue Code of 1986, as amended, or the &#8220;Code,&#8221; commencing with our tax year ended November&#160;30,
2014.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. We seek
to achieve our investment objectives by investing primarily in equity and junior debt tranches of CLOs that are collateralized by a portfolio
consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across
various industry sectors. We may also invest in other related securities and instruments or other securities and instruments that the
Adviser believes are consistent with our investment objectives, including senior debt tranches of CLOs, LAFs, securities issued by other
securitization vehicles, such as credit-linked notes and CBOs, and synthetic investments, such as significant risk transfer securities
and credit risk transfer securities issued by banks or other financial institutions. We may also acquire securities issued by other investment
companies, including closed-end funds, business development companies (&#8220;BDCs&#8221;,) mutual funds, and exchange-traded funds (&#8220;ETFs&#8221;,)
and may otherwise invest indirectly in securities consistent with our investment objectives. The amount that we will invest in other
securities and instruments, which may include investments in debt and other securities issued by CLOs collateralized by non-U.S. loans
or securities of other collective investment vehicles, will vary from time to time and, as such, may constitute a material part of our
portfolio on any given date, all as based on the Adviser&#8217;s assessment of prevailing market conditions.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
CLO securities in which we primarily seek to invest are rated below investment grade or, in the case of CLO equity securities, are unrated,
and are considered speculative with respect to timely payment of interest and repayment of principal. Unrated and below investment grade
securities are also sometimes referred to as &#8220;junk&#8221; securities. In addition, the CLO equity and junior debt securities in
which we invest are highly leveraged (with CLO equity securities typically being leveraged ten times), which magnifies our risk of loss
on such investments. LAFs are short- to medium-term facilities often provided by the bank that will serve as the placement agent or arranger
on a CLO transaction. LAFs typically incur leverage between four and six times prior to a CLO&#8217;s pricing.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">These
investment objectives and strategies are not fundamental policies of ours and may be changed by our board of directors without prior
approval of our stockholders. See <b><i>&#8220;Business.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
the primary CLO market (<i>i.e.</i>, acquiring securities at the inception of a CLO), we seek to invest in CLO securities that the Adviser
believes have the potential to generate attractive risk-adjusted returns and to outperform other similar CLO securities issued within
the respective vintage period. In the secondary CLO market (<i>i.e.</i>, acquiring existing CLO securities), we seek to invest in CLO
securities that the Adviser believes have the potential to generate attractive risk-adjusted returns.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 4; Options: NewSection --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div style="border: Black 1pt solid; padding: 10pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser pursues a differentiated strategy within the CLO market focused on:</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;proactive
sourcing and identification of investment opportunities;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;utilization
of the Adviser&#8217;s methodical investment analysis and due diligence process;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;active
involvement at the CLO structuring and formation stage; and</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;taking,
in many instances, significant stakes in CLO equity and junior debt tranches.</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
believe that the Adviser&#8217;s direct and often longstanding relationships with CLO collateral managers, its CLO structural expertise
and its relative scale in the CLO market will enable us to source and execute investments with attractive economics and terms relative
to other CLO opportunities.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When
we make a significant primary market investment in a particular CLO tranche, we generally expect to be able to influence the CLO&#8217;s
key terms and conditions. In particular, the Adviser believes that, although typically exercised only a minority of the time in the Adviser&#8217;s
experience, the protective rights associated with holding a majority position in a CLO equity tranche (such as the ability to call the
CLO after the non-call period, to refinance/reprice certain CLO debt tranches after a period of time and to influence potential amendments
to the governing documents of the CLO) may reduce our risk in these investments. We may acquire a majority position in a CLO tranche
directly, or we may benefit from the advantages of a majority position where both we and other accounts managed by the Adviser collectively
hold a majority position, subject to any restrictions on our ability to invest alongside such other accounts. See <b><i>&#8220;Conflicts
of Interest&#8201;&#8212;&#8201;Co-Investments and Related Party Transactions.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
seek to construct a portfolio of CLO securities that provides varied exposure across a number of key categories, including:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;number
of borrowers underlying each CLO;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;industry
type of a CLO&#8217;s underlying borrowers;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;number
and investment style of CLO collateral managers; and</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;CLO
vintage period.</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser has a long-term investment horizon and invests primarily with a buy-and-hold mentality. However, on an ongoing basis, the Adviser
actively monitors each investment and may sell positions if circumstances change from the time of investment or if the Adviser believes
it is in our best interest to do&#160;so.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>&#8220;Names
Rule&#8221; Policy</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
accordance with the requirements of the 1940 Act, we have adopted a policy to invest at least 80% of our assets in the particular type
of investments suggested by our name. Accordingly, under normal circumstances, we invest at least 80% of the aggregate of our net assets
and borrowings for investment purposes in credit and credit-related instruments. For purposes of this policy, we consider credit and
credit- related instruments to include, without limitation: (i)&#160;equity and debt tranches of CLOs, LAFs, securities issued by other
securitization vehicles, such as credit-linked notes and CBOs, and synthetic investments, such as significant risk transfer securities
and credit risk transfer securities issued by banks or other financial institutions; (ii)&#160;secured and unsecured floating rate and
fixed rate loans; (iii)&#160;investments in corporate debt obligations, including bonds, notes, debentures, commercial paper and other
obligations of corporations to pay interest and repay principal; (iv)&#160;debt issued by governments, their agencies, instrumentalities,
and central banks; (v)&#160;commercial paper and short-term notes; (vi)&#160;preferred stock; (vii)&#160;convertible debt securities;
(viii)&#160;certificates of deposit, bankers&#8217; acceptances and time deposits; and (ix)&#160;other credit-related instruments. Our
investments in derivatives, other investment companies, and other instruments designed to obtain indirect exposure to credit and credit-related
instruments are counted towards our 80% investment policy to the extent such instruments have similar economic characteristics to the
investments included within that policy.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
80% policy with respect to investments in credit and credit-related instruments is not fundamental and may be changed by our board
of directors without stockholder approval. Stockholders will be provided with sixty (60) days&#8217; notice in the manner prescribed
by the SEC before making any change to this policy. Our investments in derivatives, other investment companies, and other
instruments designed to obtain indirect exposure to credit and credit-related instruments are counted towards our 80% investment
policy to the extent such instruments have similar economic characteristics to the investments included within that policy.</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 5 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div style="border: Black 1pt solid; padding: 1pt 10pt"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Eagle
Point Credit Management</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser manages our investments subject to the supervision of our board of directors pursuant to an amended and restated investment advisory
agreement, or the &#8220;Investment Advisory Agreement.&#8221; An affiliate of the Adviser, Eagle Point Administration, performs, or
arranges for the performance of, our required administrative services. For a description of the fees and expenses that we pay to the
Adviser and the Administrator, see <b><i>&#8220;The Adviser and the Administrator&#8201;&#8212;&#8201;Investment Advisory Agreement&#8201;&#8212;&#8201;Management
Fee and Incentive Fee&#8221;</i></b> and <b><i>&#8220;The Adviser and the Administrator&#8201;&#8212;&#8201;The Administrator and the
Administration Agreement.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser is registered as an investment adviser with the SEC. As of March&#160;31, 2023, the Adviser, collectively with Eagle Point Income
Management, an affiliate of the Adviser, had approximately $7.8&#160;billion of total assets under management (including capital commitments
that were undrawn as of such date). The Adviser&#8217;s diversified investor base is comprised of institutional investors, high net worth
individuals and retail investors. Based on the Adviser&#8217;s CLO equity assets under management, the Adviser believes that,&#160;collectively
with Eagle Point Income Management, it is among the largest CLO equity investors in the market.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser was established in November&#160;2012 by Thomas P. Majewski and Stone Point Capital LLC, or &#8220;Stone Point,&#8221; as investment
manager of the Trident Funds and related investment vehicles, which we refer to collectively as the &#8220;Trident Funds.&#8221; The
Adviser is wholly owned by Eagle Point Holdings LP (&#8220;EP Holdings&#8221;). EP Holdings, in turn, is primarily owned by certain of
the Trident Funds through intermediary holding companies. Additionally, certain of the Adviser&#8217;s employees also hold indirect economic
interests in the Adviser. The Adviser is ultimately governed through intermediary holding companies by a board of managers, or the &#8220;Adviser&#8217;s
Board of Managers,&#8221; which includes Mr.&#160;Majewski and certain principals of Stone Point. Stone Point, an investment adviser
registered with the SEC, is a specialized private equity firm focused on the financial services industry. The &#8220;Senior Investment
Team&#8221; is led by Mr.&#160;Majewski, Managing Partner and founder of the Adviser, and is also comprised of Daniel W. Ko, Senior Principal
and Portfolio Manager, and Daniel M. Spinner, Senior Principal and Portfolio Manager. The Senior Investment Team is primarily responsible
for our day-to-day investment management and the implementation of our investment strategy and process. See <b><i>&#8220;The Adviser
and the Administrator.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each
member of the Senior Investment Team is a CLO industry specialist who has been directly involved in the CLO market for the majority of
his career and has built relationships with key market participants, including CLO collateral managers, investment banks and investors.
Members of the Senior Investment Team have been involved in the CLO market as:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;the
head of the CLO business at various investment banks;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;a
lead CLO structurer and collateralized debt obligation, or &#8220;CDO,&#8221; workout specialist at an investment bank;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;a
CLO equity and debt investor;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;principal
investors in CLO collateral management firms; and</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span>&#9679;</span>&#8239;&#8239;&#8239;&#8239;a
lender and mergers and acquisitions adviser to CLO collateral management firms.</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
believe that the complementary, yet highly specialized, skill set of each member of the Senior Investment Team provides the Adviser with
a competitive advantage in its CLO-focused investment strategy. See <b><i>&#8220;The Adviser and the Administrator&#8201;&#8212;&#8201;Portfolio
Managers.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition to managing our investments, the Adviser, the Adviser&#8217;s affiliates and the members of the Senior Investment Team manage
investment accounts for other clients, including Eagle Point Income Company Inc., or &#8220;Eagle Point Income Company&#8221; or &#8220;EIC,&#8221;
a publicly traded closed-end management investment company that is registered under the 1940 Act and for which Eagle Point Income Management
serves as investment adviser and Eagle Point Institutional Income Fund, or &#8220;Eagle Point Institutional Income&#8221; or &#8220;EPIIF,&#8221;
a non-listed, closed-end management investment company that is registered under the 1940&#160;Act, privately offered pooled investment
vehicles and institutional separate accounts. Many of these accounts pursue an investment strategy that substantially or partially overlaps
with the strategy that we pursue. See &#8220;<b><i>Risk Factors&#8201;&#8212;&#8201;Risks Related to Our Business and Structure&#8201;&#8212;&#8201;There
are significant actual and potential conflicts of interest which could impact our investment returns.</i></b>&#8221;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>CLO
Overview</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
investment portfolio is comprised primarily of investments in the equity and junior debt tranches of CLOs. The CLOs that we primarily
target are securitization vehicles that pool portfolios of primarily below investment grade U.S. senior secured loans. Such pools of
underlying assets are often referred to as a CLO&#8217;s &#8220;collateral.&#8221; While the vast majority of the portfolio of most CLOs
consists of senior secured&#160;loans, many CLOs enable the CLO collateral manager to invest up to 10% of the portfolio in assets that
are not first lien senior secured loans, including second lien loans, unsecured loans, senior secured bonds and senior unsecured bonds.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs
are generally required to hold a portfolio of assets that is highly diversified by underlying borrower and industry and that is subject
to a variety of asset concentration limitations. Most CLOs are non-static, revolving structures that generally allow for reinvestment
over a specific period of time (the &#8220;reinvestment period&#8221;) which is typically up to five&#160;years. The terms and covenants
of a typical CLO structure are, with certain exceptions, based primarily on the cash flow generated by, and the par value (as opposed
to the market price or fair value) of, the collateral. These covenants include collateral coverage tests, interest coverage tests and
collateral quality tests.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A
CLO funds the purchase of a portfolio of primarily senior secured loans via the issuance of CLO equity and debt securities in the form
of multiple, primarily floating rate, debt tranches. The CLO debt tranches typically are rated &#8220;AAA&#8221; (or its equivalent)
at the most senior level down to &#8220;BB&#8221; or &#8220;B&#8221; (or its equivalent), which is below investment grade, at the junior
level by Moody&#8217;s Investors Service,&#160;Inc., or &#8220;Moody&#8217;s,&#8221; S&amp;P Global Ratings, or &#8220;S&amp;P,&#8221;
and/or Fitch Ratings,&#160;Inc., or &#8220;Fitch.&#8221; The interest rate on the CLO debt tranches is the lowest at the AAA-level and
generally increases at each level down the rating scale. The CLO equity tranche is unrated and typically represents approximately 8%
to 11% of a CLO&#8217;s capital structure. Below investment grade and unrated securities are sometimes referred to as &#8220;junk&#8221;
securities. The diagram below is for illustrative purposes only and highlights a hypothetical structure intended to depict a typical
CLO. A minority of CLOs also include a B-rated debt tranche (in which we may invest), and the structure of CLOs in which we invest may
otherwise vary from this example. The left column represents the CLO&#8217;s assets, which support the liabilities and equity in the
right column. The right column shows the various classes of debt and equity issued by the hypothetical CLO in order of seniority as to
rights in payments from the assets. The&#160;percentage ranges appearing below the rating of each class represents the&#160;percent such
class comprises of the overall &#8220;capital stack&#8221; (i.e., total debt and equity issued by the CLO).</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="tm2429841d6_backcoverimg002.jpg"/>&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 7 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs
have two priority-of-payment schedules (commonly called &#8220;waterfalls&#8221;), which are detailed in a CLO&#8217;s indenture and
govern how cash generated from a CLO&#8217;s underlying collateral is distributed to the CLO&#8217;s equity and debt investors. The interest
waterfall applies to interest payments received on a CLO&#8217;s underlying collateral. The principal waterfall applies to cash generated
from principal on the underlying collateral, primarily through loan repayments and the proceeds from loan sales. Through the interest
waterfall, any excess interest-related cash flow available after the required quarterly interest payments to CLO debt investors are made
and certain CLO expenses (such as administration and collateral management fees) are paid is then distributed to the CLO&#8217;s equity
investors each quarter, subject to compliance with certain tests.</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A
CLO&#8217;s indenture typically requires that the maturity dates of a CLO&#8217;s assets, typically five to eight years from the date
of issuance of a senior secured loan, be shorter than the maturity date of the CLO&#8217;s liabilities, typically 12 to 13&#160;years
from the date of issuance. However, CLO investors do face reinvestment risk with respect to a CLO&#8217;s underlying portfolio. In addition,
in most CLO transactions, CLO debt investors are subject to prepayment risk in that the holders of a majority of the equity tranche can
direct a call or refinancing of a CLO, which would cause the CLO&#8217;s outstanding CLO debt securities to be repaid at par. See &#8220;<b><i>Risk
Factors&#8201;&#8212;&#8201;Risks Related to Our Investments&#8201;&#8212;&#8201;We and our investments are subject to reinvestment
risk</i></b>.&#8221;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Our
Structure</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
were organized as Eagle Point Credit Company LLC, a Delaware limited liability company, on March&#160;24, 2014, converted to a Delaware
corporation on October&#160;6, 2014 and completed our initial public offering on October&#160;7, 2014. We have two wholly-owned subsidiaries:
(1)&#160;Eagle Point Credit Company Sub (Cayman) Ltd., or the &#8220;Cayman Subsidiary&#8221; and (2)&#160;Eagle Point Credit Company
Sub II (Cayman) Ltd., or the &#8220;Cayman II Subsidiary.&#8221; We generally gain access to certain newly issued Regulation&#160;S securities
and hold other securities through the Cayman Subsidiary, and hold certain other investments through the Cayman II Subsidiary. Regulation&#160;S
securities are securities of U.S. and non-U.S. issuers that are issued through offerings made pursuant to Regulation&#160;S under the
Securities Act of 1933, as amended, or the &#8220;Securities Act.&#8221; Each of our subsidiaries is advised by the Adviser pursuant
to the Investment Advisory Agreement. The following chart reflects our organizational structure and our relationship with the Adviser
and the Administrator as of the date of this prospectus:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="tm2429841d6_prosimg02.jpg"/>&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Financing
and Hedging Strategy</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leverage
by the Company.</i></b></span>&#160;&#160;&#160;We may use leverage as and to the extent permitted by the 1940 Act. We are permitted
to obtain leverage using any form of financial leverage instruments, including funds borrowed from banks or other financial institutions,
margin facilities, notes or Preferred Stock and leverage&#160;attributable to reverse repurchase agreements or similar transactions.
Over the long term, management expects us to operate under normal market conditions generally with leverage within a range of 25% to
35% of total assets, although the actual amount of our leverage will vary over time. Certain instruments that create leverage are considered
to be senior securities under the 1940 Act.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 8 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid">


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">With
respect to senior securities representing indebtedness (<i>i.e.</i>, borrowing or deemed borrowing, including our 6.6875% notes due 2028,
or the &#8220;2028 Notes,&#8221; our 5.375% notes due 2029, or the &#8220;2029&#160;Notes,&#8221; our 6.75% notes due 2031, or the &#8220;2031
Notes,&#8221; and collectively with the 2028 Notes and the 2029 Notes, the &#8220;Notes&#8221;), other than temporary borrowings as defined
under the 1940 Act, we are required under current law to have an asset coverage of at least 300%, as measured at the time of borrowing
and calculated as the ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) over the
aggregate amount of our outstanding senior securities representing indebtedness. With respect to senior securities that are stocks (<i>i.e.</i>,
shares of our Preferred Stock), we are required under current law to have an asset coverage of at least 200%, as measured at the time
of the issuance of any such shares of Preferred Stock and calculated as the ratio of our total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of our outstanding senior securities representing indebtedness plus the
aggregate liquidation preference of any outstanding shares of Preferred Stock.</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
of March&#160;31, 2023, we had two series of Preferred Stock outstanding, the 6.50% Series&#160;C Term Preferred Stock due 2031, or the
&#8220;Series&#160;C Term Preferred Stock,&#8221; and the 6.75% Series&#160;D Preferred Stock, which is &#8220;perpetual&#8221; and has
no fixed maturity date, or the &#8220;Series&#160;D Preferred Stock&#8221; and together with the Series&#160;C Term Preferred Stock and
any additional shares of Preferred Stock, which the Company may issue from time to time, the &#8220;Preferred Stock.&#8221;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
of March&#160;31, 2023, our leverage, including the outstanding Notes and the Preferred Stock,&#160;represented approximately 33.4% of
our total assets (less current liabilities). On a pro&#160;forma basis, our leverage, including the outstanding Notes and the Preferred
Stock, represented approximately 33.8% of our total assets (less current liabilities) as of April&#160;30, 2023 (based on management&#8217;s
unaudited estimate of our NAV as of such date). As of March&#160;31, 2023, our asset coverage ratios in respect of (i)&#160;senior securities
representing indebtedness and (ii)&#160;our outstanding Preferred Stock, each as calculated pursuant to Section&#160;18 of the 1940 Act,
were 443% and 299%, respectively. In the event we fail to meet our applicable asset coverage ratio requirements, we may not be able to
incur additional debt and/or issue additional Preferred Stock, and could be required by law or otherwise to sell a portion of our investments
to repay some debt or redeem shares of Preferred Stock (if any) when it is disadvantageous to do so, which could have a material adverse
effect on our operations, and we may not be able to make certain distributions or pay dividends of an amount necessary to continue to
qualify as a RIC for U.S. federal income tax purposes.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
expect that we will, or that we may need to, raise additional capital in the future to fund our continued growth, and we may do so by
entering into a credit facility, issuing additional shares of Preferred Stock or debt securities or through other leveraging instruments.
Subject to the limitations under the 1940&#160;Act, we may incur additional leverage opportunistically and may choose to increase or
decrease our leverage. In addition, we may borrow for temporary, emergency or other purposes as permitted under the 1940 Act, which indebtedness
would be in addition to the asset coverage requirements described above. By leveraging our investment portfolio, we may create an opportunity
for increased net income and capital appreciation. However, the use of leverage also involves significant risks and expenses, which will
be borne entirely by our stockholders, and our leverage strategy may not be successful. For example, the more leverage is employed, the
more likely a substantial change will occur in our NAV. Accordingly, any event that adversely affects the value of an investment would
be magnified to the extent leverage is utilized. See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to Our Investments&#8201;&#8212;&#8201;We
may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing
in us&#8221;</i></b> and see also &#8220;<b><i>Business&#8201;&#8212;&#8201;Our Structure&#8201;&#8212;&#8201;Other Investment Techniques</i></b>&#8221;
for a more detailed description of the Company&#8217;s investment techniques.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Transactions.</i></b></span>&#160;&#160;&#160;We may engage in &#8220;Derivative Transactions,&#8221; as described below, from time to
time. To the extent we engage in Derivative Transactions, we expect to do so to hedge against interest rate, credit, currency and/or
other risks, or for other investment or risk management purposes. We may use Derivative Transactions for investment purposes to the extent
consistent with our investment objectives if the Adviser deems it appropriate to do so. We may purchase and sell a variety of derivative
instruments, including exchange-listed and over-the-counter, or &#8220;OTC,&#8221; options, futures, options on futures, swaps and similar
instruments, various interest rate transactions, such as swaps, caps, floors or collars, and credit transactions and credit default swaps.
We also may purchase and sell derivative instruments that combine features of these instruments. Collectively, we refer to these financial
management techniques as &#8220;Derivative Transactions.&#8221; Our use of Derivative Transactions, if any, will generally be deemed
to create leverage for us and involves significant risks. No assurance can be given that our strategy and use of derivatives will be
successful, and our investment performance could diminish compared with what it would have been if Derivative Transactions were not used.
See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Related to Our Investments&#8201;&#8212;&#8201;We are subject to risks associated
with any hedging or Derivative Transactions in which we participate&#8221;</i></b>.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>






</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 9 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Temporary
Defensive Position.</i></b></span>&#160;&#160;&#160;We may take a temporary defensive position and invest all or a substantial portion
of our total assets in cash or cash equivalents, government securities or short-term fixed income securities during periods in which
we believe that adverse market, economic, political or other conditions make it advisable to maintain a temporary defensive position.
As the CLOs and LAFs in which we invest are generally illiquid in nature, we may not be able to dispose of such investments and take
a defensive position. To the extent that we invest defensively, we likely will not achieve our investment objectives.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Operating
and Regulatory Structure</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
are an externally managed, non-diversified closed-end management investment company that has registered as an investment company under
the 1940 Act. As a registered closed-end management investment company, we are required to meet certain regulatory tests. See <b><i>&#8220;Regulation
as a Closed-End Management Investment Company.&#8221;</i></b> In addition, we have elected to be treated, and intend to qualify annually,
as a RIC under Subchapter M of the Code, commencing with our tax year ended on November&#160;30, 2014.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
investment activities are managed by the Adviser and supervised by our board of directors. Under the Investment Advisory Agreement, we
have agreed to pay the Adviser an annual base management fee based on our &#8220;Total Equity Base&#8221; as well as an incentive fee
based on our &#8220;Pre-Incentive Fee Net Investment Income.&#8221; See <b><i>&#8220;The Adviser and the Administrator&#8201;&#8212;&#8201;Investment
Advisory Agreement&#8201;&#8212;&#8201;Management Fee and Incentive Fee.&#8221;</i></b> &#8220;Total Equity Base&#8221; means the NAV
attributable to the common stock and the paid-in, or stated, capital of the Preferred Stock.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
have also entered into an administration agreement, which we refer to as the &#8220;Administration Agreement,&#8221; under which we have
agreed to reimburse the Administrator for our allocable portion of overhead and other expenses incurred by the Administrator in performing
its obligations under the Administration Agreement. See <b><i>&#8220;The Adviser and the Administrator&#8201;&#8212;&#8201;The Administrator
and the Administration Agreement.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Conflicts
of Interest</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
executive officers and directors, and the Adviser and certain of its affiliates and their officers and employees, including the Senior
Investment Team, have several conflicts of interest as a result of the other activities in which they engage. The Adviser and the Administrator
are affiliated with other entities engaged in the financial services business. In particular, the Adviser and the Administrator are affiliated
with Eagle Point Income Management and Stone Point, and certain members of the Adviser&#8217;s Board of Managers are principals of Stone
Point. Pursuant to certain management agreements, Stone Point has received delegated authority to act as the investment manager of the
Trident Funds. See <b><i>&#8220;Control Persons, Principal Stockholders and Selling Stockholders.&#8221;</i></b> The Adviser and the
Administrator are wholly owned by Eagle Point Holdings LP (&#8220;EP Holdings&#8221;). EP Holdings, in turn, is primarily owned by certain
of the Trident Funds through intermediary holding companies. The Trident Funds and other private equity funds managed by Stone Point
invest in financial services companies. These relationships may cause the Adviser&#8217;s or the Administrator&#8217;s and certain of
their affiliates&#8217; interests, and the interests of their officers and employees, including the Senior Investment Team, to diverge
from our interests and may result in conflicts of interest that may not be foreseen or resolved in a manner that is always or exclusively
in our best interest.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
executive officers and directors, as well as other current and potential future affiliated persons, officers and employees of the Adviser
and certain of its affiliates, may serve as officers, directors or principals of, or manage the accounts for, other entities, including
EIC and EPIIF, with investment strategies that substantially or partially overlap with the strategy that we pursue. Accordingly, they
may have obligations to investors in those entities, the fulfillment of which obligations may not be in the best interests of us or our
stockholders. Further, certain of our stockholders are affiliated with our Adviser or may from time to time have business relationships
with the Adviser. In such cases, such stockholders may have an incentive to vote shares held by them in a manner that takes such relationships
into account. As a result of these relationships and separate business activities, the Adviser has conflicts of interest in allocating
management time, services and functions among us, other advisory clients and other business activities. See <b><i>&#8220;Conflicts of
Interest.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 10 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div style="border: Black 1pt solid; padding: 1pt 10pt">


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
order to address such conflicts of interest, we have, among other things, adopted a code of ethics under Rule&#160;17j-1 of the 1940
Act. Similarly, the Adviser has separately adopted the &#8220;Adviser Code of Ethics.&#8221; The Adviser Code of Ethics requires the
officers and employees of the Adviser to act in the best interests of the Adviser and its client accounts (including us), act in good
faith and in an ethical manner, avoid conflicts of interests with the client accounts to the extent reasonably possible and identify
and manage conflicts of interest to the extent that they arise. Personnel subject to each code of ethics may invest in securities for
their personal investment accounts, including securities that may be purchased or held by us, so long as such investments are made in
accordance with the code&#8217;s requirements. Our directors and officers, and the officers and employees of the Adviser, are also required
to comply with applicable provisions of the U.S. federal securities laws and make prompt reports to supervisory personnel of any actual
or suspected violations of law.</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Pursuant
to the investment allocation policies and procedures of the Adviser and Eagle Point Income Management, they seek to allocate investment
opportunities among accounts in a manner that is fair and equitable over time. In addition, an account managed by the Adviser, such as
us, is expected to be considered for the allocation of investment opportunities together with other accounts managed by certain affiliates
of the Adviser, including Eagle Point Income Management. There is no assurance that such opportunities will be allocated to any particular
account equitably in the short-term or that any such account, including us, will be able to participate in all investment opportunities
that are suitable for it. See <b><i>&#8220;Conflicts of Interest&#8201;&#8212;&#8201;Code of Ethics and Compliance Procedures.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Co-Investment
with Affiliates.</i></b></span>&#160;&#160;&#160;In certain instances, we co-invest on a concurrent basis with other accounts managed
by the Adviser and may do so with other accounts managed by certain of the Adviser&#8217;s affiliates, subject to compliance with applicable
regulations and regulatory guidance and the Adviser&#8217;s written allocation procedures. Exemptive relief granted by the SEC to us,
Eagle Point Credit Management and certain of our affiliates permits us to participate in certain negotiated co-investments alongside
other accounts, including EIC and EPIIF, managed by the Adviser, or certain of its affiliates, subject to certain conditions including
(i)&#160;that a majority of our Directors who have no financial interest in the transaction and a majority of our Directors who are not
&#8220;interested persons,&#8221; as defined in the 1940 Act, of us approve the co-investment and (ii)&#160;the price, terms and conditions
of the co-investment are the same for each participant. See <b><i>&#8220;Conflicts of Interest&#8201;&#8212;&#8201;Co-Investments and
Related Party Transactions.&#8221;</i></b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Summary
Risk Factors</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
value of our assets, as well as the market price of our securities, will fluctuate. Our investments should be considered risky, and you
may lose all or part of your investment in us. Investors should consider their financial situation and needs, other investments, investment
goals, investment experience, time&#160;horizons, liquidity needs and risk tolerance before investing in our securities. An investment
in our securities may be speculative in that it involves a high degree of risk and should not be considered a complete investment program.
We are designed primarily as a long-term investment vehicle, and our securities are not an appropriate investment for a short-term trading
strategy. We can offer no assurance that returns, if any, on our investments will be commensurate with the risk of investment in us,
nor can we provide any assurance that enough appropriate investments that meet our investment criteria will be available.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
following is a summary of certain principal risks of an investment in us. See <b><i>&#8220;Risk Factors&#8221;</i></b> for a more complete
discussion of the risks of investing in our securities, including certain risks not summarized below.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in">&#160;</td>
<td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Risks of Investing in CLOs and Other Structured
Debt Securities.</i></b></span>&#160;&#160;&#160;CLOs and other structured finance securities are generally backed by a pool of credit-related
assets that serve as collateral. Accordingly, CLO and structured finance securities present risks similar to those of other types of
credit investments, including default (credit), interest rate and prepayment risks. In addition, CLOs and other structured finance securities
are often governed by a complex series of legal documents and contracts, which increases the risk of dispute over the interpretation
and enforceability of such documents relative to other types of investments.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Subordinated Securities Risk.</i></b></span>&#160;&#160;&#160;CLO
equity and junior debt securities that we may acquire are subordinated to more senior tranches of CLO debt. CLO equity and junior debt
securities are subject to increased risks of default relative to the holders of superior priority interests in the same CLO. In addition,
at the time of issuance, CLO equity securities are under-collateralized in that the face amount of the CLO debt and CLO equity of a CLO
at inception exceed its total assets. We will typically be in a subordinated or first loss position with respect to realized losses on
the underlying assets held by the CLOs in which we are invested.</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 11 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid">


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in">&#160;</td>
<td style="width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>High Yield Investment Risk.</i></b></span>&#160;&#160;&#160;The
CLO equity and junior debt securities that we acquire are typically rated below investment grade, or in the case of CLO equity securities
unrated, and are therefore considered &#8220;higher yield&#8221; or &#8220;junk&#8221; securities and are considered speculative with
respect to timely payment of interest and repayment of principal. The senior secured loans and other credit-related assets underlying
CLOs are also typically higher yield investments. Investing in CLO equity and junior debt securities and other high yield investments
involves greater credit and liquidity risk than investment grade obligations, which may adversely impact our performance.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Leverage Risk.</i></b></span>&#160;&#160;&#160;The
use of leverage, whether directly or indirectly through investments such as CLO equity or junior debt securities that inherently involve
leverage, may magnify our risk of loss. CLO equity or junior debt securities are very highly leveraged (with CLO equity securities typically
being leveraged ten times), and therefore the CLO securities in which we invest are subject to a higher degree of loss since the use
of leverage magnifies losses.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Credit Risk.</i></b></span>&#160;&#160;&#160;If
(1)&#160;a CLO in which we invest, (2)&#160;an underlying asset of any such CLO or (3)&#160;any other type of credit investment in our
portfolio declines in price or fails to pay interest or principal when due because the issuer or debtor, as the case may be, experiences
a decline in its financial status, our income, NAV and/or market price would be adversely impacted.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Key Personnel Risk.</i></b></span>&#160;&#160;&#160;We
are dependent upon the key personnel of the Adviser for our future success.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Conflicts of Interest Risk.</i></b></span>&#160;&#160;&#160;Our
executive officers and directors, and the Adviser and certain of its affiliates and their officers and employees, including the Senior
Investment Team, have several conflicts of interest as a result of the other activities in which they engage. See <b><i>&#8220;Conflicts
of Interest.&#8221;</i></b></td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Prepayment Risk.</i></b></span>&#160;&#160;&#160;The
assets underlying the CLO securities in which we invest are subject to prepayment by the underlying corporate borrowers. In addition,
the CLO securities and related investments in which we invest are subject to prepayment risk. If we or a CLO collateral manager are unable
to reinvest prepaid amounts in a new investment with an expected rate of return at least equal to that of the investment repaid, our
investment performance will be adversely impacted.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>LIBOR Risk.</i></b></span>&#160;&#160;&#160;Certain
CLO securities in which we invest continue to earn interest at (or, from the perspective of the Company as CLO equity investor, obtain
financing at) a floating rate based on LIBOR. After the global financial crisis, regulators globally determined that existing interest
rate benchmarks should be reformed based on concerns that LIBOR was susceptible to manipulation. Replacement rates that have been identified
include the Secured Overnight Financing Rate (SOFR, which is intended to replace U.S. dollar LIBOR and measures the cost of overnight
borrowings through repurchase agreement transactions collateralized with U.S. Treasury securities) and the Sterling Overnight Index Average
Rate (SONIA, which is intended to replace pound sterling LIBOR and measures the overnight interest rate paid by banks for unsecured transactions
in the sterling market). Each of LIBOR, SONIA and SOFR is referred to herein as a &#8220;Benchmark.&#8221; With respect to our investments
in CLO equity securities, to the extent that any LIBOR replacement rate (or the relevant credit spread adjustment) utilized for senior
secured loans differs from that utilized for debt of a CLO that holds those loans, for the duration of such mismatch, the CLO would experience
an interest rate mismatch between its assets and liabilities, which could have an adverse impact on the cash flows distributed to CLO
equity investors as well as our net investment income and portfolio returns until such mismatch is corrected or minimized. As of the
date hereof, certain senior secured loans have transitioned to utilizing SOFR based interest rates and certain CLO debt securities have
also transitioned to SOFR.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">Certain underlying loans held by CLOs do not include a &#8220;fall back&#8221; provision that addresses
how interest rates will be determined once LIBOR stops being published, or otherwise leave certain aspects of the replacement rate to
be negotiated between the loan issuer and the lender group. For example, certain loans held by CLOs in which we invest provide for a
negotiated &#8220;credit spread adjustment&#8221; (i.e., a marginal increase in the applicable replacement
rate to compensate lenders for the tendency of SOFR and other alternative rates to price lower than LIBOR). If a CLO&#8217;s collateral
manager and other members of the lending group agree to (or fail to reject) an amendment to an underlying loan that provides for a below-market
spread adjustment, then the equity investors in such CLO (such as the Company) would be disadvantaged if the debt securities issued by
the CLO have a larger spread adjustment.</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 12 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid">


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in">&#160;</td>
<td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Liquidity Risk.</i></b></span>&#160;&#160;&#160;Generally, there is no public market for the CLO investments we target. As such, we may not be able to sell such investments quickly, or at all. If we are able to sell such investments, the prices we receive may not reflect the Adviser&#8217;s assessment of their fair value or the amount paid for such investments by us.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Incentive Fee Risk.</i></b></span>&#160;&#160;&#160;Our incentive fee structure and the formula for calculating the fee payable to the Adviser may incentivize the Adviser to pursue speculative investments and use leverage in a manner that adversely impacts our performance.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Fair Valuation of Our Portfolio Investments.</i></b></span>&#160;&#160;&#160;Generally, there is no public market for the CLO investments we target. As a result, the Adviser values these securities at least quarterly, or more frequently as may be required from time to time, at fair value. The Adviser&#8217;s determinations of the fair value of our investments have a material impact on our net earnings through the recording of unrealized appreciation or depreciation of investments and may cause our NAV on a given date to understate or overstate, possibly materially, the value that we ultimately realize on one or more of our investments.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Limited Investment Opportunities Risk.</i></b></span>&#160;&#160;&#160;The market for CLO securities is more limited than the market for other credit related investments. We can offer no assurances that sufficient investment opportunities for our capital will be available.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Non-Diversification Risk.</i></b></span>&#160;&#160;&#160;We are a non-diversified investment company under the 1940 Act and expect to hold a narrower range of investments than a diversified fund under the 1940 Act.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Market Risk.</i></b></span>&#160;&#160;&#160;Political, regulatory, economic and social developments, and developments that impact specific economic sectors, industries or segments of the market, can affect the value of our investments. A disruption or downturn in the capital markets and the credit markets could impair our ability to raise capital, reduce the availability of suitable investment opportunities for us, or adversely and materially affect the value of our investments, any of which would negatively affect our business. These risks may be magnified if certain events or developments adversely interrupt the global supply chain, and could affect companies worldwide.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>LAFs Risk.</i></b></span>&#160;&#160;&#160;We may invest in LAFs, which are short to medium term facilities often provided by the bank that will serve as placement agent or arranger on a CLO transaction and which acquire loans on an interim basis which are expected to form part of the portfolio of a future CLO. Investments in LAFs have risks similar to those applicable to investments in CLOs. Leverage is typically utilized in such a facility and as such the potential risk of loss will be increased for such facilities employing leverage. In the event a planned CLO is not consummated, or the loans are not eligible for purchase by the CLO, the Company may be responsible for either holding or disposing of the loans. This could expose the Company primarily to credit and/or mark-to-market losses, and other risks.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Synthetic Investments Risk.</i></b></span>&#160;&#160;&#160;We may invest in synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions, or acquire interests in lease agreements that have the general characteristics of loans and are treated as loans for withholding tax purposes. In addition to the credit risks associated with the applicable reference assets, we will usually have a contractual relationship only with the counterparty of such synthetic investment, and not with the reference obligor of the reference asset. Accordingly, we generally will have no right to directly enforce compliance by the reference obligor with the terms of the reference asset nor will we have any rights of setoff against the reference obligor or rights with respect to the reference asset. We will not directly benefit from the collateral supporting the reference asset and will not have the benefit of the remedies that would normally be available to a holder of such reference asset. In addition, in the event of the insolvency of the counterparty, we may be treated as a general creditor of such counterparty, and will not have any claim with respect to the reference asset.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Currency Risk.</i></b></span>&#160;&#160;&#160;Although we primarily make investments denominated in U.S. dollars, we may make investments denominated in other currencies. Our investments denominated in currencies other than U.S. dollars will be subject to the risk that the value of such currency will decrease in relation to the U.S. dollar. We may or may not hedge currency risk.</td></tr>
</table>






<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 13 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid">


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in">&#160;</td>
<td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Hedging Risk.</i></b></span>&#160;&#160;&#160;Hedging transactions seeking to reduce risks may result in poorer overall performance than if we had not engaged in such hedging transactions. Additionally, such transactions may not fully hedge the relevant risks.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Reinvestment Risk.</i></b></span>&#160;&#160;&#160;CLOs will typically generate cash from asset repayments and sales that may be reinvested in substitute assets, subject to compliance with applicable investment tests. If the CLO collateral manager causes the CLO to purchase substitute assets at a lower yield than those initially acquired or sale proceeds are maintained temporarily in cash, it would reduce the excess interest-related cash flow, thereby having a negative effect on the fair value of our assets and the market value of our securities. In addition, the reinvestment period for a CLO may terminate early, which would cause the holders of the CLO&#8217;s securities to receive principal payments earlier than anticipated. There can be no assurance that we will be able to reinvest such amounts in an alternative investment that provides a comparable return relative to the credit risk assumed.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><b><i>Interest Rate Risk.</i></b>&#160;&#160;&#160;The price of certain of our investments may be significantly affected by changes in interest rates, including recent increases in interest rates.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Refinancing Risk.</i></b></span>&#160;&#160;&#160;If we incur debt financing and subsequently refinance such debt, the replacement debt may be at a higher cost and on less favorable terms and conditions. If we fail to extend, refinance or replace such debt financings prior to their maturity on commercially reasonable terms, our liquidity will be lower than it would have been with the benefit of such financings, which would limit our ability to grow, and holders of our common stock would not benefit from the potential for increased returns on equity that incurring leverage creates.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Tax Risk.</i></b></span>&#160;&#160;&#160;If we fail to qualify for tax treatment as a RIC under Subchapter M of the Code for any reason, or otherwise become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distributions to our stockholders, and the amount of income available for payment of our other liabilities.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Derivatives Risk.</i></b></span>&#160;&#160;&#160;Derivative instruments in which we may invest may be volatile and involve various risks different from, and in certain cases greater than, the risks presented by other instruments. The primary risks related to Derivative Transactions include counterparty, correlation, liquidity, leverage, volatility, OTC trading, operational and legal risks. In addition, a small investment in derivatives could have a large potential impact on our performance, effecting a form of investment leverage on our portfolio. In certain types of Derivative Transactions, we could lose the entire amount of our investment; in other types of Derivative Transactions the potential loss is theoretically unlimited.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Counterparty Risk.</i></b></span>&#160;&#160;&#160;We may be exposed to counterparty risk, which could make it difficult for us or the CLOs in which we invest to collect on obligations, thereby resulting in potentially significant losses.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Global Economy Risk.</i></b></span>&#160;&#160;&#160;Global economies and financial markets are highly interconnected, and conditions and events in one country, region or financial market may adversely impact issuers in a different country, region or financial market.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Banking Risk.</i></b></span>&#160;&#160;&#160;The possibility of future bank failures poses risks of reduced financial market liquidity at clearing, cash management and other custodial financial institutions. The failure of banks which hold cash on behalf of the Company, the Company&#8217;s underlying obligors, the collateral managers of the CLOs in which the Company invests, or the Company&#8217;s service providers could adversely affect the Company&#8217;s ability to pursue its investment strategies and objectives. For example, if an underlying obligor has a commercial relationship with a bank that has failed or is otherwise distressed, such company may experience delays or other disruptions in meeting its obligations and consummating business transactions. Additionally, if a collateral manager has a commercial relationship with a distressed bank, the manager may experience issues conducting its operations or consummating transactions on behalf of the CLOs it manages, which could negatively affect the performance of such CLOs (and, therefore, the performance of the Company).</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><b><i>Price Risk</i></b>.&#160;&#160;&#160;Investors who buy shares at different times will likely pay different prices.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Russia Risk</i></b></span>.&#160;&#160;&#160;Russia&#8217;s military incursion into Ukraine, the response of the United States and other countries, and the potential for wider conflict, has increased volatility and uncertainty in the financial markets and may adversely affect the Company.</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


</div><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 14 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div style="padding: 1pt 10pt; border: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Our
Corporate Information</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
offices are located at 600 Steamboat Road, Suite&#160;202, Greenwich, CT 06830, and our telephone number is (203) 340-8500.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 15 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div style="border: Black 1pt solid; padding: 1pt 10pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


<a id="sa_002"></a><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>FEES
AND EXPENSES</b></p>


<p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Information
about the Company&#8217;s fees and expenses may be found in the &#8220;Fees and Expenses&#8221; section of the Company&#8217;s most recent
Annual Report on Form&#160;N-CSR, as amended, for the fiscal year ended December&#160;31, 2022, filed with the SEC on February&#160;24,
2023, which is incorporated by reference herein.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>


</div><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 16 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_003"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>RISK
FACTORS</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><i>Investing
in our securities involves a number of significant risks. In addition to the other information contained in this prospectus, you should
consider carefully the following information before making an investment in our securities. The risks set out below are not the only
risks we face. Additional risks and uncertainties not presently known to us or not presently deemed material by us might also impair
our operations and performance and the value of our securities. If any of the following events occur, our business, financial condition
and results of operations could be materially adversely affected and the value of our securities may be impaired. In such case, the price
of our securities could decline, and you may lose all or part of your investment.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Risks
Related to Our Investments</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Investing
in senior secured loans indirectly through CLO securities involves particular risks.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
obtain exposure to underlying senior secured loans through our investments in CLOs, but may obtain such exposure directly or indirectly
through other means from time to time. Such loans may become nonperforming or impaired for a variety of reasons. Nonperforming or impaired
loans may require substantial workout negotiations or restructuring that may entail a substantial reduction in the interest rate and/or
a substantial write-down of the principal of the loan. In addition, because of the unique and customized nature of a loan agreement and
the private syndication of a loan, certain loans may not be purchased or sold as easily as publicly traded securities, and, historically,
the trading volume in the loan market has been small relative to other markets. Loans may encounter trading delays due to their unique
and customized nature, and transfers may require the consent of an agent bank and/or borrower. Risks associated with senior secured loans
include the fact that prepayments generally may occur at any time without premium or penalty.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, the portfolios of certain CLOs in which we invest may contain middle market loans. Loans to middle market companies may carry
more inherent risks than loans to larger, publicly traded entities. These companies generally have more limited access to capital and
higher funding costs, may be in a weaker financial position, may need more capital to expand or compete, and may be unable to obtain
financing from public capital markets or from traditional sources, such as commercial banks. Middle market companies typically have narrower
product lines and smaller market shares than large companies. Therefore, they tend to be more vulnerable to competitors&#8217; actions
and market conditions, as well as general economic downturns. These companies may also experience substantial variations in operating
results. The success of a middle market business may also depend on the management talents and efforts of one or two persons or a small
group of persons. The death, disability or resignation of one or more of these persons could have a material adverse impact on the obligor.
Accordingly, loans made to middle market companies may involve higher risks than loans made to companies that have greater financial
resources or are otherwise able to access traditional credit sources. Middle market loans are less liquid and have a smaller trading
market than the market for broadly syndicated loans and may have default rates or recovery rates that differ (and may be better or worse)
than has been the case for broadly syndicated loans or investment grade securities. There can be no assurance as to the levels of defaults
and/or recoveries that may be experienced with respect to middle market loans in any CLO in which we may invest. As a consequence of
the forgoing factors, the securities issued by CLOs that primarily invest in middle market loans (or hold significant portions thereof)
are generally considered to be a riskier investment than securities issued by CLOs that primarily invest in broadly syndicated loans.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Covenant-lite
loans may comprise a significant portion of the senior secured loans underlying the CLOs in which we invest. Over the past decade, the
senior secured loan market has evolved from one in which covenant-lite loans represented a minority of the market to one in which such
loans represent a significant majority of the market. Generally, covenant-lite loans provide borrower companies more freedom to negatively
impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative
action of the borrower, rather than by a deterioration in the borrower&#8217;s financial condition. Accordingly, to the extent that the
CLOs that we invest in hold covenant-lite loans, our CLOs may have fewer rights against a borrower and may have a greater risk of loss
on such investments as compared to investments in or exposure to loans with financial maintenance covenants.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 17 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments in CLO securities and other structured finance securities involve certain risks.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
investments consist primarily of CLO securities, and we may invest in other related structured finance securities. CLOs and
structured finance securities are generally backed by an asset or a pool of assets (typically senior secured loans and other
credit-related assets in the case of a CLO) that serve as collateral. We and other investors in CLO and related structured finance
securities ultimately bear the credit risk of the underlying collateral. In most CLOs, the structured finance securities are issued
in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine
and subordinated/equity according to their degree of risk. If there are defaults or the relevant collateral otherwise underperforms,
scheduled payments to senior tranches of such securities take precedence over those of junior tranches which are the focus of our
investment strategy, and scheduled payments to junior tranches have a priority in right of payment to subordinated/equity
tranches.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLO
and other structured finance securities may present risks similar to those of the other types of debt obligations and, in fact, such
risks may be of greater significance in the case of CLO and other structured finance securities. For example, investments in structured
vehicles, including CBOs and equity and junior debt securities issued by CLOs, involve risks, including credit risk and market risk.
Changes in interest rates and credit quality may cause significant price fluctuations. A CBO is a trust which is often backed by a diversified
pool of high risk, below investment grade fixed income securities. The collateral can be from many different types of fixed income securities,
such as high yield debt, residential privately issued mortgage-related securities, commercial privately issued mortgage related securities,
trust preferred securities and emerging market debt. The pool of high yield securities underlying CBOs is typically separated into tranches
representing different degrees of credit quality. The higher quality tranches have greater degrees of protection and pay lower interest
rates, whereas the lower tranches, with greater risk, pay higher interest rates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition to the general risks associated with investing in debt securities, CLO securities carry additional risks, including: (1)&#160;the
possibility that distributions from collateral assets will not be adequate to make interest or other payments; (2)&#160;the quality of
the collateral may decline in value or default; (3)&#160;our investments in CLO equity and junior debt tranches will likely be subordinate
in right of payment to other senior classes of CLO debt; and (4)&#160;the complex structure of a particular security may not be fully
understood at the time of investment and may produce disputes with the issuer or unexpected investment results. Changes in the collateral
held by a CLO may cause payments on the instruments we hold to be reduced, either temporarily or permanently. Structured investments,
particularly the subordinated interests in which we invest, are less liquid than many other types of securities and may be more volatile
than the assets underlying the CLOs we may target. In addition, CLO and other structured finance securities may be subject to prepayment
risk. Further, the performance of a CLO or other structured finance security may be adversely affected by a variety of factors, including
the security&#8217;s priority in the capital structure of the issuer thereof, the availability of any credit enhancement, the level and
timing of payments and recoveries on and the characteristics of the underlying receivables, loans or other assets that are being securitized,
remoteness of those assets from the originator or transferor, the adequacy of and ability to realize upon any related collateral and
the capability of the servicer of the securitized assets. There are also the risks that the trustee of a CLO does not properly carry
out its duties to the CLO, potentially resulting in loss to the CLO. In addition, the complex structure of the security may produce unexpected
investment results, especially during times of market stress or volatility. Investments in structured finance securities may also be
subject to liquidity risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments in the primary CLO market involve certain additional risks.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Between
the pricing date and the effective date of a CLO, the CLO collateral manager will generally expect to purchase additional collateral
obligations for the CLO. During this period, the price and availability of these collateral obligations may be adversely affected by
a number of market factors, including price volatility and availability of investments suitable for the CLO, which could hamper the ability
of the collateral manager to acquire a portfolio of collateral obligations that will satisfy specified concentration limitations and
allow the CLO to reach the target initial par amount of collateral prior to the effective date. An inability or delay in reaching the
target initial par amount of collateral may adversely affect the timing and amount of interest or principal payments received by the
holders of the CLO debt securities and distributions on the CLO equity securities and could result in early redemptions which may cause
CLO equity and debt investors to receive less than face value of their investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 18 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
portfolio of investments may lack diversification among CLO securities which may subject us to a risk of significant loss if one or more
of these CLO securities experience a high level of defaults on collateral.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
portfolio may hold investments in a limited number of CLO securities. Beyond the asset diversification requirements associated with
our qualification as a RIC under the Code, we do not have fixed guidelines for diversification, we do not have any limitations on
the ability to invest in any one CLO, and our investments may be concentrated in relatively few CLO securities. As our portfolio may
be less diversified than the portfolios of some larger funds, we are more susceptible to risk of loss if one or more of the CLOs in
which we are invested experiences a high level of defaults on its collateral. Similarly, the aggregate returns we realize may be
significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one
investment. We may also invest in multiple CLOs managed by the same CLO collateral manager, thereby increasing our risk of loss in
the event the CLO collateral manager were to fail, experience the loss of key portfolio management employees or sell its
business.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Failure
to maintain a broad range of underlying obligors across the CLOs in which we invest would make us more vulnerable to defaults.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may be subject to concentration risk since CLO portfolios tend to have a certain amount of overlap across underlying obligors. This trend
is generally exacerbated when demand for bank loans by CLO issuers outpaces supply. Market analysts have noted that the overlap of obligor
names among CLO issuers has increased recently and is particularly evident across CLOs of the same year of origination, as well as with
CLOs managed by the same asset manager. To the extent we invest in CLOs which have a high&#160;percentage of overlap, this may increase
the likelihood of defaults on our CLO investments occurring together.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
portfolio is focused on CLO securities, and the CLO securities in which we invest may hold loans that are concentrated in a limited number
of industries.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
portfolio is focused on securities issued by CLOs and related investments, and the CLOs in which we invest may hold loans that are concentrated
in a limited number of industries. As a result, a downturn in the CLO industry or in any particular industry that the CLOs in which we
invest are concentrated could significantly impact the aggregate returns we realize.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Failure
by a CLO in which we are invested to satisfy certain tests will harm our operating results.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
failure by a CLO in which we invest to satisfy financial covenants, including with respect to adequate collateralization and/or interest
coverage tests, would lead to a reduction in its payments to us. In the event that a CLO fails certain tests, holders of CLO senior debt
would be entitled to additional payments that would, in turn, reduce the payments we, as holder of junior debt or equity tranches, would
otherwise be entitled to receive. Separately, we may incur expenses to the extent necessary to seek recovery upon default or to negotiate
new terms, which may include the waiver of certain financial covenants, with a defaulting CLO or any other investment we may make. If
any of these occur, it could materially and adversely affect our operating results and cash flows.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Negative
loan ratings migration may also place pressure on the performance of certain of our investments.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Per
the terms of a CLO&#8217;s indenture, assets rated &#8220;CCC+&#8221; or lower or their equivalent in excess of applicable limits typically
do not receive full par credit for purposes of calculation of the CLO&#8217;s overcollateralization tests. As a result, negative rating
migration could cause a CLO to be out of compliance with its overcollateralization tests. This could cause a diversion of cash flows
away from the CLO equity and junior debt tranches in favor of the more senior CLO debt tranches until the relevant overcollateralization
test breaches are cured. This could have a negative impact on our NAV and cash flows.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments in CLOs and other investment vehicles result in additional expenses to us.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
invest in CLO securities and may invest, to the extent permitted by law, in the securities and other instruments of other investment
companies, including private funds, and, to the extent we so invest, will bear our ratable share of a CLO&#8217;s or any such investment
vehicle&#8217;s expenses, including management and performance fees. In addition to the management and performance fees borne by our
investments in CLOs we also remain obligated to pay management and incentive fees to the Adviser with respect to the assets invested
in the securities and other instruments of other investment vehicles, including CLOs. With respect to each of these investments, each
holder of our common stock bears his or her share of the management and incentive fee of the Adviser as well as indirectly bearing the
management and performance fees charged by the underlying advisor and other expenses of any investment vehicles in which we invest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 19 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
the course of our investing activities, we pay management and incentive fees to the Adviser and reimburse the Adviser for certain expenses
it incurs. As a result, investors in our securities invest on a &#8220;gross&#8221; basis and receive distributions on a &#8220;net&#8221;
basis after expenses, potentially resulting in a lower rate of return than an investor might achieve through direct investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments in CLO securities may be less transparent to us and our stockholders than direct investments in the collateral.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
invest primarily in equity and junior debt tranches of CLOs and other related investments. Generally, there may be less information available
to us regarding the collateral held by such CLOs than if we had invested directly in the debt of the underlying obligors. As a result,
our stockholders do not know the details of the collateral of the CLOs in which we invest or receive the reports issued with respect
to such CLO. In addition, none of the information contained in certain monthly reports nor any other financial information furnished
to us as a noteholder in a CLO is audited and reported upon, nor is an opinion expressed, by an independent public accountant. Our CLO
investments are also subject to the risk of leverage associated with the debt issued by such CLOs and the repayment priority of senior
debt holders in such CLOs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>CLO
investments involve complex documentation and accounting considerations.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs
and other structured finance securities in which we invest are often governed by a complex series of legal documents and contracts. As
a result, the risk of dispute over interpretation or enforceability of the documentation may be higher relative to other types of investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
accounting and tax implications of the CLO investments that we make are complicated. In particular, reported earnings from CLO equity
securities are recorded under U.S. generally accepted accounting principles, or &#8220;GAAP,&#8221; based upon an effective yield calculation.
Current taxable earnings on certain of these investments, however, will generally not be determinable until after the end of the fiscal
year of each individual CLO that ends within our fiscal year, even though the investments are generating cash flow throughout the fiscal
year. The tax treatment of certain of these investments may result in higher distributable earnings in the early&#160;years and a capital
loss at maturity, while for reporting purposes the totality of cash flows are reflected in a constant yield to maturity.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are dependent on the collateral managers of the CLOs in which we invest, and those CLOs are generally not registered under the 1940 Act.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
rely on CLO collateral managers to administer and review the portfolios of collateral they manage. The actions of the CLO collateral
managers may significantly affect the return on our investments; however, we, as investors of the CLO, typically do not have any direct
contractual relationship with the collateral managers of the CLOs in which we invest. The ability of each CLO collateral manager to identify
and report on issues affecting its securitization portfolio on a timely basis could also affect the return on our investments, as we
may not be provided with information on a timely basis in order to take appropriate measures to manage our risks. We will also rely on
CLO collateral managers to act in the best interests of a CLO it manages; however, such CLO collateral managers are subject to fiduciary
duties owed to other classes of notes besides those in which we invest; therefore, there can be no assurance that the collateral managers
will always act in the best interest of the class or classes of notes in which we are invested. If any CLO collateral manager were to
act in a manner that was not in the best interest of the CLOs (<i>e.g.</i>, gross negligence, with reckless disregard or in bad faith),
this could adversely impact the overall performance of our investments. Furthermore, since the underlying CLO issuer often provides an
indemnity to its CLO collateral manager, we may not be incentivized to pursue actions against the collateral manager since any such action,
if successful, may ultimately be borne by the underlying CLO issuer and payable from its assets, which could create losses to us as investors
in the CLO. In addition, to the extent we invest in CLO equity, liabilities incurred by the CLO manger to third parties may be borne
by us to the extent the CLO is required to indemnify its collateral manager for such liabilities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, the CLOs in which we invest are generally not registered as investment companies under the 1940 Act. As investors in these
CLOs, we are not afforded the protections that stockholders in an investment company registered under the 1940 Act would have.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 20 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
collateral managers of the CLOs in which we invest may not continue to manage such CLOs.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Given
that we invest in CLO securities issued by CLOs which are managed by unaffiliated collateral managers, we are dependent on the skill
and expertise of such managers. We believe our Adviser&#8217;s ability to analyze and diligence potential CLO managers differentiates
our approach to investing in CLO securities. However, we cannot assure you that, for any CLO we invest in, the collateral manager in
place when we invest in such CLO securities will continue to manage such CLO through the life of our investment. Collateral managers
are subject to removal or replacement by other holders of CLO securities without our consent, and may also voluntarily resign as collateral
manager or assign their role as collateral manager to another entity. There can be no assurance that any removal, replacement, resignation
or assignment of any particular CLO manager&#8217;s role will not adversely affect the returns on the CLO securities in which we invest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments in CLO securities may be subject to special anti-deferral provisions that could result in us incurring tax or recognizing
income prior to receiving cash distributions related to such income.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Some
of the CLOs in which we invest may constitute &#8220;passive foreign investment companies,&#8221; or &#8220;PFICs.&#8221; If we acquire
interests treated as equity for U.S. federal income tax purposes in PFICs (including equity tranche investments and certain debt tranche
investments in CLOs that are PFICs), we may be subject to federal income tax on a portion of any &#8220;excess distribution&#8221; or
gain from the disposition of such shares even if such income is distributed as a taxable dividend by us to our stockholders. Certain
elections may be available to mitigate or eliminate such tax on excess distributions, but such elections (if available) will generally
require us to recognize our share of the PFIC&#8217;s income for each tax year regardless of whether we receive any distributions from
such PFIC. We must nonetheless distribute such income to maintain our status as a RIC. Treasury Regulations generally treat our income
inclusion with respect to a PFIC with respect to which we have made a qualified electing fund, or &#8220;QEF,&#8221; election, as qualifying
income for purposes of determining our ability to be subject to tax as a RIC if (i)&#160;there is a current distribution out of the earnings
and profits of the PFIC that are attributable to such income inclusion or (ii)&#160;such inclusion is derived with respect to our business
of investing in stock, securities, or currencies. As such, we may be restricted in our ability to make QEF elections with respect to
our holdings in issuers that could be treated as PFICs in order to ensure our continued qualification as a RIC and/or maximize our after-tax
return from these investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
we hold 10% or more of the interests treated as equity (by vote or value) for U.S. federal income tax purposes in a foreign corporation
that is treated as a controlled foreign corporation, or &#8220;CFC&#8221; (including equity tranche investments and certain debt tranche
investments in a CLO treated as a CFC), we may be treated as receiving a deemed distribution (taxable as ordinary income) each tax year
from such foreign corporation in an amount equal to our pro&#160;rata share of the corporation&#8217;s income for the tax year (including
both ordinary earnings and capital gains). If we are required to include such deemed distributions from a CFC in our income, we will
be required to distribute such income to maintain our RIC status regardless of whether or not the CFC makes an actual distribution during
such tax year. Treasury Regulations generally treat our income inclusion with respect to a CFC as qualifying income for purposes of determining
our ability to be subject to tax as a RIC either if (i)&#160;there is a current distribution out of the earnings and profits of the CFC
that are attributable to such income inclusion or (ii)&#160;such inclusion is derived with respect to our business of investing in stock,
securities, or currencies. As such, we may limit and/or manage our holdings in issuers that could be treated as CFCs in order to ensure
our continued qualification as a RIC and/or maximize our after-tax return from these investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
we are required to include amounts from CLO securities in income prior to receiving the cash distributions representing such income,
we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity
capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may fail to
qualify for RIC tax treatment and thus become subject to corporate-level income tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 21 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>If
a CLO in which we invest is treated as engaged in a U.S. trade or business for U.S. federal income tax purposes, such CLO could be subject
to U.S. federal income tax on a net basis, which could affect our operating results and cash flows.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each
CLO in which we invest will generally operate pursuant to investment guidelines intended to ensure the CLO is not treated as engaged
in a U.S. trade or business for U.S. federal income tax purposes. Each CLO will generally receive an opinion of counsel, subject to
certain assumptions (including compliance with the investment guidelines) and limitations, that the CLO will not be engaged in a
U.S. trade or business for U.S. federal income tax purposes. If a CLO fails to comply with the investment guidelines or the Internal
Revenue Service, or the &#8220;IRS,&#8221; otherwise successfully asserts that the CLO should be treated as engaged in a U.S. trade
or business for U.S. federal income tax purposes, such CLO could be subject to U.S. federal income tax on a net basis, which could
reduce the amount available to distribute to junior debt and equity holders in such CLO, including the Company.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>If
a CLO in which we invest fails to comply with certain U.S. tax disclosure requirements, such CLO may be subject to withholding requirements
that could materially and adversely affect our operating results and cash flows.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
U.S. Foreign Account Tax Compliance Act provisions of the Code, or &#8220;FATCA&#8221; imposes a withholding tax of 30% on U.S. source
periodic payments, including interest and dividends to certain non-U.S. entities, including certain non-U.S. financial institutions and
investment funds, unless such non-U.S. entity complies with certain reporting requirements regarding its U.S. account holders and its
U.S. owners. Most CLOs in which we invest will be treated as non-U.S. financial entities for this purpose, and therefore will be required
to comply with these reporting requirements to avoid the 30% withholding. If a CLO in which we invest fails to properly comply with these
reporting requirements, it could reduce the amount available to distribute to equity and junior debt holders in such CLO, which could
materially and adversely affect the fair value of the CLO&#8217;s securities, our operating results and cash flows.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Increased
competition in the market or a decrease in new CLO issuances may result in increased price volatility or a shortage of investment opportunities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
recent&#160;years there has been a marked increase in the number of, and flow of capital into, investment vehicles established to pursue
investments in CLO securities whereas the size of this market is relatively limited. While we cannot determine the precise effect of
such competition, such increase may result in greater competition for investment opportunities, which may result in an increase in the
price of such investments relative to the risk taken on by holders of such investments. Such competition may also result under certain
circumstances in increased price volatility or decreased liquidity with respect to certain positions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, the volume of new CLO issuances and CLO refinancings varies over time as a result of a variety of factors including new regulations,
changes in interest rates, and other market forces. As a result of increased competition and uncertainty regarding the volume of new
CLO issuances and CLO refinancings, we can offer no assurances that we will deploy all of our capital in a timely manner or at all. Prospective
investors should understand that we may compete with other investment vehicles, as well as investment and commercial banking firms, which
have substantially greater resources, in terms of financial wherewithal and research staffs, than may be available to us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks associated with our wholly-owned subsidiaries.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
invest indirectly through wholly-owned subsidiaries, including the Cayman Subsidiary through which we expect to invest in securities
of U.S. and non-U.S. issuers that are issued in private offerings without registration with the SEC pursuant to Regulation&#160;S under
the Securities Act. Such wholly-owned subsidiaries are not separately registered under the 1940 Act and are not subject to all the investor
protections of the 1940 Act. In addition, changes in the laws of the Cayman Islands could result in the inability of the Cayman Subsidiary
and Cayman II Subsidiary to operate as anticipated.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
and our investments are subject to interest rate risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Since
we have issued Preferred Stock and Notes, and since we may incur leverage (including through Preferred Stock and/or debt securities)
to make investments, our net investment income depends, in part, upon the difference between the rate at which we borrow funds and the
rate at which we invest those funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 22 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Because
of inflationary pressure, the U.S. government has recently increased interest rates. Interest rates may rise rather than fall, in
the future. In a rising interest rate environment, any additional leverage that we incur may bear a higher interest rate than our
current leverage. There may not, however, be a corresponding increase in our investment income. Any reduction in the level of rate
of return on new investments relative to the rate of return on our current investments, and any reduction in the rate of return on
our current investments, could adversely impact our net investment income, reducing our ability to service the interest obligations
on, and to repay the principal of, our indebtedness, as well as our capacity to pay distributions to our stockholders. See
&#8220;&#8212; <b><i>Benchmark Floor Risk</i></b>.&#8221;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
fair value of certain of our investments may be significantly affected by changes in interest rates. Although senior secured loans are
generally floating rate instruments, our investments in senior secured loans through investments in junior equity and debt tranches of
CLOs are sensitive to interest rate levels and volatility. For example, because CLO debt securities are floating rate securities, a reduction
in interest rates would generally result in a reduction in the coupon payment and cash flow we receive on our CLO debt investments. Further,
there may be some difference between the timing of interest rate resets on the assets and liabilities of a CLO. Such a mismatch in timing
could have a negative effect on the amount of funds distributed to CLO equity investors. In addition, CLOs may not be able to enter into
hedge agreements, even if it may otherwise be in the best interests of the CLO to hedge such interest rate risk. Furthermore, in the
event of a significant rising interest rate environment and/or economic downturn, loan defaults may increase and result in credit losses
that may adversely affect our cash flow, fair value of our assets and operating results. In the event that our interest expense were
to increase relative to income, or sufficient financing became unavailable, our return on investments and cash available for distribution
to stockholders or to make other payments on our securities would be reduced. In addition, future investments in different types of instruments
may carry a greater exposure to interest rate risk.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Benchmark
Floor Risk</i></span>.&#160;&#160;&#160;Because CLOs generally issue debt on a floating rate basis, an increase in the relevant Benchmark
will increase the financing costs of CLOs. Many of the senior secured loans held by these CLOs have Benchmark floors such that, when
the relevant Benchmark is below the stated Benchmark floor, the stated Benchmark floor (rather than the Benchmark itself) is used to
determine the interest payable under the loans. Therefore, if the relevant Benchmark increases but stays below the average Benchmark
floor rate of the senior secured loans held by a CLO, there would not be a corresponding increase in the investment income of such CLOs.
The combination of increased financing costs without a corresponding increase in investment income in such a scenario could result in
the CLO not having adequate cash to make interest or other payments on the securities which we hold.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>LIBOR
Risk</i></span>.&#160;&#160;&#160;Certain CLO securities in which we invest continue to earn interest at (or, from the perspective of
the Company as CLO equity investor, obtain financing at) a floating rate based on LIBOR. After the global financial crisis, regulators
globally determined that existing interest rate benchmarks should be reformed based on concerns that LIBOR was susceptible to manipulation.
In a speech on July&#160;27, 2017, the then-Chief Executive of the Financial Conduct Authority of the UK (the &#8220;FCA&#8221;) announced
the FCA&#8217;s intention to cease sustaining LIBOR. On March&#160;5, 2021, the FCA announced that all LIBOR settings will either cease
to be provided by any administrator, or no longer be representative immediately after December&#160;31, 2021, for all GBP, EUR, CHF and
JPY LIBOR settings and one-week and two-month US dollar LIBOR settings, and immediately after June&#160;30, 2023 for the remaining US
dollar LIBOR settings, including three-month US dollar LIBOR. In addition, based on supervisory guidance from regulators, many banks
have ceased issuance of new LIBOR-based instruments as of January&#160;1, 2022.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 23 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Replacement
rates that have been identified include the Secured Overnight Financing Rate (SOFR, which is intended to replace U.S. dollar LIBOR
and measures the cost of overnight borrowings through repurchase agreement transactions collateralized with U.S. Treasury
securities) and the Sterling Overnight Index Average Rate (SONIA, which is intended to replace GBP LIBOR and measures the overnight
interest rate paid by banks for unsecured transactions in the sterling market), although other replacement rates could be adopted by
market participants. On April&#160;3, 2018, the New York Federal Reserve Bank began publishing its alternative rate, the Secured
Overnight Financing Rate (&#8220;SOFR&#8221;). The Bank of England followed suit on April&#160;23, 2018 by publishing its proposed
alternative rate, the Sterling Overnight Index Average (&#8220;SONIA&#8221;). Each of SOFR and SONIA significantly differ from
LIBOR, both in the actual rate and how it is calculated, and therefore it is unclear whether and when markets will adopt either of
these rates as a widely accepted replacement for LIBOR. On July&#160;29, 2021, the Alternative Reference Rates Committee
(&#8220;ARRC&#8221;) announced that it recommended &#8220;Term SOFR,&#8221; a similar forward-looking term rate which will be based
on SOFR, for business loans. CME Group currently publishes the Term SOFR Rate in one-month, three-month and six-month tenors. As of
the date of this prospectus, it is unclear how the market will respond to ARRC&#8217;s formal recommendation. If no widely accepted
conventions develop, it is uncertain what effect broadly divergent interest rate calculation methodologies in the markets will have
on the price and liquidity of leverage loans or CLO securities and the ability for CLOs to effectively mitigate interest rate risks.
Many CLOs, as well as underlying loans held by CLOs, which have moved to a SOFR-based rate (such as Term SOFR), have included a
credit spread adjustment to account for the fact that USD LIBOR has historically tracked lower than Term SOFR. However, the credit
spread adjustment utilized for CLO liabilities may differ from the credit spread adjustments utilized for the underlying loans. To
the extent CLO liabilities may differ from the credit spread adjustments that exceeds the average credit spread adjustment of the
loans which they hold, this could negatively impact the returns on the CLO equity investments which we hold. In general, varying
market approaches on what benchmark replacement to adopt, as well as what credit spread adjustment to utilize, may create
significant uncertainty for CLO managers (and the CLO market generally) and negatively affect returns on CLO investments.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Potential
Effects of Alternative Reference Rates.</i></span>&#160;&#160;&#160;For CLOs that issue debt based on Term SOFR, investors should be
aware that such CLO debt may fluctuate from one interest accrual period to another in response to changes in Term SOFR. Term SOFR has
a limited history of use as a benchmark rate and, as a risk-free rate, differs in material respects from LIBOR. Neither the historical
performance of LIBOR nor Term SOFR should be taken as an indication of future performance of Term SOFR during the term of any CLO. Changes
in the levels of Term SOFR will affect the amount of interest payable on the CLO debt securities, the distributions on the CLO equity
and the trading price of the CLO securities, but it is impossible to predict whether such levels will rise or fall.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
LIBOR is currently being reformed, investors should be aware that: (a)&#160;any changes to LIBOR could affect the level of the published
rate, including to cause it to be lower and/or more volatile than it would otherwise be; (b)&#160;if the applicable rate of interest
on any CLO security is calculated with reference to a tenor which is discontinued, such rate of interest will then be determined by the
provisions of the affected CLO security, which may include determination by the relevant calculation agent in its discretion; (c)&#160;the
administrator of LIBOR will not have any involvement in the CLOs or loans and may take any actions in respect of LIBOR without regard
to the effect of such actions on the CLOs or loans; and (d)&#160;any uncertainty in the value of LIBOR or, the development of a widespread
market view that LIBOR has been manipulated or any uncertainty in the prominence of LIBOR as a benchmark interest rate due to the recent
regulatory reform may adversely affect the liquidity of the securities in the secondary market and their market value. Any of the above
or any other significant change to the setting of LIBOR could have a material adverse effect on the value of, and the amount payable
under, (i)&#160;any underlying asset of the CLO which pay interest linked to a LIBOR rate and (ii)&#160;the CLO securities in which we
invest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Once
LIBOR is eliminated as a benchmark rate, it is uncertain whether broad replacement conventions in the CLO markets will develop and, if
conventions develop, what those conventions will be and whether they will create adverse consequences for the issuer or the holders of
CLO securities. Currently, the CLOs we are invested in generally contemplate a scenario where LIBOR is no longer available by requiring
the CLO administrator to calculate a replacement rate primarily through dealer polling on the applicable measurement date. However, there
is uncertainty regarding the effectiveness of the dealer polling processes, including the willingness of banks to provide such quotations,
which could adversely impact our net investment income. Some of the CLOs we are invested in have included, or have been amended to include,
language permitting the CLO investment manager to implement a market replacement rate (like those proposed by the ARRC) upon the occurrence
of certain material disruption events. However, we cannot ensure that all CLOs in which we are invested will have such provisions, nor
can we ensure the CLO investment managers will undertake the suggested amendments when able, nor can we ensure that the credit spread
adjustments utilized will be favorable to CLO equity investors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
no replacement conventions develop, it is uncertain what effect broadly divergent interest rate calculation methodologies in the
markets will have on the price and liquidity of CLO securities and the ability of the collateral manager to effectively mitigate
interest rate risks. While the issuers and the trustee of a CLO may enter into a reference rate amendment or the collateral manager
may designate a designated reference rate, in each case, subject to the conditions described in a CLO indenture, there can be no
assurance that a change to any alternative benchmark rate (a)&#160;will be adopted, (b)&#160;will effectively mitigate interest rate
risks or result in an equivalent methodology for determining the interest rates on the floating rate instrument, (c)&#160;will be
adopted prior to any date on which the issuer suffers adverse consequences from the elimination or modification or potential
elimination or modification of LIBOR or (d)&#160;will not have a material adverse effect on the holders of the CLO securities.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 24 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, the effect of a phase out of LIBOR on U.S. senior secured loans, the underlying assets of the CLOs in which we invest, is currently
unclear. As discussed above, to the extent that any replacement rate or credit spread adjustment utilized for senior secured loans differs
from that utilized for a CLO that holds those loans, the CLO would experience an interest rate mismatch between its assets and liabilities,
which could have an adverse impact on our net investment income and portfolio returns.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Base
Rate Mismatch</i></span>.&#160;&#160;&#160;Many underlying corporate borrowers can elect to pay interest based on a 1-month, 3-month
and/or other term base rates in respect of the loans held by CLOs in which we are invested, in each case plus an applicable spread, whereas
CLOs generally pay interest to holders of the CLO&#8217;s debt tranches based today on 3-month term plus a spread. The 3-month term rate
may fluctuate in excess of other potential term rates, which may result in many underlying corporate borrowers electing to pay interest
based on a shorter, but in any event lower, base rate. This mismatch in the rate at which CLOs earn interest and the rate at which they
pay interest on their debt tranches negatively impacts the cash flows on a CLO&#8217;s equity tranche, which may in turn adversely affect
our cash flows and results of operations. Unless spreads are adjusted to account for such increases, these negative impacts may worsen
as the amount by which the 3-month term rate exceeds such other chosen term base rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">To
the extent that any LIBOR replacement rate utilized for senior secured loans differs from that utilized for debt of a CLO that holds
those loans (including instances where the replacement rate is utilized for such loans prior to it being utilized by the CLO), for the
duration of such mismatch, the CLO would experience an interest rate mismatch between its assets and liabilities, which could have an
adverse impact on the cash flows distributed to CLO equity investors as well as our net investment income and portfolio returns until
such mismatch is corrected or minimized, which would be expected to occur when both the underlying senior secured loans and the CLO debt
securities utilize the same LIBOR replacement rate. As of the date hereof, certain senior secured loans have transitioned to utilizing
SOFR based interest rates and certain CLO debt securities have also transitioned to SOFR.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
Rate Environment</i></span>.&#160;&#160;&#160;The senior secured loans underlying the CLOs in which we invest typically have floating
interest rates. A rising interest rate environment may increase loan defaults, resulting in losses for the CLOs in which we invest. In
addition, increasing interest rates may lead to higher prepayment rates, as corporate borrowers look to avoid escalating interest payments
or refinance floating rate loans. See &#8220;&#8212; <b><i>Risks Related to Our Investments&#8201;&#8212;&#8201;Our investments are
subject to prepayment risk.</i></b>&#8221; Further, a general rise in interest rates will increase the financing costs of the CLOs. However,
since many of the senior secured loans within these CLOs have Benchmark floors, if the Benchmark is below the applicable Benchmark floor,
there may not be corresponding increases in investment income which could result in the CLO not having adequate cash to make interest
or other payments on the securities which we hold.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For
detailed discussions of the risks associated with a rising interest rate environment, see <b><i>&#8220;&#8212; Risks Related to Our Investments&#8201;&#8212;&#8201;We
and our investments are subject to interest rate risk&#8221; and &#8220;&#8212; Risks Related to Our Investments&#8201;&#8212;&#8201;We
and our investments are subject to risks associated with investing in high-yield and unrated, or &#8220;junk,&#8221; securities.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments are subject to credit risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
a CLO in which we invest, an underlying asset of any such CLO or any other type of credit investment in our portfolio declines in
price or fails to pay interest or principal when due because the issuer or debtor, as the case may be, experiences a decline in its
financial status either or both our income and NAV may be adversely impacted. Non-payment would result in a reduction of our income,
a reduction in the value of the applicable CLO security or other credit investment experiencing non-payment and, potentially, a
decrease in our NAV. With respect to our investments in CLO securities and credit investments that are secured, there can be no
assurance that liquidation of collateral would satisfy the issuer&#8217;s obligation in the event of non-payment of scheduled
dividend, interest or principal or that such collateral could be readily liquidated. In the event of bankruptcy of an issuer, we
could experience delays or limitations with respect to its ability to realize the benefits of any collateral securing a CLO security
or credit investment. To the extent that the credit rating assigned to a security in our portfolio is downgraded, the market price
and liquidity of such security may be adversely affected. In addition, if a CLO in which we invest triggers an event of default as a
result of failing to make payments when due or for other reasons, the CLO would be subject to the possibility of liquidation, which
could result in full loss of value to the CLO equity and junior debt investors. CLO equity tranches are the most likely tranche to
suffer a loss of all of their value in these circumstances. Heightened inflationary pressures could increase the risk of default by
the Company&#8217;s underlying obligors.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 25 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments are subject to prepayment risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Although
the Adviser&#8217;s valuations and projections take into account certain expected levels of prepayments, the collateral of a CLO may
be prepaid more quickly than expected. Prepayment rates are influenced by changes in interest rates and a variety of factors beyond our
control and consequently cannot be accurately predicted. Early prepayments give rise to increased reinvestment risk, as a CLO collateral
manager might realize excess cash from prepayments earlier than expected. If a CLO collateral manager is unable to reinvest such cash
in a new investment with an expected rate of return at least equal to that of the investment repaid, this may reduce our net income and
the fair value of that asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, in most CLO transactions, CLO debt investors, such as us, are subject to prepayment risk in that the holders of a majority
of the equity tranche can direct a call or refinancing of a CLO, which would cause such CLO&#8217;s outstanding CLO debt securities to
be repaid at par. Such prepayments of CLO debt securities held by us also give rise to reinvestment risk if we are unable to reinvest
such cash in a new investment with an expected rate of return at least equal to that of the investment repaid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing
in us.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
have incurred leverage through the issuance of the Preferred Stock and the Notes. We may incur additional leverage, directly or indirectly,
through one or more special purpose vehicles, indebtedness for borrowed money, as well as leverage in the form of Derivative Transactions,
additional shares of Preferred Stock, debt securities and other structures and instruments, in significant amounts and on terms that
the Adviser and our board of directors deem appropriate, subject to applicable limitations under the 1940 Act. Such leverage may be used
for the acquisition and financing of our investments, to pay fees and expenses and for other purposes. Such leverage may be secured and/or
unsecured. Any such leverage does not include leverage embedded or inherent in the CLO structures in which we invest or in derivative
instruments in which we may invest. Accordingly, there is a layering of leverage in our overall structure.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
more leverage we employ, the more likely a substantial change will occur in our NAV. Accordingly, any event that adversely affects the
value of an investment would be magnified to the extent leverage is utilized. For instance, any decrease in our income would cause net
income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect our ability to make
distributions and other payments to our securityholders. Leverage is generally considered a speculative investment technique. Our ability
to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions
and competitive pressures. The cumulative effect of the use of leverage with respect to any investments in a market that moves adversely
to such investments could result in a substantial loss that would be greater than if our investments were not leveraged.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
a registered closed-end management investment company, we are required to meet certain asset coverage requirements, as defined under
the 1940 Act, with respect to any senior securities. With respect to senior securities representing indebtedness (<i>i.e.</i>,
borrowings or deemed borrowings, including the Notes), other than temporary borrowings as defined under the 1940 Act, we are
required under current law to have an asset coverage of at least 300%, as measured at the time of borrowing and calculated as the
ratio of our total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount of
our outstanding senior securities representing indebtedness. With respect to senior securities that are stocks (<i>i.e.</i>, shares
of our Preferred Stock), we are required under current law to have an asset coverage of at least 200%, as measured at the time of
the issuance of any such shares of Preferred Stock and calculated as the ratio of our total assets (less all liabilities and
indebtedness not represented by senior securities) over the aggregate amount of our outstanding senior securities representing
indebtedness plus the aggregate liquidation preference of any outstanding shares of Preferred Stock. If legislation were passed that
modifies this section of the 1940 Act and increases the amount of senior securities that we may incur, we may increase our leverage
to the extent then permitted by the 1940 Act and the risks associated with an investment in us may increase.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 26 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
our asset coverage declines below 300% (or 200%, as applicable), we would not be able to incur additional debt or issue additional Preferred
Stock, and could be required by law to sell a portion of our investments to repay some debt or redeem shares of Preferred Stock when
it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make certain
distributions or pay dividends of an amount necessary to continue to be subject to tax as a RIC. The amount of leverage that we employ
will depend on the Adviser&#8217;s and our board of directors&#8217; assessment of market and other factors at the time of any proposed
borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, any debt facility into which we may enter would likely impose financial and operating covenants that restrict our business
activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions
required to maintain our ability to be subject to tax as a RIC under Subchapter M of the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
following table is furnished in response to the requirements of the SEC and illustrates the effect of leverage on returns from an investment
in our common stock assuming various annual returns, net of expenses. The calculations in the table below are hypothetical and actual
returns may be higher or lower than those appearing in the table below.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 36%">Assumed Return on Our Portfolio (Net of Expenses)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">-10%</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: center"/><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">-5%</td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">0%</td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">5%</td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">10%</td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Corresponding Return to Common Stockholder<sup>(1)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-17.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-10.17</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-2.94</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.29</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11.51</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="text-indent: -0.25in; margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify">(1)
&#8239;&#8239;Assumes (i)&#160;$765.9&#160;million in assets as of March&#160;31, 2023; (ii)&#160;$529.8&#160;million in net assets as of
March&#160;31, 2023; and (iii)&#160;an annualized average interest rate on our indebtedness and preferred equity, as of
March&#160;31, 2023, of 6.18%.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Based
on our assumed leverage described above, our investment portfolio would have been required to experience an annual return of at least
2.03% to cover annual dividend and interest payments on our outstanding Preferred Stock and additional indebtedness.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investments may be highly subordinated and subject to leveraged securities risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
portfolio includes equity and junior debt investments in CLOs, which involve a number of significant risks. CLOs are typically very highly
levered (with CLO equity securities being leveraged ten times), and therefore the junior equity and debt tranches in which we are currently
invested and in which we invest will be subject to a higher degree of risk of total loss. In particular, investors in CLO securities
indirectly bear risks of the collateral held by such CLOs. We generally have the right to receive payments only from the CLOs, and generally
not have direct rights against the underlying borrowers or the entity that sponsored the CLO. While the CLOs we target generally enable
an equity investor therein to acquire interests in a pool of senior secured loans without the expenses associated with directly holding
the same investments, we generally pay a proportionate share of the CLOs&#8217; administrative, management and other expenses if we make
a CLO equity investment. In addition, we may have the option in certain CLOs to contribute additional amounts to the CLO issuer for purposes
of acquiring additional assets or curing coverage tests, thereby increasing our overall exposure and capital at risk to such CLO. Although
it is difficult to predict whether the prices of assets underlying CLOs will rise or fall, these prices (and, therefore, the prices of
the CLOs&#8217; securities) are influenced by the same types of political and economic events that affect issuers of securities and capital
markets generally. The interests we acquire in CLOs generally are thinly traded or have only a limited trading market. CLO securities
are typically privately offered and sold, even in the secondary market. As a result, investments in CLO securities are illiquid.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 27 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
and our investments are subject to risks associated with investing in high-yield and unrated, or &#8220;junk,&#8221; securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
invest primarily in securities that are rated below investment grade or, in the case of CLO equity securities, are not rated by a
nationally recognized statistical rating organization. The primary assets underlying our CLO security investments are senior secured
loans, although these transactions may allow for limited exposure to other asset classes including unsecured loans, high yield
bonds, emerging market loans or bonds and structured finance securities with underlying exposure to CBO and CDO tranches,
residential mortgage-backed securities, commercial mortgage-backed securities, trust preferred securities and other types of
securitizations. CLOs generally invest in lower-rated debt securities that are typically rated below Baa/BBB by Moody&#8217;s,
S&amp;P or Fitch. In addition, we may obtain direct exposure to such financial assets/instruments. Securities that are not rated or
are rated lower than Baa by Moody&#8217;s or lower than BBB by S&amp;P or Fitch are sometimes referred to as &#8220;high
yield&#8221; or &#8220;junk.&#8221; High-yield debt securities have greater credit and liquidity risk than investment grade
obligations. High-yield debt securities are generally unsecured and may be subordinated to certain other obligations of the issuer
thereof. The lower rating of high-yield debt securities and below investment grade loans reflects a greater possibility that adverse
changes in the financial condition of an issuer or in general economic conditions or both may impair the ability of the issuer
thereof to make payments of principal or interest.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Risks
of high-yield debt securities may include:</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left">(1)</td>
    <td style="text-align: justify">limited
liquidity and secondary market support;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">(2)</td>
    <td style="text-align: justify">substantial
marketplace volatility resulting from changes in prevailing interest rates;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">(3)</td>
    <td style="text-align: justify">subordination
to the prior claims of banks and other senior lenders;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">(4)</td>
    <td style="text-align: justify">the
operation of mandatory sinking fund or call/redemption provisions during periods of declining interest rates that could cause the CLO
issuer to reinvest premature redemption proceeds in lower-yielding debt obligations;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">(5)</td>
    <td style="text-align: justify">the
possibility that earnings of the high-yield debt security issuer may be insufficient to meet its debt service;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">(6)</td>
    <td style="text-align: justify">the
declining creditworthiness and potential for insolvency of the issuer of such high-yield debt securities during periods of rising interest
rates and/or economic downturn; and</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">(7)</td>
    <td style="text-align: justify">greater
susceptibility to losses and real or perceived adverse economic and competitive industry conditions than higher grade securities.</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">An
economic downturn or an increase in interest rates could severely disrupt the market for high-yield debt securities and adversely affect
the value of outstanding high-yield debt securities and the ability of the issuers thereof to repay principal and interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Issuers
of high-yield debt securities may be highly leveraged and may not have available to them more traditional methods of financing. The risk
associated with acquiring (directly or indirectly) the securities of such issuers generally is greater than is the case with highly rated
securities. For example, during an economic downturn or a sustained period of rising interest rates, issuers of high-yield debt securities
may be more likely to experience financial stress, especially if such issuers are highly leveraged. During such periods, timely service
of debt obligations also may be adversely affected by specific issuer developments, or the issuer&#8217;s inability to meet specific
projected business forecasts or the unavailability of additional financing. The risk of loss due to default by the issuer is significantly
greater for the holders of high-yield debt securities because such securities may be unsecured and may be subordinated to obligations
owed to other creditors of the issuer of such securities. In addition, the CLO issuer may incur additional expenses to the extent it
(or any investment manager) is required to seek recovery upon a default on a high yield bond (or any other debt obligation) or participate
in the restructuring of such obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A
portion of the loans held by CLOs in which we invest may consist of second lien loans. Second lien loans are secured by liens on the
collateral securing the loan that are subordinated to the liens of at least one other class of obligations of the related obligor, and
thus, the ability of the CLO issuer to exercise remedies after a second lien loan becomes a defaulted obligation is subordinated to,
and limited by, the rights of the senior creditors holding such other classes of obligations. In many circumstances, the CLO issuer may
be prevented from foreclosing on the collateral securing a second lien loan until the related first lien loan is paid in full. Moreover,
any amounts that might be realized as a result of collection efforts or in connection with a bankruptcy or insolvency proceeding involving
a second lien loan must generally be turned over to the first lien secured lender until the first lien secured lender has realized the
full value of its own claims. In addition, certain of the second lien loans contain provisions requiring the CLO issuer&#8217;s interest
in the collateral to be released in certain circumstances. These lien and payment obligation subordination provisions may materially
and adversely affect the ability of the CLO issuer to realize value from second lien loans and adversely affect the fair value of and
income from our investment in the CLO&#8217;s securities.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 28 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks associated with loan assignments and participations.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We,
or the CLOs in which we invest, may acquire interests in loans either directly (by way of assignment, or &#8220;Assignments&#8221;) or
indirectly (by way of participation, or &#8220;Participations&#8221;). The purchaser by an Assignment of a loan obligation typically
succeeds to all the rights and obligations of the selling institution and becomes a lender under the loan or credit agreement with respect
to the debt obligation. In contrast, Participations acquired by us or the CLOs in which we invest in a portion of a debt obligation held
by a selling institution, or the &#8220;Selling Institution,&#8221; typically result in a contractual relationship only with such Selling
Institution, not with the obligor. We or the CLOs in which we invest would have the right to receive payments of principal, interest
and any fees to which we (or the CLOs in which we invest) are entitled under the Participation only from the Selling Institution and
only upon receipt by the Selling Institution of such payments from the obligor. In purchasing a Participation, we or the CLOs in which
we invest generally will have no right to enforce compliance by the obligor with the terms of the loan or credit agreement or other instrument
evidencing such debt obligation, nor any rights of setoff against the obligor, and we or the CLOs in which we invest may not directly
benefit from the collateral supporting the debt obligation in which it has purchased the Participation. As a result, we or the CLOs in
which we invest would assume the credit risk of both the obligor and the Selling Institution. In the event of the insolvency of the Selling
Institution, we or the CLOs in which we invest will be treated as a general creditor of the Selling Institution in respect of the Participation
and may not benefit from any setoff between the Selling Institution and the obligor.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
holder of a Participation in a debt obligation may not have the right to vote to waive enforcement of any default by an obligor. Selling
Institutions commonly reserve the right to administer the debt obligations sold by them as they see fit and to amend the documentation
evidencing such debt obligations in all respects. However, most participation agreements with respect to senior secured loans provide
that the Selling Institution may not vote in favor of any amendment, modification or waiver that (1)&#160;forgives principal, interest
or fees, (2)&#160;reduces principal, interest or fees that are payable, (3)&#160;postpones any payment of principal (whether a scheduled
payment or a mandatory prepayment), interest or fees or (4)&#160;releases any material guarantee or security without the consent of the
participant (at least to the extent the participant would be affected by any such amendment, modification or waiver).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A
Selling Institution voting in connection with a potential waiver of a default by an obligor may have interests different from ours, and
the Selling Institution might not consider our interests in connection with its vote. In addition, many participation agreements with
respect to senior secured loans that provide voting rights to the participant further provide that, if the participant does not vote
in favor of amendments, modifications or waivers, the Selling Institution may repurchase such Participation at par. An investment by
us in a synthetic security related to a loan involves many of the same considerations relevant to Participations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
lack of liquidity in our investments may adversely affect our business.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">High-yield
investments, including subordinated CLO securities and collateral held by CLOs in which we invest, generally have limited liquidity.
As a result, prices of high-yield investments have at times experienced significant and rapid decline when a substantial number of holders
(or a few holders of a significantly large &#8220;block&#8221; of the securities) decided to sell. In addition, we (or the CLOs in which
we invest) may have difficulty disposing of certain high-yield investments because there may be a thin trading market for such securities.
To the extent that a secondary trading market for non-investment grade high-yield investments does exist, it would not be as liquid as
the secondary market for highly rated investments. Reduced secondary market liquidity would have an adverse impact on the fair value
of the securities and on our direct or indirect ability to dispose of particular securities in response to a specific economic event
such as deterioration in the creditworthiness of the issuer of such securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 29 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
secondary market trading volumes increase, new loans frequently contain standardized documentation to facilitate loan trading that
may improve market liquidity. There can be no assurance, however, that future levels of supply and demand in loan trading will
provide an adequate degree of liquidity or that the current level of liquidity will continue. Because holders of such loans are
offered confidential information relating to the borrower, the unique and customized nature of the loan agreement, and the private
syndication of the loan, loans are not purchased or sold as easily as publicly traded securities are purchased or sold. Although a
secondary market may exist, risks similar to those described above in connection with an investment in high-yield debt investments
are also applicable to investments in lower rated loans.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
securities issued by CLOs generally offer less liquidity than other investment grade or high-yield corporate debt, and are subject to
certain transfer restrictions that impose certain financial and other eligibility requirements on prospective transferees. Other investments
that we may purchase in privately negotiated transactions may also be illiquid or subject to legal restrictions on their transfer. As
a result of this illiquidity, our ability to sell certain investments quickly, or at all, in response to changes in economic and other
conditions and to receive a fair price when selling such investments may be limited, which could prevent us from making sales to mitigate
losses on such investments. In addition, CLOs are subject to the possibility of liquidation upon an event of default, which could result
in full loss of value to the CLO equity and junior debt investors. CLO equity tranches are the most likely tranche to suffer a loss of
all of their value in these circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may be exposed to counterparty risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may be exposed to counterparty risk, which could make it difficult for us or the CLOs in which we invest to collect on the obligations
represented by investments and result in significant losses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may hold investments (including synthetic securities) that would expose us to the credit risk of our counterparties or the counterparties
of the CLOs in which it invests. In the event of a bankruptcy or insolvency of such a counterparty, we or a CLO in which such an investment
is held could suffer significant losses, including the loss of that part of our or the CLO&#8217;s portfolio financed through such a
transaction, declines in the value of our investment, including declines that may occur during an applicable stay period, the inability
to realize any gains on our investment during such period and fees and expenses incurred in enforcing our rights. If the CLO enters into
or owns synthetic securities, the CLO may fall within the definition of &#8220;commodity pool&#8221; under CFTC rules, and the collateral
manager of the CLO may be required to register as a commodity pool operator with the CFTC, which could increase costs for the CLO and
reduce amounts available to pay to the residual tranche.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, with respect to certain swaps and synthetic securities, neither a CLO nor we usually has a contractual relationship with the
entities, referred to as &#8220;Reference Entities&#8221; whose payment obligations are the subject of the relevant swap agreement or
security. Therefore, neither the CLOs nor we generally have a right to directly enforce compliance by the Reference Entity with the terms
of this kind of underlying obligation, any rights of set-off against the Reference Entity or any voting rights with respect to the underlying
obligation. Neither the CLOs nor we will directly benefit from the collateral supporting the underlying obligation and will not have
the benefit of the remedies that would normally be available to a holder of such underlying obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Furthermore,
we may invest in unsecured notes which are linked to loans or other assets held by a bank or other financial institution on its balance
sheet (so called &#8220;credit-linked notes&#8221;). Although the credit-linked notes are tied to the underlying performance of the assets
held by the bank, such credit-linked notes are not secured by such assets and we have no direct or indirect ownership of the underlying
assets. Thus, as a holder of such credit-linked notes, we would be subject to counterparty risk of the bank which issues the credit-linked
notes (in addition to the risk associated with the assets themselves). To the extent the relevant bank experiences an insolvency event
or goes into receivership, we may not receive payments on the credit-linked notes, or such payments may be delayed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 30 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks associated with defaults on an underlying asset held by a CLO.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A
default and any resulting loss as well as other losses on an underlying asset held by a CLO may reduce the fair value of our
corresponding CLO investment. A wide range of factors could adversely affect the ability of the borrower of an underlying asset to
make interest or other payments on that asset. To the extent that actual defaults and losses on the collateral of an investment
exceed the level of defaults and losses factored into its purchase price, the value of the anticipated return from the investment
will be reduced. The more deeply subordinated the tranche of securities in which we invest, the greater the risk of loss upon a
default. For example, CLO equity is the most subordinated tranche within a CLO and is therefore subject to the greatest risk of loss
resulting from defaults on the CLO&#8217;s collateral, whether due to bankruptcy or otherwise. Any defaults and losses in excess of
expected default rates and loss model inputs will have a negative impact on the fair value of our investments, will reduce the cash
flows that we receive from our investments, adversely affect the fair value of our assets and could adversely impact our ability to
pay dividends. Furthermore, the holders of the junior equity and debt tranches typically have limited rights with respect to
decisions made with respect to collateral following an event of default on a CLO. In some cases, the senior most class of notes can
elect to liquidate the collateral even if the expected proceeds are not expected to be able to pay in full all classes of notes. We
could experience a complete loss of our investment in such a scenario.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, the collateral of CLOs may require substantial workout negotiations or restructuring in the event of a default or liquidation.
Any such workout or restructuring is likely to lead to a substantial reduction in the interest rate of such asset and/or a substantial
write-down or write-off of all or a portion the principal of such asset. Any such reduction in interest rates or principal will negatively
affect the fair value of our portfolio.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks associated with LAFs.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may invest capital in LAFs, which are short- to medium-term facilities often provided by the bank that will serve as placement agent
or arranger on a CLO transaction and which acquire loans on an interim basis which are expected to form part of the portfolio of a future
CLO. Investments in LAFs have risks similar to those applicable to investments in CLOs. There typically will be no assurance that the
future CLO will be consummated or that the loans held in such a loan accumulation facility are eligible for purchase by the CLO. In the
event a planned CLO is not consummated, or the loans are not eligible for purchase by the CLO, the Company may be responsible for either
holding or disposing of the loans. This could expose the Company primarily to credit and/or mark-to-market losses, and other risks. Leverage
is typically utilized in such a facility and as such the potential risk of loss will be increased for such facilities employing leverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Furthermore,
we likely will have no consent rights in respect of the loans to be acquired in such a facility and in the event we do have any consent
rights, they will be limited. In the event a planned CLO is not consummated, or the loans are not eligible for purchase by the CLO, we
may be responsible for either holding or disposing of the loans. This could expose us primarily to credit and/or mark-to-market losses,
and other risks. LAFs typically incur leverage from four to six times prior to a CLO&#8217;s closing and as such the potential risk of
loss will be increased for such facilities that employ leverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
synthetic strategy involves certain additional risks.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may invest in synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks
or other financial institutions, or acquire interests in lease agreements that have the general characteristics of loans and are treated
as loans for withholding tax purposes. In addition to the credit risks associated with the applicable reference assets, we will usually
have a contractual relationship only with the counterparty of such synthetic investment, and not with the reference obligor of the reference
asset. Accordingly, we generally will have no right to directly enforce compliance by the reference obligor with the terms of the reference
asset nor will we have any rights of setoff against the reference obligor or rights with respect to the reference asset. We will not
directly benefit from the collateral supporting the reference asset and will not have the benefit of the remedies that would normally
be available to a holder of such reference asset. In addition, in the event of the insolvency of the counterparty, we may be treated
as a general creditor of such counterparty, and will not have any claim with respect to the reference asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks associated with the bankruptcy or insolvency of an issuer or borrower of a loan that we hold or of an underlying
asset held by a CLO in which we invest.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
the event of a bankruptcy or insolvency of an issuer or borrower of a loan that we hold or of an underlying asset held by a CLO or other
vehicle in which we invest, a court or other governmental entity may determine that our claims or those of the relevant CLO are not valid
or not entitled to the treatment we expected when making our initial investment decision.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 31 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Various
laws enacted for the protection of debtors may apply to the underlying assets in our investment portfolio. The information in this and
the following paragraph represents a brief summary of certain points only, is not intended to be an extensive summary of the relevant
issues and is applicable with respect to U.S. issuers and borrowers only. The following is not intended to be a summary of all relevant
risks. Similar avoidance provisions to those described below are sometimes available with respect to non-U.S. issuers or borrowers, and
there is no assurance that this will be the case which may result in a much greater risk of partial or total loss of value in that underlying
asset.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
a court in a lawsuit brought by an unpaid creditor or representative of creditors of an issuer or borrower of underlying assets, such
as a trustee in bankruptcy, were to find that such issuer or borrower did not receive fair consideration or reasonably equivalent value
for incurring the indebtedness constituting such underlying assets and, after giving effect to such indebtedness, the issuer or borrower
(1)&#160;was insolvent; (2)&#160;was engaged in a business for which the remaining assets of such issuer or borrower constituted unreasonably
small capital; or (3)&#160;intended to incur, or believed that it would incur, debts beyond our ability to pay such debts as they mature,
such court could decide to invalidate, in whole or in part, the indebtedness constituting the underlying assets as a fraudulent conveyance,
to subordinate such indebtedness to existing or future creditors of the issuer or borrower or to recover amounts previously paid by the
issuer or borrower in satisfaction of such indebtedness. In addition, in the event of the insolvency of an issuer or borrower of underlying
assets, payments made on such underlying assets could be subject to avoidance as a &#8220;preference&#8221; if made within a certain
period of time (which may be as long as one year under U.S. Federal bankruptcy law or even longer under state laws) before insolvency.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
underlying assets may be subject to various laws for the protection of debtors in other jurisdictions, including the jurisdiction of
incorporation of the issuer or borrower of such underlying assets and, if different, the jurisdiction from which it conducts business
and in which it holds assets, any of which may adversely affect such issuer&#8217;s or borrower&#8217;s ability to make, or a creditor&#8217;s
ability to enforce, payment in full, on a timely basis or at all. These insolvency considerations will differ depending on the jurisdiction
in which an issuer or borrower or the related underlying assets are located and may differ depending on the legal status of the issuer
or borrower.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks associated with any hedging or Derivative Transactions in which we participate.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may in the future purchase and sell a variety of derivative instruments. To the extent we engage in Derivative Transactions, we expect
to do so to hedge against interest rate, credit, currency and/or other risks or for other investment or risk management purposes. We
may use Derivative Transactions for investment purposes to the extent consistent with our investment objectives if the Adviser deems
it appropriate to do so. Derivative Transactions may be volatile and involve various risks different from, and in certain cases, greater
than the risks presented by other instruments. The primary risks related to Derivative Transactions include counterparty, correlation,
illiquidity, leverage, volatility and OTC trading, operational and legal risks. A small investment in derivatives could have a large
potential impact on our performance, effecting a form of investment leverage on our portfolio. In certain types of Derivative Transactions,
we could lose the entire amount of our investment. In other types of Derivative Transactions, the potential loss is theoretically unlimited.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
following is a more detailed discussion of primary risk considerations related to the use of Derivative Transactions that investors should
understand before investing in our securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Counterparty
risk</i></span>.&#160;&#160;&#160;Counterparty risk is the risk that a counterparty in a Derivative Transaction will be unable to
honor its financial obligation to us, or the risk that the reference entity in a credit default swap or similar derivative will not
be able to honor its financial obligations. Certain participants in the derivatives market, including larger financial institutions,
have experienced significant financial hardship and deteriorating credit conditions. If our counterparty to a Derivative Transaction
experiences a loss of capital, or is perceived to lack adequate capital or access to capital, it may experience margin calls or
other regulatory requirements to increase equity. Under such circumstances, the risk that a counterparty will be unable to honor its
obligations may increase substantially. If a counterparty becomes bankrupt, we may experience significant delays in obtaining
recovery (if at all) under the derivative contract in bankruptcy or other reorganization proceeding; if our claim is unsecured, we
will be treated as a general creditor of such prime broker or counterparty and will not have any claim with respect to the
underlying security. We may obtain only a limited recovery or may obtain no recovery in such circumstances. The counterparty risk
for cleared derivatives is generally lower than for uncleared OTC derivatives since generally a clearing organization becomes
substituted for each counterparty to a cleared derivative and, in effect, guarantees the parties&#8217; performance under the
contract as each party to a trade looks only to the clearing house for performance of financial obligations. However, there can be
no assurance that the clearing house, or its members, will satisfy its obligations to us.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 32 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Correlation
risk</i></span>.&#160;&#160;&#160;When used for hedging purposes, an imperfect or variable degree of correlation between price movements
of the derivative instrument and the underlying investment sought to be hedged may prevent us from achieving the intended hedging effect
or expose us to the risk of loss. The imperfect correlation between the value of a derivative and our underlying assets may result in
losses on the Derivative Transaction that are greater than the gain in the value of the underlying assets in our portfolio.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser may not hedge against a particular risk because it does not regard the probability of the risk occurring to be sufficiently high
as to justify the cost of the hedge, or because it does not foresee the occurrence of the risk. These factors may have a significant
negative effect on the fair value of our assets and the market value of our securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity
risk</i></span>.&#160;&#160;&#160;Derivative Transactions, especially when traded in large amounts, may not be liquid in all circumstances,
so that in volatile markets we would not be able to close out a position without incurring a loss. Although both OTC and exchange-traded
derivatives markets may experience a lack of liquidity, OTC non-standardized derivative transactions are generally less liquid than exchange-traded
instruments. The illiquidity of the derivatives markets may be due to various factors, including congestion, disorderly markets, limitations
on deliverable supplies, the participation of speculators, government regulation and intervention, and technical and operational or system
failures. In addition, daily limits on price fluctuations and speculative position limits on exchanges on which we may conduct transactions
in derivative instruments may prevent prompt liquidation of positions, subjecting us to the potential of greater losses. As a result,
we may need to liquidate other investments to meet margin and settlement payment obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leverage
risk</i></span>.&#160;&#160;&#160;Trading in Derivative Transactions can result in significant leverage and risk of loss. Thus, the leverage
offered by trading in derivative instruments will magnify the gains and losses we experience and could cause our NAV to be subject to
wider fluctuations than would be the case if we did not use the leverage feature in derivative instruments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Volatility
risk</i></span>.&#160;&#160;&#160;The prices of many derivative instruments, including many options and swaps, are highly volatile. Price
movements of options contracts and payments pursuant to swap agreements are influenced by, among other things, interest rates, changing
supply and demand relationships, trade, fiscal, monetary and exchange control programs and policies of governments, and national and
international political and economic events and policies. The value of options and swap agreements also depends upon the price of the
securities or currencies underlying them.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>OTC
trading</i></span>.&#160;&#160;&#160;Derivative Transactions that may be purchased or sold may include instruments not traded on an
organized market. The risk of non-performance by the counterparty to such Derivative Transaction may be greater and the ease with
which we can dispose of or enter into closing transactions with respect to such an instrument may be less than in the case of an
exchange traded instrument. In addition, significant disparities may exist between &#8220;bid&#8221; and &#8220;ask&#8221; prices
for certain derivative instruments that are not traded on an exchange. Such instruments are often valued subjectively and may result
in mispricings or improper valuations. Improper valuations can result in increased cash payment requirements to counterparties or a
loss of value, or both. In contrast, cleared derivative transactions benefit from daily mark-to-market pricing and settlement, and
segregation and minimum capital requirements applicable to intermediaries. Derivatives are also subject to operational and legal
risks. Operational risk generally refers to risk related to potential operational issues, including documentation issues, settlement
issues, system failures, inadequate controls, and human errors. Legal risk generally refers to insufficient documentation,
insufficient capacity or authority of counterparty, or legality or enforceability of a contract. Transactions entered into directly
between two counterparties generally do not benefit from such protections; however, certain uncleared derivative transactions are
subject to minimum margin requirements which may require us and our counterparties to exchange collateral based on daily
marked-to-market pricing. OTC trading generally exposes us to the risk that a counterparty will not settle a transaction in
accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because
of a credit or liquidity problem, thus causing us to suffer a loss. Such &#8220;counterparty risk&#8221; is accentuated for
contracts with longer maturities where events may intervene to prevent settlement, or where we have concentrated our transactions
with a single or small group of counterparties.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 33 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may be subject to risks associated with investments in other investment companies.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may invest in securities of other investment companies, including closed-end funds, BDCs, mutual funds, and ETFs, and may otherwise invest
indirectly in securities consistent with our investment objectives, subject to statutory limitations prescribed by the 1940 Act. These
limitations include in certain circumstances a prohibition on us acquiring more than 3% of the voting shares of any other investment
company, and a prohibition on investing more than 5% of our total assets in securities of any one investment company or more than 10%
of our total assets in securities of all investment companies. Subject to applicable law and/or pursuant to an exemptive order obtained
from the SEC or under an exemptive rule&#160;adopted by the SEC, we may invest in certain other investment companies (including ETFs
and money market funds) and business development companies beyond these statutory limits or otherwise provided that certain conditions
are met. We will indirectly bear our proportionate share of any management fees and other expenses paid by such other investment companies,
in addition to the fees and expenses that we regularly bear. We may only invest in other investment companies to the extent that the
asset class exposure in such investment companies is consistent with the permissible asset class exposure for us had we invested directly
in securities, and the portfolios of such investment companies are subject to similar risks as we are.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Investors
will bear indirectly the fees and expenses of the CLO equity securities in which we invest.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Investors
will bear indirectly the fees and expenses (including management fees and other operating expenses) of the CLO equity securities in which
we invest. CLO collateral manager fees are charged on the total assets of a CLO but are assumed to be paid from the residual cash flows
after interest payments to the CLO senior debt tranches. Therefore, these CLO collateral manager fees (which generally range from 0.35%
to 0.50% of a CLO&#8217;s total assets) are effectively much higher when allocated only to the CLO equity tranche. The calculation does
not include any other operating expense ratios of the CLOs, as these amounts are not routinely reported to shareholders on a basis consistent
with this methodology; however, it is estimated that additional operating expenses of 0.30% to 0.70% could be incurred. In addition,
CLO collateral managers may earn fees based on a&#160;percentage of the CLO&#8217;s equity cash flows after the CLO equity has earned
a cash-on-cash return of its capital and achieved a specified &#8220;hurdle&#8221; rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
and our investments are subject to reinvestment risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
part of the ordinary management of its portfolio, a CLO will typically generate cash from asset repayments and sales and reinvest those
proceeds in substitute assets, subject to compliance with its investment tests and certain other conditions. The earnings with respect
to such substitute assets will depend on the quality of reinvestment opportunities available at the time. If the CLO collateral manager
causes the CLO to purchase substitute assets at a lower yield than those initially acquired (for example, during periods of loan compression
or need to satisfy the CLO&#8217;s covenants) or sale proceeds are maintained temporarily in cash, it would reduce the excess interest-related
cash flow that the CLO collateral manager is able to achieve. The investment tests may incentivize a CLO collateral manager to cause
the CLO to buy riskier assets than it otherwise would, which could result in additional losses. These factors could reduce our return
on investment and may have a negative effect on the fair value of our assets and the market value of our securities. In addition, the
reinvestment period for a CLO may terminate early, which would cause the holders of the CLO&#8217;s securities to receive principal payments
earlier than anticipated. In addition, in most CLO transactions, CLO debt investors are subject to the risk that the holders of a majority
of the equity tranche, who can direct a call or refinancing of a CLO, causing such CLO&#8217;s outstanding CLO debt securities to be
repaid at par earlier than expected. There can be no assurance that we will be able to reinvest such amounts in an alternative investment
that provides a comparable return relative to the credit risk assumed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
and our investments are subject to risks associated with non-U.S. investing.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">While
we invest primarily in CLOs that hold underlying U.S. assets, these CLOs may be organized outside the United States. We may also invest
in CLOs that hold collateral that are non-U.S. assets or otherwise invest in securities of non-U.S. issuers to the extent consistent
with our investment strategies and objectives.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 34 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Investing
in foreign entities may expose us to additional risks not typically associated with investing in U.S. issuers. These risks include changes
in exchange control regulations, political and social instability, restrictions on the types or amounts of investment, expropriation,
imposition of foreign taxes, less liquid markets and less available information than is generally the case in the U.S., higher transaction
costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual
obligations, lack of uniform accounting and auditing standards, currency fluctuations and greater price volatility. Further, we, and
the CLOs in which we invest, may have difficulty enforcing creditor&#8217;s rights in foreign jurisdictions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, international trade tensions may arise from time to time which could result in trade tariffs, embargoes or other restrictions
or limitations on trade. The imposition of any actions on trade could trigger a significant reduction in international trade, supply
chain disruptions, an oversupply of certain manufactured goods, substantial price reductions of goods and possible failure of individual
companies or industries, which could have a negative impact on the value of the CLO securities that we hold.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Foreign
markets also have different clearance and settlement procedures, and in certain markets there have been times when settlements have failed
to keep pace with the volume of securities transactions, making it difficult to conduct such transactions. Delays in settlement could
result in periods when our assets are uninvested. Our inability to make intended investments due to settlement problems or the risk of
intermediary counterparty failures could cause it to miss investment opportunities. The inability to dispose of an investment due to
settlement problems could result either in losses to the funds due to subsequent declines in the value of such investment or, if we have
entered into a contract to sell the security, could result in possible liability to the purchaser. Transaction costs of buying and selling
foreign securities also are generally higher than those involved in domestic transactions. Furthermore, foreign financial markets have,
for the most part, substantially less volume than U.S. markets, and securities of many foreign companies are less liquid and their prices
more volatile than securities of comparable domestic companies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
economies of individual non-U.S. countries may also differ favorably or unfavorably from the U.S. economy in such respects as growth
of gross domestic product, rate of inflation, volatility of currency exchange rates, depreciation, capital reinvestment, resources self-sufficiency
and balance of payments position.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Russia
Risk</i></span>.&#160;&#160;&#160;Russia&#8217;s military incursion into Ukraine, the response of the United States and other countries,
and the potential for wider conflict, has increased volatility and uncertainty in the financial markets and may adversely affect the
Company. Immediately following Russia&#8217;s invasion, the United States and other countries imposed wide-ranging economic sanctions
on Russia, individual Russian citizens, and Russian banking entities and other businesses, including those in the energy sector. These
unprecedented sanctions have been highly disruptive to the Russian economy and, given the interconnectedness of today&#8217;s global
economy, could have broad and unforeseen macroeconomic implications. The ultimate nature, extent and duration of Russia&#8217;s military
actions (including the potential for cyberattacks and espionage), and the response of state governments and businesses, cannot be predicted
at this time. However, further escalation of the conflict could result in significant market disruptions, and negatively affect global
supply chains, inflation and global growth. These and any related events could negatively impact the performance of the Company&#8217;s
underlying obligors and/or the market value of the Company&#8217;s common shares or Preferred Stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Currency
Risk</i></span>.&#160;&#160;&#160;Any of our investments that are denominated in currencies other than U.S. dollars will be subject to
the risk that the value of such currency will decrease in relation to the U.S. dollar. Although we will consider hedging any non-U.S.
dollar exposures back to U.S. dollars, an increase in the value of the U.S. dollar compared to other currencies in which we make investments
would otherwise reduce the effect of increases and magnify the effect of decreases in the prices of our non-U.S. dollar denominated investments
in their local markets. Fluctuations in currency exchange rates will similarly affect the U.S. dollar equivalent of any interest, dividends
or other payments made that are denominated in a currency other than U.S. dollars.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Any
unrealized losses we experience on our portfolio may be an indication of future realized losses, which could reduce our income available
for distribution or to make payments on our other obligations.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As
a registered closed-end management investment company, we are required to carry our investments at market value or, if no market
value is ascertainable, at the fair value as determined in good faith by the Adviser. Decreases in the market values or fair values
of our investments are recorded as unrealized depreciation. Any unrealized losses in our portfolio could be an indication of an
issuer&#8217;s inability to meet its repayment obligations to us with respect to the affected investments. This could result in
realized losses in the future and ultimately in reductions of our income available for distribution or to make payments on our other
obligations in future periods.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 35 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
our distributions exceed our taxable income and capital gains realized during a taxable year, all or a portion of the distributions made
in the same taxable year may be recharacterized as a return of capital to our common stockholders. A return of capital distribution will
generally not be taxable to our stockholders. However, a return of capital distribution will reduce a stockholder&#8217;s cost basis
in shares of our common stock on which the distribution was received, thereby potentially resulting in a higher reported capital gain
or lower reported capital loss when those shares of our common stock are sold or otherwise disposed of.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>A
portion of our income and fees may not be qualifying income for purposes of the income source requirement.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Some
of the income and fees that we may recognize will not satisfy the qualifying income requirement applicable to RICs. In order to ensure
that such income and fees do not disqualify us as a RIC for a failure to satisfy such requirement, we may need to recognize such income
and fees indirectly through one or more entities classified as corporations for U.S. federal income tax purposes. Such corporations will
be subject to U.S. corporate income tax on their earnings, which ultimately will reduce our return on such income and fees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Risks
Relating to an Investment in Our Securities</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Common
stock of closed-end management investment companies frequently trades at discounts to their respective NAVs, and we cannot assure you
that the market price of our common stock will not decline below our NAV per share.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Common
stock of closed-end management investment companies frequently trades at discounts to their respective NAVs and our common stock may
also be discounted in the market. This characteristic of closed-end management investment companies is separate and distinct from the
risk that our NAV per share may decline. We cannot predict whether shares of our common stock will trade above, at or below our NAV per
share. The risk of loss associated with this characteristic of closed-end management investment companies may be greater for investors
expecting to sell common stock purchased in an offering soon after such offering. In addition, if our common stock trades below our NAV
per share, we will generally not be able to sell additional common stock to the public at market price except (1)&#160;in connection
with a rights offering to our existing stockholders, (2)&#160;with the consent of the majority of the holders of our common stock, (3)&#160;upon
the conversion of a convertible security in accordance with its terms or (4)&#160;under such circumstances as the SEC may permit. See
&#8220;<b><i>Description of Our Capital Stock&#8201;&#8212;&#8201;Repurchase of Shares and Other Discount Measures.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
common stock price may be volatile and may decrease substantially.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher
or lower than the price you paid to purchase shares of our common stock, depending on many factors, some of which are beyond our control
and may not be directly related to our operating performance. These factors include the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">price and volume fluctuations in the overall stock market from time
to time;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">investor demand for shares of our common stock;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">significant volatility in the market price and
trading volume of securities of registered closed-end management investment companies or other companies in our sector, which are not
necessarily related to the operating performance of these companies;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">changes in regulatory policies or tax guidelines
with respect to RICs or registered closed-end management investment companies;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">failure to qualify as a RIC, or the loss of RIC status;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">any shortfall in revenue or net income or any
increase in losses from levels expected by investors or securities analysts;</p>
</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 36 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in">&#160;</td>
<td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">changes, or perceived changes, in the value of our portfolio investments;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">departures of any members of the Senior Investment Team;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">operating performance of companies comparable to us; or</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">general economic conditions and trends and other external factors.</td></tr>
</table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
and the Adviser could be the target of litigation.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
or the Adviser could become the target of securities class action litigation or other similar claims if our stock price fluctuates significantly
or for other reasons. The outcome of any such proceedings could materially adversely affect our business, financial condition, and/or
operating results and could continue without resolution for long periods of time. Any litigation or other similar claims could consume
substantial amounts of our management&#8217;s time and attention, and that time and attention and the devotion of associated resources
could, at times, be disproportionate to the amounts at stake. Litigation and other claims are subject to inherent uncertainties, and
a material adverse impact on our financial statements could occur for the period in which the effect of an unfavorable final outcome
in litigation or other similar claims becomes probable and reasonably estimable. In addition, we could incur expenses associated with
defending ourselves against litigation and other similar claims, and these expenses could be material to our earnings in future periods.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Sales
in the public market of substantial amounts of our common stock may have an adverse effect on the market price of our common stock.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Sales
of substantial amounts of our common stock, including by the selling stockholders, or the availability of such common stock for sale,
whether or not actually sold, could adversely affect the prevailing market price of our common stock. If this occurs and continues, it
could impair our ability to raise additional capital through the sale of equity securities should we desire to do so. For a discussion
of the adverse effect that the concentration of beneficial ownership may have on the market price of our common stock, see <b><i>&#8220;&#8212;&#160;Risks
Related to Our Business and Structure&#8201;&#8212;&#8201;Significant stockholders may control the outcome of matters submitted to
our stockholders or adversely impact the market price of our securities.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
stockholders will experience dilution in their ownership&#160;percentage if they do not participate in our dividend reinvestment plan.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">All
distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested
in shares of our common stock. As a result, our stockholders that do not participate in our dividend reinvestment plan will experience
dilution in their ownership&#160;percentage of our common stock over time<i>.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Your
interest in us may be diluted if you do not fully exercise your subscription rights in any rights offering.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
the event we issue subscription rights to purchase shares of our common stock to existing stockholders, stockholders who do not fully
exercise their rights should expect that they will, at the completion of the offer, own a smaller proportional interest in us than would
otherwise be the case if they fully exercised their rights. We cannot state precisely the amount of any such dilution in share ownership
because we do not know at this time what proportion of the shares will be purchased as a result of the offer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, if the subscription price is less than our net asset value per share, then our stockholders would experience an immediate dilution
of the aggregate net asset value of their shares as a result of the offer. The amount of any decrease in net asset value is not predictable
because it is not known at this time what the subscription price and net asset value per share will be on the expiration date of the
rights offering or what proportion of the shares will be purchased as a result of the offer. Such dilution could be substantial.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
impact of tax legislation on us, our stockholders and our investments is uncertain.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Changes
in tax laws, regulations or administrative interpretations or any amendments thereto could adversely affect us, the entities in which
we invest, or our stockholders. You are urged to consult with your tax advisor with respect to the impact of any such legislation or
other regulatory or administrative developments and proposals and their potential effect on your investment in us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 37 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
Preferred Stock and Notes may cause the NAV and market value of our common stock to be more volatile.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Preferred Stock and Notes, and any future issuances of additional series of Preferred Stock or debt securities or other indebtedness,
may cause the NAV and market value of our common stock to become more volatile. If the dividend rate on the Preferred Stock or interest
rate payable on our indebtedness were to approach the net rate of return on our investment portfolio, the benefit of leverage to the
common stockholders would be reduced. If the dividend rate on the Preferred Stock or interest rate payable on our indebtedness were to
exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the common stockholders than if
we had not issued Preferred Stock or incurred any indebtedness. Any decline in the NAV of our investments would be borne entirely by
the common stockholders. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease
in NAV to the common stockholders than if we were not leveraged through the issuance of Preferred Stock and debt securities. This greater
NAV decrease would also tend to cause a greater decline in the market price for our common stock. We might be in danger of failing to
maintain the required asset coverage of the Preferred Stock or indebtedness or of losing our ratings, if any, on the Preferred Stock
or indebtedness or, in an extreme case, our current investment income might not be sufficient to meet the dividend requirements on the
Preferred Stock or interest payments on our indebtedness. In order to counteract such an event, we might need to liquidate investments
in order to fund a redemption of some or all of the Preferred Stock or debt. In addition, we would pay (and the common stockholders would
bear) all costs and expenses relating to the issuance and ongoing maintenance of the Preferred Stock or indebtedness, including higher
advisory fees if our total return exceeds the dividend rate on the Preferred Stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Market
yields may increase, which would result in a decline in the price of our Preferred Stock or Notes.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
prices of fixed income investments, such as our Preferred Stock and Notes, vary inversely with changes in market yields. The market yields
on securities comparable to our Preferred Stock and Notes may increase, which would result in a decline in the secondary market price
of shares of our Preferred Stock and Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
Preferred Stock is subject to a risk of early redemption, and holders may not be able to reinvest their funds.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may voluntarily redeem some or all of the outstanding shares of our Preferred Stock on or after the date stated in the applicable governing
documents. We also may be forced to redeem some or all of the outstanding shares of any of our Preferred Stock to meet regulatory requirements
and the asset coverage requirements of such shares. Any such redemption may occur at a time that is unfavorable to holders of the respective
Preferred Stock. We may have an incentive to redeem any of our outstanding Preferred Stock voluntarily if market conditions allow us
to issue other Preferred Stock or debt securities at a rate that is lower than the dividend rate on the outstanding Preferred Stock.
If we redeem shares of Preferred Stock, the holders of such redeemed shares face the risk that the return on an investment purchased
with proceeds from such redemption may be lower than the return previously obtained from the investment in the Preferred Stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>An
active trading market for the Preferred Stock may not exist, which could adversely affect the market price of our Preferred stock or
a holder&#8217;s ability to sell their shares.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
outstanding Preferred Stock is currently listed on the NYSE and future preferred stock also may be listed on the NYSE. However, we cannot
provide any assurances that an active trading market for the Preferred Stock will exist in the future or that you will be able to sell
your shares of the Preferred Stock. Even if an active trading market does exist, shares of the Preferred Stock may trade at a discount
from the liquidation preference for such shares depending on prevailing interest rates, the market for similar securities, our credit
ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. To the extent an
active trading market does not exist, the liquidity and trading price for shares of the Preferred Stock may be harmed. Accordingly, holders
may be required to bear the financial risk of an investment in the Preferred Stock for an indefinite period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 38 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
Preferred Stock is subordinate to the rights of holders of senior indebtedness.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">While
Preferred Stockholders, including holders of the Series&#160;C Term Preferred Stock and Series&#160;D Preferred Stock, will have equal
liquidation and distribution rights to any other series of Preferred Stock, they are subordinated to the rights of holders of our other
senior indebtedness, including the Notes. Therefore, dividends, distributions and other payments to Preferred Stockholders in liquidation
or otherwise may be subject to prior payments due to the holders of senior indebtedness. In addition, the 1940 Act may provide debt holders
with voting rights that are superior to the voting rights of our Preferred Stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Holders
of our Preferred Stock bear dividend risk.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may be unable to pay dividends on our Preferred Stock under some circumstances. The terms of any future indebtedness we may incur could
preclude the payment of dividends in respect of equity securities, including our Preferred Stock, under certain conditions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>To
the extent that our distributions represent a return of capital for U.S. federal income tax purposes, holders of our Preferred Stock
may recognize an increased gain or a reduced loss upon subsequent sales (including cash redemptions) of their shares of Preferred Stock.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
dividends payable by us on our Preferred Stock may exceed our current and accumulated earnings and profits as determined for U.S. federal
income tax purposes. If that were to occur, it would result in the amount of distributions that exceed our earnings and profits being
treated first as a return of capital to the extent of a holder&#8217;s adjusted tax basis in the holder&#8217;s Preferred Stock and then,
to the extent of any excess over the holder&#8217;s adjusted tax basis in the holder&#8217;s Preferred Stock, as capital gain. Any distribution
that is treated as a return of capital will reduce the holder&#8217;s adjusted tax basis in the holder&#8217;s Preferred Stock, and subsequent
sales (including cash redemptions) of such holder&#8217;s Preferred Stock will result in recognition of an increased taxable gain or
reduced taxable loss due to the reduction in such adjusted tax basis. See &#8220;<b><i>U.S. Federal Income Tax Matters&#8201;&#8212;&#8201;Taxation
of U.S. resident holders of our stock</i></b>.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>There
is a risk of delay in our redemption of our Preferred Stock, and we may fail to redeem such securities as required by their terms.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
generally make investments in CLO vehicles whose securities are not traded in any public market. Substantially all of the investments
we presently hold and the investments we expect to acquire in the future are, and will be, subject to legal and other restrictions on
resale and will otherwise be less liquid than publicly traded securities. The illiquidity of our investments may make it difficult for
us to obtain cash equal to the value at which we record our investments quickly if a need arises. If we are unable to obtain sufficient
liquidity prior to the redemption date for an outstanding series of Preferred Stock, including the Series&#160;C Term Preferred Stock,
we may be forced to engage in a partial redemption or to delay a required redemption. If such a partial redemption or delay were to occur,
the market price of shares of our Preferred Stock might be adversely affected.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
debt securities are unsecured and therefore effectively subordinated to any secured indebtedness we may incur in the future.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
debt securities, including the Notes, are not secured by any of our assets or any of the assets of our subsidiaries. As a result, our
debt securities are subordinated to any secured indebtedness we or our subsidiaries may incur in the future (or any indebtedness that
is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness.
In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our future secured indebtedness and the
secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive
full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of our debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
debt securities are structurally subordinated to the indebtedness and other liabilities of our subsidiaries.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
debt securities, including the Notes, are obligations exclusively of Eagle Point Credit Company Inc. and not of any of our
subsidiaries. None of our subsidiaries are or will act as a guarantor of our debt securities and our debt securities will not be
required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of any such subsidiary are not
directly available to satisfy the claims of our creditors, including holders of our debt securities.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 39 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Except
to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors (including holders of Preferred
Stock or debt, if any) of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims
of our creditors, including holders of our debt securities) with respect to the assets of such subsidiaries. Even if we were recognized
as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the
assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently,
our debt securities are structurally subordinated to all indebtedness and other liabilities (including trade payables) of our subsidiaries
and any subsidiaries that we may in the future acquire or establish as financing vehicles or otherwise.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>An
active trading market for our debt securities may not exist, which could adversely affect the market price of our debt securities or
a holder&#8217;s ability to sell them.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each
series of our Notes currently is listed on the NYSE and future debt securities also may be listed on the NYSE. However, we cannot provide
any assurances that an active trading market for our debt securities will exist in the future or that you will be able to sell our debt
securities, including the Notes. Even if an active trading market does exist, our debt securities may trade at a discount from their
initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general
economic conditions, our financial condition, performance and prospects and other factors. To the extent an active trading market does
not exist, the liquidity and trading price for our debt securities may be harmed. Accordingly, holders may be required to bear the financial
risk of an investment in our debt securities for an indefinite period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>A
downgrade, suspension or withdrawal of the credit rating assigned by a rating agency to us or our Preferred Stock or debt securities,
if any, or change in the debt markets could cause the liquidity or market value of our Preferred Stock or debt securities to decline
significantly.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any
credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes
in any credit ratings will generally affect the market value of our Preferred Stock and debt securities, including the Notes. These credit
ratings may not reflect the potential impact of risks relating to the structure or marketing of our Preferred Stock and debt securities.
Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing
organization in its sole discretion. Neither we nor any underwriter undertakes any obligations to obtain or maintain any credit ratings
or to advise holders of our Preferred Stock or debt securities of any changes in any credit ratings. There can be no assurance that any
credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the
rating agencies if, in their judgment, future circumstances relating to the basis of the credit rating, such as adverse changes in the
Company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely
to fluctuate in the future, which could have an adverse effect on the market prices of our Preferred Stock and debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
indenture governing our debt securities contains limited protection for holders of our debt securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
indenture governing our debt securities, including the Notes, offers limited protection to holders of our debt securities. The terms
of the indenture do not restrict our or any of our subsidiaries&#8217; ability to engage in, or otherwise be a party to, a variety of
corporate transactions, circumstances or events that could have an adverse impact on your investment in our debt securities. In particular,
the terms of the indenture do not place any restrictions on our or our subsidiaries&#8217; ability to:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify">issue
securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations
that would be equal in right of payment to our debt securities, (2)&#160;any indebtedness or other obligations that would be secured
and therefore rank effectively senior in right of payment to our debt securities to the extent of the values of the assets securing
such debt, (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank
structurally senior to our debt securities and (4)&#160;securities, indebtedness or obligations issued or incurred by our
subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to our debt
securities with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation
that would cause a&#160;violation of Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 40 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in">&#160;</td>
<td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
<td style="text-align: justify">pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to our debt securities, other than a&#160;distribution, dividend or purchase that would cause a violation of Section&#160;18(a)(1)(B) of the 1940 Act or any successor provisions;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">enter into transactions with affiliates;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span></td>
<td style="text-align: justify">create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">make investments; or</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td>&#160;</td>
<td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
<td style="text-align: justify">create restrictions on the payment of dividends or other amounts to us from our subsidiaries.</td></tr>
</table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Furthermore,
the terms of the indenture do not protect holders of our debt securities in the event that we experience changes (including significant
adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries
adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity, except as required
under the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of our debt securities
may have important consequences for you as a holder of our debt securities, including making it more difficult for us to satisfy our
obligations with respect to our debt securities or negatively affecting the trading value of our debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Other
debt we issue or incur in the future could contain more protections for its holders than the indenture and our debt securities, including
additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the
market for and trading levels and prices of our debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Any
optional redemption provision may materially adversely affect the return on our debt securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
debt securities may be redeemable in whole or in part at any time or from time to time at our sole option as set forth in the applicable
indenture or otherwise. We may choose to redeem any of our debt securities, including the Notes, at times when prevailing interest rates
are lower than the interest rate paid on the applicable debt securities. In this circumstance, holders may not be able to reinvest the
redemption proceeds in a comparable security at an effective interest rate as high as that of the debt securities being redeemed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>If
we default on our obligations to pay our other indebtedness, we may not be able to make payments on our debt securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any
default under any agreements governing the Notes, our future indebtedness or under other indebtedness to which we may be a party
that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us
unable to pay principal, premium, if any, and interest on our debt securities and substantially decrease the market value of our
debt securities. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet
required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the
various covenants, including financial and operating covenants, in the instruments governing any future indebtedness, we could be in
default under the terms of the agreements governing such indebtedness. In the event of such default, the holders of such
indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid
interest, the lenders of the debt we may incur in the future could elect to terminate their commitments, cease making further loans
and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating
performance declines, we may in the future need to seek to obtain waivers from the required lenders or holders of any debt that we
may incur in the future to avoid being in default. If we breach our covenants under our debt and seek a waiver, we may not be able
to obtain a waiver from the required lenders or holders of the debt. If this occurs, we would be in default and our lenders or debt
holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to
repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because any future debt will
likely have customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated,
we may be unable to repay or finance the amounts due. See &#8220;<b><i>Description of Our Debt Securities</i></b>.&#8221;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 41 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>FATCA
withholding may apply to payments to certain foreign entities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Payments
made under our debt securities, including the Notes, to a foreign financial institution, or &#8220;FFI,&#8221; or non-financial foreign
entity, or &#8220;NFFE&#8221; (including such an institution or entity acting as an intermediary), may be subject to a U.S. withholding
tax of 30% under U.S. Foreign Account Tax Compliance Act provisions of the Code (commonly referred to as &#8220;FATCA&#8221;). This withholding
tax may apply to certain payments of interest on our debt securities unless the FFI or NFFE complies with certain information reporting,
withholding, identification, certification and related requirements imposed by FATCA. Depending upon the status of a holder and the status
of an intermediary through which any of our debt securities are held, the holder could be subject to this 30% withholding tax in respect
of any interest paid on our debt securities as well as any proceeds from the sale or other disposition of our debt securities. You should
consult your own tax advisors regarding FATCA and how it may affect your investment in our debt securities. See <i>&#8220;<b>U.S . Federal
Income Tax Matters&#8201;&#8212;&#8201;Taxation of Securityholders&#8201;&#8212;&#8201;FATCA Withholding on Payments to Certain Foreign
Entities</b></i>&#8221; in this prospectus for more information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
impact of tax legislation on us, our stockholders and our investments is uncertain.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Changes
in tax laws, regulations or administrative interpretations or any amendments thereto could adversely affect us, the entities in which
we invest, or our noteholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Biden Administration has enacted significant changes to the existing U.S. tax rules&#160;that include, among others, a minimum tax on
book income and profits of certain multinational corporations, and there are a number of proposals in the U.S. Congress that would similarly
modify the existing U.S. tax rules. The impact of this new legislation on us, the entities in which we invest and our noteholders is
uncertain. Any new legislation and any Treasury Regulations, administrative interpretations or court decisions interpreting such legislation
could affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our stockholders
and could have other adverse consequences. You are urged to consult with your tax advisor with respect to the impact of any such legislation
or other regulatory or administrative developments and proposals and their potential effect on your investment in us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Risks
Relating to Our Business and Structure</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
investment portfolio is recorded at fair value in accordance with the 1940 Act. As a result, there will be uncertainty as to the value
of our portfolio investments.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under
the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at
fair value as determined by the Adviser in accordance with written valuation policies and procedures, subject to oversight by our board
of directors, in accordance with Rule&#160;2a-5 under the 1940 Act. Typically, there is no public market for the type of investments
we target. As a result, our Adviser values these securities at least quarterly based on relevant information compiled by itself and third-party
pricing services (when available), and with the oversight, of our board of directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 42 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
determination of fair value and, consequently, the amount of unrealized gains and losses in our portfolio, are to a certain degree
subjective and dependent on a valuation process approved and overseen by our board of directors. Certain factors that may be
considered in determining the fair value of our investments include non-binding indicative bids and the number of trades (and the
size and timing of each trade) in an investment. Valuation of certain investments is also based, in part, upon third party valuation
models which take into account various market inputs. Investors should be aware that the models, information and/or underlying
assumptions utilized by the Adviser or such models will not always correctly capture the fair value of an asset. Because such
valuations, and particularly valuations of securities that are not publicly traded like those we hold, are inherently uncertain,
they may fluctuate over short periods of time and may be based on estimates. The Adviser&#8217;s determinations of fair value may
differ materially from the values that would have been used if an active public market for these securities existed. The
Adviser&#8217;s determinations of the fair value of our investments have a material impact on our net earnings through the recording
of unrealized appreciation or depreciation of investments and may cause our NAV on a given date to understate or overstate, possibly
materially, the value that we may ultimately realize on one or more of our investments. See <b><i>&#8220;Conflicts of
Interest&#8201;&#8212;&#8201;Valuation.&#8221;</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
financial condition and results of operations depend on the Adviser&#8217;s ability to effectively manage and deploy capital.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
ability to achieve our investment objectives depends on the Adviser&#8217;s ability to effectively manage and deploy capital, which depends,
in turn, on the Adviser&#8217;s ability to identify, evaluate and monitor, and our ability to acquire, investments that meet our investment
criteria.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Accomplishing
our investment objectives on a cost-effective basis is largely a function of the Adviser&#8217;s handling of the investment process,
its ability to provide competent, attentive and efficient services and our access to investments offering acceptable terms, either in
the primary or secondary markets. Even if we are able to grow and build upon our investment operations, any failure to manage our growth
effectively could have a material adverse effect on our business, financial condition, results of operations and prospects. The results
of our operations will depend on many factors, including the availability of opportunities for investment, readily accessible short and
long-term funding alternatives in the financial markets and economic conditions. Furthermore, if we cannot successfully operate our business
or implement our investment policies and strategies as described in this prospectus, it could adversely impact our ability to pay dividends
or make distributions. In addition, because the trading methods employed by the Adviser on our behalf are proprietary, stockholders will
not be able to determine details of such methods or whether they are being followed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are reliant on Eagle Point Credit Management LLC continuing to serve as the Adviser.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser manages our investments. Consequently, our success depends, in large part, upon the services of the Adviser and the skill and
expertise of the Adviser&#8217;s professional personnel, in particular, Thomas P. Majewski. Incapacity of Mr.&#160;Majewski could have
a material and adverse effect on our performance. There can be no assurance that the professional personnel of the Adviser will continue
to serve in their current positions or continue to be employed by the Adviser. We can offer no assurance that their services will be
available for any length of time or that the Adviser will continue indefinitely as our investment adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
Adviser and the Administrator each has the right to resign on 90&#160;days&#8217; notice, and we may not be able to find a suitable replacement
within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results
of operations.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser has the right, under the Investment Advisory Agreement, and the Administrator has the right under the Administration Agreement,
to resign at any time upon 90&#160;days&#8217; written notice, whether we have found a replacement or not. If the Adviser or the Administrator
resigns, we may not be able to find a new investment adviser or hire internal management, or find a new administrator, as the case may
be, with similar expertise and ability to provide the same or equivalent services on acceptable terms within 90&#160;days, or at all.
If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results
of operations, as well as our ability to make distributions to our stockholders and other payments to securityholders, are likely to
be adversely affected and the market price of our securities may decline. In addition, the coordination of our internal management and
investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives
having the expertise possessed by the Adviser and the Administrator and their affiliates. Even if we are able to retain comparable management
and administration, whether internal or external, the integration of such management and their lack of familiarity with our investment
objectives and operations would likely result in additional costs and time delays that may adversely affect our financial condition,
business and results of operations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 43 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
success will depend on the ability of the Adviser to attract and retain qualified personnel in a competitive environment.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
growth will require that the Adviser attract and retain new investment and administrative personnel in a competitive market. The Adviser&#8217;s
ability to attract and retain personnel with the requisite credentials, experience and skills will depend on several factors including
its ability to offer competitive compensation, benefits and professional growth opportunities. Many of the entities, including investment
funds (such as private equity funds, mezzanine funds and business development companies) and traditional financial services companies,
with which the Adviser will compete for experienced personnel have greater resources than the Adviser has.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>There
are significant actual and potential conflicts of interest which could impact our investment returns.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
executive officers and directors, and the Adviser and certain of its affiliates and their officers and employees, including the Senior
Investment Team, have several conflicts of interest as a result of the other activities in which they engage. For example, the members
of the Adviser&#8217;s investment team are and may in the future become affiliated with entities engaged in business activities similar
to ours, including EIC and EPIIF, and may have conflicts of interest in allocating their time. Moreover, each member of the Senior Investment
Team is engaged in other business activities which divert their time and attention. The professional staff of the Adviser will devote
as much time to us as such professionals deem appropriate to perform their duties in accordance with the Investment Advisory Agreement.
However, such persons may be committed to providing investment advisory and other services for other clients, and engage in other business
ventures in which we have no interest. As a result of these separate business activities, the Adviser has conflicts of interest in allocating
management time, services and functions among us, other advisory clients and other business ventures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
incentive fee structure may incentivize the Adviser to pursue speculative investments, use leverage when it may be unwise to do so, or
refrain from de-levering when it would otherwise be appropriate to do so.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
incentive fee payable by us to the Adviser may create an incentive for the Adviser to pursue investments on our behalf that are riskier
or more speculative than would be the case in the absence of such compensation arrangement. Such a practice could result in our investing
in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during
economic downturns. The incentive fee payable to the Adviser is based on our Pre-Incentive Fee Net Investment Income, as calculated in
accordance with our Investment Advisory Agreement. This may encourage the Adviser to use leverage to increase the return on our investments,
even when it may not be appropriate to do so, and to refrain from de-levering when it would otherwise be appropriate to do so. Under
certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our securities. See
<b><i>&#8220;&#8212; Risks Related to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential
for gain or loss on amounts invested and will increase the risk of investing in us.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may be obligated to pay the Adviser incentive compensation even if we incur a loss or with respect to investment income that we have
accrued but not received.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser is entitled to incentive compensation for each fiscal quarter based, in part, on our Pre-Incentive Fee Net Investment Income,
if any, for the immediately preceding calendar quarter above a performance threshold for that quarter. Accordingly, since the performance
threshold is based on a&#160;percentage of our NAV, decreases in our NAV make it easier to achieve the performance threshold. Our Pre-Incentive
Fee Net Investment Income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we
may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for
that quarter. Thus, we may be required to pay the Adviser incentive compensation for a fiscal quarter even if there is a decline in the
value of our portfolio or we incur a net loss for that quarter. In addition, we accrue an incentive fee on accrued income that we have
not yet received in cash. However, the portion of the incentive fee that is attributable to such income will be paid to the Adviser,
without interest, only if and to the extent we actually receive such income in cash.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 44 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
Adviser&#8217;s liability is limited under the Investment Advisory Agreement, and we have agreed to indemnify the Adviser against certain
liabilities, which may lead the Adviser to act in a riskier manner on our behalf than it would when acting for its own account.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under
the Investment Advisory Agreement, the Adviser does not assume any responsibility to us other than to render the services called for
under the agreement, and it is not responsible for any action of our board of directors in following or declining to follow the Adviser&#8217;s
advice or recommendations. The Adviser maintains a contractual and fiduciary relationship with us. Under the terms of the Investment
Advisory Agreement, the Adviser, its officers, managers, members, agents, employees and other affiliates are not liable to us for acts
or omissions performed in accordance with and pursuant to the Investment Advisory Agreement, except those resulting from acts constituting
willful misfeasance, bad faith, gross negligence or reckless disregard of the Adviser&#8217;s duties under the Investment Advisory Agreement.
In addition, we have agreed to indemnify the Adviser and each of its officers, managers, members, agents, employees and other affiliates
from and against all damages, liabilities, costs and expenses (including reasonable legal fees and other amounts reasonably paid in settlement)
incurred by such persons arising out of or based on performance by the Adviser of its obligations under the Investment Advisory Agreement,
except where attributable to willful misfeasance, bad faith, gross negligence or reckless disregard of the Adviser&#8217;s duties under
the Investment Advisory Agreement. These protections may lead the Adviser to act in a riskier manner when acting on our behalf than it
would when acting for its own account.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
Adviser may not be able to achieve the same or similar returns as those achieved by other portfolios managed by the Senior Investment
Team.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Although
the Senior Investment Team manages other investment portfolios, including accounts using investment objectives, investment strategies
and investment policies similar to ours, we cannot assure you that we will be able to achieve the results realized by such portfolios.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may experience fluctuations in our NAV and quarterly operating results.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
could experience fluctuations in our NAV from month to month and in our quarterly operating results due to a number of factors, including
the timing of distributions to our stockholders, fluctuations in the value of the CLO securities that we hold, our ability or inability
to make investments that meet our investment criteria, the interest and other income earned on our investments, the level of our expenses
(including the interest or dividend rate payable on the debt securities or Preferred Stock we issue), variations in and the timing of
the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic
conditions. As a result of these factors, our NAV and results for any period should not be relied upon as being indicative of our NAV
and results in future periods.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
board of directors may change our operating policies and strategies without stockholder approval, the effects of which may be adverse.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
board of directors has the authority to modify or waive our current operating policies, investment criteria and strategies, other than
those that we have deemed to be fundamental, without prior stockholder approval. We cannot predict the effect any changes to our current
operating policies, investment criteria and strategies would have on our business, NAV, operating results and value of our securities.
However, the effects of any such changes could adversely impact our ability to pay dividends and cause you to lose all or part of your
investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
management&#8217;s estimates of certain metrics relating to our financial performance for a period are subject to revision based on our
actual results for such period.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
management makes and publishes unaudited estimates of certain metrics indicative of our financial performance, including the NAV per
share of our common stock and the range of NAV per share of our common stock on a monthly basis, and the range of the net investment
income and realized gain/loss per share of our common stock on a quarterly basis. While any such estimate will be made in good faith
based on our most recently available records as of the date of the estimate, such estimates are subject to financial closing
procedures, the Adviser&#8217;s final determination of the fair value of our applicable investments as of the end of the applicable
quarter and other developments arising between the time such estimate is made and the time that we finalize our quarterly financial
results and may differ materially from the results reported in the audited financial statements and/or the unaudited financial
statements included in filings we make with the SEC. As a result, investors are cautioned not to place undue reliance on any
management estimates presented in this prospectus or any related amendment to this prospectus or related prospectus supplement and
should view such information in the context of our full quarterly or annual results when such results are available.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 45 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
will be subject to corporate-level income tax if we are unable to maintain our RIC status for U.S. federal income tax purposes.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
can offer no assurance that we will be able to maintain RIC status. To obtain and maintain RIC tax treatment under the Code, we must
meet certain annual distribution, income source and asset diversification requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
annual distribution requirement for a RIC will be satisfied if we distribute dividends to our stockholders each tax year of an amount
generally at least equal to 90% of the sum of our net ordinary income and realized net short-term capital gains in excess of realized
net long-term capital losses, if any. Because we use debt financing, we are subject to certain asset coverage requirements under the
1940 Act and may be subject to financial covenants that could, under certain circumstances, restrict us from making distributions necessary
to satisfy the distribution requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment
and thus become subject to corporate-level income tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
income source requirement will be satisfied if we obtain at least 90% of our income for each tax year from dividends, interest, gains
from the sale of our securities or similar sources.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
asset diversification requirement will be satisfied if we meet certain asset composition requirements at the end of each quarter of our
tax year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the
loss of RIC status. Because most of our investments are expected to be in CLO securities for which there will likely be no active public
market, any such dispositions could be made at disadvantageous prices and could result in substantial losses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
we fail to qualify for RIC tax treatment for any reason and remain or become subject to corporate income tax, the resulting corporate
taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For
federal income tax purposes, we will include in income certain amounts that we have not yet received in cash, such as original issue
discount or market discount, which may arise if we acquire a debt security at a significant discount to par, or payment-in-kind interest,
which represents contractual interest added to the principal amount of a debt security and due at the maturity of the debt security.
We also may be required to include in income certain other amounts that we have not yet, and may not ever, receive in cash. Our investments
in payment-in-kind interest may represent a higher credit risk than loans for which interest must be paid in full in cash on a regular
basis. For example, even if the accounting conditions for income accrual are met, the issuer of the security could still default when
our actual collection is scheduled to occur upon maturity of the obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Since,
in certain cases, we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the
annual distribution requirement necessary to maintain RIC tax treatment under the Code. In addition, since our incentive fee is payable
on our income recognized, rather than cash received, we may be required to pay advisory fees on income before or without receiving cash
representing such income. Accordingly, we may have to sell some of our investments at times and/or at prices we would not consider advantageous,
raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from
other sources, we may fail to qualify for RIC tax treatment and thus become subject to corporate-level income tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 46 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
cash distributions to stockholders may change and a portion of our distributions to stockholders may be a return of capital.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
amount of our cash distributions may increase or decrease at the discretion of our board of directors, based upon its assessment of
the amount of cash available to us for this purpose and other factors. Unless we are able to generate sufficient cash through the
successful implementation of our investment strategy, we may not be able to sustain a given level of distributions and may need to
reduce the level of our cash distributions in the future. Further, to the extent that the portion of the cash generated from our
investments that is recorded as interest income for financial reporting purposes is less than the amount of our distributions, all
or a portion of one or more of our future distributions, if declared, may comprise a return of capital. Accordingly, stockholders
should not assume that the sole source of any of our distributions is net investment income. Any reduction in the amount of our
distributions would reduce the amount of cash received by our stockholders and could have a material adverse effect on the market
price of our shares. See <b><i>&#8220;&#8212; Risks Related to Our Investments&#8201;&#8212;&#8201;Our investments are subject to
prepayment risk&#8221; and &#8220;&#8212; Any unrealized losses we experience on our portfolio may be an indication of future
realized losses, which could reduce our income available for distribution or to make payments on our other
obligations.&#8221;</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Our
stockholders may receive shares of our common stock as distributions, which could result in adverse tax consequences to them.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
order to satisfy certain annual distribution requirements to maintain RIC tax treatment under Subchapter M of the Code, we may declare
a large portion of a distribution in shares of our common stock instead of in cash even if a stockholder has opted out of participation
in the DRIP. Historically, we have not declared any portion of our distributions in shares of our common stock. As long as at least 20%
of such distribution is paid in cash and certain requirements are met, the entire distribution will be treated as a dividend for U.S.
federal income tax purposes. As a result, a stockholder generally would be subject to tax on 100% of the fair market value of the distribution
on the date the distribution is received by the stockholder in the same manner as a cash distribution, even though most of the distribution
was paid in shares of our common stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Because
we expect to distribute substantially all of our ordinary income and net realized capital gains to our stockholders, we may need additional
capital to finance the acquisition of new investments and such capital may not be available on favorable terms, or at all.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
order to maintain our RIC status, we are required to distribute at least 90% of the sum of our net ordinary income and realized net short-term
capital gains in excess of realized net long-term capital losses, if any. As a result, these earnings will not be available to fund new
investments, and we will need additional capital to fund growth in our investment portfolio. If we fail to obtain additional capital,
we could be forced to curtail or cease new investment activities, which could adversely affect our business, operations and results.
Even if available, if we are not able to obtain such capital on favorable terms, it could adversely affect our net investment income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>A
disruption or downturn in the capital markets and the credit markets could impair our ability to raise capital and negatively affect
our business.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may be materially affected by market, economic and political conditions globally and in the jurisdictions and sectors in which we invest
or operate, including conditions affecting interest rates and the availability of credit. Unexpected volatility, illiquidity, governmental
action, currency devaluation or other events in the global markets in which we directly or indirectly hold positions could impair our
ability to carry out our business and could cause us to incur substantial losses. These factors are outside our control and could adversely
affect the liquidity and value of our investments, and may reduce our ability to make attractive new investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
particular, economic and financial market conditions significantly deteriorated for a significant part of the past decade as
compared to prior periods. Global financial markets experienced considerable declines in the valuations of equity and debt
securities, an acute contraction in the availability of credit and the failure of a number of leading financial institutions. As a
result, certain government bodies and central banks worldwide, including the U.S. Treasury Department and the U.S. Federal Reserve,
undertook unprecedented intervention programs, the effects of which remain uncertain. Although certain financial markets have
improved, to the extent economic conditions experienced during the past decade recur, they may adversely impact our investments.
Signs of deteriorating sovereign debt conditions in Europe and elsewhere and uncertainty regarding the U.S. economy more generally
could lead to further disruption in the global markets. Trends and historical events do not imply, forecast or predict future
events, and past performance is not necessarily indicative of future results. There can be no assurance that the assumptions made or
the beliefs and expectations currently held by the Adviser will prove correct, and actual events and circumstances may vary
significantly.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may be subject to risk arising from a default by one of several large institutions that are dependent on one another to meet their liquidity
or operational needs, so that a default by one institution may cause a series of defaults by the other institutions. This is sometimes
referred to as &#8220;systemic risk&#8221; and may adversely affect financial intermediaries with which we interact in the conduct of
our business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
also may be subject to risk arising from a broad sell off or other shift in the credit markets, which may adversely impact our income
and NAV. In addition, if the value of our assets declines substantially, we may fail to maintain the minimum asset coverage imposed upon
us by the 1940 Act. Any such failure would affect our ability to issue additional Preferred Stock, debt securities and other senior securities,
including borrowings, and may affect our ability to pay distributions on our capital stock, which could materially impair our business
operations. Our liquidity could be impaired further by an inability to access the capital markets or to obtain additional debt financing.
For example, we cannot be certain that we would be able to obtain debt financing on commercially reasonable terms, if at all. See <b>&#8220;&#8212;
<i>If we are unable to obtain and/or refinance additional debt capital, our business could be materially adversely affected.</i>&#8221;
</b>In previous market cycles, many lenders and institutional investors have previously reduced or ceased lending to borrowers. In the
event of such type of market turmoil and tightening of credit, increased market volatility and widespread reduction of business activity
could occur, thereby limiting our investment opportunities. Moreover, we are unable to predict when economic and market conditions may
be favorable in future periods. Even if market conditions are broadly favorable over the long term, adverse conditions in particular
sectors of the financial markets could adversely impact our business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>If
we are unable to refinance and/or obtain additional debt capital, our business could be materially adversely affected.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
have obtained debt financing in order to obtain funds to make additional investments and grow our portfolio of investments. Such debt
capital may take the form of a term credit facility with a fixed maturity date or other fixed term instruments, and we may be unable
to extend, refinance or replace such debt financings prior to their maturity. If we are unable to refinance and/or obtain additional
debt capital on commercially reasonable terms, our liquidity will be lower than it would have been with the benefit of such financings,
which would limit our ability to grow our business. In addition, our stockholders would not benefit from the potential for increased
returns on equity that incurring leverage creates. Any such limitations on our ability to grow and take advantage of leverage may decrease
our earnings, if any, and distributions to stockholders, which in turn may lower the trading price of our securities. In addition, in
such event, we may need to liquidate certain of our investments, which may be difficult to sell if required, meaning that we may realize
significantly less than the value at which we have recorded our investments. Furthermore, to the extent we are not able to raise capital
and are at or near our targeted leverage ratios, we may receive smaller allocations, if any, on new investment opportunities under the
Adviser&#8217;s allocation policy.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Debt
capital that is available to us in the future, if any, including upon the refinancing of then-existing debt prior to its maturity, may
be at a higher cost and on less favorable terms and conditions than costs and other terms and conditions at which we can currently obtain
debt capital. In addition, if we are unable to repay amounts outstanding under any such debt financings and are declared in default or
are unable to renew or refinance these debt financings, we may not be able to make new investments or operate our business in the normal
course. These situations may arise due to circumstances that we may be unable to control, such as lack of access to the credit markets,
a severe decline in the value of the U.S. dollar, an economic downturn or an operational problem that affects third parties or us, and
could materially damage our business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
may be more susceptible than a diversified fund to being adversely affected by any single corporate, economic, political or regulatory
occurrence.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
are classified as &#8220;non-diversified&#8221; under the 1940 Act. As a result, we can invest a greater portion of our assets in
obligations of a single issuer than a &#8220;diversified&#8221; fund. We may therefore be more susceptible than a diversified fund
to being adversely affected by any single corporate, economic, political or regulatory occurrence. In particular, because our
portfolio of investments may lack diversification among CLO securities and related investments, we are susceptible to a risk of
significant loss if one or more of these CLO securities and related investments experience a high level of defaults on the
collateral that they hold.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 48 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Regulations
governing our operation as a registered closed-end management investment company affect our ability to raise additional capital and the
way in which we do so. The raising of debt capital may expose us to risks, including the typical risks associated with leverage.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under
the provisions of the 1940 Act, we are permitted, as a registered closed-end management investment company, to issue senior securities
(including debt securities, Preferred Stock and/or borrowings from banks or other financial institutions); provided we meet certain asset
coverage requirements (<i>i.e.</i>, 300% for senior securities representing indebtedness and 200% in the case of the issuance of Preferred
Stock under current law). See <b><i>&#8220;&#8212; Risks Related to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio,
which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us&#8221;</i></b> for
details concerning how asset coverage is calculated. If the value of our assets declines, we may be unable to satisfy this test. If that
happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our
indebtedness (including by redeeming a portion of any series of Preferred Stock or notes that may be outstanding) at a time when such
sales or redemptions may be disadvantageous. Also, any amounts that we use to service or repay our indebtedness would not be available
for distributions to our stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
are not generally able to issue and sell shares of our common stock at a price below the then current NAV per share (exclusive of any
distributing commission or discount). We may, however, sell shares of our common stock at a price below the then current NAV per share
(1)&#160;in connection with a rights offering to our existing stockholders, (2)&#160;with the consent of the majority of our common stockholders,
(3)&#160;upon the conversion of a convertible security in accordance with its terms or (4)&#160;under such circumstances as the SEC may
permit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Provisions
of the General Corporation Law of the State of Delaware and our certificate of incorporation and bylaws could deter takeover attempts
and have an adverse effect on the price of our securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
General Corporation Law of the State of Delaware, or the &#8220;DGCL,&#8221; contains provisions that may discourage, delay or make more
difficult a change in control of us or the removal of our directors. Our certificate of incorporation and bylaws contain provisions that
limit liability and provide for indemnification of our directors and officers. These provisions and others also may have the effect of
deterring hostile takeovers or delaying changes in control or management. We are subject to Section&#160;203 of the DGCL, the application
of which is subject to any applicable requirements of the 1940 Act. This section generally prohibits us from engaging in mergers and
other business combinations with stockholders that beneficially own 15% or more of our voting stock, or with their affiliates, unless
our directors or stockholders approve the business combination in the prescribed manner. If our board of directors does not approve a
business combination, Section&#160;203 of the DGCL may discourage third parties from trying to acquire control of us and increase the
difficulty of consummating such an offer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our certificate
of incorporation classifying our board of directors in three classes serving staggered three-year terms, and provisions of our certificate
of incorporation authorizing our board of directors to classify or reclassify shares of our Preferred Stock in one or more classes or
series, to cause the issuance of additional shares of our capital stock, and to amend our certificate of incorporation, without stockholder
approval, in certain instances. These provisions, as well as other provisions of our certificate of incorporation and bylaws, may delay,
defer or prevent a transaction or a change in control that might otherwise be in the best interests of our securityholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Significant
stockholders may control the outcome of matters submitted to our stockholders or adversely impact the market price or liquidity of our
securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">To
the extent any stockholder, individually or acting together with other stockholders, controls a significant number of our voting
securities (as defined in the 1940 Act) or any class of voting securities, they may have the ability to control the outcome of
matters submitted to our stockholders for approval, including the election of directors and any merger, consolidation or sale of all
or substantially all of our assets, and may cause actions to be taken that you may not agree with or that are not in your interests
or those of other securityholders.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 49 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">This
concentration of beneficial ownership also might harm the market price of our securities by:</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify">delaying,
deferring or preventing a change in corporate control;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify">impeding
a merger, consolidation, takeover or other business combination involving us; or</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">discouraging
a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to the risk of legislative and regulatory changes impacting our business or the markets in which we invest.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legal
and regulatory changes</i></span>.&#160;&#160;&#160;Legal and regulatory changes could occur and may adversely affect us and our ability
to pursue our investment strategies and/or increase the costs of implementing such strategies. New or revised laws or regulations may
be imposed by the Commodity Futures Trading Commission, or the &#8220;CFTC,&#8221; the SEC, the U.S. Federal Reserve, other banking regulators,
other governmental regulatory authorities or self-regulatory organizations that supervise the financial markets that could adversely
affect us. In particular, these agencies are empowered to promulgate a variety of new rules&#160;pursuant to recently enacted financial
reform legislation in the United States. We also may be adversely affected by changes in the enforcement or interpretation of existing
statutes and rules&#160;by these governmental regulatory authorities or self-regulatory organizations. Such changes, or uncertainty regarding
any such changes, could adversely affect the strategies and plans set forth in this prospectus and may result in our investment focus
shifting from the areas of expertise of the Senior Investment Team to other types of investments in which the investment team may have
less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our results
of operations and the value of your investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Investments</i></span>.&#160;&#160;&#160;The derivative investments in which we may invest are subject to comprehensive statutes, regulations
and margin requirements. In particular, certain provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the &#8220;Dodd-Frank
Act,&#8221; requires certain standardized derivatives to be executed on a regulated market and cleared through a central counterparty,
which may result in increased margin requirements and costs for us. The Dodd-Frank Act also established minimum margin requirements on
certain uncleared derivatives which may result in us and our counterparties posting higher margin amounts for uncleared derivatives.
In addition, we have claimed an exclusion from the definition of the term &#8220;commodity pool operator&#8221; pursuant to CFTC No-Action
Letter 12-38 issued by the staff of the CFTC Division of Swap Dealer and Intermediary Oversight. For us to continue to qualify for this
exclusion, (i)&#160;the aggregate initial margin and premiums required to establish our positions in derivative instruments subject to
the jurisdiction of the U.S. Commodity Exchange Act, as amended, or the &#8220;CEA,&#8221; and (other than positions entered into for
hedging purposes) may not exceed five&#160;percent of our liquidation value, (ii)&#160;the net notional value of our aggregate investments
in CEA-regulated derivative instruments (other than positions entered into for hedging purposes) may not exceed 100% of our liquidation
value, or (iii)&#160;we must meet an alternative test appropriate for a &#8220;fund of funds&#8221; as set forth in CFTC No-Action Letter
12-38. In the event we fail to qualify for the exclusion and the Adviser is required to register as a &#8220;commodity pool operator&#8221;
in connection with serving as our investment adviser and becomes subject to additional disclosure, recordkeeping and reporting requirements,
our expenses may increase. The Adviser has claimed an exclusion from the definition of the term &#8220;commodity pool operator&#8221;
under the CEA pursuant to CFTC Regulation&#160;4.5 under the CEA promulgated by the CFTC with respect to us, and we currently intend
to operate in a manner that would permit the Adviser to continue to claim such exclusion.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 50 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under
SEC Rule&#160;18f-4, related to the use of derivatives, short sales, reverse repurchase agreements and certain other transactions by
registered investment companies, we are permitted to enter into derivatives and other transactions that create future payment or
delivery obligations, including short sales, notwithstanding the senior security provisions of the 1940 Act if we comply with
certain value-at-risk leverage limits and derivatives risk management program and board oversight and reporting requirements or
comply with a &#8220;limited derivatives users&#8221; exception. We have elected to rely on the limited derivatives users exception.
We may change this election and comply with the other provisions of Rule&#160;18f-4 related to derivatives transactions at any time
and without notice. To satisfy the limited derivatives users exception, we have adopted and implemented written policies and
procedures reasonably designed to manage our derivatives risk and limit our derivatives exposure in accordance with Rule&#160;18f-4.
Rule&#160;18f-4 also permits us to enter into reverse repurchase agreements or similar financing transactions notwithstanding the
senior security provisions of the 1940 Act if we aggregate the amount of indebtedness associated with our reverse repurchase
agreements or similar financing transactions with the aggregate amount of any other senior securities representing indebtedness when
calculating our asset coverage ratios as discussed above or treat all such transactions as derivatives transactions for all purposes
under Rule&#160;18f-4. In addition, we are permitted to invest in a security on a when-issued or forward-settling basis, or with a
non-standard settlement cycle, and the transaction will be deemed not to involve a senior security under the 1940 Act, provided that
(i)&#160;we intend to physically settle the transaction and (ii)&#160;the transaction will settle within 35&#160;days of its trade
date (the &#8220;Delayed-Settlement Securities Provision&#8221;). We may otherwise engage in such transactions that do not meet the
conditions of the Delayed-Settlement Securities Provision so long as we treat any such transaction as a &#8220;derivatives
transaction&#8221; for purposes of compliance with the rule. Furthermore, we are permitted to enter into an unfunded commitment
agreement, and such unfunded commitment agreement will not be subject to the asset coverage requirements under the 1940 Act, if we
reasonably believe, at the time we enter into such agreement, that we will have sufficient cash and cash equivalents to meet our
obligations with respect to all such agreements as they come due. We cannot predict the effects of these requirements. The Adviser
intends to monitor developments and seek to manage our assets in a manner consistent with achieving our investment objective, but
there can be no assurance that it will be successful in doing so.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Securitizations</i></span>.&#160;&#160;&#160;Section&#160;619 of the Dodd-Frank Act, commonly referred to as the &#8220;Volcker Rule,&#8221;
generally prohibits, subject to certain exemptions, covered banking entities from engaging in proprietary trading or sponsoring, or acquiring
or retaining an ownership interest in, a hedge fund or private equity fund, or &#8220;covered funds,&#8221; (which have been broadly
defined in a way which could include many CLOs). Given the limitations on banking entities investing in CLOs that are covered funds,
the Volcker Rule&#160;may adversely affect the market value or liquidity of any or all of the investments held by us. Although the Volcker
Rule&#160;and the implementing rules&#160;exempt &#8220;loan securitizations&#8221; from the definition of covered fund, not all CLOs
will qualify for this exemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
June&#160;2020, the five federal agencies responsible for implementing the Volcker Rule&#160;adopted amendments to the Volcker Rule&#8217;s
implementing regulations, including changes relevant to the treatment of securitizations (the &#8220;Volcker Changes&#8221;). Among other
things, the Volcker Changes ease certain aspects of the &#8220;loan securitization&#8221; exclusion, and create additional exclusions
from the &#8220;covered fund&#8221; definition, and narrow the definition of &#8220;ownership interest&#8221; to exclude certain &#8220;senior
debt interests.&#8221; Also, under the Volcker Changes, a debt interest would no longer be considered an &#8220;ownership interest&#8221;
solely because the holder has the right to remove or replace the manager following a cause-related default. The Volcker Changes were
effective October&#160;1, 2020It is currently unclear how, or if, the Volcker Changes will affect the CLO securities in which the Company
invests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Risk Retention.</i></span>&#160;&#160;&#160;In October&#160;2014, six federal agencies (the Federal Deposit Insurance Corporation, or
the &#8220;FDIC,&#8221; the Comptroller of the Currency, the Federal Reserve Board, the SEC, the Department of Housing and Urban Development
and the Federal Housing Finance Agency) adopted joint final rules&#160;implementing certain credit risk retention requirements contemplated
in Section&#160;941 of the Dodd-Frank Act, or the &#8220;Final U.S. Risk Retention Rules.&#8221; These rules&#160;were published in the
Federal Register on December&#160;24, 2014. With respect to the regulation of CLOs, the Final U.S. Risk Retention Rules&#160;require
that the &#8220;sponsor&#8221; or a &#8220;majority owned affiliate&#8221; thereof (in each case as defined in the rules), will retain
an &#8220;eligible vertical interest&#8221; or an &#8220;eligible horizontal interest&#8221; (in each case as defined therein) or any
combination thereof in the CLO in the manner required by the Final U.S. Risk Retention Rules.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 51 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Final U.S. Risk Retention Rules&#160;became fully effective on December&#160;24, 2016, or the &#8220;Final U.S. Risk Retention
Effective Date,&#8221; and to the extent applicable to CLOs, the Final U.S. Risk Retention Rules&#160;contain provisions that may
adversely affect the return of our investments. On February&#160;9, 2018, a three judge panel of the United States Court of Appeals
for the District of Columbia Circuit, or the &#8220;DC Circuit Court,&#8221; rendered a decision in <i>The Loan Syndications and
Trading Association v. Securities and Exchange Commission and Board of Governors of the Federal Reserve System</i>,
No.&#160;1:16-cv-0065, in which the DC Circuit Court held that open market CLO collateral managers are not
&#8220;securitizers&#8221; subject to the requirements of the Final U.S. Risk Retention Rules, or the &#8220;DC Circuit
Ruling.&#8221; Thus, collateral managers of open market CLOs are no longer required to comply with the Final U.S. Risk Retention
Rules&#160;at this time. As such, it is possible that some collateral managers of open market CLOs will decide to dispose of the
notes (or cause their majority owned affiliates to dispose of the notes) constituting the &#8220;eligible vertical interest&#8221;
or &#8220;eligible horizontal interest&#8221; they were previously required to retain, or decide to take other action with respect
to such notes that is not otherwise prohibited by the Final U.S. Risk Retention Rules. To the extent either the underlying
collateral manager or its majority-owned affiliate divests itself of such notes, this will reduce the degree to which the relevant
collateral manager&#8217;s incentives are aligned with those of the noteholders of the CLO (which may include us as a CLO
noteholder), and could influence the way in which the relevant collateral manager manages the CLO assets and/or makes other
decisions under the transaction documents related to the CLO in a manner that is adverse to us.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">There
can be no assurance or representation that any of the transactions, structures or arrangements currently under consideration by or currently
used by CLO market participants will comply with the Final U.S. Risk Retention Rules&#160;to the extent such rules&#160;are reinstated
or otherwise become applicable to open market CLOs. The ultimate impact of the Final U.S. Risk Retention Rules&#160;on the loan securitization
market and the leveraged loan market generally remains uncertain, and any negative impact on secondary market liquidity for securities
comprising a CLO may be experienced due to the effects of the Final U.S. Risk Retention Rules&#160;on market expectations or uncertainty,
the relative appeal of other investments not impacted by the Final U.S. Risk Retention Rules&#160;and other factors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>EU/UK
Risk Retention.</i></span>&#160;&#160;&#160;The securitization industry in both European Union (&#8220;EU&#8221;) and the United Kingdom
(&#8220;UK&#8221;) has also undergone a number of significant changes in the past few&#160;years. Regulation (EU) 2017/2402 relating
to a European framework for simple, transparent and standardized securitization (as amended by Regulation (EU) 2021/557 and as further
amended from time to time, the &#8220;EU Securitization Regulation&#8221;) applies to certain specified EU investors, and Regulation
(EU) 2017/2402 relating to a European framework for simple, transparent and standardised securitization in the form in effect on 31&#160;December&#160;2020
(which forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the &#8220;EUWA&#8221;)) (as
amended by the Securitization (Amendment) (EU Exit) Regulations&#160;2019 and as further amended from time to time, the &#8220;UK Securitization
Regulation&#8221; and, together with the EU Securitization Regulation, the &#8220;Securitization Regulations&#8221;) applies to certain
specified UK investors, in each case, who are investing in a &#8220;securitisation&#8221; (as such term is defined under each Securitization
Regulation).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
due diligence requirements of Article&#160;5 of the EU Securitization Regulation (the &#8220;EU Due Diligence Requirements&#8221;) apply
to each investor that is an &#8220;institutional investor&#8221; (as such term is defined in the EU Securitization Regulation), being
an investor which is one of the following: (a)&#160;an insurance undertaking as defined in Directive 2009/138/EC of the European Parliament
and of the Council of 25&#160;November&#160;2009 on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency&#160;II)
(recast) (&#8220;Solvency II&#8221;); (b)&#160;a reinsurance undertaking as defined in Solvency II; (c)&#160;subject to certain conditions
and exceptions, an institution for occupational retirement provision falling within the scope of Directive (EU) 2016/2341 of the European
Parliament and of the Council of 14 December&#160;2016 on the activities and supervision of institutions for occupational retirement
provision (IORPs) (the &#8220;IORP Directive&#8221;), or an investment manager or an authorised entity appointed by an institution for
occupational retirement provision pursuant to the IORP Directive; (d)&#160;an alternative investment fund manager (&#8220;AIFM&#8221;)
as defined in Directive 2011/61/EU of the European Parliament and of the Council of 8 June&#160;2011 on Alternative Investment Fund&#160;Managers
that manages and/or markets alternative investment funds in the EU; (e)&#160;an undertaking for the collective investment in transferable
securities (&#8220;UCITS&#8221;) management company, as defined in Directive 2009/65/EC of the European Parliament and of the Council
of 13 July&#160;2009 on the coordination of laws, regulations and administrative provisions relating to undertakings for collective investment
in transferable securities (UCITS) (the &#8220;UCITS Directive&#8221;); (f)&#160;an internally managed UCITS, which is an investment
company authorised in accordance with the UCITS Directive and which has not designated a management company authorised under the UCITS
Directive for its management; or (g)&#160;a credit institution as defined in Regulation (EU) No 575/2013 of the European Parliament and
of the Council of 26 June&#160;2013 on prudential requirements for credit institutions and investment firms (the &#8220;CRR&#8221;) for
the purposes of the CRR, or an investment firm as defined in the CRR, in each case, such investor an &#8220;EU Institutional Investor.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 52 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
due diligence requirements of Article&#160;5 of the UK Securitization Regulation (the &#8220;UK Due Diligence Requirements&#8221;
and, together with the EU Due Diligence Requirements, the &#8220;Due Diligence Requirements&#8221;) apply to each investor that is
an &#8220;institutional investor&#8221; (as such term is defined in the UK Securitization Regulation), being an investor which is
one of the following: (a)&#160;an insurance undertaking as defined in the Financial Services and Markets Act 2000 (as amended, the
&#8220;FSMA&#8221;); (b)&#160;a reinsurance undertaking as defined in the FSMA; (c)&#160;an occupational pension scheme as defined
in the Pension Schemes Act 1993 that has its main administration in the UK, or a fund manager of such a scheme appointed under the
Pensions Act 1995 that, in respect of activity undertaken pursuant to that appointment, is authorised under the FSMA; (d)&#160;an
AIFM (as defined in the Alternative Investment Fund&#160;Managers Regulations&#160;2013 (the &#8220;AIFM Regulations&#8221;)) which
markets or manages AIFs (as defined in the AIFM Regulations) in the UK; (e)&#160;a management company as defined in the FSMA;
(f)&#160;a UCITS as defined by the FSMA, which is an authorised open ended investment company as defined in the FSMA; (g)&#160;a FCA
investment firm as defined by the CRR as it forms part of UK domestic law by virtue of EUWA (the &#8220;UK CRR&#8221;); or
(h)&#160;a CRR investment firm as defined in the UK CRR, in each case, such investor a &#8220;UK Institutional Investor&#8221; and,
such investors together with EU Institutional Investors, &#8220;Institutional Investors.&#8221;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Among
other things, the applicable Due Diligence Requirements require that prior to holding a &#8220;securitisation position&#8221; (as defined
in each Securitization Regulation) an Institutional Investor (other than the originator, sponsor or original lender) has verified that:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left">(1)</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the originator, sponsor or original lender will
retain on an ongoing basis a material net economic interest which, in any event, shall be not less than five per cent. in the securitization,
determined in accordance with Article&#160;6 of the applicable Securitization Regulation, and has disclosed the risk retention to such
Institutional Investor;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">(2)</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(in the case of each EU Institutional Investor
only) the originator, sponsor or securitization special purpose entity (&#8220;SSPE&#8221;) has, where applicable, made available the
information required by Article&#160;7 of the EU Securitization Regulation in accordance with the frequency and modalities provided for
thereunder;</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">(3)</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(in the case of each UK Institutional Investor only) the originator,
sponsor or SSPE:</p>
</td></tr>
</table><div>


</div><p style="margin: 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.45in">&#160;</td>
    <td style="padding-left: -0.5in; text-align: left; width: 0.2in">(i)</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">if established in the UK has, where applicable,
made available the information required by Article&#160;7 of the UK Securitization Regulation (the &#8220;UK Transparency Requirements&#8221;)
in accordance with the frequency and modalities provided for thereunder; or</p>
</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">(ii)</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">if established in a country other than the UK,
where applicable, made available information which is substantially the same as that which it would have made available under the UK Transparency
Requirements if it had been established in the UK, and has done so with such frequency and modalities as are substantially the same as
those with which it would have made information available under the UK Transparency Requirements if it had been established in the UK;
and</p>
</td></tr>
</table><div>


</div><p style="margin: 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; text-align: left; width: 0.2in">(4)</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of each Institutional Investor, where
the originator or original lender either (i)&#160;is not a credit institution or an investment firm (each as defined in the applicable
Securitization Regulation) or (ii)&#160;is established in a third country (being (x)&#160;in respect of the EU Securitization Regulation,
a country other than an EU member state, or (y)&#160;in respect of the UK Securitization Regulation, a country other than the UK), the
originator or original lender grants all the credits giving rise to the underlying exposures on the basis of sound and well-defined criteria
and clearly established processes for approving, amending, renewing and financing those credits and has effective systems in place to
apply those criteria and processes in order to ensure that credit-granting is based on a thorough assessment of the obligor&#8217;s creditworthiness.</p>
</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Due Diligence Requirements further require that prior to holding a securitisation position, an Institutional Investor, other than the
originator, sponsor or original lender, carry out a due diligence assessment which enables it to assess the risks involved, including
but not limited to (a)&#160;the risk characteristics of the individual securitisation position and the underlying exposures; and (b)&#160;all
the structural features of the securitization that can materially impact the performance of the securitisation position, including the
contractual priorities of payment and priority of payment-related triggers, credit enhancements, liquidity enhancements, market value
triggers, and transaction-specific definitions of default.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 53 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
addition, pursuant to the applicable Due Diligence Requirements, while holding a securitization position, an Institutional Investor,
other than the originator, sponsor or original lender, is subject to various ongoing monitoring obligations, including but not limited
to: (a)&#160;establishing appropriate written procedures to monitor compliance with the Due Diligence Requirements and the performance
of the securitisation position and of the underlying exposures; (b)&#160;performing stress tests on the cash flows and collateral values
supporting the underlying exposures or, in the absence of sufficient data on cash flows and collateral values, stress tests on loss assumptions,
having regard to the nature, scale and complexity of the risk of the securitisation position; (c)&#160;ensuring internal reporting to
its management body so that the management body is aware of the material risks arising from the securitisation position and so that those
risks are adequately managed; and (d)&#160;being able to demonstrate to its competent authorities, upon request, that it has a comprehensive
and thorough understanding of the securitisation position and underlying exposures and that it has implemented written policies and procedures
for the risk management of the securitisation position and for maintaining records of (i)&#160;the verifications and due diligence in
accordance with the applicable Due Diligence Requirements and (ii)&#160;any other relevant information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any
Institutional Investor that fails to comply with the applicable Due Diligence Requirements in respect of a securitization position which
it holds may become subject to a range of regulatory sanctions including, in the case of a credit institution, investment firm, insurer
or reinsurer, a punitive regulatory capital charge with respect to such securitization position, or, in certain other cases, a requirement
to take corrective action.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs
issued in Europe are generally structured in compliance with the Securitization Regulations so that prospective investors subject to
the Securitization Regulations can invest in compliance with such requirements. To the extent a CLO is structured in compliance with
the Securitization Regulations, our ability to invest in the residual tranches of such CLOs could be limited, or we could be required
to hold our investment for the life of the CLO. If a CLO has not been structured to comply with the Securitization Regulations, it will
limit the ability of Institutional Investors to purchase CLO securities, which may adversely affect the price and liquidity of the securities
(including the residual tranche) in the secondary market. Additionally, the Securitization Regulations and any regulatory uncertainty
in relation thereto may reduce the issuance of new CLOs and reduce the liquidity provided by CLOs to the leveraged loan market generally.
Reduced liquidity in the loan market could reduce investment opportunities for collateral managers, which could negatively affect the
return of our investments. Any reduction in the volume and liquidity provided by CLOs to the leveraged loan market could also reduce
opportunities to redeem or refinance the securities comprising a CLO in an optional redemption or refinancing and could negatively affect
the ability of obligors to refinance of their collateral obligations, either of which developments could increase defaulted obligations
above historic levels.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Japanese
Risk Retention.</i></span>&#160;&#160;&#160;The Japanese Financial Services Agency (the &#8220;JFSA&#8221;) published a risk retention
rule&#160;as part of the regulatory capital regulation of certain categories of Japanese investors seeking to invest in securitization
transactions (the &#8220;JRR Rule&#8221;). The JRR Rule&#160;mandates an &#8220;indirect&#8221; compliance requirement, meaning that
certain categories of Japanese investors will be required to apply higher risk weighting to securitization exposures they hold unless
the relevant originator commits to hold a retention interest equal to at least 5% of the exposure of the total underlying assets in the
transaction (the &#8220;Japanese Retention Requirement&#8221;) or such investors determine that the underlying assets were not &#8220;inappropriately
originated.&#8221; The Japanese investors to which the JRR Rule&#160;applies include banks, bank holding companies, credit unions (<i>shinyo
kinko</i>), credit cooperatives (<i>shinyo kumiai</i>), labor credit unions (<i>rodo kinko</i>), agricultural credit cooperatives (<i>nogyo
kyodo kumiai</i>), ultimate parent companies of large securities companies and certain other financial institutions regulated in Japan
(such investors, &#8220;Japanese Affected Investors&#8221;). Such Japanese Affected Investors may be subject to punitive capital requirements
and/or other regulatory penalties with respect to investments in securitizations that fail to comply with the Japanese Retention Requirement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
JRR Rule&#160;became effective on March&#160;31, 2019. At this time, there are a number of unresolved questions and no established
line of authority, precedent or market practice that provides definitive guidance with respect to the JRR Rule, and no assurances
can be made as to the content, impact or interpretation of the JRR Rule. In particular, the basis for the determination of whether
an asset is &#8220;inappropriately originated&#8221; remains unclear and, therefore, unless the JFSA provides further specific
clarification, it is possible that CLO securities we have purchased may contain assets deemed to be &#8220;inappropriately
originated&#8221; and, as a result, may not be exempt from the Japanese Retention Requirement. The JRR Rule&#160;or other similar
requirements may deter Japanese Affected Investors from purchasing CLO securities, which may limit the liquidity of CLO securities
and, in turn, adversely affect the price of such CLO securities in the secondary market. Whether and to what extent the JFSA may
provide further clarification or interpretation as to the JRR Rule&#160;is unknown.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 54 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Funds Rule</i></span>.&#160;&#160;&#160;On February&#160;9, 2022, the SEC proposed certain rules&#160;and amendments under the Investment
Advisers Act of 1940, as amended, to enhance the regulations applicable to private fund advisers (the &#8220;Proposed Private Fund&#160;Rules&#8221;)
that, if adopted in their current form, would affect investment advisers such as the CLO collateral managers, by, among other things,
(i)&#160;requiring such managers to comply with additional reporting and compliance obligations, (ii)&#160;prohibiting certain types
of preferential treatment, including, among other things, the provision of information regarding portfolio holdings of the private fund,
and (iii)&#160;prohibiting or imposing requirements on certain business practices, including prohibiting certain types of indemnification
(which could include indemnification provided for in the CLO&#8217;s management agreement) and requiring fairness opinions for adviser-led
secondary transactions. Because most CLOs in which we invest rely on Section&#160;3(c)(7)&#160;of the 1940 Act, each such CLO will be
considered a &#8220;private fund&#8221; within the meaning of the Proposed Private Fund&#160;Rules. The costs in complying with certain
of the reporting and compliance obligations under the Proposed Private Fund&#160;Rules&#160;could be substantial, and it is unclear if
the costs of preparing such reports would be borne by the CLO or the CLO&#8217;s collateral manager. If the CLOs in which we invest are
responsible for such expenses, it could affect the return on our investments in CLO securities. In addition, if any CLO collateral manager
were prohibited from discussing the underlying portfolio of CLO assets with investors, entirely or absent highly specific disclosure,
it could result in a reduction or elimination of any CLO collateral manager&#8217;s ability to provide information to us relating to
such CLO&#8217;s assets other than the reporting required by the CLO&#8217;s transaction documents. In addition, the Proposed Private
Fund&#160;Rules&#160;could adversely affect a CLO&#8217;s ability to consummate a refinancing or other optional redemption. As a result,
adoption of the Proposed Private Fund&#160;Rules&#160;could have a material and adverse effect on the market value and/or liquidity of
the CLO securities in which we invest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>The
SEC staff could modify its position on certain non-traditional investments, including investments in CLO securities.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
staff of the SEC from time to time has undertaken a broad review of the potential risks associated with different asset management activities,
focusing on, among other things, liquidity risk and leverage risk. The staff of the Division of Investment Management of the SEC has,
in correspondence with registered management investment companies, previously raised questions about the level of, and special risks
associated with, investments in CLO securities. While it is not possible to predict what conclusions, if any, the staff may reach in
these areas, or what recommendations, if any, the staff might make to the SEC, the imposition of limitations on investments by registered
management investment companies in CLO securities could adversely impact our ability to implement our investment strategy and/or our
ability to raise capital through public offerings, or could cause us to take certain actions that may result in an adverse impact on
our stockholders, our financial condition and/or our results of operations. We are unable at this time to assess the likelihood or timing
of any such regulatory development.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>General
Risk Factors</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Terrorist
actions, natural disasters, outbreaks or pandemics may disrupt the market and impact our operations.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Terrorist
acts, acts of war, natural disasters, outbreaks or pandemics may disrupt our operations, as well as the operations of the businesses
in which we invest. Such acts have created, and continue to create, economic and political uncertainties and have contributed to global
economic instability. For example, many countries have experienced outbreaks of infectious illnesses in recent decades, including swine
flu, avian influenza, SARS and COVID-19. Since December&#160;2019, the spread of COVID-19 has caused social unrest and commercial disruption
on a global scale.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Global
economies and financial markets are highly interconnected, and conditions and events in one country, region or financial market may
adversely impact issuers in a different country, region or financial market. The COVID-19 pandemic has magnified these risks and has
had, and may continue to have, a material adverse impact on local economies in the affected jurisdictions and also on the global
economy, as cross border commercial activity and market sentiment have been impacted by the outbreak and government and other
measures seeking to contain its spread. The effects of the COVID-19 pandemic contributed to increased volatility in global financial
markets and likely will affect countries, regions, companies, industries and market sectors more dramatically than others. The
COVID-19 pandemic has had, and any other outbreak of an infectious disease or serious environmental or public health concern could
have, a significant negative impact on economic and market conditions, could exacerbate pre-existing political, social and economic
risks in certain countries or regions and could trigger a prolonged period of global economic slowdown, which may impact us and our
underlying investments.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 55 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Following
the onset of the pandemic, certain CLOs experienced increased defaults by underlying borrowers. Obligor defaults and rating agency downgrades
caused, and may in the future cause, payments that would have otherwise been made to the CLO equity or CLO debt securities to instead
be diverted to buy additional loans within a given CLO or paid to senior CLO debt holders as an early amortization payment. In addition,
defaults and downgrades of underlying obligors caused, and may in the future cause, a decline in the value of CLO securities generally.
If CLO cash flows or income decrease as a result of the pandemic, the portion of our distribution comprised of a return of capital could
increase or distributions could be reduced.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>We
are subject to risks related to cybersecurity and other disruptions to information systems.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
are highly dependent on the communications and information systems of the Adviser, the Administrator and their affiliates as well as
certain other third-party service providers. We, and our service providers, are susceptible to operational and information security risks.
While we, the Adviser and the Administrator have procedures in place with respect to information security, technologies may become the
target of cyber-attacks or information security breaches that could result in the unauthorized gathering, monitoring, release, misuse,
loss or destruction of our and/or our stockholders&#8217; confidential and other information, or otherwise disrupt our operations or
those of our service providers. Disruptions or failures in the physical infrastructure or operating systems and cyber-attacks or security
breaches of the networks, systems or devices that we and our service providers use to service our operations, or disruption or failures
in the movement of information between service providers could disrupt and impact the service providers&#8217; and our operations, potentially
resulting in financial losses, the inability of our stockholders to transact business and of us to process transactions, inability to
calculate our NAV, misstated or unreliable financial data, violations of applicable privacy and other laws, regulatory fines, penalties,
litigation costs, increased insurance premiums, reputational damage, reimbursement or other compensation costs, and/or additional compliance
costs. Our service providers&#8217; policies and procedures with respect to information security have been established to seek to identify
and mitigate the types of risk to which we and our service providers are subject. As with any risk management system, there are inherent
limitations to these policies and procedures as there may exist, or develop in the future, risks that have not been anticipated or identified.
There can be no assurance that we or our service providers will not suffer losses relating to information security breaches (including
cyber-attacks) or other disruptions to information systems in the future.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 56 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_004"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>USE
OF PROCEEDS</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Unless
otherwise specified in the applicable prospectus supplement, we intend to use the proceeds from the sale of our securities pursuant to
this prospectus to acquire investments in accordance with our investment objectives and strategies described in this prospectus, to make
distributions to our stockholders and for general working capital purposes. In addition, we may also use all or a portion of the net
proceeds from the sale of our securities to repay any Preferred Stock or outstanding indebtedness, including the Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
currently anticipate that it will generally take approximately three to six&#160;months after the completion of any offering of securities
to invest substantially all of the net proceeds of the offering in our targeted investments, although such period may vary and depends
on the size of the offering and the availability of appropriate investment opportunities consistent with our investment objectives and
market conditions. We cannot assure you we will achieve our targeted investment pace, which may negatively impact our returns. Until
appropriate investments or other uses can be found, we will invest in temporary investments, such as cash, cash equivalents, U.S. government
securities and other high-quality debt investments that mature in one year or less, which we expect will have returns substantially lower
than the returns that we anticipate earning from investments in CLO securities and related investments. Investors should expect, therefore,
that before we have fully invested the proceeds of the offering in accordance with our investment objectives and strategies, assets invested
in these instruments would earn interest income at a modest rate, which may not exceed our expenses during this period. To the extent
that the net proceeds from an offering have not been fully invested in accordance with our investment objectives and strategies prior
to the next payment of a distribution to our stockholders, a portion of the proceeds may be used to pay such distribution and may represent
a return of capital.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
may use the proceeds from the sale of our securities to pay the printing, legal, filing and other similar expenses of any offering of
common stock by the selling stockholders who are not our affiliates at the time of the offering. However, the selling stockholders will
bear all other expenses, including any brokerage fees, underwriting discounts and commissions, of any such offering. We will not receive
any proceeds from any sale of common stock by the selling stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SENIOR SECURITIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 0.25in">Information about
the Company&#8217;s outstanding senior securities as of the end of each fiscal year since its inception may be found in the &#8220;Supplemental
Information&#8201;&#8212;&#8201;Senior Securities Table&#8221; section of the Company&#8217;s most recent Annual Report on Form&#160;N-CSR,
as amended, for the fiscal year ended December&#160;31, 2022, filed with the SEC on February&#160;24, 2023, which is incorporated by
reference herein.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRICE RANGE OF COMMON STOCK</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 0.25in">Our common stock
began trading on October&#160;8, 2014 and is currently traded on the NYSE under the symbol &#8220;ECC.&#8221; The following table lists
the high and low closing sale price for our common stock, the high and low closing sale price as a&#160;percentage of NAV and distributions
declared per share each quarter since January&#160;1, 2021.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: left"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td colspan="5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><b>Closing Sales Price</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>Premium<span style="clear: both; display: block;"><br/></span> (Discount)<span style="clear: both; display: block;"><br/></span>
of High<span style="clear: both; display: block;"><br/></span> Sales Price</b></td>
<td style="text-align: left"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>Premium<span style="clear: both; display: block;"><br/></span> (Discount)<span style="clear: both; display: block;"><br/></span>
of Low<span style="clear: both; display: block;"><br/></span> Sales Price</b></td>
<td style="text-align: left"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>Distributions</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; text-align: left"><b>Period </b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><b>NAV<sup>(1)</sup></b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><b>High</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><b>Low </b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>to
NAV<sup>(2)</sup></b></span></td>
<td style="text-align: left"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>to
NAV<sup>(2)</sup></b></span></td>
<td style="text-align: left"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><b>Declared<sup>(3)</sup></b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal year ending December&#160;31,
2021</b></span><b><span style="font-size: 10pt"><sup>(5)</sup></span></b></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="white-space: nowrap; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="white-space: nowrap; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="white-space: nowrap; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="white-space: nowrap; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="white-space: nowrap; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="text-align: right; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="white-space: nowrap; text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td>
<td style="width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8203;</b></span></td></tr>
<tr style="vertical-align: bottom; ">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First quarter </span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.02</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.98</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.3</span></td>
<td style="text-align: left">)%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15.8</span></td>
<td style="text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span>%</td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.24</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second quarter </span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.97</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.40</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.15</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span>%</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span>)%</td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.30</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td></tr>
<tr style="vertical-align: bottom; ">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third quarter </span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.98</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.40</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.73</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.0</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span>%</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8.9</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span>)%</td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.36</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth quarter </span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.39</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.49</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.70</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.7</span></td>
<td style="text-align: left">%</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span>%</td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.86</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td>
<td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></td></tr>
</table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 57 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: left"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td colspan="5" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><b>Closing Sales Price</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>Premium<span style="clear: both; display: block;"><br/></span> (Discount)<span style="clear: both; display: block;"><br/></span>
of High<span style="clear: both; display: block;"><br/></span> Sales Price</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>Premium<span style="clear: both; display: block;"><br/></span> (Discount)<span style="clear: both; display: block;"><br/></span>
of Low<span style="clear: both; display: block;"><br/></span> Sales Price</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="text-align: center"><b>&#160;</b></td>
<td style="white-space: nowrap; text-align: center"><b>Distributions</b></td>
<td style="text-align: center"><b>&#160;</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; text-align: left; width: 23%"><b>Period </b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 10%"><b>NAV<sup>(1)</sup></b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 10%"><b>High</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 10%"><b>Low </b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><b>to
NAV<sup>(2)</sup></b></span></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif"><b>to
NAV<sup>(2)</sup></b></span></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 10%"><b>Declared<sup>(3)</sup></b></td>
<td style="text-align: center; width: 1%"><b>&#160;</b></td>
    <td>&#160;</td></tr>


<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 244px; padding-top: 3.25pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    year ending December&#160;31, 2022</b></span></td>
    <td style="width: 0px; text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="width: 0px; text-align: center">&#160;</td>
    <td style="width: 0px; text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="width: 0px; text-align: center">&#160;</td>
    <td style="width: 8px; text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="width: 0px; text-align: center">&#160;</td>
    <td style="width: 8px; text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="width: 8px; text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="width: 8px; text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="width: 0px; text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    quarter </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.64</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.27</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.98</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.9</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: center">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.42</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
    quarter </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.08</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.30</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.41</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.9</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.42</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
    quarter </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.22</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.60</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.5</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.67</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth
    quarter </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.07</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.69</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.08</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.9</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.92</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    year ending December&#160;31, 2023</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 0.5pt; text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    quarter </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.10</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.70</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.6</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right">%</td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.48</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">(1) &#8239;&#8239;NAV per share is determined
as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices.
The NAVs shown are based on outstanding shares at the end of each period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">(2)&#8239;&#8239;&#8239;Calculated as of the respective
high or low closing sales price divided by the quarter end NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: -0.25in; margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify">(3)&#8239;&#8239;&#8239;Represents
the cash distributions (including dividends, dividends reinvested and returns of capital, if any) per share that we have declared on
our common stock in the specified quarter. Tax characteristics of distributions will vary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="text-indent: -0.25in; margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify">(4)&#8239;&#8239;&#8239;&#8239;For
the fiscal year ending December&#160;31, 2021, as reported on our 2021 Form&#160;1099-DIV, distributions made by us did not comprise
of a return of capital.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="margin: 0pt 0 0pt -0.25in; text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify">(5)&#8239;&#8239;&#8239;&#8239;For
the fiscal year ending December&#160;31, 2022, as reported on our 2022 Form&#160;1099-DIV, distributions made by us did not comprise
of a return of capital.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Shares of closed-end
management investment companies may trade at a market price that is less than the NAV that is attributable to those shares. The possibility
that our shares of common stock will trade at a discount to NAV or at a premium that is unsustainable over the long term is separate
and distinct from the risk that our NAV will decrease. It is not possible to predict whether our shares will trade at, above or below
NAV in the future. Our NAV per share was $9.10 as of March&#160;31, 2023. The closing sales price for shares of our common stock on the
NYSE on June&#160;5, 2023 was $10.17, which represented a 11.8% premium to NAV per share.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On June&#160;5,
2023, the last reported closing sales price of our common stock was $10.17 per share. As of June&#160;5, 2023, we had 10 stockholders
of record of our common stock (which does not reflect holders whose shares are held in street name by a broker, bank or other nominee).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_007"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>ADDITIONAL BUSINESS INFORMATION</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Additional Information on the Structural Advantages of CLOs</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs are generally
required to hold a portfolio of assets that is highly diversified by underlying borrower and industry and that is subject to a variety
of asset concentration limitations. Most CLOs are non-static, revolving structures that generally allow for reinvestment over a reinvestment
period, which is typically up to five&#160;years. The terms and covenants of a typical CLO structure are, with certain exceptions, based
primarily on the cash flow generated by, and the par value (as opposed to the market price or fair value) of, the collateral. These covenants
include collateral coverage tests, interest coverage tests and collateral quality tests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs
have two priority-of-payment schedules (commonly called &#8220;waterfalls&#8221;), which are detailed in a CLO&#8217;s indenture and
govern how cash generated from a CLO&#8217;s underlying collateral is distributed to the CLO&#8217;s equity and debt investors. The
interest waterfall applies to interest payments received on a CLO&#8217;s underlying collateral. The principal waterfall applies to
cash generated from principal on the underlying collateral, primarily through loan repayments and the proceeds from loan sales.
Through the interest waterfall, any excess interest-related cash flow available after the required quarterly interest payments to
CLO debt investors are made and certain CLO expenses (such as administration and management fees) are paid is then distributed to
the CLO&#8217;s equity investors each quarter, subject to compliance with certain tests.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 58 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Adviser believes
that excess interest-related cash flow is an important driver of CLO equity returns. In addition, relative to certain other high-yielding
credit investments such as mezzanine or subordinated debt, CLO equity is expected to have a shorter payback period with higher front-end
loaded quarterly cash flows during the early&#160;years of a CLO&#8217;s life if there is no disruption in the interest waterfall due
to a failure to remain in compliance with certain tests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Most CLOs are non-static,
revolving structures that generally allow for reinvestment over a reinvestment period, which is typically up to five&#160;years. Specifically,
a CLO&#8217;s collateral manager normally has broad latitude&#8201;&#8212;&#8201;within a specified set of asset eligibility and diversity
criteria&#8201;&#8212;&#8201;to manage and modify a CLO&#8217;s portfolio over time. We believe that skilled CLO collateral managers
can add significant value to both CLO&#160;equity and debt investors through a combination of their credit expertise and a strong understanding
of how to manage effectively within the rules-based structure of a CLO.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">After the CLO&#8217;s
reinvestment period has ended, in accordance with the CLO&#8217;s principal waterfall, cash generated from principal payments or other
proceeds are generally distributed to repay CLO debt investors in order of seniority. That is, the AAA tranche investors are repaid first,
the AA tranche investors second and so on, with any remaining principal being distributed to the equity tranche investors. In certain
instances, principal may be reinvested after the end of the reinvestment period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs contain a variety
of structural features and covenants that are designed to enhance the credit protection of CLO debt investors, including overcollateralization
tests and interest coverage tests. The overcollateralization tests and interest coverage tests require CLOs to maintain certain levels
of overcollateralization (measured as par value of assets to liabilities subject to certain adjustments) and interest coverage, respectively.
If a CLO breaches an overcollateralization test or interest coverage test, excess interest-related cash flow that would otherwise be
available for distribution to the CLO equity tranche investors is diverted to prepay CLO debt investors in order of seniority until such
time as the covenant breach is cured. If the covenant breach is not or cannot be cured, the CLO equity investors (and potentially other
debt tranche investors) may experience a deferral of cash flow, a partial or total loss of their investment and/or the CLO may eventually
experience an event of default. For this reason, CLO equity investors are often referred to as being in a first loss position. The Adviser
will have no control over whether or not the CLO is able to satisfy its relevant interest coverage tests or overcollateralization tests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CLOs also typically
have interest diversion tests, which also act to ensure that CLOs maintain adequate overcollateralization. If a CLO breaches an interest
diversion test, excess interest-related cash flow that would otherwise be available for distribution to the CLO equity tranche investors
is diverted to acquire new loan collateral until the test is satisfied. Such diversion would lead to payments to the equity investors
being delayed and/or reduced.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Cash flow CLOs do
not have mark-to-market triggers and, with limited exceptions (such as the proportion of assets rated &#8220;CCC+&#8221; or lower (or
their equivalent) by which such assets exceed a specified concentration limit, discounted purchases and defaulted assets), CLO covenants
are generally calculated using the par value of collateral, not the market value or purchase price. As a result, a decrease in the market
price of a CLO&#8217;s performing collateral portfolio does not generally result in a requirement for the CLO collateral manager to sell
assets (i.e., no forced sales) or for CLO equity investors to contribute additional capital (i.e., no margin calls).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 59 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Overview of Senior Secured Loans</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Senior
secured loans have the most senior position in a borrower&#8217;s capital structure or share the senior position with other senior
debt securities of the borrower. This capital structure position generally gives holders of senior secured loans a priority claim on
some or all of the borrower&#8217;s assets in the event of default and therefore the lenders will be paid before certain other
creditors of the borrower. Broadly syndicated senior secured loans are typically originated and structured by banks on behalf of
corporate borrowers with proceeds often used for leveraged buyout transactions, mergers and acquisitions, stock repurchases,
recapitalizations, refinancings, financing capital expenditures, and internal growth. Broadly syndicated senior secured loans are
typically acquired through both primary bank syndications and in the secondary market, and distributed by the arranging bank to a
diverse group of investors primarily consisting of CLOs, loan and high-yield bond registered funds, loan separate accounts, banks,
insurance companies, finance companies and hedge funds. Senior secured loans are floating rate instruments, typically making
quarterly interest payments based on a spread over LIBOR. We believe that senior secured loans represent an attractive and stable
base of collateral for CLOs. In most cases, a senior secured loan will be secured by specific collateral of the issuer.
Historically, many of these investments have traded at or near par (<i>i.e.</i>, 100% of face value), although they more recently
have traded at greater discounts on the current market environment, the Adviser may also purchase stressed and distressed senior
secured loans at a material discount to par, if the Adviser believes that there are attractive opportunities to generate capital
appreciation by making such investments.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Senior secured loans
generally are negotiated between a borrower and several financial institution lenders represented by one or more lenders acting as agent
of all the lenders. The agent is responsible for negotiating the loan agreement that establishes the terms and conditions of the senior
secured loan and the rights of the borrower and the lenders. The agent is responsible for negotiating the loan agreement that establishes
the terms and conditions of the senior secured loan and the rights of the borrower and the lenders. Senior secured loans also have contractual
terms designed to protect lenders. Senior secured loans also have contractual terms designed to protect lenders. These covenants may
include mandatory prepayment out of excess cash flows, restrictions on dividend payments, the maintenance of minimum financial ratios,
limits on indebtedness and financial tests. Breach of these covenants generally is an event of default and, if not&#160;waived by the
lenders, may give lenders the right to accelerate principal and interest payments. Other&#160;senior secured loans may be issued with
less restrictive covenants which are often referred to as &#8220;covenant-lite&#8221; transactions. In a &#8220;covenant-lite&#8221;
loan, the covenants that require the borrower to &#8220;maintain&#8221; certain financial ratios are eliminated altogether, and the lenders
are left to rely only on covenants that restrict a company from &#8220;incurring&#8221; or actively engaging certain action. But a covenant
that only restricts a company from incurring new debt cannot be violated simply by a deteriorating financial condition, the company has
to take affirmative action to breach it. The impact of these covenant-lite transactions may be to retard the speed with which lenders
will be able to take control over troubled deals. We generally acquire senior secured loans of borrowers that, among other things, in
the Adviser&#8217;s judgment, can make timely payments on their senior secured loans and that satisfy other credit standards established
by the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When we purchase
first and second lien senior floating rate loans and other floating rate debt securities, coupon rates are floating, not fixed and are
tied to a benchmark lending rate. The interest rates of these floating rate debt securities vary periodically based upon a benchmark
indicator of prevailing interest rates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When we purchase
an Assignment, we succeed to all the rights and obligations under the loan agreement of the assigning lender and becomes a lender under
the loan agreement with the same rights and obligations as the assigning lender. These rights include the ability to vote along with
the other lenders on such matters as enforcing the terms of the loan agreement (<i>e.g.</i>, declaring defaults, initiating collection
action,&#160;etc.). Taking such actions typically requires a vote of the lenders holding at least a majority of the investment in the
loan, and may require a vote by lenders holding two-thirds or more of the investment in the loan. Because we typically do not hold a
majority of the investment in any loan, we will not be able by ourselves to control decisions that require a vote by the lenders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">While we believe
that senior secured loans and CLO securities have certain attractive fundamental attributes, such securities are subject to a number
of risks as discussed in the &#8220;<b><i>Risk Factors</i></b>&#8221; section of this prospectus. Among our primary targeted investments,
the risks associated with CLO equity are generally greater than those associated with CLO debt. In addition, many of the statistics and
data noted in this prospectus relate to historical periods when market conditions were, in some cases, materially different than they
are as of the date of this prospectus. As with other asset classes, market conditions and dynamics for senior secured loans and CLO securities
evolve over time. For example, over the past decade, the senior secured loan market has evolved from one in which covenant-lite loans
represented a minority of the market to one in which such loans represent a significant majority of the market.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_008"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>THE ADVISER AND THE ADMINISTRATOR</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our board of directors
is responsible for the overall management and supervision of our business and affairs, including the appointment of advisers and sub-advisers.
Pursuant to the Investment Advisory Agreement, our board of directors has appointed Eagle Point Credit Management LLC as our investment
adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 60 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>The Adviser</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Adviser is registered
as an investment adviser with the SEC. As of March&#160;31, 2023, the Adviser, collectively with Eagle Point Income Management, an affiliate
of the Adviser, had approximately $7.8&#160;billion of total assets under management (including capital commitments that were undrawn
as of such date). Based on the Adviser&#8217;s CLO equity assets under management, the Adviser believes that, collectively with Eagle
Point Income Management, it is among the largest CLO equity investors in the market.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Adviser was
established in 2012 by Thomas P. Majewski and Stone Point. The Adviser is wholly owned by Eagle Point Holdings LP (&#8220;EP Holdings&#8221;).
EP Holdings, in turn, is primarily owned by certain of the Trident Funds through intermediary holding companies. Additionally, the Adviser&#8217;s
Senior Investment Team also holds an indirect ownership interest in the Adviser. The Adviser is ultimately governed through intermediary
holding companies by the Adviser&#8217;s Board of Managers, which includes Mr.&#160;Majewski and certain principals of Stone Point. See
<b><i>&#8220;&#8212; Adviser&#8217;s Board of Managers.&#8221;</i></b> The Adviser is located at 600&#160;Steamboat Road, Suite&#160;202,
Greenwich, CT 06830. Stone Point, an investment adviser registered with the SEC, is a specialized private equity firm focused on the
financial services industry.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition to managing
our investments, the Adviser and its affiliates and the members of the Senior Investment Team manage investment accounts for other clients,
including EIC, a publicly traded, closed-end management investment company that is registered under the 1940 Act and for which Eagle
Point Income Management serves as investment adviser, and EPIIF, a non-listed, closed-end management investment company that is registered
under the 1940 Act, as well as multiple privately offered pooled investment vehicles and institutional separate accounts. Many of these
accounts pursue an investment strategy that substantially or partially overlaps with the strategy that we pursue. The Adviser&#8217;s
affiliation with Stone Point and certain of the Trident Funds, and the management of EIC and EPIIF and such other vehicles and accounts
by the Adviser&#8217;s affiliates and Senior Investment Team, give rise to certain conflicts of interest. See <b><i>&#8220;Conflicts
of Interest.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Portfolio Managers</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We are managed by
members of the Senior Investment Team. The Senior Investment Team is led by Mr.&#160;Majewski, Managing Partner of the Adviser, and is
also comprised of Daniel W. Ko, Senior Principal and Portfolio Manager, and Daniel M. Spinner, Senior Principal and Portfolio Manager.
The Senior Investment Team is primarily responsible for our day-to-day investment management and the implementation of our investment
strategy and process.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each member of the
Senior Investment Team is a CLO industry specialist who has been directly involved in the CLO market for the majority of his career and
has built relationships with key market participants, including CLO collateral managers, investment banks and investors. Members of the
Senior Investment Team have been involved in the CLO market as:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify">the head of the CLO business at various investment banks;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a lead CLO structurer and CDO workout specialist at an investment
bank;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a CLO equity and debt investor;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">principal investors in CLO collateral management firms;
and</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a lender and mergers and acquisitions adviser to CLO collateral
management firms.</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We believe that
the complementary, yet highly specialized, skill set of each member of the Senior Investment Team provides the Adviser with a competitive
advantage in its CLO-focused investment strategy.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Biographical information
on the Senior Investment Team, each of whom has served as a portfolio manager since our inception, is set forth below:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Thomas
P. Majewski, Managing Partner of the Adviser (since November&#160;2012)</i></b></span><b>.</b>&#160;&#160;&#160;Mr.&#160;Majewski is
the Managing Partner and founder of the Adviser and a director, Chairman and Chief Executive Officer of Eagle Point Income Company.
He serves as a trustee, Chairman and Chief Executive Officer of Eagle Point Institutional Income Fund. Mr.&#160;Majewski has been
involved in the formation and/or monetization of many CLO transactions across multiple market cycles. Mr.&#160;Majewski led the
creation of some of the earliest refinancing CLOs, introducing techniques that are now commonplace in the market.
Mr.&#160;Majewski&#8217;s experience in the CLO market dates back to the 1990s. He has spent his entire career in the structured
finance and credit markets. Mr.&#160;Majewski is a member of the Adviser&#8217;s Board of Managers and the Adviser&#8217;s
investment committee. Mr.&#160;Majewski is also the Managing Partner of Eagle Point Income Management.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 61 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Prior to joining
the Adviser in September&#160;2012, Mr.&#160;Majewski was a Managing Director and U.S. Head of CLO Banking at RBS Securities Inc., or
&#8220;RBS,&#8221; from September&#160;2011 through September&#160;2012, where he was responsible for all aspects of RBS&#8217;s new-issue
CLO platform. Prior to joining RBS, Mr.&#160;Majewski was the U.S. country head at AMP Capital Investors (US) Ltd. and AE Capital Advisers
(US) LLC, where he was responsible for investing in credit, structured products and other private assets on behalf of several Australian
investors. Prior to this, Mr.&#160;Majewski was a Managing Director and head of CLO banking at Merrill Lynch Pierce Fenner and Smith
Inc. Mr.&#160;Majewski also has held leadership positions within the CLO groups at JPMorgan Securities Inc. and Bear, Stearns&#160;&amp;
Co. Inc. Mr.&#160;Majewski formerly served as a member of the board of managers and investment committee of Marble Point, and as a director
of Marble Point Loan Financing Limited, an investment fund managed by Marble Point listed on the London Stock Exchange. Mr.&#160;Majewski
has a B.S. from Binghamton University and has been a Certified Public Accountant (inactive).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Mr.&#160;Majewski
also serves as chairman of the board of directors of Eagle Point Income Company and chairman of the board of trustees of Eagle Point
Institutional Income Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Daniel
W. Ko, Portfolio Manager (since December&#160;2012).</i></b></span>&#160;&#160;&#160;Mr.&#160;Ko is a Senior Principal and Portfolio
Manager of the Adviser and Eagle Point Income Management. Mr.&#160;Ko is responsible for manager evaluation and structuring investment
opportunities in the primary CLO market, analyzing secondary CLO market opportunities, executing trades and monitoring investments. Mr.&#160;Ko
has specialized in structured finance throughout his entire career.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Prior to joining
the Adviser in December&#160;2012, Mr.&#160;Ko was with Bank of America Merrill Lynch, or &#8220;BAML,&#8221; for the previous six&#160;years,
most recently as Vice President of the CLO structuring group, where he was responsible for modeling the projected deal cash flows, negotiating
deal terms with both equity and debt investors and coordinating the rating process. In addition, he was responsible for exploring non-standard
structuring initiatives such as financing trades with dynamic leverage, emerging market CBOs and European&#160;CLOs. Prior to joining
the CLO structuring group, Mr.&#160;Ko managed BAML&#8217;s legacy CLO, trust-preferred securities CDO and asset-backed securities CDO
portfolios. Prior to Bank of America&#8217;s merger with Merrill Lynch, Mr.&#160;Ko was an associate in Merrill Lynch&#8217;s CDO structuring
group, Mr.&#160;Ko&#160;graduated magna cum laude from the University of Pennsylvania&#8217;s Wharton School with a B.S. in finance and
accounting.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Daniel
M. Spinner (CAIA), Portfolio Manager (since February&#160;2013)</i></b></span><b>.</b>&#160;&#160;&#160;Mr.&#160;Spinner is a Senior
Principal and Portfolio Manager of the Adviser and Eagle Point Income Management. Mr.&#160;Spinner is primarily responsible for manager
evaluation and due diligence and for monitoring investments. Mr.&#160;Spinner is also actively involved in investor relations and communications.
Mr.&#160;Spinner is an alternative asset management industry specialist with 20&#160;years of experience advising, financing and investing
in alternative asset management firms and funds. Mr.&#160;Spinner&#8217;s experience in the CLO market dates back to the late 1990s.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Prior to joining
the Adviser in February&#160;2013, Mr.&#160;Spinner was an Investment Analyst at the 1199SEIU Benefit and Pension Funds, from June&#160;2009
to February&#160;2013, where he oversaw the private equity, special opportunities credit and real estate allocations. The 1199SEIU Benefit
and Pension Funds are collectively among the largest Taft-Hartley plans in the United States. Prior to this, Mr.&#160;Spinner was a Managing
Director at Bear, Stearns&#160;&amp; Co. Inc. focused on alternative asset managers. Prior to Bear Stearns, Mr.&#160;Spinner was the
co-founder and president of Structured Capital Partners,&#160;Inc., a financial holding company formed to invest in structured credit
managers. Mr.&#160;Spinner was credit trained at Chase Manhattan Bank where he began his career as an investment banker and spent seven&#160;years
in the Financial Institutions Group (including at JPMorgan Securities Inc. post-merger), where he had coverage responsibility for asset
management firms including CLO collateral managers. Mr.&#160;Spinner formerly served as a member of the board of managers and investment
committee of Marble Point. Mr.&#160;Spinner earned a B.A., summa cum laude, from Gettysburg College and an M.B.A. from Columbia University.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 62 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following table
sets forth accounts within each category listed for which members of the Senior Investment Team are jointly and primarily responsible
for day-to-day portfolio management as of December&#160;31, 2022. Among the accounts listed below, one of the &#8220;Registered Investment
Companies&#8221; (with total assets of $14.5&#160;million), seven of the &#8220;Other Pooled Investment Vehicles&#8221; (with total assets
of $2,350.1&#160;million) and 26 of the &#8220;Other Accounts&#8221; (with total assets of $1,710.6&#160;million) are subject to a performance
fee. In addition, we are subject to a performance fee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Registered Investment Companies</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Other Pooled Investment Vehicle</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Other Accounts</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Portfolio Manager</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number of<br/>
 Accounts</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total Assets<br/>
 (in millions)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number of<br/>
 Accounts</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total Assets<br/>


    (in millions)<sup>(1)</sup></td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number of<br/>
 Accounts</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total Assets<br/>
 (in millions)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; font: 10pt Times New Roman, Times, Serif; text-align: left">Thomas P. Majewski</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">2</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">163.0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">10</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">2,652.4</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">55</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">4,617.9</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Daniel W. Ko</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">163.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,652.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">55</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,617.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Daniel M. Spinner</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">163.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,652.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">55</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,617.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">(1)
&#8239;&#8239;Total Assets are estimated and unaudited and may vary from final audited figures. Total assets exclude amounts invested in the
equity of another investment vehicle managed by the portfolio manager so as to avoid double counting.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
of Portfolio Managers.</i></b></span>&#160;&#160;&#160;The investment professionals are paid out of the total revenues of the Adviser
and certain of its affiliates, including the advisory fees earned with respect to providing advisory services to us. Professional compensation
at the Adviser is structured so that key professionals benefit from strong investment performance generated on the accounts that the
Adviser and such affiliates manage and from their longevity with the Adviser. Each member of the Senior Investment Team has indirect
equity ownership interests in the Adviser and related long-term incentives. Members of the Senior Investment Team also receive a fixed
base salary and an annual market and performance-based cash bonus. The bonus is determined by the Adviser&#8217;s Board of Managers,
and is based on both quantitative and qualitative analysis of several factors, including the profitability of the Adviser and the contribution
of the individual employee. Many of the factors considered by management in reaching its compensation determinations will be impacted
by our long-term performance and the value of our assets as well as the portfolios managed for the Adviser&#8217;s and such affiliates&#8217;
other clients.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Owned in the Company by Portfolio Managers.</i></b></span>&#160;&#160;&#160;The table below sets forth the dollar range of the value
of the shares of our common stock that are owned beneficially by each portfolio manager as of December&#160;31, 2022. For purposes of
this table, beneficial ownership is defined to mean a direct or indirect pecuniary interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b>Name of Portfolio
    Manager</b></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center"/>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Dollar Range<br/> of Equity Securities<br/> in the Company<span style="font-size: 10pt"><sup>(1)</sup>&#160;</span></b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 81%; font: 10pt Times New Roman, Times, Serif; text-align: left">Thomas P. Majewski</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 16%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,001&#8201;&#8211;&#8201;$500,000</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Daniel M. Spinner</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,001&#8201;&#8211;&#8201;$500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Daniel W. Ko</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,001&#8201;&#8211;&#8201;$500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">(1)
&#8239;&#8239;Dollar ranges are as follows: None, $1&#8201;&#8211;&#8201;$10,000, $10,001&#8201;&#8211;&#8201;$50,000,
$50,001&#8201;&#8211;&#8201;$100,000, $100,001&#8201;&#8211;&#8201;$500,000, $500,001&#8201;&#8211;&#8201;$1,000,000 and over
$1,000,000.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Adviser&#8217;s Board of Managers</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
Adviser is ultimately governed through intermediary holding companies by the Adviser&#8217;s Board of Managers, which governs and
oversees the overall activities of the Adviser. The Adviser&#8217;s Board of Managers is comprised of Mr.&#160;Majewski,
Mr.&#160;James Carey, Mr.&#160;Scott Bronner and Mr.&#160;James Matthews. The Adviser&#8217;s Board of Managers is also responsible
for governance and oversight of certain affiliates of the Adviser, including Eagle Point Income Management.
Mr.&#160;Majewski&#8217;s biographical information is included above under <b><i>&#8220;&#8212; Portfolio Managers&#8221;</i></b>
and Mr.&#160;Matthews&#8217; biographical information is included under <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#8220;Management&#8201;&#8212;&#8201;Biographical
Information about each Director&#8221;</i></b></span> below. Biographical information regarding each other member of the
Adviser&#8217;s Board of Managers is summarized below:</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 63 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>James
D. Carey.</i></b></span>&#160;&#160;&#160;Mr.&#160;Carey is a Senior Principal of Stone Point and a member of the investment committees
of the Trident Funds. Mr.&#160;Carey is also a member of the Adviser&#8217;s Board of Managers. Mr.&#160;Carey joined Stone Point in
1997 from Merrill Lynch&#160;&amp; Co. Prior to joining Merrill Lynch&#160;&amp; Co., Mr.&#160;Carey was a corporate attorney with Kelley
Drye&#160;&amp; Warren LLP. Mr.&#160;Carey is a director of a number of portfolio companies of the Trident Funds managed by Stone Point,
including Alliant Insurance Services,&#160;Inc., the holding company of Amherst Pierpont Securities LLC, Enstar Group Limited, Privilege
Underwriters,&#160;Inc., HireRight and Sedgwick Claims Management Services,&#160;Inc.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Mr.&#160;Carey
holds a B.S. from Boston College, a J.D. from Boston College Law School and an M.B.A. from the Duke University Fuqua School of Business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Scott
Bronner.</i></b></span>&#160;&#160;&#160;Mr.&#160;Bronner is a Managing Director at Stone Point. Mr.&#160;Bronner is also a member of
the Adviser&#8217;s Board of Managers. Mr.&#160;Bronner joined Stone Point in 2009. He is a director of a number of portfolio companies
of the Trident Funds managed by Stone Point. Prior to joining Stone Point, Mr.&#160;Bronner was an Analyst in the Private Equity Division
at Lehman Brothers Inc.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Investment Advisory Agreement</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Services.</i></b></span>&#160;&#160;&#160;Subject
to the overall supervision of our board of directors, the Adviser manages the day-to-day operations of, and provides investment advisory
and management services to, us. Under the terms of our Investment Advisory Agreement, the Adviser:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify">determines the composition of our portfolio,
the nature and timing of the changes to our portfolio and the manner of implementing such changes;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">identifies, evaluates and negotiates
the structure of the investments we make (including performing due diligence on our prospective investments);</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">executes, closes, services and monitors the investments
we make;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">determines the securities and other assets that we purchase,
retain or sell; and</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">provides us with such other investment
advisory, research and related services as we may from time to time reasonably require for the investment of our funds.</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Adviser&#8217;s
services under the Investment Advisory Agreement are not exclusive, and both it and its members, officers and employees are free to furnish
similar services to other persons and entities so long as its services to us are not impaired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Investment Advisory
Agreement was most recently approved by the board of directors in May&#160;2023. A discussion regarding the basis for the board of directors&#8217;
most recent approval of the Investment Advisory Agreement will be included in our semi-annual report for the period ending June&#160;30,
2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Duration
and Termination.</i></b></span>&#160;&#160;&#160;Unless earlier terminated as described below, the Investment Advisory Agreement will
remain in effect if approved annually by our board of directors or by the affirmative vote of the holders of a majority of our outstanding
voting securities, including, in either case, approval by a majority of our directors who are not &#8220;interested persons&#8221; of
any party to such agreement, as such term is defined in Section&#160;2(a)(19) of the 1940 Act. The Investment Advisory Agreement will
automatically terminate in the event of its assignment. The Investment Advisory Agreement may also be terminated by our board of directors
or the affirmative vote of a majority of our outstanding voting securities without penalty upon not less than 60&#160;days&#8217; written
notice to the Adviser and by the Adviser upon not less than 90&#160;days&#8217; written notice to us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Indemnification.</i></b></span>&#160;&#160;&#160;The
Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of its
duties or by reason of the reckless disregard of its duties and obligations, the Adviser and its officers, managers, partners,
agents, employees, controlling persons, members and any other person or entity affiliated with it are entitled to indemnification
from us for any damages, liabilities, costs and expenses (including reasonable attorneys&#8217; fees and amounts reasonably paid in
settlement) arising from the rendering of the Adviser&#8217;s services under the Investment Advisory Agreement or otherwise as our
investment adviser.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 64 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management
Fee and Incentive Fee.</i></b></span>&#160;&#160;&#160;We pay the Adviser a fee for its services under the Investment Advisory Agreement
consisting of two components&#8201;&#8212;&#8201;a base management fee and an incentive fee. To the extent permitted by applicable
law, the Adviser may elect to defer all or a portion of these fees for a specified period of time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The base management
fee is calculated and payable quarterly in arrears and equals an annual rate of 1.75% of our &#8220;Total Equity Base.&#8221; &#8220;Total
Equity Base&#8221; means the NAV attributable to our common stockholders and the paid-in capital of our Preferred Stock. The base management
fee is calculated based on the Total Equity Base at the end of the most recently completed calendar quarter and, with respect to any
common stock or Preferred Stock issued or repurchased during such quarter, is adjusted to reflect the number of days during such quarter
that such common stock and/or Preferred Stock, if any, was outstanding. In addition, the base management fee for any partial quarter
is pro-rated (based on the number of days actually elapsed at the end of such partial quarter relative to the total number of days in
such calendar quarter).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition, we
pay the Adviser an incentive fee based on our performance. The incentive fee is calculated and payable quarterly in arrears and equals
20% of our &#8220;Pre-Incentive Fee Net Investment Income&#8221; for the immediately preceding quarter, subject to a hurdle and a &#8220;catch
up&#8221; feature. No incentive fees are payable to our investment adviser in respect of any capital gains. For this purpose, &#8220;Pre-Incentive
Fee Net Investment Income&#8221; means interest income, dividend income and any other income (including any other fees, such as commitment,
origination, structuring, diligence and consulting fees or other fees that we receive from an investment) accrued during the calendar
quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement
to Eagle Point Administration, and any interest expense and/or dividends paid on any issued and outstanding debt or Preferred Stock,
but excluding the incentive fee). Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest
feature (such as original issue discount, debt instruments PIK interest and zero-coupon securities), accrued income that we have not
yet received in cash. Pre-Incentive Fee Net Investment Income does not include any capital gains or losses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Pre-Incentive Fee
Net Investment Income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding calendar
quarter, is compared to a hurdle of 2.00% of our NAV per quarter (or an annualized hurdle rate of 8.00%). For such purposes, our quarterly
rate of return is determined by dividing our Pre-Incentive Fee Net Investment Income by our reported net assets as of the prior period
end. Our net investment income used to calculate this part of the incentive fee is also included in the calculation of the Total Equity
Base which is used to calculate the 1.75% base management fee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The incentive fee in each calendar
quarter is paid to the Adviser as follows:</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">no incentive fee in any calendar quarter
in which our Pre-Incentive Fee Net Investment Income does not exceed the hurdle of 2.00% of our NAV (or an annualized hurdle rate of
8.00%);</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">100% of our Pre-Incentive Fee Net Investment
Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the hurdle but is less than
2.50% of our NAV in any calendar quarter (or an annualized rate of 10.00%). We refer to this portion of our Pre-Incentive Fee Net Investment
Income (which exceeds the hurdle but is less than 2.50% of our NAV) as the &#8220;catch-up.&#8221; The &#8220;catch-up&#8221; is meant
to provide the Adviser with 20% of our Pre-Incentive Fee Net Investment Income as if a hurdle did not apply if this net investment income
meets or exceeds 2.50% of our NAV in any calendar quarter; and</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">20% of the amount of our Pre-Incentive
Fee Net Investment Income, if any, that exceeds 2.50% of our NAV in any calendar quarter is payable to the Adviser (that is, once the
hurdle is reached and the catch-up is achieved, 20% of all Pre-Incentive Fee Net Investment Income thereafter is paid to the Adviser).</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">You should be aware
that a rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our investments. Accordingly,
an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial
increase of the amount of incentive fees payable to the Adviser with respect to Pre-Incentive Fee Net Investment Income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 65 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The portion of such
incentive fee that is attributable to deferred interest (such as PIK interest or original issue discount) will be paid to the Adviser,
without interest, only if and to the extent we actually receive such deferred interest in cash, and any accrual will be reversed if and
to the extent such interest is reversed in connection with any write-off or similar treatment of the investment giving rise to any deferred
interest accrual. Any reversal of such amounts would reduce net income for the quarter by the net amount of the reversal (after taking
into account the reversal of incentive fees payable) and would result in a reduction of the incentive fees for such quarter.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">No incentive fee
is payable to the Adviser on capital gains, whether realized or unrealized. In addition, the amount of the incentive fee is not affected
by any realized or unrealized losses that we may suffer.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The payment of monthly
dividends on our Preferred Stock (including on any shares of Preferred Stock that may be held by officers or other affiliates of the
Adviser) is not subject to Pre-Incentive Fee Net Investment Income meeting or exceeding any hurdle rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following is
a graphical representation of the calculation of the incentive fee as well as examples of its application.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Quarterly Incentive Fee Based on Net Investment
Income</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Pre-Incentive Fee Net Investment Income</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>(expressed
as a&#160;percentage of the value of net assets)</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;<img alt="" src="tm2429841d6_prosimg001.jpg"/></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>Examples of Quarterly Incentive Fee Calculation
(amounts expressed as a&#160;percentage of the value of net assets, and are not annualized)*</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Alternative 1:</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Assumptions</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income (including interest, distributions, fees,&#160;etc.) = 1.25% Hurdle rate</span><span style="font-size: 10pt"><sup>(1)</sup></span>&#160;=
2.00%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
management fee</span><span style="font-size: 10pt"><sup>(2)</sup></span>&#160;= 0.4375%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses (legal, accounting, custodian, transfer agent,&#160;etc.)</span><span style="font-size: 10pt"><sup>(3)</sup></span>&#160;= 0.25%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Pre-Incentive Fee Net Investment Income</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">(investment income&#8201;&#8211;&#8201;(base management
fee + other expenses)) = 0.5625%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Pre-Incentive Fee Net Investment Income does not exceed the
hurdle rate, therefore there is no incentive fee.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Alternative 2:</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Assumptions</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income (including interest, distributions, fees,&#160;etc.) = 2.70% Hurdle rate</span><span style="font-size: 10pt"><sup>(1)</sup></span>&#160;=
2.00%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
management fee</span><span style="font-size: 10pt"><sup>(2)</sup></span>&#160;= 0.4375%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses (legal, accounting, custodian, transfer agent,&#160;etc.)</span><span style="font-size: 10pt"><sup>(3)</sup></span>&#160;= 0.25%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Pre-Incentive Fee Net Investment Income</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">(investment income&#8201;&#8211;&#8201;(base management
fee + other expenses)) = 2.0125%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>


</div><!-- Field: Page; Sequence: 66 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Pre-Incentive Fee Net Investment Income exceeds the hurdle rate,
therefore there is an incentive fee.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>Incentive fee = (100% &#215; &#8220;Catch-Up&#8221;) + (the greater
of 0% AND (20% &#215; (Pre-Incentive Fee Net Investment Income&#8201;&#8211;&#8201;2.50%)))</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= (100.0% &#215; (Pre-Incentive Fee Net Investment Income&#8201;&#8211;&#8201;2.00%))
+ 0%</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= 100.0% &#215; (2.0125%&#8201;&#8211;&#8201;2.00%)</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= 100.0% &#215; 0.0125%</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= 0.0125%</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Alternative 3:</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Assumptions</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
income (including interest, distributions, fees,&#160;etc.) = 3.25% Hurdle rate</span><span style="font-size: 10pt"><sup>(1)</sup></span>&#160;=
2.00%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
management fee</span><span style="font-size: 10pt"><sup>(2)</sup></span>&#160;= 0.4375%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses (legal, accounting, custodian, transfer agent,&#160;etc.)</span><span style="font-size: 10pt"><sup>(3)</sup></span>&#160;= 0.25%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Pre-Incentive Fee Net Investment Income</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">(investment income&#8201;&#8211;&#8201;(base management
fee + other expenses)) = 2.5625%</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Pre-Incentive Fee Net Investment Income exceeds the hurdle rate,
therefore there is an incentive fee.</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>Incentive fee = (100% &#215; &#8220;Catch-Up&#8221;) + (the greater
of 0% AND (20% &#215; (Pre-Incentive Fee Net Investment Income&#8201;&#8211;&#8201;2.50%)))</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= (100.0% &#215; (2.50%&#8201;&#8211;&#8201;2.00%)) + (20% &#215;
(Pre-Incentive Fee Net Investment Income&#8201;&#8211;&#8201;2.50%))</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= (100.0% &#215; (2.50%&#8201;&#8211;&#8201;2.00%)) + (20% &#215;
(2.5625%&#8201;&#8211;&#8201;2.50%))</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= 0.5000% + .0125%</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><i>= 0.5125%</i></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0pt"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">*&#8239;&#8239;&#8239;&#8239;&#8239;The hypothetical amount
of Pre-Incentive Fee Net Investment Income shown is based on a&#160;percentage of net assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(1)&#8239;&#8239;&#8239;&#8239;Represents 8.00% annualized hurdle
rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(2)&#8239;&#8239;&#8239;&#8239;Represents 1.75% annualized base
management fee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(3)&#8239;&#8239;&#8239;&#8239;Excludes organizational and offering
expenses.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">During the fiscal&#160;years
ended December&#160;31, 2022, 2021 and 2020, we incurred base management and incentive fees (inclusive of incentive fees voluntarily
waived by the Adviser) of $26.1&#160;million, $20.2&#160;million and $14.2&#160;million, respectively, and paid $23.5&#160;million, $19.0&#160;million
and $13.0&#160;million, respectively, to the Adviser pursuant to the Investment Advisory Agreement. The waived incentive fee is not subject
to recoupment by the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 67 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Payment
of Expenses.</i></b></span>&#160;&#160;&#160;The Adviser&#8217;s investment team, when and to the extent engaged in providing
investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such
services, are provided and paid for by the Adviser. We bear all other costs and expenses of our operations and transactions,
including (without limitation): (1)&#160;the cost of calculating our NAV (including the cost and expenses of any independent
valuation firm); (2)&#160;interest payable on debt, if any, incurred to finance our investments; (3)&#160;fees and expenses,
including legal fees and expenses and travel expenses, incurred by the Adviser or payable to third parties relating to performing
due diligence on prospective investments, monitoring our investments and, if necessary, enforcing our rights; (4)&#160;brokerage
fees and commissions; (5)&#160;federal and state registration fees and exchange listing fees; (6)&#160;federal, state and local
taxes; (7)&#160;costs of offerings or repurchases of our common stock and other securities; (8)&#160;the base management fee and any
incentive fee; (9)&#160;distributions on shares of our common stock and other securities; (10)&#160;administration fees payable to
the Administrator under the Administration Agreement; (11)&#160;direct costs and expenses of administration and operation, including
printing, mailing, long distance telephone and staff, including fees payable in connection with outsourced administrative functions;
(12)&#160;transfer agent and custody fees and expenses; (13) independent director fees and expenses; (14) the costs of any reports,
proxy statements or other notices to our stockholders, including printing costs; (15)&#160;costs of holding stockholder meetings;
(16) litigation, indemnification and other non-recurring or extraordinary expenses; (17) fees and expenses associated with marketing
and investor relations efforts; (18) dues, fees and charges of any trade association of which we are a member; (19) fees and
expenses associated with independent audits and outside legal costs; (20) fidelity bond; (21) directors and officers/ errors and
omissions liability insurance, and any other insurance premiums; (22) costs associated with our reporting and compliance obligations
under the 1940 Act and applicable U.S. federal and state securities laws; and (23) all other expenses reasonably incurred by us or
the Administrator in connection with administering our business, such as the allocable portion of overhead and other expenses
incurred by the Administrator in performing its obligations under the Administration Agreement, including rent, the fees and
expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related
expenses of our chief compliance officer, chief financial officer, chief operating officer and their respective support staff.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>License Agreement</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We have entered
into a license agreement, or the &#8220;License Agreement,&#8221; with the Adviser pursuant to which the Adviser has granted us a non-exclusive,
royalty-free license to use the &#8220;Eagle Point Credit&#8221; name and logo. Under the License Agreement, we have a right to use the
&#8220;Eagle Point Credit&#8221; name and logo, for so long as the Adviser or one of its affiliates remains our investment adviser. The
License Agreement is terminable by either party at any time in its sole discretion upon 60&#160;days&#8217; prior written notice and
is also terminable by the Adviser in the case of certain events, including certain events of non-compliance. Other than with respect
to this license, we have no legal right to the &#8220;Eagle Point Credit&#8221; name and logo.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>The Administrator and the Administration Agreement</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
have entered into the Administration Agreement, pursuant to which the Administrator furnishes us with office facilities, equipment
and clerical, bookkeeping and record-keeping services at such facilities. Under the Administration Agreement, the Administrator
performs, or arranges for the performance of, our required administrative services, which include being responsible for the
financial records which we are required to maintain and preparing reports to our stockholders. In addition, the Administrator
provides us with accounting services; assists us in determining and publishing our NAV; oversees the preparation and filing of our
tax returns; monitors our compliance with tax laws and regulations; and prepares, and assists us with any audits by an independent
public accounting firm of, our financial statements. The Administrator is also responsible for the printing and dissemination of
reports to our stockholders and the maintenance of our website; provides support for our investor relations; generally oversees the
payment of our expenses and the performance of administrative and professional services rendered to us by others; and provides such
other administrative services as we may from time to time designate. Payments under the Administration Agreement are equal to an
amount based upon our allocable portion of the Administrator&#8217;s overhead in performing its obligations under the Administration
Agreement, including rent, the fees and expenses associated with performing compliance functions and our allocable portion of the
compensation of our chief financial officer and chief compliance officer and our allocable portion of the compensation of any
administrative support staff. Our allocable portion of such total compensation is based on an allocation of the time spent on us
relative to other matters. To the extent the Administrator outsources any of its functions, we pay the fees on a direct basis,
without profit to the Administrator. Certain accounting and other administrative services have been delegated by the Administrator
to SS&amp;C Technologies,&#160;Inc., or &#8220;SS&amp;C,&#8221; for which the fee is calculated based on our net assets (subject to
a monthly minimum), and certain investor relations related services have been delegated to ICR, LLC, or &#8220;ICR,&#8221; whose
charges are payable monthly. The Administration Agreement may be terminated by us without penalty upon not less than
60&#160;days&#8217; written notice to the Administrator and by the Administrator upon not less than 90&#160;days&#8217; written
notice to us. The Administration Agreement will remain in effect if approved by the board of directors, including by a majority of
our independent directors, on an annual basis. During the fiscal&#160;years ended December&#160;31, 2022, 2021 and 2020, we incurred
expenses of $0.8&#160;million, $0.7&#160;million and $0.7&#160;million, respectively, under, and paid $0.7&#160;million,
$0.7&#160;million and $0.7&#160;million, respectively, to the Administrator pursuant to the Administration Agreement. During the
fiscal&#160;years ended December&#160;31, 2022, 2021 and 2020, we incurred expenses of $0.3&#160;million, $0.3&#160;million and
$0.2&#160;million, respectively, under, and paid $0.3&#160;million, $0.3&#160;million and $0.1&#160;million, respectively, to
SS&amp;C. We also incurred expenses of $0.2&#160;million for each fiscal year ended December&#160;31, 2022, 2021 and 2020 payable to
ICR.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When considering
the approval of the Administration Agreement, the board of directors considers, among other factors, (i)&#160;the reasonableness of the
compensation paid by us to the Administrator and any third-party service providers in light of the services provided, the quality of
such services, any cost savings to us as a result of the arrangements and any conflicts of interest, (ii)&#160;the methodology employed
by the Administrator in determining how certain expenses are allocated to the Company, (iii)&#160;the breadth, depth and quality of such
administrative services provided, (iv)&#160;certain comparative information on expenses borne by other companies for somewhat similar
services known to be available and (v)&#160;the possibility of obtaining such services from a third party. The Administration Agreement
was most recently reapproved by the board of directors in May&#160;2022.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitation
on Liability and Indemnification.</i></b></span>&#160;&#160;&#160;The Administration Agreement provides that the Administrator and its
officers, directors, employees agents, control persons and affiliates are not liable to us or any of our stockholders for any act or
omission by it or its employees in the supervision or management of our investment activities or for any damages, liabilities, costs
and expenses (including reasonable attorneys&#8217; fees and amounts reasonably paid in settlement) or losses sustained by us or our
stockholders, except that the foregoing exculpation does not extend to any act or omission constituting willful misfeasance, bad faith,
gross negligence or reckless disregard of its obligations under the Administration Agreement. The Administration Agreement also provides
for indemnification by us of the Administrator&#8217;s members, directors, officers, employees, agents, control persons and affiliates
for liabilities incurred by them in connection with their services to us, subject to the same limitations and to certain conditions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 69 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>MANAGEMENT</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our board of directors
is responsible for the overall management and supervision of our business and affairs, including the appointment of advisers and sub-advisers.
Our directors may appoint officers who assist in managing our day-to-day affairs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>The Board of Directors</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The board of directors
currently consists of six members, four of whom are not &#8220;interested persons&#8221; (as defined in the 1940 Act) of us. We refer
to these directors as our &#8220;independent directors.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under our certificate
of incorporation and bylaws, our board of directors is divided into three classes with staggered three-year terms. The term of only one
of the three classes expires at each annual meeting of our stockholders. The classification of our board of directors across staggered
terms may prevent replacement of a majority of the directors for up to a two-year period.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Duties of Directors; Meetings and Committees</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under our certificate
of incorporation, our board of directors is responsible for managing our affairs, including the appointment of advisers and sub-advisers.
The board of directors appoints officers who assist in managing our day-to-day affairs.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The board of directors
has appointed Mr.&#160;Matthews as Chairperson. The Chairperson presides at meetings of the board of directors and may call meetings
of the board and any committee whenever he deems necessary. The Chairperson participates in the preparation of the agenda for meetings
of the board of directors and the identification of information to be presented to the board of directors with respect to matters to
be acted upon by the directors. The Chairperson also acts as a liaison with our management, officers and attorneys and the other directors
generally between meetings. The Chairperson may perform such other functions as may be requested by the board of directors from time
to time. Except for any duties specified in this prospectus or pursuant to our certificate of incorporation or bylaws, or as assigned
by the board of directors, the designation of a director as Chairperson does not impose on that director any duties, obligations or liability
that are greater than the duties, obligations or liability imposed on any other director, generally.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The board of directors
has designated Mr.&#160;Weiss as Lead Independent Director. The Lead Independent Director generally acts as a liaison between the other
independent directors and our management, officers and attorneys between meetings of the board of directors. The Lead Independent Director
may perform such other functions as may be requested by the board of directors from time to time. Except for any duties specified in
this prospectus or pursuant to our certificate of incorporation or bylaws, or as assigned by the board of directors, the designation
of a director as Lead Independent Director does not impose on that director any duties, obligations or liability that are greater than
the duties, obligations or liability imposed on any other director, generally.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The board of directors
believes that this leadership structure is appropriate because it allows the board of directors to exercise informed judgment over matters
under its purview, and it allocates areas of responsibility among committees or working groups of directors and the full board of directors
in a manner that enhances effective oversight. The board of directors also believes that having a majority of independent directors is
appropriate and in the best interest of our stockholders. Nevertheless, the board of directors also believes that having interested persons
serve on the board of directors brings corporate and financial viewpoints that are, in the board of directors&#8217; view, crucial elements
in its decision-making process. In addition, the board of directors believes that Mr.&#160;Majewski, Managing Partner of the Adviser,
provides the board of directors with the Adviser&#8217;s perspective in managing and sponsoring us. The leadership structure of the board
of directors may be changed, at any time and in the discretion of the board of directors, including in response to changes in circumstances
or our characteristics. During the fiscal year ended December&#160;31, 2022, the board of directors held four regular meetings.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Committees of the Board of Directors</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The board of directors
has established two standing committees: the audit committee and the nominating committee. The current membership of each committee is
set forth below. Interested directors are generally able to attend and participate in any committee meeting, as appropriate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 70 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 49%; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
    </b></span></td>
    <td style="border-bottom: white 1pt solid; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 49%; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
    </b></span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 3.25pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    W. Appleby </span></td>
    <td>&#160;</td>
    <td style="padding-top: 3.25pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    W. Appleby, Chair </span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
    F. McDonald </span></td>
    <td>&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
    F. McDonald </span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    E. Tramontano </span></td>
    <td>&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    E. Tramontano </span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    L. Weiss, Chair </span></td>
    <td>&#160;</td>
    <td style="padding-top: 3.5pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    L. Weiss</span></td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Audit Committee</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">All of the members
of the audit committee are independent directors, and each member is financially literate with at least one having accounting or financial
management expertise. The board of directors has adopted a written charter for the audit committee. The audit committee recommends to
the full board of directors the independent registered public accounting firm for us, oversees the work of the independent registered
public accounting firm in connection with our audit, communicates with the independent registered public accounting firm on a regular
basis and provides a forum for the independent registered public accounting firm to report and discuss any matters it deems appropriate
at any time. Mr.&#160;Weiss serves as Chairperson of the audit committee. The audit committee also functions as our qualified legal compliance
committee and is responsible for the confidential receipt, retention and consideration of any report of evidence of (1)&#160;a material
violation of applicable federal or state securities law, (2)&#160;a material breach of fiduciary duty arising under federal or state
law or (3)&#160;a similar material violation of any federal or state law by us or any of our officers, directors, employees or agents
that has occurred, is ongoing or is about to occur. The audit committee met four times during the fiscal year ended December&#160;31,
2022.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b><i>Nominating Committee</i></b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The nominating committee
is comprised of all of the independent directors. The nominating committee periodically reviews the committee structure, conducts an
annual self-assessment of the board of directors and makes the final selection and nomination of candidates to serve as independent directors.
In addition, the nominating committee makes recommendations regarding the compensation of the Company&#8217;s independent directors for
approval by the board of directors as there is no separate compensation committee of the Company. The board of directors nominates and
selects our interested directors and the officers. Mr.&#160;Appleby serves as Chairperson of the nominating committee. The nominating
committee met three times during the fiscal year ended December&#160;31, 2022.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In reviewing a potential
nominee and in evaluating the re-nomination of current independent directors, the nominating committee will generally apply the following
criteria: (1)&#160;the nominee&#8217;s reputation for integrity, honesty and adherence to high ethical standards; (2)&#160;the nominee&#8217;s
business acumen, experience and ability to exercise sound judgment; (3)&#160;a commitment to understand the Company and the responsibilities
of a director of an investment company; (4)&#160;a commitment to regularly attend and participate in meetings of the board of directors
and its committees; (5)&#160;the ability to understand potential conflicts of interest involving management of the Company and to act
in the interests of all stockholders; and (6)&#160;the absence of a real or apparent conflict of interest that would impair the nominee&#8217;s
ability to represent the interests of all the stockholders and to fulfill the responsibilities of an independent director. The nominating
committee does not necessarily place the same emphasis on each criteria and each nominee may not have each of these qualities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As long as an existing
independent director continues, in the opinion of the nominating committee, to satisfy these criteria, we anticipate that the nominating
committee would favor the re-nomination of an existing independent director rather than nominate a new candidate. Consequently, while
the nominating committee will consider nominees recommended by stockholders to serve as independent directors, the nominating committee
may only act upon such recommendations if there is a vacancy on the board of directors or a committee and it determines that the selection
of a new or additional independent director is in our best interests. In the event that a vacancy arises or a change in membership is
determined to be advisable, the nominating committee will, in addition to any stockholder recommendations, consider candidates identified
by other means, including candidates proposed by members of the nominating committee. The nominating committee may retain a consultant
to assist it in a search for a qualified candidate. The nominating committee has adopted procedures for the selection of independent
directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 71; Options: NewSection; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The nominating committee
has not adopted a formal policy with regard to the consideration of diversity in identifying individuals for election as independent
directors, but the nominating committee will consider such factors as it may deem are in the best interests of the Company and the stockholders.
Such factors may include the individual&#8217;s professional experience, education, skills and other individual qualities or attributes,
including gender, race or national origin.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For any stockholder
recommendation for independent director to be included in our proxy statement, it must be submitted in compliance with all of the pertinent
provisions of Rule&#160;14a-8 under the Exchange Act to be considered by the nominating committee. In evaluating a nominee recommended
by a stockholder, the nominating committee, in addition to the criteria discussed above, may consider the objectives of the stockholder
in submitting that nomination and whether such objectives are consistent with the interests of all stockholders. If the board of directors
determines to include a stockholder&#8217;s candidate among the slate of nominees, the candidate&#8217;s name will be placed on our proxy
card. If the nominating committee or the board of directors determines not to include such candidate among the board of directors&#8217;
designated nominees and the stockholder has satisfied the requirements of Rule&#160;14a-8, the stockholder&#8217;s candidate will be
treated as a nominee of the stockholder who originally nominated the candidate. In that case, the candidate will not be named on the
proxy card distributed with our proxy statement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
stockholder who is entitled to vote at the applicable annual meeting and who intends to nominate a director must comply with the advance
notice procedures in our bylaws. To be timely, a stockholder&#8217;s notice must be delivered by a nationally recognized courier service
or mailed by first class United States mail, postage or delivery charges prepaid, and received at our principal executive offices addressed
to the attention of the Secretary not less than ninety (90) days nor more than one hundred twenty (120) days in advance of the anniversary
of the date our proxy statement was released to the stockholders in connection with the previous year&#8217;s annual meeting of stockholders;
provided, however, that in the event that no annual meeting was held in the previous year or the date of the annual meeting has been
changed by more than thirty (30) days from the date contemplated at the time of the previous year&#8217;s proxy statement, notice by
the stockholder must be received by the Secretary no later than the close of business on the later of (x)&#160;the ninetieth (90</span><span style="font-size: 10pt">th</span>)
day prior to such annual meeting and (y)&#160;the seventh (7<span style="font-size: 10pt">th</span>) day following the day on which public
announcement of the date of such meeting is first made. Such stockholder&#8217;s notice to the Secretary shall set forth (i)&#160;as
to each person whom the stockholder proposes to nominate for election or reelection as a director, (a)&#160;the name, age, business address
and residence address of the person, (b)&#160;the principal occupation or employment of the person, (c)&#160;the class and number of
shares of our capital stock that are beneficially owned by the person and (d)&#160;any other information relating to the person that
is required to be disclosed in solicitations for proxies for election of directors pursuant to the rules&#160;and regulations of the
SEC under Section&#160;14 of the Exchange Act, and (ii)&#160;as to the stockholder giving the notice (a)&#160;the name and record address
of the stockholder and (b)&#160;the class and number of shares of our capital stock that are beneficially owned by the stockholder. We
may require any proposed nominee to furnish such other information as may reasonably be required to determine the eligibility of such
proposed nominee to serve as a director.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Stockholders may
communicate with the directors as a group or individually. Any such communication should be sent to the board of directors or an individual
director c/o&#160;the Secretary of the Company at the following address: 600 Steamboat Road, Suite&#160;202, Greenwich, CT 06830. The
Secretary may determine not to forward any letter to directors that does not relate to the business of the Company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Risk Oversight</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As a registered
investment company, we are subject to a variety of risks, including investment risks, financial risks, compliance risks and operational
risks. As part of its overall activities, the board of directors oversees the management of our risk management structure by various
departments of the Adviser and the Administrator, as well as by our chief compliance officer. The responsibility to manage our risk management
structure on a day-to-day basis is subsumed within the Adviser&#8217;s overall investment management responsibilities. The Adviser has
its own, independent interest in risk management.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The
board of directors recognizes that it is not possible to identify all of the risks that may affect us or to develop processes and
controls to eliminate or mitigate their occurrence or effects. The board of directors discharges risk oversight as part of its
overall activities. In addressing issues regarding our risk management between meetings, appropriate representatives of the Adviser
communicate with the Chairperson of the board of directors, the relevant committee chair or our chief compliance officer, who is
directly accountable to the board of directors. As appropriate, the Chairperson of the board of directors and the committee chairs
confer among themselves, with our chief compliance officer, the Adviser, other service providers and external fund counsel to
identify and review risk management issues that may be placed on the board of director&#8217;s agenda and/or that of an appropriate
committee for review and discussion with management.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 72; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Compliance Policies and Procedures</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We have adopted
and implemented written policies and procedures reasonably designed to detect and prevent violation of the federal securities laws and
are required to review these compliance policies and procedures annually for their adequacy and the effectiveness of their implementation.
The chief compliance officer is responsible for administering the policies and procedures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Biographical Information about each Director</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Please refer to
the section of the Company&#8217;s April&#160;12, 2023 definitive proxy statement on Schedule&#160;14A for the annual meeting of the
Company&#8217;s stockholders entitled &#8220;Information about the Directors and Nominees,&#8221; which is incorporated by reference
herein, for a discussion of the Company&#8217;s Directors, their principal occupations during the past five&#160;years and other information
about them. Effective April&#160;2023, the current principal occupation of Paul E. Tramontano (Independent Director) is Executive Managing
Director at Cresset Asset Management, LLC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Executive Officers</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Please refer to
the section of the Company&#8217;s April&#160;12, 2023 definitive proxy statement on Schedule&#160;14A for the annual meeting of the
Company&#8217;s stockholders entitled &#8220;Information about the Officers who are Not Directors,&#8221; which is incorporated by reference
herein, for certain biographical and other information relating to the officers of the Company who are not Directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Director Compensation</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Please refer to
the section of the Company&#8217;s April&#160;12, 2023 definitive proxy statement on Schedule&#160;14A for the annual meeting of the
Company&#8217;s stockholders entitled &#8220;Information about the Directors and Nominees&#8201;&#8212;&#8201;Compensation,&#8221;
which is incorporated by reference herein, for certain information relating to the compensation paid to our independent directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Director Ownership of Company Shares</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The table below
sets forth the dollar range of the value of our common stock and the Preferred Stock that is owned beneficially by each director as of
December&#160;31, 2022. For purposes of this table, beneficial ownership is defined to mean a direct or indirect pecuniary interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Director</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dollar Range of Equity <br/>
Securities in the Company<sup>(1)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate Dollar Range of Equity<br/>
Securities in the Fund&#160;Complex<sup>(1)</sup></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interested Directors</i></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas P. Majewski</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James R. Matthews</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Independent Directors</i></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott W. Appleby</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin F. McDonald</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul E. Tramontano</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$ 100,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey L. Weiss</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$&#8239;100,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over$&#8239;100,000</span></td>
    <td>&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">(1)
&#8239;&#8239;&#8239;&#8239;Dollar ranges are as follows: None, $1&#8201;&#8211;&#8201;$10,000, $10,001&#8201;&#8211;&#8201;$50,000,
$50,001&#8201;&#8211;&#8201;$100,000 and over $100,000.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 73; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><div><a id="sa_010"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>DETERMINATION OF NET ASSET VALUE</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We determine the
NAV per share of our common stock by dividing the value of our portfolio investments, cash and other assets (including interest accrued
but not collected) less all of our liabilities (including accrued expenses, the aggregate liquidation preference of our Preferred Stock,
borrowings and interest payables) by the total number of outstanding shares of our common stock on a quarterly basis (or more frequently,
as appropriate). The most significant estimate inherent in the preparation of our financial statements is the valuation of investments
and the related amounts of unrealized appreciation and depreciation of investments recorded. There is no single method for determining
fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances
of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Rule&#160;2a-5
under the 1940 Act establishes requirements for determining fair value in good faith for purposes of the 1940 Act. Pursuant to Rule&#160;2a-5,
our board has elected to designate the Adviser as &#8220;valuation designee&#8221; to perform fair value determinations in respect of
our portfolio investments that do not have readily available market quotations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We account for our
investments in accordance with GAAP, and the Adviser fair values our investment portfolio in accordance with the provisions of the FASB
ASC Topic 820 <i>Fair Value Measurements and Disclosures</i> of the Financial Accounting Standards Board&#8217;s Accounting Standards
Codification, as amended, which defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures
about fair value measurements. Fair value is the estimated amount that would be received to sell an asset, or paid to transfer a liability,
in an orderly transaction between market participants at the measurement date (i.e., the exit price).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In valuing our investments
in CLO debt, CLO equity and LAFs, the Adviser considers a variety of relevant factors, including price indications from a third-party
pricing service, recent trading prices for specific investments, recent purchases and sales known to the Adviser in similar securities
and output from a third-party financial model. The third-party financial model contains detailed information on the characteristics of
CLOs, including recent information about assets and liabilities, and is used to project future cash flows. Key inputs to the model, including
assumptions for future loan default rates, recovery rates, prepayment rates, reinvestment rates and discount rates are determined by
considering both observable and third-party market data and prevailing general market assumptions and conventions as well as those of
the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Specifically, the
Adviser utilizes a third-party pricing service in connection with the valuation of our investments in CLO debt. However, if pricing from
such third-party pricing service is determined to be stale or otherwise not reflective of current market conditions, the Adviser may
use an average of independent broker quotes to determine fair value. The Adviser engages a third-party independent valuation firm as
an input to the valuation of the fair value of the Company&#8217;s investments in CLO equity. The valuation firm&#8217;s advice is only
one factor considered in the valuation of such investments, and the Adviser does not rely on such advice in determining the fair value
of our investments in accordance with the 1940 Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our investment portfolio
is valued at least each quarter in accordance with the Adviser&#8217;s valuation policies and procedures. Fair valuations are ultimately
determined by the Adviser&#8217;s valuation committee, which is comprised of a majority of non-investment personnel. Our board of directors
oversees the valuation designee and the process that it uses to determine the fair value of our assets. In this regard, the board receives
periodic and, as applicable, prompt reporting regarding certain material valuation matters, as required by Rule&#160;2a-5 under the 1940
Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_011"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>DIVIDEND REINVESTMENT PLAN</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Information about
the Company&#8217;s dividend reinvestment plan may be found in the &#8220;Supplemental Information&#8201;&#8212;&#8201;Dividend Reinvestment
Plan&#8221; section of the Company&#8217;s most recent Annual Report on Form&#160;N-CSR, as amended, for the fiscal year ended December&#160;31,
2022, filed with the SEC on February&#160;24, 2023, which is incorporated by reference herein.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 74; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_012"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>CONFLICTS OF INTEREST</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Affiliations of the Adviser and the Administrator</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our executive officers
and directors, and the Adviser and certain of its affiliates and their officers and employees, including the Senior Investment Team,
have several conflicts of interest as a result of the other activities in which they engage. The Adviser and the Administrator are affiliated
with other entities engaged in the financial services business. In particular, the Adviser and the Administrator are affiliated with
Eagle Point Income Management and Stone Point, and certain members of the Adviser&#8217;s Board of Managers are principals of Stone Point.
Pursuant to certain management agreements, Stone Point has received delegated authority to act as the investment manager of the Trident
Funds, which hold a significant number of shares of our common stock. See <b><i>&#8220;Control Persons, Principal Stockholders and Selling
Stockholders.&#8221;</i></b> The Adviser and the Administrator are wholly owned by Eagle Point Holdings LP (&#8220;EP Holdings&#8221;).
EP Holdings, in turn, is primarily owned by certain of the Trident Funds through intermediary holding companies. The Trident Funds and
other private equity funds managed by Stone Point invest in financial services companies. Further, the Adviser and its affiliates engage
and may in the future engage in a variety of business activities, including investment management, financing, and software analytics.
As such, the Adviser and its affiliates may have multiple business relationships with CLO collateral managers that encompass a range
of activities, such as investing in CLOs managed by a CLO collateral manager on behalf of the Company, financing, or investing in other
securities issued by, other vehicles managed by such CLO collateral manager or an affiliate thereof, or otherwise providing advisory,
research or data services to such CLO collateral manager for compensation. These relationships may cause the Adviser&#8217;s, the Administrator&#8217;s
and certain of their affiliates&#8217; interests, and the interests of their officers and employees, including the Senior Investment
Team, to diverge from our interests and may result in conflicts of interest that may not be foreseen, which conflicts may not be resolved
in a manner that is always or exclusively in our best interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Other Accounts</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Adviser is responsible
for the investment decisions made on our behalf. There are no restrictions on the ability of the Adviser and certain of its affiliates
(including Eagle Point Income Management, and Stone Point) to manage accounts for multiple clients, including accounts for affiliates
of the Adviser or their directors, officers or employees, following the same, similar or different investment objectives, philosophies
and strategies as those used by the Adviser for our account. In those situations, the Adviser and its affiliates may have conflicts of
interest in allocating investment opportunities between us and any other account managed by such person. See <b><i>&#8220;&#8212; Allocation
of Opportunities&#8221;</i></b> below. Such conflicts of interest would be expected to be heightened where the Adviser manages an account
for an affiliate or its directors, officers or employees. In addition, certain of these accounts may provide for higher management fees
or have incentive fees or may allow for higher expense reimbursements, all of which may contribute to a conflict of interest and create
an incentive for the Adviser to favor such other accounts. Further, accounts managed by the Adviser or certain of its affiliates hold,
and may in the future be allocated, certain investments in CLOs, such as debt tranches, which conflict with the positions held by other
accounts in such CLOs, such as us. In these cases, when exercising the rights of each account with respect to such investments, the Adviser
and/or its affiliates will have a conflict of interest as actions on behalf of one account may have an adverse effect on another account
managed by the Adviser or such affiliate, including us. In such cases, such conflicts may not be resolved in a manner that is always
or exclusively in our best interests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition, Eagle
Point Income Management, Stone Point and their affiliates, and the investment funds managed by Eagle Point Income Management, Stone Point
and such affiliates, may also invest in companies that compete with the Adviser and that therefore manage other accounts and funds that
compete for investment opportunities with us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our executive officers
and directors, as well as other current and potential future affiliated persons, officers and employees of the Adviser and certain of
its affiliates, may serve as officers, directors or principals of, or manage the accounts for, other entities, including EIC and EPIIF,
with investment strategies that substantially or partially overlap with the strategy that we pursue. Accordingly, they may have obligations
to investors in those entities, the fulfillment of which obligations may not be in the best interests of us or our stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 75; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Further, the professional
staff of the Adviser and Administrator will devote as much time to us as such professionals deem appropriate to perform their duties
in accordance with the Investment Advisory Agreement and Administration Agreement, respectively. However, such persons are also committed
to providing investment advisory and other services for other clients, including Eagle Point Income Company, unregistered pooled investment
vehicles, and separately managed accounts, and engage in other business ventures in which we have no interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Certain of the Adviser&#8217;s,
the Administrator&#8217;s and their affiliates&#8217; senior personnel and ultimate managers serve and may serve as officers, directors,
managers or principals of other entities that operate in the same or a related line of business as the Adviser, the Administrator, and
their affiliates, or that are service providers to firms or entities such as the Adviser, the Administrator, the Company, CLOs or other
similar entities. Accordingly, such persons may have obligations to investors in those entities the fulfillment of which may not be in
our best interest. In addition, certain of such persons hold direct and indirect personal investments in various companies, including
certain investment advisers and other operating companies, some of which do or may provide services to the Adviser, the Administrator,
us, or other accounts serviced by the Adviser, the Administrator, or their affiliates, or to any issuer in which the Company may invest.
The Company may pay fees or other compensation to any such operating company or financial institution for services received. Further,
these relationships may result in conflicts of interest that may not be foreseen or may not be resolved in a manner that is always or
exclusively in our best interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition, payments
under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator&#8217;s overhead. See
<b><i>&#8220;The Adviser and the Administrator&#8201;&#8212;&#8201;The Administrator and the Administration Agreement&#8221;</i></b>
above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As a result of these
separate business activities and payment structure, the Adviser and Administrator have conflicts of interest in allocating management
and administrative time, services and functions among the Company, other accounts that they provide services to, their affiliates and
other business ventures or clients.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Allocation of Opportunities</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As a fiduciary,
the Adviser owes a duty of loyalty to its clients and must treat each client fairly. When the Adviser purchases or sells securities for
more than one account, the trades must be allocated in a manner consistent with its fiduciary duties. To this end, the Adviser and Eagle
Point Income Management have adopted and reviewed policies and procedures pursuant to which they allocate investment opportunities appropriate
for more than one client account in a manner deemed appropriate in their sole discretion to achieve a fair and equitable result over
time. Pursuant to these policies and procedures, when allocating investment opportunities, the Adviser and Eagle Point Income Management
may take into account regulatory, tax or legal requirements applicable to an account. In allocating investment opportunities, the Adviser
and Eagle Point Income Management may use rotational, percentage or other allocation methods provided that doing so is consistent with
the Adviser&#8217;s and Eagle Point Income Management&#8217;s internal conflict of interest and allocation policies and the requirements
of the Investment Advisers Act of 1940, or the &#8220;Advisers Act,&#8221; the 1940 Act and other applicable laws. In addition, an account
managed by the Adviser, such as us, is expected to be considered for the allocation of investment opportunities together with other accounts
managed by affiliates of the Adviser, including Eagle Point Income Management. There is no assurance that such opportunities will be
allocated to any particular account equitably in the short-term or that any such account, including us, will be able to participate in
all investment opportunities that are suitable for it.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Leverage</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We previously incurred
leverage through the issuance of the Preferred Stock and the Notes. We may incur additional leverage, directly or indirectly, through
one or more special purpose vehicles, indebtedness for borrowed money, as well as leverage in the form of Derivative Transactions, additional
shares of Preferred Stock, debt securities and other structures and instruments, in significant amounts and on terms that the Adviser
and our board of directors deem appropriate, subject to applicable limitations under the 1940 Act. Such leverage may be used for the
acquisition and financing of our investments, to pay fees and expenses and for other purposes. Such leverage may be secured and/or unsecured.
Any such leverage does not include leverage embedded or inherent in the CLO structures in which we invest or in derivative instruments
in which we may invest. The more leverage we employ, the more likely a substantial change will occur in our NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 76; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Accordingly, any event that adversely
affects the value of an investment would be magnified to the extent leverage is utilized. Our incentive fee structure and the formula
for calculating the fee payable to the Adviser may incentivize the Adviser to pursue speculative investments and use leverage in a manner
that adversely impacts our performance. The incentive fee payable to the Adviser is based on our Pre-Incentive Fee Net Investment Income,
as calculated in accordance with our Investment Advisory Agreement. This may encourage the Adviser to use leverage to increase the return
on our investments, even when it may not be appropriate to do so, and to refrain from de-levering when it would otherwise be appropriate
to do so. In addition, because our management fee is based in part on the paid-in capital of any Preferred Stock that we issue, we may
have an incentive to incur leverage by issuing additional Preferred Stock when it is not appropriate to do so or when it is advantageous
to use other forms of leverage, such as issuing debt. Under certain circumstances, the use of leverage may increase the likelihood of
default, which would impair the value of our securities.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Allocation of Expenses and Selection of Service Providers</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">From time to time,
the Adviser and the Administrator will be required to determine how certain costs and expenses are to be allocated among the Company
and certain other accounts. Often, an expense is relevant only to the Company and would be borne only by us. However, it is sometimes
the case that costs and expenses are relevant to more than one account. To the extent the Company, on the one hand, and Adviser, Administrator
and/or one or more accounts, on the other hand, incur costs or expenses that are applicable to more than one of them, the Adviser and
the Administrator will allocate such costs and expenses in a manner that they determine to be fair and reasonable, notwithstanding their
potential interest in the outcome, and may make corrective allocations should they determine that such corrections are necessary or advisable.
Further, the Adviser and the Administrator and their affiliates, and their respective personnel and the investment funds serviced by
such persons, have interests in companies that provide services to asset management firms such as the Adviser, and to other businesses.
Because of these relationships, such persons have a conflict of interest when considering service providers with respect to the Company
and have an incentive to select those service providers in which such persons have an interest. The selection of such a service provider
may result in the Company bearing fees and expenses paid to a service provider that is affiliated with, or otherwise has a relationship
with, the Adviser, the Administrator or their affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition, the
Adviser and the Administrator have a conflict of interest where a service provider provides services directly to the Adviser and/or the
Administrator or an affiliate thereof, and separately provides services to the Company, in that the Adviser, the Administrator and/or
an affiliate thereof may potentially obtain services at a lower cost than it otherwise could have as a result of the service provider&#8217;s
work performed on behalf of, and the compensation paid to the service provider by, the Company. In addition, the Adviser and the Administrator
and their affiliates may use some of the same service providers as are retained on behalf of the Company and, in some cases, fee rates,
amounts or discounts may be offered to the Adviser, the Administrator and/or their affiliates by a third party service provider which
differ from those offered to the Company as a result of scheduled or ad hoc rate changes, differences in the scope, type or nature of
the service or transaction, alternative fee arrangements and negotiation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Valuation</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Generally, there
is not a public market for the CLO investments we target. As a result, the Adviser reviews and determines, in good faith, in accordance
with the 1940 Act, the value of, these securities based on relevant information compiled by itself and third-party pricing services (when
available) as described under <b><i>&#8220;Determination of Net Asset Value.&#8221;</i></b> Our interested directors are associated with
the Adviser and have an interest in the Adviser&#8217;s economic success. The participation of the Adviser&#8217;s investment professionals
in our valuation process, and the interest of our interested directors in the Adviser, could result in a conflict of interest as the
base management fee paid to the Adviser is based, in part, on our assets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 77; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Co-Investments and Related Party Transactions</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In
the ordinary course of business, we may enter into transactions with persons who are affiliated with us by reason of being under
common control of the Adviser or its affiliates, including Eagle Point Income Management and Stone Point. In order to ensure that we
do not engage in any prohibited transactions with any persons affiliated with us, we have implemented certain policies and
procedures whereby our executive officers screen each of our transactions for any possible affiliations between us, the Adviser and
its affiliates and our employees, officers and directors. We will not enter into any such transactions unless and until we are
satisfied that doing so is consistent with the 1940 Act, applicable SEC exemptive rules, interpretations or guidance, or the terms
of our exemptive order (as discussed below), as applicable. Our affiliations may require us to forgo attractive investment
opportunities. For example, we may be limited in our ability to invest in CLOs managed by certain affiliates of the Adviser.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In certain instances,
we co-invest on a concurrent basis with other accounts managed by the Adviser and may do so with other accounts managed by certain of
our Adviser&#8217;s affiliates, subject to compliance with applicable regulations and regulatory guidance and our written allocation
procedures. We have received exemptive relief from the SEC that permits us to participate in certain negotiated co-investments alongside
other accounts, including EIC and EPIIF, managed by the Adviser or certain of its affiliates, subject to certain conditions, including
that (i)&#160;a majority of our directors who have no financial interest in the transaction and a majority of our directors who are not
interested persons, as defined in the 1940 Act, of ours approve the co-investment and (ii)&#160;the price, terms and conditions of the
co-investment are the same for each participant. The Adviser may determine not to allocate certain potential co-investment opportunities
to the Company after taking into account regulatory requirements or other considerations. See <b><i>&#8220;&#8212; Allocation of Opportunities&#8221;
</i></b>above. A copy of our application for exemptive relief, including all of the conditions, and the related order are available on
the SEC&#8217;s website at <i>www.sec.gov</i>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Stone Point-Related Investments</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Portfolio companies
of investment funds managed by Stone Point and other affiliates of Stone Point may engage in lending activities, which could result in
us investing in CLOs that include loans underwritten by such a portfolio company or affiliate. In addition, the CLOs in which we expect
to invest consist principally of senior secured loans, which in many cases may be issued to operating companies that are primarily owned
by private equity funds, including funds that may be managed by Stone Point or its affiliates. In addition to the above, because portfolio
companies of such investment funds engage in a wide range of businesses, such entities may engage in other activities now or in the future
that create a conflict of interest for the Adviser with respect to its management of us. Any of these potential transactions and activities
may result in the Adviser having a conflict of interest that may not be resolved in a manner that is always or exclusively in our best
interest or in the best interest of our stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Material Non-Public Information</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">By reason of the
advisory and/or other activities of the Adviser and its affiliates, the Adviser and its affiliates may acquire confidential or material
non-public information or be restricted from initiating transactions in certain securities. The Adviser will not be free to divulge,
or to act upon, any such confidential or material non-public information and, due to these restrictions, it may not be able to initiate
a transaction for our account that it otherwise might have initiated. As a result, we may be frozen in an investment position that we
otherwise might have liquidated or closed out or may not be able to acquire a position that we might otherwise have acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Code of Ethics and Compliance Procedures</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In order to address the
conflicts of interest described above, we have adopted a code of ethics under Rule&#160;17j-l of the 1940 Act. Similarly, the Adviser
has separately adopted the &#8220;Adviser Code of Ethics.&#8221; The Adviser Code of Ethics requires the officers and employees of the
Adviser to act in the best interests of the Adviser and its client accounts (including us), act in good faith and in an ethical manner,
avoid conflicts of interests with the client accounts to the extent reasonably possible and identify and manage conflicts of interest
to the extent that they arise. Personnel subject to each code of ethics may invest in securities for their personal investment accounts,
including securities that may be purchased or held by us, so long as such investments are made in accordance with the code&#8217;s requirements.
In addition, our code of ethics and the Adviser&#8217;s Code of Ethics are incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and are available on the EDGAR Database on the SEC&#8217;s website at <i>www.sec.gov.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 78; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our directors and
officers, and the officers and employees of the Adviser, are also required to comply with applicable provisions of the U.S. federal securities
laws and make prompt reports to supervisory personnel of any actual or suspected violations of law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition, the
Adviser has built a professional working environment, firm-wide compliance culture and compliance procedures and systems designed to
protect against potential incentives that may favor one account over another. The Adviser has adopted policies and procedures that address
the allocation of investment opportunities, execution of portfolio transactions, personal trading by employees and other potential conflicts
of interest that are designed to ensure that all client accounts are treated equitably over time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_013"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>U.S. FEDERAL INCOME TAX MATTERS</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following is
a summary of certain U.S. federal income tax consequences generally applicable to the purchase, ownership, and disposition of our securities,
including our common stock and Preferred Stock, which collectively will be referred to as &#8220;stock,&#8221; as well as our debt securities,
or &#8220;notes,&#8221; issued as of the date of this prospectus. Unless otherwise stated, this summary deals only with our securities
held as capital assets for U.S. federal tax purposes (generally, property held for investment).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As used herein,
a &#8220;U.S. holder&#8221; means a beneficial owner of the securities that is for U.S. federal income tax purposes any of the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span></td>
    <td style="text-align: justify">an individual citizen or resident of the United States;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a corporation (or any other entity
treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state
or other political subdivision thereof (including the District of Columbia);</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a trust if it (a)&#160;is subject to
the primary supervision of a court within the United States and one or more United States persons have the authority to control all substantial
decisions of the trust or (b)&#160;has a valid election in effect under applicable United States Treasury regulations, or &#8220;Treasury
Regulations,&#8221; to be treated as a United States person; or</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">an estate, the income of which is subject to U.S. federal
income taxation regardless of its source.</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The term &#8220;non-U.S.
holder&#8221; means a beneficial owner of the securities (other than a partnership or any other entity or other arrangement treated as
a partnership for U.S. federal income tax purposes) that is not a U.S. holder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">An individual may,
subject to exceptions, be deemed to be a resident of the United States for U.S. federal income tax purposes, as opposed to a non-resident
alien, by, among other ways, being present in the United States (i)&#160;on at least 31&#160;days in the calendar year, and (ii)&#160;for
an aggregate of at least 183&#160;days during a three-year period ending in the current calendar year, counting for such purposes all
of the days present in the current year, one-third of the days present in the immediately preceding calendar year, and one-sixth of the
days present in the second preceding calendar year. Individuals who are residents for such purposes are subject to U.S. federal income
tax as if they were United States citizens.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">This summary does
not represent a detailed description of the U.S. federal income tax consequences applicable to you, as a holder of our securities, if
you are a person subject to special tax treatment under the</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">U.S. federal income tax laws, including,
without limitation:</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a dealer in securities or currencies;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a financial institution;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a RIC;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a real estate investment trust;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a tax-exempt organization;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">an insurance company;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>


</div><!-- Field: Page; Sequence: 79; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top; text-align: justify">
    <td style="width: 0.25in">&#160;</td>
    <td style="padding-left: -0.5in; width: 0.2in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a person holding the securities as
part of a hedging, integrated, conversion or constructive sale transaction or a straddle;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a trader in securities that has elected the mark-to-market
method of accounting for their securities;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a person subject to alternative minimum tax;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a partnership or other pass-through entity for U.S. federal
income tax purposes;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a U.S. holder whose &#8220;functional
currency&#8221; (as defined in Section&#160;985 of the Code) is not the U.S.&#160;dollar;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a CFC;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">a PFIC;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">A United States expatriate or foreign persons or entities
(except to the extent set forth below); or</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; text-align: justify">
    <td>&#160;</td>
    <td style="padding-left: -0.5in; text-align: left"><span>&#9679;</span>&#160;</td>
    <td style="text-align: justify">A holder that is subject to special tax accounting rules&#160;under
Section&#160;451(b)&#160;of the Code.</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If a partnership
(including any entity classified or arrangement treated as a partnership for U.S. federal income tax purposes) holds the securities,
the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are
a partnership or a partner in a partnership holding our securities, you should consult your own tax advisors regarding the tax consequences
of an investment in our securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">This summary is based on
the Code, Treasury Regulations, rulings and judicial decisions as of the date hereof. Those authorities may be changed, possibly on a
retroactive basis, so as to result in U.S. federal income tax consequences different from those summarized below. This summary does not
represent a detailed description of the U.S. federal income tax consequences that may be applicable to you in light of your particular
circumstances and does not address the effects of any aspects of U.S. estate or gift, or state, local or non-U.S. income, estate, or
gift tax laws. It is not intended to be, and should not be construed to be, legal or tax advice to any particular purchaser of our securities.
We have not sought and will not seek any ruling from the IRS. No assurance can be given that the IRS would not assert, or that a court
would not sustain, a position contrary to any of the tax aspects set forth below. <b>You should consult your own tax advisors concerning
the particular U.S. federal income tax consequences to you of the ownership of our securities, as well as the consequences to you arising
under the laws or other guidance of any other taxing jurisdiction.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Important U.S. Federal Income Tax Considerations Affecting Us</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We have elected
to be treated, and intend to qualify each tax year thereafter, as a RIC under the Code. Accordingly, we must satisfy certain requirements
relating to sources of our income and diversification of our total assets and certain distribution requirements to maintain our RIC status
and to avoid being subject to U.S. federal income or excise tax on any undistributed taxable income. To the extent we qualify for treatment
as a RIC and satisfy the applicable distribution requirements, we will not be subject to U.S. federal income tax on income paid to our
stockholders in the form of dividends or capital gain dividends.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">To
qualify as a RIC for U.S. federal income tax purposes, we must derive at least 90% of our gross income each tax year from dividends,
interest, payments with respect to securities loans, gains from the sale or other disposition of stock, securities or foreign
currencies, net income derived from an interest in a qualified publicly traded partnership, or other income (including, but not
limited to, gains from options, futures or forward contracts) derived with respect to our business of investing in stock, securities
and currencies, or the &#8220;90% Gross Income Test.&#8221; A &#8220;qualified publicly traded partnership&#8221; is a publicly
traded partnership that meets certain requirements with respect to the nature of its income. To qualify as a RIC, we must also
satisfy certain requirements with respect to the diversification of our assets. We must have, at the close of each quarter of the
tax year, at least 50% of the value of our total assets represented by cash, cash items, U.S. government securities, securities of
other RICs and other securities that, in respect of any one issuer, do not represent more than 5% of the value of our assets nor
more than 10% of the voting securities of that issuer. In addition, at those times, not more than 25% of the value of our assets may
be invested in securities (other than U.S. government securities or the securities of other RICs) of any one issuer, or of two or
more issuers, which we control and which are engaged in the same or similar trades or businesses or related trades or businesses, or
of one or more qualified publicly traded partnerships, or the &#8220;Asset Diversification Tests.&#8221; If we fail to satisfy the
90% Gross Income Test, we will nevertheless be considered to have satisfied the test if (i)&#160;(a)&#160;such failure is due to
reasonable cause and not due to willful neglect and (b)&#160;we report the failure pursuant to Treasury Regulations to be adopted,
and (ii)&#160;we pay a tax equal to the excess non-qualifying income. If we fail to meet any of the Asset Diversification Tests with
respect to any quarter of any tax year, we will nevertheless be considered to have satisfied the requirements for such quarter if we
cure such failure within six&#160;months and either (i)&#160;such failure is de minimis or (ii)&#160;(a)&#160;such failure is due to
reasonable cause and not due to willful neglect and (b)&#160;we report the failure under Treasury Regulations to be adopted and pay
an excise tax. If we fail to qualify as a RIC for more than two consecutive taxable&#160;years and then seek to re-qualify as a RIC,
we generally would be required to recognize gain to the extent of any unrealized appreciation in our assets unless we elect to pay
U.S. corporate income tax on any such unrealized appreciation during the succeeding 5-year period.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 80; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As a RIC, we generally
will not be subject to federal income tax on our investment company taxable income (as that term is defined in the Code) and net capital
gains (the excess of net long-term capital gains over net short-term capital loss), if any, that we distribute in each tax year as dividends
to stockholders, provided that we distribute dividends of an amount at least equal to the sum of 90% of our investment company taxable
income, determined without regard to any deduction for dividends paid, plus 90% of our net tax-exempt interest income for such tax year,
or the &#8220;90% Distribution Requirement.&#8221; We intend to distribute to our stockholders, at least annually, substantially all
of our investment company taxable income, net tax-exempt income and net capital gains. In order to avoid incurring a nondeductible 4%
federal excise tax obligation, the Code requires that we distribute (or be deemed to have distributed) by December&#160;31 of each calendar
year dividends of an amount generally at least equal to the sum of (i)&#160;98% of our ordinary income (taking into account certain deferrals
and elections) for such calendar year, (ii)&#160;98.2% of our capital gain net income, adjusted for certain ordinary losses and generally
computed on the basis of the one-year period ending on October&#160;31 of such calendar year (unless we have made an election under Section&#160;4982(e)(4)&#160;of
the Code to have our required distribution from net income measured using the one-year period ending on November&#160;30 of such calendar
year) and (iii)&#160;100% of any ordinary income and capital gain net income from prior calendar&#160;years (as previously computed)
that were not paid out during such calendar&#160;years and on which we incurred no U.S. federal income tax, or the &#8220;Excise Tax
Distribution Requirement.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any dividends declared
by us during October, November&#160;or December&#160;of any calendar year, payable to stockholders of record on a specified date in such
a month and actually paid during January&#160;of the following calendar year, will be treated for federal income tax purposes as if it
had been paid by us, as well as received by our U.S. stockholders, on December&#160;31 of the calendar year in which the distribution
was declared.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We have previously
incurred, and may incur in the future, the 4% federal excise tax on a portion of our income and capital gains. While we intend to distribute
income and capital gains to minimize our exposure to the 4% federal excise tax, we may not be able to, or may choose not to, distribute
amounts sufficient to avoid the imposition of the tax entirely. In that event, we generally will be liable for the 4% federal excise
tax only on the amount by which we do not meet the excise tax avoidance requirement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we do not qualify
as a RIC or fail to satisfy the 90% Distribution Requirement for any tax year, we would be subject to corporate income tax on our taxable
income, and all distributions from earnings and profits, including distributions of net capital gains (if any), will be taxable to the
shareholder as ordinary income. Such distributions generally would be eligible (i)&#160;to be treated as qualified dividend income in
the case of individual and other non-corporate shareholders and (ii)&#160;for the dividends received deduction, or the &#8220;DRD,&#8221;
in the case of certain corporate shareholders. In addition, in order to requalify for taxation as a RIC, we may be required to recognize
unrealized gains, pay substantial taxes and interest, and make certain distributions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For purposes of
the 90% Gross Income Test, income that we earn from equity interests in certain entities that are not treated as corporations or as qualified
publicly traded partnerships for U.S. federal income tax purposes (<i>e.g.</i>, certain CLOs that are treated as partnerships) will generally
have the same character for us as in the hands of such an entity; consequently, we may be required to limit our equity investments in
any such entities that earn fee income, rental income, or other nonqualifying income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 81; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Because
we expect to use debt financing, we may be prevented by covenants contained in our debt financing agreements from making
distributions to our stockholders in certain circumstances. In addition, under the 1940 Act, we are generally not permitted to make
distributions to our stockholders while our debt obligations and other senior securities are outstanding unless certain &#8220;asset
coverage&#8221; tests are met. Restrictions on our ability to make distributions to our stockholders may prevent us from satisfying
the 90% Distribution Requirement or the Excise Tax Distribution Requirement and, therefore, may jeopardize our qualification for
taxation as a RIC, or subject us to the 4% U.S. federal excise tax.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Some of the income
and fees that we may recognize will not satisfy the 90% Gross Income Test. In order to ensure that such income and fees do not disqualify
us as a RIC for a failure to satisfy such test, we may be required to recognize such income and fees indirectly through one or more entities
treated as corporations for U.S. federal income tax purposes. Such corporations will be subject to U.S. corporate income tax on their
earnings, which ultimately will reduce our return on such income and fees.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may be required
to recognize taxable income in circumstances in which we do not receive cash. For example, if we hold debt instruments that are treated
under applicable tax rules&#160;as having OID (which may arise if we receive warrants in connection with the origination of a loan or
possibly in other circumstances), we must include in income each tax year a portion of the OID that accrues over the life of the obligation,
regardless of whether cash representing such income is received by us in the same tax year. We may also have to include in income other
amounts that we have not yet received in cash, such as contractual PIK interest (which represents contractual interest added to the loan
balance and due at the end of the loan term) and deferred loan origination fees that are paid after origination of the loan or are paid
in non-cash compensation such as warrants or stock. Because any original issue discount or other amounts accrued will be included in
our investment company taxable income for the tax year of accrual, we may be required to make a distribution to our stockholders in order
to satisfy the 90% Distribution Requirement or the Excise Tax Distribution Requirement, even though we will not have received any corresponding
cash amount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may invest (directly
or indirectly through an investment in an equity interest in a CLO treated as a partnership for U.S. federal income tax purposes) a portion
of our net assets in below investment grade instruments. Investments in these types of instruments may present special tax issues for
us. U.S. federal income tax rules&#160;are not entirely clear about issues such as when we may cease to accrue interest, original issue
discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received
on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy
or workout context are taxable. These and other issues will be addressed by us to the extent necessary in order to seek to ensure that
we distribute sufficient income that we do not become subject to U.S. federal income or excise tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Some
of the CLOs in which we invest may constitute PFICs for U.S. federal income tax purposes. Because we acquire interests treated as
equity for U.S. federal income tax purposes in PFICs (including equity tranche investments and certain debt tranche investments in
CLOs that are PFICs), we may be subject to federal income tax on a portion of any &#8220;excess distribution&#8221; or gain from the
disposition of such shares even if such income is distributed as a taxable dividend by us to our stockholders. Additional charges in
the nature of interest may be imposed on us in respect of deferred taxes arising from any such excess distributions or gains. If we
invest in a PFIC and elect to treat the PFIC as a QEF in lieu of the foregoing requirements, we will be required to include in
income each tax year our proportionate share of the ordinary earnings and net capital gain of the QEF, even if such income is not
distributed to us. Alternatively, we can elect to mark-to-market at the end of each tax year (as well as on certain other dates
described in the Code) our shares in a PFIC; in this case, we will recognize as ordinary income any increase in the value of such
shares, and as an ordinary loss any decrease in such value to the extent it does not exceed prior increases included in our ordinary
income. Under either election, we may be required to recognize in a tax year taxable income in excess of our distributions from
PFICs and our proceeds from dispositions of PFIC stock during that tax year, and we may be required to distribute such taxable
income in order to satisfy the 90% Gross Income Test, the Excise Tax Distribution Requirement or the 90% Distribution Requirement.
Our ability to make either election will depend on factors beyond our control and is subject to restrictions which may limit the
availability of the benefit of these elections. Treasury Regulations generally treat our income inclusion with respect to a PFIC
with respect to which we have made a qualified electing fund, or &#8220;QEF,&#8221; election, as qualifying income for purposes of
determining our ability to be subject to tax as a RIC if (i)&#160;there is a current distribution out of the earnings and profits of
the PFIC that are attributable to such income inclusion or (ii)&#160;such inclusion is derived with respect to our business of
investing in stock, securities, or currencies. As such, we may be restricted in our ability to make QEF elections with respect to
our holdings in issuers that could be treated as PFICs in order to limit our tax liability or maximize our after-tax return from
these investments.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 82; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we hold 10% or
more of the interests treated as equity (by vote or value) for U.S. federal income tax purposes in a foreign corporation that is treated
as a CFC (including equity tranche investments and certain debt tranche investments in a CLO treated as CFC), we may be treated as receiving
a deemed distribution (taxable as ordinary income) each tax year from such foreign corporation in an amount equal to our pro&#160;rata
share of the corporation&#8217;s income for the tax year (including both ordinary earnings and capital gains), whether or not the corporation
makes an actual distribution during such tax year. This deemed distribution is required to be included in the income of a U.S. Shareholder
of a CFC regardless of whether the shareholder has made a QEF election with respect to such CFC. In general, a foreign corporation will
be classified as a CFC if more than 50% of the shares of the corporation, measured by reference to combined voting power or value, is
owned (directly, indirectly or by attribution) by U.S. Shareholders. A &#8220;U.S. Shareholder,&#8221; for this purpose, is any U.S.
person that possesses (actually or constructively) 10% or more of the combined voting power or value of all classes of shares of a foreign
corporation. If we are treated as receiving a deemed distribution from a CFC, we will be required to include such deemed distribution
in our investment company taxable income regardless of whether we receive any actual distributions from such CFC, and we must distribute
such income in order to satisfy the Excise Tax Distribution Requirement or the 90% Distribution Requirement. Treasury Regulations generally
treat our income inclusion with respect to a CFC as qualifying income for purposes of determining our ability to be subject to tax as
a RIC either if (i)&#160;there is a current distribution out of the earnings and profits of the CFC that are attributable to such income
inclusion or (ii)&#160;such inclusion is derived with respect to our business of investing in stock, securities, or currencies. As such,
we may limit and/or manage our holdings in issuers that could be treated as CFCs in order to limit our tax liability or maximize our
after-tax return from these investments.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">FATCA generally
imposes a U.S. federal withholding tax of 30% on U.S. source periodic payments, including interest and dividends to certain non-U.S.
entities, including certain non-U.S. financial institutions and investment funds, unless such non-U.S. entity complies with certain reporting
requirements regarding its United States account holders and its United States owners. Most CLOs in which we invest will be treated as
non-U.S. financial entities for this purpose, and therefore will be required to comply with these reporting requirements to avoid the
30% withholding. If a CLO in which we invest fails to properly comply with these reporting requirements, it could reduce the amounts
available to distribute to equity and junior debt holders in such CLO, which could materially and adversely affect our operating results
and cash flows.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under Section&#160;988
of the Code, gains or losses attributable to fluctuations in exchange rates between the time we accrue income, expenses or other liabilities
denominated in a foreign currency and the time we actually collect such income or pay such expenses or liabilities are generally treated
as ordinary income or loss. Similarly, gains or losses on foreign currency forward, futures and options contracts, similar financial
instruments as well as upon the disposition of debt securities denominated in a foreign currency, to the extent attributable to fluctuations
in exchange rates between the acquisition and disposition dates, are also treated as ordinary income or loss. Any such transactions that
are not directly related to our investment in securities (possibly including speculative currency positions or currency derivatives not
used for hedging purposes) also could, under future Treasury Regulations, produce income not among the types of &#8220;qualifying income&#8221;
for purposes of the 90% Gross Income test.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Gain or loss realized
by us from the sale or exchange of warrants acquired by us as well as any loss attributable to the lapse of such warrants generally will
be treated as capital gain or loss. The treatment of such gain or loss as long-term or short-term will depend on how long we held a particular
warrant. Upon the exercise of a warrant acquired by us, our tax basis in the stock purchased under the warrant will equal the sum of
the amount paid for the warrant plus the strike price paid on the exercise of the warrant.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
transactions in futures contracts and options will be subject to special provisions of the Code that, among other things, may affect
the character of our realized gains and losses realized (<i>i.e.</i>, may affect whether gains or losses are ordinary or capital, or
short-term or long-term), may accelerate recognition of income to us and may defer our losses. These rules&#160;could, therefore,
affect the character, amount and timing of distributions to stockholders. These provisions also (a)&#160;will require us to
mark-to-market certain types of the positions in our portfolio (<i>i.e.</i>, treat them as if they were closed out), and
(b)&#160;may cause us to recognize income without receiving cash with which to make distributions in amounts necessary to satisfy
the 90% Distribution Requirement for qualifying to be taxed as a RIC or the Excise Tax Distribution Requirement. We will monitor our
transactions, will make the appropriate tax elections and will make the appropriate entries in our books and records when we acquire
any futures contract, option or hedged investment in order to mitigate the effect of these rules&#160;and prevent our
disqualification from being taxed as a RIC.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 83; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Generally, our hedging
transactions (including certain covered call options) may result in &#8220;straddles&#8221; for U.S. federal income tax purposes. The
straddle rules&#160;may affect the character of our realized gains (or losses). In addition, our realized losses on positions that are
part of a straddle may be deferred under the straddle rules, rather than being taken into account in calculating the taxable income for
the taxable year in which the losses are realized. Because only a few regulations implementing the straddle rules&#160;have been promulgated,
the tax consequences to us of engaging in hedging transactions are not entirely clear. Hedging transactions may increase the amount of
our realized short-term capital gain which is taxed as ordinary income when distributed to shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may make one
or more of the elections available under the Code which are applicable to straddles. If we make any of the elections, the amount, character
and timing of the recognition of gains or losses from the affected straddle positions will be determined under rules&#160;that vary according
to the election(s)&#160;made. The rules&#160;applicable under certain of the elections may operate to accelerate the recognition of gains
or losses from the affected straddle positions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Because the straddle
rules&#160;may affect the character of gains or losses, defer losses and/or accelerate the recognition of gains or losses from the affected
straddle positions, the amount which may be distributed to shareholders, and which will be taxed to them as ordinary income or long-term
capital gain, may be increased or decreased as compared to a fund that did not engage in such hedging transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Certain of our investment
practices are subject to special and complex U.S. federal income tax provisions that may, among other things, (i)&#160;convert dividends
that would otherwise constitute qualified dividend income into ordinary income, (ii)&#160;treat dividends that would otherwise be eligible
for deductions available to certain U.S. corporations under the Code as ineligible for such treatment, (iii)&#160;disallow, suspend or
otherwise limit the allowance of certain losses or deductions, (iv)&#160;convert long-term capital gains into short-term capital gains
or ordinary income, (v)&#160;convert an ordinary loss or deduction into a capital loss (the deductibility of which is more limited),
(vi)&#160;cause us to recognize income or gain without a corresponding receipt of cash, (vii)&#160;adversely alter the characterization
of certain complex financial transactions, and (viii)&#160;produce income that will not qualify as good income for purposes of the 90%
Gross Income Test. While we may not always be successful in doing so, we will seek to avoid or minimize the adverse tax consequences
of our investment practices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may recognize
gain (but not loss) from a constructive sale of certain &#8220;appreciated financial positions&#8221; if we enter into a short sale,
offsetting notional principal contract, or forward contract transaction with respect to the appreciated position or substantially identical
property. Appreciated financial positions subject to this constructive sale treatment include interests (including options and forward
contracts and short sales) in stock and certain other instruments. Constructive sale treatment does not apply if the transaction is closed
out no later than thirty days after the end of the tax year in which the transaction was initiated, and the underlying appreciated securities
position is held unhedged for at least the next sixty days after the hedging transaction is closed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Gain or loss from
a short sale of property is generally considered as capital gains or loss to the extent the property used to close the short sale constitutes
a capital asset in our hands. Except with respect to certain situations where the property used to close a short sale has a long-term
holding period on the date the short sale is entered into, gains on short sales generally are short-term capital gains. A loss on a short
sale will be treated as a long-term capital loss if, on the date of the short sale, &#8220;substantially identical property&#8221; has
been held by us for more than one year. In addition, entering into a short sale may result in suspension of the holding period of &#8220;substantially
identical property&#8221; held by us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Gain
or loss on a short sale will generally not be realized until such time as the short sale is closed. However, as described above in
the discussion of constructive sales, if we hold a short sale position with respect to securities that have appreciated in value,
and we then acquire property that is the same as or substantially identical to the property sold short, we generally will recognize
gain on the date we acquire such property as if the short sale were closed on such date with such property. Similarly, if we hold an
appreciated financial position with respect to securities and then enter into a short sale with respect to the same or substantially
identical property, we generally will recognize gain as if the appreciated financial position were sold at its fair market value on
the date we enter into the short sale. The subsequent holding period for any appreciated financial position that is subject to these
constructive sale rules&#160;will be determined as if such position were acquired on the date of the constructive sale.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 84; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>Taxation of Stockholders</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of U.S. Resident Holders of Our Stock</i></span>.&#160;&#160;&#160;Dividends and distributions on our shares are generally subject to
federal income tax as described herein, even though such dividends and distributions may economically represent a return of a particular
stockholder&#8217;s investment. Such distributions are likely to occur in respect of shares purchased at a time when our NAV reflects
gains that are either unrealized, or realized but not distributed. Such realized gains may be required to be distributed even when our
NAV also reflects unrealized losses. Certain dividends and distributions declared by us in October, November, or December&#160;to stockholders
of record of such month of a calendar year and paid by us in January&#160;of the following calendar year will be treated by stockholders
as if received on December&#160;31 of the calendar year in which they were declared. In addition, certain other distributions made after
the close of our tax year may be &#8220;spilled back&#8221; and treated as paid by us (except for purposes of the nondeductible 4% federal
excise tax) during such tax year. In such case, stockholders will be treated as having received such dividends in the tax year in which
the distributions were actually made.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Stockholders receiving
any distribution from us in the form of additional shares pursuant to the DRIP will be treated as receiving a taxable distribution in
an amount generally equal to the cash that would have been received if they had elected to receive the distribution in cash, unless we
issue new shares that are trading at or above NAV, in which case such stockholders will be treated as receiving a distribution equal
to the fair market value of the shares received, determined as of the reinvestment date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We will inform stockholders
of the source and tax status of all distributions promptly after the close of each calendar year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For federal income
tax purposes, distributions paid out of our current or accumulated earnings and profits will, except in the case of distributions of
qualified dividend income and capital gain dividends described below, be taxable as ordinary dividend income. Certain income distributions
paid by us (whether paid in cash or reinvested in additional shares of our stock) to individual taxpayers are taxed at rates applicable
to net long-term capital gains. This tax treatment applies only if certain holding period requirements and other requirements are satisfied
by the stockholder and the dividends are attributable to qualified dividend income received by us, and there can be no assurance as to
what portion of our dividend distributions will qualify for favorable treatment. For this purpose, &#8220;qualified dividend income&#8221;
means dividends received from United States corporations and &#8220;qualified foreign corporations,&#8221; provided that we satisfy certain
holding period and other requirements in respect of the stock of such corporations. The maximum individual rate applicable to qualified
dividend income is either 15% or 20%, depending on whether the individual&#8217;s income exceeds certain threshold amounts. Given our
investment strategies, it is not anticipated that a significant portion of our dividends will be eligible to be treated as qualified
dividend income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Dividends distributed
from our investment company taxable income which have been reported by us and received by certain of our corporate stockholders will
qualify for the DRD to the extent of the amount of qualifying dividends received by us from certain domestic corporations for the tax
year. A dividend received by us will not be treated as a qualifying dividend (i)&#160;to the extent the stock on which the dividend is
paid is considered to be &#8220;debt-financed&#8221; (generally, acquired with borrowed funds), (ii)&#160;if we fail to meet certain
holding period requirements for the stock on which the dividend is paid or (iii)&#160;to the extent we are under an obligation (pursuant
to a short sale or otherwise) to make related payments with respect to positions in substantially similar or related property. Moreover,
the DRD may be disallowed or reduced if an otherwise eligible corporate stockholder fails to satisfy the foregoing requirements with
respect to shares of our stock or by application of the Code. Given our investment strategies, it is not anticipated that a significant
portion of our dividends will be eligible for the DRD.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 85; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Capital
gain dividends distributed to a stockholder are characterized as long-term capital gains, regardless of how long the stockholder has
held our shares. A distribution of an amount in excess of our current and accumulated earnings and profits will be treated by a
stockholder as a return of capital which is applied against and reduces the stockholder&#8217;s tax basis in our shares. To the
extent that the amount of any such distribution exceeds a stockholder&#8217;s tax basis in our shares, the excess will be treated by
the stockholder as gain from a sale or exchange of the shares. Distributions of gains from the sale or other disposition of our
investments that we owned for one year or less are characterized as ordinary income.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Certain distributions
reported by us as Section&#160;163(j)&#160;interest dividends may be treated as interest income by stockholders for purposes of the tax
rules&#160;applicable to interest expense limitations under Section&#160;163(j)&#160;of the Code. Such treatment by stockholders is generally
subject to holding period requirements and other potential limitations, although the holding period requirements are generally not applicable
to dividends declared by money market funds and certain other funds that declare dividends daily and pay such dividends on a monthly
or more frequent basis. The amount that we are eligible to report as a Section&#160;163(j)&#160;dividend for a tax year is generally
limited to the excess of our business interest income over the sum of our (i)&#160;business interest expense and (ii)&#160;other deductions
properly allocable to our business interest income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may elect to
retain our net capital gains or a portion thereof for investment and be subject to tax at corporate rates on the amount retained. In
such case, we may designate the retained amount as undistributed net capital gains in a notice to our stockholders who will be treated
as if each received a distribution of the pro&#160;rata share of such net capital gain, with the result that each stockholder will: (i)&#160;be
required to report the pro&#160;rata share of such net capital gain on the applicable tax return as long-term capital gains; (ii)&#160;receive
a refundable tax credit for the pro&#160;rata share of tax paid by us on the net capital gain; and (iii)&#160;increase the tax basis
for the shares of our stock held by an amount equal to the deemed distribution less the tax credit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The IRS currently
requires that a RIC that has two or more classes of stock allocate to each such class proportionate amounts of each type of its income
(such as ordinary income and capital gains) based upon the&#160;percentage of total dividends paid to each class for the tax year. Accordingly,
we intend each year to allocate capital gain dividends, if any, between our shares of common stock and shares of Preferred Stock in proportion
to the total dividends paid to each class with respect to such tax year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The benefits of
the reduced tax rates applicable to long-term capital gains and qualified dividend income may be impacted by the application of the alternative
minimum tax to noncorporate stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Although we currently
do not intend to do so, we have the ability to declare a large portion of a distribution in shares of our stock. Generally, were we to
declare such a distribution, we would allow stockholders to elect payment in cash and/or shares of equivalent value. Under published
IRS guidance, the entire distribution by a publicly offered RIC will generally be treated as a taxable distribution for U.S. federal
income tax purposes, and count towards RIC distribution requirements under the Code, if certain conditions are satisfied. Among other
things, the aggregate amount of cash available to be distributed to all stockholders is required to be at least 20% of the aggregate
declared distribution. If too many stockholders elect to receive cash, the cash available for distribution is required to be allocated
among the stockholders electing to receive cash (with the balance of the distribution paid in stock) under a formula provided in the
applicable IRS guidance. Each stockholder electing to receive cash would be entitled to receive cash in an amount equal to at least the
lesser of (i)&#160;the portion of the distribution such stockholder elected to receive in cash and (ii)&#160;such stockholder&#8217;s
entire distribution multiplied by the&#160;percentage limitation on cash available for distribution. The number of shares of our stock
distributed would thus depend on the applicable&#160;percentage limitation on cash available for distribution, the stockholders&#8217;
individual elections to receive cash or stock, and the value of the shares of stock. Each stockholder generally would be treated as having
received a taxable distribution on the date the distribution is received in an amount equal to the cash that such stockholder would have
received if the entire distribution had been paid in cash, even if such stockholder received all or most of the distribution in shares
of our stock. This may result in a stockholder having to pay tax on such distribution, even if no cash is received.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Selling
stockholders will generally recognize gain or loss in an amount equal to the difference between the amount realized on the sale and
the stockholder&#8217;s adjusted tax basis in the shares sold. The gain or loss will generally be a capital gain or loss. The
current maximum tax rate applicable to net capital gains recognized by individuals and other non-corporate taxpayers is:
(i)&#160;the same as the maximum ordinary income tax rate for gain recognized on the sale of capital assets held for one year or
less; or (ii)&#160;generally 15% or 20% (depending on whether the stockholder&#8217;s income exceeds certain threshold amounts) for
gains recognized on the sale of capital assets held for more than one year (as well as certain capital gain dividends).</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 86; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Gain or loss, if
any, recognized by a holder in connection with our redemption of shares of the Preferred Stock generally will be characterized as gain
or loss from a sale or exchange of Preferred Stock if the redemption (a)&#160;is &#8220;not essentially equivalent to a dividend&#8221;
with respect to the stockholder, (b)&#160;results in a &#8220;complete termination&#8221; of holder&#8217;s ownership of our stock, or
(c)&#160;is &#8220;substantially disproportionate&#8221; with respect to the holder, in each case, within the meaning of Section&#160;302(b)&#160;of
the Code. In determining whether any of these alternative tests has been met, stock considered to be owned by a holder of Preferred Stock
by reason of certain constructive ownership rules&#160;under the Code and the related administrative guidance promulgated thereunder
as well as judicial interpretations thereof, as well as stock actually owned by the holder, generally must be taken into account. The
determination as to whether any of the alternative tests described above will be satisfied with respect to a holder of Preferred Stock
depends upon the facts and circumstances at the time that the determination must be made.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Holders of Preferred
Stock are advised to consult their tax advisors to determine their own tax treatment in the event of a redemption of such stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Even if a redemption
of Preferred Stock is treated as a sale or exchange, a portion of the amount received by a holder on the redemption may be characterized
as dividend income for federal income tax purposes to the extent such portion is attributable to declared but unpaid dividends. If a
redemption of Preferred Stock from a holder is not treated as a sale or exchange for federal income tax purposes, the proceeds of such
distribution generally will be characterized for federal income tax purposes as a dividend.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The IRS currently
requires that a RIC that has two or more classes of stock allocate to each class proportionate amounts of each type of its income (such
as ordinary income, capital gains, qualified dividend income and dividends qualifying for the DRD) based upon the&#160;percentage of
total dividends paid to each class for the tax year. Accordingly, we intend to allocate capital gain distributions and distributions
of qualified dividend income and distributions qualifying for the DRD, if any, between our common shares and Preferred Stock in proportion
to the total distributions paid to each class with respect to such tax year.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any loss realized
upon the sale or exchange of shares of our stock with a holding period of six&#160;months or less will be treated as a long-term capital
loss to the extent of any capital gain dividends received (or amounts designated as undistributed capital gains) with respect to such
shares. In addition, all or a portion of a loss realized by a stockholder on a sale or other disposition of shares of our stock may be
disallowed under &#8220;wash sale&#8221; rules&#160;to the extent the stockholder acquires other shares of our stock (whether through
the reinvestment of distributions or otherwise) within a period of 61&#160;days beginning 30&#160;days before and ending 30&#160;days
after the date of disposition of our shares. Any disallowed loss will result in an adjustment to the stockholder&#8217;s tax basis in
some or all of the other shares of our stock acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
commissions or other sales charges paid upon a purchase of our shares cannot be taken into account for purposes of determining gain or
loss on a sale of the shares before the 91</span><span style="font-size: 10pt">st</span> day after their purchase to the extent a sales
charge is reduced or eliminated in a subsequent acquisition of our shares, during the period beginning on the date of such sale and ending
on January&#160;31 of the calendar year following the calendar year in which the sale is made, pursuant to a reinvestment right. Any
disregarded amounts will result in an adjustment to a stockholder&#8217;s tax basis in some or all of any other shares of our stock acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We or your financial
intermediary is also generally required by law to report to each stockholder and to the IRS cost basis information for shares of our
stock sold by or redeemed from the stockholder. This information includes the adjusted cost basis of the shares, the gross proceeds from
disposition and whether the gain or loss is long-term or short-term. The adjusted cost basis of shares will be based on the default cost
basis reporting method selected by us, unless a stockholder, before the sale or redemption, informs us that it has selected a different
IRS-accepted method offered by us. These requirements, however, will not apply for investments through a tax-advantaged account. Stockholders
should consult their financial intermediaries and tax advisers to determine the best cost basis method for their tax situation, and to
obtain more information about how these cost basis reporting requirements apply to them.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 87; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Medicare
Tax on Net Investment Income</i></span>.&#160;&#160;&#160;A 3.8% tax is imposed under Section&#160;1411 of the Code on the
&#8220;net investment income&#8221; of certain U.S. citizens and residents and on the undistributed net investment income of certain
estates and trusts. Among other items, net investment income generally includes payments of interest or dividends on, and net gains
recognized from the sale, exchange, redemption, retirement or other taxable disposition of our securities (unless the securities are
held in connection with certain trades or businesses), less certain deductions. Prospective investors in our securities should
consult their own tax advisors regarding the effect, if any, of this tax on their ownership and disposition of our securities.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Non-U.S. Holders of Our Stock.</i></span>&#160;&#160;&#160;Whether an investment in the shares of our stock is appropriate for a non-U.S.
holder will depend upon that person&#8217;s particular circumstances. An investment in the shares by a non-U.S. holder may have adverse
tax consequences. Non-U.S. holders should consult their tax advisors before investing in our stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Subject to the discussions
below, distributions of our &#8220;investment company taxable income&#8221; to non-U.S. holders (including interest income and net short-term
capital gain) are generally expected to be subject to withholding of U.S. federal taxes at a 30% rate (or lower rate provided by an applicable
treaty) to the extent of our current and accumulated earnings and profits. If the distributions are effectively connected with a U.S.
trade or business of the non-U.S. holder, we will not be required to withhold U.S. federal tax if the non-U.S. holder complies with applicable
certification and disclosure requirements, although the distributions will be subject to U.S. federal income tax at the rates applicable
to U.S. persons. Special certification requirements apply to a non-U.S. holder that is a foreign partnership or a foreign trust, and
such entities are urged to consult their own tax advisors. Backup withholding will not be applied to payments that have been subject
to the 30% (or lower applicable treaty rate) withholding tax described in this paragraph.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In addition, with
respect to certain distributions made by RICs to non-U.S. holders, no withholding is required and the distributions generally are not
subject to U.S. federal income tax if (i)&#160;the distributions are properly reported in a notice timely delivered to our stockholders
as &#8220;interest-related dividends&#8221; or &#8220;short-term capital gain dividends,&#8221; (ii)&#160;the distributions are derived
from sources specified in the Code for such dividends and (iii)&#160;certain other requirements are satisfied. Depending on the circumstances,
we may report all, some or none of our potentially eligible dividends as derived from such qualified net interest income or as qualified
short-term capital gain, and a portion of our distributions, which may be significant (e.g., interest from non-U.S. sources or any foreign
currency gains) would be ineligible for this potential exemption from withholding. Moreover, in the case of shares of our stock held
through an intermediary, the intermediary may have withheld U.S. federal income tax even if we reported the payment as derived from such
qualified net interest income or qualified short-term capital gain. Hence, no assurance can be provided as to whether any amount of our
dividends or distributions will be eligible for this exemption from withholding or if eligible, will be reported as such by us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Actual or deemed
distributions of our net long-term capital gains to a non-U.S. holder, and gains realized by a non-U.S. holder upon the sale of our stock,
will not be subject to federal withholding tax and generally will not be subject to U.S. federal income tax unless, (i)&#160;the distributions
or gains, as the case may be, are effectively connected with a U.S. trade or business of the Non-U.S. holder and, if an income tax treaty
applies, are attributable to a permanent establishment maintained by the non-U.S. holder in the United States or (ii)&#160;in the case
of an individual stockholder, the stockholder is present in the United States for a period or periods aggregating 183&#160;days or more
during the year of the sale or the receipt of the distributions or gains and certain other conditions are met.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we distribute
our net capital gains in the form of deemed rather than actual distributions (which we may do in the future), a non-U.S. holder will
be entitled to a U.S. federal income tax credit or tax refund equal to the stockholder&#8217;s allocable share of the tax we pay on the
capital gains deemed to have been distributed. In order to obtain the refund, the non-U.S. holder would be required to obtain a U.S.
taxpayer identification number and file a U.S. federal income tax return even if the non-U.S. holder would not otherwise be required
to obtain a U.S. taxpayer identification number or file a U.S. federal income tax return. For a corporate non-U.S. holder, distributions
(both actual and deemed), and gains realized upon the sale of our stock that are effectively connected with a U.S. trade or business
may, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate (or at a lower rate if provided
for by an applicable treaty). Accordingly, investment in the shares may not be appropriate for a non-U.S. holder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 88; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A
non-U.S. holder who is a non-resident alien individual, and who is otherwise subject to withholding of U.S. federal income tax, may
be subject to information reporting and backup withholding of U.S. federal income tax on distributions unless the non-U.S. holder
provides us or the distribution paying agent with an IRS Form&#160;W-8BEN,&#160;IRS Form&#160;W-8BEN-E, or an acceptable substitute
form, or otherwise meets documentary evidence requirements for establishing that it is a non-U.S. holder or otherwise establishes an
exemption from backup withholding.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Non-U.S. holders
may also be subject to U.S. estate tax with respect to their investment in our shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Non-U.S. persons
should consult their own tax advisors with respect to the U.S. federal income tax and withholding tax, and state, local and foreign tax
consequences of an investment in the shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of U.S. resident holders of our notes.</i></span>&#160;&#160;&#160;Except as discussed below, payments or accruals of interest on our
notes generally will be taxable to a U.S. holder as ordinary interest income at the time they are received (actually or constructively)
or accrued, in accordance with the U.S. holder&#8217;s regular method of tax accounting. In addition, if the issue price of our notes
(<i>i.e</i>., the first price at which a substantial amount of the notes is sold to investors) is less than their &#8220;stated redemption
price at maturity&#8221; (<i>i.e</i>., the sum of all payments to be made on the notes, other than payments of &#8220;qualified stated
interest&#8221;) by more than a specified <i>de minimis</i> amount, the notes will be considered as having been issued for U.S. federal
income tax purposes with OID. In the case of the notes, the term &#8220;qualified stated interest&#8221; generally means that interest
that is unconditionally payable at least annually and at a single fixed rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If the notes are
issued with OID, a U.S. holder generally will be required to include the OID in gross income as ordinary interest income in advance of
the receipt of cash attributable to that income and regardless of such holder&#8217;s regular method of tax accounting. Such OID will
be included in gross income for each day during each tax year in which a note is held by a U.S. holder using a constant yield method
that reflects the compounding of interest. This means that a U.S. holder will be required to include increasingly greater amounts of
OID over time. Alternatively, if a U.S. holder acquires a note with <i>de minimis</i> OID (<i>i.e</i>., discount that is not OID), the
U.S. holder generally will be required to include the <i>de minimis</i> OID in income at the time a principal payment on the note is
made in proportion to the amount paid. Any amount of <i>de minimis</i> OID that a U.S. holder has included in income will be characterized
as capital gain. Notice will be given if we determine that any of our notes will be issued with OID. We are required to provide information
returns stating the amount of OID accrued on the notes held by persons of record, other than certain U.S. tax-exempt holders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Upon the sale, exchange,
redemption or retirement of our notes, a U.S. holder generally will recognize capital gain or loss equal to the difference between the
amount realized on the sale, exchange, redemption or retirement (excluding any amounts representing accrued and unpaid interest, which
are treated as ordinary income) and the U.S. holder&#8217;s adjusted tax basis in the note. A U.S. holder&#8217;s tax basis in our notes
generally will equal the amount of the U.S. holder&#8217;s initial investment in the note increased by OID, if any, previously included
in income with respect to such notes, and reduced by any cash payments on the notes other than qualified stated interest. Capital gain
or loss generally will be long-term capital gain or loss if the note was held for more than one year. Long-term capital gains recognized
by individuals and certain other non-corporate U.S. holders generally are eligible for preferential rates of taxation, currently at a
rate of either 15% or 20%, depending on whether the U.S. holder&#8217;s income exceeds certain threshold amounts, and the deductibility
of capital losses is subject to certain limitations prescribed under the Code. The distinction between capital gain or loss and ordinary
income or loss is also important in other contexts, such as, for example, for purposes of the limitations on a U.S. holder&#8217;s ability
to offset capital losses against ordinary income.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
a U.S. holder acquires a note for an amount that is less than its principal amount, the amount of the difference generally will be
treated as &#8220;market discount&#8221; for U.S. federal income tax purposes, unless that difference is less than a specified de
minimis amount. Under the market discount rules, a U.S. holder will be required to treat any principal payment on, or any gain on
the sale, exchange, retirement or other disposition of, a note as ordinary income to the extent of the market discount that the U.S.
holder has not previously included in income and are treated as having accrued on the Note at the time of the payment or
disposition. In addition, a U.S. holder may be required to defer, until the maturity of a note or its earlier sale or other
disposition in a taxable transaction, the deduction of all or a portion of the interest expense on any indebtedness attributable to
the note. A U.S. holder may elect, on a note-by-note basis, to deduct such deferred interest expense in a tax year prior to the tax
year of disposition. If a U.S. holder makes this election, it will only apply to any note with respect to which it is made, and such
election is irrevocable without the consent of the IRS. U.S. holders should consult their own tax advisors before making this
election.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 89; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any market discount
on a note will be considered to accrue ratably during the period from the date of acquisition to the maturity date of the note, unless
a U.S. holder elects to accrue such market discount on a constant interest method. In addition, a U.S. holder may make a separate election
to include market discount in income currently as it accrues, on either a ratable or constant yield method, in which case the rule&#160;described
above regarding deferral of interest deductions will not apply. If a U.S. holder makes this election, it will apply to all debt instruments
acquired with market discount (including, if applicable, a note) that the U.S. holder acquires on or after the first day of the first
tax year to which the election applies. A U.S. holder may not revoke this election without the consent of the IRS. U.S. holders should
consult their own tax advisors before making either of such election.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If a U.S. holder
acquires a note for an amount in excess of its stated principal amount, the U.S. holder will be considered to have purchased the note
at a &#8220;premium.&#8221; A U.S. holder generally may elect to amortize such premium over the remaining term of the note on a constant
yield method as an offset to interest when includible in taxable income under the U.S. holder&#8217;s regular accounting method. If a
U.S. holder makes this election, it will apply to all debt instruments acquired with premium (including, if applicable, a note) that
the U.S. holder acquires on or after the first day of the first tax year to which the election applies. A U.S. holder may not revoke
this election without the consent of the IRS. If a U.S. holder does not elect to amortize premium on the note, that premium will decrease
the gain or increase the loss the U.S. holder would otherwise recognize on disposition of the note.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of non-U.S. holders of our notes.</i></span>&#160;&#160;&#160;A non-U.S. holder generally will not be subject to U.S. federal income
or withholding taxes on payments of principal or stated interest on our notes provided that, in the case of interest on a note (i)&#160;the
interest is not effectively connected with the conduct by the non-U.S. holder of a trade or business within the U.S., (ii)&#160;the non-U.S.
holder is not a controlled foreign corporation related to us through sufficient stock ownership, (iii)&#160;the recipient is not a bank
receiving interest described in Section&#160;881(c)(3)(A)&#160;of the Code, (iv)&#160;the non-U.S. holder does not own (actually or constructively)
10% or more of the total combined voting power of all classes of our stock, and (v)(A)&#160;the non-U.S. holder provides to the applicable
withholding agent a statement on an IRS Form&#160;W-8BEN or W-8BEN-E (or other applicable U.S. nonresident withholding tax certification
form) signed under penalties of perjury that includes its name and address and certifies that it is not a United States person for U.S.
federal income tax purposes in compliance with applicable requirements, or satisfies documentary evidence requirements for establishing
that it is a non-U.S. holder, or (B)&#160;a securities clearing organization, bank, or other financial institution that holds customer
securities in the ordinary course of its trade or business (<i>i.e.</i>, a &#8220;financial institution&#8221;) and holds a note certifies
to us under penalties of perjury that either it or another financial institution has received the required statement from the non-U.S.
holder certifying that it is a non-U.S. person and furnishes us with a copy of the statement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A non-U.S. holder
that is not exempt from tax under these rules&#160;generally will be subject to withholding of U.S. federal income tax on payments of
interest on our notes at a rate of 30% unless (i)&#160;the interest is effectively connected with the conduct of a U.S. trade or business,
in which case the interest will be subject to U.S. federal income tax on a net income basis as applicable to U.S. holders generally (unless
an applicable income tax treaty provides otherwise), or (ii)&#160;an applicable income tax treaty provides for a lower rate of, or exemption
from, this withholding. In the case of a non-U.S. holder that is classified as a corporation for U.S. federal income tax purposes and
receives income that is effectively connected with the conduct of a U.S. trade or business, such income may also be subject to a branch
profits tax (which is generally imposed on a non-U.S. corporation on the actual or deemed repatriation from the United States of earnings
and profits attributable to a United States trade or business) at a 30% rate. The branch profits tax may not apply (or may apply at a
reduced rate) if the non-U.S. holder is a qualified resident of a country with which the U.S. has an income tax treaty.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">To claim the benefit
of an income tax treaty or to claim exemption from withholding because interest is effectively connected with a U.S. trade or business,
the non-U.S. holder must timely provide the appropriate, properly executed applicable U.S. nonresident withholding tax certification
IRS form signed under penalties of perjury to the applicable withholding agent.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 90; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Generally, a non-U.S.
holder will not be subject to U.S. federal income or withholding taxes on any amount that constitutes capital gain upon the sale, exchange,
redemption or retirement of a note, provided the gain is not effectively connected with the conduct of a trade or business in the United
States by the non-U.S. holder (and, if required by an applicable income tax treaty, is not attributable to a United States &#8220;permanent
establishment&#8221; maintained by the non-U.S. holder). Certain other exceptions may be applicable, and a non-U.S. holder should consult
its tax advisor in this regard.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A note that is held
by an individual who, at the time of death, is not a citizen or resident of the United States (as specially defined for U.S. federal
estate tax purposes) generally will not be subject to U.S. federal estate tax, unless, at the time of death, (i)&#160;such individual
directly or indirectly, actually or constructively, owns ten&#160;percent or more of the total combined voting power of all classes of
our stock entitled to vote within the meaning of Section&#160;871(h)(3)&#160;of the Code and the Treasury Regulations thereunder or (ii)&#160;such
individual&#8217;s interest in the Notes is effectively connected with the individual&#8217;s conduct of a U.S. trade or business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Shelter Reporting Regulations.</i></span>&#160;&#160;&#160;Under applicable Treasury Regulations, if a U.S. holder recognizes a loss
with respect to our securities of $2&#160;million or more for a non-corporate U.S. holder or $10&#160;million or more for a corporate
U.S. holder in any single tax year (or a greater loss over a combination of tax&#160;years), the U.S. holder may be required to file
with the IRS a disclosure statement on IRS Form&#160;8886. The fact that a loss is reportable under these regulations does not affect
the legal determination of whether the taxpayer&#8217;s treatment of the loss is proper. Significant monetary penalties apply to a failure
to comply with this reporting requirement. States may also have a similar reporting requirement. U.S. holders of our securities should
consult their own tax advisors to determine the applicability of these Treasury Regulations in light of their individual circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">U.S. holders of
a RIC are not excepted. Future guidance may extend the current exception from this reporting requirement to U.S. holders of most or all
RICs. The fact that a loss is reportable under these regulations does not affect the legal determination of whether the taxpayer&#8217;s
treatment of the loss is proper. Significant monetary penalties apply to a failure to comply with this reporting requirement. States
may also have a similar reporting requirement. U.S. holders of our securities should consult their own tax advisors to determine the
applicability of these Treasury Regulations in light of their individual circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding.</i></span>&#160;&#160;&#160;A U.S. holder (other than an &#8220;exempt recipient,&#8221; including
a C corporation and certain other persons who, when required, demonstrate their exempt status) may be subject to backup withholding at
a rate of 24% on, and will be subject to information reporting requirements with respect to, payments of principal or interest (including
OID, if any) on, and proceeds from the sale, exchange, redemption or retirement of, our securities. In general, if a non-corporate U.S.
holder subject to information reporting fails to furnish a correct taxpayer identification number or otherwise fails to comply with applicable
backup withholding requirements, backup withholding at the applicable rate may apply.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If you are a non-U.S.
holder, generally, the applicable withholding agent is generally required to report to the IRS and to you payments of interest, including
OID (if any), on our securities and the amount of tax, if any, withheld with respect to those payments. Copies of the information returns
reporting such interest payments and any withholding may also be made available to the tax authorities in the country in which you reside
under the provisions of a treaty or agreement. In general, backup withholding will not apply to payments of interest on your securities
if you have provided to the applicable withholding agent the required certification that you are not a U.S. person and the applicable
withholding agent does not have actual knowledge or reason to know that you are a U.S. person. Information reporting and, depending on
the circumstances, backup withholding will apply to payment to you of the proceeds of a sale or other disposition (including a retirement
or redemption) of your securities within the United States or conducted through certain U.S.-related financial intermediaries, unless
you certify under penalties of perjury that you are not a U.S. person or you otherwise establish an exemption, and the applicable withholding
agent does not have actual knowledge or reason to know that you are a U.S. person.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">You
should consult your own tax advisor regarding the application of information reporting and backup withholding in your particular
circumstance and the availability of and procedure for obtaining an exemption from backup withholding. Backup withholding is not an
additional tax, and any amounts withheld under the backup withholding rules&#160;may be allowed as a refund or a credit against your
U.S. federal income tax liability, provided the required information is timely furnished to the IRS.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 91; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>FATCA
Withholding on Payments to Certain Foreign Entities.</i></span>&#160;&#160;&#160;FATCA generally imposes a U.S. federal withholding tax
of 30% on interest earned in respect of a debt instrument, such as our notes and payments of dividends made with respect to shares of
our stock to certain non-U.S. entities (including, in some circumstances, where such an entity is acting as an intermediary) that fail
to comply (or be deemed compliant) with certain certification and information reporting requirements. FATCA withholding taxes apply to
all withholdable payments without regard to whether the beneficial owner of the payment would otherwise be entitled to an exemption from
withholding taxes pursuant to an applicable tax treaty with the United States or under U.S. domestic law. If FATCA withholding taxes
are imposed with respect to any payments of interest or proceeds made under our debt securities, holders that are otherwise eligible
for an exemption from, or reduction of, U.S. federal withholding taxes with respect to such interest or proceeds will be required to
seek a credit or refund from the IRS in order to obtain the benefit of such exemption or reduction, if any. Securityholders may be requested
to provide additional information to enable the applicable withholding agent to determine whether withholding is required.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Proposed Treasury
Regulations eliminate the application of withholding imposed under FATCA with respect to payments of gross proceeds. Pursuant to these
proposed Treasury Regulations, the Company and any other applicable withholding agent may (but is not required to) rely on this proposed
change to FATCA withholding until final regulations are issued or until such proposed Treasury Regulations are rescinded. Prospective
holders of in our securities should consult their own tax advisors regarding the effect, if any, of the FATCA rules&#160;for them based
on their particular circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
preceding discussion of material U.S. federal income tax considerations is for general information only and is not tax advice. We urge
you to consult your own tax advisor with respect to the particular tax consequences to you of an investment in our securities, including
the possible effect of any pending legislation or proposed regulations</i></b></span><i>.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_014"></a></div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><b>DESCRIPTION OF OUR SECURITIES</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">This prospectus
contains a summary of our common stock, Preferred Stock, subscription rights and debt securities. These summaries are not meant to be
a complete description of each security. However, this prospectus and the accompanying prospectus supplement will contain the material
terms and conditions for each security being offered thereby.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The following are our authorized classes
of securities as of June&#160;5, 2023:</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(1)<br/>
Title of Class</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(2)<br/>
Amount Authorized</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(3)<br/>
Amount Held by <br/>
Us or for Our<br/>
 Account</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(4)<br/>
Amount <br/>
Outstanding <br/>
Exclusive of <br/>
Amounts Shown <br/>
Under (3)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock, par value $0.001 per share </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000,000 shares </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,662,524 shares </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&#160;C Term Preferred stock, par value $0.001 per share </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,100,000 shares </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,172,553 shares </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series&#160;D Preferred stock, par value $0.001 per share </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000 shares </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,093,245 shares </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028 Notes </span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">$69,000,000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center">&#8212;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center">$32,423,800</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2029 Notes </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$100,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$93,250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2031 Notes </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$44,850,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$44,850,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 92; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><div><a id="sa_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF OUR CAPITAL STOCK</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>The following description
is based on relevant portions of the DGCL and on our certificate of incorporation and bylaws. This summary is not necessarily complete,
and we refer you to the DGCL, our certificate of incorporation and our amended and restated bylaws for a more detailed description of
the provisions summarized below.</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Capital Stock</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our authorized stock
consists of 100,000,000 shares of common stock, par value $0.001 per share, and 20,000,000 shares of Preferred Stock, par value $0.001
per share. There are no outstanding options or warrants to purchase our stock. No stock has been authorized for issuance under any equity
compensation plans. Under Delaware law, our stockholders generally are not personally liable for our debts or obligations.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Common Stock</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">All shares of our
common stock have equal rights as to earnings, assets, dividends and voting and, when they are issued, will be duly authorized, validly
issued, fully paid and nonassessable. Distributions may be paid to holders of our common stock if, as and when authorized by the board
of directors and declared by us out of funds legally available therefrom. Such distributions may be payable in cash, shares of our common
stock or a combination thereof. Shares of our common stock have no preemptive, exchange, conversion or redemption rights and are freely
transferable, except when their transfer is restricted by U.S.&#160;federal and state securities laws or by contract. In the event of
our liquidation, dissolution or winding up, each share of our common stock would be entitled to share ratably in all of our assets that
are legally available for distribution after we pay all debts and other liabilities and subject to any preferential rights of holders
of our Preferred Stock, if any Preferred Stock is outstanding at such time. Each share of common stock is entitled to one vote on all
matters submitted to a vote of stockholders, including the election of directors. Except as provided with respect to any other class
or series of stock, holders of our common stock will possess exclusive voting power. There is no cumulative voting in the election of
directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Preferred Stock</b></p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We are authorized
to issue 20,000,000 shares of Preferred Stock. As of June&#160;5, 2023, we had 3,265,798 shares of Preferred Stock outstanding. Our certificate
of incorporation authorizes our board of directors to classify and reclassify any unissued shares of Preferred Stock into other classes
or series of Preferred Stock without stockholder approval. If we issue Preferred Stock, costs of the offering will be borne immediately
at such time by the holders of our common stock and result in a reduction of the NAV per share of our common stock at that time. We may
issue Preferred Stock at any time. Prior to issuance of shares of each class or series, our board of directors is required by the DGCL
and by our certificate of incorporation to set the terms, preferences, conversion or other rights, voting powers, restrictions, limitations
as to dividends or other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, our board
of directors could authorize the issuance of shares of Preferred Stock with terms and conditions that could have the effect of delaying,
deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise
be in their best interest.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series&#160;C
Term Preferred Stock.</i></b></span>&#160;&#160;&#160;As of June&#160;5, 2023, we had 2,172,553 shares of Series&#160;C Term Preferred
Stock outstanding.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption.</i></span>&#160;&#160;&#160;We
are required to redeem all outstanding shares of the Series&#160;C Term Preferred Stock on June&#160;30, 2031. In addition, if we fail
to maintain asset coverage (as defined in Section&#160;18(h)&#160;of the 1940 Act) of at least 200% as of the close of business on the
last business day of any calendar quarter and such failure is not cured by the close of business on the date that is 30 calendar days
following the filing date of our Annual Report on Form&#160;N-CSR, Semiannual Report on Form&#160;N-CSRS or Quarterly Report on Form&#160;N-PORT,
as applicable, for that quarter, we will be required to redeem the number of shares of our Preferred Stock (which at our discretion may
include any number or portion of the Series&#160;C Term Preferred Stock), that, when combined with any debt securities redeemed for failure
to maintain the asset coverage required by the indenture governing such securities, (1)&#160;result in us having asset coverage of at
least 200% and (2)&#160;if fewer, the maximum number of shares of Preferred Stock that can be redeemed out of funds legally available
for such redemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 93; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In connection with any redemption for
failure to maintain such asset coverage, we may, in our sole option, redeem such additional number of shares of Preferred Stock that
will result in asset coverage up to and including 285%. At any time after June&#160;16, 2024, we may, in our sole option, redeem the
outstanding shares of Series&#160;C Term Preferred Stock in whole or, from time to time, in part, out of funds legally available for
such redemption. The price that we will pay to redeem shares of the Series&#160;C Term Preferred Stock pursuant to any redemption will
equal $25 per share plus an amount equal to accumulated but unpaid dividends, if any, on such shares (whether or not earned or declared,
but excluding interest on such dividends) to, but excluding, the redemption date.</p><div>


</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking
and Liquidation.</i></span>&#160;&#160;&#160;The shares of Series&#160;C Term Preferred Stock are senior securities that constitute capital
stock. The Series&#160;C Term Preferred Stock rank (i)&#160;senior to shares of our common stock in priority of payment of dividends
and as to the distribution of assets upon dissolution, liquidation or the winding-up of our affairs; (ii)&#160;equal in priority with
the Series&#160;D Preferred Stock and all other future series of Preferred Stock we may issue as to payment of dividends and as to distributions
of assets upon dissolution, liquidation or the winding-up of our affairs; and (iii)&#160;subordinate in right of payment to the holders
of the Notes and any future senior indebtedness. In the event of liquidation, dissolution or winding up of our affairs, holders of Series&#160;C
Term Preferred Stock will be entitled to receive a liquidation distribution equal to $25 per share, plus an amount equal to accumulated
but unpaid dividends, if any, on such shares (whether or not earned or declared, but excluding interest on such dividends) to, but excluding,
the payment date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.</i></span>&#160;&#160;&#160;We
intend to pay monthly dividends on the Series&#160;C Term Preferred Stock at a fixed annual rate of 6.50% of the liquidation preference
($1.625 per share per year), or the &#8220;Series&#160;C Dividend Rate.&#8221; If we fail to redeem the Series&#160;C Term Preferred
Stock as required on June&#160;30, 2031, or fail to pay any dividend on the payment date for such dividend, the Series&#160;C Dividend
Rate will increase by 2% per annum until we redeem the Series&#160;C Term Preferred Stock or pay the dividend, as applicable. The Series&#160;C
Dividend Rate will be computed on the basis of a 360-day year consisting of twelve 30-day&#160;months.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights.</i></span>&#160;&#160;&#160;Except as otherwise provided in our certificate of incorporation or as otherwise required by law,
(1)&#160;each holder of Series&#160;C Term Preferred Stock is entitled to one vote for each share of Series&#160;C Term Preferred Stock
held on each matter submitted to a vote of our stockholders and (2)&#160;the holders of all outstanding Preferred Stock, including the
Series&#160;C Term Preferred Stock, and common stock vote together as a single class; provided that holders of Preferred Stock, including
the Series&#160;C Term Preferred Stock, voting separately as a class, are entitled to elect at least two (2)&#160;of our directors and,
if we fail to pay dividends on any outstanding shares of Preferred Stock, including the Series&#160;C Term Preferred Stock, in an amount
equal to two (2)&#160;full&#160;years of dividends, and continuing until such failure is cured, will be entitled to elect a majority
of our directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series&#160;D
Preferred Stock.</i></b></span>&#160;&#160;&#160;As of June&#160;5, 2023, we had 1,093,245 shares of Series&#160;D Preferred Stock outstanding.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption.</i></span>&#160;&#160;&#160;The
Series&#160;D Preferred Stock has no maturity date and will remain outstanding indefinitely unless redeemed by us. In addition, if we
fail to maintain asset coverage (as defined in Section&#160;18(h)&#160;of the 1940 Act) of at least 200% as of the close of business
on the last business day of any calendar quarter and such failure is not cured by the close of business on the date that is 30 calendar
days following the filing date of our Annual Report on Form&#160;N-CSR, Semiannual Report on Form&#160;N-CSRS or Quarterly Report on
Form&#160;N-PORT, as applicable, for that quarter, we will be required to redeem the number of shares of our Preferred Stock (which at
our discretion may include any number or portion of the Series&#160;D Preferred Stock), that, when combined with any debt securities
redeemed for failure to maintain the asset coverage required by the indenture governing such securities, (1)&#160;result in us having
asset coverage of at least 200% and (2)&#160;if fewer, the maximum number of shares of Preferred Stock that can be redeemed out of funds
legally available for such redemption. In connection with any redemption for failure to maintain such asset coverage, we may, in our
sole option, redeem such additional number of shares of Preferred Stock that will result in asset coverage up to and including 285%.
At any time after November&#160;29, 2026, we may, in our sole option, redeem the outstanding shares of Series&#160;Preferred Stock in
whole or, from time to time, in part, out of funds legally available for such redemption. The price that we will pay to redeem shares
of the Series&#160;D Preferred Stock pursuant to any redemption will equal $25 per share plus an amount equal to accumulated but unpaid
dividends, if any, on such shares (whether or not earned or declared, but excluding interest on such dividends) to, but excluding, the
redemption date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 94; Value: 68 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></span>&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking
and Liquidation.</i></span>&#160;&#160;&#160;The shares of Series&#160;D Preferred Stock are senior securities that constitute capital
stock. The Series&#160;D Preferred Stock rank (i)&#160;senior to shares of our common stock in priority of payment of dividends and as
to the distribution of assets upon dissolution, liquidation or the winding-up of our affairs; (ii)&#160;equal in priority with the Series&#160;C
Term Preferred Stock and all other future series of Preferred Stock we may issue as to payment of dividends and as to distributions of
assets upon dissolution, liquidation or the winding-up of our affairs; and (iii)&#160;subordinate in right of payment to the holders
of the Notes and any future senior indebtedness. In the event of liquidation, dissolution or winding up of our affairs, holders of Series&#160;D
Preferred Stock will be entitled to receive a liquidation distribution equal to $25 per share, plus an amount equal to accumulated but
unpaid dividends, if any, on such shares (whether or not earned or declared, but excluding interest on such dividends) to, but excluding,
the payment date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.</i></span>&#160;&#160;&#160;We
intend to pay monthly dividends on the Series&#160;D Preferred Stock at a fixed annual rate of 6.75% of the liquidation preference ($1.6875
per share per year), or the &#8220;Series&#160;D Dividend Rate.&#8221; If we fail to pay any dividend on the payment date for such dividend,
the Series&#160;D Dividend Rate will increase by 2% per annum until we redeem the Series&#160;D Preferred Stock or pay the dividend,
as applicable. The Series&#160;D Dividend Rate will be computed on the basis of a 360-day year consisting of twelve 30-day&#160;months.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights.</i></span>&#160;&#160;&#160;Except as otherwise provided in our certificate of incorporation or as otherwise required by law,
(1)&#160;each holder of Series&#160;D Preferred Stock is entitled to one vote for each share of Series&#160;D Preferred Stock held on
each matter submitted to a vote of our stockholders and (2)&#160;the holders of all outstanding Preferred Stock, including the Series&#160;D
Preferred Stock, and common stock vote together as a single class; provided that holders of Preferred Stock, including the Series&#160;D
Preferred Stock, voting separately as a class, are entitled to elect at least two (2)&#160;of our directors and, if we fail to pay dividends
on any outstanding shares of Preferred Stock, including the Series&#160;D Preferred Stock, in an amount equal to two (2)&#160;full&#160;years
of dividends, and continuing until such failure is cured, will be entitled to elect a majority of our directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Provisions of the DGCL and Our Certificate of Incorporation and
Bylaws</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitation
on Liability of Directors and Officers; Indemnification and Advance of Expenses.</i></span>&#160;&#160;&#160;The indemnification of our
officers and directors is governed by Section&#160;145 of the DGCL, our certificate of incorporation and bylaws. Subsection (a)&#160;of
DGCL Section&#160;145 empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an
action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent
of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts
paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if (1)&#160;such
person acted in good faith, (2)&#160;in a manner such person reasonably believed to be in or not opposed to the best interests of the
corporation and (3)&#160;with respect to any criminal action or proceeding, such person had no reasonable cause to believe the person&#8217;s
conduct was unlawful.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Subsection (b)&#160;of
DGCL Section&#160;145 empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any
threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of
the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of
the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise
against expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection with the defense or
settlement of such action or suit if such person acted in good faith and in a manner the person reasonably believed to be in, or not
opposed to, the best interests of the corporation, and except that no indemnification may be made in respect of any claim, issue or matter
as to which such person has been adjudged to be liable to the corporation unless and only to the extent that the Delaware Court of Chancery
or the court in which such action or suit was brought determines upon application that, despite the adjudication of liability but in
view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Delaware
Court of Chancery or such other court deems proper.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 95 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">DGCL Section&#160;145
further provides that to the extent that a present or former director or officer is successful, on the merits or otherwise, in the defense
of any action, suit or proceeding referred to in subsections (a)&#160;and (b)&#160;of Section&#160;145, or in defense of any claim, issue
or matter therein, such person will be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred
by such person in connection with such action, suit or proceeding. In all cases in which indemnification is permitted under subsections
(a)&#160;and (b)&#160;of Section&#160;145 (unless ordered by a court), it will be made by the corporation only as authorized in the specific
case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances
because the applicable standard of conduct has been met by the party to be indemnified. Such determination must be made, with respect
to a person who is a director or officer at the time of such determination, (1)&#160;by a majority vote of the directors who are not
parties to such action, suit or proceeding, even though less than a quorum, (2)&#160;by a committee of such directors designated by majority
vote of such directors, even though less than a quorum, (3)&#160;if there are no such directors, or if such directors so direct, by independent
legal counsel in a written opinion or (4)&#160;by the stockholders. The statute authorizes the corporation to pay expenses incurred by
an officer or director in advance of the final disposition of a proceeding upon receipt of an undertaking by or on behalf of the person
to whom the advance will be made, to repay the advances if it is ultimately determined that he or she was not entitled to indemnification.
DGCL Section&#160;145 also provides that indemnification and advancement of expenses permitted under such Section&#160;are not to be
exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement,
vote of stockholders or disinterested directors or otherwise. DGCL Section&#160;145 also authorizes the corporation to purchase and maintain
liability insurance on behalf of its directors, officers, employees and agents regardless of whether the corporation would have the statutory
power to indemnify such persons against the liabilities insured.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our certificate
of incorporation provides that our directors will not be liable to us or our stockholders for monetary damages for breach of fiduciary
duty as a director to the fullest extent permitted by the current DGCL or as the DGCL may hereafter be amended. DGCL Section&#160;102(b)(7)&#160;provides
that the personal liability of a director to a corporation or its stockholders for breach of fiduciary duty as a director may be eliminated
except for liability (1)&#160;for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (2)&#160;for
acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3)&#160;under Section&#160;174
of the DGCL, relating to unlawful payment of dividends or unlawful stock purchases or redemption of stock or (4)&#160;for any transaction
from which the director derives an improper personal benefit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our certificate
of incorporation provides for the indemnification of any person to the full extent permitted, and in the manner provided, by the current
DGCL or as the DGCL may hereafter be amended. In addition, we have entered into indemnification agreements with each of our directors
and officers in order to effect the foregoing.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delaware
Anti-Takeover Law.</i></span>&#160;&#160;&#160;The DGCL and our certificate of incorporation and bylaws contain provisions that could
make it more difficult for a potential acquirer to acquire us by means of a tender offer, proxy contest or otherwise. These provisions
are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire
control of us to negotiate first with our board of directors. These measures may delay, defer or prevent a transaction or a change in
control that might otherwise be in the best interests of our stockholders. These provisions could have the effect of depriving stockholders
of an opportunity to sell their shares at a premium over prevailing market prices by discouraging a third party from seeking to obtain
control over us. Such attempts could have the effect of increasing our expenses and disrupting our normal operations. We believe that
the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because the negotiation
of such proposals may improve their terms. Our board of directors has considered these provisions and has determined that the provisions
are in the best interests of us and our stockholders generally.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We are subject to
the provisions of Section&#160;203 of the DGCL regulating corporate takeovers. In general, these provisions prohibit a Delaware corporation
from engaging in any business combination with any interested stockholder for a period of three&#160;years following the date that the
stockholder became an interested stockholder, unless:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">prior to such time, the board of directors approved either the
business combination or the transaction which resulted in the stockholder becoming an interested stockholder;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 96 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">upon consummation of the transaction that resulted in the stockholder
becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding
at the time the transaction commenced; or</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">on or after the date the business combination is approved by the
board of directors and authorized at a meeting of stockholders, by at least two-thirds of the outstanding voting stock that is not owned
by the interested stockholder.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Section&#160;203 defines &#8220;business
combination&#8221; to include the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any merger or consolidation involving the corporation and the
interested stockholder;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any sale, transfer, pledge or other disposition (in one transaction
or a series of transactions) of 10% or more of either the aggregate market value of all the assets of the corporation or the aggregate
market value of all the outstanding stock of the corporation involving the interested stockholder;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">subject to certain exceptions, any transaction that results in
the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any transaction involving the corporation that has the effect
of increasing the proportionate share of the stock of any class or series of the corporation owned by the interested stockholder; or</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the receipt by the interested stockholder of the benefit of any
loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In general, Section&#160;203
defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation
and any entity or person affiliated with or controlling or controlled by any of these entities or persons.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The statute could
prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Election
of Directors.</i></b></span>&#160;&#160;&#160;Our bylaws provide that the affirmative vote of a plurality of all votes cast by stockholders
present in person or by proxy at an annual or special meeting of the stockholders and entitled to vote thereat will be sufficient to
elect a director. Under our certificate of incorporation, our board of directors may amend the bylaws to alter the vote required to elect
directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For so long as any
series of our Preferred Stock are outstanding, the holders of our Preferred Stock, voting as a class, will be entitled to elect two of
our directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Classified
Board of Directors.</i></b></span>&#160;&#160;&#160;Our board of directors is divided into three classes of directors serving staggered
three-year terms, with the term of office of only one of the three classes expiring each year. A classified board may render a change
in control of us or removal of our incumbent management more difficult. We believe, however, that the longer time required to elect a
majority of a classified board of directors helps to ensure the continuity and stability of our management and policies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Number
of Directors; Removal; Vacancies.</i></b></span>&#160;&#160;&#160;Our certificate of incorporation provides that the number of directors
will be set only by the board of directors in accordance with our bylaws. Our bylaws provide that a majority of our entire board of directors
may at any time increase or decrease the number of directors. However, unless our bylaws are amended, the number of directors may never
be less than four nor more than eight. Under the DGCL, unless the certificate of incorporation provides otherwise (which our certificate
of incorporation does not), directors on a classified board such as our board of directors may be removed only for cause, by the affirmative
vote of stockholders. Under our certificate of incorporation and bylaws and subject to applicable stockholder election requirements of
the 1940 Act, any vacancy on the board of directors, including a vacancy resulting from an enlargement of the board of directors, may
be filled only by vote of a majority of the directors then in office. The limitations on the ability of our stockholders to remove directors
and fill vacancies could make it more difficult for a third-party to acquire, or discourage a third-party from seeking to acquire, control
of us.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Action
by Stockholders.</i></b></span>&#160;&#160;&#160;Under our certificate of incorporation, stockholder action can be taken only at an annual
or special meeting of stockholders or by unanimous written consent in lieu of a meeting. This may have the effect of delaying consideration
of a stockholder proposal until the next annual meeting.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 97 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
Notice Provisions for Stockholder Nominations and Stockholder Proposals.</i></b></span>&#160;&#160;&#160;Our bylaws provide that with
respect to an annual meeting of stockholders, nominations of persons for election to the board of directors and the proposal of business
to be considered by stockholders may be made only (1)&#160;by or at the direction of the board of directors, (2)&#160;pursuant to our
notice of meeting or (3)&#160;by a stockholder who is entitled to vote at the meeting and who has complied with the advance notice procedures
of the bylaws. Nominations of persons for election to the board of directors at a special meeting may be made only (1)&#160;by or at
the direction of the board of directors or (2)&#160;provided that the board of directors has determined that directors will be elected
at the meeting, by a stockholder who is entitled to vote at the meeting and who has complied with the advance notice provisions of the
bylaws.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The purpose of requiring
stockholders to give us advance notice of nominations and other business is to afford our board of directors a meaningful opportunity
to consider the qualifications of the proposed nominees and the advisability of any other proposed business and, to the extent deemed
necessary or desirable by our board of directors, to inform stockholders and make recommendations about such qualifications or business,
as well as to provide a more orderly procedure for conducting meetings of stockholders. Although our bylaws do not give our board of
directors any power to disapprove stockholder nominations for the election of directors or proposals recommending certain action, they
may have the effect of precluding a contest for the election of directors or the consideration of stockholder proposals if proper procedures
are not followed and of discouraging or deterring a third party from conducting a solicitation of proxies to elect its own slate of directors
or to approve its own proposal without regard to whether consideration of such nominees or proposals might be harmful or beneficial to
us and our stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholder
Meetings.</i></b></span>&#160;&#160;&#160;Our bylaws provide that any action required or permitted to be taken by stockholders at an
annual meeting or special meeting of stockholders may only be taken if it is properly brought before such meeting. In addition, our certificate
of incorporation provides that, in lieu of a meeting, any such action may be taken by unanimous written consent of our stockholders.
In addition, our bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders,
including proposed nominations of candidates for election to the board of directors. Stockholders at an annual meeting may only consider
proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors,
or by a stockholder of record on the record date for the meeting who is entitled to vote at the meeting and who has delivered timely
written notice in proper form to the secretary of the stockholder&#8217;s intention to bring such business before the meeting. These
provisions could have the effect of delaying until the next stockholder meeting stockholder actions that are favored by the holders of
a majority of our outstanding voting securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Calling
of Special Meetings of Stockholders.</i></b></span>&#160;&#160;&#160;Our bylaws provide that, except as required by law, special meetings
of stockholders may be called by the secretary at the request of the Chairman of the Board of Directors, the Chief Executive Officer
or by a resolution duly adopted by the affirmative vote of a majority of the Directors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conflict
with the 1940 Act.</i></b></span>&#160;&#160;&#160;Our bylaws provide that, if and to the extent that any provision of the DGCL or bylaws
conflicts with any provision of the 1940 Act, the applicable provision of the 1940 Act will control.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exclusive
Forum.</i></b></span>&#160;&#160;&#160;Our bylaws provide that, unless the Company consents to the selection of an alternative forum
in writing, the Court of Chancery, or if that court does not have jurisdiction, the United States District Court for the District of
Delaware shall be the sole and exclusive forum for (a)&#160;any derivative action or proceeding brought on behalf of the Company, (b)&#160;any
action asserting a claim of breach of any duty owed by any director or officer or other agent of the Company to the Company or to the
stockholders of the Company, (c)&#160;any action asserting a claim against the Company or any Director or officer or other agent of the
Company arising pursuant to any provision of the DGCL or our certificate of incorporation or our Bylaws, or (d)&#160;any action asserting
a claim against the Company or any Director or officer or other agent of the Company that is governed by the internal affairs doctrine.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">This choice of forum
provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or
any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. Alternatively,
if a court were to find the choice of forum provision contained in our bylaws to
be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions,
which could harm our business, operating results and financial condition.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 98 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Conversion to Open-End Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may be converted
to an open-end management investment company at any time if approved by each of the following: (i)&#160;a majority of our directors then
in office, (ii)&#160;the holders of not less than 75% of our outstanding shares entitled to vote thereon and (iii)&#160;such vote or
votes of the holders of any class or classes or series of shares as may be required by the 1940 Act. In considering whether to vote on
any proposal to convert us to an open-end management investment company, our board of directors may consider any potential benefits to
stockholders that may potentially be achieved based on the circumstances and related risks, and whether it would be in the long-term
best interests of stockholders to do so in light of any necessary changes in our investment policies and other factors. The composition
of our portfolio likely could prohibit us from complying with regulations of the SEC applicable to open-end management investment companies.
Accordingly, conversion likely would require significant changes in our investment policies and may require liquidation of a substantial
portion of relatively illiquid portions of its portfolio, to the extent such positions are held. In the event of conversion, the shares
of our common stock would cease to be listed on the NYSE or other national securities exchange or market system. Any outstanding shares
of our Preferred Stock would be redeemed by us prior to such conversion. Our board of directors believes, however, that the closed-end
structure is desirable, given our investment objectives and policies. Investors should assume, therefore, that it is unlikely that the
board of directors would vote to convert us to an open-end management investment company. Stockholders of an open-end management investment
company may require the open-end management investment company to redeem their shares at any time (except in certain circumstances as
authorized by or under the 1940 Act) at their NAV, less such redemption charge, if any, as might be in effect at the time of a redemption.
We would expect to pay all such redemption requests in cash, but intends to reserve the right to pay redemption requests in a combination
of cash or securities. If such partial payment in securities were made, investors may incur brokerage costs in converting such securities
to cash. If we were converted to an open-end fund, it is likely that new shares of our common stock would be sold at NAV plus a sales
load.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Repurchase of Shares and Other Discount Measures</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Because shares of
common stock of closed-end management investment companies that are listed on an exchange frequently trade at a discount to their NAVs,
the board of directors may from time to time determine that it may be in the interest of the holders of our common stock to take certain
actions intended to reduce such discount. The board of directors, in consultation with the Adviser, will review at least annually the
possibility of open market repurchases and/or tender offers for shares of our common stock and will consider such factors as the market
price of shares of our common stock, the NAV per share of our common stock, the liquidity of our assets, the effect on our expenses,
whether such transactions would impair our status as a RIC or result in a failure to comply with applicable asset coverage requirements,
general economic conditions and such other events or conditions, which may have a material effect on our ability to consummate such transactions.
There are no assurances that the board of directors will, in fact, decide to undertake either of these actions or, if undertaken, that
such actions will result in shares of our common stock trading at a price which is equal to or approximates their NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 99 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In recognition of
the possibility that shares of our common stock might trade at a discount to the NAV of such shares and that any such discount may not
be in the interest of the holders of our common stock, the board of directors, in consultation with the Adviser, from time to time may
review the possible actions to reduce any such discount.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF OUR PREFERRED STOCK</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We are authorized
to issue up to 20,000,000 shares of Preferred Stock. As of June&#160;5, 2023, we had 2,172,553 shares of Series&#160;C Term Preferred
Stock outstanding and 1,093,245 shares of Series&#160;D Preferred Stock outstanding. See <b><i>&#8220;Description of our Capital Stock&#8201;&#8212;&#8201;Preferred
Stock&#8201;&#8212;&#8201;Series&#160;C Term Preferred Stock&#8221;</i></b> and <b><i>&#8220;Description of our Capital Stock&#8201;&#8212;&#8201;Preferred
Stock&#8201;&#8212;&#8201;Series&#160;D Preferred Stock&#8221;</i></b> for a description of our outstanding Preferred Stock. We may
issue additional Preferred Stock from time to time in one or more series without stockholder approval. Prior to issuance of shares of
each series, our board of directors is required by Delaware law and by our certificate of incorporation to set the terms, preferences,
conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms
or conditions of redemption for each series. Thus, the board of directors could authorize the issuance of shares of Preferred Stock with
terms and conditions that could have the effect of delaying, deferring or preventing a transaction or a change in control that might
involve a premium price for holders of our common stock or otherwise be in their best interest. You should note, however, that any such
an issuance must adhere to the requirements of the 1940 Act, Delaware law and any other limitations imposed by law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">With respect to
senior securities that are stocks (i.e., shares of our Preferred Stock), we are required under current law to have an asset coverage
of at least 200%, as measured at the time of the issuance of any such shares of Preferred Stock and calculated as the ratio of our total
assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount of our outstanding senior
securities representing indebtedness plus the aggregate liquidation preference of any outstanding shares of Preferred Stock. In addition
the 1940 Act requires that (i)&#160;the holders of shares of Preferred Stock must be entitled as a class to elect two directors at all
times and to elect a majority of the directors if dividends or other distribution on the Preferred Stock are in arrears by two&#160;years
or more and (ii)&#160;such class of stock have complete priority over any other class of stock as to distribution of assets and payment
of dividends or other distributions, which shall be cumulative. Some matters under the 1940 Act require the separate vote of the holders
of any issued and outstanding Preferred Stock. We believe that the availability for issuance of Preferred Stock will provide us with
increased flexibility in structuring future financings and acquisitions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For any series of
Preferred Stock that we may issue, our board of directors will determine and the certificate of designation and the prospectus supplement
relating to such series will describe:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the designation and number of shares of such series;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the rate and time at which, and the preferences and conditions
under which, any dividends or other distributions will be paid on shares of such series, as well as whether such dividends or other distributions
are participating or non-participating;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any provisions relating to convertibility or exchangeability of
the shares of such series, including adjustments to the conversion price of such series;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the rights and preferences, if any, of holders of shares of such
series upon our liquidation, dissolution or winding up of our affairs;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the voting powers, if any, of the holders of shares of such series;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any provisions relating to the redemption of the shares of such
series;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any limitations on our ability to pay dividends or make distributions
on, or acquire or redeem, other securities while shares of such series are outstanding;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any conditions or restrictions on our ability to issue additional
shares of such series or other securities;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if applicable, a discussion of certain U.S. federal income tax
considerations; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any other relative powers, preferences and participating, optional
or special rights of shares of such series, and the qualifications, limitations or restrictions thereof.</td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></p><div>


</div><!-- Field: Page; Sequence: 100 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">All shares of Preferred
Stock that we may issue will be of equal rank and identical except as to the particular terms thereof that may be fixed by our board
of directors, and all shares of each series of Preferred Stock will be identical except as to the dates from which dividends or other
distributions, if any, thereon will be cumulative.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF OUR SUBSCRIPTION RIGHTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following is
a general description of the terms of the subscription rights we may issue from time to time. Particular terms of any subscription rights
we offer will be described in the prospectus supplement relating to such subscription rights.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may issue subscription
rights to our stockholders to purchase common stock. Subscription rights may be issued independently or together with any other offered
security and may or may not be transferable by the person purchasing or receiving the subscription rights. We will not offer transferable
subscription rights to our stockholders at a price equivalent to less than the then current NAV per share of common stock, taking into
account underwriting commissions, unless we first file a post-effective amendment that is declared effective by the SEC with respect
to such issuance and the common stock to be purchased in connection with the rights represents no more than one-third of our outstanding
common stock at the time such rights are issued. In connection with any subscription rights offering to our stockholders, we may enter
into a standby underwriting, backstop or other arrangement with one or more persons pursuant to which such persons would purchase any
offered securities remaining unsubscribed for after such subscription rights offering. In connection with a subscription rights offering
to our stockholders, we would distribute certificates evidencing the subscription rights and a prospectus supplement to our stockholders
on the record date that we set for receiving subscription rights in such subscription rights offering. Our common stockholders will indirectly
bear all of the expenses incurred by us in connection with any subscription rights offerings, regardless of whether any common stockholder
exercises any subscription rights.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A prospectus supplement
will describe the particular terms of any subscription rights we may issue, including the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the period of time the offering would remain open (which shall
be open a minimum number of days such that all record holders would be eligible to participate in the offering and shall not be open
longer than 120&#160;days);</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the title and aggregate number of such subscription rights;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the exercise price for such subscription rights (or method of
calculation thereof);</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the currency or currencies, including composite currencies, in
which the price of such subscription rights may be payable;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if applicable, the designation and terms of the securities with
which the subscription rights are issued and the number of subscription rights issued with each such security or each principal amount
of such security;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the ratio of the offering (which, in the case of transferable
rights, will require a minimum of three shares to be held of record before a person is entitled to purchase an additional share);</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the number of such subscription rights issued to each stockholder;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the extent to which such subscription rights are transferable
and the market on which they may be traded if they are transferable;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the date on which the right to exercise such subscription rights
shall commence, and the date on which such right shall expire (subject to any extension);</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if applicable, the minimum or maximum number of subscription rights
that may be exercised at one time;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 101 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the extent to which such subscription rights include an over-subscription
privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any termination right we may have in connection with such subscription
rights offering;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the terms of any rights to redeem, or call such subscription rights;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">information with respect to book-entry procedures, if any;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the terms of the securities issuable upon exercise of the subscription
rights;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the material terms of any standby underwriting, backstop or other
purchase arrangement that we may enter into in connection with the subscription rights offering;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if applicable, a discussion of certain U.S. federal income tax
considerations applicable to the issuance or exercise of such subscription rights; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any other terms of such subscription rights, including exercise,
settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each subscription
right will entitle the holder of the subscription right to purchase for cash or other consideration such amount of shares of common stock
at such subscription price as shall in each case be set forth in, or be determinable as set forth in, the prospectus supplement relating
to the subscription rights offered thereby. Subscription rights may be exercised as set forth in the prospectus supplement beginning
on the date specified therein and continuing until the close of business on the expiration date for such subscription rights set forth
in the prospectus supplement. After the close of business on the expiration date, all unexercised subscription rights will become void.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Upon receipt of payment
and the subscription rights certificate properly completed and duly executed at the corporate trust office of the subscription rights
agent or any other office indicated in the prospectus supplement we will forward, as soon as practicable, the shares of common stock
purchasable upon such exercise. If less than all of the rights represented by such subscription rights certificate are exercised, a new
subscription certificate will be issued for the remaining rights. Prior to exercising their subscription rights, holders of subscription
rights will not have any of the rights of holders of the securities purchasable upon such exercise. To the extent permissible under applicable
law, we may determine to offer any unsubscribed offered securities directly to persons other than stockholders, to or through agents,
underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 102 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF OUR DEBT SECURITIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As of June&#160;5,
2023, we had $32,423,800 aggregate principal amount of the 2028 Notes outstanding, $93,250,000 aggregate principal amount of the 2029
Notes outstanding and $44,850,000 aggregate principal amount of the 2031 Notes outstanding. We may issue additional debt securities in
one or more series. The specific terms of each series of debt securities will be described in the particular prospectus supplement relating
to that series. The prospectus supplement may or may not modify the general terms found in this prospectus and will be filed with the
SEC. For a complete description of the terms of a particular series of debt securities, you should read both this prospectus and the
prospectus supplement relating to that series. See <b><i>&#8220;&#8212; 2028 Notes,&#8221; &#8220;&#8212; 2029 Notes,&#8221;</i></b><i>and
<b>&#8220;&#8212; 2031 Notes&#8221;</b></i> below for a description of certain specific terms of our outstanding debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As required by federal
law for all bonds and notes of companies that are publicly offered, the Notes and any future debt securities we may issue, are governed
by a document called an &#8220;indenture.&#8221; An indenture is a contract between us and a financial institution acting as trustee
on your behalf, and is subject to and governed by the Trust Indenture Act of 1939, as amended. The trustee has two main roles. First,
the trustee can enforce your rights against us if we default. There are some limitations on the extent to which the trustee acts on your
behalf, described in the second paragraph under <b><i>&#8220;&#8212; Events of Default&#8201;&#8212;&#8201;Remedies if an Event of
Default Occurs.&#8221;</i></b> Second, the trustee performs certain administrative duties for us with respect to our debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Because this section
is a summary, it does not describe every aspect of the debt securities and the indenture. We urge you to read the indenture because it,
and not this description, defines your rights as a holder of debt securities. We have filed the indenture with the SEC. See <b><i>&#8220;Additional
Information&#8221;</i></b> for information on how to obtain a copy of the indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A prospectus supplement,
which will accompany this prospectus, will describe the particular terms of any series of debt securities being offered, including, as
applicable, the following:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the designation or title of the series of debt securities;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the total principal amount of the series of debt securities;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the&#160;percentage of the principal amount at which the series
of debt securities will be offered;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the date or dates on which principal will be payable;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the rate or rates (which may be either fixed or variable) and/or
the method of determining such rate or rates of interest, if any;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the date or dates from which any interest will accrue, or the
method of determining such date or dates, and the date or dates on which any interest will be payable;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the terms for redemption, extension or early repayment, if any;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the currencies in which the series of debt securities are issued
and payable;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">whether the amount of payments of principal, premium or interest,
if any, on a series of debt securities will be determined with reference to an index, formula or other method (which could be based on
one or more currencies, commodities, equity indices or other indices) and how these amounts will be determined;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the place or places, if any, other than or in addition to the
City of New York, of payment, transfer, conversion and/or exchange of the debt securities;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the denominations in which the offered debt securities will be
issued;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the provision for any sinking fund;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any restrictive covenants;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any Events of Default (as described below);</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">whether the series of debt securities are issuable in certificated
form;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any provisions for defeasance or covenant defeasance;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></p><div>


</div><!-- Field: Page; Sequence: 103 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if applicable, a discussion of U.S. federal income tax considerations;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">whether and under what circumstances we will pay additional amounts
in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem the debt securities rather
than pay the additional amounts (and the terms of this option);</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any provisions for convertibility or exchangeability of the debt
securities into or for any other securities;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">whether the debt securities are subject to subordination and the
terms of such subordination;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the listing, if any, on a securities exchange; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">any other terms.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Unless the prospectus
supplement states otherwise, principal (and premium, if any) and interest, if any, will be paid by us in immediately available funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">For purposes of
this prospectus, any reference to the payment of principal of or premium or interest, if any, on debt securities will include additional
amounts if required by the terms of the debt securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">While any indebtedness and
other senior securities remain outstanding, we must make provisions to prohibit any distribution to our stockholders or the repurchase
of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. We may
also borrow amounts up to 5% of the value of our total assets for temporary or emergency purposes without regard to asset coverage. For
a discussion of the risks associated with leverage, see <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating to Our Business
and Structure&#8201;&#8212;&#8201;Regulations governing our operation as a registered closed-end management investment company affect
our ability to raise additional capital and the way in which we do so. The raising of debt capital may expose us to risks, including
the typical risks associated with leverage.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The indenture provides
that any debt securities proposed to be sold under this prospectus and an attached prospectus supplement, or &#8220;offered debt securities,&#8221;
and any debt securities issuable upon the upon conversion or exchange of other offered securities, or &#8220;underlying debt securities,&#8221;
may be issued under the indenture in one or more series.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The indenture does
not limit the amount of debt securities that may be issued thereunder from time to time. Debt securities issued under the indenture,
when a single trustee is acting for all debt securities issued under the indenture, are called the &#8220;indenture securities.&#8221;
The indenture also provides that there may be more than one trustee thereunder, each with respect to one or more different series of
indenture securities. See <b><i>&#8220;&#8212;&#160;Resignation of Trustee&#8221;</i></b> section below. At a time when two or more trustees
are acting under the indenture, each with respect to only certain series, the term &#8220;indenture securities&#8221; means the one or
more series of debt securities with respect to which each respective trustee is acting. In the event that there is more than one trustee
under the indenture, the powers and trust obligations of each trustee described in this prospectus will extend only to the one or more
series of indenture securities for which it is trustee. If two or more trustees are acting under the indenture, then the indenture securities
for which each trustee is acting would be treated as if issued under separate indentures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We refer you to
the applicable prospectus supplement for information with respect to any deletions from, modifications of or additions to the Events
of Default or our covenants that are described below, including any addition of a covenant or other provision providing event risk or
similar protection.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We expect that we
will usually issue debt securities in book-entry only form represented by global securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Debt Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Pursuant
to the indenture, we have the ability, without the consent of the holders thereof, to reopen the 2028 Notes, 2029 Notes or 2031
Notes and issue additional 2028 Notes, 2029 Notes or 2031 Notes having identical terms and conditions as the 2028 Notes, 2029 Notes
or 2031 Notes, respectively, except for the offering price and the issue date, in one or more series. We may also issue additional
series of debt securities under the indenture and other debt securities in accordance with the limitations of the 1940 Act. In
addition, we may also enter certain other evidences of indebtedness (including bank borrowings and commercial paper) representing
senior securities. We may also borrow in amounts up to 5% of our total assets if the borrowing is for temporary purposes only (i.e.,
if it is to be repaid within 60&#160;days and not extended or renewed).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 104 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conversion and Exchange</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If any debt securities
are convertible into or exchangeable for other securities, the prospectus supplement will explain the terms and conditions of the conversion
or exchange, including the conversion price or exchange ratio (or the calculation method), the conversion or exchange period (or how
the period will be determined), if conversion or exchange will be mandatory or at the option of the holder or us, provisions for adjusting
the conversion price or the exchange ratio and provisions affecting conversion or exchange in the event of the redemption of the underlying
debt securities. These terms may also include provisions under which the number or amount of other securities to be received by the holders
of the debt securities upon conversion or exchange would be calculated according to the market price of the other securities as of a
time stated in the prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Payment and Paying Agents</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Unless the prospectus
supplement relating to such debt security states otherwise, we will pay interest to the person listed in the applicable trustee&#8217;s
records as the owner of the debt security at the close of business on a particular day in advance of each due date for interest, even
if that person no longer owns the security on the interest due date. That day, usually about two weeks in advance of the interest due
date, is called the &#8220;record date.&#8221; Because we will pay all the interest for an interest period to the holders on the record
date, holders buying and selling the debt security must work out between themselves the appropriate purchase price. The most common manner
is to adjust the sales price of the security to prorate interest fairly between buyer and seller based on their respective ownership
periods within the particular interest period. This prorated interest amount is called &#8220;accrued interest.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Payments on Global Securities</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will make payments on
debt securities so long as they are represented by a global security in accordance with the applicable policies of the depositary as
in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect
holders who own beneficial interests in the global security. An indirect holder&#8217;s right to those payments will be governed by the
rules&#160;and practices of the depositary and its participants, as described under <b><i>&#8220;Book-Entry Issuance.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Payments on Certificated Securities</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In the event our
debt securities become represented by certificates, unless the prospectus supplement relating to such debt security states otherwise,
we will make payments on our debt securities as follows. We will pay interest that is due on an interest payment date by a check mailed
on the interest payment date to the securityholder at his or her address shown on the trustee&#8217;s records as of the close of business
on the record date. We will make all payments of principal and premium, if any, by check at the office of the trustee in New York, New
York and/or at other offices that may be specified in the Indenture or a notice to holders against surrender of the security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Alternatively, if
the holder asks us to do so, we will pay any amount that becomes due on a debt security by wire transfer of immediately available funds
to an account at a bank in the United States, on the due date. To request payment by wire, the holder must give the trustee appropriate
transfer instructions at least 15 business days before the requested wire payment is due. In the case of any interest payment due on
an interest payment date, the instructions must be given by the person who is the holder on the relevant regular record date. Any wire
instructions, once properly given, will remain in effect unless and until new instructions are given in the manner described above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Payment When Offices Are Closed</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If
any payment is due on a debt security on a day that is not a business day, we will make the payment on the next day that is a
business day. Payments made on the next business day in this situation will be treated under the indenture as if they were made on
the original due date. Such payment will not result in a default under any debt security or the indenture, and no interest will
accrue on the payment amount from the original due date to the next day that is a business day.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 105 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Book-entry and other
indirect holders should consult their banks or brokers for information on how they will receive payments.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Events of Default</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">You will have rights
if an Event of Default occurs in respect of debt securities of your series and is not cured, as described later in this subsection. The
term &#8220;Event of Default&#8221; in respect of the debt securities of your series means any of the following (unless the prospectus
supplement relating to such debt security states otherwise):</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We do not pay the principal of, or any premium on, a debt security
of the series when due and payable, and such default is not cured within five days.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We do not pay interest on a debt security of the series when due,
and such default is not cured within 30&#160;days.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We do not deposit any sinking fund payment in respect of debt
securities of the series on its due date, and do not cure this default within five days.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We remain in breach of any other covenant with respect to debt
securities of the series for 60&#160;days after we receive a written notice of default stating we are in breach. The notice must be sent
by either the trustee or holders of at least 25% of the principal amount of debt securities of the series.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We file for bankruptcy or certain other events of bankruptcy,
insolvency or reorganization occur and in the case of certain orders or decrees entered against us under any bankruptcy law, such order
or decree remains undischarged or unstayed for a period of 90&#160;days.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">On the last business day of each of twenty-four consecutive calendar&#160;months,
all series of our debt securities issued under the indenture together have an asset coverage, as defined in the 1940 Act, of less than
100% after giving effect to exemptive relief, if any, granted to us by the SEC.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">Any other Event of Default in respect of debt securities of the
series described in the applicable prospectus supplement occurs.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">An Event of Default
for a particular series of debt securities does not necessarily constitute an Event of Default for any other series of debt securities
issued under the same or any other indenture. The trustee may withhold notice to the holders of the debt securities of any default, except
in the payment of principal or interest, if it in good faith considers the withholding of notice to be in the best interests of the holders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Remedies if an Event of Default Occurs</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If an Event of Default
has occurred and is continuing (unless the prospectus supplement relating to such debt security states otherwise), the following remedies
are available. The trustee or the holders of not less than 25% in principal amount of the debt securities of the affected series may
declare the entire principal amount of all of the debt securities of that series to be due and immediately payable. This is called a
declaration of acceleration of maturity. In certain circumstances, a declaration of acceleration of maturity may be canceled by the holders
of a majority in principal amount of the debt securities of the affected series if (1)&#160;we have deposited with the trustee all amounts
due and owing with respect to the debt securities of that series (other than principal that has become due solely by reason of such acceleration)
and certain other amounts, and (2)&#160;any other Events of Default with respect to that series have been cured or waived.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The trustee is not
required to take any action under the indenture at the request of any holders unless the holders offer the trustee protection from expenses
and liability reasonably satisfactory to it (called an &#8220;indemnity&#8221;). If indemnity reasonably satisfactory to the trustee
is provided, the holders of a majority in principal amount of the outstanding debt of the relevant series may direct the time, method
and place of conducting any lawsuit or other formal legal action seeking any remedy available to the trustee. The trustee may refuse to follow those directions
in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or
Event of Default.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 106 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Before you are allowed
to bypass the trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your
interests relating to the debt securities, the following must occur:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">you must give the applicable trustee written notice that an Event
of Default has occurred and remains uncured;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the holders of at least 25% in principal amount of all outstanding
debt securities of the relevant series must make a written request that the trustee take action because of the default and must offer
the trustee reasonable indemnity, security or both against the cost and other liabilities of taking that action;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the trustee must not have taken action for 60&#160;days after
receipt of the above notice and offer of indemnity and/or security; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">the holders of a majority in principal amount of debt securities
of the relevant series must not have given the trustee a direction inconsistent with the above notice during that 60-day period.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">However, you are
entitled at any time to bring a lawsuit for the payment of money due on your debt securities on or after the due date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Book-entry and other
indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the
trustee and how to declare or cancel an acceleration of maturity.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each year, we will
furnish to the trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the
Indenture and the debt securities, or else specifying any default.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Waiver of Default</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The holders of a
majority in principal amount of the debt securities of the affected series may waive any past defaults other than a default:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">in the payment of principal or interest; or</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">in respect of a covenant that cannot be modified or amended without
the consent of each holder.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Merger or Consolidation</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under the terms
of the indenture, we are generally permitted to consolidate or merge with another entity. We are also permitted to sell all or substantially
all of our assets to another entity. However, we may not take any of these actions unless all the following conditions are met:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">where we merge out of existence or convey or transfer all of our
assets, the resulting entity must agree to be legally responsible for our obligations under the debt securities;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">immediately after the transaction, no default or Event of Default
will have happened and be continuing;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">we must deliver certain certificates and documents to the trustee;
and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">we must satisfy any other requirements specified in the prospectus
supplement relating to a particular series of debt securities.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Modification or Waiver</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">There are three
types of changes we can make to the indenture and the debt securities issued thereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Changes Requiring Your Approval</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">First, there are
changes that we cannot make to debt securities without specific approval of all of the holders. The following is a list of those types
of changes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">change the stated maturity of the principal of or interest on
a debt security;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></p><div>


</div><!-- Field: Page; Sequence: 107 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">change the terms of any sinking fund with respect to any debt
security;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">reduce any amounts due on a debt security;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">reduce the amount of principal payable upon acceleration of the
maturity of a debt security following a default;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">adversely affect any right of repayment at the holder&#8217;s
option;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">change the place or currency of payment on a debt security;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">impair your right to sue for payment following the date on which
such amount is due and payable;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">adversely affect any right to convert or exchange a debt security
in accordance with its terms;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">reduce the&#160;percentage in principal amount of holders of debt
securities whose consent is needed to modify or amend the indenture;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">reduce the&#160;percentage in principal amount of holders of debt
securities whose consent is needed to waive compliance with certain provisions of the indenture or to waive certain defaults; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">modify any other aspect of the provisions of the indenture dealing
with supplemental indentures, waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Changes Not Requiring Approval</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The second type
of change does not require any vote by the securityholders. This type is limited to clarifications and certain other changes that would
not materially adversely affect holders of outstanding debt securities in any material respect. We also do not need any approval to make
any change that affects only debt securities to be issued under the indenture after the change takes effect.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Changes Requiring Majority Approval</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any other change to the indenture
and debt securities would require the following approval:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if the change affects only one series of debt securities, it must
be approved by the holders of a majority in principal amount of that series; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if the change affects more than one series of debt securities
issued under the same indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by
the change, with all affected series voting together as one class for this purpose.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In each case, the required approval
must be given by written consent.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The holders of a majority
in principal amount of all of the series of debt securities issued under the indenture, voting together as one class for this purpose,
may waive our compliance with some of our covenants in the indenture. However, we cannot obtain a waiver of a payment default or of any
of the matters covered by the bullet points included above under <b><i>&#8220;&#8212; Changes Requiring Your Approval.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Further Details Concerning Voting</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When taking a vote,
we will use the following rules&#160;to decide how much principal to attribute to the Notes and any future indebtedness:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">for original issue discount securities, we will use the principal
amount that would be due and payable on the voting date if the maturity of these debt securities were accelerated to that date because
of a default;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">for debt securities whose principal amount is not known (for example,
because it is based on an index), we will use a special rule&#160;for that debt security described in the prospectus supplement; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">for debt securities denominated in one or more foreign currencies,
we will use the U.S. dollar equivalent.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 108 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Debt securities will not
be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or
redemption. Debt securities will also not be eligible to vote if they have been fully defeased as described later under <b><i>&#8220;&#8212;
Defeasance&#8201;&#8212;&#8201;Full Defeasance.&#8221;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We will generally
be entitled to set any day as a record date for the purpose of determining the holders of outstanding indenture securities that are entitled
to vote or take other action under the indenture. However, the record date may not be more than 30&#160;days before the date of the first
solicitation of holders to vote on or take such action. If we set a record date for a vote or other action to be taken by holders of
one or more series, that vote or action may be taken only by persons who are holders of outstanding indenture securities on the record
date and must be taken within eleven&#160;months following the record date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Book-entry and other
indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change
the indenture or debt securities or request a waiver.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Satisfaction and Discharge; Defeasance</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may satisfy and
discharge our obligations under the indenture by delivering to the trustee for cancellation all outstanding debt securities and by depositing
with the trustee after the debt securities have become due and payable, or otherwise, moneys sufficient to pay all of the outstanding
debt securities and paying all other sums payable under the indenture by us. Such discharge is subject to terms contained in the Indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Defeasance</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following defeasance
provisions will be applicable to each series of debt securities (unless the prospectus supplement relating to such debt security states
otherwise). &#8220;Defeasance&#8221; means that, by depositing with the trustee an amount of cash and/or government securities sufficient
to pay all principal and interest, if any, on the debt securities when due and satisfying any additional conditions noted below, we will
be deemed to have been discharged from our obligations under the debt securities. In the event of a &#8220;covenant defeasance,&#8221;
upon depositing such funds and satisfying similar conditions discussed below we would be released from certain covenants under the indenture
relating to the applicable debt securities. The consequences to the holders of such securities would be that, while they would no longer
benefit from certain covenants under the indenture, and while such securities could not be accelerated for any reason, the holders of
applicable debt securities nonetheless would be guaranteed to receive the principal and interest owed to them.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Covenant Defeasance</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under current U.S.
federal income tax law and the indenture, we can make the deposit described below and be released from some of the restrictive covenants
in the indenture under which the particular series was issued. This is called &#8220;covenant defeasance.&#8221; In that event, you would
lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside
in trust to repay your debt securities. In order to achieve covenant defeasance, the following must occur:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if the debt securities of a particular series are denominated
in U.S. dollars, we must deposit in trust for the benefit of all holders of such securities a combination of cash and U.S . government
or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the debt
securities on their various due dates;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">we must deliver to the trustee a legal opinion of our counsel
confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the debt
securities any differently than if we did not make the deposit and just repaid the debt securities ourselves at maturity;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">we must deliver to the trustee a legal opinion and officers&#8217;
certificate stating that all conditions precedent to covenant defeasance have been complied with;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">defeasance must not result in a breach or violation of, or result
in a default under, of the indenture or any of our other material agreements or instruments; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">no default or Event of Default with respect to the applicable
series shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization
shall occur during the next 90&#160;days.</td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 109 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we accomplish
covenant defeasance, you can still look to us for repayment of the debt securities if there were a shortfall in the trust deposit or
the trustee is prevented from making payment. In fact, if one of the remaining Events of Default occurred (such as our bankruptcy) and
the debt securities became immediately due and payable, there might be a shortfall. Depending on the event causing the default, you may
not be able to obtain payment of the shortfall.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Full Defeasance</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If there is a change
in U.S. federal income tax law, as described below, we can legally release ourselves from all payment and other obligations on the debt
securities of a particular series (called &#8220;full defeasance&#8221;) if we put in place the following other arrangements for you
to be repaid:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">if the debt securities of a particular series are denominated
in U.S. dollars, we must deposit in trust for the benefit of all holders of such securities a combination of money and U.S. government
or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on such securities
on their various due dates;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">we must deliver to the trustee a legal opinion confirming that
there has been a change in current U.S. federal income tax law or an IRS ruling that allows us to make the above deposit without causing
you to be taxed on the debt securities any differently than if we did not make the deposit. Under current U.S. federal income tax law
the deposit and our legal release from the debt securities would be treated as though we paid you your share of the cash and notes or
bonds at the time the cash and notes or bonds were deposited in trust in exchange for your debt securities and you would recognize gain
or loss on the debt securities at the time of the deposit;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">we must deliver to the trustee a legal opinion and officers&#8217;
certificate stating that all conditions precedent to defeasance have been complied with;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">defeasance must not result in a breach or violation of, or constitute
a default under, of the Indenture or any of our other material agreements or instruments; and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: center; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">no default or Event of Default with respect to the applicable
series shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization
shall occur during the next 90&#160;days.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we ever did accomplish
full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the debt securities. You could
not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from
claims of our lenders and other creditors if we ever became bankrupt or insolvent. If your debt securities were effectively subordinated,
such subordination would not prevent the trustee under the indenture from applying the funds available to it from the deposit referred
to in the first bullet of the preceding paragraph to the payment of amounts due in respect of such Notes for the benefit of the subordinated
debtholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Form, Exchange and Transfer of Certificated Registered Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Holders may exchange
their certificated securities, if any, for debt securities of smaller denominations or combined into fewer debt securities of larger
denominations, as long as the total principal amount is not changed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Holders may exchange
or transfer their certificated securities at the office of the trustee. We have appointed the trustee to act as our agent for registering
debt securities in the names of holders transferring debt securities. We may appoint another entity to perform these functions or perform
them ourselves.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Holders will not
be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or
other governmental charge associated with the transfer or exchange. The transfer or exchange will be made only if our transfer agent
is satisfied with the holder&#8217;s proof of legal ownership.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 110 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we have designated
additional transfer agents for your debt security, they will be named in your prospectus supplement. We may appoint additional transfer
agents or cancel the appointment of any particular transfer agent. We may also approve a change in the office through which any transfer
agent acts.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If we redeem any
securities of a particular series, we may block the transfer or exchange of those securities selected for redemption during the period
beginning 15&#160;days before the day we mail the notice of redemption and ending on the day of that mailing, in order to determine and
fix the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of any certificated security selected
for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any security that will be
partially redeemed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Resignation of Trustee</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Each trustee may
resign or be removed with respect to one or more series of indenture securities provided that a successor trustee is appointed to act
with respect to these series. In the event that two or more persons are acting as trustee with respect to different series of indenture
securities under the indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any
other trustee.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concerning the Trustee</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The trustee serves
as transfer agent for our common stock and the Preferred Stock and agent for our DRIP. We will appoint the trustee as registrar and paying
agent under the indenture.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Governing Law</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The indenture and
our debt securities will be governed by, and construed in accordance with, the laws of the State of New York.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2028 Notes</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following description
of the specific terms of the 2028 Notes supplements and, to the extent inconsistent with, replaces the description of the general terms
and provisions of our debt securities set forth above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General.</i></span>&#160;&#160;&#160;As
of June&#160;5, 2023, we had $32,423,800 aggregate principal amount of the 2028 Notes outstanding. The 2028 Notes were issued in denominations
of $25 and integral multiples of $25 in excess thereof. The 2028 Notes will mature on April&#160;30, 2028 and 100% of the aggregate principal
amount will be paid at maturity (unless the 2028 Notes are earlier redeemed as described below). The 2028 Notes are not subject to any
sinking fund, and holders of the 2028 Notes do not have the option to have the 2028 Notes repaid prior to the stated maturity date. The
interest rate of the 2028 Notes is 6.6875% per year, and interest payments are made every March&#160;31, June&#160;30, September&#160;30
and December&#160;31. The regular record dates for interest payments are every March&#160;15, June&#160;15, September&#160;15 and December&#160;15.
The interest periods for the 2028 Notes are the periods from and including an interest payment date to, but excluding, the next interest
payment date or the stated maturity date, as the case may be. American Stock Transfer&#160;&amp; Trust Company, LLC serves as trustee
under the indenture governing the 2028 Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The 2028 Notes are
our unsecured obligations and, upon our liquidation, dissolution or winding up, will rank (1)&#160;senior to the outstanding shares of
our common stock and our Preferred Stock, (2)&#160;<i>pari&#160;passu</i> (or equally) with our existing and future unsecured indebtedness,
(3)&#160;effectively subordinated to any existing or future secured indebtedness (including indebtedness that is initially unsecured
to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness, and (4)&#160;structurally
subordinated to all existing and future indebtedness of our subsidiaries, financing vehicles or similar facilities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 111 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><i>Redemption.</i>&#160;&#160;&#160;The
2028 Notes may be redeemed in whole or in part at any time or from time to time on or after April&#160;30, 2021 at our option, upon not
less than 30-days&#8217; nor more than 60-days&#8217; written notice by mail prior to the date fixed for redemption thereof, at a redemption
price equal to $25 per 2028 Note plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption. If we
fail to maintain asset coverage (as defined in the 1940 Act) with respect to securities issued under the indenture, including the 2028
Notes, of at least the&#160;percentage required under Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions (currently
300%) as of close of business on the last business day of any calendar quarter and such failure is not cured as of the close of business
on a certain date, we will fix a redemption date and proceed to redeem 2028 Notes as described below at a price equal to 100% of the
aggregate principal amount thereof plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption. We
will redeem out of funds legally available an aggregate principal amount of securities issued under the indenture (which at our discretion
may include any number or portion of the 2028 Notes) that, when combined with any shares of our Preferred Stock redeemed pursuant to
mandatory redemption for failing to maintain the asset coverage required by 1940 Act for such Preferred Stock, (1)&#160;results in us
having asset coverage of at least the&#160;percentage required under Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions
or (2)&#160;if smaller, the maximum aggregate principal amount of such securities that can be redeemed out of funds legally available
for such redemption; provided that in connection with any such redemption for failure to maintain the asset coverage required by the
1940 Act, we may, at our sole option, redeem such additional amount of securities, including the 2028 Notes, that will result in our
having asset coverage of up to and including 385%.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">On February&#160;14,
2022, we redeemed 50% or $32.4&#160;million of the aggregate principal amount of the issued and outstanding 2028 Notes at a redemption
price of $25 per 2028 Note plus accrued and unpaid interest to, but excluding the date of redemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Covenants.</i></span>&#160;&#160;&#160;In
addition to any other covenants described above, as well as standard covenants relating to payment of principal and interest, maintaining
an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following
covenants apply to the 2028 Notes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2028
Notes remain outstanding, we will remain a non-diversified closed-end management investment company for purposes of the 1940 Act.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2028
Notes remain outstanding, our payment obligations under the indenture and the 2028 Notes will at all times rank <i>pari&#160;passu</i>,
without preference or priority, with all of our existing and future unsecured indebtedness and senior to any Preferred Stock we may issue.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2028
Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18,
or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either
case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional
borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with
respect to such borrowings equals at least 300% after such borrowings. See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating
to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts
invested and will increase the risk of investing in us.&#8221;</i></b></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2028
Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18,
or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any
exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment
company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare
any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order
to maintain the closed-end investment company&#8217;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit
us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our
asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration
of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that
we may declare dividends on our Preferred Stock as long as such asset coverage with respect to our borrowings or other indebtedness is
not below 200%).</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">If, at any time, we are not subject to the reporting requirements
of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we have agreed to furnish to holders
of the 2028 Notes and the trustee, for the period of time during which the 2028 Notes are outstanding, our audited annual consolidated financial statements,
within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements, within 60&#160;days
after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance
with applicable GAAP.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 112 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2029 Notes</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following description
of the specific terms of the 2029 Notes supplements and, to the extent inconsistent with, replaces the description of the general terms
and provisions of our debt securities set forth above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General.</i></span>&#160;&#160;&#160;As
of June&#160;5, 2023, we had $93,250,000 aggregate principal amount of the 2029 Notes outstanding. The 2029 Notes were issued in denominations
of $25 and integral multiples of $25 in excess thereof. The 2029 Notes will mature on January&#160;31, 2029 and 100% of the aggregate
principal amount will be paid at maturity (unless the 2029 Notes are earlier redeemed as described below). The 2029 Notes are not subject
to any sinking fund, and holders of the 2029 Notes do not have the option to have the 2029 Notes repaid prior to the stated maturity
date. The interest rate of the 2029 Notes is 5.375% per year, and interest payments are made every March&#160;31, June&#160;30, September&#160;30
and December&#160;31. The regular record dates for interest payments are every March&#160;15, June&#160;15, September&#160;15 and December&#160;15.
The interest periods for the 2029 Notes are the periods from and including an interest payment date to, but excluding, the next interest
payment date or the stated maturity date, as the case may be. American Stock Transfer&#160;&amp; Trust Company, LLC serves as trustee
under the indenture governing the 2029 Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The 2029 Notes are
our unsecured obligations and, upon our liquidation, dissolution or winding up, will rank (1)&#160;senior to the outstanding shares of
our common stock and our Preferred Stock, (2)&#160;<i>pari&#160;passu</i> (or equally) with our existing and future unsecured indebtedness,
(3)&#160;effectively subordinated to any existing or future secured indebtedness (including indebtedness that is initially unsecured
to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness, and (4)&#160;structurally
subordinated to all existing and future indebtedness of our subsidiaries, financing vehicles or similar facilities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption.</i></span>&#160;&#160;&#160;The
2029 Notes may be redeemed in whole or in part at any time or from time to time on or after January&#160;31, 2025 at our option, upon
not less than 30-days&#8217; nor more than 60-days&#8217; written notice by mail prior to the date fixed for redemption thereof, at a
redemption price equal to $25 per 2029 Note plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Covenants.</i></span>&#160;&#160;&#160;In
addition to any other covenants described above, as well as standard covenants relating to payment of principal and interest, maintaining
an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following
covenants apply to the 2029 Notes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2029
Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2029
Notes remain outstanding, our payment obligations under the indenture and the 2029 Notes will at all times rank <i>pari&#160;passu</i>,
without preference or priority, with all of our existing and future unsecured indebtedness and senior to any Preferred Stock we may issue.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2029
Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18,
or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either
case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional
borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with
respect to such borrowings equals at least 300% after such borrowings. See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating
to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts
invested and will increase the risk of investing in us.&#8221;</i></b></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 113 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2029
Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18,
or any successor provisions, whether or not
we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC,
if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek
such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding
the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#8217;s
status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution
upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect
to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase
and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our Preferred Stock
as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">If, at any time, we are not subject to the reporting requirements
of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we have agreed to furnish to holders
of the 2029 Notes and the trustee, for the period of time during which the 2029 Notes are outstanding, our audited annual consolidated
financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements,
within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material
respects, in accordance with applicable GAAP.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2031 Notes</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The following description
of the specific terms of the 2031 Notes supplements and, to the extent inconsistent with, replaces the description of the general terms
and provisions of our debt securities set forth above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General.</i></span>&#160;&#160;&#160;As
of June&#160;5, 2023, we had $44,850,000 aggregate principal amount of the 2031 Notes outstanding. The 2031 Notes were issued in denominations
of $25 and integral multiples of $25 in excess thereof. The 2031 Notes will mature on March&#160;31, 2031 and 100% of the aggregate principal
amount will be paid at maturity (unless the 2031 Notes are earlier redeemed as described below). The 2031 Notes are not subject to any
sinking fund, and holders of the 2031 Notes do not have the option to have the 2031 Notes repaid prior to the stated maturity date. The
interest rate of the 2031 Notes is 6.75% per year, and interest payments are made every March&#160;31, June&#160;30, September&#160;30
and December&#160;31. The regular record dates for interest payments are every March&#160;15, June&#160;15, September&#160;15 and December&#160;15.
The interest periods for the 2031 Notes are the periods from and including an interest payment date to, but excluding, the next interest
payment date or the stated maturity date, as the case may be. American Stock Transfer&#160;&amp; Trust Company, LLC serves as trustee
under the indenture governing the 2031 Notes.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The 2031 Notes are
our unsecured obligations and, upon our liquidation, dissolution or winding up, will rank (1)&#160;senior to the outstanding shares of
our common stock and our Preferred Stock, (2)&#160;<i>pari&#160;passu</i> (or equally) with our existing and future unsecured indebtedness,
(3)&#160;effectively subordinated to any existing or future secured indebtedness (including indebtedness that is initially unsecured
to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness, and (4)&#160;structurally
subordinated to all existing and future indebtedness of our subsidiaries, financing vehicles or similar facilities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption.</i></span>&#160;&#160;&#160;The
2031 Notes may be redeemed in whole or in part at any time or from time to time on or after March&#160;29, 2024 at our option, upon not
less than 30-days&#8217; nor more than 60-days&#8217; written notice by mail prior to the date fixed for redemption thereof, at a redemption
price equal to $25 per 2031 Note plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Covenants.</i></span>&#160;&#160;&#160;In
addition to any other covenants described above, as well as standard covenants relating to payment of principal and interest, maintaining
an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following
covenants apply to the 2031 Notes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2031
Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 114 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2031
Notes remain outstanding, our payment obligations under the indenture and the 2031 Notes will at all times rank <i>pari&#160;passu</i>,
without preference or priority, with all of our existing and future unsecured indebtedness and senior to any Preferred Stock we may issue.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2031
Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18,
or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either
case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional
borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with
respect to such borrowings equals at least 300% after such borrowings. See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating
to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts
invested and will increase the risk of investing in us.&#8221;</i></b></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">We have agreed that, for the period of time during which the 2031
Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18,
or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any
exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment
company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare
any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order
to maintain the closed-end investment company&#8217;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit
us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our
asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration
of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that
we may declare dividends on our Preferred Stock as long as such asset coverage with respect to our borrowings or other indebtedness is
not below 200%).</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">If, at any time, we are not subject to the reporting requirements
of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we have agreed to furnish to holders
of the 2031 Notes and the trustee, for the period of time during which the 2031 Notes are outstanding, our audited annual consolidated
financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements,
within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material
respects, in accordance with applicable GAAP.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&#160;</p><div>


</div><div><a id="sa_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BOOK-ENTRY ISSUANCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Unless otherwise
indicated in the applicable prospectus supplement, securities will be issued in the form of one or more global certificates, or &#8220;global
securities,&#8221; registered in the name of a depositary or its nominee. Unless otherwise indicated in the applicable prospectus supplement,
the depositary will be The Depository Trust Company, or &#8220;DTC.&#8221; DTC has informed us that its nominee will be Cede&#160;&amp;
Co. Accordingly, we expect Cede&#160;&amp; Co. to be the initial registered holder of all securities that are issued in global form.
No person that acquires a beneficial interest in those securities will be entitled to receive a certificate representing that person&#8217;s
interest in the securities except as described herein or in the applicable prospectus supplement. Unless and until definitive securities
are issued under the limited circumstances described below, all references to actions by holders of securities issued in global form
will refer to actions taken by DTC upon instructions from its participants, and all references to payments and notices to holders will
refer to payments and notices to DTC or Cede&#160;&amp; Co., as the registered holder of these securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">DTC
has informed us that it is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking
organization&#8221; within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing
corporation&#8221; within the meaning of the New York Uniform Commercial Code, and a &#8220;clearing agency&#8221; registered
pursuant to the provisions of Section&#160;17A of the Exchange Act. DTC holds and provides asset servicing for over 3.5&#160;million
issues of U.S. and non-U.S. equity issues, corporate and municipal debt issues, and money market instruments from over 100 countries
that DTC&#8217;s participants, or &#8220;Direct Participants,&#8221; deposit with DTC. DTC also facilitates the post-trade
settlement among Direct Participants of sales and other securities transactions in deposited securities through electronic
computerized book-entry transfers and pledges between Direct Participants&#8217; accounts. This eliminates the need for physical
movement of securities certificates. Direct Participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust
companies, clearing corporations and certain other organizations. DTC is a wholly-owned subsidiary of The Depository
Trust&#160;&amp; Clearing Corporation, or &#8220;DTCC.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 115 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">DTCC is the holding
company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing
agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others such as both
U.S. and non-U.S. securities brokers and dealers, banks, trust companies and clearing corporations that clear through or maintain a custodial
relationship with a Direct Participant, either directly or indirectly, or &#8220;Indirect Participants.&#8221; DTC has a S&amp;P rating
of AA+. The DTC Rules&#160;applicable to its participants are on file with the SEC. More information about DTC can be found at <i>www.dtcc.com</i>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Purchases of securities
under the DTC system must be made by or through Direct Participants, which will receive a credit for the securities on DTC&#8217;s records.
The ownership interest of each actual purchaser of each security, or the &#8220;Beneficial Owner,&#8221; is in turn to be recorded on
the Direct and Indirect Participants&#8217; records. Beneficial Owners will not receive written confirmation from DTC of their purchase.
Beneficial Owners are, however, expected to receive written confirmations providing details of the transaction, as well as periodic statements
of their holdings, from the Direct or Indirect Participant through which the Beneficial Owner entered into the transaction. Transfers
of ownership interests in the securities are to be accomplished by entries made on the books of Direct and Indirect Participants acting
on behalf of Beneficial Owners. Beneficial Owners will not receive certificates representing their ownership interests in the securities,
except in the event that use of the book-entry system for the securities is discontinued.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">To facilitate subsequent
transfers, all securities deposited by Direct Participants with DTC are registered in the name of DTC&#8217;s partnership nominee, Cede&#160;&amp;
Co., or such other name as may be requested by an authorized representative of DTC. The deposit of the securities with DTC and their
registration in the name of Cede&#160;&amp; Co. or such other DTC nominee do not effect any change in beneficial ownership. DTC has no
knowledge of the actual Beneficial Owners of the securities; DTC&#8217;s records reflect only the identity of the Direct Participants
to whose accounts the securities are credited, which may or may not be the Beneficial Owners. The Direct and Indirect Participants will
remain responsible for keeping account of their holdings on behalf of their customers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Conveyance of notices
and other communications by DTC to Direct Participants, by Direct Participants to Indirect Participants, and by Direct Participants and
Indirect Participants to Beneficial Owners will be governed by arrangements among them, subject to any statutory or regulatory requirements
as may be in effect from time to time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Redemption notices
will be sent to DTC. If less than all of the securities within an issue are being redeemed, DTC&#8217;s practice is to determine by lot
the amount of the interest of each Direct Participant in such issue to be redeemed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Neither DTC nor
Cede&#160;&amp; Co. (nor any other DTC nominee) will consent or vote with respect to securities unless authorized by a Direct Participant
in accordance with DTC&#8217;s Procedures. Under its usual procedures, DTC mails an Omnibus Proxy to us as soon as possible after the
record date. The Omnibus Proxy assigns Cede&#160;&amp; Co.&#8217;s consenting or voting rights to those Direct Participants to whose
accounts securities are credited on the record date (identified in a listing attached to the Omnibus Proxy).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Redemption
proceeds, distributions and interest payments on the securities will be made to Cede&#160;&amp; Co., or such other nominee as may be
requested by an authorized representative of DTC. DTC&#8217;s practice is to credit Direct Participants&#8217; accounts upon
DTC&#8217;s receipt of funds and corresponding detail information from us or the applicable trustee or depositary on the payment
date in accordance with their respective holdings shown on DTC&#8217;s records. Payments by Participants to Beneficial Owners will
be governed by standing instructions and customary practices, as is the case with securities held for the accounts of customers in
bearer form or registered in &#8220;street name,&#8221; and will be the responsibility of such Participant and not of DTC nor its
nominee, the applicable trustee or depositary, or us, subject to any statutory or regulatory requirements as may be in effect from
time to time. Payment of redemption proceeds, distributions and interest payments to Cede&#160;&amp; Co. (or such other nominee as
may be requested by an authorized representative of DTC) is the responsibility of us or the applicable trustee or depositary.
Disbursement of such payments to Direct Participants will be the responsibility of DTC, and disbursement of such payments to the
Beneficial Owners will be the responsibility of Direct and Indirect Participants.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 116 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">DTC may discontinue
providing its services as securities depository with respect to the securities at any time by giving reasonable notice to us or to the
applicable trustee or depositary. Under such circumstances, in the event that a successor securities depository is not obtained, certificates
are required to be printed and delivered. We may decide to discontinue use of the system of book-entry-only transfers through DTC (or
a successor securities depository). In that event, certificates will be printed and delivered to DTC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The information
in this section concerning DTC and DTC&#8217;s book-entry system has been obtained from sources that we believe to be reliable, but we
take no responsibility for the accuracy thereof.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">None of the Company,
the Adviser, any registrar and transfer agent, trustee, any depositary, or any agent of any of them, will have any responsibility or
liability for any aspect of DTC&#8217;s or any participant&#8217;s records relating to, or for payments made on account of, beneficial
interests in a global security, or for maintaining, supervising or reviewing any records relating to such beneficial interests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Secondary trading
in notes and debentures of corporate issuers is generally settled in clearing-house or next-day funds. In contrast, beneficial interests
in a global security, in some cases, may trade in the DTC&#8217;s same-day funds settlement system, in which case secondary market trading
activity in those beneficial interests would be required by DTC to settle in immediately available funds. There is no assurance as to
the effect, if any, that settlement in immediately available funds would have on trading activity in such beneficial interests. Also,
settlement for purchases of beneficial interests in a global security upon the original issuance of this security may be required to
be made in immediately available funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PLAN OF DISTRIBUTION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may offer, from
time to time, up to $1,000,000,000 of our common stock, Preferred Stock, subscription rights to purchase shares of our common stock,
or debt securities in one or more underwritten public offerings, at-the-market offerings, negotiated transactions, block trades, best
efforts or a combination of these methods. In addition, this prospectus relates to 5,822,728 shares of our common stock that may be sold
by the selling stockholders. We or the selling stockholders may sell securities directly or through agents we designate from time to
time. Any underwriter or agent involved in the offer and sale of the securities will be named in the applicable prospectus supplement.
A prospectus supplement or supplements will also describe the terms of the offering of the securities, including: the purchase price
of the securities and the proceeds, if any, we will receive from the sale; any overallotment options under which underwriters may purchase
additional securities from us; any agency fees or underwriting discounts and other items constituting agents&#8217; or underwriters&#8217;
compensation; the public offering price; any discounts or concessions allowed or re-allowed or paid to dealers; and any securities exchange
or market on which the securities may be listed. Only underwriters named in the prospectus supplement will be underwriters of the securities
offered by such prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The distribution
of the securities may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at
prevailing market prices at the time of sale, at prices related to such prevailing market prices, or at negotiated prices, provided,
however, that the offering price per share of our common stock, less any underwriting commissions or discounts, must equal or exceed
the NAV per share of our common stock at the time of the offering except (1)&#160;in connection with a rights offering to our existing
stockholders, (2)&#160;with the consent of the majority of our common stockholders, (3)&#160;the conversion of a convertible security
in accordance with its terms or (4)&#160;under such circumstances as the SEC may permit. The price at which securities may be distributed
may represent a discount from prevailing market prices.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 117 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In connection with
the sale of the securities, underwriters or agents may receive compensation from us or from purchasers of the securities, for whom they
may act as agents, in the form of discounts, concessions or commissions. Our common stockholders will indirectly bear such fees and expenses
as well as any other fees and expenses incurred by us in connection with any sale of securities. Underwriters may sell the securities
to or through dealers and such dealers may
receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers
for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of the securities may be deemed
to be underwriters under the Securities Act, and any discounts and commissions they receive from us and any profit realized by them on
the resale of the securities may be deemed to be underwriting discounts and commissions under the Securities Act. Any such underwriter
or agent will be identified and any such compensation received from us will be described in the applicable prospectus supplement. The
maximum aggregate commission or discount to be received by any member of the Financial Industry Regulatory Authority or independent broker-dealer
will not be greater than 8% of the gross proceeds of the sale of securities offered pursuant to this prospectus and any applicable prospectus
supplement. We may also reimburse the underwriter or agent for certain fees and legal expenses incurred by it.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any underwriter
may engage in overallotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation&#160;M
under the Exchange Act. Overallotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions
permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering
or other short-covering transactions involve purchases of the securities, either through exercise of the overallotment option or in the
open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim a selling
concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering transaction to
cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced,
the underwriters may discontinue any of the activities at any time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Any underwriters
that are qualified market makers on the NYSE may engage in passive market making transactions in our common stock on NYSE in accordance
with Regulation&#160;M under the Exchange Act, during the business day prior to the pricing of the offering, before the commencement
of offers or sales of our common stock. Passive market makers must comply with applicable volume and price limitations and must be identified
as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent
bid for such security; if all independent bids are lowered below the passive market maker&#8217;s bid, however, the passive market maker&#8217;s
bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities
at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may sell securities
directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and
we will describe any commissions we will pay the agent in the applicable prospectus supplement. Unless the prospectus supplement states
otherwise, our agent will act on a best-efforts basis for the period of its appointment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Unless otherwise
specified in the applicable prospectus supplement, each series of securities will be a new issue with no trading market, other than our
common stock, which is traded on the NYSE. We may elect to list any other series of securities on any exchanges, but we are not obligated
to do so. We cannot guarantee the liquidity of the trading markets for any securities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Under agreements
that we may enter, underwriters, dealers and agents who participate in the distribution of shares of our securities may be entitled to
indemnification by us against certain liabilities, including liabilities under the Securities Act, or contribution with respect to payments
that the agents or underwriters may make with respect to these liabilities. Underwriters, dealers and agents may engage in transactions
with, or perform services for, us in the ordinary course of business.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">If so indicated
in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit offers by certain
institutions to purchase our securities from us pursuant to contracts providing for payment and delivery on a future date. Institutions
with which such contracts may be made include commercial and savings banks, insurance companies, pension funds, investment companies,
educational and charitable institutions and others, but in all cases such institutions must be approved by us. The obligations of any
purchaser under any such contract will be subject to the condition that the purchase of our securities shall not at the time of delivery
be prohibited under the laws of the jurisdiction to which such purchaser is subject. The underwriters and such other agents will not
have any responsibility in respect of the validity or performance of such contracts.
Such contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set
forth the commission payable for solicitation of such contracts.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 118 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may enter into
Derivative Transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated
transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities
covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may
use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock,
and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third
parties in such sale transactions will be underwriters and, if not identified in this prospectus, will be identified in the applicable
prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">In order to comply
with the securities laws of certain states, if applicable, our securities offered hereby will be sold in such jurisdictions only through
registered or licensed brokers or dealers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGULATION AS A CLOSED-END MANAGEMENT INVESTMENT
COMPANY</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As a registered
closed-end management investment company, we are subject to regulation under the 1940 Act. Under the 1940 Act, unless authorized by vote
of a majority of our outstanding voting securities, we may not:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">change our classification to an open-end management investment
company;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">alter any of our fundamental policies, which are set forth below
in <b><i>&#8220;&#8212; Investment Restrictions;&#8221;</i></b> or</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">change the nature of our business so as to cease to be an investment
company.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A majority of the
outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (a)&#160;67% or more of such company&#8217;s
voting securities present at a meeting if more than 50% of the outstanding voting securities of such company are present or represented
by proxy, or (b)&#160;more than 50% of the outstanding voting securities of such company.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As with other companies
regulated by the 1940 Act, a registered closed-end management investment company must adhere to certain substantive regulatory requirements.
A majority of our directors must be persons who are not &#8220;interested persons&#8221; of us, as that term is defined in the 1940 Act.
We are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect the closed-end management
investment company. Furthermore, as a registered closed-end management investment company, we are prohibited from protecting any director
or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless
disregard of the duties involved in the conduct of such person&#8217;s office. We may also be prohibited under the 1940 Act from knowingly
participating in certain transactions with our affiliates absent exemptive relief or other prior approval by the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We will generally
not be able to issue and sell shares of our common stock at a price below the then current NAV per share (exclusive of any distributing
commission or discount). See <b><i>&#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating to Our Business and Structure&#8201;&#8212;&#8201;Regulations
governing our operation as a registered closed-end management investment company affect our ability to raise additional capital and the
way in which we do so. The raising of debt capital may expose us to risks, including the typical risks associated with leverage.&#8221;
</i></b>We may, however, sell shares of our common stock at a price below the then current NAV per share if our board of directors determines
that such sale is in our best interests and the best interests of our stockholders, and the holders of a majority of the shares of our
common stock, approves such sale. In addition, we may generally issue new shares of our common stock at a price below NAV in rights offerings
to existing stockholders, in payment of dividends and in certain other limited circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Restrictions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our investment objectives
and our investment policies and strategies described in this prospectus, except for the eight investment restrictions designated as fundamental
policies under this caption, are not fundamental and may be changed by the board of directors without stockholder approval.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 119 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As referred to above,
the following eight investment restrictions are designated as fundamental policies and, as such, cannot be changed without the approval
of the holders of a majority of our outstanding voting securities:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(1)&#160;&#160;&#160;We
may not borrow money, except as permitted by (i)&#160;the 1940 Act, or interpretations or modifications by the SEC, SEC staff or other
authority with appropriate jurisdiction, or (ii)&#160;exemptive or other relief or permission from the SEC, SEC staff or other authority
with appropriate jurisdiction;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(2)&#160;&#160;&#160;We
may not engage in the business of underwriting securities issued by others, except to the extent that we may be deemed to be an underwriter
in connection with the disposition of portfolio securities;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(3)&#160;&#160;&#160;We
may not purchase or sell physical commodities or contracts for the purchase or sale of physical commodities. Physical commodities do
not include futures contracts with respect to securities, securities indices, currency or other financial instruments;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(4)&#160;&#160;&#160;We
may not purchase or sell real estate, which term does not include securities of companies which deal in real estate or mortgages or investments
secured by real estate or interests therein, except that we reserve freedom of action to hold and to sell real estate acquired as a result
of our ownership of securities;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(5)&#160;&#160;&#160;We
may not make loans, except to the extent permitted by (i)&#160;the 1940 Act, or interpretations or modifications by the SEC, SEC staff
or other authority with appropriate jurisdiction, or (ii)&#160;exemptive or other relief or permission from the SEC, SEC staff or other
authority with appropriate jurisdiction. For purposes of this investment restriction, the purchase of debt obligations (including acquisitions
of loans, loan participations or other forms of debt instruments) shall not constitute loans by us;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(6)&#160;&#160;&#160;We
may not issue senior securities, except to the extent permitted by (i)&#160;the 1940 Act, or interpretations or modifications by the
SEC, the SEC staff or other authority with appropriate jurisdiction, or (ii)&#160;exemptive or other relief or permission from the SEC,
SEC staff or other authority with appropriate jurisdiction;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(7)&#160;&#160;&#160;We
may not invest in any security if as a result of such investment, 25% or more of the value of our total assets, taken at market value
at the time of each investment, are in the securities of issuers in any particular industry except (a)&#160;securities issued or guaranteed
by the U.S. government and its agencies and instrumentalities or tax-exempt securities of state and municipal governments or their political
subdivisions (however, not including private purpose industrial development bonds issued on behalf of non-government issuers), or (b)&#160;as
otherwise provided by the 1940 Act, as amended from time to time, and as modified or supplemented from time to time by (i)&#160;the rules&#160;and
regulations promulgated by the SEC under the 1940 Act, as amended from time to time, and (ii)&#160;any exemption or other relief applicable
to us from the provisions of the 1940 Act, as amended from time to time. For purposes of this restriction, in the case of investments
in loan participations between us and a bank or other lending institution participating out the loan, we will treat both the lending
bank or other lending institution and the borrower as &#8220;issuers.&#8221; For purposes of this restriction, an investment in a CLO,
collateralized bond obligation, CDO or a swap or other derivative will be considered to be an investment in the industry (if any) of
the underlying or reference security, instrument or asset; and</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">(8)&#160;&#160;&#160;We
may not engage in short sales, purchases on margin, or the writing of put or call options, except as permitted by (i)&#160;the 1940 Act,
or interpretations or modifications by the SEC, SEC staff or other authority with appropriate jurisdiction or (ii)&#160;exemptive or
other relief or permission from the SEC, SEC staff or other authority with appropriate jurisdiction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The latter part
of certain of our fundamental investment restrictions (<i>i.e.</i>, the references to &#8220;except to the extent permitted by (i)&#160;the
1940 Act, or interpretations or modifications by the SEC, the SEC staff or other authority with appropriate jurisdiction, or (ii)&#160;exemptive
or other relief or permission from the SEC, SEC staff or other authority with appropriate jurisdiction&#8221;) provides us with flexibility
to change our limitations in connection with changes in applicable law, rules, regulations or exemptive relief. The language used in
these restrictions provides the necessary flexibility to allow our board of directors to respond efficiently to these kinds of developments
without the delay and expense of a stockholder meeting.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 120 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our
80% policy with respect to investments in credit and credit-related instruments is not fundamental and may be changed by our board
of directors without stockholder approval. Stockholders will be provided with sixty (60) days&#8217; notice in the manner prescribed
by the SEC before making any change to this policy. Our investments in derivatives, other investment companies, and other
instruments designed to obtain indirect exposure to credit and credit-related instruments are counted towards our 80% investment
policy to the extent such instruments have similar economic characteristics to the investments included within that policy.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Whenever an investment
policy or investment restriction set forth in this prospectus states a maximum&#160;percentage of assets that may be invested in any
security or other asset or describes a policy regarding quality standards, such&#160;percentage limitation or standard shall be determined
immediately after and as a result of our acquisition of such security or asset. Accordingly, any later increase or decrease resulting
from a change in values, assets or other circumstances or any subsequent rating change made by a rating agency (or as determined by the
Adviser if the security is not rated by a rating agency) will not compel us to dispose of such security or other asset. Notwithstanding
the foregoing, we must always be in compliance with the borrowing policies set forth above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Proxy Voting Policies and Procedures</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We have delegated
our proxy voting responsibility to the Adviser. The Proxy Voting Policies and Procedures of the Adviser are set forth below. The guidelines
will be reviewed periodically by the Adviser and our independent directors, and, accordingly, are subject to change. For purposes of
these Proxy Voting Policies and Procedures described below, &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refers to the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Introduction</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">An investment adviser
registered under the Advisers Act has a fiduciary duty to act solely in the best interests of its clients. As part of this duty, we recognize
that we must vote client securities in a timely manner free of conflicts of interest and in the best interests of our clients.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">These policies and
procedures for voting proxies for our investment advisory clients are intended to comply with Section&#160;206 of, and Rule&#160;206(4)-6
under, the Advisers Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Proxy Policies</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Based on the nature
of our investment strategy, we do not expect to receive proxy proposals but may from time to time receive amendments, consents or resolutions
applicable to investments held by us. It is our general policy to exercise our voting or consent authority in a manner that serves the
interests of the Company&#8217;s stockholders. We may occasionally be subject to material conflicts of interest in voting proxies due
to business or personal relationships we maintain with persons having an interest in the outcome of certain votes. If at any time we
become aware of a material conflict of interest relating to a particular proxy proposal, our chief compliance officer will review the
proposal and determine how to vote the proxy in a manner consistent with interests of the Company&#8217;s stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Proxy Voting Records</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Information regarding
how we voted proxies relating to portfolio securities during the most recent 12-month period ended June&#160;30 is available, without
charge: (1)&#160;upon request, by calling toll free&#160;(844) 810-6501; and (2)&#160;on the SEC&#8217;s website at <i>http://www.sec.gov</i>.
You may also obtain information about how we voted proxies by making a written request for proxy voting information to: Eagle Point Credit
Management LLC, 600 Steamboat Road, Suite&#160;202, Greenwich, CT 06830.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Privacy Policy</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We
are committed to protecting your privacy. This privacy notice explains our privacy policies and those of our affiliated companies.
The terms of this notice apply to both current and former stockholders. We will safeguard, according to strict standards of security
and confidentiality, all information we receive about you. With regard to this information, we maintain procedural safeguards that
are reasonably designed to comply with federal standards. We have implemented procedures that are designed to restrict access to
your personal information to authorized employees of the Adviser, the Administrator and their affiliates who need to know your
personal information to perform their jobs, and in connection with servicing your account. Our goal is to limit the collection and
use of information about you. While we may share your personal information with our affiliates in connection with servicing your
account, our affiliates are not permitted to share your information with non-affiliated entities, except as permitted or required by
law.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 121 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When you purchase
shares of our common stock and in the course of providing you with products and services, we and certain of our service providers, such
as a transfer agent, may collect personal information about you, such as your name, address, social security number or tax identification
number. This information may come from sources such as account applications and other forms, from other written, electronic or verbal
correspondence, from your transactions, from your brokerage or financial advisory firm, financial adviser or consultant, and/or information
captured on applicable websites.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We do not disclose
any personal information provided by you or gathered by us to non-affiliated third parties, except as permitted or required by law or
for our everyday business purposes, such as to process transactions or service your account. For example, we may share your personal
information in order to send you annual and semiannual reports, proxy statements and other information required by law, and to send you
information we believe may be of interest to you. We may disclose your personal information to unaffiliated third party financial service
providers (which may include a custodian, transfer agent, accountant or financial printer) who need to know that information in order
to provide services to you or to us. These companies are required to protect your information and use it solely for the purpose for which
they received it or as otherwise permitted by law. We may also provide your personal information to your brokerage or financial advisory
firm and/or to your financial adviser or consultant, as well as to professional advisors, such as accountants, lawyers and consultants.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We reserve the right
to disclose or report personal or account information to non-affiliated third parties in limited circumstances where we believe in good
faith that disclosure is required by law, such as in accordance with a court order or at the request of government regulators or law
enforcement authorities or to protect our rights or property. We may also disclose your personal information to a non-affiliated third
party at your request or if you consent in writing to the disclosure.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADDITIONAL INVESTMENTS AND TECHNIQUES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our primary investment
strategies are described elsewhere in this prospectus. The following is a description of the various investment policies that may be
engaged in as a secondary strategy, and a summary of certain attendant risks.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment in Debt Securities, Other Types of Credit Instruments
and Other Credit Investments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Debt
Securities.</i></span>&#160;&#160;&#160;We may invest in debt securities, including debt securities rated below investment grade, or
&#8220;junk&#8221; securities. Debt securities of corporate and governmental issuers in which we may invest are subject to the risk of
an issuer&#8217;s inability to meet principal and interest payments on the obligations (credit risk) and also may be subject to price
volatility due to such factors as interest rate sensitivity, market perception of the creditworthiness of the issuer and general market
liquidity (market risk).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Defaulted
Securities.</i></span>&#160;&#160;&#160;We may invest in defaulted securities. The risk of loss due to default may be considerably greater
with lower-quality securities because they are generally unsecured and are often subordinated to other debt of the issuer. Investing
in defaulted debt securities involves risks such as the possibility of complete loss of the investment where the issuer does not restructure
to enable it to resume principal and interest payments. If the issuer of a security in our portfolio defaults, we may have unrealized
losses on the security, which may lower our NAV. Defaulted securities tend to lose much of their value before they default. Thus, our
NAV may be adversely affected before an issuer defaults. In addition, we may incur additional expenses if it must try to recover principal
or interest payments on a defaulted security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 122 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certificates
of Deposit, Bankers&#8217; Acceptances and Time Deposits.</i></span>&#160;&#160;&#160;We may acquire certificates of deposit,
bankers&#8217; acceptances and time deposits. Certificates of deposit are negotiable certificates issued against funds deposited in
a commercial bank for a definite period of time and earning a specified return. Bankers&#8217; acceptances are negotiable drafts or
bills of exchange, normally drawn by an importer or exporter to pay for specific merchandise, which are &#8220;accepted&#8221; by a
bank, meaning in effect that the bank unconditionally agrees to pay the face value of the instrument on maturity. Certificates of
deposit and bankers&#8217; acceptances acquired by us will be dollar-denominated obligations of domestic banks, savings and loan
associations or financial institutions at the time of purchase, have capital, surplus and undivided profits in excess of
$100&#160;million (including assets of both domestic and foreign branches), based on latest published reports, or less than
$100&#160;million if the principal amount of such bank obligations are fully insured by the U.S. government. In addition to
purchasing certificates of deposit and bankers&#8217; acceptances, to the extent permitted under our investment objectives and
policies stated in this prospectus, we may make interest-bearing time or other interest-bearing deposits in commercial or savings
banks. Time deposits are non-negotiable deposits maintained at a banking institution for a specified period of time at a specified
interest rate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commercial
Paper and Short-Term Notes.</i></span>&#160;&#160;&#160;We may invest a portion of our assets in commercial paper and short-term notes.
Commercial paper consists of unsecured promissory notes issued by corporations. Issues of commercial paper and short-term notes will
normally have maturities of less than nine&#160;months and fixed rates of return, although such instruments may have maturities of up
to one year. Commercial paper and short-term notes will consist of issues rated at the time of purchase &#8220;A-2&#8221; or higher by
S&amp;P, &#8220;Prime-1&#8221; or &#8220;Prime-2&#8221; by Moody&#8217;s, or similarly rated by another nationally recognized statistical
rating organization or, if unrated, will be determined by the Adviser to be of comparable quality.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>CLO
Class&#160;M Notes, Fee Notes and Participation Agreements.</i></span>&#160;&#160;&#160;We may acquire CLO Class&#160;M notes, fee notes
and participation agreements with CLO collateral managers. There is not an active secondary market for CLO Class&#160;M notes, fee notes
and participation agreements. Further, CLO Class&#160;M notes, fee notes and participation agreements may have significant restrictions
on transfer and require continued ownership of certain amounts of CLO equity in the related CLO for the instrument to be valid. CLO Class&#160;M
notes, fee notes and participation agreements are also subject to the risk of early call of the CLO, and may have no make-whole or other
yield protection provisions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Zero
Coupon Securities.</i></span>&#160;&#160;&#160;Among the debt securities in which we may invest are zero coupon securities. Zero coupon
securities are debt obligations that do not entitle the holder to any periodic payment of interest prior to maturity or a specified date
when the securities begin paying current interest. They are issued and traded at a discount from their face amount or par value, which
discount varies depending on the time remaining until cash payments begin, prevailing interest rates, liquidity of the security and the
perceived credit quality of the issuer. The market prices of zero coupon securities generally are more volatile than the prices of securities
that pay interest periodically and in cash and are likely to respond to changes in interest rates to a greater degree than do other types
of debt securities having similar maturities and credit quality. Original issue discount earned on zero coupon securities must be included
in our income. Thus, to quality for tax treatment as a RIC and to avoid a certain excise tax on undistributed income, we may be required
to distribute as a dividend an amount that is greater than the total amount of cash we actually receive. These distributions must be
made from our cash assets or, if necessary, from the proceeds of sales of portfolio securities. We will not be able to purchase additional
income-producing securities with cash used to make such distributions, and our current income ultimately could be reduced as a result.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>U.S.
Government Securities.</i></span>&#160;&#160;&#160;We may invest in debt securities issued or guaranteed by agencies,
instrumentalities and sponsored enterprises of the U.S. Government. Some U.S. government securities, such as U.S. Treasury bills,
notes and bonds, and mortgage-related securities guaranteed by the Government National Mortgage Association, are supported by the
full faith and credit of the U.S.; others, such as those of the Federal Home Loan Banks, or &#8220;FHLBs,&#8221; or the Federal Home
Loan Mortgage Corporation, or &#8220;FHLMC,&#8221; are supported by the right of the issuer to borrow from the U.S. Treasury;
others, such as those of the Federal National Mortgage Association, or &#8220;FNMA,&#8221; are supported by the discretionary
authority of the U.S. Government to purchase the agency&#8217;s obligations; and still others, such as those of the Student Loan
Marketing Association, are supported only by the credit of the issuing agency, instrumentality or enterprise. Although U.S.
Government-sponsored enterprises, such as the FHLBs, FHLMC, FNMA and the Student Loan Marketing Association, may be chartered or
sponsored by Congress, they are not funded by Congressional appropriations, and their securities are not issued by the U.S. Treasury
or supported by the full faith and credit of the U.S. Government and involve increased credit risks. Although legislation has been
enacted to support certain government sponsored entities, including the FHLBs, FHLMC and FNMA, there is no assurance that the
obligations of such entities will be satisfied in full, or that such obligations will not decrease in value or default. It is
difficult, if not impossible, to predict the future political, regulatory or economic changes that could impact the government
sponsored entities and the values of their related securities or obligations. In addition, certain governmental entities, including
FNMA and FHLMC, have been subject to regulatory scrutiny regarding their accounting policies and practices and other concerns that
may result in legislation, changes in regulatory oversight and/or other consequences that could adversely affect the credit quality,
availability or investment character of securities issued by these entities. U.S. Government debt securities generally involve lower
levels of credit risk than other types of debt securities of similar maturities, although, as a result, the yields available from
U.S. Government debt securities are generally lower than the yields available from such other securities. Like other debt
securities, the values of U.S. government securities change as interest rates fluctuate. Fluctuations in the value of portfolio
securities will not affect interest income on existing portfolio securities but will be reflected in our NAV.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 123 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Distressed Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may invest in
distressed investments including loans, loan participations, or bonds, many of which are not publicly traded and which may involve a
substantial degree of risk. In certain periods, there may be little or no liquidity in the markets for these securities or instruments.
In addition, the prices of such securities or instruments may be subject to periods of abrupt and erratic market movements and above-average
price volatility. It may be more difficult to value such securities and the spread between the bid and asked prices of such securities
may be greater than normally expected. If the Adviser&#8217;s evaluation of the risks and anticipated outcome of an investment in a distressed
security should prove incorrect, we may lose a substantial portion or all of our investment or we may be required to accept cash or securities
with a value less than our original investment.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may hold long
and short positions in common stock, Preferred Stock and convertible securities of U.S. and non-U.S. issuers. We also may invest in depositary
receipts or shares relating to non-U.S. securities. Equity securities fluctuate in value, often based on factors unrelated to the fundamental
economic condition of the issuer of the securities, including general economic and market conditions, and these fluctuations can be pronounced.
We may purchase securities in all available securities trading markets and may invest in equity securities without restriction as to
market capitalization, such as those issued by smaller capitalization companies, including micro-cap companies.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exchange-Traded Notes (&#8220;ETNs&#8221;)</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may invest in
ETNs. ETNs are a type of senior, unsecured, unsubordinated debt security issued by financial institutions that combines both aspects
of bonds and ETFs. An ETN&#8217;s returns are based on the performance of a market index minus fees and expenses. Similar to ETFs, ETNs
are listed on an exchange and traded in the secondary market. However, unlike an ETF, an ETN can be held until the ETN&#8217;s maturity,
at which time the issuer will pay a return linked to the performance of the market index to which the ETN is linked minus certain fees.
Unlike regular bonds, ETNs do not make periodic interest payments and principal is not protected. ETNs are subject to credit risk and
the value of an ETN may drop due to a downgrade in the issuer&#8217;s credit rating, despite the underlying market benchmark or strategy
remaining unchanged. The value of an ETN may also be influenced by time to maturity, level of supply and demand for the ETN, volatility
and lack of liquidity in underlying assets, changes in the applicable interest rates, changes in the issuer&#8217;s credit rating, and
economic, legal, political, or geographic events that affect the referenced underlying asset. When we invest in ETNs we will bear our
proportionate share of any fees and expenses borne by the ETN. Our decision to sell our ETN holdings may be limited by the availability
of a secondary market. In addition, although an ETN may be listed on an exchange, the issuer may not be required to maintain the listing
and there can be no assurance that a secondary market will exist for an ETN.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Securities</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Preferred
securities in which we may invest include trust preferred securities, monthly income preferred securities, quarterly income bond
securities, quarterly income debt securities, quarterly income preferred securities, corporate trust securities, traditional
Preferred Stock, contingent-capital securities, hybrid securities (which have characteristics of both equity and fixed-income
instruments) and public income notes. Preferred securities are typically issued by corporations, generally in the form of
interest-bearing notes or preferred securities, or by an affiliated business trust of a corporation, generally in the form of
beneficial interests in subordinated debentures or similarly structured securities. The preferred securities market consists of both
fixed and adjustable coupon rate securities that are either perpetual in nature in that they have no maturity dates or have stated
maturity dates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 124 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment in Relatively New Issuers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may invest in
the securities of new issuers. Investments in relatively new issuers, <i>i.e.</i>, those having continuous operating histories of less
than three&#160;years, may carry special risks and may be more speculative because such issuers are relatively unseasoned. Such issuers
may also lack sufficient resources, may be unable to generate internally the funds necessary for growth and may find external financing
to be unavailable on favorable terms or even totally unavailable. Certain issuers may be involved in the development or marketing of
a new product with no established market, which could lead to significant losses. Securities of such issuers may have a limited trading
market which may adversely affect their disposition and can result in their being priced lower than might otherwise be the case. If other
investors who invest in such issuers seek to sell the same securities when we attempt to dispose of our holdings, we may receive lower
prices than might otherwise be the case.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Demand Deposit Accounts</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We may hold a significant
portion of our cash assets in interest-bearing or non-interest-bearing demand deposit accounts at our custodian or another depository
institution insured by the FDIC. The FDIC is an independent agency of the U.S. government, and FDIC deposit insurance is backed by the
full faith and credit of the U.S. government. We expect to hold cash that exceeds the amounts insured by the FDIC for such accounts.
As a result, in the event of a failure of a depository institution where we hold such cash, our cash is subject to the risk of loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Simultaneous Investments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Investment decisions,
made by the Adviser on our behalf, are made independently from those of the other funds and accounts advised by the Adviser and its affiliates.
If, however, such other accounts wish to invest in, or dispose of, the same securities as us, available investments will be allocated
equitably between us and other accounts. This procedure may adversely affect the size of the position we obtain or dispose of or the
price we pay.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Short Sales</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">When we engage in
a short sale of a security, we must, to the extent required by law, borrow the security sold short and deliver it to the counterparty.
We may have to pay a fee to borrow particular securities and would often be obligated to pay over any payments received on such borrowed
securities. If the price of the security sold short increases between the time of the short sale and the time that we replace the borrowed
security, we will incur a loss; conversely, if the price declines, we will realize a capital gain. Any gain will be decreased, and any
loss increased, by the transaction costs described above.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">To the extent we
engage in short sales, we will comply with the applicable provisions of Rule&#160;18f-4 with respect to such transactions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONTROL PERSONS, PRINCIPAL STOCKHOLDERS AND
SELLING STOCKHOLDERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">A control person
is a person who beneficially owns more than 25% of the voting securities of a company. The following table sets forth certain ownership
information as of May&#160;31, 2023 with respect to shares of our common stock, our Series&#160;C Term Preferred Stock and Series&#160;D
Preferred Stock held by (1)&#160;those persons who directly or indirectly own, control or hold with the power to vote, 5% or more of
the outstanding shares of our common stock, our Series&#160;C Term Preferred Stock and our Series&#160;D Preferred Stock, (2)&#160;all
of our officers and directors as a group and (3)&#160;selling stockholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 125 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">This
prospectus also relates to 5,822,728 shares of our common stock that may be offered for resale by the stockholders identified below.
The selling stockholders acquired their shares of our common stock in connection with our conversion to a corporation. The Adviser
is primarily owned by the selling stockholders. We are registering the shares to permit the stockholders and their pledgees, donees,
transferees and other successors-in-interest that receive their shares from a stockholder as a gift, partnership distribution or
other non-sale related transfer after the date of this prospectus to resell the shares when and as they deem appropriate. We do not
know how long the stockholders will hold the shares before selling them, if at all, or how many shares they will sell, if any, and
we currently have no agreements, arrangements or understandings with the stockholders regarding the sale of any of the resale
shares. We may pay the printing, legal, filing and other similar expenses of any offering of common stock by the selling
stockholders who are not our affiliates at the time of the offering. The selling stockholders will bear all other expenses,
including any brokerage fees, underwriting discounts and commissions, of any such offering.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; border-bottom: white 1pt solid"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; border-bottom: white 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="white-space: nowrap; border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Common Stock</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Beneficially
    Owned<sup>(1)</sup><br/>
    &#160;Immediately Prior to<br/>
    Offering </b></span></p></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; border-bottom: white 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
    Stock<br/>
    Beneficially Owned<sup>(1)</sup>&#160;<br/>
    Immediately Prior to<br/>
    Offering </b></span></td>
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p></td>
    <td colspan="2" style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Shares
                                            of<br/>
                                            Common<br/>
                                            Stock</b></span></p></td>
    <td style="white-space: nowrap; border-bottom: white 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="4" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock<br/>
    Beneficially<br/>
    Owned<sup>(1)</sup>&#160;Following<br/>
    the Offering </b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Address </b></span></td>
    <td style="white-space: nowrap; border-bottom: white 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; border-bottom: white 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    </b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Offered</b></span></td>
    <td style="white-space: nowrap; border-bottom: white 1pt solid; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    </b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%
    </b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="white-space: nowrap"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 1pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="white-space: nowrap; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trident Capital
    IX, L.P.(2)</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,822,728</span></td>
    <td style="white-space: nowrap; text-align: right; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7</span></td>
    <td style="white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: right"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: right"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: right"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,822,728</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: right"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: right"><span style="font-size: 10pt">&#160;</span></td>
    <td style="white-space: nowrap; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="white-space: nowrap; width: 1%; text-align: right"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Beneficial ownership is determined in accordance with the rules&#160;of
the SEC and includes voting or investment power with respect to the securities.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Trident ECC Aggregator, LP is the sole record owner of 5,822,728
shares of our Common Stock. In its capacity as sole general partner of Trident ECC Aggregator, LP, Trident Capital IX L.P. shares dispositive
power with respect to, and may be deemed to beneficially own, all of the Common Shares directly owned by Trident ECC Aggregator, LP.
Trident Capital IX L.P. is a Cayman Islands limited partnership and Trident ECC Aggregator, LP is a Delaware limited partnership. The
principal business and principal office address of each of Trident Capital IX L.P. and Trident ECC Aggregator, LP is 20&#160;Horseneck
Lane, Greenwich, CT 06830.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">All directors and
officers of the Company as a group own less than 1.0% of each of our common stock and our aggregate outstanding Preferred Stock.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BROKERAGE ALLOCATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Since we acquire
and dispose of most of our investments in privately negotiated transactions or in the over-the-counter markets, we are generally not
required to pay a stated brokerage commission. However, to the extent a broker-dealer is involved in a transaction, the price paid or
received by us, as applicable, may reflect a mark-up or mark-down. Subject to policies established by our board of directors, the Adviser
will be primarily responsible for selecting brokers and dealers to execute transactions with respect to the publicly traded securities
portion of our portfolio transactions and the allocation of brokerage commissions. The Adviser does not expect to execute transactions
through any particular broker or dealer but will seek to obtain the best net results for us under the circumstances, taking into account
such factors as price (including the applicable brokerage commission or dealer spread), size of order, difficulty of execution and operational
facilities of the firm and the firm&#8217;s risk and skill in positioning blocks of securities. The Adviser generally will seek reasonably
competitive trade execution costs but will not necessarily pay the lowest spread or commission available. Subject to applicable legal
requirements and consistent with Section&#160;28(e)&#160;of the Exchange Act, the Adviser may select a broker based upon brokerage or
research services provided. In return for such services, we may pay a higher commission than other brokers would charge if the Adviser
determines in good faith that such commission is reasonable in relation to the services provided.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>LEGAL MATTERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Certain legal matters
in connection with the securities offered by this prospectus will be passed upon for us by Dechert LLP, Boston, Massachusetts. Dechert
LLP also represents the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CUSTODIAN AND TRANSFER AGENT</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Our portfolio securities
are held pursuant to a custodian agreement between us and Wells Fargo Bank, National Association. The principal business address of Wells
Fargo Bank, National Association is 9062&#160;Old Annapolis Road, Columbia, MD 21045.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in"></p><div>


</div><!-- Field: Page; Sequence: 126 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">American Stock Transfer&#160;&amp;
Trust Company, LLC serves as our transfer agent, registrar, dividend disbursement agent and stockholder servicing agent, as well as agent
for our DRIP. The principal business address of American Stock&#160;&amp; Transfer Company, LLC is 6201 15th Avenue, Brooklyn, NY 11219.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">KPMG LLP, an independent
registered public accounting firm located at 345 Park Avenue, New York, NY 10154-0102, provides audit services, tax return preparation,
and assistance and consultation with respect to the preparation of filings with the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="sa_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADDITIONAL INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We file with or
submit to the SEC annual and semi-annual reports, proxy statements and other information meeting the informational requirements of the
Exchange Act or pursuant to Rule&#160;30b2-1 under the 1940 Act. The SEC maintains a website that contains reports, proxy and information
statements and other information we file with the SEC at www.sec.gov. This information is also available free of charge by writing us
at Eagle Point Credit Company Inc., 600 Steamboat Road, Suite&#160;202, Greenwich, CT 06830, Attention: Investor Relations, by telephone
at (844) 810-6501, or on our website at <i>www.eaglepointcreditcompany.com.</i> Information on our website is not incorporated by reference
into or a part of this prospectus.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Unresolved Staff Comments: Not Applicable.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&#160;</p><div>


</div><div><a id="sa_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INCORPORATION BY REFERENCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">As noted above,
this prospectus is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221;
the information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents.
The information incorporated by reference is considered to be part of this prospectus, and later information that we file with the SEC
will automatically update and supersede this information.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">We incorporate by
reference any future filings (including those made after the date of the filing of the registration statement of which this prospectus
is a part) we will make with the SEC under Sections&#160;13(a), 13(c), 14, or 15(d)&#160;of the Exchange Act or pursuant to Rule&#160;30b2-1
under the 1940 Act including any filings on or after the date of this prospectus from the date of filing (excluding any information furnished,
rather than filed), until we have sold all of the offered securities to which this prospectus and any accompanying prospectus supplement
relates or the offering is otherwise terminated. The information incorporated by reference is an important part of this prospectus. Any
statement in a document incorporated by reference into this prospectus will be deemed to be automatically modified or superseded to the
extent a statement contained in (1)&#160;this prospectus or (2)&#160;any other subsequently filed document that is incorporated by reference
into this prospectus modifies or supersedes such statement. The documents incorporated by reference herein include:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">our <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465923024867/tm237093d3_ncsra.htm" style="-sec-extract: exhibit">Annual Report on Form&#160;N-CSR, as amended, for the fiscal year ended December&#160;31, 2022, filed with the SEC on February&#160;24, 2023</a>;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; color: blue; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">our <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465923044291/tm2310479d2_def14a.htm" style="-sec-extract: exhibit">Definitive Proxy Statement on Schedule&#160;14A for the annual meeting of the stockholders, filed with the SEC on April&#160;12, 2023</a>;</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; color: blue; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">our <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1604174/000110465923059739/tm2315713d2_8k.htm" style="-sec-extract: exhibit">Current Report on Form&#160;8-K filed on May&#160;12, 2023</a>;
and</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; color: blue; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span>&#9679;</span></td><td style="text-align: justify">our <a href="http://www.sec.gov/Archives/edgar/data/1604174/000110465923063336/tm2316110d1_n30b2.htm" style="-sec-extract: exhibit">Interim Report filed pursuant to Rule&#160;30b2-1 under the 1940 Act, for the quarter ended March&#160;31, 2023, filed with the SEC on May&#160;23, 2023</a>.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; color: blue; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The Company will
provide without charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral request,
a copy of any and all of the documents that have been or may be incorporated by reference in this prospectus or the accompanying prospectus
supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All filings filed by the
Company pursuant to the Exchange Act or pursuant to Rule&#160;30b2-1 under the 1940 Act after the date of this registration statement
and prior to effectiveness of the registration statement shall be deemed to be incorporated by reference into this prospectus.</p><div>






</div><p style="margin: 0">&#160;</p><div>


</div><p style="margin: 0"></p><div>


</div><!-- Field: Page; Sequence: 127; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="margin: 0">&#160;</p><div>


</div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2429841d6_backcover.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2429841-6/tm2429841-6_424b2seq1" --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><p style="margin: 0"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="margin: 0">&#160;</p><div>


</div><p style="margin: 0"></p><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>$100,000,000</b></span></p><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="tm2429841d6_backcoverimg001.jpg"/></p><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Eagle Point Credit
Company Inc.</b></span></p><div>


</div><p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 10pt"><b>7.75%
Notes due 2030</b></span></p><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 216.75pt"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 216.75pt"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 216.75pt"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>PROSPECTUS SUPPLEMENT</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>December 4, 2024</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 261pt"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 261pt"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 261pt"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><i>Joint Book-Running
Managers</i></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
    <td style="text-align: center; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lucid Capital
    Markets</b></span></td>
<td style="text-align: center; width: 25%"><b>B. Riley Securities</b></td><td style="width: 25%; text-align: center"><b>Piper Sandler</b></td><td style="text-align: justify; width: 25%"><span style="font-size: 10pt"><b>Janney
                                            Montgomery Scott</b></span></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><i>Lead Managers</i></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: center"><span style="font-size: 10pt"><b>InspereX</b></span></td><td style="text-align: center; width: 50%"><span style="font-size: 10pt"><b>William
                                            Blair</b></span></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><i>Co-Managers</i></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><i>&#160;</i></span></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 50%; text-align: center"><span style="font-size: 10pt"><b>Clear Street</b></span></td><td style="text-align: center; width: 50%"><span style="font-size: 10pt"><b>Wedbush
                                            Securities</b></span></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 1; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ck0001604174-20241204.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:ck0001604174="http://www.eaglepointcreditcompany.com/20241204" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cef-pre="http://xbrl.sec.gov/cef-pre/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" targetNamespace="http://www.eaglepointcreditcompany.com/20241204" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef-pre/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.eaglepointcreditcompany.com/role/RiskFactors" id="RiskFactors">
        <link:definition>0000 - Disclosure - Risk Factors</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eaglepointcreditcompany.com/role/DESCRIPTIONOFOURCAPITALSTOCK" id="DESCRIPTIONOFOURCAPITALSTOCK">
        <link:definition>0001 - Disclosure - DESCRIPTION OF OUR CAPITAL STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eaglepointcreditcompany.com/role/DESCRIPTIONOFOURSECURITIES" id="DESCRIPTIONOFOURSECURITIES">
        <link:definition>0002 - Disclosure - DESCRIPTION OF OUR SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eaglepointcreditcompany.com/role/LeverageOfPortfolio" id="LeverageOfPortfolio">
        <link:definition>0003 - Disclosure - Leverage of portfolio</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eaglepointcreditcompany.com/role/SENIORSECURITIESLEVERAGE" id="SENIORSECURITIESLEVERAGE">
        <link:definition>0004 - Disclosure - SENIOR SECURITIES LEVERAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.eaglepointcreditcompany.com/role/Cover" id="Cover">
        <link:definition>0005 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001604174-20241204_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001604174-20241204_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001604174-20241204_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="CommonStocksMember" id="ck0001604174_CommonStocksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditRatingDowngradeMayImpactLiquidityAndValueMember" id="ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" id="ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IndentureOffersLimitedProtectionForHoldersMember" id="ck0001604174_IndentureOffersLimitedProtectionForHoldersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiquidityRiskMember" id="ck0001604174_LiquidityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManagementOfferingMember" id="ck0001604174_ManagementOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NoActiveMarketMayDevelopFor2030NotesMember" id="ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" id="ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" id="ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Notes2030Member" id="ck0001604174_Notes2030Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionalRedemptionMayNegativelyAffectReturnsMember" id="ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredStocksMember" id="ck0001604174_PreferredStocksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksRelatedToOfferingMember" id="ck0001604174_RisksRelatedToOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesATermPreferredStockMember" id="ck0001604174_SeriesATermPreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesBTermPreferredStockMember" id="ck0001604174_SeriesBTermPreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesCTermPreferredStockMember" id="ck0001604174_SeriesCTermPreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TestMember" id="ck0001604174_TestMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnsecuredNotes5375Due2029Member" id="ck0001604174_UnsecuredNotes5375Due2029Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnsecuredNotes66875Due2028Member" id="ck0001604174_UnsecuredNotes66875Due2028Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnsecuredNotes675Due2031Member" id="ck0001604174_UnsecuredNotes675Due2031Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnsecuredNotes775Due2030Member" id="ck0001604174_UnsecuredNotes775Due2030Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ck0001604174-20241204_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#RiskOnly"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#SecurityOnly"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesCTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesCTermPreferredStockMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_PreferredStocksMember" xlink:label="loc_ck0001604174_PreferredStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_TestMember" xlink:label="loc_ck0001604174_TestMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesATermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesATermPreferredStockMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesBTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesBTermPreferredStockMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CommonStocksMember" xlink:label="loc_ck0001604174_CommonStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes66875Due2028Member" xlink:label="loc_ck0001604174_UnsecuredNotes66875Due2028Member_9"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes5375Due2029Member" xlink:label="loc_ck0001604174_UnsecuredNotes5375Due2029Member_10"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes675Due2031Member" xlink:label="loc_ck0001604174_UnsecuredNotes675Due2031Member_11"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes775Due2030Member" xlink:label="loc_ck0001604174_UnsecuredNotes775Due2030Member_12"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030Member" xlink:label="loc_ck0001604174_Notes2030Member_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_SeriesCTermPreferredStockMember_1" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_PreferredStocksMember_2" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_TestMember_3" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_SeriesATermPreferredStockMember_1" order="4" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_SeriesBTermPreferredStockMember_2" order="5" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_CommonStocksMember_1" order="6" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes66875Due2028Member_9" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes5375Due2029Member_10" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes675Due2031Member_11" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes775Due2030Member_12" order="4" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_Notes2030Member_13" order="5" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" xlink:label="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" xlink:label="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember" xlink:label="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember" xlink:label="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_IndentureOffersLimitedProtectionForHoldersMember" xlink:label="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember" xlink:label="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" xlink:label="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_7" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_8" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_9" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_10" order="4" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_11" order="5" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_12" order="6" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_13" order="7" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ck0001604174-20241204_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CommonStocksMember" xlink:label="loc_ck0001604174_CommonStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CommonStocksMember" xlink:label="loc_ck0001604174_CommonStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember" xlink:label="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember" xlink:label="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" xlink:label="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" xlink:label="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_IndentureOffersLimitedProtectionForHoldersMember" xlink:label="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_IndentureOffersLimitedProtectionForHoldersMember" xlink:label="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_LiquidityRiskMember" xlink:label="loc_ck0001604174_LiquidityRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_LiquidityRiskMember" xlink:label="loc_ck0001604174_LiquidityRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_ManagementOfferingMember" xlink:label="loc_ck0001604174_ManagementOfferingMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_ManagementOfferingMember" xlink:label="loc_ck0001604174_ManagementOfferingMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember" xlink:label="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember" xlink:label="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" xlink:label="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" xlink:label="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" xlink:label="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" xlink:label="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030Member" xlink:label="loc_ck0001604174_Notes2030Member_19"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030Member" xlink:label="loc_ck0001604174_Notes2030Member_20"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030Member" xlink:label="loc_ck0001604174_Notes2030Member_21"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember" xlink:label="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember" xlink:label="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_PreferredStocksMember" xlink:label="loc_ck0001604174_PreferredStocksMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_PreferredStocksMember" xlink:label="loc_ck0001604174_PreferredStocksMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_RisksRelatedToOfferingMember" xlink:label="loc_ck0001604174_RisksRelatedToOfferingMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_RisksRelatedToOfferingMember" xlink:label="loc_ck0001604174_RisksRelatedToOfferingMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesATermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesATermPreferredStockMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesATermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesATermPreferredStockMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesBTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesBTermPreferredStockMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesBTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesBTermPreferredStockMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesCTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesCTermPreferredStockMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesCTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesCTermPreferredStockMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_TestMember" xlink:label="loc_ck0001604174_TestMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_TestMember" xlink:label="loc_ck0001604174_TestMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes5375Due2029Member" xlink:label="loc_ck0001604174_UnsecuredNotes5375Due2029Member_36"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes5375Due2029Member" xlink:label="loc_ck0001604174_UnsecuredNotes5375Due2029Member_37"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes5375Due2029Member" xlink:label="loc_ck0001604174_UnsecuredNotes5375Due2029Member_38"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes66875Due2028Member" xlink:label="loc_ck0001604174_UnsecuredNotes66875Due2028Member_39"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes66875Due2028Member" xlink:label="loc_ck0001604174_UnsecuredNotes66875Due2028Member_40"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes66875Due2028Member" xlink:label="loc_ck0001604174_UnsecuredNotes66875Due2028Member_41"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes675Due2031Member" xlink:label="loc_ck0001604174_UnsecuredNotes675Due2031Member_42"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes675Due2031Member" xlink:label="loc_ck0001604174_UnsecuredNotes675Due2031Member_43"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes675Due2031Member" xlink:label="loc_ck0001604174_UnsecuredNotes675Due2031Member_44"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes775Due2030Member" xlink:label="loc_ck0001604174_UnsecuredNotes775Due2030Member_45"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes775Due2030Member" xlink:label="loc_ck0001604174_UnsecuredNotes775Due2030Member_46"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes775Due2030Member" xlink:label="loc_ck0001604174_UnsecuredNotes775Due2030Member_47"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes775Due2030Member" xlink:label="loc_ck0001604174_UnsecuredNotes775Due2030Member_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_50"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_CommonStocksMember_0" xml:lang="en-US">This member stands for Common Stocks.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_CommonStocksMember_1" xml:lang="en-US">Common Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_0" xml:lang="en-US">Credit Rating Downgrade May Impact Liquidity And Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_1" xml:lang="en-US">Credit Rating Downgrade May Impact Liquidity And Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_0" xml:lang="en-US">Default On Other Debt May Prevent 2030 Notes Payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_1" xml:lang="en-US">Default On Other Debt May Prevent 2030 Notes Payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_0" xml:lang="en-US">Indenture Offers Limited Protection For Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_1" xml:lang="en-US">Indenture Offers Limited Protection For Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_LiquidityRiskMember_0" xml:lang="en-US">This member stand for risks related to offering liquidity risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_LiquidityRiskMember_1" xml:lang="en-US">Liquidity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_ManagementOfferingMember_0" xml:lang="en-US">Management Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_ManagementOfferingMember_1" xml:lang="en-US">This member stand for risks related to offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_0" xml:lang="en-US">No Active Market May Develop For 2030 Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_1" xml:lang="en-US">No Active Market May Develop For 2030 Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_0" xml:lang="en-US">Notes 2030 Are Subordinated To Subsidiary Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_1" xml:lang="en-US">2030 Notes Are Subordinated To Subsidiary Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_0" xml:lang="en-US">Notes 2030 Are Unsecured And Rank Equally With Other Unsecured Debt [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_1" xml:lang="en-US">2030 Notes Are Unsecured And Rank Equally With Other Unsecured Debt [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_Notes2030Member_0" xml:lang="en-US">Notes 2030 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_Notes2030Member_1" xml:lang="en-US">Notes 2030 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001604174_Notes2030Member_2" xml:lang="en-US">2030 Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_0" xml:lang="en-US">Optional Redemption May Negatively Affect Returns [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_1" xml:lang="en-US">Optional Redemption May Negatively Affect Returns [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_PreferredStocksMember_0" xml:lang="en-US">This member stands for Preferred Stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_PreferredStocksMember_1" xml:lang="en-US">Preferred Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_RisksRelatedToOfferingMember_0" xml:lang="en-US">Risks Related To Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_RisksRelatedToOfferingMember_1" xml:lang="en-US">This member stand for risks related to offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_SeriesATermPreferredStockMember_0" xml:lang="en-US">Series A Term Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_SeriesATermPreferredStockMember_1" xml:lang="en-US">Represent the member of Series A term Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_SeriesBTermPreferredStockMember_0" xml:lang="en-US">Series B Term Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_SeriesBTermPreferredStockMember_1" xml:lang="en-US">Represent the member of Series B Term Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_SeriesCTermPreferredStockMember_0" xml:lang="en-US">This member stands for Series C Term Preferred Stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_SeriesCTermPreferredStockMember_1" xml:lang="en-US">Series C Term Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_TestMember_0" xml:lang="en-US">Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_TestMember_1" xml:lang="en-US">It represents as a.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_UnsecuredNotes5375Due2029Member_0" xml:lang="en-US">Unsecured Notes 5.375% Due 2029 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_UnsecuredNotes5375Due2029Member_1" xml:lang="en-US">This member stands for unsecured notes 5.375% due 2029.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001604174_UnsecuredNotes5375Due2029Member_2" xml:lang="en-US">5.375% Unsecured Notes Due 2029 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_UnsecuredNotes66875Due2028Member_0" xml:lang="en-US">Unsecured Notes 6.6875% Due 2028 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_UnsecuredNotes66875Due2028Member_1" xml:lang="en-US">This member stands for unsecured notes 6.6875% due 2028.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001604174_UnsecuredNotes66875Due2028Member_2" xml:lang="en-US">6.6875% Unsecured Notes Due 2028 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_UnsecuredNotes675Due2031Member_0" xml:lang="en-US">This member stands for unsecured notes 6.75% due 2031.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_UnsecuredNotes675Due2031Member_1" xml:lang="en-US">Unsecured Notes 6.75% Due 2031 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001604174_UnsecuredNotes675Due2031Member_2" xml:lang="en-US">6.75% Unsecured Notes Due 2031 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001604174_UnsecuredNotes775Due2030Member_0" xml:lang="en-US">Unsecured Notes 7.75% Due 2030 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001604174_UnsecuredNotes775Due2030Member_1" xml:lang="en-US">This member stands for unsecured notes due 2030.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001604174_UnsecuredNotes775Due2030Member_2" xml:lang="en-US">7.75% Unsecured Notes Due 2030 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001604174_UnsecuredNotes775Due2030Member_3" xml:lang="en-US">7.75% Unsecured Notes Due 2030 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flags</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_0" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_CommonStocksMember_1" xlink:to="lab_ck0001604174_CommonStocksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_CommonStocksMember_2" xlink:to="lab_ck0001604174_CommonStocksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_3" xlink:to="lab_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_4" xlink:to="lab_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_5" xlink:to="lab_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_6" xlink:to="lab_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_7" xlink:to="lab_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_8" xlink:to="lab_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_LiquidityRiskMember_9" xlink:to="lab_ck0001604174_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_LiquidityRiskMember_10" xlink:to="lab_ck0001604174_LiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_ManagementOfferingMember_11" xlink:to="lab_ck0001604174_ManagementOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_ManagementOfferingMember_12" xlink:to="lab_ck0001604174_ManagementOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_13" xlink:to="lab_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_14" xlink:to="lab_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_15" xlink:to="lab_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_16" xlink:to="lab_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_17" xlink:to="lab_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_18" xlink:to="lab_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030Member_19" xlink:to="lab_ck0001604174_Notes2030Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030Member_20" xlink:to="lab_ck0001604174_Notes2030Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_Notes2030Member_21" xlink:to="lab_ck0001604174_Notes2030Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_22" xlink:to="lab_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_23" xlink:to="lab_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_PreferredStocksMember_24" xlink:to="lab_ck0001604174_PreferredStocksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_PreferredStocksMember_25" xlink:to="lab_ck0001604174_PreferredStocksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_RisksRelatedToOfferingMember_26" xlink:to="lab_ck0001604174_RisksRelatedToOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_RisksRelatedToOfferingMember_27" xlink:to="lab_ck0001604174_RisksRelatedToOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_SeriesATermPreferredStockMember_28" xlink:to="lab_ck0001604174_SeriesATermPreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_SeriesATermPreferredStockMember_29" xlink:to="lab_ck0001604174_SeriesATermPreferredStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_SeriesBTermPreferredStockMember_30" xlink:to="lab_ck0001604174_SeriesBTermPreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_SeriesBTermPreferredStockMember_31" xlink:to="lab_ck0001604174_SeriesBTermPreferredStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_SeriesCTermPreferredStockMember_32" xlink:to="lab_ck0001604174_SeriesCTermPreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_SeriesCTermPreferredStockMember_33" xlink:to="lab_ck0001604174_SeriesCTermPreferredStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_TestMember_34" xlink:to="lab_ck0001604174_TestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_TestMember_35" xlink:to="lab_ck0001604174_TestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes5375Due2029Member_36" xlink:to="lab_ck0001604174_UnsecuredNotes5375Due2029Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes5375Due2029Member_37" xlink:to="lab_ck0001604174_UnsecuredNotes5375Due2029Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes5375Due2029Member_38" xlink:to="lab_ck0001604174_UnsecuredNotes5375Due2029Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes66875Due2028Member_39" xlink:to="lab_ck0001604174_UnsecuredNotes66875Due2028Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes66875Due2028Member_40" xlink:to="lab_ck0001604174_UnsecuredNotes66875Due2028Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes66875Due2028Member_41" xlink:to="lab_ck0001604174_UnsecuredNotes66875Due2028Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes675Due2031Member_42" xlink:to="lab_ck0001604174_UnsecuredNotes675Due2031Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes675Due2031Member_43" xlink:to="lab_ck0001604174_UnsecuredNotes675Due2031Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes675Due2031Member_44" xlink:to="lab_ck0001604174_UnsecuredNotes675Due2031Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes775Due2030Member_45" xlink:to="lab_ck0001604174_UnsecuredNotes775Due2030Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes775Due2030Member_46" xlink:to="lab_ck0001604174_UnsecuredNotes775Due2030Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes775Due2030Member_47" xlink:to="lab_ck0001604174_UnsecuredNotes775Due2030Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001604174_UnsecuredNotes775Due2030Member_48" xlink:to="lab_ck0001604174_UnsecuredNotes775Due2030Member_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_49" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_50" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ck0001604174-20241204_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#N2"/>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesCTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesCTermPreferredStockMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_PreferredStocksMember" xlink:label="loc_ck0001604174_PreferredStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_TestMember" xlink:label="loc_ck0001604174_TestMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesATermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesATermPreferredStockMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_SeriesBTermPreferredStockMember" xlink:label="loc_ck0001604174_SeriesBTermPreferredStockMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CommonStocksMember" xlink:label="loc_ck0001604174_CommonStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes66875Due2028Member" xlink:label="loc_ck0001604174_UnsecuredNotes66875Due2028Member_9"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes5375Due2029Member" xlink:label="loc_ck0001604174_UnsecuredNotes5375Due2029Member_10"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes675Due2031Member" xlink:label="loc_ck0001604174_UnsecuredNotes675Due2031Member_11"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_UnsecuredNotes775Due2030Member" xlink:label="loc_ck0001604174_UnsecuredNotes775Due2030Member_12"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030Member" xlink:label="loc_ck0001604174_Notes2030Member_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_AllCoregistrantsMember" xlink:label="loc_cef_AllCoregistrantsMember_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember" xlink:label="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember" xlink:label="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember" xlink:label="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember" xlink:label="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_IndentureOffersLimitedProtectionForHoldersMember" xlink:label="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember" xlink:label="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001604174-20241204.xsd#ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember" xlink:label="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_SeriesCTermPreferredStockMember_1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_PreferredStocksMember_2" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_TestMember_3" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_SeriesATermPreferredStockMember_1" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_SeriesBTermPreferredStockMember_2" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001604174_CommonStocksMember_1" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes66875Due2028Member_9" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes5375Due2029Member_10" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes675Due2031Member_11" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_UnsecuredNotes775Due2030Member_12" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001604174_Notes2030Member_13" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember_7" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember_8" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember_9" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember_10" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_IndentureOffersLimitedProtectionForHoldersMember_11" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember_12" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember_13" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2429841d6_backcoverimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429841d6_backcoverimg001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !F 58# 2(  A$! Q$!_\0
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MM+J)Q$?CS_@B[^R7J7[#/[0__!1[]FVXU5M>\/Z#X@_9N\7?#K6[ATFU&_\
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MUW3KRPU(3V?GVL;6=W"[07%O9"":ZDDMR98Q"LD7QCXK\:W7_!/;]CO]G#P
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M\_=T[GPW_P $5_B+X)MOA5<_LM>"(7U;5_V;_AO\'_%WQ[^(,ENEE)XH^/\
M^T;;^-OB7X_T2.&)@M]<^#=0@7P_K/B"]%WJ.H7"QZ0]X3X=623]N[F\6S,8
M7SBTXC"X"&,22,L4%JK,ZB$RN6%JTVRU><K:3WEK)<VN_P#DR_X-7+Y+_P #
M_MGB6YO)M6E\:_!S4=6N]1EEN;V]EO\ P[XWNQ<7LMU)+=?:!<O>V=PC2);K
MJ-G?R16\3RSA_P"ISXC^#=0\>^&KKPQ9>(-0\*QZM!)8ZIK.C2R6GB"WT>YQ
M%J*:%JL#>9I-]=6AFLDO41KF"*YEGLWM;V&WN[?TN,,)2P'%>/R^+7U6A1H3
MI2A:=Y5(4JDI.UE=^TM:-DDK)*SOR\%XZKC^&,%C+-XJM7Q$*ZJ)P?N3J12O
M*]TE%-/O;R/Q'_:O^)'Q/_X*:_&CQE_P3T_9\M-:\.?LV_#SQ9I=O^VC^TO"
MA@TC5]/T*\M;_4OV?OA7JL8GM-7\6W^I6L6G^,YT2YBL[*>[TO5M+.E65_%X
ME^=_@Y_P3P^/W[2'B"U_8[_:,U/4H/\ @GY^P7\>?$%C\+K:>]N%\9_M'6.F
MB'7OA/X?\5ZK=/=)K7@[X2>#O$0\)ZA<C3;"XOM5UK4+6POK;6_!UOJJ_P!(
M/PV^$WP]^$_@W0_ 'PZ\,:;X0\&>&HXH=%\/:+:QZ?8V\4-PEXLT\<*I)>W]
MSJ"-J-_JU\\^K:K>R3W.J7EW+<W)F]!BM(H6D92V99&E?B,#S& 5G&Q%PQ14
M0X(#; [ RO+))S0SJ=#"5,'1P]%TY).%24(^TIU%*\JL9-.7/*/N;VC%NR;M
M;LK</4\5BH8JOB:L7%MNG&4G"2:=HNS2LGKZHQ]+TJWL+2&SAB^R0QV<-JMI
M!%':6UND<4=NJ6L5M'%#"BPQ00QQ0*L,$4$:PQQEY#)X%^TQ^R]\)_VG/ \'
M@GXF:!?W2Z1K-AXH\&^)_#&JW7AOX@_#[QAH@230O$WPT\96%Q;ZMX*U^PN(
M(I6O-+F6RO=.BU'2M7L+_3-7U*UN?IA8$4@@OP21EL\D@GD@GJ/6E>!9 P9I
M K*58*Y0D'K\Z;9%/)P4=3SUZ5XE.I55656;U;;44[QU333T\_3[E;VI8.A[
M*-*%^6-O>:][W=5WZI;/JV>*?#JQ^+?A;X>OHGC35-!\?^/M"L)=.TOQ(LT/
MA2R^($FGV<;:3JVJV5G8ZK%X8N]0S]EUY=,L;C3QJ$%]J>F:-:6MU';M_.G_
M ,%*O^">G_!37_@H/\6O@G\3;+PE^RU\(;7X%K<W'A&RC^.?Q#\?3ZO?77B'
M0-:F;6-5M_@1X72!9KCPQ:(4L=+1+"*YN%DN[UFCFC_J7$"@Y+,WRJISL!)4
M,-Q945MQW<X8 8&P+ELP+80H597F\Q(Q$LSR>;<;0S-\UQ,))WY=L!Y&4!B
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M_$CW5_;V&F;;WX1+K-YNFBBAMC<W-I/J,Y^R6T\D\PE@_9?_ ((Q?M"?&O\
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MZ?)=)&9I+5+JTDMVN4@4H9C#YH?RA(F\X4GY@1_.[^SS_P $C/\ @H7^R_\
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GL&$!^;!95!8!0Q(5</HHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2429841d6_backcoverimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429841d6_backcoverimg002.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $W IX# 2(  A$! Q$!_\0
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MV5UZ?F8UZ]+#4I5:KLH[?/?\CW;)50,8/KQTZ_@>>]4Q*&X*E?\ >B0#^?\
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M1_T-^$O_ !+*!_4MO/\ >;_OI/\ &C>?[S?]])_C7\M/_#%__!M-_P!$X_\
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MA\5O%[>!"DGVD^,/,"1_,H_8O_X-IA][X;Y_W?&'[>__ +-XE'X_I1_PQ?\
M\&TX_P":;H?IXP_;Z!^O/B3'Z5I#(.(*=_99/Q@KM<W_ !AL[.U[7LO-Z:+8
M3S[(:MJ=7->$_P#9OA_XRZ+M[3>_OJWP+>[>I^@$/_!+K7?!GC?X;>+/A9^T
M-H_@*#0?V.?$/['OCW1V_9E^$%U8>*M&\0>)M<\=+XV\%^ _#:^&/@?\/GD\
M>ZX9?%?@Y_@[XP\':AX31M-ECM+F3_A+1Z5^PG_P3L_X8T\>_%3XB_\ "PO
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MTL9\)>"?"_C.#8WQ M/&$C^4OQS_ ,,8?\&TO_1-A_X6'[?'_P TU)_PQ?\
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M/=!U[5]$N?C=\4;?XB@^(M$T&9]#9O"JK#;2P1;Y;EC%^5__  QA_P &TO\
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M8/\ T/X4U^_:]!]!_*OP$_X+>_ZS]F7_ '?C!_Z'\*:^M\._^2UR?_K[6_\
M4>N?'^)7_)$9M_@H?^G$?@G1117]:+9_XY_FC^2*/\.'_7N'Y,****#4****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHJ*FT/^OM/\RZ>\_P#K
MU4_(]Y_9:_Y.;_9Y_P"RX_"+_P!63H-?TT_\%.O^3'OC5_W2W_U;_@2OYEOV
M6O\ DYO]GG_LN/PB_P#5DZ#7]-/_  4Z_P"3'OC5_P!TM_\ 5O\ @2OQ#Q+_
M .3@<(?]C++/_4ZD?LWAO_R0W%O_ &*<Q_\ 4>N?R.T445^[5?X^,_[#J_\
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MH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'&_\U&/_ ,@?@M17[T_\/NY/^C8D_P##U7'_ ,Z&C_A]W)_T;$G_ (>JX_\
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M44 %%%% !1110 4444 %%%% !1110 4444 %?./A;_DZ3XQ?]D%_9Q_]6/\
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M0X)_\2^7_P L#^S?#K_HK.,O_$2?_P I/@K_ (98_:;_ .C<OCU_X:+XD?\
MS-T?\,L?M-_]&Y?'K_PT7Q(_^9NOO7_A\Y^T]_T(7P$_\)SXE?\ SQ:/^'SG
M[3W_ $(7P$_\)SXE?_/%H_M/Q,_Z)#@G_P 2^7_RP/[-\.O^BLXR_P#$2?\
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M2?\ \I/@K_AEC]IO_HW+X]?^&B^)'_S-T?\ #+'[3?\ T;E\>O\ PT7Q(_\
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MO</R8445^OWP"_8Y^#/CWX-_LZZ_K7PH^-WCWQ#\:=4\2Z1XQ\:?#7Q(=/\
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M]0\;WWB3X<>-M T'Q'_PAGB^Z^&?B\^(_P#A!/$_&=%\;YQ_8&#@-@_*2 P
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MPM-8\4^%OB9?^$O&VH:#\1_@1X9\1W?PS^*9U(> _P#A.OB</ >N:+KFA_\
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M'[-X;_\ )#<6_P#8IS'_ -1ZY_([1117[M5_CXS_ +#J_P#Z;H'XE2_@8/\
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MT_&6]\->%?"7CCQ#XIT:R\#7?B]_#?Q+\7:=X%7Q VMZQHFB(K'/A3Q(%+
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M;8\-^&?"OP;3QS\%[?Q_\1?V>++5;#X1^-?^$]UOPUIMBNOIL8>-=%7PZO\
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M[AE@2?,(!(/&1CZJE6-D7=PHSCC/?GO[?Y&:^>?"/_)TGQ@_[(+^SE_ZL?\
M:QKY_#RI*CB$X+ZRX1]O-2=_B]U<MN6UKV:9[M;VOUO#7:^KIR]A%)77P\]W
MN]>6U_,^CJ_ /_@M[_K/V9?]WXP?^A_"FOW\K\ _^"WO^L_9E_W?C!_Z'\*:
M^N\.?^2RR3_K[7_],5SY7Q,_Y(O.?\%#_P!.'X)T445_6D'RSC4?P0G5YO23
M7^3/Y'IKFP_LU\<Z=+E]8I_YH]M^"'QZ\7_ 77M>U7P_I/AOQ+I'B[P]J?@[
MQSX*\;Z0=1\-^*O#2\?V/K6B#!!*LR-CAT9XW#1LRGVV;]N_XL6?BSX<ZUX1
M\*_#CP-X8^&-MXETGP[\-/#'AO5W\#_V=XV*MXU;6E_X2(>)-<_X2=T62,1Q
MHJR@S >:SNWQ+17D5^'\DQ^,J8F6!6,J5E[[UM#E35VKI7DFTI./.DK1E%.Q
M[5'/<YP.%ITHXUX2&'=HK_GXI-;/M'E3LG9N5VFS[+U#]M3QNLGB^#P[\-?A
M!X,T#Q1\(?$WP:OM*T'PYJY-EX9UM0FNZW_;0\1#Q)KOB$[02OB=?%JEMS8!
M9RV1;_MC?$JWTF+11H?@'R(/V<]3_9I8_P!D:S_R(VN:HNL?VUSXD_Y&+RT&
M1W//_"#]J]3_ .">T/PM\=_%[0/@C\2O@YX,\<P>.K[Q+??\)?KUWJ7_  DV
M@_V'X/UW7?[#T8Z-X@D01M_8>UR-K!"Q5@P##H]7_9K@_:=G^'_C;X->'O!O
MPSTC6?BUJGP \9>#?"MCJQL/!&I^'QK^O/XVUM-9\1(/$4O_  C@5F6.%5SH
MBB-3G:/CL36X9PF.Q.!Q.1\E/"JC*564[Q:E&M&"_B2J\W+0JJ\EKRMMRE./
M-]52H\09QET,;A\YO/7W4FG=\K[*-KVT6SZ)(\I@_;M^*L/A>WTX>&OAW_PG
MUK\-3\(K3XT?\(WJO_"R+#P*2,Z3_;I\0?\ "/;\<?\ "4#PH(N<F,MAJ\'^
M,/QH\4?&>^\$7GB>P\-Z9/\ #OX=^&_AKI \/6FM:;_:'AKP4[2:,=</B#Q(
M<>(2[,QQ@<\"OL?2OV"/">JP?#1S^TCX?TZ_^-&L>/-'^$5I<^ -;=O%VI^!
M=8U_1&&L:ROB,OHGA[Q6G.U%9F/B (@9\K2+^QSXB\8^&OV8_!5E;>#/!?BC
MQ,?VB1XY\5+::K_:EKIWPL\:!-9U7QH6D4>('\+2,J>!_P#A&7C4.P)=8_F&
M^&S#@?#XBG7P^#6$<)55B)7GJY1E&37-?1.A4@XQ7*I6Y4KKG53 \95L$J&(
MQGUO989:>Y:W->W67-!W>MEOIIPV@_\ !0'XJZ!:^%]2F\#?"+6?B7X,\&GP
M5X/^,FJ>#]3U#XC:%X<.E#1C<%EU\:"9"=RL@\,?9W1F\R!F8M7-Z%^VI\1]
M.^'>C> M;\(_#'Q]/X7TCQ/X9\(>-?&WAO5_$?B3PII?CD-_;N[/B(^&]?!)
M4^"1XJ\)+G8@)*%U?0\.?LL_#/QKXUTGP[X!_:+M?&GA_4O"&J>)_MGA7X1?
M$KQ'\2;'4]"UA=".CCX6^'@2JC+*2_BY6RIPNW:Q]V\7?L=^'?@A\+/VKK/Q
M>=+\;^)/!ME^S)XF\"^+!H^L>'-4L--\<>-]=37,:("1X?\ $(Q(",$[BH."
M"*RS'$\!47.K3P,L54Q<J=24$JD72<)R@I).<7&*E5DJD%:FD]824K/3!X'C
M[$^QHK&K"0P*FHMV?M%52=KV=W%4E9[W>ZMI\X:Q^V?\0?$?P]'A'7/ OPIU
M+Q,/AKIOPB/Q3N_#2:G\2&\":(5(TDD^(3X=W* 0OBA?":QD.Y:-F"LO4:=^
MWQ\3-/\ "6GZ&? 'PFU'7]*^"VI_ '_A8&J^&_&7_"<7_P ,0<C1<?\ "2?\
M(R06&X\G+_-ZY^E_VB?^"?\ 8^(OC9Y'P1OM%T7POKGQ=\+?"76?"EKHVKY^
M&^/ACH'CPZUQXC0:_P"'_P#A'!K?B@C"@%@![?,W['7PH^'?BW]M/PQ\+?$\
M&F?$CP#_ &W\3+'[7>6!L-+\6C1/!^N)HFM[5*DX71&(YP#R<@'*PE?@W&Y?
MB:E+)%-93AJO$%6DVY27U:,<,HM.=HWEBX^XI1IN4$U%J[<8O_7+!8RA5Q6<
MZXC$4\II/1+_ &N2J2=[?W$[M75]7T.1@_;+^*]G\2/AA\4+'3O!-OKWPP^%
M^F_!RSTBVTC6G\,^+/ ^B:4=(.C^-]$;Q+N!$VN^8A!Q&P79M"KMZ&U_;A\9
M:=XF;5-)^%WP?TOP1=^ ]5^&/B/X:V7AO5_^$;\5^&-=Z'6M;/B)O$GB#Q%C
M'_%4'Q:5('S Y.?I3]I?X'_#*?\ 9UU3Q_X4\!_!B'XCZ#\5_#'@O^UOV7_B
M'K7Q#\,KX7UT#"^,_P#B?1#0]>'B//S[I"#P7;-;'[*G[).M>%_ ?QYU#XV?
ML_\ A74O'NB6WPQO/AMI?QRU7_A#_"SG7-5\2:)KHDU]=?E$4>$9A(6C!E$<
M(<O*D;\=+->#)</PS?%Y*I5,%4Q'#E"DJD(SG&G*&)J2C^\IMJ']H4Y.<5^[
M334H2:4O3EE'&.'XD678;.7R9K0P^:5G9M?\)L'P5#=/?_5N7KU36WP'\;_V
MC/%/QUF^'1UOPMX!\)6'PS\.GP=X1TOP3H^L:;IMCI@UE5 QK_B/Q;]U$5 3
MR57YLG)/I_Q3_;;\2?%Z[\0:YXI^!G[.5OXWUZUTRT_X67I7@_Q@?'%A_88(
MT+6-$UT_$4,/$'A-CO # @@*#Y?RU]*?'+]EKX0^)/C)X-^&GA^&V^"GQ$M/
MA?J?BCXR^ /AGX;^)'QITRQ\0_VI$=#T?P1HBN0WB(:"9AN9(O!H4*IC; EE
MK^!OV%/A[X6^+OQU^'7QB\>3ZM;^!/V=M3^*_A.\M_#VL:7LBUO276;7M;T,
M;MS>$MIV^$^I)^;&"!TQS;@JC@,LIXK 5,&L%&OB\-!<[J5(XZI2YVO9U$JL
M4Z-*I?FG"5.<9ZIV?)5R/C*AFN983"XU8N=9T/;MV2IN"J\EVUIS7FEL[PMV
M/GCQ7^W?\5/$FD>(H+?PI\-/"OBWQZ/"W_"Q?B1X8\(K8^-OB-_P@H/]A_VS
M(?$)\/MO)R?^$:\*R[<[8O+0!!V6J_\ !1KXHW^IWNJ6WPQ^"NFZOK7CCP+\
M2?$.J6FD^,QJ&N^.? Y3^PM8*#XDA&V^6JIX88%U7< PWR;NAU[_ ()I?$K3
M?AY/XFTKQ+-K?C*V\":9\0+OPC_PKKQCIOAO_A&-;56;1=#^*6?^$:\0?$,!
ME)\+ 9 96(PP)[B/]D/X6?"OX5_M@Z5XA\8>'?BC\7_A3\.O EY>VEIX9UG3
M?^%9^)M=U25U.C:X2&UU25&" 6W%4*C+%9Q6*\-L1AZ,E@EBZD\32A1A%R?L
MW*K1IS5I3DE!N=+W6U&,(6A&*M%]>&P/B)0J5(QQOU2E0P]:5=M6]HG!N+T2
MUBH3UMJY:MO4^0#^UO\ $4V/B_2Y_"WPOU.P\8_'8_M :Q:>(?"'_"2:8?$[
M%2=%_L3Q!XD_X1K_ (1X_P!M+CYO^YXSS4?QM_:M\;_&[PEX=^']_P"&/!?@
M[P7X=\2ZEXFM-"\+1^*U=/$6L[S%J2-XZU[Q2V@P1/+-+'X5\,F7P@KSS'S"
MK!5^7J*^XCP]D<\;0Q]+ K"+"T:52@_>_>2JTXQE+635XQI0BG;1/2S<G+XI
M<19RL#B\OJ8WZW.O6J0K[?N^24K+_MYREVOR]0HHHKT:SYI\R^!U:*CZ)M?Y
M'BTERJ49?&J=5R^:T_4]Y_9:_P"3F_V>?^RX_"+_ -63H-?U;_MC_!KQ3^T)
M^SMX^^$W@^?0=/\ %'BU/#PTJ\\57&K6/AZ"70_%V@^(C_:UQHVA^)IO+==&
M,0CBLY&=I%W"*,.1_*1^RU_R<W^SS_V7'X1?^K)T&OZ?O^"C/B?Q'X-_8_\
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M5_\ .ZH_X<Q_M/?]#[\!/_"C^)7_ ,[JO@K_ (:G_:;_ .CC?CU_X=WXD?\
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M\(?_ %7&@5]#]G^H_F:^>/V4/^36_P!G'_LA?PA_]5QH%?E%3_=,9_U]P?\
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MC8>,8_'BC!\71^.8O$,?B[^WBY8FYD\3N2I^9F54C&SX1_9=^!_@76/#&O\
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MB)X,O(/!T^D^+?@!\=?&?A#QO\,K3XE:?INCZEX'T-HUCT?QQX^\-^%/#/Q
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M'HX'.,;E4:\,'C7A%B?9^T72;I<W*^NL>=K;5.SNM#Z%\8_M)^-O&'@KXC^
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M/_0_A37[]KT'T'\J_ 3_ (+>_P"L_9E_W?C!_P"A_"FOK?#O_DM<G_Z^UO\
MU'KGQ_B5_P D1FW^"A_Z<1^"=%%%?UHMG_CG^:/Y(H_PX?\ 7N'Y,****#4*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHJ*FT/\ K[3_ #+I
M[S_Z]5/R/>?V6O\ DYO]GG_LN/PB_P#5DZ#7];_[3WP\^&'Q;^"7C'P-\8/%
MDW@?X?:RWAJ;7?%$>OZ3X9.ER:-XLT37=&F37M>AN-#LV;7=(TN(F:-R^_[,
M-K7";OY(/V6O^3F_V>?^RX_"+_U9.@U_43_P4(+']D?XH'MGP/N_\.1X,_KC
M]/P_FOQ_S;$Y#CHYSA$G7R[+IXF%_P":G4C.+79J459]]3]U\*8TGP;G\JV'
M^M0A.$G0_P"?B5/%-P_[>2M\S\]A_P $\?\ @FX?^;M-1^A^-_P$4X_'P&1G
MKW_"F?\ #O;_ ()L_P#1V.K?^'L^!'_SOZ_+&BOXXC]+'Q%E'EC/$NC3E*%)
M?6JJ22=G9>S?1(\E9IPTI3B_#W)<+*,FI5LV=OK3N_>H-1;?)O5O:W/3MN?J
M=_P[V_X)L_\ 1V.K?^'L^!'_ ,[^G?\ #O/_ ()M_P#1V6I?^'P^!'_SOJ_,
M?3=!US6/M']E:5J6I?9?^/S^R;(ZEW)]NGZ]:(=!UR]O[C2H-#UNYU"U_P"/
MRTM-'UG^T]/_ ,X]/<]ZK_B:[Q*_Y=/$_P![_:ZWRVI^H2S/AIV_XP'@[$^C
MOR??!_%^A^G'_#O/_@FW_P!'9:E_X?#X$?\ SOJ/^'>?_!-O_H[+4O\ P^'P
M(_\ G?5^7]YIU]IMU]AU6QN=-N/^?2\L_P"S,?3I^G;TJQIGAOQ'K$7GZ5H>
MMZE;C_EZTG1]9U+\LT?\37^*'?$?^%=;_P"5D_VEPU_T;?@_\/\ Y6?IQ_P[
MS_X)M_\ 1V6I?^'P^!'_ ,[ZF_\ #O;_ ()L_P#1V.K?^'L^!'_SOZ_+&:&>
M&7R)X/LUQ^7I[=/7CMVHK.?TL_$JG;VLL2KWY?\ :ZJVM?>GYHJ.9\-*_P#Q
M@/!V&]7;G^Z"^']3]3O^'>W_  39_P"CL=6_\/9\"/\ YW]._P"'>?\ P3;_
M .CLM2_\/A\"/_G?5^5]6/L5]]D^W?8;G^S_ +7]B^U_8_\ B6=<8_I1#Z6?
MB54O[*6)=K<W^UU7O>VU/R82S/AIV_XP'@[$^COR??!_%^A^I'_#O/\ X)M_
M]'9:E_X?#X$?_.^IO_#O;_@FS_T=CJW_ (>SX$?_ #OZ_,F'PWXCFL/[5@T/
M7+G3^?\ B;?V/K/]F<=,GOT_'O6/1/Z5_B5I[9XCKR_[76\K[T_0(YGPTK_\
M8#P=AO5VY_N@OA_4_4[_ (=[?\$V?^CL=6_\/9\"/_G?T?\ #O;_ ()L_P#1
MV.K?^'L^!'_SOZ_+G['??8/M_P!@N?[/^V_8OMGV+_B6>F?Z],]ZKT0^EGXE
M0O&E+%+GMS6QE57MM?\ =:[O\1_VIPU_T1?!O_@3_P#D3]3Q_P $]O\ @FQW
M_:RU?\/C9\"/Y_\ "O\ ^E)_P[V_X)L_]'8ZM_X>SX$?_._K\T;/PKXBU*U-
M]I7AS6]2M_\ G[M-'UG4OZ?SXQ^)K'O+.^TZZN+&^L;G3;BU!_T2[M/[-_R?
M\]J=3Z5_B50M*J\0O:WY;8NJOAM>]X:_$NP_[4X:_P"B+X-_\"E_\B?J-_P[
MV_X)L_\ 1V.K?^'L^!'_ ,[^C_AWM_P39_Z.QU;_ ,/9\"/_ )W]?EC16?\
MQ-IXB5-WB7;OBZKW_P"X?D+^U.&O^B+X-_\  G_\B?J=_P .]O\ @FS_ -'8
MZM_X>SX$?_._H_X=[?\ !-G_ *.QU;_P]GP(_P#G?U^7-G9WVI2^186-SJ5Q
M_P ^EG9_VE_]?G_ZWTKT?\3:>(E/9XE7[8NJMO\ N'YA_:G#7_1%\&_^!/\
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M/I/XC?M?_M#?%*>9O$/Q(U?2])N RIH/A*Z7PWIR(QR41O#XSKR'CY/%9V\
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M-/V6?BMX3T#PM_;)\-_M*7GAJS\3+JY.H12'1'\0:-K>M2E5:3_A%O[>7PH
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M]6FW\4;IMV;_ #!USQ%XA\3ZO?>(/%&M:AXBU[40%NM4U^[&H:C>JHVJJJ
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M #+I[S_Z]5/R/>?V6O\ DYO]GG_LN/PB_P#5DZ#7]2'_  4,_P"32/BK_O\
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M?CE+XT^'?@WX5Z'X6@\%>$_"=U?^([ZUM=8U?Q)J>N>(]7$AUG5=:US7E4E
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M7PM\;?!SQA?^ O'NE'1-?MK+2[T"UN]'U#3;_2]=.-"UG1-:T  Z]X>4\%6
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M(M3VO!&<U>DXT/PJ?\$_!.BBBOZP6S_QS_-'\FT?X</^O</R84444&H4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
L% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2429841d6_prosimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429841d6_prosimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != JX# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOFGM(W=L74H&21D\ #\*[&L/PG_R![C_ +"=_P#^E<U !_PA?A7_ *%K1O\
MP B_^)H_X0OPK_T+6C?^ $7_ ,36Y10!A_\ "%^%?^A:T;_P B_^)H_X0OPK
M_P!"UHW_ ( 1?_$UN44 8?\ PA?A7_H6M&_\ (O_ (FC_A"_"O\ T+6C?^ $
M7_Q-;E% &'_PA?A7_H6M&_\  "+_ .)H_P"$+\*_]"UHW_@!%_\ $UN44 8?
M_"%^%?\ H6M&_P# "+_XFC_A"_"O_0M:-_X 1?\ Q-;E% &'_P (7X5_Z%K1
MO_ "+_XFC_A"_"O_ $+6C?\ @!%_\36Y10!A_P#"%^%?^A:T;_P B_\ B:/^
M$+\*_P#0M:-_X 1?_$UN44 8?_"%^%?^A:T;_P  (O\ XFC_ (0OPK_T+6C?
M^ $7_P 36Y10!A_\(7X5_P"A:T;_ , (O_B:/^$+\*_]"UHW_@!%_P#$UN44
M 8?_  A?A7_H6M&_\ (O_B:/^$+\*_\ 0M:-_P" $7_Q-;E% &'_ ,(7X5_Z
M%K1O_ "+_P")H_X0OPK_ -"UHW_@!%_\36Y10!A_\(7X5_Z%K1O_   B_P#B
M:/\ A"_"O_0M:-_X 1?_ !-;E% &'_PA?A7_ *%K1O\ P B_^)H_X0OPK_T+
M6C?^ $7_ ,36Y10!Q>M>$O#<6J^'4C\/:2BRZ@Z2*ME& Z_99VP>.1E5./4
M]JV/^$+\*_\ 0M:-_P" $7_Q-&N_\ACPQ_V$W_\ 22XK<H P_P#A"_"O_0M:
M-_X 1?\ Q-'_  A?A7_H6M&_\ (O_B:W** ,/_A"_"O_ $+6C?\ @!%_\31_
MPA?A7_H6M&_\ (O_ (FMRB@##_X0OPK_ -"UHW_@!%_\31_PA?A7_H6M&_\
M "+_ .)K<HH P_\ A"_"O_0M:-_X 1?_ !-'_"%^%?\ H6M&_P# "+_XFMRB
M@##_ .$+\*_]"UHW_@!%_P#$T?\ "%^%?^A:T;_P B_^)K<HH P_^$+\*_\
M0M:-_P" $7_Q-'_"%^%?^A:T;_P B_\ B:W** ,/_A"_"O\ T+6C?^ $7_Q-
M'_"%^%?^A:T;_P  (O\ XFMRB@##_P"$+\*_]"UHW_@!%_\ $T?\(7X5_P"A
M:T;_ , (O_B:W** ,/\ X0OPK_T+6C?^ $7_ ,31_P (7X5_Z%K1O_ "+_XF
MMRB@##_X0OPK_P!"UHW_ ( 1?_$T?\(7X5_Z%K1O_ "+_P")K<HH P_^$+\*
M_P#0M:-_X 1?_$T?\(7X5_Z%K1O_   B_P#B:W** ,/_ (0OPK_T+6C?^ $7
M_P 36/XM\)>&[;P9KL\'A[28IHM/N'CDCLHU9&$;$$$#((/>NTK#\:?\B+XA
M_P"P9<_^BFH /^$+\*_]"UHW_@!%_P#$T?\ "%^%?^A:T;_P B_^)K<HH P_
M^$+\*_\ 0M:-_P" $7_Q-'_"%^%?^A:T;_P B_\ B:W** ,/_A"_"O\ T+6C
M?^ $7_Q-'_"%^%?^A:T;_P  (O\ XFMRB@##_P"$+\*_]"UHW_@!%_\ $T?\
M(7X5_P"A:T;_ , (O_B:W** ,/\ X0OPK_T+6C?^ $7_ ,31_P (7X5_Z%K1
MO_ "+_XFMRB@##_X0OPK_P!"UHW_ ( 1?_$T?\(7X5_Z%K1O_ "+_P")K<HH
M P_^$+\*_P#0M:-_X 1?_$T?\(7X5_Z%K1O_   B_P#B:W** ,/_ (0OPK_T
M+6C?^ $7_P 31_PA?A7_ *%K1O\ P B_^)K<HH P_P#A"_"O_0M:-_X 1?\
MQ-'_  A?A7_H6M&_\ (O_B:W** ,/_A"_"O_ $+6C?\ @!%_\31_PA?A7_H6
MM&_\ (O_ (FMRB@##_X0OPK_ -"UHW_@!%_\31_PA?A7_H6M&_\  "+_ .)K
M<HH P_\ A"_"O_0M:-_X 1?_ !-'_"%^%?\ H6M&_P# "+_XFMRB@##_ .$+
M\*_]"UHW_@!%_P#$T?\ "%^%?^A:T;_P B_^)K<HH P_^$+\*_\ 0M:-_P"
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2429841d6_prosimg02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429841d6_prosimg02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #M D\# 2(  A$! Q$!_\0
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ME_\ *CD/^'FO_!-S_I(-^Q!_XE?\!O\ YOJ/^'FO_!-S_I(-^Q!_XE?\!O\
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M )0_^ZA_;*_Z!G_X.7_RHY#_ (>:_P#!-S_I(-^Q!_XE?\!O_F^H_P"'FO\
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M[*]KVO97[!1116184444 %%%% !1110 4444 %%%% !1110 4444 ?'GB?\
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M!O\ YOJ^WZ* T\_O7^1\0?\ #S7_ ()N?])!OV(/_$K_ (#?_-]1_P /-?\
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M&=(\*?M;^"(K_P .?L\>./#7PL^).K^%?%?P<U_X7^+?$FLVBZWX<\):K?\
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MK_\ U0WCZOM^@?3YO\D?F1J7_*2/]I/_ +,@_8+_ /5\_P#!2:OH>OGC4O\
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MWA7X?:KX21-6^#'@6VL+F7P>=5T[6[Z6UFN+:_O;VWT53;V>E^)M1^]_&?\
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M-*IB^:4JF*P^#]E"IB7&;J3D\74QE?%3C56'Q=&OEU%86E/*JU;'_E3\+?\
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MUY93Q>(I25+$UXUH5L+%4ZE3%>7_ +&WQR^*OQ*_;2_X*C?#+QQXOO-?\"_
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M9=F%3#9C3QV"Y)5EAG2I8>C4CA8SZ#_@IH<_\$V_^"@QR#G]A_\ :O.1T/\
MQ8;Q[R.3P>W)^M?<%?$'_!37_E&Y_P %!O\ LR#]J_\ ]4-X^K[?K(V^RO7_
M -M1^9&I?\I(_P!I/_LR#]@O_P!7S_P4FKZ'KYXU+_E)'^TG_P!F0?L%_P#J
M^?\ @I-7T/7VV4?\B_#_ /<7_P!/5#Y7,_\ ?:OI2_\ 34 HHHKTC@"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)
M/V%_^2H?\%(O^SW_  ?_ .N[/V!*_0NOST_87_Y*A_P4B_[/?\'_ /KNS]@2
MOT+KX#&?[YBO^PBM_P"G)'V6'_W?#_\ 7BC_ .FH!1117,;!1110 4444 %%
M%% !1110 4444 %%%% !1110!\0?\$^?^2#>/O\ L]__ (*:_P#KR3]J^OM^
MOB#_ ()\_P#)!O'W_9[_ /P4U_\ 7DG[5]?;] WN_7_(****!!1110 4444
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MU?\ BBRO="M[2.PUR^.K:5<:K\.6AO/%'A2ZOXM*U'[3=J[#XF\+_P#!,O\
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M[3-<MKSQ'XDUFWN;30/"NFZ/<7-Q';O>W][IED5N#\8? O\ X)R?M2? -/\
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M^^8K_L(K?^G)'VF'_P!WP_\ UXH_^FH!1117,;!1110 4444 %%%% !1110
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M_P"2#_A ?^"D?_1U_P"Q!_XKY^//_P!,UH_X0'_@I'_T=?\ L0?^*^?CS_\
M3-:/^&K_ (\_](ROVW__  OO^";G_P!,&H_X:O\ CS_TC*_;?_\ "^_X)N?_
M $P:@->T?_)?_D@_X0'_ (*1_P#1U_[$'_BOGX\__3-:/^$!_P""D?\ T=?^
MQ!_XKY^//_TS6C_AJ_X\_P#2,K]M_P#\+[_@FY_],&H_X:O^//\ TC*_;?\
M_"^_X)N?_3!J U[1_P#)?_D@_P"$!_X*1_\ 1U_[$'_BOGX\_P#TS6C_ (0'
M_@I'_P!'7_L0?^*^?CS_ /3-:/\ AJ_X\_\ 2,K]M_\ \+[_ ()N?_3!J/\
MAJ_X\_\ 2,K]M_\ \+[_ ()N?_3!J U[1_\ )?\ Y(/^$!_X*1_]'7_L0?\
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M\I(_VD_^S(/V"_\ U?/_  4FKZ'K[;*/^1?A_P#N+_Z>J'RN9_[[5]*7_IJ
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MF^/_  ]XJ\-Z[X$UKP_:^+-'\:Z-KFEZIX2U;PK?:>FK67B73?$EC=3Z-?\
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M5OQ0NO\ @DK^V;:V[:_X=_:(TVQ^(\2^ ]8L]9N?VC_VF)=$C\8Z3^U]X_\
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M $2[_AGSQY_PN?\ Y%3['_R7G_AIO_A!_P#D>/\ BHO^3</^14_XHW_D+_\
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M&VE2<IT6\U^/^7S]/N/*_P#@GS_R0;Q]_P!GO_\ !37_ ->2?M7U]OU\"?\
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M_3YO\D?F1J7_ "DC_:3_ .S(/V"__5\_\%)J^AZ^>-2_Y21_M)_]F0?L%_\
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M7V/1:*\Z_P"';7[-7_0R?MD_^+)/^"C'_P!%31_P[:_9J_Z&3]LG_P 62?\
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MH **** "BBB@ HHHH **** "BBB@ HHHH ^(/^"?/_)!O'W_ &>__P %-?\
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M_P!%?1_P[Y^ W_0_?MO_ /BS7_@I'_\ 17T!IW?W?\$^WZ*^(/\ AWS\!O\
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MH_V7O'7C.]\"6?P]_:%TG7?#?B#Q=\//B,NI^#? EY#\,/C=X.\/_%OQ7=_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA;3=$GUS38_"?A:36UO]+O\ 5-7M+W^EB@&G%V:L[)_>%%%% @HHHH ****
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MUOK\EQ+J"ZS&FHO,]R"Y^N$_X)[_  '1$5OB#^W#(RJJF1_^"FO_  4A#R$
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M#5I2<8RM)^SK5+I0H05:K)M)0I^THT>;5-N]7$T8VBF[SN[1C*4?TZ_X=\_
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M_ ]Y]C\<?#SP5XGT[47\/?VKIFJ^'K&XT^^MOWZS?J=7XZ:)^U1I'[8VH_\
M!,OXS:'X#\7?#O3O^'D?[2'P_BT+QE;O!J5Q)\,?V&O^"DW@2XUBW=K6S$MI
MJ=QH4D[PB'?I6H?;]"N9)KO2[B9_V+IU*<Z4N2I%QDX4:EG:_)B,/AL51EHW
M;GP^,PU1)VDE5BI1C-2C&85(58J<)*<5.M3<EMST*];#U8WM9\E:A6IW3<6Z
M;<93BXSD4445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA7Y!_L:?L@? WX^?L)_\$SOB;X_MOBGI?Q \#_\ !/;]G'P3X=\9_"3]HO\
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M[*'_ "7G_@IK_P!GO^ ?_7;?_!/FOM^OB#]E#_DO/_!37_L]_P  _P#KMO\
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,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45430719615472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 04, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001604174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">424B2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EAGLE POINT CREDIT COMPANY INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="text">
    <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. We seek to achieve our investment objectives by investing primarily in equity and junior debt tranches of CLOs that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. We may also invest in other related securities and instruments or other securities and instruments that the Adviser believes are consistent with our investment objectives, including senior debt tranches of CLOs, LAFs, securities issued by other securitization vehicles, such as credit-linked notes and CBOs, and synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions. We may also acquire securities issued by other investments companies, including closed-end funds, business development companies, mutual funds, and exchange-traded funds, and may otherwise invest indirectly in securities consistent with our investment objectives. The amount that we will invest in other securities and instruments, which may include investments in debt and other securities issued by CLOs collateralized by non-U.S. loans or securities of other collective investment vehicles, will vary from time to time and, as such, may constitute a material part of our portfolio on any given date, all as based on the Adviser&#8217;s assessment of prevailing market conditions.</p>
  <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="text">
    <div>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_03"><strong>RISK FACTORS</strong></span></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><i>Investing in the 2030 Notes involves a number of significant risks. You should carefully consider the risks described below and all other information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus and the documents incorporated by reference in this prospectus supplement and the accompanying prospectus before making a decision to purchase the 2030 Notes. The risks and uncertainties described below are not the only ones facing us. Additional risks and uncertainties not presently known to us, or not presently deemed material by us, may also impair our operations and performance.</i></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><i>If any of the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, our net asset value and the trading price of the 2030 Notes could decline and you may lose all or part of your investment.</i></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Risks Related to the Offering</strong></p>
      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The 2030 Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur in the future and will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by and us and our general liabilities (total liabilities, less debt).</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the 2030 Notes are effectively subordinated to any secured indebtedness we may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the 2030 Notes. In addition, the 2030 Notes will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by us and our general liabilities (total liabilities, less debt).</p>
        </div>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The 2030 Notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will be obligations exclusively of Eagle Point Credit Company Inc. and not of any of our subsidiaries. None of our subsidiaries will be or will act as a guarantor of the 2030 Notes and the 2030 Notes will not be required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of any such subsidiary are not directly available to satisfy the claims of our creditors, including holders of the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the 2030 Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the 2030 Notes will be structurally subordinated to all indebtedness and other liabilities of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish.</p>
        </div>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>There is no existing trading market for the 2030 Notes and, even if the NYSE approves the listing of the 2030 Notes, an active trading market for the 2030 Notes may not develop, which could limit your ability to sell the 2030 Notes and/or the market price of the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will be a new issue of debt securities for which there is no trading market. We intend to list the 2030 Notes on the NYSE within 30 days of the original issue date under the symbol &#8220;ECCU.&#8221; However, there is no assurance that the 2030 Notes will be approved for listing on the NYSE. Moreover, even if the listing of the 2030 Notes is approved, we cannot provide any assurances that an active trading market will develop or be maintained for the 2030 Notes or that you will be able to sell your 2030 Notes. If the 2030 Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the 2030 Notes, but they are not obligated to do so. The underwriters may discontinue any market-making activities in the 2030 Notes at any time at their sole discretion.</p>
        </div>

      <div style="display:none">

          <div>&#160;</div>

      </div>
    </div>

      <div>&#160;</div>

    <div>

        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Accordingly, we cannot assure you that the 2030 Notes will be approved for listing on the NYSE, that a liquid trading market will develop or be maintained for the 2030 Notes, that you will be able to sell your 2030 Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the 2030 Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the 2030 Notes for an indefinite period of time.</p>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>A downgrade, suspension or withdrawal of the credit rating assigned by a rating agency to us or the 2030 Notes, if any, or change in the debt markets could cause the liquidity or market value of the 2030 Notes to decline significantly.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in any credit ratings will generally affect the market value of the 2030 Notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the 2030 Notes. Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization in its sole discretion. Neither we nor any underwriter undertakes any obligation to obtain or maintain any credit ratings or to advise holders of 2030 Notes of any changes in any credit ratings. There can be no assurance that any credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the rating agencies if in their judgment future circumstances relating to the basis of the credit ratings, such as adverse changes in our Company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future, which could have an adverse effect on the market prices of the 2030 Notes.</p>
        </div>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The indenture under which the 2030 Notes will be issued contains limited protection for holders of the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The indenture under which the 2030 Notes will be issued offers limited protection to holders of the 2030 Notes. The terms of the indenture and the 2030 Notes do not restrict our or any of our subsidiaries&#8217; ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have an adverse impact on your investment in the 2030 Notes. In particular, the terms of the indenture and the 2030 Notes do not place any restrictions on our or our subsidiaries&#8217; ability to:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">issue securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations that would be equal in right of payment to the 2030 Notes, (2)&#160;any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the 2030 Notes to the extent of the values of the assets securing such debt, (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank structurally senior to the 2030 Notes and (4)&#160;securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the 2030 Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the 2030 Notes, other than a distribution, dividend or purchase that would cause a violation of Section&#160;18(a)(1)(B)&#160;of the 1940 Act or any successor provisions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">enter into transactions with affiliates;</td>
              </tr>

          </table>
        </div>

      <div style="display:none">

          <div>&#160;</div>

      </div>
    </div>

      <div>&#160;</div>

    <div>

        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">make investments; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">create restrictions on the payment of dividends or other amounts to us from our subsidiaries.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Furthermore, the terms of the indenture and the 2030 Notes do not protect holders of the 2030 Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity, except as required under the 1940 Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the 2030 Notes may have important consequences for you as a holder of the 2030 Notes, including making it more difficult for us to satisfy our obligations with respect to the 2030 Notes or negatively affecting the trading value of the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the 2030 Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the 2030 Notes.</p>
        </div>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The optional redemption provision may materially adversely affect your return on the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are redeemable in whole or in part at any time or from time to time on or after June 30, 2027 at our sole option at the redemption price set forth under the caption &#8220;<strong><em>Description of the Notes &#8212; Optional Redemption</em></strong>&#8221; in this prospectus supplement. We may choose to redeem the 2030 Notes at times when prevailing interest rates are lower than the interest rate paid on the 2030 Notes. In this circumstance, you may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the 2030 Notes being redeemed.</p>
        </div>

      <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any default under the agreements governing our indebtedness or under other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the 2030 Notes and substantially decrease the market value of the 2030 Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the 2030 Notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders of the debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating performance declines, we may in the future need to refinance or restructure our debt, including the 2030 Notes, sell assets, reduce or delay capital investments, seek to raise additional capital or seek to obtain waivers from the required lenders or holders of any debt that we may incur in the future to avoid being in default. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the 2030 Notes or our other debt. If we breach our covenants under our debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or holders. If this occurs, we would be in default and our lenders or debt holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because any future debt will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due.</p>
        </div>

    </div>
  <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtTableTextBlock', window );">Long Term Debt [Table Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="h_06"><strong><span style="font-size:10pt;font-family:Times New Roman">DESCRIPTION OF THE NOTES</span></strong></span></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The following description of the particular terms of the 2030 Notes supplements and, to the extent inconsistent with, replaces the description of the general terms and provisions of our debt securities set forth in the accompanying prospectus.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes to be sold pursuant to this prospectus supplement will be issued under an indenture, dated as of December&#160;4, 2015, between us and Equiniti Trust Company, LLC (formerly known as American Stock Transfer&#160;&amp; Trust Company, LLC), and a sixth supplemental indenture thereto, to be entered into between us and Equiniti Trust Company, LLC, as trustee. We refer to the indenture and the sixth supplemental indenture thereto collectively as the &#8220;Indenture&#8221; and to Equiniti Trust Company, LLC as the &#8220;Trustee.&#8221; The 2030 Notes are governed by the Indenture, as required by federal law for all bonds and notes of companies that are publicly offered. An indenture is a contract between us and the financial institution acting as trustee on your behalf, and is subject to, and governed by the Trust Indenture Act of 1939, as amended. The Trustee has two main roles. First, the Trustee can enforce your rights against us if we default. There are some limitations on the extent to which the Trustee acts on your behalf, described in the second paragraph under &#8220;<strong><i>&#8212; Events of Default&#8201;&#8212;&#8201;Remedies if an Event of Default Occurs</i></strong>.&#8221; Second, the Trustee performs certain administrative duties for us with respect to the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This section includes a description of the material terms of the 2030 Notes and the Indenture. Because this section is a summary, however, it does not describe every aspect of the 2030 Notes and the Indenture. We urge you to read the Indenture because it, and not this description, defines your rights as a holder of the 2030 Notes. The Indenture has been attached as an exhibit to the registration statement of which this prospectus supplement forms a part and has been filed with the SEC. See &#8220;<strong><i>Additional Information</i></strong>&#8221; in this prospectus supplement for information on how to obtain a copy of the Indenture.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>General</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes initially are being offered in the aggregate principal amount of $100,000,000.</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will mature on June 30, 2030 and 100% of the aggregate principal amount will be paid at maturity (unless the 2030 Notes are earlier redeemed as described below). The interest rate of the 2030 Notes is 7.75% per year and will be paid every March 31, June 30, September 30 and December 31. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment. Interest payments on the 2030 Notes offered by this prospectus supplement will commence on March 31, 2025. The regular record dates for interest payments will be every March 15, June 15, September 15 and December 15. The first record date for the 2030 Notes offered by this prospectus supplement will be March 15, 2024. If a record date for an interest payment falls on a non-business day, the record date will be the next business day. The initial interest period for the 2030 Notes offered by this prospectus supplement will be the period from and including &#160;December 10, 2024, to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.</p>
            </div>

          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will issue the 2030 Notes offered pursuant to this prospectus supplement in denominations of $25 and integral multiples of $25 in excess thereof. The 2030 Notes will not be subject to any sinking fund and holders of the 2030 Notes will not have the option to have the 2030 Notes repaid prior to June 30, 2030.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Indenture does not contain any provisions that give you protection in the event we issue a large amount of debt. Other than the restrictions described under &#8220;<strong><i>&#8212; Merger or Consolidation</i></strong>,&#8221; the Indenture does not contain any covenants or other provisions designed to afford holders of the 2030 Notes protection in the event we are acquired by another entity.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Pursuant to the Indenture, we have the ability, without the consent of the holders thereof, to reopen the 2030 Notes and issue additional 2030 Notes having identical terms and conditions as the 2030 Notes, except for the offering price and the issue date, in one or more series. We may also issue additional series of debt securities under the Indenture and other debt securities in accordance with the limitations of the 1940 Act. Under the 1940 Act, so long as any 2030 Notes are outstanding, additional debt securities, including the Existing Notes, must rank in parity with the 2030 Notes with respect to the payment of interest and as to the distribution of assets upon dissolution, liquidation or the winding-up of our affairs. In addition, we may also enter certain other evidences of indebtedness (including bank borrowings and commercial paper) representing senior securities. We may also borrow in amounts up to 5% of our total assets if the borrowing is for temporary purposes only (i.e., if it is to be repaid within 60&#160;days and not extended or renewed).</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Under the current requirements of the 1940 Act, immediately after issuing any senior securities representing indebtedness (i.e., indebtedness other than borrowings for temporary purposes), including the 2030 Notes and the Existing Notes, we must have an asset coverage of at least 300%. Asset coverage means the ratio which the value of our total assets (including the proceeds of indebtedness), less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness. Other types of borrowings also may result in our being subject to similar covenants in credit agreements.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">While any indebtedness and senior securities remain outstanding, we cannot make distributions to our stockholders or repurchase our capital stock unless we meet the applicable asset coverage requirements under the 1940 Act at the time of, and after giving effect to, the distribution or repurchase.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Ranking</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are unsecured obligations of us and, upon our liquidation, dissolution or winding up, will rank (1)&#160;senior to the outstanding shares of our common stock and our preferred stock, (2)&#160;<i>pari&#160;passu</i>&#160;(or equally) with our existing and future unsecured indebtedness, including the Existing Notes, (3)&#160;effectively subordinated to any existing or future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness and (4)&#160;structurally subordinated to all existing and future indebtedness of our subsidiaries, financing vehicles or similar facilities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Optional Redemption</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes may be redeemed in whole or in part at any time or from time to time on or after June 30, 2027 at our option, upon not less than 30-days&#8217; nor more than 60-days&#8217; written notice by mail prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the aggregate principal amount thereof plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">You may be prevented from exchanging or transferring the 2030 Notes when they are subject to redemption. If the 2030 Notes become represented by certificates and, in case any 2030 Notes are to be redeemed in part only, the redemption notice will provide that, upon surrender of such 2030 Note, you will receive, without a charge, a new 2030 Note or 2030 Notes of authorized denominations representing the principal amount of your remaining unredeemed 2030 Notes. Any exercise of our option to redeem the 2030 Notes will be done in compliance with the 1940 Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we redeem only some of the 2030 Notes, the Trustee will determine the method for selection of the particular 2030 Notes to be redeemed, in accordance with the Indenture and the rules&#160;of the NYSE. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the 2030 Notes called for redemption.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Global Securities</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">DTC will act as securities depository for the 2030 Notes. The 2030 Notes will initially be issued in the form of one or more fully registered 2030 Notes in global form, or &#8220;Global Notes,&#8221; registered in the name of Cede&#160;&amp; Co. (DTC&#8217;s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One Global Note will be issued for each issuance of the 2030 Notes, in the aggregate principal amount thereof, and will be deposited with DTC. As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all the 2030 Notes represented by a Global Note and investors will be permitted to own only beneficial interests in a Global Note. For more information about these arrangements, see &#8220;<strong><i>&#8212; Global Notes; Book-Entry</i></strong>&#8221; below and &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Termination of a Global Security</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If a global security is terminated for any reason, interests in it will be exchanged for certificates in non-book-entry form (certificated securities). After that exchange, the choice of whether to hold the certificated 2030 Notes directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in a global security transferred on termination to their own names, so that they will be holders. See &#8220;<strong><i>&#8212; Form, Exchange and Transfer of Certificated Registered Securities</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Conversion and Exchange</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are not convertible into or exchangeable for other securities.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Payment and Paying Agents</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will pay interest to the person listed in the Trustee&#8217;s records as the owner of the 2030 Notes at the close of business on a particular day in advance of each due date for interest, even if that person no longer owns any of the 2030 Notes on the interest due date. That day, usually about two weeks in advance of the interest due date, is called the &#8220;record date.&#8221; Because we will pay all the interest for an interest period to the holders on the record date, holders buying and selling the 2030 Notes must work out between themselves the appropriate purchase price. The most common manner is to adjust the sales price of the 2030 Notes to prorate interest fairly between buyer and seller based on their respective ownership periods within the particular interest period. This prorated interest amount is called &#8220;accrued interest.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Payments on Global Securities</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will make payments on the 2030 Notes so long as they are represented by Global Notes in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the Global Notes. An indirect holder&#8217;s right to those payments will be governed by the rules&#160;and practices of the depositary and its participants, as described under &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Payments on Certificated Securities</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In the event the 2030 Notes become represented by certificates, we will make payments on the 2030 Notes as follows. We will pay interest that is due on an interest payment date by a check mailed on the interest payment date to the holder of the 2030 Notes at his or her address shown on the Trustee&#8217;s records as of the close of business on the record date. We will make all payments of principal and premium, if any, by check at the office of the Trustee in Brooklyn, New York and/or at other offices that may be specified in the Indenture or a notice to holders against surrender of the 2030 Note.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Alternatively, if the holder asks us to do so, we will pay any amount that becomes due on the 2030 Notes by wire transfer of immediately available funds to an account at a bank in the United States, on the due date. To request payment by wire, the holder must give the Trustee appropriate transfer instructions at least 15 business days before the requested wire payment is due. In the case of any interest payment due on an interest payment date, the instructions must be given by the person who is the holder on the relevant regular record date. Any wire instructions, once properly given, will remain in effect unless and until new instructions are given in the manner described above.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Payment When Offices Are Closed</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If any payment is due on the 2030 Notes on a day that is not a business day, we will make the payment on the next day that is a business day. Payments made on the next business day in this situation will be treated under the Indenture as if they were made on the original due date. Such payment will not result in a default under the 2030 Notes or the Indenture, and no interest will accrue on the payment amount from the original due date to the next day that is a business day.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Events of Default</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">You will have rights if an Event of Default occurs in respect of the 2030 Notes and is not cured, as described later in this subsection. The term &#8220;Event of Default&#8221; in respect of the 2030 Notes means any of the following:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We do not pay the principal of, or any premium on, any 2030 Note when due and payable, and such default is not cured within five days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We do not pay interest on any 2030 Note when due, and such default is not cured within 30&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We remain in breach of any other covenant with respect to the 2030 Notes for 60&#160;days after we receive a written notice of default stating we are in breach. The notice must be sent by either the Trustee or holders of at least 25% of the principal amount of the 2030 Notes.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">We file for bankruptcy, or certain other events of bankruptcy, insolvency or reorganization occur, and in the case of certain orders or decrees entered against us under any bankruptcy law, such order or decree remains undischarged or unstayed for a period of 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">On the last business day of each of twenty-four consecutive calendar&#160;months, all series of our debt securities issued under the Indenture together have an asset coverage, as defined in the 1940 Act, of less than 100% after giving effect to exemptive relief, if any, granted to us by the SEC.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">An Event of Default for the 2030 Notes does not necessarily constitute an Event of Default for any other series of debt securities issued under the same or any other indenture. The Trustee may withhold notice to the holders of the 2030 Notes of any default, except in the payment of principal or interest, if it in good faith considers the withholding of notice to be in the best interests of the holders.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Remedies if an Event of Default Occurs</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If an Event of Default has occurred and is continuing, the following remedies are available. The Trustee or the holders of not less than 25% in principal amount of the 2030 Notes may declare the entire principal amount of all of the 2030 Notes to be due and immediately payable. This is called a declaration of acceleration of maturity. In certain circumstances, a declaration of acceleration of maturity may be canceled by the holders of a majority in principal amount of the 2030 Notes if (1)&#160;we have deposited with the Trustee all amounts due and owing with respect to the 2030 Notes (other than principal that has become due solely by reason of such acceleration) and certain other amounts, and (2)&#160;any other Events of Default have been cured or waived.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Trustee is not required to take any action under the Indenture at the request of any holders unless the holders offer the Trustee protection from expenses and liability reasonably satisfactory to it (called an &#8220;indemnity&#8221;). If indemnity reasonably satisfactory to the Trustee is provided, the holders of a majority in principal amount of the 2030 Notes may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the Trustee. The Trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Before you are allowed to bypass the Trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the 2030 Notes, the following must occur:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">you must give the Trustee written notice that an Event of Default has occurred and remains uncured;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">the holders of at least 25% in principal amount of the 2030 Notes must make a written request that the Trustee take action because of the default and must offer the Trustee reasonable indemnity, security or both against the cost and other liabilities of taking that action;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">the Trustee must not have taken action for 60&#160;days after receipt of the above notice and offer of indemnity and/or security; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">the holders of a majority in principal amount of the 2030 Notes must not have given the Trustee a direction inconsistent with the above notice during that 60-day period.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">However, you are entitled at any time to bring a lawsuit for the payment of money due on your 2030 Notes on or after the due date thereof.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Book-entry and other indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the Trustee and how to declare or cancel an acceleration of maturity.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Each year, we will furnish to the Trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the Indenture and the 2030 Notes, or else specifying any default.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Waiver of Default</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The holders of a majority in principal amount of the 2030 Notes may waive any past defaults other than a default:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">in the payment of principal or interest; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">in respect of a covenant that cannot be modified or amended without the consent of each holder.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Merger or Consolidation</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Under the terms of the Indenture, we are generally permitted to consolidate or merge with another entity. We are also permitted to sell all or substantially all of our assets to another entity. However, we may not take any of these actions unless all the following conditions are met:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">where we merge out of existence or convey or transfer all of our assets, the resulting entity must agree to be legally responsible for our obligations under the 2030 Notes;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">immediately after the transaction, no Default or Event of Default will have happened and be continuing; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver certain certificates and documents to the Trustee.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Modification or Waiver</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">There are three types of changes we can make to the Indenture and the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Changes Requiring Your Approval</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">First, there are changes that we cannot make to your 2030 Notes without your specific approval. The following is a list of those types of changes:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">change the stated maturity of the principal of or interest on the 2030 Notes;</td>
              </tr>

          </table>
        </div>

          <div>&#160;</div>

        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce any amounts due on the 2030 Notes;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce the amount of principal payable upon acceleration of the maturity of a 2030 Note following a default;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">change the place or currency of payment on a 2030 Note;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">impair your right to sue for payment on the 2030 Notes following the date on which such amount is due and payable;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce the&#160;percentage in principal amount of holders of 2030 Notes whose consent is needed to modify or amend the Indenture;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">reduce the&#160;percentage in principal amount of holders of 2030 Notes whose consent is needed to waive compliance with certain provisions of the Indenture or to waive certain defaults; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">modify any other aspect of the provisions of the Indenture dealing with supplemental indentures, waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Changes Not Requiring Approval</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The second type of change does not require any vote by the holders of the 2030 Notes. This type is limited to clarifications and certain other changes that would not materially adversely affect holders of the 2030 Notes in any material respect. We also do not need any approval to make any change that affects only 2030 Notes to be issued under the Indenture after the change takes effect.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Changes Requiring Majority Approval</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Any other change to the Indenture and the 2030 Notes would require the following approval:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">if the change affects only the 2030 Notes, it must be approved by the holders of a majority in principal amount of the 2030 Notes; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">if the change affects more than one series of debt securities issued under the Indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">In each case, the required approval must be given by either written consent or written ballot.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The holders of a majority in principal amount of all of the series of debt securities issued under the Indenture, voting together as one class for this purpose, may waive our compliance with some of our covenants in the Indenture. However, we cannot obtain a waiver of a payment default or of any of the matters covered by the bullet points included above under &#8220;<strong><i>&#8212; Changes Requiring Your Approval</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Further Details Concerning Voting</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">When taking a vote, we will use the following rules&#160;to decide how much principal to attribute to the 2030 Notes:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption. The 2030 Notes will also not be eligible to vote if they have been fully defeased as described later under &#8220;<strong><i>&#8212; Defeasance&#8201;&#8212;&#8201;Full Defeasance</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We will generally be entitled to set any day as a record date for the purpose of determining the holders of the 2030 Notes that are entitled to vote or take other action under the Indenture. However, the record date may not be more than 30&#160;days before the date of the first solicitation of holders to vote on or take such action and not later than the date on which solicitation is completed. If we set a record date for a vote or other action to be taken by holders of the 2030 Notes, that vote or action may be taken only by persons who are holders of the 2030 Notes on the record date and must be taken within eleven&#160;months following the record date.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Book-entry and other indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change the Indenture or the 2030 Notes or request a waiver.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Satisfaction and Discharge; Defeasance</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We may satisfy and discharge our obligations under the Indenture by delivering to the Trustee for cancellation all outstanding 2030 Notes or by depositing with the Trustee after the 2030 Notes have become due and payable, or otherwise, moneys sufficient to pay all of the outstanding 2030 Notes and paying all other sums payable under the Indenture by us. Such discharge is subject to terms contained in the Indenture.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Defeasance</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The following defeasance provisions will be applicable to the 2030 Notes. &#8220;Defeasance&#8221; means that, by depositing with the Trustee an amount of cash and/or government securities sufficient to pay all principal and interest, if any, on the 2030 Notes when due and satisfying any additional conditions noted below, we will be deemed to have been discharged from our obligations under the 2030 Notes. In the event of a &#8220;covenant defeasance,&#8221; upon depositing such funds and satisfying similar conditions discussed below we would be released from certain covenants under the Indenture relating to the 2030 Notes. The consequences to the holders of the 2030 Notes would be that, while they would no longer benefit from certain covenants under the Indenture, and while the 2030 Notes could not be accelerated for any reason, the holders of 2030 Notes nonetheless would be guaranteed to receive the principal and interest owed to them.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Covenant Defeasance</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Under current U.S. federal income tax law and the Indenture, we can make the deposit described below and be released from some of the restrictive covenants in the Indenture under which the 2030 Notes were issued. This is called &#8220;covenant defeasance.&#8221; In that event, you would lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside in trust to repay your 2030 Notes. In order to achieve covenant defeasance, the following must occur:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">since the 2030 Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the 2030 Notes a combination of cash and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the 2030 Notes on their various due dates;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the 2030 Notes any differently than if we did not make the deposit and just repaid the debt securities ourselves at maturity;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion and officers&#8217; certificate stating that all conditions precedent to covenant defeasance have been complied with;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">defeasance must not result in a breach or violation of, or result in a default under, the Indenture or any of our other material agreements or instruments; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">no default or Event of Default with respect to the 2030 Notes shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization shall occur during the next 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we accomplish covenant defeasance, you can still look to us for repayment of the 2030 Notes if there were a shortfall in the trust deposit or the Trustee is prevented from making payment. In fact, if one of the remaining Events of Default occurred (such as our bankruptcy) and the 2030 Notes became immediately due and payable, there might be a shortfall. Depending on the event causing the default, you may not be able to obtain payment of the shortfall.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><i>Full Defeasance</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If there is a change in U.S. federal income tax law, as described below, we can legally release ourselves from all payment and other obligations on the 2030 Notes (called &#8220;full defeasance&#8221;) if we put in place the following other arrangements for you to be repaid:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">since the 2030 Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the 2030 Notes a combination of money and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the 2030 Notes on their various due dates;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion confirming that there has been a change in current U.S. federal income tax law or an IRS ruling that allows us to make the above deposit without causing you to be taxed on the 2030 Notes any differently than if we did not make the deposit. Under current U.S. federal income tax law the deposit and our legal release from the 2030 Notes would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your 2030 Notes and you would recognize gain or loss on the 2030 Notes at the time of the deposit;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">we must deliver to the Trustee a legal opinion and officers&#8217; certificate stating that all conditions precedent to defeasance have been complied with;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">defeasance must not result in a breach or violation of, or constitute a default under, the Indenture or any of our other material agreements or instruments; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">no default or Event of Default with respect to the 2030 Notes shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization shall occur during the next 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we ever did accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the 2030 Notes. You could not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever became bankrupt or insolvent. If your 2030 Notes were effectively subordinated as described under &#8220;<strong><i>&#8212; Ranking</i></strong>,&#8221; such subordination would not prevent the Trustee under the Indenture from applying the funds available to it from the deposit referred to in the first bullet of the preceding paragraph to the payment of amounts due in respect of such 2030 Notes for the benefit of the subordinated debtholders.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>

            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Covenants</strong></p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In addition to any other covenants described in the accompanying prospectus, as well as standard covenants relating to payment of principal and interest, maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following covenants will apply to the 2030 Notes:</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes remain outstanding, our payment obligations under the Indenture and the 2030 Notes will at all times rank&#160;<i>pari&#160;passu</i>, without preference or priority, with all of our existing and future unsecured indebtedness and senior to any preferred stock we may issue.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with respect to such borrowings equals at least 300% after such borrowings. See &#8220;<strong><i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us</i></strong>&#8221; in the accompanying prospectus.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#8217;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our preferred stock as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).</td>
                  </tr>

              </table>
            </div>

          <div style="display:none">

              <div>&#160;</div>

          </div>
        </div>

          <div>&#160;</div>

        <div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">If, at any time, we are not subject to the reporting requirements of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we agree to furnish to holders of the 2030 Notes and the Trustee, for the period of time during which the 2030 Notes are outstanding, our audited annual consolidated financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements, within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance with applicable GAAP.</td>
                  </tr>

              </table>
            </div>

          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Form, Exchange and Transfer of Certificated Registered Securities</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">2030 Notes in physical, certificated form will be issued and delivered to each person that DTC identifies as a beneficial owner of the related 2030 Notes only if:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">DTC notifies us at any time that it is unwilling or unable to continue as depositary for the Global Notes and a successor depositary is not appointed within 90&#160;days; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">DTC ceases to be registered as a clearing agency under the Exchange Act and a successor depositary is not appointed within 90&#160;days.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Holders may exchange their certificated securities for 2030 Notes of smaller denominations or combined into fewer 2030 Notes of larger denominations, as long as the total principal amount is not changed and as long as the denomination is equal to or greater than $25.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Holders may exchange or transfer their certificated securities at the office of the Trustee. We have appointed the Trustee to act as our agent for registering 2030 Notes in the names of holders transferring 2030 Notes. We may appoint another entity to perform these functions or perform them ourselves.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Holders will not be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange will be made only if our transfer agent is satisfied with the holder&#8217;s proof of legal ownership.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">We may appoint additional transfer agents or cancel the appointment of any particular transfer agent. We may also approve a change in the office through which any transfer agent acts.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">If we redeem any of the 2030 Notes, we may block the transfer or exchange of those 2030 Notes selected for redemption during the period beginning 15&#160;days before the day we mail the notice of redemption and ending on the day of that mailing, in order to determine and fix the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of any certificated 2030 Notes selected for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any 2030 Note that will be partially redeemed.</p>
        </div>

          <div>&#160;</div>

        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Resignation of Trustee</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Trustee may resign or be removed with respect to the 2030 Notes, provided that a successor trustee is appointed to act with respect to the 2030 Notes. In the event that two or more persons are acting as trustee with respect to different series of indenture securities under the Indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any other trustee.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Concerning the Trustee</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Trustee serves as trustee for the Existing Notes, transfer agent for our common stock and Preferred Stock and agent for our dividend reinvestment plan. We will appoint the Trustee as registrar and paying agent under the Indenture.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Governing Law</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Indenture and the 2030 Notes will be governed by, and construed in accordance with, the laws of the State of New York.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Global Notes; Book-Entry</strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Global Notes</i></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Ownership of beneficial interests in a Global Note will be limited to persons who have accounts with DTC, or the DTC participants, or persons who hold interests through DTC participants. We expect that under procedures established by DTC:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">upon deposit of a Global Note with DTC&#8217;s custodian, DTC will credit portions of the principal amount of the Global Note to the accounts of the DTC participants designated by the underwriters, if applicable; and</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">ownership of beneficial interests in a Global Note will be shown on, and transfer of ownership of those interests will be effected only through, records maintained by DTC (with respect to interests of DTC participants) and the records of DTC participants (with respect to other owners of beneficial interests in the Global Note).</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Beneficial interests in Global Notes may not be exchanged for 2030 Notes in physical, certificated form except in the limited circumstances described under &#8220;<strong><i>&#8212; Form, Exchange and Transfer of Certificated Registered Securities</i></strong>.&#8221;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Book-Entry Procedures for Global Notes</i></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">All interests in the Global Notes will be subject to the operations and procedures of DTC. The operations and procedures of DTC are controlled by that settlement system and may be changed at any time. Neither we nor the underwriters are responsible for those operations or procedures. See &#8220;<strong><i>Book-Entry Issuance</i></strong>&#8221; in the accompanying prospectus for a description of DTC&#8217;s operations and procedures.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">So long as DTC&#8217;s nominee is the registered owner of a Global Note, that nominee will be considered the sole owner or holder of the 2030 Notes represented by that Global Note for all purposes under the Indenture. Except as provided under &#8220;<strong><i>&#8212; Form, Exchange and Transfer of Certificated Registered Securities</i></strong>,&#8221; owners of beneficial interests in a Global Note:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">will not be entitled to have 2030 Notes represented by the Global Note registered in their names;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">will not receive or be entitled to receive physical, certificated 2030 Notes; and</td>
              </tr>

          </table>
        </div>

          <div>&#160;</div>

        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">will not be considered the owners or holders of the 2030 Notes under the Indenture for any purpose, including with respect to the giving of any direction, instruction or approval to the Trustee under the Indenture.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">As a result, each investor who owns a beneficial interest in a Global Note must rely on the procedures of DTC to exercise any rights of a holder of 2030 Notes under the Indenture (and, if the investor is not a participant or an indirect participant in DTC, on the procedures of the DTC participant through which the investor owns its interest). Payments of principal and interest with respect to the 2030 Notes represented by a Global Note will be made by the Trustee to DTC&#8217;s nominee as the registered holder of the Global Note. Neither we nor the Trustee will have any responsibility or liability for the payment of amounts to owners of beneficial interests in a Global Note, for any aspect of the records relating to or payments made on account of those interests by DTC, or for maintaining, supervising or reviewing any records of DTC relating to those interests.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Payments by participants and indirect participants in DTC to the owners of beneficial interests in a Global Note will be governed by standing instructions and customary industry practice and will be the responsibility of those participants or indirect participants and DTC.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Transfers between participants in DTC will be effected under DTC&#8217;s procedures and will be settled in same-day funds.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtTitleTextBlock', window );">Long Term Debt, Title [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">DESCRIPTION OF THE NOTES</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtStructuringTextBlock', window );">Long Term Debt, Structuring [Text Block]</a></td>
<td class="text">
            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes initially are being offered in the aggregate principal amount of $100,000,000.</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will mature on June 30, 2030 and 100% of the aggregate principal amount will be paid at maturity (unless the 2030 Notes are earlier redeemed as described below). The interest rate of the 2030 Notes is 7.75% per year and will be paid every March 31, June 30, September 30 and December 31. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment. Interest payments on the 2030 Notes offered by this prospectus supplement will commence on March 31, 2025. The regular record dates for interest payments will be every March 15, June 15, September 15 and December 15. The first record date for the 2030 Notes offered by this prospectus supplement will be March 15, 2024. If a record date for an interest payment falls on a non-business day, the record date will be the next business day. The initial interest period for the 2030 Notes offered by this prospectus supplement will be the period from and including &#160;December 10, 2024, to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.</p>
            </div>
          <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtDividendsAndCovenantsTextBlock', window );">Long Term Debt, Dividends and Covenants [Text Block]</a></td>
<td class="text">
            <div>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Covenants</strong></p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">In addition to any other covenants described in the accompanying prospectus, as well as standard covenants relating to payment of principal and interest, maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following covenants will apply to the 2030 Notes:</p>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes remain outstanding, our payment obligations under the Indenture and the 2030 Notes will at all times rank&#160;<i>pari&#160;passu</i>, without preference or priority, with all of our existing and future unsecured indebtedness and senior to any preferred stock we may issue.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with respect to such borrowings equals at least 300% after such borrowings. See &#8220;<strong><i>Risk Factors&#8201;&#8212;&#8201;Risks Relating to Our Investments&#8201;&#8212;&#8201;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us</i></strong>&#8221; in the accompanying prospectus.</td>
                  </tr>

              </table>
              <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#8217;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our preferred stock as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).</td>
                  </tr>

              </table>
            </div>

              <div>&#160;</div>

            <div>
              <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

                  <tr style="vertical-align:top">
                    <td style="width:0.25in">&#160;</td>
                    <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                    <td style="text-align:justify">If, at any time, we are not subject to the reporting requirements of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we agree to furnish to holders of the 2030 Notes and the Trustee, for the period of time during which the 2030 Notes are outstanding, our audited annual consolidated financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements, within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance with applicable GAAP.</td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember', window );">Notes 2030 Are Unsecured And Rank Equally With Other Unsecured Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The 2030 Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur in the future and will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by and us and our general liabilities (total liabilities, less debt).</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the 2030 Notes are effectively subordinated to any secured indebtedness we may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the 2030 Notes. In addition, the 2030 Notes will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by us and our general liabilities (total liabilities, less debt).</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember', window );">Notes 2030 Are Subordinated To Subsidiary Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The 2030 Notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will be obligations exclusively of Eagle Point Credit Company Inc. and not of any of our subsidiaries. None of our subsidiaries will be or will act as a guarantor of the 2030 Notes and the 2030 Notes will not be required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of any such subsidiary are not directly available to satisfy the claims of our creditors, including holders of the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the 2030 Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the 2030 Notes will be structurally subordinated to all indebtedness and other liabilities of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember', window );">No Active Market May Develop For 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>There is no existing trading market for the 2030 Notes and, even if the NYSE approves the listing of the 2030 Notes, an active trading market for the 2030 Notes may not develop, which could limit your ability to sell the 2030 Notes and/or the market price of the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes will be a new issue of debt securities for which there is no trading market. We intend to list the 2030 Notes on the NYSE within 30 days of the original issue date under the symbol &#8220;ECCU.&#8221; However, there is no assurance that the 2030 Notes will be approved for listing on the NYSE. Moreover, even if the listing of the 2030 Notes is approved, we cannot provide any assurances that an active trading market will develop or be maintained for the 2030 Notes or that you will be able to sell your 2030 Notes. If the 2030 Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the 2030 Notes, but they are not obligated to do so. The underwriters may discontinue any market-making activities in the 2030 Notes at any time at their sole discretion.</p>
        </div>

          <div>&#160;</div>

        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Accordingly, we cannot assure you that the 2030 Notes will be approved for listing on the NYSE, that a liquid trading market will develop or be maintained for the 2030 Notes, that you will be able to sell your 2030 Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the 2030 Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the 2030 Notes for an indefinite period of time.</p>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember', window );">Credit Rating Downgrade May Impact Liquidity And Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>A downgrade, suspension or withdrawal of the credit rating assigned by a rating agency to us or the 2030 Notes, if any, or change in the debt markets could cause the liquidity or market value of the 2030 Notes to decline significantly.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in any credit ratings will generally affect the market value of the 2030 Notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the 2030 Notes. Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization in its sole discretion. Neither we nor any underwriter undertakes any obligation to obtain or maintain any credit ratings or to advise holders of 2030 Notes of any changes in any credit ratings. There can be no assurance that any credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the rating agencies if in their judgment future circumstances relating to the basis of the credit ratings, such as adverse changes in our Company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future, which could have an adverse effect on the market prices of the 2030 Notes.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_IndentureOffersLimitedProtectionForHoldersMember', window );">Indenture Offers Limited Protection For Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The indenture under which the 2030 Notes will be issued contains limited protection for holders of the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The indenture under which the 2030 Notes will be issued offers limited protection to holders of the 2030 Notes. The terms of the indenture and the 2030 Notes do not restrict our or any of our subsidiaries&#8217; ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have an adverse impact on your investment in the 2030 Notes. In particular, the terms of the indenture and the 2030 Notes do not place any restrictions on our or our subsidiaries&#8217; ability to:</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">issue securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations that would be equal in right of payment to the 2030 Notes, (2)&#160;any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the 2030 Notes to the extent of the values of the assets securing such debt, (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank structurally senior to the 2030 Notes and (4)&#160;securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the 2030 Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the 2030 Notes, other than a distribution, dividend or purchase that would cause a violation of Section&#160;18(a)(1)(B)&#160;of the 1940 Act or any successor provisions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">enter into transactions with affiliates;</td>
              </tr>

          </table>
        </div>

          <div>&#160;</div>

        <div>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">make investments; or</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">

              <tr style="vertical-align:top">
                <td style="width:0.25in">&#160;</td>
                <td style="width:0.25in"><span style="font-family:Symbol">&#183;</span></td>
                <td style="text-align:justify">create restrictions on the payment of dividends or other amounts to us from our subsidiaries.</td>
              </tr>

          </table>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Furthermore, the terms of the indenture and the 2030 Notes do not protect holders of the 2030 Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity, except as required under the 1940 Act.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the 2030 Notes may have important consequences for you as a holder of the 2030 Notes, including making it more difficult for us to satisfy our obligations with respect to the 2030 Notes or negatively affecting the trading value of the 2030 Notes.</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the 2030 Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the 2030 Notes.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember', window );">Optional Redemption May Negatively Affect Returns [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>The optional redemption provision may materially adversely affect your return on the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The 2030 Notes are redeemable in whole or in part at any time or from time to time on or after June 30, 2027 at our sole option at the redemption price set forth under the caption &#8220;<strong><em>Description of the Notes &#8212; Optional Redemption</em></strong>&#8221; in this prospectus supplement. We may choose to redeem the 2030 Notes at times when prevailing interest rates are lower than the interest rate paid on the 2030 Notes. In this circumstance, you may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the 2030 Notes being redeemed.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember', window );">Default On Other Debt May Prevent 2030 Notes Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="text">
        <div>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the 2030 Notes.</i></strong></p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>
          <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">Any default under the agreements governing our indebtedness or under other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the 2030 Notes and substantially decrease the market value of the 2030 Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the 2030 Notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders of the debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating performance declines, we may in the future need to refinance or restructure our debt, including the 2030 Notes, sell assets, reduce or delay capital investments, seek to raise additional capital or seek to obtain waivers from the required lenders or holders of any debt that we may incur in the future to avoid being in default. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the 2030 Notes or our other debt. If we breach our covenants under our debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or holders. If this occurs, we would be in default and our lenders or debt holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because any future debt will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due.</p>
        </div>
      <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes66875Due2028Member', window );">6.6875% Unsecured Notes Due 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtTitleTextBlock', window );">Long Term Debt, Title [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">6.6875% Unsecured Notes due 2028</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtPrincipal', window );">Long Term Debt, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,423,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes5375Due2029Member', window );">5.375% Unsecured Notes Due 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtTitleTextBlock', window );">Long Term Debt, Title [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">5.375% Unsecured Notes due 2029</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtPrincipal', window );">Long Term Debt, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes675Due2031Member', window );">6.75% Unsecured Notes Due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtTitleTextBlock', window );">Long Term Debt, Title [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">6.75% Unsecured Notes due 2031</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtPrincipal', window );">Long Term Debt, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,850,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes775Due2030Member', window );">7.75% Unsecured Notes Due 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtTitleTextBlock', window );">Long Term Debt, Title [Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">7.75% Unsecured Notes due 2030</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtPrincipal', window );">Long Term Debt, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001604174_Notes2030Member', window );">2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LongTermDebtPrincipal', window );">Long Term Debt, Principal</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtDividendsAndCovenantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtDividendsAndCovenantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtStructuringTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtStructuringTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LongTermDebtTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LongTermDebtTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_IndentureOffersLimitedProtectionForHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_IndentureOffersLimitedProtectionForHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes66875Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes66875Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes5375Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes5375Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes675Due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes675Due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes775Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001604174_UnsecuredNotes775Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001604174_Notes2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001604174_Notes2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M KRXIBTR/%P$+EB"$!!?ZZT5X$S,HL\CBK)X3,3.U%U&;P,J\XKXGO+/<,Z
ML'2D&^24RZI<)0V8<,C_Z+^PKPGA(N#DA$Z!X"-4@3_"+V _B#_KM&KHB\C!
M/=]"&Z[8)%?P:3@G/ MKP;=@/33+%OAW0]-__+=G1X=/GP,,ZQI0@V]C"1S/
MW:19CG@$G.^C0SR!NV54'9*1HS+F,V7D#UY&_C JP=XC#?Z<$F,$89C.<I?<
M(1+O6/#B\C^3G\_./[Q]?YE<>&F3,>2.#HX/DC?$6N!JRYP8HF'L718"./VW
MLDWJZ[+-@6\ [URV><Z7F@'KIT7I04!+5'=FB&@D91!#\?*4Y-F]@*P/7FY2
MV/:"=P4R>@T"8PTHUR+BK->YP[N<T.+IG*E\P\),GYL0HBPK!Q2&^!O]D;Z-
M+R]$JZY)V%> :"1;@!+@( ZT@+D;WX-?:<LVX*QP+N1^'_$/*4!AGI$[ PAB
MW5; @H##Q)!G-L% P^5;V$6% "$J[($15@=90&N4!8IQ8(/),IWC]UI8[&S!
MN U$M6U-?)]PMT#N]K$H;VE_"$5@ ?%?%PX.O@B$"K#"YX*\!BAD%=%MN4;-
M",F*O@D_T1W#IZ?)Q9(N"% *-P[4#6?!'<L6Y\BM\3!S8#\36DTY_,1(&4^X
MN$_88ILWS*?"E^>$F3/G=PRKI@LP^6N'_UHNX9[<@C9$+/D:]#=7U/S- I@#
M,@_@;FG>.G_;*#)$>0(,D4,8VN&/PETC]=%;&Z 2A!$*+D;[RO.X32PQILE[
M L)[T720=<+R;V&K%7STNP_QMXC;POG:0E4SV67%J*=_=W14X)QP[+H%;0Q.
MH.OC5>C;(.= @+@%2=-;IY*&MLB7!:*TXE/1VJ @?,2S9/ _(&!("!+B@-(*
M=]24S*3+MJD;>(GH@ 0W+1.V'7TXB"I"5\8@A-.56$]YELZ B1/^[C5E$_]J
MDN2L#,R:?::G+L00JV?.GYH^M%&)0W=.\L\@J?Z2'P$0 H?+X-A(L6?()AD!
M)UUD0 K=-?#W9&O1\X2_&?(R@ $A>@ N?(<5!U@4MPYWP_1\11:GB/G-OF(;
MB!@1E_@38W\,!WX%]5Y4+^U&@)A83N<9J'H+(L0)V@1UF;?\ ^J-5;MNYANC
MK6>K# P)Y)YSYQ!/&)379;Y LZ%<VBMRG\2 @?<%*(- 5)(=_./ 73(G@R-6
M*.&NKN&DZ56*&I@]/+#_Q16#E1<6X$<HC%R)9& )J#%WJ"^A= 0RV:P"<+,J
M?DTDAOD8[@@)O.8/KE4[%3T=- .K&W= UI4M>#4B$7J8^GN0\Y>1\C;FA_HQ
MR(R*L+Y+8'C*'DXP!.VG!PE[R_?*69Y=B80!0R('V42T#6N\3J] 1WM7@FQ-
MSMF0.F?5 & _G]+'D?G$Z!Q_]0T(\4'D]-^O^)\@*%'[39.K-D5"+JL!::0D
ML(4%5HX,,@(5_"@KN< 4XQV(*2=67$E8B/Z/B$&)J>,Y)B\#?,*OM?&:BS>K
M4E3+2<-%L@+HULL-K3G/TVSE+V@0ZT<P_O6GN5LW'<8&Q\#OIWXUMMU@)R5H
MN&@.R4>5^+M7P500=N9WM?W>KE/@ * RE,AI$PH[$"=CWP[@"XCLFFVX&%9$
M&+%4_U*P[.MY25%5X(0+ZVT X(A&5[94T!E0$09Z0.)^"L*,%>YT !RL7,GV
M;TE7 E[^ #6E!Z_F;FPK_!*Q"*B&6<'0&N+A@67"_J= W847I\,L]2X&E9(+
MX#X,:@O'8&.J2ZKJ8F E(M+= O4"!('DLOJ:>&M%+M&B#.)555TQE9=E-<!>
M)HD3Y,"_O?G;Y6MR@Y8WM L'IQ!9W45#--,D+'N/+^%!B&.PCT=](:QMYZ ^
M-*Q+,\@V+)T!MOT-/Y'%Y5M;]/BM[!],8G?+0HW<G>AQ,9X2W#IOK3$@C<]'
M3C'$8<9+A%!WG^+-(' BM<(=PM\6Z<;3,W"2JPPM.]X*>D38Y<HJSV8U*_,$
MW2!'!\]?GY__-J5_'SY/_E+> @RK2;1!%/?HMW3!.SIT=K[8!9W27VS8ZC3Y
M%<B^I-4M5FS% ?RZ+CI!?)VG!=N<Y4VV<(37?FOJXMZ&-;1+P0]$;S+\,O4G
M#. 4_28EQ E'5!F$R$,8%6E0?0%;\3Z0%2X;ACZI=:2'T^7@W@G:&\)B>CK!
M@Z!>/">/(#O+HC=+L?D$01<.3-.%P-NXL905)NB^J"<6L_'$JE@'#)T8B8$O
MP2(H-HB_3+Q>A@&/<I7-C7^,7QPPP"?6O&=S7YP@EILM4_'P(UT1HJ)S!@44
MR<:4_'9D[BD&;@R-K-*/[".DD_4\5N@$EG=4M1 UC;GL BZT'/@TW@==0@%P
M:!G?^!N/U6V#J"8NU)Z?C+!Q(][-1BX0+!U'BU:.XD#?G<WGQ/*O4$8$'">\
M=H1\7T)S$Z$*L;B^E"@F#R,)QF/T9F3S%A&-8*&$A4LS^N)Z:@C=7@-GP%_0
M@OJ597I35O@IN*9(7=M*[XM2_%=>)C"O03!HQ"SVUFR1*_#UZ[1:H2LHNBMU
MW/04Y927";1 X1*2T=8MWD>8)=GN)/"72.@.22<K%\09 7* +'"LVX)B;QB]
MJ=>2 B5:ZJ)*;XDYL!9HJ1@1*KLJ-.*GOP2*GF_8I9<,W+82/BKS%!/179-@
M8TBK4VN>MN*Q#$!&58^O(W(4F#,C^8DWS+B0\PT &V@G/@**@\+Z[-$=:PYB
M;#4CZ,DJ;CG\5C-Z+5K7U<[ 5,G9K0.XFJV)-?"1B;33[F:$!(4C>H>AY;!;
MCDR,IG;=Y52% 34^UX76)>(X20JP$^=D&K(?E(*=I(4Q-:@6Z0+(!T7J5"U/
M_:PRQ)34]A5FR+"O'5&YW4R8#&%1-!@B/3M$Q(@"F$$;1"PB!CAC@PTE'OMF
MKM)"(YH WPS]1AW6F+QQ&0F'6]PBN[4,?^9_-\#Z:]9^O>5->O@,F1A#@QG:
MT!VRSL[2Q9I$5@U@W7H4%^A**^+="(R^QK0-?2J'NQ/"U_!53/2>79+-,;2(
M6.LYQM"[5X#H4Z'%)/#OD@L0.%,TB*9_M(LK(BNQ!>99-6]7Z,M![:J+<;.T
MSNI!5F,"R^)/M]!#4A2W!SQ7)K=IA5X%%K]!G_ ! ,]%E=NP"K%%Q6%U89DC
M,1 -"[]:IS6'9!#?\^PC@@0.XA^,S:#8?F -I/"'84-4I:PU%(:\#.280I9>
MB!L,E7!O PS)='&)2;"K9OO%D=[42+[J4@ARBV/C<S])6N7@!P%6=WP/;F'E
M_Q@^/N!B G6+&1TPK6S.#I3@4.]:L!*KM1S=%5<IB:*)-](I'D_V%VH;&W9&
M4B*):VA9'\3CO(5T+EIKC.1H]MZ$-)#A^U=>7'3C,WV13E[5H/^P#O)@2*WS
M=,[:I\*,*:10T-T-LS]]]\=_.WQV_%SL01N\KZ*,!HPHI"$P..P1,4Y.ZU/:
M.]P?<:-8SR@[(#0 Q_YC !ZYU2D2+XYPX356)=D[^KR/#,? R*<=>9;8DW.O
MS8R$1/S]#L9$<.=PDN/]H:!#"-?$#M<[7&<<=@N^!0[QT>GID+&?R?NK!CS"
M>R?[D478@[2!L3*.BE%' F:]O76OPGK+AKR<@X?KW-K]#C3NS.S['S&E+D76
MC^%WQBG8?,%Z.2< LD/H+ORS9V;5&/A15N:IIG5>"FL]?+:7[@/I[)WM*](<
M_G!R ,9&HVP1D :X4UU6[/I E;]^KA2]9BL5^,*L%<8 RFZ&'I)B@5R"N*1/
M*:!X.,;J63?ZR(Q%<)R K] JEQ.?NU@WY?SC8/X<W@4BMF0?WI.*+62CW4_\
MUJ-=/QB8+S\/F*3M"G[LF4U*4H07C4.,V$@HS'(I\XP3D58.<R I90H79W4:
ML:Y)"PG'TB]MA'G?[\@A72!UE)'DD@3+Y1*^B8J/?UZ"+GD&IF&R%Y@S_T*4
MEAHLVN' UC[)P/#-.LU9-.4.[F&6SC]&V_"?)4PR^6;/89W.EKHP8[W,1SP-
MRBJ:<49<+?8IN<'Z(;&?VPH?1K[XN?*5]9SM&HX*=M(-O/?<?4)-G?B!ZK<&
MWC8AJJ,&[RN+&W27#6>KE'VO7%JS3\OK4^RZU^T-Z 6P$;)3)-P1/M\0XT76
M@)_C_#[@ ;!_3.A%!PKM![->;LL*P[X5PJ*5Y$O*A@:.>0T*=7F;D"M*7  3
MC()BE"VM@YLD>**5.*?)VYB"P!IEUI/]RTWZ>HE/96S8]1<2T01SYD8'4!M7
MB5=LH0A/.DX?TOE T8/#II0O*KZ"N;AIT/E#P2W&F:'X14 %<1;"W9'P7F1
MM: /L@^VK6U0DQ0Z(U^'Q%?LHRX</GL3<I8TU*_.K:UNB+<$*8+DK=.81368
M52(>'K9(^!3!.&"(H 6O!$0L\R[JLQ R-SLO ;'20@P]T<8IE$+5=&+<B./<
M*!XBEGUTCL^%X(,'*LK)P^Q1LVL^5-]OP]9X\ X*_K/=.6;EE6M-IP,!N^+Z
M#2]C"*U&4LW8F*@<0*M0[C@2<.) *\IQ<L#"K=Q>H_^$13 ED%GW"^;"]%)N
MV7'(@8G_:$&]E.*YI_@J\0Y:D0\B#MOH:.@UK1EB .= U4"Z](0$F+H%+>2<
MIE.0H7+T/'FKD'OOE__N@@+*<NW>V+'Z??#M::IH4,DF&M\4[XBZJ4E.>6UG
M ,[H=M2/AA.E5Y5S_,X51K *<F*U54\-Y%?Z^XGRK,1IYHU5T?=QJ[=I=A-8
ME.>8N2M8-'F[?^))"I%[@=R]+EO4O.1=(\UZB5B"^P0,8$!MH>!!@,*]%N@"
MS2?H9UEE[2HX@CGI7#PN/>AQK4&DV2P<2G]Q#-_E&+WP.01A1[Z,IFZ1;6:4
MON]%C;IT@@D;WA07(*7O YM$I0]C]8@$6-+L81NP8?F@LW>OG_1L3H,(VUFF
M6<X:X6H-X""&Q%8BU[AX=F?981#,%"%C+0"K&^S#PF!#Y<IVQ.3 DII?5 G0
M1?!(& YB>P^)NKEE';='4)@4 ^6KO>2];>CI<I%Z&"&@I!P)V?.52MV0&(9R
M%,I46DA&+MPL(@-\L+QR[$HFK7D^KUIQ!;3%.LW"O4J42*EM&8(=(SF7G=TB
M*"F%0_RJZ%;/M.1F3L0@&L&255<IJM""#BYY0$,7JUE:EK62^!BG';&MP)AI
M;QC>G9/O$\$1)52:Q$LB-Y.-C7$P$ZF5J$Q@I/&9"\?AKLHQLHIA:>(0$G+9
MCB43:VVA1KEH>9F%R['\0TS/N&))2N:J%(G+J@WR-)E9_(S0/W'4JO91]#&F
MJAH$EVI%63+]:T<M^J;,$.)2*.%UE"%&!MJDE 9T/#D-A8/2'/"F2*5X;(OP
M0KY%A2]J-AEQ&&@Y5A"#?,13Z=YF%;DY*-KO-2X17G)SS,T1F*D <=N^!-+Z
MV+U +>D2&$/ 5'X^\^T C]*D4+,$[4ZO3*CODZOF6:TTIPFZMBPBG<%!OX18
M>E=:.7*^$);K]L!RX)H_=C?:&^)/"C%'R<.AX"IX"I7S3).73GP>:+,Q[HEV
MF^<:S$"#92(]'E#*427E8X5A\'1,-.NFDR#N.:C78<S7Q/+$VA&RSS 0.Y\#
MPZ.JF(E1:;JP*=7(E;QE,>@Q #M44#5:H?29!56'!Z%[Q<%XPP?A(9?H[)HD
MOY3%U>,/P,Q!?\4;1L1AF^DRN+_&*[+E@SLJR=[5:C%X3'./P]$",81'XN%Q
MSYJS.]9\]?KR_/W%NP\7;]\D;W]./OSE=?+F[8?7EV3NA.*?1=^ L%DE6PSY
M4(TEN8BQOQX=%U&!)LH@BK740GR]CVH"%']1DIF$LM2;ULWY"P:2IJ,.5X3U
M3#S696J,NZ^!0;:INE*WUIQUPGE*Q\$,GU F(.7EPFY?@4Y,;A-JN7)X.H%W
MFUOG"LW%?PW\#Q/.D@\5,)80MOWEE_-D#S4%+.&6LC!8\@Q^1H<7$Q"\) 7"
M?TQ7Z^<#:^PS3:5)G7UJKLU!)/#$G@/B31C/8WB0;]+SZWOOE]UE^&OG*,.2
MZOAL$4#LI[C/EDR]*YKQC#5B\U[HPYI8*6G&8R"-5_@@F]4%!AP K)P'<_$B
MW+-UM\%?EV!74T5%>LO^#424$K5HJ3I@KX:OBPZ.LW4+$FQ.%0Q8^(A94 :A
M2!208PAY8/<^FBB ;RJ_R3]'24EZ)SZ<.G/7:;X4:PNQFZJD.: +O^H>F<'H
M#\Z._F5R^,/Q#P2$%#-:<-<?]&&'^5SPW=N24D.2JLS)C9Q5JO[K8XC*KB#]
M0+PS<=E/6XNY9WU3%2L)=;ER['!,(X>W\![O#;#?2^?LDHC@$/0781_<;@+Y
M'YAIZ5K]+NIK49?*:^\Y>\6[PS\<'#Z7O\M/[]5W0$8NOV3>2=Z2;@;GRBB&
M*>DZ5%U>4]%JCT7Z^L]M7%D1P]]94'":Z#/X 6D(-@%M3_*2LRBUCV&#=B9F
M\FO<ZAZ?! [08EB&$BQ16TD[C\ %\*8R$?U<2YO5]M!X/4NTDF+\&',,,R:&
MSR NSI!FTJ8!C5R*)@#Q/EUGL\P[?2MI D.@J0&IG,9-%(^V2@5DU+4XF^@D
M_I/++'>+X).X?'T^!=W&<R!;(7QARK"E3TVWY"I4%Z8$/DY 6PJW%L?"587^
M:A<<+=KV $[R[X<'!Y,#_K_A#'O8 -F6A?57PB-X*GCY#\&!L?4[*B/)[$\;
M7A*5VKVVR$47[A5IIE6>.0V<\A5URJWW->O&9",-9[0_G3X]_0.:VLD&4T5]
MM:SNB7'YU[2"6ST^G(237KIUP_):3NSE]_&AU$V'[ZN%2)G_2[@5XBPI-7((
M+3%2J4M) 5E <K,GN;.";FZ%B>G"Q0I4^NPR0B%QZH@L)/5HZ'-ATN (EW$+
M@;D?_'#H/(JW,."G]8A%8F!<(>*TQCEM/H#UZ.#H5 KJW16ID9@ 62T(8A+2
MZ.W#ETR;.T*]B>X(_Q'NZ/ TOJ-#^=H2Y8S]UF#MP?U/![L)^\#.=XP*O2\,
M(<>=>&$7T:\-WK]BO]0U^ ]Q*N,7GY 4?ED+?0OL*E.W4H"Q-/^;D+J 2?]4
M@ADJAOL;-&02/.JA#KI[E'I@2_70GK;2XI:=$42'WQ#@$=-?!'XE6ZXEXE*K
M#4ZRC9O'4$AO"^#O:5*0(P:+/0K58X!/'YUZ9_@5:I4K(.<,WO!_Q2R:3W/O
M62B7XZ7V7L?C\%U6B'>T8!_M]KB\7X7BM8V/P5&^HO[*/(].B6S!I9;X3"1%
MNI+9JQD:]Z1$F6#OD8J,*;ND1)ADR2A;P(=6M1E6D'?LW6&7@@^91ED20<@,
M*WF_8FH)^6S.?<8)QL[>19<;&0:W+D!&XNW<R:QLU1=5U":=+<1TZ2(GK"UA
MY]<A+4N.&J2 ^;MXQC#) RSWR(HV>;]I5P+[# +E(IW:)R7:4.E&T1'K9*T=
MIXI$[<.Z.^6'AJKV@F?U(K(3@U<UZJ54D(5?+<CKY96KR!:(,Y.FR6^]A C*
MC<Y+MI$0\3HJB:FRG_02(^+L/>M]?ZW5FP+:54NZ2O%1HL;(6/R6[TBC,[D[
MGG&1/>\3(VUB%[G6.;&J7<./4=<'XVE5=G>;T>$>MVN?&;5<IEG5[51P:^Z4
M\Y8T5XNOQU%6D43M(Z>G2=9!OZ_$DSC(0C@):D,UYYY3P.GWD7MPMQO3U"V
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M2QCRO)PF>W!BWP,6<:( /> Z6R=$/<[M<X4&YL>0WD/+I$;J_+.%>] ^6)8
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MQD/&X34?IAL(A.^=[$<.P1ZD#8R5<52,.I(IU]M;]RILD' HN#MXN,ZMW>]
MXS'<?M@U,P-7!:>HE0JY960>N..2I''\LV=FLS"-&DW?I]YOK$+(][E>LY/2
M5Q#47* 0:@-L[87369ENQ7:!S#SV);"(^$YG7T\ZY1DA%2_PCXH[ H/F?'_"
MF420C78_B>HL_*X?#,R!:IO[ +/F@F/"CSVS21W+I:)QB!$;"662["?)RE57
M4D],@TC)E$2L:])".W?P^+V06KKO=X0#.BKN-&0EE^3"+Y?PS6A&@.2:Y)F#
MA_8"<^9?B,).W>D'*6"?9&#X9IWF+)JH+?XL!2RPV_"?E?D'OI30=H22+75A
MQC:)3W4T*.LG;4J5H+3FUF%T<=*%3,I%OOBY\I7UG/'!XL3HJ?VW)@VX3VBE
M$C]0V\[ VWARNB;@OK*XP6@)9PGSY:Q=9=I.=0Q,[D&P"?J4SOSF[0WH!; 1
MLM$ERR-\OB'&BZP!/T?_0A[ U8Q8^9G3?@J,&)05YGO2Z)B6.2:.5IAPC=@2
MRX(H$B'NKPDF?V%R45H'+WD(1/I2<2I%-114.6$]V;_<I*^7D.^-;I0C/T5+
MG2@09DV8T6JFW%*;=R%>\0-$>-+Q^9/.!XH>'#:ERCLS^D^GGU!.#^/,4/@Z
MH(+$BG *>4EU6]A\ %NQX$H\.$-SN;JS%N_H_H_%H=APAW47=K]ICJ_&-K:Z
MX+CLA"!YZS1D70VFD\]UY"LQ03I%, ZD:PL@D&_8I?-WQZC/0B@:6JG]$/ 5
MYZ<4R.P",6Y\A7;5$<L^*8G/A>"CBF+IF65WS8?J^RS9$Q6"0X+_['-YB(?C
M:^22'H=<TN/Q/-"W:X'H>S\:FX(R;P+"G/'9WSNXHF+<QS'^L8>:];M:+09-
M2)HZ/ORJ/H[CG29+[6JU&!@A6>IXO*G:O7P<=ZR!-%DJOH51[$'#DAF 7-^'
MK&HA\S*4_LB4K@@1^VVG>MDVG%V)6JPTS\*1V;FP S*X(\<[EH!0"@7US"SE
ME^09YZP,T];LZ"F^2I*35N2#2+0Z.AJ&C&OF%\!E@DP#P45/:%^&#I919)Y.
MH4,U!BAU$$^^1A[9<<@C.Q[/ =,Q,6\+D1Q4IH@<Y1W/D;,7]$[MB5&>LJ/(
MM8#G:\3!CT,<_/CDZ_*4G0:]=[5:#(P0]#X>+X"]'T\97^-"^D#(:*2BIQN9
MN&:_4-T/'BWB27]DIVQO<,<AUVCD$[L,PB@G[L%) ;RVZKD!^)6!PGE;8"<!
M0^^L%'\/]?G X?5>1?4:LPX$"G[?T#8-E9L%3>W%#C:-OFNLF5X%GN@^!(RV
M-NV"$:"^A1:.L7.KK%W%S3_"B.>!L6V+CF6[<*:=RUU!X0N?.A]VY ?NF>'I
MP=30<%9P888W)?S)X\0+AT8_IJ@C$CC7!-@&;%@^Z.S=ZR<_"V?_A^TLTRQG
MC\ *&WOYQ@0ZY,^KNU8=#H89)<BQ%6A[A4U4/S=#Q480D_/*U/V6%0,('AE#
M@]C>0Z)N4>'8-'A1R64*YSW1T^5B]?@6+9*QRU?*O2J<. ;E*%2@TQ\?6EYQ
M-QWVFE!33'8%MP5U_PR-XBAY0ZE-FX',FK%BV\YNN7$-A1JX_6^Y KM3>BM0
M9VRU")?LNDCR,BUJP2\=/(>.3NRWT+*M)16O<;4-^XID&KRY87AWKNVIXTI:
M4W%+Y$;,T^.73=24C)3 2.,S%WX2/".K.!9-#H:DFVS'DHGUMJ%'8='R,M29
MU+L>C5-IPIV \+,I$I<U&^5I<K/Q,T+_Q%&K.DQT'&&J:D'2C<?%(?UK1R_*
M39DMI.=N(*MA1I:MM+UFQY/?4"I,F@/>%&29;1=>R+?N;GL7.PB"?,13Z=YT
M^F%K>S.*\)*;8VZ.P$P%B-OV)9#6Q^X%:LF6QOP)G![(9[X=X%%A/J=?@G:G
M5R;4]\E5\ZQ6FM/*[(%Q@I]/++TKI4&!@N6ZO>N46FUIN,G>$']2B#FJ&I_C
M&-R&]$<?*5+.,TU>.O%YH\^.<4^\&S@PFA,YT&$%W*6MFW*%4FY>E77]6&%H
M&XMEP3%J.@-X#NIU&/,U\3PNTSG[YS );3X'AH>">3$Q*DT7-J4Z.:5@71RZ
MF'PVJ+9^C?3$XY">>#R>6OC]]/MGV"4ZM&)A*GK5(E$=/1NW9G;:AV17J\60
M".DQQT]'K9ES8:>7W+P+&\D^-HUDD8;8"#0C->ZP;W::)+.KU6+PA"29X_&:
M_L_K;C^^Z(-!,+[%;;B\$%P>@T/(CSD>SVWIPN&=JL^#Q]]II;ZL=DJK%;#*
MS8OCHY.CXV<'!S\^N1DXU4GPG)Z,>TY/I\<C7."'42XPOO1##[FKU6) !#_I
MR;B?=/=<X&2GGM-=K1:#)WA.3[[&C(OQ11\,@O$M;D%E80(_C($A. 9/'C;J
M8I0)C*_UX-,?]YC #\='IP<'6YE \.>=C->U?#_=S@..#\=YP$Y=>;M:+89#
M<.6=C->O? 4>L-.*EEVM%H,GJ(PGXRKC9_* G>J*=VQQ&),7@LEC4 CJXLEX
M-O7#6,!.-4%9S;* DY-G8RP@:'DGXRK4TS$6<##. G:JZNUJM1@.0<L[&6_1
M]!58P$Y5P5VM%H'G-*B+I^/JXN>Q@/%%'PJ".[8XC,G" @[&H!!TQ=/Q1B0/
M8@'C:SWX\(<]%K"%]D^#;G<ZKCC=LVW*^"H//LC7B/">!D7N]/AWIO/3G6I[
MNUHM!D_0"$\?-DUG',-/>CAY>"#_S^.F'&NG"MZ3^MJYYE7:I"]^7*=7[M>T
MNJ(J$K>$Y0^ $3QB[ZC^T)3KGQX!!<W*IBE7],]KERY<A0_ WY<E4('\\ 36
MORVKC_2-%_\'4$L#!!0    ( .J AEEZ 5O)Z (  .4-   -    >&PO<W1Y
M;&5S+GAM;-U7;6O;,!#^*\(=HX4Q)_%FXM4Q;(;"8!N%]L.^%266'8$L>;+<
M)?WUTUF.\U)=V?IA;PZ)I7MT]SPZG222MF8KV,V:,4,VM9#M(E@;T[P+PW:U
M9C5M7ZN&28N42M?4V*ZNPK;1C!8M.-4BG$TF<5A3+H,LE5U]59N6K%0GS2*8
MCB;B7A\+:XS?!,2%RU7!%L'=^<MOG3*7+XA[G[TZ.YO<75R>VL][X"((LS0<
MB+*T5'+/%P7.8%EIS<@]%8L@IX(O-0>ODM9<;)UY!H:5$DH38R?*0*RUM \.
MGKH>Y&"(4W.I=,_M&-SO<AA^ NQZ() +,0J<!<Z0I0TUAFEY93O]X-[X"")#
M^W;;6(65IMOI[&VP=^A?EF2I=,'T4=Z=*4L%*T&.YM4:WD8U(8#&J-HV"DXK
M)6FO8><Q-&S8%1/B!@KD:WD4>U,>K.<$5E..32MH:+HPK@/Q#Z.YV =AXV>%
M)0V_5^9#9V<C^SX4"KO6K.2;OK\I1WXL^A2/3IM&;-\+7LF:N;G_-&&6TIT?
M62O-'RP;5,K*&I@.R#W3AJ\.+=\U;6[9QNRJ:5/BFF?_H.;?F^>*2::I.!1M
M2_]OSO*S%0\'ZI_0W)\JIXIW(L-ABQ^<(T>GR&@E<%HO@B]P)X@]*5EV7!@N
MA]Z:%P63CPX3&][0I;W#CN+;\04K:2?,[0@N@GW[,RMX5R?CJ&M(Q#!JW_X$
MTYO&XU5AN;@LV(85^=#5U;)O$MNPK,,##J?(5?_X$<S'87X$,(P'4X#Y."^,
MYW^:SQR=C\,P;7,O,D=]YJB/\_(A>?_!>/P^B7W\,TV2*(IC+*-Y[E608WF+
M8_CZHV':P /C :9?RS6^VGB%/%T'V)H^52'83/%*Q&:*YQH0?][ (TG\JXWQ
M@ >V"ECM +^?!VK*[Q-%L*J8-FP'XTB28 C4HK]&XQC)3@P?__I@NR2*DL2/
M .97$$48 KL11S %H %#HJB_!T_NHW!W3X7[/W;9#U!+ P04    " #J@(99
MEXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S
M9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X
M 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO
M3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)
MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( .J AEFV0E<F,@$  " "   /    >&PO=V]R:V)O;VLN>&ULC5'12L-
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M/UY_ 5!+ 0(4 Q0    ( .J AED'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ZH"&66*+;XGN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ ZH"&69E<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #J@(99KK($J]U)   6.0$ &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ ZH"&67H!6\GH @  Y0T   T              ( !(%(  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " #J@(99EXJ[',     3 @  "P
M    @ $S50  7W)E;',O+G)E;'-02P$"% ,4    " #J@(99MD)7)C(!   @
M @  #P              @ $<5@  >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ ZH"&620>FZ*M    ^ $  !H              ( !>U<  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ZH"&6660>9(9 0  SP,
M !,              ( !8%@  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  JED

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>13</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>12</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="tm2429841d6_424b2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ck0001604174-20241204.xsd</File>
    <File>ck0001604174-20241204_def.xml</File>
    <File>ck0001604174-20241204_lab.xml</File>
    <File>ck0001604174-20241204_pre.xml</File>
    <File doctype="424B2" isUsgaap="true" original="tm2429841d6_424b2.htm">tm2429841d6_424b2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>tm2429841d6_backcoverimg001.jpg</File>
    <File>tm2429841d6_backcoverimg002.jpg</File>
    <File>tm2429841d6_prosimg001.jpg</File>
    <File>tm2429841d6_prosimg02.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/cef/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2429841d6_424b2.htm": {
   "nsprefix": "ck0001604174",
   "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
   "dts": {
    "schema": {
     "local": [
      "ck0001604174-20241204.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ck0001604174-20241204_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001604174-20241204_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001604174-20241204_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2429841d6_424b2.htm"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 12,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 13,
   "entityCount": 1,
   "segmentCount": 12,
   "elementCount": 212,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2024": 22,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20241204to20241204",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2429841d6_424b2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241204to20241204",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2429841d6_424b2.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "verboseLabel": "Amendment Flags",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "ck0001604174_CommonStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "CommonStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Common Stocks.",
        "label": "Common Stocks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_CreditRatingDowngradeMayImpactLiquidityAndValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "CreditRatingDowngradeMayImpactLiquidityAndValueMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Rating Downgrade May Impact Liquidity And Value [Member]",
        "documentation": "Credit Rating Downgrade May Impact Liquidity And Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Default On Other Debt May Prevent 2030 Notes Payments [Member]",
        "documentation": "Default On Other Debt May Prevent 2030 Notes Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ck0001604174_IndentureOffersLimitedProtectionForHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "IndentureOffersLimitedProtectionForHoldersMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indenture Offers Limited Protection For Holders [Member]",
        "documentation": "Indenture Offers Limited Protection For Holders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "ck0001604174_NoActiveMarketMayDevelopFor2030NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "NoActiveMarketMayDevelopFor2030NotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Active Market May Develop For 2030 Notes [Member]",
        "documentation": "No Active Market May Develop For 2030 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ck0001604174_Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes 2030 Are Subordinated To Subsidiary Liabilities [Member]",
        "documentation": "2030 Notes Are Subordinated To Subsidiary Liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes 2030 Are Unsecured And Rank Equally With Other Unsecured Debt [Member]",
        "documentation": "2030 Notes Are Unsecured And Rank Equally With Other Unsecured Debt [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_Notes2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "Notes2030Member",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes 2030 [Member]",
        "documentation": "Notes 2030 [Member]",
        "terseLabel": "2030 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_OptionalRedemptionMayNegativelyAffectReturnsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "OptionalRedemptionMayNegativelyAffectReturnsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Optional Redemption May Negatively Affect Returns [Member]",
        "documentation": "Optional Redemption May Negatively Affect Returns [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ck0001604174_PreferredStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "PreferredStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Preferred Stock.",
        "label": "Preferred Stocks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ck0001604174_SeriesATermPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "SeriesATermPreferredStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Term Preferred Stock [Member]",
        "documentation": "Represent the member of Series A term Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_SeriesBTermPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "SeriesBTermPreferredStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Term Preferred Stock [Member]",
        "documentation": "Represent the member of Series B Term Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_SeriesCTermPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "SeriesCTermPreferredStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Series C Term Preferred Stock.",
        "label": "Series C Term Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_TestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "TestMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Test [Member]",
        "documentation": "It represents as a."
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ck0001604174_UnsecuredNotes5375Due2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "UnsecuredNotes5375Due2029Member",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Notes 5.375% Due 2029 [Member]",
        "documentation": "This member stands for unsecured notes 5.375% due 2029.",
        "terseLabel": "5.375% Unsecured Notes Due 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_UnsecuredNotes66875Due2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "UnsecuredNotes66875Due2028Member",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Notes 6.6875% Due 2028 [Member]",
        "documentation": "This member stands for unsecured notes 6.6875% due 2028.",
        "terseLabel": "6.6875% Unsecured Notes Due 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_UnsecuredNotes675Due2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "UnsecuredNotes675Due2031Member",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for unsecured notes 6.75% due 2031.",
        "label": "Unsecured Notes 6.75% Due 2031 [Member]",
        "terseLabel": "6.75% Unsecured Notes Due 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001604174_UnsecuredNotes775Due2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.eaglepointcreditcompany.com/20241204",
     "localname": "UnsecuredNotes775Due2030Member",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Notes 7.75% Due 2030 [Member]",
        "documentation": "This member stands for unsecured notes due 2030.",
        "terseLabel": "7.75% Unsecured Notes Due 2030 [Member]",
        "verboseLabel": "7.75% Unsecured Notes Due 2030 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-24-126297-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-126297-xbrl.zip
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MY6>O70;_*;V.F_Z/?O4/4$L#!!0    ( .J AEF.^!([: 0  &@D   =
M8VLP,# Q-C T,3<T+3(P,C0Q,C T7V1E9BYX;6S=6MMRXC@0?9^O\++/QAA"
M"*DD4TS([E)%0@HRNWES";L!%;+$2#+@^?J5#(80+K&=>-;9%_"E+^=TBU:K
MBZNO2Y\8<^ ",WI=LLN5D@'491ZFX^M2($?F1>GKS9<K@NGT4G\,D0!#Z5!Q
M79I(.;NTK,5B45X..2DS/K:JE4K-B@5+*\E(,87X4N =Z44MEK6MY_ONP)V
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M-7 ?VUY]N*!_O7MHA?#J?U!+ P04    " #J@(99#I_XR6,$   N)P  '0
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M8;NT(",M7F=2DGORJG1A52\4&*M<6@!Z^\9^ H:!-Y^!>8]2#Q@#5WE] &\
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MP7#4[KK6=>CX43\(AY:U&0^WK&UK$,>CPX\?[^[N2EUX*.JZH8B").R*"+^
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MC4TX  ICF$@--/&)JL[@X30;S,W#]#U>JP2/@A8QII)US(9H;VPSF^7W8*V
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M@1>^]I=AT!6B%[&YQMJ4%BYT78!"!W><A+)J*I2M;_P<66"G5*WL[ZVO_ O
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M/PDHGFGZ,^G2.X[_PP!X:L]%6+MQ@EO)':C3!5P.Q2Q0&*N7M-S-@MK@47U
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M&[1;+@.."6?8">#35>#T8*+$C85$Y7+5MGX' ="_<['\]_&U5=[=1SNE<NT
M0HG1(/!U,P$WLC:KY=J65=LI;^_7R^6UIIG1-.L_3=-\275T:@OK3"MJ*N#]
MS+VRJX]NUR[O_?4?3>OB]+1YU3K_?;*AMM[,\M#[89W3N.T8MCM;&$WE=2#/
M^R@2A^H/V//L'FD3W<YJV&3ML>#-OU40&H.ZJ BG0CWN32YI#P!1+-,L?95S
M^J 6K19[F<T'LMEJ;DXS.//)!0=_QO.Z=F-/IU2DH:P+'N#RCFVOM%?_569K
M]1)N^OR>SJ&ADUIU^<PT;Y92_U[\2&:N^Q>@7W:9__\.K\U%IDG?Q2@G=Z[
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MZ([X+<-Q"*\,HG=X<!>A>^,2?R!)O4?9)R]\>(HZ6!590.4]'4"[0(Q]\1-
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MFELMMXVE &U*G<',*3>6W?&Z=!FDOMUG"Q=(%XXL[8WGZ<9)3$FO ENO)JP
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M[-2->YLOR"SN9>$\^3D4-XE*DF7%,UMS>7VE5_APV:<DP\32D\0BILZ]"KI
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MJC5^2MLW%6_IL8O"><NEO0)8X-7&'F[X]$G>Z$(3EPWS9O%[I]8U:BCYEZ=
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M?O^)&=.U<MTN'SR(7*]3WU?Q(']*9)1"GG7B^X,6?:U[&3?_3MQX_)!L>#[
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MA__]\<BWBX<[,K8H\RO5_H4:+Z6(2! +YXR^4HS!)'*Y4=P:^\HU/I*R;UZ
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M5<'&T5!#OK#'0)9W<72HRO[7O4..WXD[H' 0#@R\&?SR.NZ#I5@53E*D!0,
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M9"9\S/*1;ZX0TL8E&(?%D)O>')H4X] [CZY ZZ4 ^(5V][W"\D2WD>;X^JY
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M%G["2VW2I":$U+A]65OKA=PT:PK7O6-\SHFQA=$PJ!)T)4\97BI+"D$0LAM
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M!\PJM!%*W\130]4$AR:'IKZ8-<-1,7*2,8CR4%R3'*%!ZA ,><R((_:^:Y+
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M.!O(VF1\'0?PTX'7V^]U-]]Z-F XK&7;NSCRMF"'U.HN*MADGC6F(H'NF.3
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M,M3&^C.O9360+I<J"QR6A!OE_9TK-I_Y IX8XP$NH=JHCA("UVJC8E7?+'?
M_M\SQJ1B-/;!(*=44\RR1_Z)A?<HO V96@JCQJ6"[PIO<;QNF&6J$3GT<')/
M;.PARD/ES%8!'%D!/:&BC]2"GLG=JIXHJABH01)^$Q&]!J^Q9J'Z(W2X^B2W
M@FFNW^^%:W]?M-X>))&O8?)]6'>(V1P20494Y3PR&,?Z8'WW\.KG#$>376'9
MFZXQO@JX_BT!+<\#/A7H9C1*/1L@-G9Y&Y'\C#JZ'04LYD_23-OFZTV<[XII
MTT,JSX@;B&A]CO[ A$$Z0I6.@SC4E"=P:ATD-$O&612*A+FJ+9P6&@*A@$>
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MXGOX:>WSK\&8J(H6:8"@ZF>X3$=A7RD8;^R\0RBQM<'M4=E6IA$ZE,D*=^_
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MZ3![6THJ_D%USW)T:-RDCMDD*Q"NLTOJMLS]FFG+> \Q6%[X?9Q?6. X186
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MT) U&(* P8GFTM*_MBH4_U:HMM=1,C306-:@!/96% A9KP&\\&'GJ8X\Y3,
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M/0&%:F]F6/7@>%E6'_QUK#A&KW7V_+7X-^VV\K?J4.<+HMSQ!FT),?D9"5Q
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MITE.=8R]KBAX7_A_"JU&ZFJ1!SQ'UQ\#N5,'F\>"E ?% FC2R;Q/Q<F,F,>
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MB RMT9I5959;%PJ<<<:N>J> [.)BLV35+VF:G$@3=&,*0V40WICCSX[_7'Z
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MBW?N])<?LQ?_WYL7O[Q[\>YP_G_2*C">E,NG]68\+;TH)*= "="*:@-255U
MFTHR :(=\E)__$)^K*(A1(PEC)=C#UD17)'AK^ZTJH@!X6U!& +*EK[TH^3)
M_.7X[-U;:!=#=(.RSTI3NBC;F;]J6^1-QC):/_K;D>O!ESY[,LF\V^+]E@4R
MV@%!^.[%&1Y23)M-WFS%P?EZXOROGR7R7 %)!;1([%=GW:N#/W/P9V[KSWSS
M)?LSSP[^S%YL(_P?<_8_D[-_W[*:Q@-X^^K=?[F7IV?O7[\-A__>9F.'?L#^
M+Q;TQU!=RCNQ),68]GPI I/*J1+64_&QQQ,USIBDX,K@<H#NB-O?X$.4A,:L
M00E#U)';>B.RI8Y*J5RHR/VABU92)M9?+J'HF=R5#0(!N;BIH@>%[#>QO0]0
M4.I-)!\(TER!S U#KY9;QS\"V'M6V,JSDD E%1*:++I<\*5^Q!^J^@J3P6"R
M](]S(K2*[)@L#Y&MP*T$G4&F['0 1L<R,Y0536U7BSR[6_86RJB93J!R8<[\
M3R<)G^;$:M(J&LFQNC3AV;AE(@YIIN)CENFS5PNB%-/U(U47DU^;FO9>21\R
MP7F-?H<;7LHCF!>S)>IE]"1:2W1'8$H)'@NX.=,>;E,XJ>!H'L)>_=QVA2TR
M+7[W-H*BB7W'<-/MH97>DYGKF]I1"5,_,\H^IF(# Z5K,<FTH FRFD?B1JT]
M'Z;_-V^R7[V)F3)?,(&("9FF^@N,K1K];/JM^FVB0GTZ\>:5L9ER;YBV\(#P
MR=%3IO_EPDT[EJP$<6%?%N,D>T?WXF&P%46O3557<E((G:B:5NG0IIZ*@E&!
MW'OD3XM?=EWCXNU%H,/V$Q'U\0<Z255:5"%1U,;*ZCA,DR<M_P6Y 4MJ73#W
M .RP8_B#D-59^6.F,'7I-5=^2Q3'1(T=^&Q#7[CA3.VU3/@)8KD-_L6F*GU
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M)40\IUJEQHC3O"U# Q4"O $,.5Q8%9U<YN2R16>,_C5]/KD$HHTT W#FGJ%
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M?VZXSM,O&:[S_0&N<]A&XV-]7D 6C]MY%NSFD;.B0I&<3& .5E *PZ)>2+<
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MXO?7+2GY'"QEQX)SSE8>;>N0?OR@%'*D6X[_%>,-A0CVK<PD2?W03%!/*?O
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M_;@')?32] J)FK77<'&$')7J';"A3Y[IK3*1>@X;Y>EK^?^MEW(A@0G."&G
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M2MABI@ Y(41KU"+9E-AM>:^G.#;8:@\O,%BCW;EI""A9TG 0:2!874,1!''
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MIFB9&PI ]%Y29:M<43/,8&_OX$_F"O=21B4UW7PF3)>DCX'S-4,#:)Q[&G4
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MDJ=O C46=\%MF'D"/H:$9-^>=AGN$+'$WVD.W@^C^K8/@/N&7?1"?PASGLG
M9QDYIX9QQ6']13?-U86YU.(TV70\T1\HO%P$?]_DU,YFC?4L#Y=UG.%M/9M8
M1 U#[Q*V9Z1. 2)F2H\P&)5,#?@]=L1=@\:@\$+$@GL)TY3(7601Y09T&4=M
M'4#',B:&7;$OL&$[N:%94 GEB%))R!F21NJ]4U6 ))F.%NEMX[$^_9#Q6'\^
MXK&.VVB^K?^@].U^"-OJ:HAVKX)ETU*;B[X;A8*A8SD^@N6@ !UT'%-XLF
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M]<T,*"9UR5 ?VI44(0=VQQBD5&;3&9V"<5PJA4%.L:XO:JXM$.B?'[I@PW+
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M9:(K4&[$V0+T9;?,@;4?+(]0M!SE:.8+&1G1*1\<+6^5@"VRGFZ6$X^.=:/
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M4TBY/-:D&]9=%(\2YHP18(IB72:U6^P%DV> /VZ+SCQI5-GN/(FIVS:GQ(T
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MOL=S[ $6P;,A> TSIIOK,\=;]H,YADLY'G#P)94<-L1C+1L050_P2Z-]TA,
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M"GV4*KA@R.7KDD.E%&[&Z3XL065*=?5,_<:H4:D[56U-3^:UM +;?=N FY,
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M-&BE&=$R'YP::M\4H,0++?9F\4CQ8P?M93BMJ_XQ7L.BHQ#?4L11[V@<L]V
M($%[UC$L 5*S7FCJEE7D@19"6B-7QVNA&F6;,':LK @[R+9VN+-%/][N[N66
M_IUU,J[)KV<W5 L<M<!^:GD+<Y7A$&:6 'RFHUOZ4&YI4F_:-+\BCPT3Z<S,
M4JS3,#LCSHV]9%U*C1<A?N.*Y^4<XK7!L>SL5R2\Z+''64'$C:]^O84V4"'
MFMKL3T@@O;(LV\'7'FW#;[ZR-H-'!5?&;UE#U"L=9GQ'\E"H@NA100H2O8-R
M]]%(/%#M (TWT;%$_T\(4=9UO9OS+KK]2&D6G,DW[R)&53,M* YC\-F-E>-Z
M=13G+-%)PN7K;K47>:#HM<(/%JQ#=&U72D%^O_9529.P;*:ZA"Z@[!U"*V@I
M_.#<:110)[^0+TI"HV[.&O6!P>L$$^(\'++N2)HDE'ILCR,%'47/E$EUR]W%
M?KV#$3< 1(I0K R2Z[L?G'(<_/0W&[68OH**V/06^X%HOQC+P.&'.X0JT&/X
M8-KC@GEPUE&[H;4GX05N9;H.;**+SRU+DE6;E3AS:_W>IA*=Q%Q1,EW/,;(I
M_*!)2N:!D<(5H768F_;3NNRO/)I NTVW'TC"_)2N7K%-)EZ>IR&.GNMOEQN$
MQC#M#2&@DC6NQ23E0M9#"*";7$EP%H(]![--SQ0@7+S"+ J1&(>M!INQAPH<
M3[B'6(+DF-QD^XA5FV,)6RKM(N2E&J$?_O?E=RSP( 4SQ83Z\VGZ3:<F9%3Y
MT2'OR-IQ5I9H\SD4S/C1=G&_12I(S68P*R$-Q>?C$PD5J/ *3YH=&!1HEG/.
MP"R^(T5Q1&P.-&O=U8-ND!N?A3$2,O114/X4'0EF[S0"PE 4^C+R7*B-2(=K
MSC;KJAZRJ*QDL-W8:=U4.I4DAD38&42K\_#4#;7$RZ)&S=4<^N)OR3OC[/9%
MQUIKO/BE$PR-Z*0?,$\88F>'TEB1T>"Z9D\JG/,S'IH*X@&N^AV%OY^!+#P^
M8!O[+6=E,(VN)*E)(2!>8=9U]>;S W+^N&+%&>A-UO$)S6CE>UI9^7X8D_?)
M\-TSS_[G#SG/_N4QS_XA;:/;@Q8PBJX>VE"-V86"F5BR',#19WN(J,1YLYU<
M> WQ[A(#^67Y)5+HW-'GBU_J?C<;WO,?^^OTU@B'"9?JF@@>@_=-5$K&%!H3
MBA]7;2[3/I3)7S+87:KE=8FM;UQC295X9K7YL8#;B<"ESZ;JY7I8%BJ=R2>Q
ME%9LQOR0@[XPC4+(I!_%67"!ONB*=.ZQZ[WMHEOV3IZEHB]\^O473Z./PO(%
MZCLCPJ"^"J[A1'Q ) \R&5J,->SA9/3Z^OQC\S&AHR-R+POZWS(-!P)L<!M3
M@"=ZC$<#^8!AV[CO]JU>["B9:]M=\]/EA(CL#\5.,]D?SMB(3- FPROEH!;-
MQNR%9290,8[);I@N_,8U!2RI#/2=JPKW1FRFR4MILT#+W5WL#[-59Y_U.^'_
MN^#NH2:'EI\5?1TG&4I6<[+(=Q'L7)9'6@G]R!53.9J-A-\:VL4L.RV@+:97
M)ETL%'ZP.AU8!X;%H[264+";HK'#XTDISO2$/EJGA\H\I^VO(+E3:- >L$LT
M_TZJ7-$]P$ZNHIG:,^."L=A(@&5#XF85!8;(='$,O5B.858_%K _B/4RD S9
M&:*_F&26\Q+#?&/@$:[9L\T[K2FS-0*^%9O7],-X@]RYVXU0>2OCQ6L:>O(9
M8W<@+JYM+#XXY_A2H=LR3%_2\M@3XNI2$G8/]-HEY'V="+D "=TH!DT+Z0@=
M&!LOQ_NP+8PCD^Q(N)L=053REB&7%NM"$O-F%%W>QJDHO=BZH)9.?P^+YQQI
M_-TJ7 '@F/0?FGV+3+,/^^)[,=,O>%_\$C__=Z88F:4LB7^OM-(1WX\]HIT]
MEB8=,7&UGXE8Y'TP6&_;N+IJO+X.S>"P$NMZ"X=+)*@]_F_661)E7BC)D0J<
M2Y@CD.X2LT.*\#*543P9X0$>3\$'\M&3<NFN>I7!KFA&G__MQ\5E?=ZLR.!<
MG7=#G4V/8(Z1-UDK6T-&.$;UL$XBT$,A/)#T"IFK@3-<M&F-,C"#;=?&!]#%
M,Q<+HT@KH5H:"XQS2DM_Z]_69T2=96$%RL?TS4KJ$-MHTL +95_/" %0J\TA
M!DZ4<S]5<GA=P*=CP[8I#3*#0:?EST-.4L4$ 28C'%V#L$><@S/N;-H1Y;$0
M ?#FY!@PS*R&V>ZGY:[QY:M7#)>H&,A;Q2TKKL55S:60=C>3]R4T<DC-O_ A
M"K?#@9F1O$F&;#D<7LJC0;>'PY;AR@(X"6!3MV<@)")4':AC +!-EJ=GY#W9
MI2J9D/0)# $?2@>^SU_.?:\PET:_&65DJ/8R)5^O_S!WP]\O$#X![F %XQ>U
MF0R.*TK5;'-)0UZ&,E&[*]\Z'#S(+,OQP'DHI$,QB;,!XJ6=+3I-I]<>*0:T
MF]6.*\&%_%)\O7CN1.M5]3#()1/5[%*ZSS+1 G/WED-+9_%(VID]@^X4 5>
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M]ZS8+X-" :GE<OI=+\X:\ICRD\\<,M:)FWF(,.. 4Z*<'T>UB#MVN26;C4K
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M+<D4$+FZ44*F@?JV%OQ$,E!RP]^2R!05*7%D;!7/[^@9]%1XU@W#$QW"A)>
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ME[NWC74A>JISVT41A-@M#79KF4L?A=B#?"8@S8P:[G%:F1"D][1BNS(Z#WF
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MPY,G/S*W:<!ZID0SHZ]P !"3LY!#P'_34*]]\4<2)YI$54ZZV\B$66MVQ;_
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M*7.;.G;_F0%M'+T]I14<O_[WR?,]C+>?8AOQ?A^M9Z(#@+Z145V<OD%*)$E
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MC]1MD(H<D5BW4[NP)2?Z:_?C^7Q91K B T>A-U-2W5+YP36PJVK%%LIKM&/
M^.$*-^>K,G&%#L&M[F'N_@I-"*P+U-R#FMSVJ2K)_3^G@J?<4#MVB0 Y-YCH
M^=$BE/J(.$>&(TF7-@W7Y,"1XF5QSKT'7W)8HOU*G/X'X0-V<EZ"N7"&K#'
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MR<E@(5O]\[Y2[[/1_C9&^X#/[^!@]'2C<VA[@/?\ +=1!HH1=X'?MOK33?G
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MM=.&QZ>G2#7&, &_B4_U]P,9R(KX3].X/^_5EGW<GNED%W#H9'EFLU9,3R=
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M6-22&GYVX-&&T(Z)]ANXLJ6XLM",9+F%/-(O<FPY#:=GQLLU['V 5 J1<V#
MXXV:('WX(3&:.[91%H\[5$EO8_.T=Z;;^W0WCF6@"%)+(J]NXQWZ,YNQP(Q]
MI,39V:>$?)MIPY;G=,O()\D<%ZY%B\R3F7&?\/&":L(7RA O(/(_B8<;[XM<
MXZ=D5\[@R\F5+ZLGA#4'XODY;XCJ:P4(LH+BB,.?V)G;K%G6G%;H7;F!%[X"
M%3,C^8M^I=!#(9_(IGA0Q%!VAR>;!IF*Q6ID3D3*)&@!PATDO7_]%B";&MZ
M]!I6!:?/5<MBRKSN$@7HV!KO6$*]*4RX"?Q]:YD%NPBQ?I")9W$SW@A"N\T+
MLCT,ZAVX^^P+9Q*5G<&O3/!T@#?-UCV D5]8 6@>^"_@3_1&VEV"G]$.'M("
M*!OF0&R>90#-N[?07>)ZI'KD9.5GL,"9K?%V4;Z1['.*41PP9G+\/;#$JH5_
M%%73>#4FX(HP@Q\J)PWY$Q?HPZ4 4?BUDO] V8IVEBV+=H094_!JCN2?-2@(
M!I=)B<W G]%MB1/F@T*EE"0#<0V2.3S-1=60,<D74FQ80WDF9."5%7&;NBI8
M771)*36=@"X%C5A)7VF A!O0.G.ZJ)*BO>XFHRA>SP2V\N.. I,%J!+. N+X
MA3LAL33T#%PL M_)F ?:LEEJBBX-Z!@PF/=@W+=K6#O=YSX/U$^;^-.?P.:2
M3V-SIL/FL@G+FQ).C7S]@4G$+*T]9XJFL"M=@!S9UREZ6?RJ>**%S9AY>I]]
MJ*'Y68@N!XM><>KT#V3J3I<3NU6M[N!J.*HBFIY6!CD<70X,Z,*']R2P"\1T
MAF8PGHGHXQ0_AU/RH64?4I& $1K>HE.)EL%FBH0!CX^/_W\) $I) [#9'4ZX
M!3&"U %:"LQX%Q,!^%+*%V@P_#(ET7F/PD"(/W4)D/#WQ;*>@-DEBJ((&E**
M<,3=5,Q_#4O'5M+$UV8L&_7<1;I4&%I382$[*,_4;@H<+*=4,73=-#"1E(0N
MYTJJ1X]?-RX!K>/: $.PPKJA**SI'1XN9<RO@C_%8E'42@YT!7)ZP-V#<LX6
MA9&]W\E'=H2+Q/<FZ%O 8. NQ?[A_P<%=2N2E<PTY]3%4#\G,P>#,EU3V+AY
M\&EI]W"N-XR"/?N6HV!/MU&P;^D:42;AW_)?7H,.<Y'#R,!T3\F>@_^0R97\
M!AI1\[<?\E^V68.?6FQ!&VL:V5A4-1M60$CV8;"$;6EGMK'@TE1 'Z 0$1*X
MN'U=G>T-0AH,!P[Y3VP5TSS8 2(^/OT06HOYT&?<D%["GH'ZV[CD;.<.2.)5
M9BYY*ID463['2K^FFM/$,6[7F8!;J0A@40^Z1G.G))CRVFW)6>)HXHXECX7Y
M4!Q#E:AI50^L_E<,\,#:FE4Y!2.JI>C-T*KPHR[2!,L[D^ JN7-UURBS$W/0
M&\Q/&MOSK)C!-\VDJD%W06M*O]SP43F_-1OZ2XQFH)Z!;B\TKF' Y:I:LE^C
MR2:2ZCBWM6JM;-+P6<%?.+&^MDXAQ "<G*[8;@VZLV8P_7("^A7\Y/[MR("2
MB6#+T/68>I\8ZC1G,/WV_$8;9_S&B?TU=1$CBC!QMA;OG!N0-&_^M) ZNL_Q
M,58=TT1K==0_+K7!60U[=4:)M3@>6GUBCUJ<_7*!5."U-Y\J!N,W5/ISIMG3
M*1N)^"$?AX<Y4^WK&3QK<2VS)97)<NZ8%!)1V -T\X9K$N 8<C2UR4'KRJMT
MZX-?\;?L],SRL"/ET7UR! ,GH\G2]]#A7R_)#$T#2IUG[S&JMBG1S-6^H\%1
MHTE+_J'?3GY]_78@GC@T'5?[@TX K/K*R%<JEP.M=X-?B4T)5:@Y<$$\<4(4
MBQ/I?\7=<_TE'+<82)-P5+GB>=,LX8*;?^1XS!+]1:U_)4\T-@G3*)@YUY35
MD)%#LL2:2#2#=D!JH@:/DC$%\;+_/0XQR^#<.!489ERTYYHL")M>450(%3QU
MROB1SV"+,>BBUEOC$I67=8U;*(:5+2_RNBIQ=A* DK04=#:2#\=97%@.TS3"
MC.A&\(_-D!220CZ*/!=1$1VL-954C%X.#!\^)VD@\06'C"G3=;LL6;[ .!JW
M4W9BL@60QR1GXW6L1,DV;W &WV!6X.?10^+;:H*\"W*%G55MSFGQMKVT-M1#
M^ :3,"I43F!^,3 ;D [LC! Q'-;_C3'[GB0^705]! D&SAUS4\^P: #-_J((
MA3D[K^FO"?G'FP4R977_Z5S52<'<&6X4F_J<IT4,)V_.;2/./%]C4+)I[O2
M@0OB$H/I"'H:@_OSG4S87&_"R2=->%B@($,A3D6N##BI)5Q<GDH89)2(XL>,
MEEQCM$[]!/(Z5T,!UV>: 2]?2;"*4X26I"6*?]DGH5'(#C2#B6Q?Z5 LG.!+
MQ0^%$I&E, R$*=/SY3R@=?*Y@?PFIQN-A)=L#&1>XB=Q>_W#$A+]E8-;3M#X
M!?F[Q]F"0WHN,>&R:IG17&:46,_*C9&=2DD*H$+N+I<C ?9S3VS!3-B'_Z/8
MIN["*'F-7)V_-2C<)6N !"JG QHJ^78;?!$NT-<[#,:NQ$6JS^\5>6O55QKJ
MN)P?N>EQ3$$LM0(G"HQK4#FZ!O!Y&4Q#'/I9M16Z1TZ+L'CLHND7;75&,;.T
M>ZG(H5K86<M9)E1\Q!5(O:GQGG&FU *U$<IMD:G!28$2 ,PB<!]GFOQDR[.,
MU%H7N)YP*.;7)8_'7Y(Z^I)=HO2UIOLY]QT*A)")Z,.O%WG%SN FGR]@%"JP
M)1RG'&T8?,MOE6-1>A+\%5!+,#FSS=YCW<,LIY)%5 @G&KG1^&_+'!0^A2&I
MWHVA$X\H0^F1=KK-ZJEBQ@AQ"@7JR:C6Z# (<$I1(!3^M1P7E"<+?(LTWD!"
M2L!H\&; ;+T]A]L.A#''E#:VP#%7[8QR+$R@4CF#][_+Z1EK=YB#-\=Y82@=
M/NKSFTH)/0^;5EHAJ(%:_JSD?E!&'6Q/$PB8J1$;2>:R]4#?^ES_@U4TE]8I
MYX9#]*Q'40(8*-2E'FALP_ECY9.,_]KQY #9@"T+%()_C"U"#M+,\@]B$I -
MG@L/ALM03L[1R* [HL/+-53QP(.ZZ[AQ)H2Y)(EB8G:R34G3"SX(HIQ,^XJ2
M24"*8VR7<QG"SVZI\NZI$CC.48.*&',@^!-88Q1V1!H1I5PT2B)(8"!GXI2A
MA-TA=594SXP&QG-E)DP#C('X<0LR_26-8@9&<5FB#<([K)F#!&.[GU(-4MY2
MU9$>E1QL6-]%A0X: H A=0;_S#=.E2F$J$#K%,162Y8+9K1B1% 5>=9E%<\P
M7@#Z"^SH3/P%C'C&\7]2\4@BY&H5H.>"4_0,"[A4DJW;R6@7@<^\J:P"T'MW
M1-/!7:4UZ7QD%>BJ)8,+-6Q$ 4'#_[_LFU4WB<]I8C^;J%5<+>B^H!\ \=$=
MO+VL]EILL=PX>V_=V+11H*_82;:$0[H,7:K3BI@6U].;S=-$#8.G>6G9+22J
M"PEY-#Z7=6.+"^MCLQ6A]>0-;V"H)?J5A5;2P[C6#XL%Y06=N;B4S'IW(A(?
M5?Y[$</&I"J^WOF$3M(,Z0+M&X&;PD71A0G>1_$8H2B42\0X(X":O'E/-QQ]
M84MRG FYBE;.<;.WB 'U$CY;U2Y&IFIZXY-L*:\/[%K*%UV".GG$&N&R=FYN
M4%K!CJ#/.-\7YXWK5)IJPAX9XH5!TD&<N*&N1 '?0K"<H7=17'?JS0(_:$*%
M.@RIB.7G8&-G>)]T&Z+E<*$:*=+GSK$JHA]M/UNJ^S+P78!Z;*D4@,) XN-5
M#R1EZ<_ 1A1_".W\B@PJ#Q3J@5V[F]N$(2^!PRCPO_2)[DS(/[HJLSDNEB"P
MKD=^AFJ8;%AG@SF<]D,&%A*LS8&*+0C9%OC;U*9K'38R+RJ3H'&EP %=9K!+
M;+_$!A [[F*(+;!+(QZI*4U5/!#=A)Z;/JKWZ7);'NFA\\ N:M)/]Q\UZ=T_
M7B1'S_]]<OKB;7+T^_.$?WYU\OO)Z;NW1^]>O[V'@?G[B9MT(^@TX,WC*F.0
MLBGH!!--'>VZ<ULI=4 %.<!2(.-NN<"\BD;$ /+[,6;3J8\PFR%V3%1Q05KI
M8E&!]:/J<\9V>2-#CO?T%R/S!G2:9<:1&GSSQ*M$9,VC8_1(=="4)]!;%#$=
M^28PD1?9&:SL#?Z4'+/;X)5?UF^_'1,/7H:I[R;;N@[N1?+:T_UO.7GMQVWR
MVK=TC5@Z>L?E/92#7WZ3/A;G@@2=9K-@FP:JY/"U3O*8\\N<OCA6)-!7?<S9
M*%DA=?X-5[\="9V3$KU"@=!)*8-D-LL+-&),-8M'0XQ1S":H/N1H0,"0?_EQ
M]!-/8)P7A1IA5+TE&67LK@K$=8!RKPE/".B52R:(X-77!"Y59Y>E=*X@11HM
MD=U1\JOFS PY]D-[;7@*<4)'E&.Q=L?,VAW+&6R9[$SR8:!]R7 ,_63U*/U^
M*\3O]&)=9F Y^N +[OWA_L$A^IK>G</DFN3-"$[RO_:R>9^3RG?:HNU&)QW5
M\>$!7YY7E'MX67(X.+Q'_V!G7)/\]B;9$;?%BS?NUPI'-S+!+\DD1S":-,G#
M-#CW 9=$R9?P78WQ\S9YB7EI+H&/7/=S4!W1LZ$^09?.!GS"E4-@_M7 =3&2
M01#HL^]L-I<< AA0^!'KL#2[NCG/%SYHD$?7L+=ORZ)59L'0>D'Z83A[TYM]
M$D?+W 7_5?7J5X*BX>!(V-_<)*_J$1-M=+JZH2XD3WPE.O-3:PW[F^04!17D
MZCF,Y)#5-]7=AJ+B+$U@;D_W]WEVIRWL-%@)+=R5; IW9$GQ=?P3L/+4_!W,
MB?(25I8FQ^^2_:<_/=H?A?--UXB*(#DRE!I$:%+6A.FH6+A4YQ?HW!$^A9%B
MD-.3I6>OQ@>;&[2P)K9Q(*E;_G7K<PW<A Z$A7!9(BNPB248999@E$8%M\=7
MG%,O">?)6W/9!>LE)"7)GR6[6P+;&#EM*956Y?>+DV,JW%X"BYT4TJL "-FW
M. @%?Z_%P2I1A-V 8GUXZ^#9X_WD:,(&/LZ#;_E&<4Q$:LF?W+\8'%=Y\>;D
MY"5.&V&2"OSLI\W8]&=,W3HN+0)J-LD<.>"BL'K9D,>3QQ6KZ*LB<D0G%Q;6
M6%A-O79Y?G3].KG-*+R"?%KCSFR!O@K;80Z$1&G/9 7-<HP9"EK!7VOQ/?X
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ME<E1(Q"%*?<P)H,>*(.:"&]-WMMGG;T\MEDVSXO57Z^:6#_GC;SUG 1@@B2
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MSN0BTZKL)*V5_A.7<YYA[_(RR+GK"P$[KB*7<-/(I8>4)/_NL-(E5EF[X/6
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M;G8DW[H;"W"7-@OCS0@> 4H\FRV98\Z%JEY5!O4T72-VB1%%8QX>M+4XE51
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M=9RM3&$[M/3G,/X&B=/XCB%'O@U=@O6(/H=ZW:OK58)$ #7VX-'Q(?(QX83
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MWH?>YEE!H)AYDG;M.=ORR/P_:]G?G WYXVL=P+N:6)D=YC WJG$BM0K6G#.
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MQ%@SQ-C/W^&Z$-$U^NW#$P_%-M?II\*][JB+Z)/G]B]B'*HSB1B(1Q4%=U:
MUIM3O89J$QPU^2UP5-PT3<]1PB6[8QQ19?K)F:LAJW:>K3*L+[$29A^,?'4>
MV*\O*?_%D#+1]/HH@0D1E),; G1]8WD?OJLNGSYH"MN2@LSHSD&:U#4^4UV6
M?!R8UK$1G+=ZC?IP+4<4&#::)^2GAC[Q;FRXNW0X(AA>'NKN.15&DY#F8=,X
M4++!2G+FRK_@,)'T"RDGO71H3H%"#@HT/C1]1<F!IUJ]<SY1FK,UU9-P==;6
ME107H8(2Q :6$I%*H.3="@VH94%;6W.41TZI7W3[8@][N$0J(W"KN$1+>C;
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M$&:ZSL3;-36;[B6U8@[PR\G.P7'[+I _J-QA7F(N?R];"'\4[",T/;80$G,
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M&E9QBUVR4/EMQ $+5S,6'1:4?B9H,L*;@JN-&BV?5^O 9<)N9 >SP4Q"M"Y
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MU$/#LW[0M5TL@]2KIQN).,^N>S'[.QFI'$YAVI!5Q9B#$7I$NJCC!?+5]!0
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M592#;<C#;V#KR4_GYXZ4:UD["@O8C2I@%\*'2F^A<$JS=<HKHJ?,3EX1\>$
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M'I P[D1H!0$$53YN_X]=?L[?.O"/ZU+CT)560[T,DE##VFTAK4"O$$&E8F=
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M+)U,!&N94I";-8BYSWSF.B>:$?V[I$(?6;4J"<R%O07:[@<[;!DWG6X],+A
M3*Q>7@V7%L8)'C:>[ 7U/-\1<Z?6L!2'IOFEII_YZ0=A6'-S<T<7HW(+T&W
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M/&BBZ VM.E[DDO<*5[?9])>EW3"R)-WQL6]"%[-'XQB%1B] O970CY5"CAN
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M.(W[9(#DF;;QR[?B>;TL9P+L<'1&5[?@06P'0;U8ZWN0!ISV%B+P%Z6K1"J
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M@)]734Q"<5M"01[O#/UX_G>$115ZU#+Z.[.Z4Y H *2.1QW6Q1:V:[IB'J9
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MTF33;?9 !2[A$C@+"3+''Z, :$KF--I()!2):"!-!^'7.RT\M_[FZP(B'T^
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M_96(B6/5S*T$X-N$:H:&O;"KQ0.I.OTLUVH>&9V64C9AGV#LH3K*?J+6=])
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M"OP6 =\<*65$*:@'@W-:;A.4-6X\7)W##(ZR"'HYX28:4C!-EL ?E%(@FS!
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M](H*PD&#<&FX8!Q A.DE8HB#L&%%<W1# +LI#"7Z^#THSH/JJ#S",DXV[C"
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MXX[OX[HD+H#P%A[? %1ZWU=+:$L>+6@K0^8-)B]-&3/6X[UXP$VHTD9*]CN
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MAG4SF[:'#NH][3,:(<+^CI$3?VBAU;!!.P3+ZVB7=) Y1(?7P4Q0+:[NW!A
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M,=D)\224!+&AQI@P:!@KX0.G2\0LJ]7)*=]<JDD"2S ^-GU1F03@F]!$-)W
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MU*XSH#X&UP\2YG?5&*$H;]W[:VUA0*2=UU(X$'PJ^(P/Q7PUOTPT6F06Y#G
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MUSY9HC)*"KAQ@P=N*,%$MA2;\V ]>W\6.W"]+,W"^GG65H/ BPSR3]KT55
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M<W6'XPTWFH>5&"7X.$%P::C6K$_(P[HH;#J4EF54$Z]-LY95VSIH-3B[W$0
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M:/])]&C3P6D*%9U@TLKM4%7H=XIWA$Y;"M5CFW^1]9?73&T%M@R_-5$<X$[
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MG-XXX>[5Y U)39;>EY0:9STTHH'X"'*?X@AH0WE'C5O4[(JK\T:DP^R82TC
MN-\ S4!$.@NA<Y=0OY3@P^G I_;2 HW;FU,?]:9A ^N9H\"479' H0!8SJ4
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M45^[C.[V1[;FE;V_ER;[5O2ZVVECHU!VL+"FN5 T'2;$(]@'4 TO>]9.?C*
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M58^_S*XZ>/;L".%XZQ ?O7KQ^NT?0W#^DNXU5KH$35#5IEF-YIYKGH$$)1I
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MA$L$8[A[=0-O V_S]8*8/U!+ P04    " #J@(99:Q447GMG   8:0  'P
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M=.T$TWLD\.^*KKMF67H(]^N<2 YURFS(DA^-_J]S==:O'Y;=>[>:^X3.E78
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MTW1*FE*:;7');6(T\^C0*)?K"R>@2(."SL;A?A9.^?AW80V7YCI.9L)G)1_
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MN% &A5B(##UJ:FPTJMZ7[>=NJMU#>+EC#.YR9]O$7(^A BQ+3KC)F5+=[#O
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MZ?]N4#GPK3@!ZF6F*EZ^^F%-W$<H3_)-QFM#XR61*,E("._)!,N-9&;+GHW
MR4;EC?.TFQ.X&]>%;G+&DI3A/1TOTB?B,*M($!K2EZ[X-9^]! _'+67G/FW7
M ]_@OT%$KFJ8,G;/6!UY3=<>-G'Z;[P?^UE7$GW;RE/'=#\3IY>N"$]TODR
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M(51Y(S&[H))+-^!%TY+ ,)+$"\\E%P-7\\[?UD.2!&YSU@,$"@:I@,8_!;H
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MR_'NE]5Z]<'RP!HNR]MS=N8. ?,C @RO:^0=;LN]E;)"K>]S*7(-_WG1)/Q
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M^T*VLI9.TA^\G=LSQ,$M9AAQ"UO[L6YJ\BV-R@?Y:U 9J7UU=^<-05_R7U"
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ML1Y)H(67VT)'>,MAUQVC]5C10H]UM54BOZ1P:NE,6_S@O=WN+\>!ABV('K5
M'%\N+40V(]T>X<EP)!$=Y[Z]0HO2!Z/D!;@&75U3^OMK!DW&JO#JO!:Z!;7"
M_YI"LD)J_MV%U=[&V8W$SVD51<UL04 *3>_O*>GZ*R73(X@:;H G?2+#O'O?
M3B&-1/]-AC\4(L;5?%0A,"<F)UKA9)[W94*.47&90X[A :R!4/NT3QMEQC1@
M8..AK1,;NM,U'O0:9]2/V9=1+VF0%)W(_77ZDQ4\^)S2"7;)+"S#'(C@39 E
MRK ;2DY$^N=Z!<@Y!(5T)D%/^@@X?U"&">#T<>VA(!"=:4X*T8_7OQ_VS(-R
MZGR$N,1</2B#MA5MG_S>"A4M=RWB$JJ]A@ETR/:VLR!S&]*$O"'*5;#ZHL44
M:!=H</!%ZBRBWGIC.D7-_5.:#T"AYK6-Z9J+E'Y1TF%GP7N2MTC)2.7-QM)U
M_<_[B2P.Y(.%+%A(0C7B3:RN1VG^4]NT<&;,X=^3Y(/8/\>15B$\A3DH<]Y%
MABFY^M7P> -WHU!=T>G>ALS%W<R7F8WNH9Z'OO0P3<^?2$R#G&=M1;I'QCJ:
MMO3&.-]_R$:J]_>Y7(JP\AP?0%8AA?;'K.?(B;C>B]/S,^(2&TX?Y2TG _=O
M3)7Y7Y@J7;H<UL<IU2V2$.%MSR [W\?]\'(0: 3D^V#C+C,;DU74HF-)_'/,
MX?=:./F V@-I&W3UH=A2,]U5CEL-\VM2)UM65&Q/V#>K[$!]/IZV.G-/S&;^
M#IK:HY]&YVKP4RQ_X1MXF9]D5I<R5)%9_CT6V;5KO)S0]EOQC+Z=]AV!-*OP
MO30]>Z^9F#;4.33HW,G8D21V18R+8$;]+QG&E[,YC/9#AE'9 4J06!:3 R7R
M*DDRC%7M#%,)JMXG:HV!S84X9;*.'=?;Y*,9>P45..;I;DSO+1BK=?$82BDN
M/I]XFR[N%N3JWU(D6^F>79K"M.I\3()2X8&@KLCL7\SS.=?":EYF4S)Z7\X/
M#13VY>2L/'KPT[_ZGSS_ZS(:P2D!;SII:)Z?*4E01_^S5?K$:/3G7&LC;RJ4
MM8HS'H5\(,X_1:7TTJ%,KG,G<?XH-PG1QWJP)*>GST_C;.$24 U1BD#*Q:A,
M"Q<J( SP(8?>>W\>^XU\G05Z\F98Y282SBKB-#'6?*9>1X9Y$Y@FP_3V\^:9
M)R'4.W*^QK_G-.R589ST0*=$0_;8?E0\HZ1I!FPXBJPACGTA;EQY=/_BO/TK
MC\C][Y>+2S]N1LSZ[K4+E0_>Q72[.J2-/!4"E+=+,W$QY/EGH5I(%C!<1)[R
MX6EQ?F6@T?) ?<"4]ZP7OL<;_XW6KY6OB3S)6<QYR((V]<)_S+:P)86<^6I8
MD1Q/S91A#.1CB..^&<#/,#TQ146&^1HGX$E6?B>BH2!V_ODO;8:K8VA60G8B
ML@!D)N/W%E!=N5HC\14#I!6!\V)V/A1"ZL!OO5]5^[@4BBG.H"P#[]_<D7R+
M_%SPD__(P93]QRFD,J.SA)ES(HW>KJVUTO?&%?OJ]X:?.O97MYW-#B V/7(6
M=[S]05H]<]"E,,K-,6AB!XOB[IM3KRVP9L>/$O308FG0U6A$*$1DTH+H>MDT
M$M7'FT=BML8.?TK\A0-OFHA_,N<THZF4FR2%:JN'@\@'COKT9)2UW812Q'T#
M>/-@2),2?\#1;N+5ST;I'\4U'T-N\9_U*VW]%?-X];0T 'HL:A<'2DOJ-HF$
MPZG9PM*]#;4Y+[^G"7&Q6>W-$V0^.ZI>*Z"6?<.G [\LE+T@T*?)YAM)PY^S
MEMGL_T#QW?,CR45%W8@E_77]1K(&O?5/>$]O4-UZSJ+0]N@A+5%NZ57P%[%/
M0A)AH\S.]8::)&01DS/) >1FQ2=_GNOM-]7ZH6[ZY/%FNN=6*X$6]=!.V@%'
MPY%MK4YNN><OUUU>YG](43_LW>B;YLI-4[7'G:,_2CUHZMR92R'LQ ]J^>"V
M^0''P.8US %:3??&"H]#UK_H.VGKI/>0+;3@CKK(,IHY.#^F!7!-EC%74%^$
MC7;M>)C&CO5:PII;A3_0NJ^GV^[*N@/NUPF7ACE+QNA6(G(<39T/!?GUTDX+
MC'=P/1Q+OXV(3WDY>/8XQ>:K?<;L2)N99?>2KW-TZ OHKV48!;H*%? 6E;TH
MI;8WZUI^0C;3]E5">H]IUJ(K++\B:YS\Z- RB&6FJ[=B+[\=L@N#:(=S=6/A
MT>^)SJL.)"CG1IP!?' Q*']^R\@\;5$HV'5N0#@;5Q<P3$RDJT,IPUR0:0M:
MO!0:*W@KE=6^J6 JXB::7VU0>_LFVKM>,_'IF/F[S?S+5L#IXE66W*2^#R<_
MO]U9S.KOWI"6=#MC_4[WG7NZ0N=<]*P<=S0U72SSGJ+A?XX82<*QGMME&#>M
MVYQ/Q<.98M.^_D\%23T37O6![BPSJD2\1GJ?K@/Y-1,,/DVS%,8\[*Y?YXB^
ML:/@ +X7<!3,N!,1Z&'!8!<EN+\\LOV4:9-/42MG#/BPG=G>RV-_DWB)+(5
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MW;^9L9RO/PC;@;Y%**7/^" ]ZB]-XHH> -,%#$WXD&XE4<P=[1XE1,^Y#AO
M&K-2O_$V9+(%*\7R'>E2MNTT[BU'CCA<S1DCGB//TK<!H\#2P#&:C0QSN]=
MAF%7<F9T:T2(/O!&-1N(8B#W[(9S4%+H2?)#K!!_Y& !O!/H?4X_C%*6RAZ4
MVQ;\[]>CQQ7$L0GBN]J(=N2E"\R\*LW@?/V.8C-+LI6XA#-S=M1<:@8T'+$$
MN*KPN5=SX;#90J;$"%F(E_QZ#YBBY/</WR:6<OHSA4FH+%F(/RVZA3>MWXYB
M[FYJ*(=!=D.A.$ EO+D6Q_ Y.',C#TIN^K&Q2G]#W_O5!P<UWU[YG0:VK_0[
ML>;2S;>QBQ)*M8[D;%;I._%8V5OK2"$]M_/0MC[8;J)^55>!<U0YU-L4>2+I
ML:,3!Y8D%24Y >*?03!34)8H'2-#QF./6F%3^.0L3DM?X3=1(7NZV1+!A1M(
MM5< _)_/99B1O>2P-9+4E^GZKEPEYR.)!<?]2$;BMVUWJZE/]F=N[173!JW:
M$TNYL.*Q!]]D&-7-,R>__NQ 7KL7_1GTXL"79Z$F;$I@6V\?*^J3ZR0))OPB
MS5MLD&&XW6@G?(AC0I%?6-,7[&481C':O3DJN($O?C+,@0]DZ \.XN:+E(*6
MTC44^),/:E%Q_R=;X'[RY(&.%AGF_0$B? ,RWD]'%1OWUU<9IN ,"=[EBH-'
M_=%3!]^@IS2QH&MEQ+F/'=*7+<#T!32<!%2O?+OQ_]_%__?O@MP_\L^LP.OV
M_W4;>A=M@Z@.6$'7@"VAY-#V<0!R(RP&.2F+LWH=(C>FH&R?FO0@,.E!CI.Y
MK5&S]-$M1JJ9^SM;_O&4Y:[?<@U]?C^Y@MV"]/(SN8GI)YVYU??J!L92+W$C
MC@<'1'H=.1I=GUA0G ':_<S5^%:C06:^(SZE,J6GQ)\>1?HA*S2.SSB1*./U
M[R(YU2./']:W]P&T&:?V&=R[WG;</[( 8QR5P_![FN@?'=!4,>O7'^WS$E04
M=X4QNS,EB#SR\CMQ_KC\OWFCE?.G)!-H999&[OV!+$'L?'<5(E;TT_M7'C-#
MR>#Z?WO]L]^.YJWK+X'5<(Y!BXED+:><B3P!^ANK"\%/TTSDSD4!6NV]/47(
MYTBMEPH?@<WP0ADF:DB&>2*]"PQ"#3),'KR)S:O\YQ0126$ 4QYH4\V(JY&"
M7@*J!N?6[Z" J(?LBH?5\A.-YCLNR#"MQ/>X-RL!!G9^%OL&Y6?;1__/I*:N
M;L&01A;-99)03]-;S+HU2?Q7?BIZ5SU>*<,86$KP:(-=@O;+,"4&MNP?1<C2
M,+3O=HE*D!\4I!1UP:X"7=31OGG%QTI6^[+F<PY*L[G W+KGU4BS%1.-A7BK
MWS"?<RWUCR^'48=1:Z>=,-_*+L]#2[V)E7"$5@&F;P)><K<D<H&!KM()HF'N
M>Q [S(X'_'$)J%KRY$=,6![F] *5)A3\WI(%H8-*ASO,*!.#(>X]GY:YW5ZY
MK#!5P9S-1CYX[P)EF(D5P+FD>.,R?# ^["'5NG/JT[8N2N;)DZ,>'<?D31B,
M.!E&\&CSJ^4'EB@4O4#><%;7*\,+(%]15[/WMJ?/1=5-/)W1^7"N"18F5K[L
MH5D6XQ8$7C=)F;DD!+ 011>G4G/W#QFF^1PJT^2#ORMS3N^5G$3>S#.2:-J2
MD]X.EQ[2@L#P!LH*JBDVJIH'9O[,2BT0GGJ?!QD=)R<J<(/XF7Y@?^ 1RT2=
M(UN<[ZH/"J?:1]QSK[(ZWHO ."\\-R[=^HZ_<VCASKHW710YQZEZ/X=M)>89
M;X]]C<T[NCGA!?O%ZRGZFJ:+B)*:YS9W0.U$\P>GTLY >:U;\](@>H^G(]?4
MP2N#\=UR0E]"A K$_M M(I>W\GPMO6)92B'$LA,MOEX8.A%RN%?Q1/?T<7R)
MT8(GV(L'+D5%H&1.?%:9V42)[I5AM/'.(O8KUE+\NB!AP? *Q+R\NW+#2]'N
M3K637(NHL3B;I.+?=U+>V$3%S=L(<!.>$G/:'B@ 9#1;%S5ZV1P5%34,>C;5
MRSV%C(3D%="+IE(!)\YCB)FBB1KBV/RA51]X2M283;JK]-M-E5NK\)^A",EY
M2(G/?+7K'*\!T0 U[@I27,4%9)P7K-1-TWL",;D,/A->EZ4;U;J_IW)2N7@Q
M>=S<-ZBHY>HYN:.7M=7OB1R]U\Q.9:7OS,@-3&\=<[IG[*RXY4V=OG_CR3>1
M].U(I[CT4.S8Y<9C 0,EZG<N^N*_'RW,VHRWQ&MLG=XJPX0GNP?M3\X+XXAI
MW];4]CO,7BOX2DK@/?-KP:$MHQI,UW*G7AX11$+@T%VAH]X)Z&C!&,&LRZ3.
MI.Q27J =0;ME)WYJR=<U6B/G_OHE;B\8Z Y]B^2/I5@V7%-(=7WE6A+F5ZIS
MY/P6]["JH.5GL<NH+B54=UO)D)E=_Y(3K3^].!-JDNUM(FW!9-,+D_Z]S1[I
M,@R335@-9>[^2(N4891^.X ?;A3YG[6H&9Y&&_TZ,W8QATT]-4E0/M9)W>5U
M\\QQD\V_>3K$\[PH8#E>3L2P[Z ;594&$\]CE6$/<#9N<AJ(SPIB-C'C'(8Y
M*@ %TCLX56=1<M^\-5Z&J?9B).BY'>5ON*ZUM@[R-A2$XQ=N!GD]3R\6<HTT
MOCGEWT96I&0D;H[4/Y<6,WVI(O-Q(C\7.__+(G1GVL\_[(^WU*TXYBUQ3_%S
MC20;U#R<O&L\#=S6:N7*,#@JQ:'3G*,*Z35G;;TE0,ENY?>2$FJ(6U?H^_!=
MQ*?F*#*N@Z<.!/95FO3Y"<AQB *4+:0D7P@C+N3RF3I4OX:"1KH1V%/.YZS@
MI00>< RKS!]:N\B.,?5SP>U54[OG/"D_F4Q.,+%O'(KCMF@@&S[B*7ST,K33
M$!GM7A:TG[#MI^Z.CUOPRYYJ]H:90"3:/AZ6)B? +OWSXI VY,,';%H6FTVE
MOWOF0";0.W@Z])4_.>7AS9-Q\Y83:H]H 2*_5,!?QPAMX@ME-'.1D8,N#EQ6
M76&7][":#5W@J^_%U,G=BL4/%S2?]/2^ZJ21N51Z*.5">ZSPCS/ T\W?2\].
M/[T:>FDRXR*S^W9TH96]I'(PW>K0M@M?B[AX2R?G)@&U8"PU=@W_FPNQZL2Q
MHGNDN!V]-SR(XJ2I3]4>EB^\I4P6'BO1(";1->%M4,H3.!QR!<5C0G5>0A!>
M@=^^&J<1P#CR:=HKV%%>LCRP=FOT\K=7KUX\*!DKO[I%<^1]R#"I.4=-8)!4
MKV9PG;:_#)*\JO;(*8JOP"[YH=6><.*-FV_8*]JN!I"_</DUU7:GP FI7C-0
M3FP"^GK%))#(E&'\=Q+6!,HP"V=8NH$$$Q""0D0&35DIP[WXLR@?C$=J>GZD
M[<3O8$)V%5MHN:>_V:]YJCLVS!Z@#+>GX,,DCC^U!I$<4$!)Y*GB503D)6/U
MFW K7 ]]JC,?/JT;E76@IA1>+UHG(C%H>Z)M ;5'[G;1"G_L5<"9UEV);'I^
MT._/O$W?/^Q,79^RQD2L_18HGP)F\IGBDW?N4))2J'6''Q1,J&//WCY_7%^]
M.?HU1-&^P:>>.?/L44\;=7]O$Q $!$8".U-)V3),P$/V!9L\FF7=^)AU?^%X
MQUQK ;V-K(9W (]AD^O7=(:15JA#28]I.UY"D?Q)Y;%KS)0G8;LT#T2&G.PY
MD)*2P@>/9.P>N+/2..5'KB>R6BA@P892'V&O6+^[^GH%1Q.G@*W\/ ;TD_M/
MQ5KWB@VU[1C/[&(Y?(,-VT4/W?XO]MX]'*KW_QN=DE1B''(^3$6$$%&(F4HH
M/DS(^3"5Y)0D9,J8J<0X^T3X1$Q"DL.04XF9F&$J,2&$&#-3.6>M0BO&S)Z^
MO^?9^]K[^OZ>_>QK[S^>?5V__^8RKGON][K?ZW58]_M^+X,/GS8\7VQ4\R6Q
MZ\='JL-1P4O0677-EQM5NZ'Z^&?86&'BTJGP6;P!@$R8:A<_]K>:BG46G9W3
M97=R)^XHARI7EF/@<*(\(!V:9BR-);"#NC&W$(U!299Z(-P%<&IXAN\O:*%3
MMV&UW1K!!$)GS)3U8RCNI(4>\DX5>T(4Y\4Q&;%THLB#SBII5[#0SH?F+7*1
MT74O>48W5#S-.14K[P9*G*M-==C/AQ0KRQ6C0D<:VUZ>59T[;FL_^<V'9JF&
M-GE3V=^WE$&;JD.Y/BJCCJG6F[<T#L89>(9LS&M-, NI0=1/ZXX;CRP-GX85
MH!@8XJ02N#6A#)M#G]0$;%^&<<H_+B/$9VK/SM^<7CU,W+0QQEO*M"?]?>JW
M/<A4PVT#\XFF5EYM:A5A5%G<IB<9^\=P;@ F@>>/DZ[)-O:P&9&EU99E20M9
M^$"76E)44W('LF=='N<%(#K#@[AE_*/@7N@*JQO54$%G$?GJ$Z7S%G]30:T7
MT? %/P6^C@ F\:7>Y=BO[E/3ZKU/^ ,D24:G /8)PRZCREO&L5$2/,MA2_0-
M<&#DM4BWNO+'QH,40[]8VKN%EP0I6TWC2#8:^FO;OM5T*33YP$@*N_A<Z !C
MJ/OK\O,^Q6+XUME:SVZOPX3D2B?27I="I_M7YY8*W+05F[^^R9+^VK;_Q^7N
MK-5K'=R*@DC+R'_&Q_^4%5\T*G=Q7,@WF1[2+'2(XZE5XA!02^E< 9Y8B].#
M[CV95UXIKHPK"[%HN<4+?#(7N^:?*$1,UH(5G"_]/FJ#L(E4C3L"93QBS:RY
MOYR"JP07,%)17WP&8B(DYBVN5)!C$*"&4'PFL%K\1?'?@EG-Z(4A-FL73C>;
MD%:LGHN3 %&<[H:8^"?!+(2ELSG S,"K0(4G!TQ/QY#5H:BNXGTC/&M$LAJ*
M;7 O*-<E1"N^\,QV?AR$6K^(TQ]H0ZWKOP4=&&-]+1S6YE!6HQ4I;66]'='%
MWP<:WA; V*&G?#J0AN$AW//DLGNBR2V)XKQ:^^I $:2GDP$G%#I0^XSM0;P1
M[RNV=#8T*D#-CEYC5K%E+/7)Q*]?B[N^?'0$+??0SH)>;:CAK)KXZYGG-C*&
MZHK[+(_$C'!7\U@+US]"1]FHA790@1/4;868HM24AV+$V]#D68N\^L _E<RT
MFWT/!#"97EG;D28AU\B@?C4>GV?4W&ACB?'UO>;'4,1+4!!W"3IE.GXHCMVN
MS9?:"%I'^PT(__?OX922/RT]!# Y,3$JZAWU-%X>AX6\ )+0M;R.C^U&-06E
MX _.JHL 6?1QQX#NL98$GB_.E&V%9B@C6Z.M%*S%:$).2][>C5R-O%,M:32'
M@E'#"0G-F,TXTRE,*DJZELS7GAM#,=009\"@U!KDOM  FCX7HQ0\]NV.*4L9
M$IJ(SE,%8JD=Q$-8NZXJO3+GDP-R24:J%\SR4V9<2Q\<R'V7OXKT+GNH:U-N
MZ1^U=+3C,/7ZPU+-AZZI]BM[>L^P:Y6+O%^&]H6[>%$N<!N&S0Y4V)"+\W@Y
MJ%U-&0AW8++R:3!>8Z!)7]9S8 G9=:-L;I@PVEI$1"R+O%Z:798C8?SX8Q@Y
MGB$8RQ5M;F$CI$+4=08:$9N%O,R@WT0DM?FPJR2B@VO[I(1<G=#EOQ>$)1_,
MP+ERFC2?22QI)I83[NE]-TYWQ.']DMX;*1I6?NRR:6Z9CCS=%&>84!2-D>WW
MA-+')>PV_7/!>$V164/;,8!97G1:%5[@EX0?9_[]1AIH]Y\98)S0)=W#.PA@
MYQ67-H[<1?D /GS;&RT;6!KA>__RJ?_PB+_'_\V8_[%5IC<=,6K-=XSX\^CO
MN0) %,#<NF]CDL[^&56#3V$3EB=<?PG-D,8!A8TX!C\:_A\/-5UG$_ZUT;:2
M\R_W&?Y?[O-_*?=YO8J'"]H@>@CCB8;3*PDB8@+8.1/4\M>KPM@.'?MO;0:(
M8.4XM_$W_BOA0Q\5""+< ;^M3U!=%^"C2ZL10%870@S*Y]C1"<GYE"W ]30N
M681G6I]E#51AJ2X?<:>YKLHS?6JF2SL/WV9_O5'BLN4BCE<WA9"#6$"I#Z0!
M8KJIVWDV<1%/Y_A20_FGE&M:=PTN-3[9U*@6^.'6&QKMXE9WI2U2QW:/?*#6
M+RV*39%N,[K[L=0NE$*;64P/5<+?:P)G^AR(35X>_UDR;^]A.\Q3X"[<XVSV
M4!<'#PNE]K;K9[_[%6+Z\'K\_GR2D"%##)7X'Z2Q/K01<8Z^6VTC:0=VG;;F
MD6YIOG%_3 G@)\44:7A?!+Z_X-((,=Q[?DX[ZLY)X/#R+=*#G#;,\XX>)>*J
MJ6K _J>=Z@LW=@5=&L]?VL5JRV_]?($;LA%O[R7J)#NH6'?C<15QK=#C2NDU
M4G/KX%23GKXZV8,0^^W9NB&;N2#T,=L)"TN@*[?O);==PTGH,ZT[>CE9DMA#
MIUK[FPREYL^;WBLA7)Y?T]$3AB" $3]O?'B4?;SO<]2722MHL9IW IB'KB^Q
M61UPR6._[@!SDYLA<^!G)W+?IFM;)R)L/VANYP]/O,H4#]K\"G$'I8+3 T;8
MB,5#4U;7&'0/"V8W80L41"M6?C50'>T^>-G4$>Y:Z-'=B$[!VVX.^"EI_]6(
M:,8Z6O70G5W]MK^CFBJM>,3%Z&O-8LE&1;Z_KJ.K\Z\KG^_[/JY]7!CKH,WO
MH4V_-#'",C+([E6>28-9#5][(B=[1\U1<07VO:/C/AJ#R^11#?:O5+[HG%!5
M:H#U$2LL\3&L_,\NH@=0W,!F):W>K,@TO?>(M'6&8C+RH?85*-YY]R&A:[_3
MX2MN(3NT8\$6_O:5 &#XVWD%^H3U7T!>$3#-54C!83AD>>QIVXJ24/[68?3M
M:,= $UMP+^E/YYB69-,:9?06Z"R6VM'77WH0K-<0>=@O3 !AZG:@-O%W8Q$=
MZBI0M:4-B&)3\J<F,&QR:E,[P@4Z70+]>O(2U+,=*L1$R C)YMBFSX%H\:U!
M;NJ>+D.(UUEC4>P*FJ$DS@R83BX!$6E;VZNA0A^(6A7::@;NJ5/>FD$.QHA$
M.\I:@U(HX&]L5"=E[PB*'71N9Y;2EX3LS3R^ 4EIJ*K0'BV=5JK:;92']BXR
M0QNE=9Q''-']97ZP/B%#*>Z=,]EQ?;&7'*4O@+D^/?^CZIS&2BJD_/#E6GAU
MTAD&MRGV%<6HUUQO*2DN.(M9H#<A#"U"':O!B>U&[\(RV,.Y&RGL>-=UPP4"
MJ-V/,S%<<12W^1"M%NO%IPG-LK(8;Y\0O<=!));I?\A?&A.7YQ9C_%GS$J72
M6SJ_Z:W_;Y_0PTM\8/!/BP[ZMX_MQ8&I]X4$,-88:M;JE;^QI;Q7"#M7O^=O
MM.URMKFNCOW?MXO^GU1_<-3_S]4?3=!_57_\_Z+ZXQ=O5Q!-70/,%V97! TI
M\2%F219*<%874W8BLL,UG$&Q9%/S<(HFI.=Q+[I=SZ[K\T\;N;;L>I?--MNS
M/?9OC_@F]F^J158BU@-X@2!ZX=?Z4>PZAYDP]2$&O@M[VM(RN@HEYS,W,JE>
M[!?5-08GHE>;*!FUV$L1^@I>QBE[VS+NE?IU>_8D0$&IAC(OIO?D*4C6RPWM
M;W6^TC-^P%UM(/%7T^FG%8$#&UGC.*.UTJGJ-;/W'D/!]N6FYOJ?;QA9#KL3
M=D0L_2:]P_",F8N';^+[".I9&P.&*0A>KQ T=M:O.PI@_2__'&^EV?PQ#P]:
MU^F$CDN$D*[9*=0M*N3(.R6 31-="+1I5,C2FA1E,X%M#@KANU@_OEUUL$O;
M2;J2IHKROW]>SN;2@\_/A[:-8\Y]+EE\F9W5U+]^U/HW,XT>6*P2]<XAY5"U
ME9?3E995=^>-BKZEBI9&[07S",/ EL:V7U^0.P2P),^-)P+8S&>*%8']&+HG
M@+V?0  ]B$;6ADH^@\PSP<B@?A>2VPGLGZ3&7QO;,)M0P$-(R#E,^2P(-[UH
M)8"=4'B-YFDC]Q%^=M40&GE_"6"/K>\00,-\ >S 07XO,,]/[3,6NN[3 MB/
MG"DR%)@U%L'/Z.&.\)7_AU=DA(\P7T<3/B0"LD**8Z9@>."?C: ^_"!K>0_N
MCVZ/X@@%AZ4WZO_RH_ %EB1UIIIKR#M)$L!T_C^/LG0=36>N:9II"\W.;\*/
MU_\5XW_%^%\Q_K^-D>!+;4#F5,Y0&_)?^XGY#$8L^V&.0Z9 C^UP8XW+R(+W
MDZ)GL^H2_0=6XO7.#B2/B])=CQ\PIA]1+).D&IRE3A%XR*C58J$/$Y_2YLN2
M9*B_.2/+&L#1[@(B'9V VH'<'1;I-3[O;PX%36&40U<+X@[-KM[,3V[3*P\K
M>#R;?OQ>S7#X>6[+!?H_=V]<\$K#>W$RM5/JS0ZT;%QX^^.ORA.U.E.3C@][
M3&,^ER:Y#>^+.GWF[$#Y0M'(T8=#)+V6N6+Y\R]BX?]<0LSQ(QY^>[C\-#YB
MW6<_OV=5?I7/F/MU-Y[:V(X)K=X@:1Z.LJM;)3SE7Z)@-^ZCO@P+8$&(]3V$
M;805WV"Y95306M:WL.FL?^.2[PM=<G0W8>0S@E]8C:^EL@#$RI*1 #;P%'$R
MB\)" Q6#8O\RRW.(?]7JZ/Q'K4YE(W=+P,=?L^J$9<371?]P,+_K9L5MBC0/
M#=;>;:[P!")N6[IRPLTCCEG$88*]]_4U*=V7NI;9?^ZBZM^V!R4)AGQ5_"32
M?' E*_'7I 6XU E/H\B F,XE6=X)B/B$MQM8;1%F1$O'X"-H3YM0R,G!<SE,
M!>PU++#$QOF2Q!!'92]?/X,NO_7&:+37TDE#3!+[%72K,KS):SSOJK[B'.)?
MK%[1M5]K(/6*HT9/KUG"INRSG2[=S&S/:;<S8[W]T1]_Q4XV'G8:>=6/J#\.
MUUA>ZO_-:+:;7G)AMXM]:0(5DH1R=0/%P)M#1NJW%5)YVFQX<A[^:-O@(BX,
MX,<)B5-]=@UQ-UH_SF8$IU)U)/G#S,W-3^I%Z(.0>Q2GH54\:O.)P)?O/A B
MX'?5]T;L4!/I8"D:,K),LG:%J8O*XT5RD"88D6R<=1F68#%Z",U>9%&+K142
M!; X(X?/=0S3 T2$DVNI@ZCNS[)<W<JG_$7V/M>MG#&2X1%3Y8=OG=R_A+_2
M&F[HNS;ME&O_XLV'#*<@1VK+%0^]8+YZ<$T^O2VKK6XRX8?WL9LB[]8(Q3?7
M1^AK68M- &7\]9H8?=QP.\]M!"=.QEKA F,X&_".:[ZSZ@K K]7JFQJU#4]3
M'GNMK R/G8(3<<8X]/6_9$ZO1HIHM$34X <GM_=3-+!A[$N%I5ANUZ0^B$K$
MF7,=SK,1VWU#"ZX7L=5B/2VVX \./S$V7-6ZV_#4V$$W?F)&0S*VL!C]8"#2
MI6/#Y\%;OZ=S4YPR$O7[BRB]2K/VZ\VU 0^_ZMM_>L.1RQW 2"Q=2>,T-*\C
MG!O/9:+\:3_>E/D]$!$;MT+9\^A0Y/K%^7SO]P6DE(A'8! MX\AJ"&C8'8_Q
M!$;N8$Z ^JN5;%;:F@!VN^E:P<[)O?>?,4IF3AR7$B(+5OF\EF=I_#TV)M,?
M!K9D4-E; ?JO-<I3I#HV@G/FXV(C0$$T R,9^W)Q2)K/3RD)'[I16<O!\6ZE
ML0G+Q;D.VJ2&[OL96^/[&/VRZ7UR[^Y?_AI;ZJCO-] :PBCX<J;W6FM#9'K^
MT>>IS8N3$W%":U*_M,LU-J.D_2:!)'3[-4YD<RM?_,=PPH/Y&I<P=AAZ_ON.
M_8__Z?R_JP[[-X^1*)GDASBA&]$^#:;QWQC^*<JH0JS6U<SB3*V$Z%JN:D;E
MG%FI%,":$;;_22W;K\6;\$=\-VB[ ";:+H!YK0LQ_!68((!90ZX8'S:+E_<2
MM1%?(X ]76%F@7K\4^GCO%VH90YJR\SC5'ZC#PID_K3[88-@T_CMM!_G;>36
M-@#Q57/H$)>50&BHI=;@]D,37)84+V3(TJ$,R^@F2>!.10M@DC@39<-TUG'E
M[Y3*1W )S:">W8>T5/C2TV.GK?T5I*9?7$XSS,#9YV1<=MQO8Z,U?C?(Q:-M
M*OM+>DM>;?_IEWIQHY)HC#EC?8>$3F=BT/5%L"S?;LB ^$5";DVTBM!AQ=_;
MRU&[P.ST/PA%[DLJYS#5L%%L@RR. *883%$!&=U6AJ_7.C[TD:>*]CB<]#ZX
M/?[Y0;>QZ6TSO23@U>HVD)KV&/*J@488A)T4)2B,$Y1,>&Z2!M\%O0C!6WRD
MUO$NCJDWE02KB^?3[M$X")EZWW/ORF/W_/VX+G2ZLNNSN3OTU%''/A$>7/2[
M\,S#CS<N?_ER/_2(G/S(@9R&].S!#7>.MT&QDN$U4U"UO?JK:/MB>,#(LS@3
MG(H-O@EKN*H.H9_,"PW:>[X.Z)["7529<@/[<1+L>72J!'OQ5.VK9Z<^@=UM
M%+7-".D(<?9M#:(KUQ0\>?QD=BFYQ]]D(QEI""G0;OY*,;7"L"DO"5-A*/%)
MGC,4ST8ID&1P]E!$>5CI=2'2;&].ZW]>UCI5]$YI1%=\YT%>T#U.H%F4V3HJ
M*'#?.U;3W4O5I/N/BM\ZV2M<^[ <Z;N'Q)[]4.1&"'TRO';M&BMPFN 8'L!]
MIK<BPLE?""P9Q3)7BP"/SJQMV#2Z!9%61%B- 9;NJ/_LZHI8WD!S'@'\']$$
MR*XLS5?\U6ZE/ZT/MEV[,V-?=?!W/E=L(0M48(O=78&KL+ Y;$9&HX08G0 D
M82GS;%(:,UD 8V\!44K]N(B'A'/GI@[#WYW:"=,KYL%E+V);[\_:*0/XT>-=
MZ#SCRE[%/KU<>T>SRM&*H-Y>N=Z++!*&&/702C>W6'P>SVQB-0Q5](?HQ;^]
MC&NPB;<""*MGH12PL)/8W:R^#PJ?$N(8]!(GPIY <X+2[8@F2W+0UY:[P)5D
M,0L!+-FS[/9VQ0N9"OL\X8\6"!?1.R"154^H!T1S5IH+A#QEN8<;[LINRD^J
MI6@:$L\#Q14E,[0+I7 XMA%*HU\IJP,ZJ[33>3);OZG<-_EFZ9I]/FC%L'8C
MABE+)!Z(GW;RY36'SGJ]C%ML+.VI*73.^R0IU1>5'(^9PYSE]Y?XP&N+^YU3
MWPM%E.'':&^>MR]O\C'5$74)-5K!CLT2TKZC X>:+"3BB]!+#AM,Q23-/^+M
M'1+ &E:.(B0,$]JL:M7B@C^PM12/:)-^'3]T\G'P;PD,E\R3'5YG"\/C:T#$
M3H0L;E,8D--1O%==N?DC7PNBK1^A<^D"&) TXV^A+L$@MID16GC']PS_PWCQ
M7;?LW/.#JE"MQ=L]!1<.1G9][&@]4W[ZW=5&W;[M.OM/.SG^6#_)^7R^[^7G
M*R4:EQ$[@GXW^S@@R^]Z4A=#7Z3[9L=&#VU]#K$<S?-$67%>_B-VWXKDUI2X
MS$\$NC>Q"Y%>@$J8%F:5$*-P.D,4Q>!)8=XDYH-RJS-"E1J<L"Y5%,N7?MSZ
M+79G1&3V57&IL%Z^#I^.4$3*8H.ZB_>#\E7 O L*'H/9.8NT (3RDN>E5<K!
M;"=GO \X.1RSJKOEIEB:91?]VJ[KF][I2+]QK;5TOC>4'E(]JYWL_,O'P^E#
MJ$%O;<0DS48G;-^ECX]9<OYRS&G#R2^L#JK>R-EQ:E$[D_8=^IZZ[D@])X"E
M*;C[(]J!7^D426A PI6AK@+(U^'DN,V@,M:.7GQXO\FE$9)PPBF-;]JPGM#+
MY,]N]J7/US$TQ"?_SD%/$)U(T<) #MUC20D@8LHN"6<7"S Y#SX2;PEO 0OH
MH:58;7#K-Z%\VS;%2(X<5P(N7=LF[@L5&[\]>/:A^]'YXJXC[\B]HG&''W\,
M7#+)>[>4J_=3:YEVM38J\^G3MH)W:O[,0B9_XN?H*NI@,+D%%[BN"*W.=X]<
MY9FFG1QN0W P8X<8)!AN7ZAIP$;YHU!O^0:.*DGEX?EZ=E?$+JF7YXSN_33
M6X,>2=, (=7R.-MG?O&(RPN 4O\LN"7_IN/T:N8#PK,9S++(,F*#8+]<Y[4J
MHF:?ZZN:DWMQPO/)R\?W[P?TJC07%#[T6\V.G%#%IF<9OW:OGI\JEE%TPJRG
M])5-D'[M,A3 (E17=CG[%\5@G?-_NA&G1GX77U93<JJQ)ZC.GG5#+0Y]YU^S
MFOZ?/]+S.^_?U5,+*=J)^H5!,25,"+ETB#IESSM$I_XV4]TC@ 4<:!# 7"L1
M#=@( 4SSB+P ]JE"*(T_WIS^<=1FE\?W(4)6N@!6-R> K5VY#>4:3@E7?V$K
MD?^P5F[M/ ?]J:5C#+60$,$=UW?GX?L+M&_CC$!:%UY.@=TXC[Z+/#)L:?,X
MF+N^/1;VM%([A1)>^]QZ=R"L!/5P3&XR]\F\A=7JRW)"^,QJ*R4_KCKD<#[1
M46$-@P+W64PQ>!K\MH!*\H#6GW;XO+,4J)0,$7V!KJ1RP,&GO\EPYV?>CDM
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ME[2@$W/XWA,(ASOW09^/G*-N9W;-H^X$=*Y]\Z %_&51V<_,N$Z2)%P1P"[
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M32/O&#M*'6=C%]ZIC#%];CINAPJ.MIYQ]PG5RDDY+91[(/?&[_W73Y'S=X&
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MS8L,#%#3ZE<&X82R:2&N>98#0IT T7-W$"PV919*;OI[U[G4 ]HO*2L6D =
MY6 78DOQB5WJ:E Q2.(X,JF;?7W'/?$!'L,DC@>4YS.B%6%ZY.6ID @;IYA-
M(9UGGO8J/'+38UZU4D_-WGYQUE'>=N<%)>WYC\\&RXT#'6R.OQKZY>64NO>*
ME>Y@-/XJ/"E3]VQJ*/ULJ07<TW7";87<\;)-;E17?G3\5=#$NU68<%0DB^TI
M*4NO^ 8 W>4Y2.GV6_\K6+%@+Y#(U\R] )HI:%L*6: X&<,1 5(<7@0WAFC<
M>L'A/FNP::4:I'<M;L='<@0B)X928B]N@2)9S3GD:B.DI#6W(1Q4K&OMK-#
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MC]OW)=^YM[1*_85-R2ON=$%HYH7#J5/O2RHNOOCH..*<MN"V*^1F)B[*.+[
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MH:P@S'1 _8).*<:C&F&2O=QOA2LE?2V/*,G&1%E5LDZRB)A#S6>I7>UXZ;(
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M3>'I8[5#.U52;8G'*A2%/Z$=]SHE\EW+6S#GG-?R!LU-W;-^U:X$,*$$]-$
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M!CC*8?HM;) ]78T-:J)%L$$&@#4<[_//3XGND?C8H)^UW6S0T@J":5R!0L?
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M!JE.K;T(Z8NAM$C>C""OQ;$$IAG'AM"N_/^MFS,+:CK+PGC0QB!;1/8U;:M
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M*(BG9>2VXP.HAO4O9V_1VL."=/KGISZ%DVO?#P7$!"C4E:ZWT,+WFC.K?T7
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M^1^;P.CHZ9&,2"XF)BYY(3XA^9\NJ &@Z( M51$<MA]0H6!P% QJ OL @-'
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M0ENBN<@^%6<*O^3AP&&>$I%%I"9VZCQZ6(62I4$9DNHEDNA2X/=OGE!1)94
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MT-5;R:E[QC3S.KTH3@)_#FB0YD:7Q]!;3X^*!I-A^W#FJHW]MNQUT#WK)4X
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M9BDE6BZ@;7Q33<-0TKJ"=R2UF^J_YCT>Y(?CLRXZ7U&H26[C98;*2H5W#44
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MGO1S0R1KN#:2JJD34?%:^P\"7>DZMK>= U\Q8,T\T(98X QT7^*'#'%FT]]
M>K)R<#"[GJQ'>SWR8\^#VM $_='?IBL'[=ZYB56HG'CA\*L@?XE-BB)&C%D;
M.!FL#:XL5@=RNF0S?(5984-&"$:6RRF/YS^R5VBK4$^96J>@]_A($V?Q;(>;
M3=88"MH)#!( =MM5^4'*(4%; +G5^KPOZ)^*C3T-JDO2$!V;15PS@]O4)=%\
MMU'J-(#=)^U>-42Q[!88^=T66UGO]\"?:I1_:Q4"1X5#S4\_N3[IH>E/?AL9
MN"D2YM"6%G4$;X;8"#GAMH/+TN1.+J'VG:,,0ZB ",I*JJ#F]F!\D4?=-405
M%F]\TD=U*U,6[^7:W1_/'W^8>\OG0H2$5NUUO<HC)?)/:_/I"+\;V\TI*_96
ML;:,#S(U5:C(O?N<#0ZM*4^E''5<]_-.+!21,$1_<,C#%J0<D1JYXH1:1EP;
M9;FWEH']7U7B"=!GUU^NKI23[B<WN_;O/![Q.HZ^VXX(V=RE[!<8Y5>!QC(W
M+L!,5YP 8F4AT#LYCG*N6YK8F#[#VP@19)4_5.P5A8YA>_7O+\3NCQ3K^VS=
MFE</8%V6Y=RCGM@9GL)TAU_W#QPPI4<^0D9R*?)V_@K:,BCKJ0KU:&6A$"'H
M;'[#EB=R8[8@)T&ZIUK$6#Q,8;H!ANGP^B&%"]#8D4@7G8JD[8%"J\9'#B0_
MG*P&^(* LAUCD9FV13G^A^'./MY34%VA*Y>M!7'7FO:P@8-G&Y-$]#;^<._1
MYBR)34="8N!/D#> )Q(,J)MZ%/8/#DNO]W'Q$N(BZ-I6SFU#R?:KL1&@_EB'
M,9%R_\OF+PR2B#ED*/,'T&FP'B7!$4JH&C-O)687=LUHB:)BV_FZO*T0NZ-+
M2D^OYVN'CZV';DJ0U NE=5YDI,,;H*R 7H5W32L-FU!)8;C1&SI?3[R^C3\J
M7_V%8I[>_J5+9YU5EWALK;E!4&A<'77L7/:[3P:YU==>F)=G%7TL)1J!NFT/
M=-N^2F.()WS,PAPEONN"'[F_H13>C%ZVYKSMD\W;#F"?[WU^76RXXGJ%O)^5
MF;ME+]7\ [--"%G29QSE/\&#*M1#>P%[N4(+H N8J?2U1%D7\*UK=KE0X=FK
M\'UP@O)"%@*V" 7DU?:IBF!$T,9]YQ!64791?J422S2MK=J:"MI)U1%Q;L-<
MJU#Q: ;668:D'7BOPK</+V)CUM##W+K7!'4#1 ']85H;(\O(_') UY% 8W1Z
M\'JH6TI<.66ZF>'I?B#^630YSGJ[@)#@,N\2-R1MU&T--1"\V+UPCXD(I8_*
M/^J)^E0,R$JC&47":T'GI^P,OCZ\G;IW( Z=(32(&YVQ[\0;4X_ .Z$'39SV
M8+M=4%$;O ?<E^7?S]61F/<I3*NCEC%#[P:$3R[$7:7&(QB+H?W%K*=WU(&C
M$M9E;$(,&*'0*5/L+>JD+5*6\,,1Y6P_2%O^FA/D?[*'>R Q# B3#%ZR+9*[
M'0@,Z&/G![[#)3S9\ICH(/FY@7/\MU)/[UQ_BS?)DZ_3=)UWGNR^QCDJM7P1
M+K)\$_OI8VG^63?;8D.TK^6?1_']'YQU+'RRM_I>]*@^^<R;[>!CY2/^_D&6
M%5OJMO5EK-'0<[OKH<9^?W\9S/?ND%BX>+4/YH3[M75X5WH;?%"A:AN[;#+Y
MNOPH&\C27F"SCL+[2@1LGM*SZ8NX]D"!H'=H8O5KBOUAD/PT2KUC;&/O].<'
MMG+W0TH[O$[PR<ES;@_>3=IK/[-('3EN[;N>F,S3H+HKJ^D1S389_(;\'SOJ
M5O;P0QD:5*RR@1L#F"'$B<)>$+&3'\*O_/A:.&.J?ST4S%L!951 ^;TN4,9]
MJC]4FI]W=-":MBF\8$^Q);CJ:CETWBT771MH/F[R3:%+DJWA@;(Z$$O%0>QR
MRE1[4BL1N#;%,T*N2YK5L,]X#UT0YQBW%FLW@7MNB^FY"[@\B95RM^#BLH)[
M+RM(?H:#(_R\F O5)R/M%U)+X^-;)'AH\^#T/@D_EPZ\'OG4^G,3J!BS[^69
M3Q:>#-X/70T%FMN)^O7T.A,S"3F3ICD$-0G%-AG41);=@]V.DD12:T'3C8[I
MWR;/?WDWF9_OW]"?*HNK^N!KZ>J=JVG]-+2?-=TG'-BQ[\9*#[.]"RTN37M'
MOM<$>O!\_=5SO',Q4[@!WL:6M:=8NG<K'=;>WLO!U$C!(>B@:_<D]/<R,_3A
M+;D;G$=_"0\=3CFZYS3!Y,K[&Z&I<94AXWVYJW>/XT7WTO" .Q_:NO.O?<HT
MA(J_7GV-L'@J.&N6USKS;&'PK0%"5/J#L.<39#F6_>NY=)4*-7^8LL 3/LCA
M/9]7H48]OU_];_X3H]C.YKL+9L9<A3I[4*ZF0DU^1]">Y_]Z7C;LK,A"*K9O
MABH4P0?GOUN%2JR:<%.AW'_:>C=S+A=U-W/K?]*6/,.'T+];8@ O&_D!%4I=
MA9IJQO_BJM1D=Q.&B+!KFD(_"^ZFMZI0"Y^[AW3YAZ9$.YFS?[+ERZM5*-:F
MQ'R,4HA6H8*WJE 3%6KZGB<[6QWUCRWZ;YIZ.P8@,+^O'\/]V/'Y7SM4IY[A
M(Q?^YX95J@KU;!GX35FL0B&^0Z9UD?L/CLYI?5;2_T+,6ZKOZ8CZ=]N//;5J
M=BK4]6AZZT'^]%_X2!5*>6P,QVZ<DJ A"[:B-!9>H?4O!_LC#DX%YQ/Y/RU0
MA>\9?^>XP5[.<A=$2OY!:Z4O\.BBLOZY U3POUFLAN?X]T0$ X_Y"Q=+OCQA
MRF>(KL2%2/5/0H6^GFP4M)GV%C,O-\):T,YR!1D,ZR+G.J"1I+@*(@5"3^XI
M5K^9FPEL-U)/CZ\Z<-H;O%<K4J'61OP^$+$GN<%[L_+>;9)NL/$SSM;\(<$!
M3)JP\1;-"#HH863C&_&IO)5P9S"FAWJ:!1T6-.ZD]='4H?F[E)J/*I2;0Z:
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MWX_W=(5^*<;E:-HY[6K;%K2FI\/R]?MJ[S6LM6]8E]+FB("QC*DLID>:Z 6
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MX!-8P+\AL &/ ^,<E<Z-.C_ &3E.E/!CA!((ZR3+6]W@P$!'XE21!9T'C1-
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M5;.IPE5->5*Y.QD<E31#FK4?;NN-$&,K:UC7PFU3,03:%KB_6M/X>?_7!45
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MAD+2U6SK0HNHY5CG^S\RG0ZPMW76%558^NM2+TL0Z?[V_PI\WD9^=PGKA+E
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MGQ:];RJ*YRRG$#1>))\#+?G'<<[KT]["(GK00G?*=M^BS%&>>E!W%_%.[OR
MWSQZC^#\0Q^;$FGR&=">#87,Y:F_64M%GGQ4$G?R?[&_%V*($HAJ%UD"(\U3
MO1JXV%/<V 0KE[+)$((V0$^):C;"_C1:%VXKW4 ?J,_0<HV;8;@,+AM]P$6$
M&T_ERI1>>)R^T^!!R6](^$5@N8L,ZOY./@M(D3:DA)#OKH]Q,L40MLU]W[P[
M]!#6F-N9T)C),*+,XP,OGG.AW>1;%H9;_-_C=9K]O:;-?S,%([H93BC.@:1\
M<X;_#U]A[#S)D";3U5KDV+TI=-F6P <X_DN$T1-_1P9-'Q@IWEGV<#ZF;%+/
MJH)C6?*B_OD=C"5?(SN)[TR+X[2+F,R529S6YX4O!=.ZBVP.^9;F06[CDA]?
M$T=JA^VP0D7NF$U'AD!O32*&>Y.(EZA,Z3,#X9-\?PD)BMVNP !.30?E9F%,
MQ@0QP&IZ_J5:+%;S'I?$0!P9"*\+Q[1#UD1T*GWY,R&]'_T&*9"?%LE%;VPV
MV5!VS!1@012;+(>![11MQMGQT,F=9#F\'N>X%3*28^W8.:G&%4-NU9%N%VES
M$65L(=%C(,+,R':ZVY,9G%@W(7\STHG43E#.\O,3&HLA[L-+<&)9ZB:*RJ7J
M1?+D?X;__]9+\!2 O81O)_23ZV(%BM*>()D+XU$D;"^2[P;^P*;?BD(FPQKH
M2VD LHV@)$E3AXB+/EQY?PU; -H&NT.'6D&#>;U[\*>XU)35O396UL*JBGG:
M/MKS(?ACXN4G(HH7ARKQ%8P&Z]TK^E29&*):QX+,D>7-Y)8WY#S[@?9N1M-H
MFI7]5.M^ WHJ_0E=H!#_<F1]IJ(&-&<G=Z&4A?$G\KS]79=1P"@#JX1IRE9>
M#BZ;RU-YQM#X\V'IJQN396&*/V8VYYQSNGXL;)?#@L\HU4$EXC#)W+1,M<O5
M:]OK<X*&-3W/F@-,!U/@*^8"QJFAZ/?BI)JCF5?#]CQUS2Y5NYGW+U/@T3N@
MBDB6#%A'(Q,1TB"71TR0! :100C!B+OS]R+8$["'@TI8"&3[H3478G>-X4^"
M]8 ![SKW3O$-6")B+QCO.^(TVFZDY=@741)O_WPX N8.+$TV?RPZ+OD7[PFO
M1=N':3"SD0PNU!X@T"O]8#!<%@<:WQ((+'@ J 0K)\" @^Z&)B&,@>6$>I0,
M:QXIKP7>"P16C* G!J*:6S4YD],=N?(3[S,<!F9/A+?>;WT8:NSC<+5BVW/G
M(_$Y>D,43T2_F<9@E4-4D$HH/U@V['ZA[Y&J@HH>&6>G]D/)=7A>_.7:S.Q
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MWI5KUIC4XDC!6SQ]QIVA:,9C*B=\%I2O/^RGE987D'<^7/_X8AO?Q]8T2%8
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MKEOM$F<H/)L6S1]=10<\_+PH@S>+]R\M' -1U8(1$)--4HSCT7801P9J#C\
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M,\;VWN^6^M/OSLD8(?]<8ELWN"#SBZW*357?'/Z1H]H1V!I>;J(INF/[)L)
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M@AX!HR(C:(Y_&)/'W ?:<U;\=(@<-JTK9P@_CQZDJ1*HV9L*6B0?T)@];PO
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MOS3UPVEZ;KW+O:)3@A^N;\!SX0HR7?)3RIXM84KR3LBC?ED&!^YLJ8#K06]
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M-#$R,#0N>'-D4$L! A0#%     @ ZH"&68[X$CMH!   :"0  !T
M     ( !W 4  &-K,# P,38P-#$W-"TR,#(T,3(P-%]D968N>&UL4$L! A0#
M%     @ ZH"&6=D*A<2-"0  #H(  !T              ( !?PH  &-K,# P
M,38P-#$W-"TR,#(T,3(P-%]L86(N>&UL4$L! A0#%     @ ZH"&60Z?^,EC
M!   +B<  !T              ( !1Q0  &-K,# P,38P-#$W-"TR,#(T,3(P
M-%]P<F4N>&UL4$L! A0#%     @ ZH"&6>#]C-D@NP, C ,8 !4
M     ( !Y1@  '1M,C0R.3@T,60V7S0R-&(R+FAT;5!+ 0(4 Q0    ( .J
MAEEK%11>>V<  !AI   ?              "  3C4 P!T;3(T,CDX-#%D-E]B
M86-K8V]V97)I;6<P,#$N:G!G4$L! A0#%     @ ZH"&60S0-]R[#@$ 92\!
M !\              ( !\#L$ '1M,C0R.3@T,60V7V)A8VMC;W9E<FEM9S P
M,BYJ<&=02P$"% ,4    " #J@(99@+?1SY -  !%%0  &@
M@ 'H2@4 =&TR-#(Y.#0Q9#9?<')O<VEM9S P,2YJ<&=02P$"% ,4    " #J
M@(99/Z[&ODZF  !:P   &0              @ &P6 4 =&TR-#(Y.#0Q9#9?
C<')O<VEM9S R+FIP9U!+!08     "0 ) )0"   U_P4    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2429841d6_424b2_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2024"
  xmlns:ck0001604174="http://www.eaglepointcreditcompany.com/20241204"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001604174-20241204.xsd" xlink:type="simple"/>
    <context id="C_20241204to20241204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes66875Due2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes66875Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes5375Due2029Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes5375Due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes675Due2031Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes675Due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes775Due2030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:UnsecuredNotes775Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174NoActiveMarketMayDevelopFor2030NotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:NoActiveMarketMayDevelopFor2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174CreditRatingDowngradeMayImpactLiquidityAndValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:CreditRatingDowngradeMayImpactLiquidityAndValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174IndentureOffersLimitedProtectionForHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:IndentureOffersLimitedProtectionForHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174OptionalRedemptionMayNegativelyAffectReturnsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:OptionalRedemptionMayNegativelyAffectReturnsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_cefRiskAxis_ck0001604174DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">ck0001604174:DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <context id="C_20241204to20241204_usgaapDebtInstrumentAxis_ck0001604174Notes2030Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001604174</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001604174:Notes2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-04</startDate>
            <endDate>2024-12-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203040648920">424B2</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="C_20241204to20241204" id="F20241202224021923_0">0001604174</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="C_20241204to20241204" id="F20241202224021923_1">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203040714240">EAGLE POINT CREDIT COMPANY INC.</dei:EntityRegistrantName>
    <cef:InvestmentObjectivesAndPracticesTextBlock
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203042042875">
    &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Our primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. We seek to achieve our investment objectives by investing primarily in equity and junior debt tranches of CLOs that are collateralized by a portfolio consisting primarily of below investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. We may also invest in other related securities and instruments or other securities and instruments that the Adviser believes are consistent with our investment objectives, including senior debt tranches of CLOs, LAFs, securities issued by other securitization vehicles, such as credit-linked notes and CBOs, and synthetic investments, such as significant risk transfer securities and credit risk transfer securities issued by banks or other financial institutions. We may also acquire securities issued by other investments companies, including closed-end funds, business development companies, mutual funds, and exchange-traded funds, and may otherwise invest indirectly in securities consistent with our investment objectives. The amount that we will invest in other securities and instruments, which may include investments in debt and other securities issued by CLOs collateralized by non-U.S. loans or securities of other collective investment vehicles, will vary from time to time and, as such, may constitute a material part of our portfolio on any given date, all as based on the Adviser&#x2019;s assessment of prevailing market conditions.&lt;/p&gt;
  </cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskFactorsTableTextBlock
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203045833870">
    &lt;div&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="h_03"&gt;&lt;strong&gt;RISK FACTORS&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;&lt;i&gt;Investing in the 2030 Notes involves a number of significant risks. You should carefully consider the risks described below and all other information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus and the documents incorporated by reference in this prospectus supplement and the accompanying prospectus before making a decision to purchase the 2030 Notes. The risks and uncertainties described below are not the only ones facing us. Additional risks and uncertainties not presently known to us, or not presently deemed material by us, may also impair our operations and performance.&lt;/i&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;&lt;i&gt;If any of the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, our net asset value and the trading price of the 2030 Notes could decline and you may lose all or part of your investment.&lt;/i&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Risks Related to the Offering&lt;/strong&gt;&lt;/p&gt;
      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The 2030 Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur in the future and will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by and us and our general liabilities (total liabilities, less debt).&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the 2030 Notes are effectively subordinated to any secured indebtedness we may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the 2030 Notes. In addition, the 2030 Notes will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by us and our general liabilities (total liabilities, less debt).&lt;/p&gt;
        &lt;/div&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The 2030 Notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will be obligations exclusively of Eagle Point Credit Company Inc. and not of any of our subsidiaries. None of our subsidiaries will be or will act as a guarantor of the 2030 Notes and the 2030 Notes will not be required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of any such subsidiary are not directly available to satisfy the claims of our creditors, including holders of the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the 2030 Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the 2030 Notes will be structurally subordinated to all indebtedness and other liabilities of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish.&lt;/p&gt;
        &lt;/div&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;There is no existing trading market for the 2030 Notes and, even if the NYSE approves the listing of the 2030 Notes, an active trading market for the 2030 Notes may not develop, which could limit your ability to sell the 2030 Notes and/or the market price of the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will be a new issue of debt securities for which there is no trading market. We intend to list the 2030 Notes on the NYSE within 30 days of the original issue date under the symbol &#x201c;ECCU.&#x201d; However, there is no assurance that the 2030 Notes will be approved for listing on the NYSE. Moreover, even if the listing of the 2030 Notes is approved, we cannot provide any assurances that an active trading market will develop or be maintained for the 2030 Notes or that you will be able to sell your 2030 Notes. If the 2030 Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the 2030 Notes, but they are not obligated to do so. The underwriters may discontinue any market-making activities in the 2030 Notes at any time at their sole discretion.&lt;/p&gt;
        &lt;/div&gt;

      &lt;div style="display:none"&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;

      &lt;div&gt;&#160;&lt;/div&gt;

    &lt;div&gt;

        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Accordingly, we cannot assure you that the 2030 Notes will be approved for listing on the NYSE, that a liquid trading market will develop or be maintained for the 2030 Notes, that you will be able to sell your 2030 Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the 2030 Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the 2030 Notes for an indefinite period of time.&lt;/p&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;A downgrade, suspension or withdrawal of the credit rating assigned by a rating agency to us or the 2030 Notes, if any, or change in the debt markets could cause the liquidity or market value of the 2030 Notes to decline significantly.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Any credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in any credit ratings will generally affect the market value of the 2030 Notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the 2030 Notes. Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization in its sole discretion. Neither we nor any underwriter undertakes any obligation to obtain or maintain any credit ratings or to advise holders of 2030 Notes of any changes in any credit ratings. There can be no assurance that any credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the rating agencies if in their judgment future circumstances relating to the basis of the credit ratings, such as adverse changes in our Company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future, which could have an adverse effect on the market prices of the 2030 Notes.&lt;/p&gt;
        &lt;/div&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The indenture under which the 2030 Notes will be issued contains limited protection for holders of the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The indenture under which the 2030 Notes will be issued offers limited protection to holders of the 2030 Notes. The terms of the indenture and the 2030 Notes do not restrict our or any of our subsidiaries&#x2019; ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have an adverse impact on your investment in the 2030 Notes. In particular, the terms of the indenture and the 2030 Notes do not place any restrictions on our or our subsidiaries&#x2019; ability to:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;issue securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations that would be equal in right of payment to the 2030 Notes, (2)&#160;any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the 2030 Notes to the extent of the values of the assets securing such debt, (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank structurally senior to the 2030 Notes and (4)&#160;securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the 2030 Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the 2030 Notes, other than a distribution, dividend or purchase that would cause a violation of Section&#160;18(a)(1)(B)&#160;of the 1940 Act or any successor provisions;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;enter into transactions with affiliates;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

      &lt;div style="display:none"&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

      &lt;/div&gt;
    &lt;/div&gt;

      &lt;div&gt;&#160;&lt;/div&gt;

    &lt;div&gt;

        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;make investments; or&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;create restrictions on the payment of dividends or other amounts to us from our subsidiaries.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Furthermore, the terms of the indenture and the 2030 Notes do not protect holders of the 2030 Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity, except as required under the 1940 Act.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the 2030 Notes may have important consequences for you as a holder of the 2030 Notes, including making it more difficult for us to satisfy our obligations with respect to the 2030 Notes or negatively affecting the trading value of the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the 2030 Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the 2030 Notes.&lt;/p&gt;
        &lt;/div&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The optional redemption provision may materially adversely affect your return on the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes are redeemable in whole or in part at any time or from time to time on or after June 30, 2027 at our sole option at the redemption price set forth under the caption &#x201c;&lt;strong&gt;&lt;em&gt;Description of the Notes &#x2014; Optional Redemption&lt;/em&gt;&lt;/strong&gt;&#x201d; in this prospectus supplement. We may choose to redeem the 2030 Notes at times when prevailing interest rates are lower than the interest rate paid on the 2030 Notes. In this circumstance, you may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the 2030 Notes being redeemed.&lt;/p&gt;
        &lt;/div&gt;

      &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Any default under the agreements governing our indebtedness or under other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the 2030 Notes and substantially decrease the market value of the 2030 Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the 2030 Notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders of the debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating performance declines, we may in the future need to refinance or restructure our debt, including the 2030 Notes, sell assets, reduce or delay capital investments, seek to raise additional capital or seek to obtain waivers from the required lenders or holders of any debt that we may incur in the future to avoid being in default. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the 2030 Notes or our other debt. If we breach our covenants under our debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or holders. If this occurs, we would be in default and our lenders or debt holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because any future debt will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due.&lt;/p&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </cef:RiskFactorsTableTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreUnsecuredAndRankEquallyWithOtherUnsecuredDebtMember"
      id="Fxbrl_20241203045943756">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The 2030 Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur in the future and will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by and us and our general liabilities (total liabilities, less debt).&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the 2030 Notes are effectively subordinated to any secured indebtedness we may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the 2030 Notes. In addition, the 2030 Notes will rank pari&#160;passu with, or equal to, all outstanding and future unsecured indebtedness issued by us and our general liabilities (total liabilities, less debt).&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174Notes2030AreSubordinatedToSubsidiaryLiabilitiesMember"
      id="Fxbrl_20241203050000022">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The 2030 Notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will be obligations exclusively of Eagle Point Credit Company Inc. and not of any of our subsidiaries. None of our subsidiaries will be or will act as a guarantor of the 2030 Notes and the 2030 Notes will not be required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of any such subsidiary are not directly available to satisfy the claims of our creditors, including holders of the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the 2030 Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the 2030 Notes will be structurally subordinated to all indebtedness and other liabilities of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish.&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174NoActiveMarketMayDevelopFor2030NotesMember"
      id="Fxbrl_20241203050004350">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;There is no existing trading market for the 2030 Notes and, even if the NYSE approves the listing of the 2030 Notes, an active trading market for the 2030 Notes may not develop, which could limit your ability to sell the 2030 Notes and/or the market price of the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will be a new issue of debt securities for which there is no trading market. We intend to list the 2030 Notes on the NYSE within 30 days of the original issue date under the symbol &#x201c;ECCU.&#x201d; However, there is no assurance that the 2030 Notes will be approved for listing on the NYSE. Moreover, even if the listing of the 2030 Notes is approved, we cannot provide any assurances that an active trading market will develop or be maintained for the 2030 Notes or that you will be able to sell your 2030 Notes. If the 2030 Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the 2030 Notes, but they are not obligated to do so. The underwriters may discontinue any market-making activities in the 2030 Notes at any time at their sole discretion.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Accordingly, we cannot assure you that the 2030 Notes will be approved for listing on the NYSE, that a liquid trading market will develop or be maintained for the 2030 Notes, that you will be able to sell your 2030 Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the 2030 Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the 2030 Notes for an indefinite period of time.&lt;/p&gt;
      </cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174CreditRatingDowngradeMayImpactLiquidityAndValueMember"
      id="Fxbrl_20241203050011679">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;A downgrade, suspension or withdrawal of the credit rating assigned by a rating agency to us or the 2030 Notes, if any, or change in the debt markets could cause the liquidity or market value of the 2030 Notes to decline significantly.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Any credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in any credit ratings will generally affect the market value of the 2030 Notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the 2030 Notes. Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization in its sole discretion. Neither we nor any underwriter undertakes any obligation to obtain or maintain any credit ratings or to advise holders of 2030 Notes of any changes in any credit ratings. There can be no assurance that any credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the rating agencies if in their judgment future circumstances relating to the basis of the credit ratings, such as adverse changes in our Company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future, which could have an adverse effect on the market prices of the 2030 Notes.&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174IndentureOffersLimitedProtectionForHoldersMember"
      id="Fxbrl_20241203050019822">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The indenture under which the 2030 Notes will be issued contains limited protection for holders of the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The indenture under which the 2030 Notes will be issued offers limited protection to holders of the 2030 Notes. The terms of the indenture and the 2030 Notes do not restrict our or any of our subsidiaries&#x2019; ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have an adverse impact on your investment in the 2030 Notes. In particular, the terms of the indenture and the 2030 Notes do not place any restrictions on our or our subsidiaries&#x2019; ability to:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;issue securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations that would be equal in right of payment to the 2030 Notes, (2)&#160;any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the 2030 Notes to the extent of the values of the assets securing such debt, (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore would rank structurally senior to the 2030 Notes and (4)&#160;securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the 2030 Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section&#160;18(a)(1)(A)&#160;of the 1940 Act or any successor provisions;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;pay distributions or dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the 2030 Notes, other than a distribution, dividend or purchase that would cause a violation of Section&#160;18(a)(1)(B)&#160;of the 1940 Act or any successor provisions;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;enter into transactions with affiliates;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;make investments; or&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;create restrictions on the payment of dividends or other amounts to us from our subsidiaries.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Furthermore, the terms of the indenture and the 2030 Notes do not protect holders of the 2030 Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity, except as required under the 1940 Act.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the 2030 Notes may have important consequences for you as a holder of the 2030 Notes, including making it more difficult for us to satisfy our obligations with respect to the 2030 Notes or negatively affecting the trading value of the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the 2030 Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the 2030 Notes.&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174OptionalRedemptionMayNegativelyAffectReturnsMember"
      id="Fxbrl_20241203050027639">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;The optional redemption provision may materially adversely affect your return on the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes are redeemable in whole or in part at any time or from time to time on or after June 30, 2027 at our sole option at the redemption price set forth under the caption &#x201c;&lt;strong&gt;&lt;em&gt;Description of the Notes &#x2014; Optional Redemption&lt;/em&gt;&lt;/strong&gt;&#x201d; in this prospectus supplement. We may choose to redeem the 2030 Notes at times when prevailing interest rates are lower than the interest rate paid on the 2030 Notes. In this circumstance, you may not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the 2030 Notes being redeemed.&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="C_20241204to20241204_cefRiskAxis_ck0001604174DefaultOnOtherDebtMayPrevent2030NotesPaymentsMember"
      id="Fxbrl_20241203050033213">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the 2030 Notes.&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Any default under the agreements governing our indebtedness or under other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the 2030 Notes and substantially decrease the market value of the 2030 Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the 2030 Notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders of the debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating performance declines, we may in the future need to refinance or restructure our debt, including the 2030 Notes, sell assets, reduce or delay capital investments, seek to raise additional capital or seek to obtain waivers from the required lenders or holders of any debt that we may incur in the future to avoid being in default. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the 2030 Notes or our other debt. If we breach our covenants under our debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or holders. If this occurs, we would be in default and our lenders or debt holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because any future debt will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due.&lt;/p&gt;
        &lt;/div&gt;
      </cef:RiskTextBlock>
    <cef:LongTermDebtTitleTextBlock
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes66875Due2028Member"
      id="Fxbrl_20241203103148645">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;6.6875% Unsecured Notes due 2028&lt;/span&gt;</cef:LongTermDebtTitleTextBlock>
    <cef:LongTermDebtPrincipal
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes66875Due2028Member"
      decimals="0"
      id="Fxbrl_20241203043041984"
      unitRef="USD">32423800</cef:LongTermDebtPrincipal>
    <cef:LongTermDebtTitleTextBlock
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes5375Due2029Member"
      id="Fxbrl_20241203103331149">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;5.375% Unsecured Notes due 2029&lt;/span&gt;</cef:LongTermDebtTitleTextBlock>
    <cef:LongTermDebtPrincipal
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes5375Due2029Member"
      decimals="0"
      id="Fxbrl_20241203043126393"
      unitRef="USD">93250000</cef:LongTermDebtPrincipal>
    <cef:LongTermDebtTitleTextBlock
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes675Due2031Member"
      id="Fxbrl_20241203103437094">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;6.75% Unsecured Notes due 2031&lt;/span&gt;</cef:LongTermDebtTitleTextBlock>
    <cef:LongTermDebtPrincipal
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes675Due2031Member"
      decimals="0"
      id="Fxbrl_20241203043315048"
      unitRef="USD">44850000</cef:LongTermDebtPrincipal>
    <cef:LongTermDebtTitleTextBlock
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes775Due2030Member"
      id="Fxbrl_20241206110824109">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;7.75% Unsecured Notes due 2030&lt;/span&gt;</cef:LongTermDebtTitleTextBlock>
    <cef:LongTermDebtPrincipal
      contextRef="C_20240930to20240930_usgaapDebtInstrumentAxis_ck0001604174UnsecuredNotes775Due2030Member"
      decimals="0"
      id="Fxbrl_20241206110857069"
      unitRef="USD">0</cef:LongTermDebtPrincipal>
    <cef:LongTermDebtTableTextBlock
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203044735112">
        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="h_06"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;DESCRIPTION OF THE NOTES&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The following description of the particular terms of the 2030 Notes supplements and, to the extent inconsistent with, replaces the description of the general terms and provisions of our debt securities set forth in the accompanying prospectus.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes to be sold pursuant to this prospectus supplement will be issued under an indenture, dated as of December&#160;4, 2015, between us and Equiniti Trust Company, LLC (formerly known as American Stock Transfer&#160;&amp;amp; Trust Company, LLC), and a sixth supplemental indenture thereto, to be entered into between us and Equiniti Trust Company, LLC, as trustee. We refer to the indenture and the sixth supplemental indenture thereto collectively as the &#x201c;Indenture&#x201d; and to Equiniti Trust Company, LLC as the &#x201c;Trustee.&#x201d; The 2030 Notes are governed by the Indenture, as required by federal law for all bonds and notes of companies that are publicly offered. An indenture is a contract between us and the financial institution acting as trustee on your behalf, and is subject to, and governed by the Trust Indenture Act of 1939, as amended. The Trustee has two main roles. First, the Trustee can enforce your rights against us if we default. There are some limitations on the extent to which the Trustee acts on your behalf, described in the second paragraph under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Events of Default&#x2009;&#x2014;&#x2009;Remedies if an Event of Default Occurs&lt;/i&gt;&lt;/strong&gt;.&#x201d; Second, the Trustee performs certain administrative duties for us with respect to the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;This section includes a description of the material terms of the 2030 Notes and the Indenture. Because this section is a summary, however, it does not describe every aspect of the 2030 Notes and the Indenture. We urge you to read the Indenture because it, and not this description, defines your rights as a holder of the 2030 Notes. The Indenture has been attached as an exhibit to the registration statement of which this prospectus supplement forms a part and has been filed with the SEC. See &#x201c;&lt;strong&gt;&lt;i&gt;Additional Information&lt;/i&gt;&lt;/strong&gt;&#x201d; in this prospectus supplement for information on how to obtain a copy of the Indenture.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;General&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes initially are being offered in the aggregate principal amount of $100,000,000.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will mature on June 30, 2030 and 100% of the aggregate principal amount will be paid at maturity (unless the 2030 Notes are earlier redeemed as described below). The interest rate of the 2030 Notes is 7.75% per year and will be paid every March 31, June 30, September 30 and December 31. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment. Interest payments on the 2030 Notes offered by this prospectus supplement will commence on March 31, 2025. The regular record dates for interest payments will be every March 15, June 15, September 15 and December 15. The first record date for the 2030 Notes offered by this prospectus supplement will be March 15, 2024. If a record date for an interest payment falls on a non-business day, the record date will be the next business day. The initial interest period for the 2030 Notes offered by this prospectus supplement will be the period from and including &#160;December 10, 2024, to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.&lt;/p&gt;
            &lt;/div&gt;

          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;We will issue the 2030 Notes offered pursuant to this prospectus supplement in denominations of $25 and integral multiples of $25 in excess thereof. The 2030 Notes will not be subject to any sinking fund and holders of the 2030 Notes will not have the option to have the 2030 Notes repaid prior to June 30, 2030.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The Indenture does not contain any provisions that give you protection in the event we issue a large amount of debt. Other than the restrictions described under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Merger or Consolidation&lt;/i&gt;&lt;/strong&gt;,&#x201d; the Indenture does not contain any covenants or other provisions designed to afford holders of the 2030 Notes protection in the event we are acquired by another entity.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Pursuant to the Indenture, we have the ability, without the consent of the holders thereof, to reopen the 2030 Notes and issue additional 2030 Notes having identical terms and conditions as the 2030 Notes, except for the offering price and the issue date, in one or more series. We may also issue additional series of debt securities under the Indenture and other debt securities in accordance with the limitations of the 1940 Act. Under the 1940 Act, so long as any 2030 Notes are outstanding, additional debt securities, including the Existing Notes, must rank in parity with the 2030 Notes with respect to the payment of interest and as to the distribution of assets upon dissolution, liquidation or the winding-up of our affairs. In addition, we may also enter certain other evidences of indebtedness (including bank borrowings and commercial paper) representing senior securities. We may also borrow in amounts up to 5% of our total assets if the borrowing is for temporary purposes only (i.e., if it is to be repaid within 60&#160;days and not extended or renewed).&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Under the current requirements of the 1940 Act, immediately after issuing any senior securities representing indebtedness (i.e., indebtedness other than borrowings for temporary purposes), including the 2030 Notes and the Existing Notes, we must have an asset coverage of at least 300%. Asset coverage means the ratio which the value of our total assets (including the proceeds of indebtedness), less all liabilities and indebtedness not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness. Other types of borrowings also may result in our being subject to similar covenants in credit agreements.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;While any indebtedness and senior securities remain outstanding, we cannot make distributions to our stockholders or repurchase our capital stock unless we meet the applicable asset coverage requirements under the 1940 Act at the time of, and after giving effect to, the distribution or repurchase.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Ranking&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes are unsecured obligations of us and, upon our liquidation, dissolution or winding up, will rank (1)&#160;senior to the outstanding shares of our common stock and our preferred stock, (2)&#160;&lt;i&gt;pari&#160;passu&lt;/i&gt;&#160;(or equally) with our existing and future unsecured indebtedness, including the Existing Notes, (3)&#160;effectively subordinated to any existing or future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness and (4)&#160;structurally subordinated to all existing and future indebtedness of our subsidiaries, financing vehicles or similar facilities.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Optional Redemption&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes may be redeemed in whole or in part at any time or from time to time on or after June 30, 2027 at our option, upon not less than 30-days&#x2019; nor more than 60-days&#x2019; written notice by mail prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the aggregate principal amount thereof plus unpaid interest payable thereon accrued to, but excluding, the date fixed for redemption.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;You may be prevented from exchanging or transferring the 2030 Notes when they are subject to redemption. If the 2030 Notes become represented by certificates and, in case any 2030 Notes are to be redeemed in part only, the redemption notice will provide that, upon surrender of such 2030 Note, you will receive, without a charge, a new 2030 Note or 2030 Notes of authorized denominations representing the principal amount of your remaining unredeemed 2030 Notes. Any exercise of our option to redeem the 2030 Notes will be done in compliance with the 1940 Act.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If we redeem only some of the 2030 Notes, the Trustee will determine the method for selection of the particular 2030 Notes to be redeemed, in accordance with the Indenture and the rules&#160;of the NYSE. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the 2030 Notes called for redemption.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Global Securities&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;DTC will act as securities depository for the 2030 Notes. The 2030 Notes will initially be issued in the form of one or more fully registered 2030 Notes in global form, or &#x201c;Global Notes,&#x201d; registered in the name of Cede&#160;&amp;amp; Co. (DTC&#x2019;s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One Global Note will be issued for each issuance of the 2030 Notes, in the aggregate principal amount thereof, and will be deposited with DTC. As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all the 2030 Notes represented by a Global Note and investors will be permitted to own only beneficial interests in a Global Note. For more information about these arrangements, see &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Global Notes; Book-Entry&lt;/i&gt;&lt;/strong&gt;&#x201d; below and &#x201c;&lt;strong&gt;&lt;i&gt;Book-Entry Issuance&lt;/i&gt;&lt;/strong&gt;&#x201d; in the accompanying prospectus.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Termination of a Global Security&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If a global security is terminated for any reason, interests in it will be exchanged for certificates in non-book-entry form (certificated securities). After that exchange, the choice of whether to hold the certificated 2030 Notes directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in a global security transferred on termination to their own names, so that they will be holders. See &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Form, Exchange and Transfer of Certificated Registered Securities&lt;/i&gt;&lt;/strong&gt;.&#x201d;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Conversion and Exchange&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes are not convertible into or exchangeable for other securities.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Payment and Paying Agents&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;We will pay interest to the person listed in the Trustee&#x2019;s records as the owner of the 2030 Notes at the close of business on a particular day in advance of each due date for interest, even if that person no longer owns any of the 2030 Notes on the interest due date. That day, usually about two weeks in advance of the interest due date, is called the &#x201c;record date.&#x201d; Because we will pay all the interest for an interest period to the holders on the record date, holders buying and selling the 2030 Notes must work out between themselves the appropriate purchase price. The most common manner is to adjust the sales price of the 2030 Notes to prorate interest fairly between buyer and seller based on their respective ownership periods within the particular interest period. This prorated interest amount is called &#x201c;accrued interest.&#x201d;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Payments on Global Securities&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;We will make payments on the 2030 Notes so long as they are represented by Global Notes in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the Global Notes. An indirect holder&#x2019;s right to those payments will be governed by the rules&#160;and practices of the depositary and its participants, as described under &#x201c;&lt;strong&gt;&lt;i&gt;Book-Entry Issuance&lt;/i&gt;&lt;/strong&gt;&#x201d; in the accompanying prospectus.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Payments on Certificated Securities&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;In the event the 2030 Notes become represented by certificates, we will make payments on the 2030 Notes as follows. We will pay interest that is due on an interest payment date by a check mailed on the interest payment date to the holder of the 2030 Notes at his or her address shown on the Trustee&#x2019;s records as of the close of business on the record date. We will make all payments of principal and premium, if any, by check at the office of the Trustee in Brooklyn, New York and/or at other offices that may be specified in the Indenture or a notice to holders against surrender of the 2030 Note.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Alternatively, if the holder asks us to do so, we will pay any amount that becomes due on the 2030 Notes by wire transfer of immediately available funds to an account at a bank in the United States, on the due date. To request payment by wire, the holder must give the Trustee appropriate transfer instructions at least 15 business days before the requested wire payment is due. In the case of any interest payment due on an interest payment date, the instructions must be given by the person who is the holder on the relevant regular record date. Any wire instructions, once properly given, will remain in effect unless and until new instructions are given in the manner described above.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Payment When Offices Are Closed&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If any payment is due on the 2030 Notes on a day that is not a business day, we will make the payment on the next day that is a business day. Payments made on the next business day in this situation will be treated under the Indenture as if they were made on the original due date. Such payment will not result in a default under the 2030 Notes or the Indenture, and no interest will accrue on the payment amount from the original due date to the next day that is a business day.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Events of Default&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;You will have rights if an Event of Default occurs in respect of the 2030 Notes and is not cured, as described later in this subsection. The term &#x201c;Event of Default&#x201d; in respect of the 2030 Notes means any of the following:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;We do not pay the principal of, or any premium on, any 2030 Note when due and payable, and such default is not cured within five days.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;We do not pay interest on any 2030 Note when due, and such default is not cured within 30&#160;days.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;We remain in breach of any other covenant with respect to the 2030 Notes for 60&#160;days after we receive a written notice of default stating we are in breach. The notice must be sent by either the Trustee or holders of at least 25% of the principal amount of the 2030 Notes.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;We file for bankruptcy, or certain other events of bankruptcy, insolvency or reorganization occur, and in the case of certain orders or decrees entered against us under any bankruptcy law, such order or decree remains undischarged or unstayed for a period of 90&#160;days.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;On the last business day of each of twenty-four consecutive calendar&#160;months, all series of our debt securities issued under the Indenture together have an asset coverage, as defined in the 1940 Act, of less than 100% after giving effect to exemptive relief, if any, granted to us by the SEC.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;An Event of Default for the 2030 Notes does not necessarily constitute an Event of Default for any other series of debt securities issued under the same or any other indenture. The Trustee may withhold notice to the holders of the 2030 Notes of any default, except in the payment of principal or interest, if it in good faith considers the withholding of notice to be in the best interests of the holders.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Remedies if an Event of Default Occurs&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If an Event of Default has occurred and is continuing, the following remedies are available. The Trustee or the holders of not less than 25% in principal amount of the 2030 Notes may declare the entire principal amount of all of the 2030 Notes to be due and immediately payable. This is called a declaration of acceleration of maturity. In certain circumstances, a declaration of acceleration of maturity may be canceled by the holders of a majority in principal amount of the 2030 Notes if (1)&#160;we have deposited with the Trustee all amounts due and owing with respect to the 2030 Notes (other than principal that has become due solely by reason of such acceleration) and certain other amounts, and (2)&#160;any other Events of Default have been cured or waived.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The Trustee is not required to take any action under the Indenture at the request of any holders unless the holders offer the Trustee protection from expenses and liability reasonably satisfactory to it (called an &#x201c;indemnity&#x201d;). If indemnity reasonably satisfactory to the Trustee is provided, the holders of a majority in principal amount of the 2030 Notes may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the Trustee. The Trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Before you are allowed to bypass the Trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the 2030 Notes, the following must occur:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;you must give the Trustee written notice that an Event of Default has occurred and remains uncured;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;the holders of at least 25% in principal amount of the 2030 Notes must make a written request that the Trustee take action because of the default and must offer the Trustee reasonable indemnity, security or both against the cost and other liabilities of taking that action;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;the Trustee must not have taken action for 60&#160;days after receipt of the above notice and offer of indemnity and/or security; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;the holders of a majority in principal amount of the 2030 Notes must not have given the Trustee a direction inconsistent with the above notice during that 60-day period.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;However, you are entitled at any time to bring a lawsuit for the payment of money due on your 2030 Notes on or after the due date thereof.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Book-entry and other indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the Trustee and how to declare or cancel an acceleration of maturity.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Each year, we will furnish to the Trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the Indenture and the 2030 Notes, or else specifying any default.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Waiver of Default&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The holders of a majority in principal amount of the 2030 Notes may waive any past defaults other than a default:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;in the payment of principal or interest; or&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;in respect of a covenant that cannot be modified or amended without the consent of each holder.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Merger or Consolidation&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Under the terms of the Indenture, we are generally permitted to consolidate or merge with another entity. We are also permitted to sell all or substantially all of our assets to another entity. However, we may not take any of these actions unless all the following conditions are met:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;where we merge out of existence or convey or transfer all of our assets, the resulting entity must agree to be legally responsible for our obligations under the 2030 Notes;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;immediately after the transaction, no Default or Event of Default will have happened and be continuing; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;we must deliver certain certificates and documents to the Trustee.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Modification or Waiver&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;There are three types of changes we can make to the Indenture and the 2030 Notes.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Changes Requiring Your Approval&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;First, there are changes that we cannot make to your 2030 Notes without your specific approval. The following is a list of those types of changes:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;change the stated maturity of the principal of or interest on the 2030 Notes;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;reduce any amounts due on the 2030 Notes;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;reduce the amount of principal payable upon acceleration of the maturity of a 2030 Note following a default;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;change the place or currency of payment on a 2030 Note;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;impair your right to sue for payment on the 2030 Notes following the date on which such amount is due and payable;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;reduce the&#160;percentage in principal amount of holders of 2030 Notes whose consent is needed to modify or amend the Indenture;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;reduce the&#160;percentage in principal amount of holders of 2030 Notes whose consent is needed to waive compliance with certain provisions of the Indenture or to waive certain defaults; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;modify any other aspect of the provisions of the Indenture dealing with supplemental indentures, waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Changes Not Requiring Approval&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The second type of change does not require any vote by the holders of the 2030 Notes. This type is limited to clarifications and certain other changes that would not materially adversely affect holders of the 2030 Notes in any material respect. We also do not need any approval to make any change that affects only 2030 Notes to be issued under the Indenture after the change takes effect.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Changes Requiring Majority Approval&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Any other change to the Indenture and the 2030 Notes would require the following approval:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;if the change affects only the 2030 Notes, it must be approved by the holders of a majority in principal amount of the 2030 Notes; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;if the change affects more than one series of debt securities issued under the Indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In each case, the required approval must be given by either written consent or written ballot.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The holders of a majority in principal amount of all of the series of debt securities issued under the Indenture, voting together as one class for this purpose, may waive our compliance with some of our covenants in the Indenture. However, we cannot obtain a waiver of a payment default or of any of the matters covered by the bullet points included above under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Changes Requiring Your Approval&lt;/i&gt;&lt;/strong&gt;.&#x201d;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Further Details Concerning Voting&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;When taking a vote, we will use the following rules&#160;to decide how much principal to attribute to the 2030 Notes:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption. The 2030 Notes will also not be eligible to vote if they have been fully defeased as described later under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Defeasance&#x2009;&#x2014;&#x2009;Full Defeasance&lt;/i&gt;&lt;/strong&gt;.&#x201d;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;We will generally be entitled to set any day as a record date for the purpose of determining the holders of the 2030 Notes that are entitled to vote or take other action under the Indenture. However, the record date may not be more than 30&#160;days before the date of the first solicitation of holders to vote on or take such action and not later than the date on which solicitation is completed. If we set a record date for a vote or other action to be taken by holders of the 2030 Notes, that vote or action may be taken only by persons who are holders of the 2030 Notes on the record date and must be taken within eleven&#160;months following the record date.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Book-entry and other indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change the Indenture or the 2030 Notes or request a waiver.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Satisfaction and Discharge; Defeasance&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;We may satisfy and discharge our obligations under the Indenture by delivering to the Trustee for cancellation all outstanding 2030 Notes or by depositing with the Trustee after the 2030 Notes have become due and payable, or otherwise, moneys sufficient to pay all of the outstanding 2030 Notes and paying all other sums payable under the Indenture by us. Such discharge is subject to terms contained in the Indenture.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Defeasance&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The following defeasance provisions will be applicable to the 2030 Notes. &#x201c;Defeasance&#x201d; means that, by depositing with the Trustee an amount of cash and/or government securities sufficient to pay all principal and interest, if any, on the 2030 Notes when due and satisfying any additional conditions noted below, we will be deemed to have been discharged from our obligations under the 2030 Notes. In the event of a &#x201c;covenant defeasance,&#x201d; upon depositing such funds and satisfying similar conditions discussed below we would be released from certain covenants under the Indenture relating to the 2030 Notes. The consequences to the holders of the 2030 Notes would be that, while they would no longer benefit from certain covenants under the Indenture, and while the 2030 Notes could not be accelerated for any reason, the holders of 2030 Notes nonetheless would be guaranteed to receive the principal and interest owed to them.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Covenant Defeasance&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Under current U.S. federal income tax law and the Indenture, we can make the deposit described below and be released from some of the restrictive covenants in the Indenture under which the 2030 Notes were issued. This is called &#x201c;covenant defeasance.&#x201d; In that event, you would lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside in trust to repay your 2030 Notes. In order to achieve covenant defeasance, the following must occur:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;since the 2030 Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the 2030 Notes a combination of cash and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the 2030 Notes on their various due dates;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;we must deliver to the Trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the 2030 Notes any differently than if we did not make the deposit and just repaid the debt securities ourselves at maturity;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;we must deliver to the Trustee a legal opinion and officers&#x2019; certificate stating that all conditions precedent to covenant defeasance have been complied with;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;defeasance must not result in a breach or violation of, or result in a default under, the Indenture or any of our other material agreements or instruments; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;no default or Event of Default with respect to the 2030 Notes shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization shall occur during the next 90&#160;days.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If we accomplish covenant defeasance, you can still look to us for repayment of the 2030 Notes if there were a shortfall in the trust deposit or the Trustee is prevented from making payment. In fact, if one of the remaining Events of Default occurred (such as our bankruptcy) and the 2030 Notes became immediately due and payable, there might be a shortfall. Depending on the event causing the default, you may not be able to obtain payment of the shortfall.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;i&gt;Full Defeasance&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If there is a change in U.S. federal income tax law, as described below, we can legally release ourselves from all payment and other obligations on the 2030 Notes (called &#x201c;full defeasance&#x201d;) if we put in place the following other arrangements for you to be repaid:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;since the 2030 Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the 2030 Notes a combination of money and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the 2030 Notes on their various due dates;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;we must deliver to the Trustee a legal opinion confirming that there has been a change in current U.S. federal income tax law or an IRS ruling that allows us to make the above deposit without causing you to be taxed on the 2030 Notes any differently than if we did not make the deposit. Under current U.S. federal income tax law the deposit and our legal release from the 2030 Notes would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your 2030 Notes and you would recognize gain or loss on the 2030 Notes at the time of the deposit;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;we must deliver to the Trustee a legal opinion and officers&#x2019; certificate stating that all conditions precedent to defeasance have been complied with;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;defeasance must not result in a breach or violation of, or constitute a default under, the Indenture or any of our other material agreements or instruments; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;no default or Event of Default with respect to the 2030 Notes shall have occurred and be continuing and no defaults or Events of Default related to bankruptcy, insolvency or reorganization shall occur during the next 90&#160;days.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If we ever did accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the 2030 Notes. You could not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever became bankrupt or insolvent. If your 2030 Notes were effectively subordinated as described under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Ranking&lt;/i&gt;&lt;/strong&gt;,&#x201d; such subordination would not prevent the Trustee under the Indenture from applying the funds available to it from the deposit referred to in the first bullet of the preceding paragraph to the payment of amounts due in respect of such 2030 Notes for the benefit of the subordinated debtholders.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;

            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Covenants&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;In addition to any other covenants described in the accompanying prospectus, as well as standard covenants relating to payment of principal and interest, maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following covenants will apply to the 2030 Notes:&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes remain outstanding, our payment obligations under the Indenture and the 2030 Notes will at all times rank&#160;&lt;i&gt;pari&#160;passu&lt;/i&gt;, without preference or priority, with all of our existing and future unsecured indebtedness and senior to any preferred stock we may issue.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with respect to such borrowings equals at least 300% after such borrowings. See &#x201c;&lt;strong&gt;&lt;i&gt;Risk Factors&#x2009;&#x2014;&#x2009;Risks Relating to Our Investments&#x2009;&#x2014;&#x2009;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us&lt;/i&gt;&lt;/strong&gt;&#x201d; in the accompanying prospectus.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#x2019;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our preferred stock as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

          &lt;div style="display:none"&gt;

              &lt;div&gt;&#160;&lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;If, at any time, we are not subject to the reporting requirements of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we agree to furnish to holders of the 2030 Notes and the Trustee, for the period of time during which the 2030 Notes are outstanding, our audited annual consolidated financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements, within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance with applicable GAAP.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Form, Exchange and Transfer of Certificated Registered Securities&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;2030 Notes in physical, certificated form will be issued and delivered to each person that DTC identifies as a beneficial owner of the related 2030 Notes only if:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;DTC notifies us at any time that it is unwilling or unable to continue as depositary for the Global Notes and a successor depositary is not appointed within 90&#160;days; or&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;DTC ceases to be registered as a clearing agency under the Exchange Act and a successor depositary is not appointed within 90&#160;days.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Holders may exchange their certificated securities for 2030 Notes of smaller denominations or combined into fewer 2030 Notes of larger denominations, as long as the total principal amount is not changed and as long as the denomination is equal to or greater than $25.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Holders may exchange or transfer their certificated securities at the office of the Trustee. We have appointed the Trustee to act as our agent for registering 2030 Notes in the names of holders transferring 2030 Notes. We may appoint another entity to perform these functions or perform them ourselves.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Holders will not be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange will be made only if our transfer agent is satisfied with the holder&#x2019;s proof of legal ownership.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;We may appoint additional transfer agents or cancel the appointment of any particular transfer agent. We may also approve a change in the office through which any transfer agent acts.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;If we redeem any of the 2030 Notes, we may block the transfer or exchange of those 2030 Notes selected for redemption during the period beginning 15&#160;days before the day we mail the notice of redemption and ending on the day of that mailing, in order to determine and fix the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of any certificated 2030 Notes selected for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any 2030 Note that will be partially redeemed.&lt;/p&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Resignation of Trustee&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The Trustee may resign or be removed with respect to the 2030 Notes, provided that a successor trustee is appointed to act with respect to the 2030 Notes. In the event that two or more persons are acting as trustee with respect to different series of indenture securities under the Indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any other trustee.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Concerning the Trustee&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The Trustee serves as trustee for the Existing Notes, transfer agent for our common stock and Preferred Stock and agent for our dividend reinvestment plan. We will appoint the Trustee as registrar and paying agent under the Indenture.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Governing Law&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The Indenture and the 2030 Notes will be governed by, and construed in accordance with, the laws of the State of New York.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Global Notes; Book-Entry&lt;/strong&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;i&gt;Global Notes&lt;/i&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Ownership of beneficial interests in a Global Note will be limited to persons who have accounts with DTC, or the DTC participants, or persons who hold interests through DTC participants. We expect that under procedures established by DTC:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;upon deposit of a Global Note with DTC&#x2019;s custodian, DTC will credit portions of the principal amount of the Global Note to the accounts of the DTC participants designated by the underwriters, if applicable; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;ownership of beneficial interests in a Global Note will be shown on, and transfer of ownership of those interests will be effected only through, records maintained by DTC (with respect to interests of DTC participants) and the records of DTC participants (with respect to other owners of beneficial interests in the Global Note).&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Beneficial interests in Global Notes may not be exchanged for 2030 Notes in physical, certificated form except in the limited circumstances described under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Form, Exchange and Transfer of Certificated Registered Securities&lt;/i&gt;&lt;/strong&gt;.&#x201d;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;i&gt;Book-Entry Procedures for Global Notes&lt;/i&gt;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;All interests in the Global Notes will be subject to the operations and procedures of DTC. The operations and procedures of DTC are controlled by that settlement system and may be changed at any time. Neither we nor the underwriters are responsible for those operations or procedures. See &#x201c;&lt;strong&gt;&lt;i&gt;Book-Entry Issuance&lt;/i&gt;&lt;/strong&gt;&#x201d; in the accompanying prospectus for a description of DTC&#x2019;s operations and procedures.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;So long as DTC&#x2019;s nominee is the registered owner of a Global Note, that nominee will be considered the sole owner or holder of the 2030 Notes represented by that Global Note for all purposes under the Indenture. Except as provided under &#x201c;&lt;strong&gt;&lt;i&gt;&#x2014; Form, Exchange and Transfer of Certificated Registered Securities&lt;/i&gt;&lt;/strong&gt;,&#x201d; owners of beneficial interests in a Global Note:&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;will not be entitled to have 2030 Notes represented by the Global Note registered in their names;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;will not receive or be entitled to receive physical, certificated 2030 Notes; and&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

          &lt;div&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

              &lt;tr style="vertical-align:top"&gt;
                &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="text-align:justify"&gt;will not be considered the owners or holders of the 2030 Notes under the Indenture for any purpose, including with respect to the giving of any direction, instruction or approval to the Trustee under the Indenture.&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;As a result, each investor who owns a beneficial interest in a Global Note must rely on the procedures of DTC to exercise any rights of a holder of 2030 Notes under the Indenture (and, if the investor is not a participant or an indirect participant in DTC, on the procedures of the DTC participant through which the investor owns its interest). Payments of principal and interest with respect to the 2030 Notes represented by a Global Note will be made by the Trustee to DTC&#x2019;s nominee as the registered holder of the Global Note. Neither we nor the Trustee will have any responsibility or liability for the payment of amounts to owners of beneficial interests in a Global Note, for any aspect of the records relating to or payments made on account of those interests by DTC, or for maintaining, supervising or reviewing any records of DTC relating to those interests.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Payments by participants and indirect participants in DTC to the owners of beneficial interests in a Global Note will be governed by standing instructions and customary industry practice and will be the responsibility of those participants or indirect participants and DTC.&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;Transfers between participants in DTC will be effected under DTC&#x2019;s procedures and will be settled in same-day funds.&lt;/p&gt;
        &lt;/div&gt;
      </cef:LongTermDebtTableTextBlock>
    <cef:LongTermDebtTitleTextBlock
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203044425896">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;DESCRIPTION OF THE NOTES&lt;/span&gt;</cef:LongTermDebtTitleTextBlock>
    <cef:LongTermDebtStructuringTextBlock
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203113713500">
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes initially are being offered in the aggregate principal amount of $100,000,000.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;The 2030 Notes will mature on June 30, 2030 and 100% of the aggregate principal amount will be paid at maturity (unless the 2030 Notes are earlier redeemed as described below). The interest rate of the 2030 Notes is 7.75% per year and will be paid every March 31, June 30, September 30 and December 31. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment. Interest payments on the 2030 Notes offered by this prospectus supplement will commence on March 31, 2025. The regular record dates for interest payments will be every March 15, June 15, September 15 and December 15. The first record date for the 2030 Notes offered by this prospectus supplement will be March 15, 2024. If a record date for an interest payment falls on a non-business day, the record date will be the next business day. The initial interest period for the 2030 Notes offered by this prospectus supplement will be the period from and including &#160;December 10, 2024, to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.&lt;/p&gt;
            &lt;/div&gt;
          </cef:LongTermDebtStructuringTextBlock>
    <cef:LongTermDebtPrincipal
      contextRef="C_20241204to20241204_usgaapDebtInstrumentAxis_ck0001604174Notes2030Member"
      decimals="0"
      id="Fxbrl_20241206151452562"
      unitRef="USD">100000000</cef:LongTermDebtPrincipal>
    <cef:LongTermDebtDividendsAndCovenantsTextBlock
      contextRef="C_20241204to20241204"
      id="Fxbrl_20241203114027683">
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Covenants&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"&gt;In addition to any other covenants described in the accompanying prospectus, as well as standard covenants relating to payment of principal and interest, maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by us and related matters, the following covenants will apply to the 2030 Notes:&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes remain outstanding, we will remain a closed-end management investment company for purposes of the 1940 Act.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes remain outstanding, our payment obligations under the Indenture and the 2030 Notes will at all times rank&#160;&lt;i&gt;pari&#160;passu&lt;/i&gt;, without preference or priority, with all of our existing and future unsecured indebtedness and senior to any preferred stock we may issue.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(A)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC, if any. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, with respect to such borrowings equals at least 300% after such borrowings. See &#x201c;&lt;strong&gt;&lt;i&gt;Risk Factors&#x2009;&#x2014;&#x2009;Risks Relating to Our Investments&#x2009;&#x2014;&#x2009;We may leverage our portfolio, which would magnify the potential for gain or loss on amounts invested and will increase the risk of investing in us&lt;/i&gt;&lt;/strong&gt;&#x201d; in the accompanying prospectus.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;We agree that, for the period of time during which the 2030 Notes are outstanding, we will not violate Section&#160;18(a)(1)(B)&#160;of the 1940 Act, as modified by the other provisions of Section&#160;18, or any successor provisions, whether or not we continue to be subject to such provisions of the 1940 Act, giving effect to (i)&#160;any exemptive relief granted to us by the SEC, if any, and (ii)&#160;no-action relief granted by the SEC to another closed-end investment company (or to us if we determine to seek such similar no-action or other relief) permitting the closed-end investment company to declare any cash dividend or distribution notwithstanding the prohibition contained in Section&#160;18(a)(1)(B)&#160;of the 1940 Act in order to maintain the closed-end investment company&#x2019;s status as a RIC under Subchapter M of the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, with respect to our borrowings or other indebtedness is below 300% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase (provided that we may declare dividends on our preferred stock as long as such asset coverage with respect to our borrowings or other indebtedness is not below 200%).&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

              &lt;div&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%"&gt;

                  &lt;tr style="vertical-align:top"&gt;
                    &lt;td style="width:0.25in"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:justify"&gt;If, at any time, we are not subject to the reporting requirements of Sections&#160;13 or 15(d)&#160;of the Exchange Act to file any periodic reports with the SEC, we agree to furnish to holders of the 2030 Notes and the Trustee, for the period of time during which the 2030 Notes are outstanding, our audited annual consolidated financial statements, within 60&#160;days after the close of our fiscal year end, and our unaudited interim consolidated financial statements, within 60&#160;days after the close of our second fiscal quarter end. All such financial statements will be prepared, in all material respects, in accordance with applicable GAAP.&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </cef:LongTermDebtDividendsAndCovenantsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
